Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,amino acid import across plasma membrane (GO:0089718),-0.6820474324234755,-2.0686506708903005,0.0,0.09793203971941332,0.083,9/24,5.61%,SLC1A3;SLC6A13;SLC47A1;SLC1A5;SLC6A9;SLC1A2;SLC7A5;SLC6A6;SLC1A1
prerank,negative regulation of endothelial cell migration (GO:0010596),-0.6105238164232758,-2.067623537063945,0.0,0.04896601985970666,0.083,15/36,9.23%,PTPRM;DCN;SP100;NR2F2;ADAMTS9;ACVRL1;NOTCH1;FGF2;DAB2IP;THBS1;RGCC;SLIT2;TGFB1;MECP2;PPARG
prerank,vascular transport (GO:0010232),-0.519445959830297,-2.0500729328134475,0.0,0.0445454764001498,0.113,27/81,10.11%,SLC24A3;SLC1A3;SLC6A13;LEPR;SLC13A3;SLC16A12;INSR;ABCC4;SLC2A1;SLCO2B1;SLCO1C1;SLC1A5;SLC6A9;SLC1A2;SLC7A5;SLCO3A1;ABCC9;SLC12A2;SLC6A6;SLC2A13;SLC1A1;TFRC;ATP8A1;SLC16A1;SLC6A1;SLC29A1;SLC16A7
prerank,positive regulation of nuclear division (GO:0051785),-0.6685442231117305,-2.0342370083959636,0.0,0.04106004790319152,0.135,11/25,17.58%,IGF1;PDGFRB;TGFA;INSR;RGCC;IGF2;LRP5;EDN1;SIRT2;EDN3;EGF
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.6113613468482979,-2.034060177034699,0.0,0.032848038322553216,0.135,11/33,7.20%,PTPRM;PTPRG;DCN;MCC;SP100;NR2F2;ADAMTS9;ACVRL1;DAB2IP;THBS1;SLIT2
prerank,transport across blood-brain barrier (GO:0150104),-0.5151090985496399,-2.0212211659112045,0.0,0.03349411775125768,0.161,27/83,10.11%,SLC24A3;SLC1A3;SLC6A13;LEPR;SLC13A3;SLC16A12;INSR;ABCC4;SLC2A1;SLCO2B1;SLCO1C1;SLC1A5;SLC6A9;SLC1A2;SLC7A5;SLCO3A1;ABCC9;SLC12A2;SLC6A6;SLC2A13;SLC1A1;TFRC;ATP8A1;SLC16A1;SLC6A1;SLC29A1;SLC16A7
prerank,vitamin D metabolic process (GO:0042359),0.9205645697081528,2.006209291192714,0.0,0.43456875127437566,0.27,1/13,0.03%,CUBN
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.8511138773579735,-2.0002727382482393,0.0,0.03847330131834094,0.208,6/10,4.50%,RAPGEF2;LYN;CXCL12;GAS6;AXL;LGALS9
prerank,cell-substrate junction assembly (GO:0007044),0.778634297749052,1.9819570124979313,0.001272264631043257,0.36313279216077965,0.405,5/33,1.11%,FN1;ITGB4;SORBS1;ACTN2;LAMC2
prerank,aorta development (GO:0035904),-0.7415694000249998,-1.9805719355529292,0.0,0.04348284576083326,0.261,9/14,13.45%,PDGFRB;JAG1;ADAMTS9;ROBO1;PKD2;ROBO2;TBX2;PDE2A;TBX1
prerank,cobalamin metabolic process (GO:0009235),0.8400710964805469,1.9328672069272494,0.0,0.624072476145165,0.684,2/17,2.69%,CUBN;AMN
prerank,regulation of acrosome reaction (GO:0060046),-0.7897469741578415,-1.9250857020445091,0.0024271844660194173,0.08501045114532406,0.495,2/10,7.24%,PLCB1;GLRA1
prerank,tetrapyrrole metabolic process (GO:0033013),0.8253542923586757,1.917047748778738,0.0015037593984962407,0.6292813481638647,0.776,2/18,2.69%,CUBN;AMN
prerank,ganglioside biosynthetic process (GO:0001574),-0.6930626202269371,-1.905010402973505,0.002680965147453083,0.10119644104339376,0.591,8/15,17.07%,ST6GALNAC3;ST3GAL1;ST3GAL5;ST8SIA4;ST6GALNAC5;ST8SIA6;B4GALT5;ST8SIA2
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.6555469354761327,1.8970581475052353,0.0,0.7105893599605202,0.862,7/76,1.72%,ADRA1B;AGTR1;GPR4;LPAR1;CHRM1;ACTN2;LPAR4
prerank,aorta morphogenesis (GO:0035909),-0.6776594825206617,-1.8945950916094103,0.0,0.10720590711708504,0.646,6/17,3.01%,PDGFRB;JAG1;ENG;ADAMTS9;MYLK;ACVRL1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.7509213519314064,-1.8902699353149053,0.0,0.10337270859271405,0.661,6/12,7.45%,ADAMTS12;DCN;SEMA6A;XDH;DAB2IP;PIK3CB
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.7767296607020671,-1.8854585088044873,0.002564102564102564,0.10036464647526414,0.672,5/11,4.58%,MECOM;ETV6;WNT5A;CD34;RUNX1
prerank,steroid metabolic process (GO:0008202),0.6574490671870853,1.8718415909941837,0.0012048192771084338,0.869798946614618,0.933,12/72,8.74%,CUBN;SULT1A1;FDFT1;STARD3;SULT2B1;HSD17B14;DHRS4;NPC1;CYP39A1;CYP51A1;MSMO1;FDX1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.8914277830283216,1.8595807044717538,0.0016286644951140066,0.8950755591316641,0.945,3/10,1.66%,DPP4;CCL5;PODXL
prerank,heart morphogenesis (GO:0003007),-0.5062615275575783,-1.8531528822564602,0.0,0.14194316471236396,0.811,17/50,14.11%,FLRT2;ENG;INSR;NOS3;PTK2;ACVRL1;TBX3;NOTCH1;EPHB4;CHD7;SOX17;HEYL;TBX2;MEGF8;TBX1;NIPBL;RYR2
prerank,heterotypic cell-cell adhesion (GO:0034113),0.7487030000549829,1.8529486673451294,0.009589041095890411,0.8558672809773021,0.955,6/25,2.84%,CXADR;DSG2;PARVA;CD200;NINJ1;ITGB7
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.8644208271008317,1.842254510439685,0.003205128205128205,0.8767441093062176,0.97,1/11,0.18%,AGTR1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.7746756748891043,-1.840424640399985,0.0049504950495049506,0.15281478697883455,0.846,5/10,7.45%,DCN;SEMA6A;XDH;DAB2IP;PIK3CB
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.760814873747199,1.8356735303926914,0.0028776978417266188,0.8595134913903918,0.977,4/27,1.72%,AGTR1;GPR4;LPAR1;LPAR4
prerank,sulfation (GO:0051923),0.8553853198694557,1.8319622896134728,0.0033613445378151263,0.8162821085581362,0.982,3/11,3.24%,UST;SULT1A1;SULT2B1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.5754958025136864,-1.8313938523211641,0.0035335689045936395,0.15977714292763656,0.875,20/27,29.11%,FLT1;PDGFRB;PRKD1;TEK;PTK2;PDGFRA;FGF2;TGFB1;KIT;EPHA8;P2RY12;FLT3;CCL19;NOD2;FGFR3;AGAP2;FGR;AMBRA1;IRS1;ATG14
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.7312477121311245,1.82508129453027,0.005449591280653951,0.8179582679523208,0.985,6/30,2.55%,GPR4;LPAR1;RTN4R;PRAG1;LPAR4;AKAP13
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.7704792624551896,-1.8246476459053766,0.0,0.16280001455806883,0.895,7/10,13.69%,GHR;LYN;STAT5B;JAK2;STAT5A;STAT3;STAT6
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.5014585411766106,-1.8244651964048542,0.0,0.15392559020713342,0.895,18/43,16.84%,BMP6;IGF1;PRKD1;WNT4;ZHX3;BMPR1B;RUNX2;FBN2;IL6R;ACVR2A;LRP5;CCN4;IL6ST;CCN1;BMPR2;CTNNBIP1;SOX11;SUCO
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.7918117259531228,1.8229404619949385,0.0015037593984962407,0.7770950167677719,0.985,3/17,2.55%,ADRA1B;ADCY9;AKAP13
prerank,positive regulation of cell junction assembly (GO:1901890),-0.4833030082585115,-1.8201919705192668,0.0,0.15264297638283555,0.908,21/56,13.96%,PTPRJ;IL1RAPL1;CNTNAP2;TEK;NRXN1;CLDN5;GRID2;KDR;TSC1;EPHB2;CLSTN2;NLGN1;ROCK1;LRRC4B;MAP4K4;DLG5;MYOC;NLGN3;SYNDIG1;BDNF;SRPX2
prerank,cell-matrix adhesion (GO:0007160),0.6152492851808237,1.8178530895791971,0.0,0.769495678626414,0.988,12/95,2.84%,FN1;ITGB4;SORBS1;ITGA10;MSLN;CD44;ITGB8;LYPD5;ACTN2;ITGBL1;EMP2;ITGB7
prerank,sarcomere organization (GO:0045214),0.7200767967046433,1.8141409062431115,0.007052186177715092,0.7508051591652113,0.989,4/27,3.66%,MYOM2;KRT19;ACTN2;CSRP3
prerank,myofibril assembly (GO:0030239),0.6738277112045459,1.8135552565204303,0.002577319587628866,0.7095227814043102,0.989,8/42,5.09%,PGM5;MYOM2;KRT19;ACTN2;TMOD3;TMOD2;CSRP3;LMOD3
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.6315416322060822,1.8037445364384233,0.00117096018735363,0.7459921808741701,0.994,21/67,16.81%,FN1;CDH13;UTRN;DOCK5;EMP2;CDK6;LIMS2;S100A10;PTK2B;DMTN;ILK;CDC42;NPNT;DOCK1;RREB1;SFRP1;GSK3B;FLNA;TESK1;CRK;ABL1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.7314071175072849,-1.8024000952606798,0.0024752475247524753,0.17831792232243174,0.937,4/11,1.02%,PLCB1;IGF1;GHR;PIK3R1
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.8156239116341207,1.7999226471259848,0.004777070063694267,0.7356360419213366,0.995,4/12,5.33%,CLU;LDLR;PFDN1;CRYAB
prerank,positive regulation of nervous system development (GO:0051962),-0.5152283734849985,-1.7995970699625423,0.0,0.17517010676002204,0.939,20/42,20.54%,IL1RAPL1;NRXN1;GRID2;TGM2;EPHB2;CLSTN2;SERPINF1;NLGN1;LRRC4B;DLG5;NLGN3;SYNDIG1;BDNF;MME;SRPX2;SOX11;EPHB3;NUMB;OPRM1;CX3CR1
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.7730850235561405,-1.799007566449076,0.0024691358024691358,0.16822795459376494,0.939,5/10,9.87%,BMP6;NEXMIF;NOTCH1;RGCC;NOTCH4
prerank,endothelial cell differentiation (GO:0045446),-0.7192290572121097,-1.7946913094385437,0.0,0.16769974736372362,0.944,8/12,17.15%,JAG1;ACVRL1;TIE1;KDR;KDM6B;SCUBE1;BMPR2;SOX18
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.5359012064664262,-1.7944700102047555,0.0,0.16126482582267976,0.944,12/34,17.58%,IGF1;PDGFRB;TGFA;INSR;ANAPC11;RGCC;IGF2;LRP5;ANAPC7;EDN1;EDN3;EGF
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.8025323284967207,1.7937251751713401,0.006535947712418301,0.7459522484924845,0.995,3/14,1.37%,ANK2;ACTN2;GAL
prerank,regulation of vasoconstriction (GO:0019229),0.7150061863589569,1.7921496431632948,0.009472259810554804,0.7220984867065996,0.996,3/27,2.65%,ADRA1B;AGTR1;CAV1
prerank,vitamin transport (GO:0051180),0.7005204943872209,1.788519989523768,0.004213483146067416,0.7164384153429694,0.997,2/29,2.69%,CUBN;AMN
prerank,regulation of complement activation (GO:0030449),0.6792162201707868,1.7861394982033887,0.005121638924455826,0.700875151884088,0.997,7/40,6.31%,CD55;CLU;CFHR1;C8A;CFH;CD81;CFP
prerank,acidic amino acid transport (GO:0015800),-0.6372304710189082,-1.7860962385119834,0.005797101449275362,0.17113623940967476,0.957,6/17,8.63%,SLC1A3;SLC6A13;SLC1A2;SLC6A6;SLC1A1;SLC6A1
prerank,regulation of immune effector process (GO:0002697),0.6724696542973699,1.784916072508612,0.0038071065989847717,0.6794612270520837,0.997,7/41,6.31%,CD55;CLU;CFHR1;C8A;CFH;CD81;CFP
prerank,regulation of actin filament depolymerization (GO:0030834),-0.6922032325307931,-1.7831464716389305,0.012690355329949238,0.1688699915674499,0.96,3/12,3.32%,PLEKHH2;SEMA5A;LIMA1
prerank,positive regulation of synapse assembly (GO:0051965),-0.5573486018799348,-1.7805419893570562,0.0037174721189591076,0.1671494381630727,0.963,12/27,13.96%,IL1RAPL1;NRXN1;GRID2;EPHB2;CLSTN2;NLGN1;LRRC4B;DLG5;NLGN3;SYNDIG1;BDNF;SRPX2
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.7575744658693084,1.7778901280904764,0.00744047619047619,0.6999731827033608,0.997,2/22,4.82%,CUBN;UBIAD1
prerank,regulation of cell-cell adhesion (GO:0022407),0.668004175407366,1.7758112975230715,0.002617801047120419,0.6876504797562656,0.997,8/39,6.10%,DPP4;CDH1;WNT1;B4GALNT2;PODXL;SPINT2;FLOT2;EFNA5
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.7162681908090621,1.7744521313190902,0.013831258644536652,0.6700937190356548,0.997,5/25,2.65%,CXADR;FGF13;DSG2;ANK2;CAV1
prerank,cell-cell junction organization (GO:0045216),0.6158942625690598,1.7722336445932656,0.0,0.660268165305089,0.997,17/79,8.29%,CDH1;CXADR;SDK1;DSG2;CDH13;NECTIN3;TJP2;TJP1;OCLN;PKP4;LIMS2;CTNNA1;CSK;PVR;TGFB2;ANG;PARD6B
prerank,positive regulation of vasoconstriction (GO:0045907),0.8190968610125329,1.7705615143617472,0.004761904761904762,0.6477072899987207,0.997,2/13,2.65%,ADRA1B;CAV1
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.6570094315360611,-1.7702568456063585,0.005405405405405406,0.1788498448595982,0.973,8/16,9.62%,IGF1;ZFPM2;NOTCH1;FGF2;GLI1;ERBB4;FGFR2;TBX2
prerank,phosphate ion homeostasis (GO:0055062),-0.7321270873950402,-1.7584523378604953,0.00510204081632653,0.19586407943882664,0.978,4/10,12.69%,ENPP1;XPR1;SFRP4;FGFR4
prerank,regulation of humoral immune response (GO:0002920),0.661021791047042,1.7580318996603175,0.0038119440914866584,0.7081328935503879,0.999,6/44,3.22%,CD55;CLU;CFHR1;C8A;CFH;CD81
prerank,regulation of amyloid fibril formation (GO:1905906),0.7711302324242508,1.754464368861586,0.01524390243902439,0.7087703887793869,0.999,4/15,5.33%,CLU;LDLR;PFDN1;CRYAB
prerank,epithelial structure maintenance (GO:0010669),0.8427502205648051,1.7491487403482349,0.014657980456026058,0.7216888181238692,0.999,2/11,1.01%,CXADR;VSIG1
prerank,integrin-mediated signaling pathway (GO:0007229),0.611460757566045,1.7489612658054625,0.0035971223021582736,0.7002522294186483,0.999,20/73,12.97%,FN1;ITGB4;ITGA10;ITGB8;ITGBL1;ADAM10;ITGB7;LAMA5;PTK2B;FYB2;FBLN1;PTPRA;ILK;CDC42;ADAMTS1;TXK;ADAM15;BCAR1;PTN;DOCK1
prerank,regulation of intracellular pH (GO:0051453),0.6805416775614306,1.7458165359421784,0.011049723756906077,0.699326771457173,1.0,14/34,16.86%,SLC9A2;CFTR;SLC9A4;SLC4A2;TMEM165;CHP1;SLC9A7;SLC9A6;GPR89B;GPR89A;SLC9A8;ATP5F1B;SLC4A4;SLC9A1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.8036571868454916,1.7453101299467784,0.017543859649122806,0.6824643691951265,1.0,1/12,0.05%,FZR1
prerank,cGMP-mediated signaling (GO:0019934),-0.6742995275786691,-1.744600087787761,0.0076726342710997444,0.21674264624011821,0.992,5/13,9.95%,IRAG1;PDE3A;GUCY1B1;PDE9A;PDE2A
prerank,adrenergic receptor signaling pathway (GO:0071875),0.7273961557971147,1.7394924595866108,0.012987012987012988,0.6993353616398467,1.0,3/20,2.55%,ADRA1B;ADCY9;AKAP13
prerank,actomyosin structure organization (GO:0031032),0.6069826112292187,1.737814748035499,0.004656577415599534,0.6910988081529835,1.0,12/75,5.09%,SORBS1;PGM5;MYOM2;PHACTR1;KRT19;ACTN2;TJP1;TMOD3;TMOD2;CSRP3;EPB41L1;LMOD3
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.6854127129911487,-1.7331477672037505,0.015113350125944584,0.236241301460238,0.994,3/12,2.51%,IL34;LYN;PTK2
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.7071499896033628,-1.729631590622288,0.00510204081632653,0.2364778224735052,0.995,4/11,2.88%,MERTK;CXCL12;GAS6;AXL
prerank,dendrite self-avoidance (GO:0070593),-0.6210799933748233,-1.7295607239948723,0.00819672131147541,0.22943547941839823,0.995,7/16,10.61%,PALLD;EMB;NEXN;DSCAML1;CNTN6;BSG;ROBO4
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.836070824007521,1.7272677510207206,0.0031746031746031746,0.7382520234070614,1.0,1/10,0.04%,FN1
prerank,entry into host (GO:0044409),0.7925483704416464,1.72245802709354,0.009523809523809525,0.7486154311787371,1.0,3/13,7.09%,CDH1;CXCR4;CBLL1
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.7145347070834727,-1.7216312025100227,0.004761904761904762,0.24083960870947635,0.996,5/11,9.69%,RAPGEF2;LYN;LGALS9;PIK3CB;PIK3CD
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.6512978684367947,-1.7206984138281038,0.00510204081632653,0.23605702074033585,0.996,9/14,13.69%,GHR;PIK3R1;LYN;STAT5B;PTK2;JAK2;STAT5A;STAT3;STAT6
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.594893704653395,-1.7195194639783458,0.012121212121212121,0.23199352117558936,0.996,10/19,13.02%,HS6ST2;NDST3;HS6ST3;XYLT1;CSGALNACT1;EXTL3;XYLT2;EXT2;HS3ST3B1;B3GAT3
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.6316228240020855,-1.717740167029574,0.005479452054794521,0.22983149862078533,0.996,8/16,15.01%,IGF1;TRPC3;CAMK2D;ROCK1;PDE9A;IL6ST;MTPN;EDN1
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.6953807428970874,1.7170849969620776,0.009681881051175657,0.7659776684299366,1.0,7/27,5.41%,FN1;WNT1;PDGFC;CDKN1A;S100A6;CDK6;CDK4
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.5710065935199647,-1.7160519526125386,0.0,0.22732689483113816,0.996,10/22,15.01%,IGF1;CAMK2D;NOTCH1;LMCD1;ROCK1;PDE9A;GLRX3;IL6ST;MTPN;EDN1
prerank,positive regulation of ion transport (GO:0043270),0.6297842372883263,1.7126485968488585,0.012531328320802004,0.7765932096831865,1.0,10/48,8.00%,ANK2;CHRM1;ACTN2;STIM2;CCL5;FHL1;GDNF;AHCYL1;ANK3;RAB3B
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.5629477112332666,-1.7056383327921165,0.014184397163120567,0.244699313989079,0.996,9/24,13.19%,SULF1;CCBE1;HIF1A;CYP1B1;PTGS2;RORA;TGFB1;IL6ST;FLT4
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.6928157860507789,1.7035909920308256,0.01020408163265306,0.8167220935243444,1.0,4/23,5.38%,DPP4;MCU;RIPOR2;MOSPD2
prerank,peptide cross-linking (GO:0018149),0.699528499808488,1.699531313557431,0.009985734664764621,0.8248916191427442,1.0,1/25,0.04%,FN1
prerank,negative regulation of response to wounding (GO:1903035),0.7354291946420822,1.6918748238875858,0.013157894736842105,0.8565162268268078,1.0,6/19,11.50%,CD109;RTN4R;EPHA4;ALOX5;CASK;CERS2
prerank,striated muscle cell development (GO:0055002),0.7793061178702378,1.691492118356922,0.01567398119122257,0.8398460534046348,1.0,4/14,5.09%,PGM5;TMOD3;TMOD2;LMOD3
prerank,phospholipid catabolic process (GO:0009395),-0.5516584537808275,-1.6893786703973652,0.01694915254237288,0.2769895529668094,0.998,9/24,20.90%,PLA2G4A;GPCPD1;ENPP2;ENPP6;GDPD1;ABHD12;PNPLA6;PLA2G4C;GDPD3
prerank,autonomic nervous system development (GO:0048483),0.7549339717666551,1.688629337528768,0.011922503725782414,0.8396811934821573,1.0,2/17,3.81%,FN1;GDNF
prerank,glycerolipid catabolic process (GO:0046503),-0.5798978342785034,-1.687384614058784,0.01488095238095238,0.2753840994955454,0.998,10/19,20.90%,PLA2G4A;GPCPD1;MGLL;ENPP6;GDPD1;ABHD12;PNPLA6;ABHD2;PLA2G4C;GDPD3
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.5928449648343892,-1.684553444588291,0.017341040462427744,0.2763568323232849,0.999,9/19,13.01%,ZFPM2;NOTCH1;RUNX1;FGF2;GLI1;ERBB4;FGFR2;TBX2;RBP4
prerank,cellular response to arsenic-containing substance (GO:0071243),0.7563044308179125,1.6837928429903062,0.016793893129770993,0.8530471566856045,1.0,5/15,6.86%,DAXX;CPEB2;ZC3H12A;MKNK2;GSTO1
prerank,neuron cell-cell adhesion (GO:0007158),-0.6375852977549462,-1.6806705945797935,0.010230179028132993,0.2806768318605569,1.0,8/14,18.29%,NRXN3;NRXN1;NCAM2;NLGN1;ASTN2;NLGN3;RET;ASTN1
prerank,lipid modification (GO:0030258),0.6457829835902508,1.6799658598926717,0.00788436268068331,0.8614112729283091,1.0,2/37,1.64%,PLPPR2;MBOAT2
prerank,negative regulation of developmental growth (GO:0048640),0.6571829682352532,1.6734993809597436,0.02557200538358008,0.8878646376636002,1.0,6/30,4.06%,FGF13;RTN4R;OSTN;CDKN1A;GDF15;DUSP10
prerank,protein localization to cell-cell junction (GO:0150105),0.7449786370939596,1.6699245532712963,0.016897081413210446,0.8949743176930111,1.0,7/15,11.60%,TJP2;TJP1;ARHGEF18;LSR;ACTB;ACTG1;JAK1
prerank,regulation of extracellular matrix organization (GO:1903053),-0.6109169352842841,-1.667222370188574,0.01483679525222552,0.3084488296465613,1.0,6/15,5.11%,AEBP1;FAP;TIE1;NOTCH1;RUNX1;RIC1
prerank,regulation of lamellipodium organization (GO:1902743),0.7647993866958871,1.6672189966914512,0.02576489533011272,0.8963625402998219,1.0,6/14,12.79%,CD44;CAPZB;TWF1;DMTN;CDC42;PDPN
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.5467263290979979,1.6657582590039774,0.0010683760683760685,0.8876384821557856,1.0,16/140,4.60%,ADRA1B;CD55;AGTR1;GPR4;LPAR1;CCR4;LPAR4;CACNA1A;CAV1;CXCR4;CACNB3;PTGFR;ACKR2;ACKR4;CCR10;ACKR3
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.5407327367672278,-1.6646165984253578,0.021406727828746176,0.30828190003340317,1.0,13/24,24.28%,PDE3A;RAPGEF2;PDE4D;PDE3B;GNAI1;PRKAR2B;PDE2A;PDE11A;PEX5L;PRKAR1B;CGAS;APLNR;RNF157
prerank,phospholipid dephosphorylation (GO:0046839),0.6460511960881313,1.664459834429492,0.014435695538057743,0.8792690448268816,1.0,1/37,0.01%,PLPPR2
prerank,phospholipid metabolic process (GO:0006644),0.5882917022408396,1.6603320269051853,0.01079136690647482,0.8912459584484256,1.0,3/71,1.69%,PLPPR2;PLB1;FDFT1
prerank,cellular response to amino acid starvation (GO:0034198),0.5765376917650997,1.6597805466755617,0.005827505827505828,0.8782691053469657,1.0,6/71,3.80%,DAPL1;RNF152;ATP6V1B1;MAP3K5;CDKN1A;SESN2
prerank,response to amino acid starvation (GO:1990928),0.574708863697011,1.657322842942289,0.006984866123399301,0.8784638638774708,1.0,6/72,3.80%,DAPL1;RNF152;ATP6V1B1;MAP3K5;CDKN1A;SESN2
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.7464663850725624,1.6530113031700464,0.02627511591962906,0.8917447157999785,1.0,3/15,7.50%,CD55;GLI3;NKAP
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.806746942650951,1.6526259533478025,0.01692047377326565,0.878449938739242,1.0,2/10,1.00%,DPP4;ADTRP
prerank,neural crest cell migration (GO:0001755),0.6252849919555327,1.6489737745733073,0.02509907529722589,0.8873899375042605,1.0,4/36,3.81%,FN1;SEMA3D;SEMA3B;GDNF
prerank,sodium ion import across plasma membrane (GO:0098719),0.7188960098737354,1.6427374046645222,0.024132730015082957,0.9152480015811149,1.0,2/17,0.16%,SLC9A2;SLC9A4
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.6776181460216988,1.6425861900625554,0.03751803751803752,0.9009033538119962,1.0,1/21,0.05%,FZR1
prerank,bone morphogenesis (GO:0060349),-0.6466547656253667,-1.641493590252793,0.023376623376623377,0.3684648641164068,1.0,7/14,14.37%,CYP26B1;BMPR1B;LRP6;LRP5;FGFR2;SFRP4;BMPR2
prerank,positive regulation of cyclase activity (GO:0031281),-0.6053275206555907,-1.6396794736874718,0.0221606648199446,0.3663118427182045,1.0,3/14,2.50%,CACNA1C;STIM1;NOS3
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.6453084612399136,-1.636758688629904,0.01837270341207349,0.3674576750756633,1.0,2/12,0.92%,PTPRJ;CBLB
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.6858970183338653,-1.6366164669313636,0.020460358056265986,0.3604373732275091,1.0,7/10,19.25%,GABRG3;GABRG2;GABRG1;GABRA3;GABRB2;GABRA1;GABRE
prerank,response to iron ion (GO:0010039),-0.6524939708258308,-1.636516572925551,0.025,0.3534938583705323,1.0,5/12,13.00%,BMP6;HIF1A;BCL2;B2M;FXN
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.6321152547823542,-1.6330566260326258,0.037783375314861464,0.35652383087394257,1.0,7/13,9.62%,ZFPM2;NOTCH1;FGF2;GLI1;ERBB4;FGFR2;TBX2
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.6844803539712976,1.6285848137882821,0.02679830747531735,0.983952264703322,1.0,5/22,6.84%,CD44;KLF4;GCNT2;FLOT2;MAPK7
prerank,smooth muscle contraction (GO:0006939),-0.6275079996592909,-1.6281687675222822,0.0106951871657754,0.36471445320985835,1.0,6/14,12.24%,SLC8A1;MYLK;SMTN;ROCK1;MYH11;ACTA2
prerank,negative regulation of cell adhesion (GO:0007162),0.5638648384771708,1.6277114327002056,0.010922330097087379,0.974707175996868,1.0,17/72,7.29%,CDH1;CDH13;ANGPT1;WNT1;B4GALNT2;PLXNB1;PODXL;ADAM10;PLXNA2;SPINT2;GCNT2;RIPOR2;DUSP1;FBLN1;DMTN;CBLL1;ERBB3
prerank,angiogenesis involved in wound healing (GO:0060055),-0.6678430636618999,-1.625366991186215,0.024875621890547265,0.3662635188326879,1.0,9/11,27.43%,ADIPOR2;CD34;NDNF;KDR;GATA2;PRCP;SRF;MCAM;HPSE
prerank,central nervous system neuron development (GO:0021954),-0.5974046904323912,-1.6239006642890592,0.03735632183908046,0.363032408813265,1.0,8/15,19.68%,RAPGEF2;MAP2;NTRK2;LHX6;GBA2;B4GALT5;ARHGAP35;HSP90AB1
prerank,nucleoside catabolic process (GO:0009164),0.7779424832277991,1.6194603759913884,0.03289473684210526,1.0,1.0,5/11,9.44%,NT5E;NT5C1A;NT5C3A;UPP2;DERA
prerank,regulation of cellular pH (GO:0030641),0.6414336799385424,1.6185268882643802,0.03651685393258427,1.0,1.0,6/29,10.06%,SLC9A2;SLC9A4;SLC4A2;CHP1;SLC9A7;SLC9A6
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.47633481757683394,-1.6159265492080601,0.008032128514056224,0.38019146783494967,1.0,18/34,25.51%,GRID2;GABRG3;GRIN2A;GRIN2B;LRRK2;GLRA1;GABRG2;GABRG1;GABRA3;NLGN3;DRD2;MPP2;GABRA1;GABRE;RAB3GAP1;INSYN2A;ARRB2;CHRNA4
prerank,camera-type eye morphogenesis (GO:0048593),-0.6910268962875846,-1.6144662951684563,0.02295918367346939,0.377027423004594,1.0,6/10,20.94%,IFT122;LRP6;TBX2;NF1;KDM2B;TENM3
prerank,dopamine metabolic process (GO:0042417),-0.5789531485854877,-1.6141325690239117,0.024615384615384615,0.3712719597915259,1.0,6/18,12.83%,MOXD1;SNCAIP;MAOB;MAOA;GCH1;DRD2
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.7195094956177668,1.6135594277699878,0.030349013657056147,1.0,1.0,1/16,0.19%,CLDN11
prerank,muscle tissue development (GO:0060537),0.7312173500363887,1.613433142099596,0.03035143769968051,1.0,1.0,5/13,6.80%,PGM5;SMO;STRA6;CSRP3;BMP4
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.6040520238973507,-1.6132993296192641,0.019390581717451522,0.3672803256862049,1.0,7/15,15.01%,IGF1;CAMK2D;ROCK1;PDE9A;IL6ST;MTPN;EDN1
prerank,epithelial cell migration (GO:0010631),0.6197333700564336,1.6124148520467978,0.026917900403768506,1.0,1.0,5/37,3.59%,DPP4;CDH13;KANK1;FAT2;KANK2
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.5155909241831625,-1.6101035383635938,0.022641509433962263,0.3701844933602823,1.0,9/26,13.19%,SULF1;CCBE1;HIF1A;CYP1B1;PTGS2;RORA;TGFB1;IL6ST;FLT4
prerank,regulation of fibroblast proliferation (GO:0048145),0.6007681062785386,1.6094857909988132,0.025348542458808618,1.0,1.0,7/45,5.41%,FN1;WNT1;PDGFC;CDKN1A;S100A6;CDK6;CDK4
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.5795133745461303,1.607271595753042,0.016149068322981366,1.0,1.0,11/62,4.45%,GPR4;STK19;MAPRE2;LPAR1;NOTCH2;RTN4R;PRAG1;LPAR4;AKAP13;NGF;EPO
prerank,regulation of transforming growth factor beta production (GO:0071634),0.6783117811053923,1.6068599819244573,0.04559270516717325,1.0,1.0,3/18,2.15%,FN1;ITGB8;CD200
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.671650309824517,-1.6030584251568785,0.024630541871921183,0.38474029979350766,1.0,4/10,7.16%,PRKG1;RDX;SERPINE2;SH2B3
prerank,selective autophagy (GO:0061912),0.5778229281369753,1.6024987307423044,0.01488833746898263,1.0,1.0,19/56,18.46%,CFTR;DYNC1I1;VIM;DDRGK1;TEX264;WDFY3;LGALS8;RAB7A;ULK1;MAP1LC3B;RB1CC1;UBE2N;DYNC1LI2;UFM1;RPS27A;UBC;DYNC1H1;HDAC6;PARK7
prerank,T cell activation (GO:0042110),0.5616681943041699,1.600329394745338,0.013221153846153846,1.0,1.0,3/69,0.58%,DPP4;CXADR;CD44
prerank,mucosal immune response (GO:0002385),0.7324614772561322,1.5984249391365926,0.032,1.0,1.0,3/15,9.97%,RAB17;OTUD7B;RNASE3
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.5545947280331524,1.5981742954364633,0.02,1.0,1.0,18/70,9.94%,FN1;POF1B;SRGAP2;PARVA;ITGB7;MEGF9;LAMA5;TMEFF2;UNK;ANTXR1;PXN;ILK;SRCIN1;LAMC1;GRHL2;OPHN1;DACT2;LAMB2
prerank,nuclear membrane disassembly (GO:0051081),0.7251187474786226,1.5977907369446653,0.0365296803652968,0.9964257985841256,1.0,1/14,0.09%,PRKCB
prerank,cellular component maintenance (GO:0043954),-0.6232613079405507,-1.5973330174376472,0.007692307692307693,0.3947383650165696,1.0,4/12,13.17%,INSR;IGF1R;MTMR2;CLDN1
prerank,keratinocyte differentiation (GO:0030216),0.6356904845654794,1.596259705297393,0.034578146611341634,0.993863225021576,1.0,2/29,0.45%,WNT16;SCEL
prerank,endothelial cell migration (GO:0043542),0.6036531842748302,1.5948907856423256,0.024691358024691357,0.990658521740729,1.0,3/37,2.06%,DPP4;CDH13;EMP2
prerank,regulation of establishment of cell polarity (GO:2000114),0.708287875431115,1.5947111597229948,0.03709428129829984,0.9794333005320117,1.0,12/16,18.79%,KANK1;GSN;RAP1B;PTK2B;RIPOR2;KRIT1;BCAS3;ARFGEF1;CDH5;SHTN1;KIF20B;ROCK2
prerank,stabilization of membrane potential (GO:0030322),-0.5749896643133046,-1.5945559850594693,0.020527859237536656,0.3968781468534894,1.0,9/16,32.17%,KCNK2;KCNK5;KCNK13;KCNK3;KCNK12;KCNK1;KCNN4;KCNK6;KCNK4
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.6085252502883647,-1.5931515220396728,0.036211699164345405,0.3949180748539636,1.0,5/13,9.87%,ENG;KDR;COL4A1;SEMA3E;NOTCH4
prerank,glycerophospholipid catabolic process (GO:0046475),-0.5083149519536327,-1.589898528235757,0.010676156583629894,0.39862994488001424,1.0,16/27,34.89%,PLA2G4A;GPCPD1;ENPP2;PNPLA8;ENPP6;GDPD1;ABHD12;PNPLA6;PLA2G4C;GDPD3;PLA2G15;PLA2G4F;PLA2G4E;LIPC;PLA2G4B;PLA2G5
prerank,regulation of feeding behavior (GO:0060259),-0.6565555736513489,-1.587065147687563,0.03412073490813648,0.40101914726128995,1.0,5/11,10.70%,LEPR;AGRP;SGIP1;CFAP20;STAT3
prerank,aggrephagy (GO:0035973),0.6433288692630077,1.5860964065088816,0.03483309143686502,1.0,1.0,11/27,18.46%,CFTR;DYNC1I1;VIM;WDFY3;UBE2N;DYNC1LI2;RPS27A;UBC;DYNC1H1;HDAC6;PARK7
prerank,diterpenoid metabolic process (GO:0016101),0.5716557597733211,1.585481340372245,0.022332506203473945,1.0,1.0,12/55,10.36%,PLB1;GPC6;NAPEPLD;OPN1SW;GPC1;ADH7;STRA6;GPC4;SDC4;GPC3;PECR;AKR1B10
prerank,embryonic axis specification (GO:0000578),0.694323234361615,1.5846299001273496,0.043343653250773995,1.0,1.0,5/15,8.69%,WNT1;COBL;SMAD6;FZD5;CXXC4
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.5999635396986955,1.58371201970828,0.032,1.0,1.0,9/39,6.84%,CDH1;ADTRP;WNT1;KLF4;B4GALNT2;PODXL;SPINT2;AKNA;MAPK7
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.5750878767060149,1.583436523260963,0.030690537084398978,0.9953816732647298,1.0,13/46,9.94%,FN1;SRGAP2;PARVA;ITGB7;MEGF9;LAMA5;TMEFF2;ANTXR1;PXN;ILK;SRCIN1;LAMC1;LAMB2
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.5220387699296992,-1.5827162026084254,0.03514376996805112,0.40876116199804363,1.0,12/23,28.20%,PRKAG2;CEMIP;TGFB1;IRGM;S1PR2;EGF;SPHK1;BMP7;STOX1;TRIM6;RIPK2;CALM3
prerank,regulation of transferase activity (GO:0051338),0.6978970761226825,1.5826759270708655,0.039334341906202726,0.9888352554682589,1.0,8/17,15.61%,SPTSSB;EMP2;NABP2;FEM1A;JMJD8;FEM1B;PINX1;HMBOX1
prerank,contractile actin filament bundle assembly (GO:0030038),0.7207041823272742,1.5814548304581488,0.03599374021909233,0.9740648359043967,1.0,2/15,0.50%,SORBS1;PHACTR1
prerank,stress fiber assembly (GO:0043149),0.7207041823272742,1.5814548304581488,0.03599374021909233,0.9740648359043967,1.0,2/15,0.50%,SORBS1;PHACTR1
prerank,mesoderm formation (GO:0001707),0.6841948056029491,1.5812162517601944,0.0374251497005988,0.9644538732817391,1.0,2/17,3.12%,ITGB4;CRB2
prerank,water transport (GO:0006833),0.737947904898946,1.5808287034734463,0.03902439024390244,0.9561098808003738,1.0,1/12,0.12%,CFTR
prerank,regulation of gastrulation (GO:0010470),0.7103956997770611,1.57999641222313,0.05132192846034215,0.9504728267829579,1.0,3/14,3.12%,PHLDB2;DAG1;CRB2
prerank,aortic valve morphogenesis (GO:0003180),-0.4819396129271909,-1.5791977268846327,0.025179856115107913,0.41389685443602797,1.0,12/30,8.93%,ELN;JAG1;NOS3;ROBO1;TIE1;NOTCH1;NFATC1;ROBO2;SLIT2;TGFB1;ROCK1;HEYL
prerank,regulation of axon regeneration (GO:0048679),0.7253071872721818,1.5787189939846493,0.055,0.9481580202842846,1.0,7/12,22.97%,RTN4R;EPHA4;CERS2;PTN;STK24;RTN4RL1;SCARF1
prerank,regulation of cell communication (GO:0010646),0.6147883032078679,1.5782452741624704,0.037383177570093455,0.9406824909039737,1.0,4/35,1.92%,CXADR;ANK2;GRK5;VEPH1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.5779025813232157,1.5763647356879948,0.027261462205700124,0.9422342614364255,1.0,18/47,16.81%,DOCK5;KANK1;LIMS2;S100A10;FBLN1;EFNA5;DMTN;ILK;CDC42;PDPN;DOCK1;RREB1;ITGB1BP1;ACTN4;FLNA;TESK1;CRK;ABL1
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.5000410113764697,-1.575962094085287,0.025735294117647058,0.4175763366406051,1.0,9/29,10.12%,FLT1;PDGFRB;PRKD1;TEK;PTK2;PDGFRA;FGF2;TGFB1;KIT
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.7741520444256242,1.5755581936834187,0.04560810810810811,0.9377036478927001,1.0,4/10,9.06%,NT5E;NT5C1A;NT5C3A;UPP2
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.6372427125569311,1.575511270665371,0.033527696793002916,0.9279075114649011,1.0,7/26,7.89%,FGFR1;EYA2;GDNF;BCL2L1;MAPK7;EYA1;UNC5B
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.6464161325992217,-1.5750606171450376,0.045112781954887216,0.41421527125887725,1.0,4/10,4.52%,ACER2;NEXMIF;PDE3B;CYP1B1
prerank,sterol transport (GO:0015918),0.6823840278055286,1.5745191181047353,0.04242424242424243,0.924730135642563,1.0,4/19,6.44%,LDLR;CAV1;STARD3;NPC1
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.709054954926321,1.573057955202822,0.04292527821939587,0.9239856846980358,1.0,4/16,9.06%,NT5E;NT5C1A;NT5C3A;UPP2
prerank,protein localization to plasma membrane (GO:0072659),0.5144710790906494,1.5722732874503713,0.005488474204171241,0.9187253504557836,1.0,27/129,10.07%,CDH1;FGF13;NECTIN3;ANK2;TSPAN5;ACTN2;SLMAP;TTC7A;ANK1;EMP2;RAP1A;CD81;S100A10;CACNB3;EHD1;FYB2;RAMP1;FLOT2;ANK3;ZFYVE27;PACS1;RAB3B;STXBP1;TNFRSF1A;MYO5A;EZR;KCNB1
prerank,embryonic heart tube development (GO:0035050),-0.6018538228363608,-1.5715133929471148,0.028132992327365727,0.4192278253881493,1.0,6/14,17.15%,IFT122;SOX17;TBX2;MEGF8;RYR2;SOX18
prerank,protein localization to cell surface (GO:0034394),0.635615648235947,1.5705185664535395,0.04564315352697095,0.9197076011559525,1.0,9/26,12.40%,ANGPT1;ANK2;EMP2;PIGU;WNT11;PTPRU;UNC50;GGA1;MESD
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.5585271498345258,-1.5704737559912818,0.022435897435897436,0.4163404804796713,1.0,4/18,7.03%,IGF1;IGFBP2;IL18;IGF2
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.6270416616718565,1.5679680374012688,0.03337969401947149,0.9264426111642874,1.0,5/26,6.34%,ANK2;ACTN2;FHL1;WWP2;STK39
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.5704373718614942,-1.5677036395810755,0.041916167664670656,0.4187473139333421,1.0,5/17,4.54%,CACNA1C;SLC8A1;GJC1;GJD3;ATP1B1
prerank,negative regulation of platelet activation (GO:0010544),-0.5806263733079764,-1.5675450360118783,0.04310344827586207,0.4134582276224718,1.0,5/16,7.16%,PRKG1;NOS3;PDGFRA;SERPINE2;SH2B3
prerank,apoptotic cell clearance (GO:0043277),-0.47629750055278736,-1.5673091342507308,0.03636363636363636,0.4086153701186839,1.0,13/30,21.76%,RHOBTB1;TGM2;GAS6;MEGF10;THBS1;NR1H3;XKR6;ITGAV;HMGB1;TXNDC5;RHOBTB2;LRP1;TYROBP
prerank,positive regulation of lyase activity (GO:0051349),-0.5858524351124403,-1.5664206664747389,0.03823529411764706,0.4059555079813347,1.0,6/14,18.10%,CACNA1C;STIM1;NOS3;NF1;FXN;ISCU
prerank,hemidesmosome assembly (GO:0031581),0.7592811057012396,1.5637522671388744,0.0380952380952381,0.9440658863301232,1.0,4/11,10.69%,ITGB4;LAMC2;LAMC1;PLEC
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.7200104279912635,1.5632748876264235,0.04559748427672956,0.9375576696590644,1.0,5/14,11.39%,NT5E;NT5C1A;NT5C3A;UPP2;UMPS
prerank,positive regulation of bone mineralization (GO:0030501),-0.47215146196115604,-1.5616832141652526,0.008,0.415392383935949,1.0,10/35,8.35%,BMP6;ADGRV1;WNT4;SLC8A1;KL;BMPR1B;FBN2;TGFB1;PKDCC;ACVR2A
prerank,cholesterol biosynthetic process (GO:0006695),0.6187213194926998,1.5609129813803968,0.05070422535211268,0.9431414209768884,1.0,13/31,18.18%,FDFT1;DHCR7;FDPS;HMGCR;INSIG1;PMVK;CYP51A1;MSMO1;ACAT2;SQLE;PLPP6;TM7SF2;HMGCS1
prerank,cellular response to alcohol (GO:0097306),0.5821567248302059,1.560732410917114,0.03655352480417755,0.935130997139804,1.0,9/42,11.13%,CDH1;CFTR;SMO;PTGFR;CTNNA1;GOLPH3;ADCY6;ADAM15;OSBPL7
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.6062231231129077,1.5600820056211864,0.059474412171507604,0.9301843378008748,1.0,10/32,16.66%,FHIT;DDX5;EP300;PMAIP1;PHLDA3;PPP1R13B;PML;PDK2;USP28;POU4F1
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.6904997746205659,1.5592421833149557,0.054945054945054944,0.9270611043167862,1.0,5/15,8.46%,SCEL;FGFR1;CELF1;TGFB2;RAI2
prerank,negative regulation of potassium ion transport (GO:0043267),0.7249308633367625,1.5583006383314564,0.05228758169934641,0.9240061598238954,1.0,4/13,6.34%,ACTN2;CAV1;PTK2B;STK39
prerank,oligosaccharide biosynthetic process (GO:0009312),0.6648533519867992,1.5580907141587388,0.03903903903903904,0.9167058398089728,1.0,4/20,5.86%,B3GALT1;ST3GAL4;B4GALNT2;FUT8
prerank,secondary alcohol biosynthetic process (GO:1902653),0.6211181007489005,1.5568941186817988,0.05070422535211268,0.9154937074982378,1.0,13/30,18.18%,FDFT1;DHCR7;FDPS;HMGCR;INSIG1;PMVK;CYP51A1;MSMO1;ACAT2;SQLE;PLPP6;TM7SF2;HMGCS1
prerank,glutamate receptor signaling pathway (GO:0007215),-0.448325905534547,-1.5564108252019164,0.013333333333333334,0.4260282198670419,1.0,12/37,6.85%,PLCB1;GRIK2;GRID2;GRM3;GRM7;GRIN2A;GRIA3;GRIA2;GRM8;GRIN2B;GRM5;GRIK3
prerank,negative regulation of neuron projection development (GO:0010977),0.5575524306683985,1.5556009317820187,0.03225806451612903,0.9148590650650094,1.0,8/56,2.88%,LPAR1;RTN4R;KANK1;PRAG1;NGEF;EPHA4;EFNB2;ITM2C
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.6093427496448421,1.5551732675200298,0.03994673768308921,0.9090406191041236,1.0,3/32,1.93%,FZR1;FOXN3;CDKN1A
prerank,lamellipodium assembly (GO:0030032),0.6324803210740734,1.5539359804334318,0.027816411682892908,0.9085113013344609,1.0,6/26,7.16%,CDH13;SRGAP2;ABLIM2;ABLIM1;DMTN;GOLPH3
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.6971810302065413,1.550614101909061,0.05,0.9209870398369304,1.0,4/15,8.17%,SMO;GDNF;BMP4;SIX1
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.5877567098850055,1.5502834444448363,0.043202033036848796,0.9151810337178391,1.0,9/41,11.60%,CD44;TJP1;CCL5;PODXL;GCNT2;PTPRU;ANK3;DENND6A;JAK1
prerank,striated muscle tissue development (GO:0014706),0.6140088634972362,1.54792308439157,0.038135593220338986,0.9211827066787834,1.0,6/29,4.13%,PGM5;SGCG;SGCD;CAV1;CSRP3;BMP5
prerank,lymphocyte mediated immunity (GO:0002449),0.7124042104896082,1.5474574607936658,0.05811965811965812,0.9157434265984671,1.0,1/12,0.15%,CD55
prerank,regulation of cholesterol esterification (GO:0010872),0.7474742925429791,1.5472079255649052,0.05348460291734198,0.9094143142664145,1.0,3/10,11.52%,AGTR1;ABCA2;STARD4
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.6853240504475198,1.5469443381436017,0.06231454005934718,0.9032612323057683,1.0,1/15,0.04%,DPP4
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.727057396937703,1.5455956110319617,0.048818897637795275,0.9036026622011324,1.0,1/12,0.09%,PRKCB
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.7461728086425885,1.5412971823496078,0.0499194847020934,0.9212887542125635,1.0,1/11,0.37%,CDH13
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.7069988830464073,1.5378448299590288,0.04292527821939587,0.9346370011711943,1.0,3/14,5.82%,CD55;CD81;RASAL3
prerank,non-motile cilium assembly (GO:1905515),-0.47568305153042845,-1.5376739033085025,0.03461538461538462,0.47948510152151863,1.0,18/30,31.80%,CEP250;IFT122;TTC8;GORAB;C2CD3;BBS1;CSNK1D;BBS4;ARL13B;FUZ;RPGRIP1L;TMEM17;TMEM107;IFT88;PIBF1;CCDC13;IFT57;DISC1
prerank,homotypic cell-cell adhesion (GO:0034109),0.5794911918953837,1.5369973724593882,0.04922279792746114,0.9320867516436866,1.0,9/39,10.71%,FN1;TJP2;HSPB1;DSC2;ILK;STXBP1;CLIC1;ACTB;ACTG1
prerank,positive regulation of protein depolymerization (GO:1901881),-0.6242351873391121,-1.536961524502907,0.04404145077720207,0.4758691360416429,1.0,3/11,9.30%,SEMA5A;STMN2;NES
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.5422428524347906,-1.5353510738997131,0.043076923076923075,0.47479187069174944,1.0,9/19,9.77%,DCN;SEMA6A;CCBE1;ROBO1;XDH;DAB2IP;PIK3CB;TSPAN12;ADAMTS3
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.7308213499421132,1.5327856047367845,0.0676818950930626,0.9499827745829338,1.0,5/10,11.18%,HDAC5;SMARCB1;PIH1D1;KMT2A;RAPGEF3
prerank,protein localization to cell periphery (GO:1990778),0.5011913318648096,1.5314377125773937,0.012008733624454149,0.9506806496444313,1.0,28/133,10.07%,CDH1;FGF13;ANK2;TSPAN5;ACTN2;SLMAP;TTC7A;ANK1;EMP2;CAV1;RAP1A;CD81;S100A10;CACNB3;EHD1;ARL3;FYB2;RAMP1;FLOT2;ANK3;ZFYVE27;PACS1;RAB3B;STXBP1;TNFRSF1A;MYO5A;EZR;KCNB1
prerank,icosanoid secretion (GO:0032309),-0.6254883711809285,-1.5286275058538956,0.0391644908616188,0.4912470603517793,1.0,4/12,12.83%,ABCC4;PNPLA8;ACE;DRD2
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.7160555723375539,1.5279387094017296,0.06188925081433225,0.9564639939007272,1.0,9/12,21.72%,KANK1;FBLN1;EFNA5;DMTN;ITGB1BP1;ACTN4;RCC2;MELTF;AP1AR
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.7160555723375539,1.5279387094017296,0.06188925081433225,0.9564639939007272,1.0,9/12,21.72%,KANK1;FBLN1;EFNA5;DMTN;ITGB1BP1;ACTN4;RCC2;MELTF;AP1AR
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.678192549345265,1.5273452811595423,0.0696594427244582,0.9524637061797118,1.0,6/15,11.60%,KLF4;TJP1;PKM;JMJD8;S100A1;JAK1
prerank,positive regulation of interleukin-2 production (GO:0032743),-0.491823950140354,-1.5258694922406684,0.03873239436619718,0.4940765952053481,1.0,7/25,11.72%,PDE4D;GLMN;RUNX1;SPTBN1;PDE4B;TRAF6;PNP
prerank,vasoconstriction (GO:0042310),-0.6215223067677312,-1.5245422799977142,0.041237113402061855,0.49262224949721456,1.0,7/11,29.63%,SLC8A1;ACTA2;EDNRB;EDN1;EDN3;HTR2B;PIK3C2A
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.5922975198526821,-1.5243776992654665,0.05221932114882506,0.48737706076630644,1.0,2/12,5.93%,IL1R1;IL18
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.5228937295294963,1.5241539335643537,0.020556227327690448,0.9639557698017822,1.0,22/78,15.22%,FZR1;CLU;TRIB2;CAV1;NFE2L2;ZYG11B;SH3RF2;NUB1;ELOB;DDRGK1;PLK3;RBX1;SUMO2;BCAP31;COP1;HSPBP1;CSNK1E;PIAS1;DDA1;GSK3A;GSK3B;MDM2
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.5850356337673582,1.5239810060346632,0.04076086956521739,0.9575100470207683,1.0,14/35,16.81%,BAIAP2L1;NOTCH2;NTRK3;TJP1;PTK2B;DAPK3;HAX1;CDC42;BCAS3;RAPGEF3;TRPM2;HRAS;ARHGDIB;ABL1
prerank,positive regulation of actin filament polymerization (GO:0030838),0.5572064917263998,1.5232759176268442,0.04509283819628647,0.9543484188945233,1.0,8/44,5.14%,BAIAP2L1;GSN;CDC42EP4;PTK2B;FCHSD2;CDC42EP5;LMOD3;FCHSD1
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.4970388636959433,1.523126859617922,0.00968783638320775,0.9478696985119839,1.0,16/142,5.94%,ADRA1B;CD55;AGTR1;LPAR1;CCR4;CACNA1A;CAV1;ATP1A2;CXCR4;PTGFR;ACKR2;ACKR4;CCR10;ACKR3;CAV2;CCRL2
prerank,regulation of Rho protein signal transduction (GO:0035023),0.5387504145279057,1.5219793402573796,0.029411764705882353,0.9472762631695073,1.0,16/72,10.78%,GPR4;LPAR1;RTN4R;KANK1;PRAG1;LPAR4;AKAP13;EPS8L2;KANK2;RIPOR2;ARHGEF18;CCDC125;BCR;OPHN1;RAF1;DLC1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.42943076529819435,-1.5216820728213043,0.021739130434782608,0.49038028712441517,1.0,13/39,9.87%,ENG;GLI2;TIE1;KDR;COL4A1;PKD2;FGF2;SEMA3E;SALL1;SLIT2;LRP6;LRP5;NOTCH4
prerank,regulation of neuron death (GO:1901214),0.5195923083887191,1.5207931587461938,0.03460207612456748,0.9472405171898894,1.0,23/82,15.65%,EGLN3;CLU;DAXX;PPARGC1A;CCL5;MAP3K5;EFNB2;CD200;FOS;CTSZ;GPR75;EGLN2;CHMP4A;CHMP4B;CHP1;CD200R1;MEF2C;GSK3B;EIF4G1;NENF;SNCB;IKBKG;ITGB2
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.5671565449186061,-1.5207419096938084,0.04619565217391304,0.4877622908505664,1.0,8/16,20.58%,INSR;IRAK3;GSPT1;OGFOD1;IGF1R;CLN3;SHFL;UPF1
prerank,aortic valve development (GO:0003176),-0.4462805669474386,-1.5194233220465283,0.031007751937984496,0.48638876192540514,1.0,15/34,14.37%,ELN;JAG1;NOS3;ROBO1;TIE1;NOTCH1;NFATC1;ROBO2;SLIT2;TGFB1;ROCK1;HEYL;TNFRSF1B;SLIT3;BMPR2
prerank,platelet aggregation (GO:0070527),0.5924790195847484,1.5193676597211332,0.0444743935309973,0.9485928493030236,1.0,7/33,10.71%,FN1;HSPB1;ILK;STXBP1;CLIC1;ACTB;ACTG1
prerank,neutrophil activation (GO:0042119),0.7175906767085329,1.5172445888643,0.04878048780487805,0.9542934898793345,1.0,3/12,11.64%,CCL5;IL15;FCER1G
prerank,positive regulation of heart rate (GO:0010460),0.6693490127458819,1.5163763981710787,0.05504587155963303,0.9521707809505423,1.0,1/17,0.06%,ADRA1B
prerank,actin cytoskeleton reorganization (GO:0031532),0.5392673128428159,1.5158792239777243,0.03907203907203907,0.9480074120643851,1.0,10/63,6.37%,CXADR;PHACTR1;PARVA;GSN;PTK7;SIPA1L1;GAB1;MCU;ANTXR1;DMTN
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.5725183380094251,-1.5153655849122873,0.04261363636363636,0.4941928012876787,1.0,3/14,7.20%,PRKG1;IGFBP5;SLIT2
prerank,epithelial cell development (GO:0002064),0.645186417875706,1.5133186370361034,0.06083086053412463,0.9564626034197713,1.0,6/20,9.76%,POF1B;ROS1;WNT5B;GRHL2;PDZD7;DACT2
prerank,purine ribonucleotide catabolic process (GO:0009154),0.6331665588259161,1.5131272653366459,0.05311077389984825,0.9507251901515178,1.0,3/21,1.83%,NT5E;NUDT4;NT5C1A
prerank,positive regulation of keratinocyte migration (GO:0051549),0.738240678800567,1.513066528839521,0.06060606060606061,0.9442423348622263,1.0,2/10,1.44%,MAPRE2;MMP9
prerank,camera-type eye development (GO:0043010),-0.4987693903778503,-1.5119395682473444,0.03503184713375796,0.49927688648618035,1.0,8/25,10.36%,CACNA1C;LAMA1;FBN1;CYP1B1;IFT122;FBN2;NES;NF1
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.5413690057925888,-1.5106191034952279,0.049315068493150684,0.49787787554111457,1.0,6/17,18.35%,PCSK5;NR1H3;SORT1;NR1H2;LPL;PCSK6
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.6201726475514667,-1.5095637380462856,0.06201550387596899,0.4958370019264389,1.0,6/11,18.79%,IL34;TGFB1;ID2;HSF1;RIPK1;CSF1
prerank,proteoglycan biosynthetic process (GO:0030166),-0.4573811740766527,-1.5094317202188334,0.02214022140221402,0.49087991376567336,1.0,16/31,16.87%,IGF1;NDST3;XYLT1;BMPR1B;CSGALNACT1;CHST8;EXTL3;XYLT2;EXT2;PXYLP1;HS3ST3B1;CANT1;B3GAT3;BMPR2;CHST10;B4GALT7
prerank,base conversion or substitution editing (GO:0016553),-0.6212048915591865,-1.5077877870312197,0.04466501240694789,0.4907461385536327,1.0,5/11,23.19%,ADAR;ADARB1;ADARB2;APOBEC1;NUDT16
prerank,maturation of 5.8S rRNA (GO:0000460),0.6600266372428648,1.5074533461612396,0.0546875,0.9720038662921885,1.0,7/17,14.55%,NSA2;PES1;EIF6;MAK16;MPHOSPH6;MTREX;RPF1
prerank,modulation by host of symbiont process (GO:0051851),0.5890182704246818,1.5071067259451099,0.05785123966942149,0.9671649204379856,1.0,10/31,12.27%,NAPEPLD;CCL5;HPN;EP300;SMARCB1;POU2F3;JUN;SMARCA4;AQP1;SP1
prerank,purine nucleotide catabolic process (GO:0006195),0.6987588302117385,1.506981719052789,0.05339805825242718,0.9612482467774813,1.0,3/13,6.84%,NT5E;NT5C1A;NT5C2
prerank,negative regulation by host of viral transcription (GO:0043922),0.6833857536419975,1.5049034579325142,0.0641025641025641,0.9664044713534815,1.0,3/12,8.32%,CCL5;POU2F3;JUN
prerank,retinoid metabolic process (GO:0001523),0.5238917146010608,1.5048788421574624,0.029904306220095694,0.9598793603348297,1.0,13/71,10.36%,PLB1;GPC6;NAPEPLD;OPN1SW;GPC1;ADH7;STRA6;GPC4;DHRS13;SDC4;GPC3;ALDH8A1;AKR1B10
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.6047586849567141,1.504472970971891,0.05698778833107191,0.9556338587896486,1.0,4/27,2.65%,FGF13;DSG2;ANK2;CAV1
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.5500112948392528,-1.50433523930819,0.0621301775147929,0.4963235709804576,1.0,4/16,6.61%,GUCY1B1;NOS3;NDNF;GUCY1A1
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.7199494587494779,1.5040428373803183,0.06174957118353345,0.951589223622311,1.0,3/10,6.56%,CD55;CD81;ZBTB7B
prerank,sphingoid metabolic process (GO:0046519),-0.6056894120633501,-1.501644502784223,0.04945054945054945,0.49961447500275696,1.0,7/12,33.30%,DEGS2;SGPP1;SPHK1;PLPP3;ASAH2;PLPP2;SPTLC3
prerank,positive regulation of lipid storage (GO:0010884),0.6430160692487228,1.5015631225727697,0.059006211180124224,0.9596203509876089,1.0,4/21,3.69%,SREBF2;ZC3H12A;IKBKE;EHD1
prerank,skin development (GO:0043588),0.5329630477448177,1.5011003431463976,0.04122497055359246,0.9560928165185762,1.0,5/65,2.33%,WNT16;ITGB4;SCEL;WNT10A;COL5A2
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.5867178017176052,1.499647506834692,0.05026455026455026,0.958046239133831,1.0,12/34,16.81%,DOCK5;LIMS2;S100A10;DMTN;ILK;CDC42;DOCK1;RREB1;FLNA;TESK1;CRK;ABL1
prerank,purine-containing compound catabolic process (GO:0072523),0.6943438637132083,1.499518244073799,0.06472491909385113,0.9524331537633359,1.0,3/13,6.84%,NT5E;NT5C1A;NT5C2
prerank,limb development (GO:0060173),-0.4745953148084655,-1.4982480932565434,0.038869257950530034,0.5056527897187807,1.0,8/28,9.96%,PCSK5;SMOC1;ZNRF3;IFT122;BMPR1B;SALL1;CHD7;MEGF8
prerank,cardiac muscle cell differentiation (GO:0055007),0.6282070378055993,1.4978435972541453,0.0712166172106825,0.9563561303333239,1.0,2/21,2.55%,CXADR;AKAP13
prerank,regulation of cell killing (GO:0031341),0.6707393674698048,1.4967351668714441,0.07186544342507645,0.9566243592738544,1.0,3/16,7.38%,CD55;CFH;TGFB2
prerank,T cell mediated immunity (GO:0002456),0.6723923112935639,1.4954696357669677,0.07037643207855974,0.9580498514418627,1.0,2/13,2.06%,CD55;EMP2
prerank,regulation of cell junction assembly (GO:1901888),0.598717148446503,1.4952916120391821,0.057342657342657345,0.952988423171357,1.0,6/27,3.22%,RAB17;PDLIM5;TJP1;OCLN;RAP1B;RAP1A
prerank,myelin maintenance (GO:0043217),0.72937949842425,1.4950497273728673,0.07023411371237458,0.9484019722354592,1.0,3/10,2.99%,CLU;ABCD1;CXCR4
prerank,negative regulation of transmembrane transport (GO:0034763),0.7212190710539378,1.4948935972655593,0.078397212543554,0.9433146385122368,1.0,1/10,0.09%,PRKCB
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.632197121297827,-1.4948404085615181,0.06091370558375635,0.5109986982309465,1.0,3/10,6.77%,PLA2G4A;ENPP2;PNPLA8
prerank,Golgi localization (GO:0051645),0.6935793868151264,1.4936930695217718,0.05872193436960276,0.9439733684212924,1.0,8/11,19.79%,ARHGAP21;CDC42;YWHAZ;RIPOR1;TBCCD1;COPG1;HOOK3;UVRAG
prerank,potassium ion export across plasma membrane (GO:0097623),-0.5650592126662461,-1.492762149287132,0.05913978494623656,0.5126338392922989,1.0,2/13,2.37%,KCNT2;KCNK5
prerank,positive regulation of lipid metabolic process (GO:0045834),0.6209349659587823,1.4924840268306263,0.06562054208273894,0.944931457058342,1.0,3/22,6.06%,SORBS1;CREBL2;CREB1
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.6302084947448267,-1.4913299607665917,0.05822784810126582,0.5123399565329282,1.0,4/10,7.35%,SOX5;ACVRL1;BMPR1B;PKDCC
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.6680331613920122,1.4910755258478332,0.08242612752721618,0.947437503855303,1.0,5/14,8.45%,CCL5;ADAM10;PTK2B;STK39;OXSR1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.4431406930441959,-1.489686814211233,0.011904761904761904,0.5124498003401051,1.0,10/34,7.31%,FLT1;PDGFRB;PRKD1;PIK3R1;TEK;PTK2;PDGFRA;FGF2;DAB2IP;TGFB1
prerank,carbohydrate biosynthetic process (GO:0016051),0.6359456160420731,1.4893860171277917,0.05,0.9514686856347943,1.0,4/21,5.86%,B3GALT1;ST3GAL4;B4GALNT2;FUT8
prerank,negative regulation of cell projection organization (GO:0031345),0.5494224581418633,1.4889488754938403,0.03807106598984772,0.9481348765892265,1.0,9/48,7.65%,LPAR1;RTN4R;KANK1;PRAG1;EPHA4;EFNB2;ITM2C;PTPN9;ADCY6
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.5836789076111877,1.487490559616021,0.0549738219895288,0.9508503426116456,1.0,6/37,7.30%,CXADR;ALCAM;NECTIN3;CRB2;PTPRD;PVR
prerank,endothelial cell proliferation (GO:0001935),-0.5221050004800121,-1.4873073939091837,0.05099150141643059,0.5148502261404058,1.0,5/17,4.68%,TEK;SEMA5A;ACVRL1;CD34;BMPER
prerank,dicarboxylic acid transport (GO:0006835),-0.47721799026736933,-1.4854005024447587,0.017421602787456445,0.5161334532066751,1.0,5/28,5.61%,SLC1A3;SLC13A3;SLC26A7;SLC1A2;SLC1A1
prerank,positive regulation of protein import (GO:1904591),0.5936481834423595,1.4851872609253383,0.0572987721691678,0.9583715823549304,1.0,10/30,15.66%,CDH1;ZC3H12A;MAVS;ARHGEF5;BAG3;ZIC1;HDAC3;UBR5;ZPR1;FLNA
prerank,negative regulation of wound healing (GO:0061045),0.6049371063752192,1.4851590375357397,0.056,0.9526730482330783,1.0,5/28,6.08%,CD109;PHLDB2;ADTRP;ALOX5;THBD
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.6308241566274512,-1.4842864989599571,0.06596306068601583,0.5148364976430566,1.0,1/10,0.28%,ABCA1
prerank,activin receptor signaling pathway (GO:0032924),-0.5416043262961168,-1.4837810755070013,0.06936416184971098,0.5113770992319606,1.0,9/15,39.03%,ACVR1B;ACVR2A;SMAD3;ACVR1C;ACVR1;SMAD2;ACVR2B;AMHR2;INHBB
prerank,endodermal cell differentiation (GO:0035987),0.5802024539255358,1.4828309705174032,0.054274084124830396,0.9602243635464577,1.0,3/31,3.90%,FN1;MMP9;COL6A1
prerank,regulation of keratinocyte migration (GO:0051547),0.7073456976619527,1.4826170515463826,0.06426332288401254,0.9557189369295707,1.0,2/12,1.44%,MAPRE2;MMP9
prerank,regulation of interleukin-13 production (GO:0032656),-0.5708254104412898,-1.4823197108758104,0.06510416666666667,0.5112382799677826,1.0,4/13,7.64%,LEF1;LGALS9;IL18;TNFRSF21
prerank,regulation of protein modification process (GO:0031399),0.5402701330404773,1.4821490531843324,0.053987730061349694,0.9523843970181215,1.0,13/50,14.83%,FN1;SESN2;PPP2CA;KDM4D;HSPB1;SPRED3;PML;PPP1R16A;ABCA2;RABL3;PLXNB2;CCDC88A;FLCN
prerank,cellular response to UV-A (GO:0071492),0.7156361515412073,1.4816598167269008,0.07952622673434856,0.9493375955350801,1.0,3/11,4.46%,OPN1SW;MMP9;TIMP1
prerank,extracellular structure organization (GO:0043062),0.4777354729020461,1.4806423783916018,0.011458333333333333,0.9496262434632321,1.0,22/204,3.20%,FN1;CDH1;ADAM12;ITGB4;THSD4;ITGA10;ADAMTS14;COL23A1;CD44;ITGB8;LAMA4;LAMC2;MMP9;COL4A3;SH3PXD2A;COL4A4;DAG1;ADAMTS7;ADAMTSL5;COL5A2;ITGB7;LAMA5
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.6800099177933948,1.4801655084160226,0.08780487804878048,0.9468416168982952,1.0,1/12,0.12%,CFTR
prerank,purine nucleotide metabolic process (GO:0006163),0.5965542839717258,1.4796209576971842,0.06330935251798561,0.9444957089301179,1.0,4/24,6.84%,NT5E;NT5C1A;FHIT;NT5C2
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.5842606312486616,1.479462358612593,0.07272727272727272,0.9399158632015149,1.0,5/29,8.65%,SORBS1;LDLR;CREBL2;CREB1;CHP1
prerank,external encapsulating structure organization (GO:0045229),0.47697132206584236,1.4793422289767217,0.010416666666666666,0.9351595611001094,1.0,22/205,3.20%,FN1;CDH1;ADAM12;ITGB4;THSD4;ITGA10;ADAMTS14;COL23A1;CD44;ITGB8;LAMA4;LAMC2;MMP9;COL4A3;SH3PXD2A;COL4A4;DAG1;ADAMTS7;ADAMTSL5;COL5A2;ITGB7;LAMA5
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.6811180063679481,1.478604678015449,0.07516339869281045,0.9339134041715523,1.0,2/13,2.17%,B3GALT1;B4GAT1
prerank,endoderm formation (GO:0001706),0.5677369857137757,1.4782287166821897,0.062087186261558784,0.9308559034146724,1.0,4/35,5.45%,FN1;MMP9;COL6A1;DUSP1
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.6994245678028794,1.478158292169104,0.07269789983844911,0.9259559236271868,1.0,3/11,6.34%,ACTN2;CAV1;STK39
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5288645672269335,1.4767085521762038,0.05223880597014925,0.9286058084367096,1.0,6/59,2.48%,CDH1;SDK1;DSG2;CDH13;NECTIN3;FAT2
prerank,response to interferon-alpha (GO:0035455),-0.5372201139884426,-1.476141771048035,0.054441260744985676,0.5258361554863428,1.0,6/16,12.52%,GAS6;AXL;ADAR;IFNAR2;IFITM3;KLHL20
prerank,regulation of T cell cytokine production (GO:0002724),0.6513708833778081,1.4747072348874948,0.08661417322834646,0.9348545716771296,1.0,4/15,11.34%,CD55;FZD5;FOXP3;TRPM4
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.5403089534924406,-1.4746550702016936,0.0633245382585752,0.5258222144319318,1.0,5/15,5.34%,PRKD1;SEMA5A;NOTCH1;FGF2;THBS1
prerank,aminoglycan catabolic process (GO:0006026),0.5824523241746048,1.4744976035811448,0.0794979079497908,0.9307626572216998,1.0,8/28,10.08%,GPC6;GPC1;GPC4;NAGLU;SDC4;GLB1;GPC3;GUSB
prerank,regulation of hemopoiesis (GO:1903706),0.711911952132746,1.4734726887081608,0.08196721311475409,0.9311203235543366,1.0,4/10,12.72%,PRKCB;LGALS3;PTN;MYSM1
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.4802594150784583,1.4728258597144872,0.015856236786469344,0.9295225950591391,1.0,17/159,7.38%,CDH1;CXADR;CLDN11;ALCAM;SDK1;DSG2;CDH13;NECTIN3;GPC6;FAT2;CRB2;GPC4;PTPRD;MYOT;PTPRF;PVR;TGFB2
prerank,mitochondrion localization (GO:0051646),-0.520725453907755,-1.4726465660257118,0.04126984126984127,0.527678761470392,1.0,9/19,16.83%,MARK1;LRRK2;MTM1;BRAT1;MFN1;ZBED3;TRAK2;ATCAY;MSTO1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.6625856255166173,1.4721617567044771,0.07790143084260731,0.9282095456619173,1.0,2/16,1.57%,AGTR1;JCAD
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.5603356225950995,-1.4721253158655039,0.052770448548812667,0.5245877953318574,1.0,5/14,28.34%,MOXD1;ALDH9A1;SLC5A7;SLC22A2;CHAT
prerank,defense response to tumor cell (GO:0002357),0.716627523552849,1.4716147659922558,0.09136212624584718,0.9262222941021099,1.0,3/10,6.95%,KLF4;DAPK1;RBMS3
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.5711669852030189,-1.47120740846552,0.059431524547803614,0.5226566187979826,1.0,5/13,8.18%,BMP6;RBPMS;DAB2;TGFB1;JAK2
prerank,mesenchyme morphogenesis (GO:0072132),-0.530367432888224,-1.4699622567458184,0.07008086253369272,0.5214954637611101,1.0,6/17,9.62%,ENG;NOS3;ACVRL1;NOTCH1;HEYL;TBX2
prerank,second-messenger-mediated signaling (GO:0019932),0.5108530509821918,1.4697410576363794,0.03968253968253968,0.9311586681378654,1.0,13/82,6.74%,AGTR1;NUDT4;CCR4;CXCR4;MCU;PPP2CA;RCAN1;ACKR2;ACKR4;CCR10;ACKR3;CCRL2;DDAH2
prerank,hemopoiesis (GO:0030097),-0.37195569247831245,-1.468899994845997,0.017857142857142856,0.5204461262618375,1.0,26/87,15.34%,FLT1;MECOM;JAG1;TEK;KIRREL3;KITLG;SNRK;MFAP5;ETV6;WNT5A;CD34;KDR;RUNX1;RUNX2;SH2B3;TGFB1;FGFR2;NOTCH4;KIT;TP53;MEIS1;TIRAP;FLT4;KAT6A;TOX;FLT3LG
prerank,negative regulation of angiogenesis (GO:0016525),-0.36172514630998137,-1.4684743373329385,0.014705882352941176,0.517221640085209,1.0,33/84,17.33%,PTPRM;DCN;SULF1;SEMA6A;TEK;ADAMTS9;CLDN5;EPN2;PDE3B;SLC12A2;DAB2IP;THBS1;COL4A2;SEMA3E;RGCC;THBS2;GTF2I;SERPINF1;PIK3CB;ROCK1;MECP2;PPARG;ISM1;NPR1;SPARC;AMOT;AGO1;HSPG2;NAXE;STAB1;HHEX;MINAR1;SPRED1
prerank,inhibitory synapse assembly (GO:1904862),0.6920738500187655,1.4684579812826122,0.07628524046434494,0.933274337011176,1.0,2/11,1.61%,FGF13;PLXNB1
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.5832714283590776,1.4680947464338245,0.0629575402635432,0.9302197283409995,1.0,5/25,6.81%,CFTR;ANK2;ACTN2;STK39;ANK3
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.6240994679361338,1.467583118751408,0.0784313725490196,0.9278079449045256,1.0,10/19,21.52%,SREBF2;HAX1;FZD5;VDAC1;GSK3A;DNM1L;HDAC6;PARK7;SREBF1;FBXW7
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.5281303923182986,-1.4666274418201053,0.0625,0.5185637519864768,1.0,9/18,13.25%,IL34;DAAM2;NOTCH1;TNFRSF21;PTPRZ1;TENM4;NF1;SLC45A3;TNFRSF1B
prerank,amino acid transport (GO:0006865),0.5380501911750944,1.4661273074935517,0.053231939163498096,0.9308576223650562,1.0,11/49,12.79%,SLC7A14;SLC36A3;SH3BP4;SLC36A4;SLC3A1;SLC25A47;SLC7A6;SLC1A4;SLC25A45;SLC25A44;PDPN
prerank,neutrophil chemotaxis (GO:0030593),0.524200797575006,1.4652470126455106,0.05086848635235732,0.9308145369127755,1.0,4/53,8.27%,CXADR;CCL5;TGFB2;LGALS3
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.5947536938191526,1.4646574801522863,0.06032171581769437,0.9290747787699396,1.0,8/30,10.33%,CLU;CD44;YJU2;ACKR3;BCL2L1;FBXO5;DDX39B;TWIST1
prerank,energy reserve metabolic process (GO:0006112),-0.5145321573102024,-1.463008655908701,0.05413105413105413,0.5254444239800479,1.0,4/19,6.03%,PID1;PRKAG2;LEPR;PHKA1
prerank,cellular response to fluid shear stress (GO:0071498),0.6800972054559374,1.4620566129700514,0.08239095315024232,0.9385164052480813,1.0,8/12,19.43%,KLF4;SREBF2;NFE2L2;MAPK7;HDAC3;MEF2C;ASS1;KLF2
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.5506223349035103,1.4615006288452972,0.06353240152477764,0.936475608973033,1.0,15/43,21.17%,FZR1;FOXN3;CDKN1A;NABP2;MRE11;HUS1B;TOPBP1;ABRAXAS1;DONSON;NBN;INTS3;CDK5RAP3;TAOK3;NABP1;CHFR
prerank,response to laminar fluid shear stress (GO:0034616),0.6989150745768486,1.4612089411919773,0.08305084745762711,0.9330885194869446,1.0,5/10,6.84%,KLF4;SREBF2;SMAD6;NFE2L2;MAPK7
prerank,vasculature development (GO:0001944),-0.5259298367171864,-1.461140433555963,0.0676056338028169,0.5272729261365718,1.0,8/16,17.15%,ERRFI1;PDGFRB;ACVRL1;PDGFRA;NOTCH4;FLT4;BMPR2;SOX18
prerank,regulation of peptide hormone secretion (GO:0090276),0.5152310502369049,1.4608356854490312,0.051932367149758456,0.9303193738886676,1.0,7/67,6.34%,DPP4;ITPR2;CCL5;CACNA1A;RAP1A;ALOX5;ABCC8
prerank,regulation of MAP kinase activity (GO:0043405),-0.3557326470959969,-1.4603416206069657,0.007936507936507936,0.525225083748018,1.0,32/92,19.60%,FLT1;PDGFRB;KSR1;PDGFD;PTPRJ;IL34;LYN;ROBO1;FGF2;DAB2IP;CDK12;IRAK3;LRRK2;SH2B3;TGFB1;PIK3CB;EZH2;TPD52L1;PIK3R6;KIT;NF1;CD300A;EDN1;SORL1;PIK3R5;EDN3;EGF;CD40;SPRY4;SPRY1;PAQR3;MST1R
prerank,negative regulation of B cell proliferation (GO:0030889),-0.5942078573463946,-1.4603185437373423,0.07792207792207792,0.5208604750225047,1.0,6/11,27.64%,LYN;TNFRSF21;CD300A;RC3H1;TYROBP;FCGR2B
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.6856109250649542,1.4599595373028886,0.09204368174726989,0.930397399110553,1.0,5/13,5.40%,CDH13;LDLR;SREBF2;CD81;CD9
prerank,positive regulation of inflammatory response (GO:0050729),0.5092366987377729,1.4583361653073696,0.054524361948955914,0.9350102446083618,1.0,14/86,9.73%,AGTR1;GPR4;NAPEPLD;IL17RA;NUPR1;NINJ1;IL15;IL16;CD81;NFKBIA;FEM1A;LBP;TNFRSF1A;NMI
prerank,negative regulation of autophagy (GO:0010507),0.5304938835238849,1.4578539764731597,0.058530510585305104,0.9327519695230767,1.0,12/54,14.87%,DAPL1;NRBP2;NUPR1;SNRNP70;TAB3;RUBCN;SMCR8;EIF4G2;WDR6;FOXK1;EIF4G1;WASHC1
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.506979289978163,1.4576736513150639,0.04508670520231214,0.929018234269253,1.0,15/72,8.31%,FN1;WNT16;FGFR1;NTRK3;CCL5;PLXNB1;PDGFC;GAB1;EPO;HAX1;MYDGF;ERBB3;TGFB2;UNC5B;MAZ
prerank,positive regulation of neuron death (GO:1901216),0.5388660091347218,1.4567540479331662,0.056265984654731455,0.9293305744623781,1.0,11/46,11.15%,CLU;DAXX;MAP3K5;EFNB2;NUPR1;FOXO3;FOS;TGFB2;TLR6;SRPK2;TLR4
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.6840387070245453,1.4566226329022756,0.08552631578947369,0.9254082028421903,1.0,2/12,2.17%,B3GALT1;B4GAT1
prerank,UV protection (GO:0009650),0.6987841765325953,1.4563812506932337,0.0761904761904762,0.9220135386201195,1.0,2/10,2.72%,SCARA3;FEN1
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.6045238350234003,1.4556010900545384,0.06881405563689605,0.9217272174985088,1.0,4/23,3.61%,ANK2;ATP1A2;DIAPH1;PTK2B
prerank,positive regulation of protein import into nucleus (GO:0042307),0.5880268257385873,1.4549859341312381,0.07702888583218707,0.9205884016722343,1.0,9/28,15.66%,CDH1;ZC3H12A;MAVS;BAG3;ZIC1;HDAC3;UBR5;ZPR1;FLNA
prerank,nucleotide catabolic process (GO:0009166),0.6383798669797849,1.4549603803738103,0.08641975308641975,0.9161632574962839,1.0,4/16,9.44%,NT5E;NT5C1A;NT5C2;DERA
prerank,regulation of activated T cell proliferation (GO:0046006),-0.45258040066209076,-1.4546649403316994,0.03614457831325301,0.5343142597751499,1.0,5/30,7.03%,IGF1;IGFBP2;LGALS9;IL18;IGF2
prerank,cellular response to cadmium ion (GO:0071276),0.6025887596820476,1.4546633702857874,0.0782608695652174,0.9131606383276991,1.0,5/24,8.53%,DAXX;MMP9;FOS;JUN;MAPK9
prerank,dermatan sulfate metabolic process (GO:0030205),0.6710219821866197,1.454172106739134,0.0717628705148206,0.9113623578311741,1.0,3/13,4.40%,UST;CHST12;DSE
prerank,aminoglycan metabolic process (GO:0006022),-0.6125725789303618,-1.4534268046411054,0.060209424083769635,0.5337891237866044,1.0,8/10,34.98%,XYLT1;XYLT2;B3GAT3;B4GALT7;CLN6;B3GAT1;CHST9;B3GALT6
prerank,calcium import into the mitochondrion (GO:0036444),0.7097078534439654,1.453381221259845,0.10154905335628227,0.9109714431783451,1.0,5/10,10.90%,MCU;MCUB;MICU1;AFG3L2;MCUR1
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.5439613655321446,1.4532882554902087,0.05419354838709677,0.9070258454466743,1.0,7/42,3.61%,CDH13;UTRN;EMP2;GFUS;CDK6;S100A10;PTK2B
prerank,dendritic spine organization (GO:0097061),-0.4610111803855982,-1.4532415802463574,0.07920792079207921,0.5301111220280019,1.0,7/26,12.25%,INSR;SHANK3;DOCK10;PAK3;EPHB2;IGF1R;MTMR2
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.5394604745851712,1.4528591955176253,0.06524466750313676,0.9048602293117637,1.0,16/48,16.81%,DOCK5;FBXW8;LIMS2;S100A10;PTPRD;DMTN;ILK;CDC42;DOCK1;RREB1;CAPRIN2;SS18L2;FLNA;TESK1;CRK;ABL1
prerank,proteoglycan metabolic process (GO:0006029),-0.44679823844020045,-1.4519952045808164,0.05442176870748299,0.529988599174827,1.0,11/26,16.87%,IGF1;ADAMTS12;SULF1;XYLT1;BMPR1B;CSGALNACT1;CHST8;CANT1;BMPR2;CHST10;B4GALT7
prerank,epidermis development (GO:0008544),0.5208903146908943,1.4519786572731066,0.048567870485678705,0.9050728137271913,1.0,10/56,8.89%,SCEL;LAMC2;EDA2R;WNT10A;CCN2;FLOT2;POU2F3;OVOL2;TGM5;GRHL2
prerank,focal adhesion assembly (GO:0048041),0.6183430067781202,1.4518449634059818,0.0703012912482066,0.9015404247612177,1.0,2/21,1.06%,SORBS1;ACTN2
prerank,adherens junction organization (GO:0034332),0.5379336309977222,1.4518075992088257,0.06060606060606061,0.8974937968536044,1.0,9/48,9.26%,CDH1;CDH13;NECTIN3;TJP1;CTNNA1;CSK;PVR;ANG;ACTB
prerank,transition metal ion transport (GO:0000041),-0.4393659161522201,-1.4517564655293058,0.058394160583941604,0.5263432449790928,1.0,10/35,12.48%,SLC30A10;TRPC3;TRPC4;SLC39A8;TFRC;ATOX1;TRPC6;TRPC5;TTYH1;SLC30A1
prerank,granulocyte chemotaxis (GO:0071621),0.5169463574136703,1.4516253217336814,0.04932182490752158,0.8942770351084851,1.0,4/55,8.27%,CXADR;CCL5;TGFB2;LGALS3
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.6270892152718021,1.4515343918091659,0.08779761904761904,0.8905803446373015,1.0,11/21,20.73%,DAG1;ADAM10;SPPL2B;HM13;BACE1;PRTN3;SPPL3;PRKCQ;SPPL2A;ADAM17;APH1A
prerank,cardiac cell development (GO:0055006),0.680105771958704,1.4512700865468335,0.09752066115702479,0.8878317577405586,1.0,1/11,0.07%,CXADR
prerank,negative regulation of protein transport (GO:0051224),0.5967989037066259,1.4510462034899512,0.09248554913294797,0.8848054588589672,1.0,8/25,13.93%,ADTRP;WWP2;HMGCR;CSK;CYP51A1;SNX12;SERGEF;RHBDF2
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.6429045682041007,1.4479583114735841,0.0794392523364486,0.8961911744685637,1.0,5/18,6.34%,MMP9;CAV1;ATP1A2;EPO;STK39
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.568601875964456,1.447108812298158,0.08287292817679558,0.8965449532229407,1.0,4/31,11.38%,FZR1;ARRDC3;DCUN1D5;DCUN1D1
prerank,regulation of gluconeogenesis (GO:0006111),0.5846911537929768,1.446808402758595,0.08831908831908832,0.8940594464277398,1.0,9/27,16.36%,PPARGC1A;OGT;EP300;ZNF692;NNMT;PDK2;PTPN2;PGP;DDB1
prerank,peptidyl-proline hydroxylation (GO:0019511),0.6844096203812289,1.446428065987107,0.09455128205128205,0.8918220274440409,1.0,2/11,7.16%,EGLN3;EGLN2
prerank,positive regulation of defense response (GO:0031349),0.5024509050440253,1.4454745263112678,0.04640371229698376,0.8925229921806468,1.0,20/89,15.83%,AGTR1;GPR4;NAPEPLD;CCL5;IL17RA;NINJ1;IL15;IL16;NFKBIA;FEM1A;POLR3B;TNFRSF1A;NMI;TLR4;POLR3C;MEF2C;TNIP1;TLR3;DHX9;POLR3G
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.676917546936943,1.445459228696259,0.07765451664025357,0.8885920026752204,1.0,3/12,4.40%,UST;CHST12;DSE
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.6978437216411054,1.4449979200664136,0.07606973058637084,0.8868674662425531,1.0,2/11,1.09%,CD44;KANK1
prerank,muscle contraction (GO:0006936),0.47348389652079936,1.4448807433138402,0.03808487486398259,0.8835061937295862,1.0,15/126,7.03%,SORBS1;MYOM2;UTRN;ACTN2;CALD1;VIM;TMOD3;SGCA;TMOD2;LMOD3;MYOT;CRYAB;GAMT;PXN;SNTB1
prerank,negative regulation of cell development (GO:0010721),-0.4703726144024647,-1.4446903526766535,0.04229607250755287,0.5447469709392366,1.0,7/25,15.38%,IGF1;FBN1;NOTCH1;APPL2;B2M;PTHLH;SORL1
prerank,actin filament depolymerization (GO:0030042),0.6858803221374566,1.4437996590662552,0.08914100486223663,0.8847916787742615,1.0,4/11,7.79%,GSN;MICAL2;TWF1;MICAL1
prerank,positive regulation of cation channel activity (GO:2001259),0.5398830630616838,1.4426737794768731,0.07362784471218206,0.8864301674300477,1.0,7/40,7.98%,ANK2;ACTN2;GAL;STAC3;ANK3;GSTO1;JPH2
prerank,amino acid import (GO:0043090),-0.48979711121486785,-1.4415093428306553,0.07419354838709677,0.5504841562661322,1.0,7/21,8.63%,SLC1A3;SLC6A13;SLC47A1;SLC7A5;SLC6A6;SLC1A1;SLC6A1
prerank,heterochromatin organization (GO:0070828),-0.5576859825517011,-1.441193545383248,0.09269662921348315,0.5470463012368815,1.0,6/14,17.33%,MECOM;PRDM16;SMCHD1;HMGA2;HP1BP3;SETDB2
prerank,atrial septum development (GO:0003283),0.6686769715272665,1.4410599986048174,0.09062003179650238,0.8908165503463183,1.0,4/13,12.26%,ANK2;NOTCH2;TGFB2;DAND5
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.5457242161925271,1.4404836757855983,0.07969151670951156,0.8898729036925309,1.0,22/42,21.35%,QARS1;EPRS1;VARS1;VARS2;FARS2;HARS1;CARS2;NARS2;LARS2;AARS1;EEF1E1;HARS2;TARS1;SARS1;SARS2;YARS1;TARS3;FARSA;DARS2;FARSB;NARS1;YARS2
prerank,positive regulation of neuron migration (GO:2001224),-0.5779391214279186,-1.4398600518747655,0.06217616580310881,0.546875579086025,1.0,5/11,13.56%,SEMA6A;RAPGEF2;DAB2IP;ARHGEF2;NIPBL
prerank,B cell receptor signaling pathway (GO:0050853),0.5589360903847889,1.4386819092535676,0.09416445623342175,0.8949901449572197,1.0,2/32,0.33%,PRKCB;NFATC2
prerank,epidermal cell differentiation (GO:0009913),0.5414127347159977,1.4385980684990232,0.07152145643693109,0.8915259462564543,1.0,2/41,0.45%,WNT16;SCEL
prerank,positive regulation of exocytosis (GO:0045921),0.5546119810279599,1.4377185314801557,0.07407407407407407,0.8922794546714098,1.0,15/35,20.28%,CFTR;SYTL4;UNC13D;SDC4;RAB7A;VPS4B;VPS4A;CHMP2A;PDCD6IP;STAM;TSG101;RAB2B;RAB27A;RAB9A;ATP6AP1
prerank,establishment of melanosome localization (GO:0032401),0.6200874535788754,1.4370624032307362,0.08957415565345081,0.8916793452503655,1.0,5/19,13.35%,RAB17;BLOC1S6;MLPH;MYO5A;MKKS
prerank,replicative senescence (GO:0090399),0.6669500850624778,1.4365844468194406,0.10049423393739704,0.8901773853563503,1.0,1/12,0.08%,WNT16
prerank,GPI anchor biosynthetic process (GO:0006506),0.5761657228775592,1.4360503682807824,0.08217270194986072,0.8889553843683707,1.0,12/30,19.29%,PIGU;GPAA1;PIGZ;PGAP2;PIGT;PIGA;PIGX;DPM2;PIGS;PIGN;PIGP;PIGQ
prerank,regulation of protein processing (GO:0070613),-0.48396435751248873,-1.43506933216562,0.07692307692307693,0.5584150575374457,1.0,9/21,25.78%,CCBE1;RUNX1;SERPINE2;LRRK2;NKD2;CLN3;GAS1;BAG2;ADAM8
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.673103145221596,1.4350055807898126,0.0945273631840796,0.8905091825152419,1.0,3/12,8.17%,SMO;GDNF;SIX1
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.5577021276636615,-1.434949578265093,0.0821917808219178,0.5545607355784317,1.0,7/13,20.98%,ENPP1;ENTPD1;ITPA;ENPP3;ENTPD3;ENTPD5;ENTPD6
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.6192000310499417,1.4348652791935546,0.08517350157728706,0.8874631467210775,1.0,7/17,16.81%,BAIAP2L1;NTRK3;HAX1;CDC42;BCAS3;HRAS;ABL1
prerank,response to acidic pH (GO:0010447),0.6593548165072618,1.4348456349707273,0.10833333333333334,0.8838316080626238,1.0,4/13,11.39%,GPR4;CHP1;RAB11FIP5;PKD2L1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.5224539326227176,1.4345271728643927,0.06715506715506715,0.8817980422212531,1.0,18/57,19.01%,FZR1;FOXN3;CDKN1A;MRE11;FBXO31;SDE2;CCND1;HUS1B;MDC1;TOPBP1;ABRAXAS1;CDK2;DONSON;NBN;CHEK2;ATF2;CDK5RAP3;TAOK3
prerank,AMP metabolic process (GO:0046033),0.6626468889234631,1.4337850306944409,0.1008130081300813,0.8817990364455708,1.0,4/13,9.99%,NT5E;NT5C1A;NUDT2;AK3
prerank,cellular response to cAMP (GO:0071320),0.564278060108267,1.4337288630807294,0.08575581395348837,0.8783522451913559,1.0,8/30,11.18%,CFTR;RAP1B;RAP1A;DMTN;AANAT;EZR;AQP1;RAPGEF3
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.6563555800251559,1.433673845561629,0.09561128526645768,0.8749422917574978,1.0,4/13,13.95%,B4GALNT2;NAGK;UAP1L1;GFPT1
prerank,response to organonitrogen compound (GO:0010243),-0.41753692668676734,-1.4295927628572525,0.027888446215139442,0.5676605571556378,1.0,16/38,21.67%,IRAK3;KAT7;RCN3;GLRA1;DNAJB12;SEL1L;DRD2;SYVN1;GLRA3;DHFR;ERLEC1;GLRA2;GLRB;BRSK2;NR1H4;UBXN6
prerank,regulation of protein import into nucleus (GO:0042306),0.5569917405976916,1.429031874196532,0.06455862977602109,0.8940318519368227,1.0,12/36,16.23%,CDH1;ZC3H12A;MAVS;BMP4;CHP1;BAG3;ZIC1;HDAC3;UBR5;ZPR1;FLNA;UFM1
prerank,negative regulation of nervous system development (GO:0051961),-0.5097772151184153,-1.4288676742484663,0.07479224376731301,0.565608925011144,1.0,6/17,15.38%,NOTCH1;APPL2;ROBO2;B2M;SLIT1;SORL1
prerank,cAMP-mediated signaling (GO:0019933),-0.45569884876967165,-1.4284499116251257,0.06188925081433225,0.5626609914624058,1.0,8/24,9.95%,PDE7B;KSR1;PDE3A;RAPGEF2;PDE4D;CAP2;ADCY1;PDE2A
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.5686622447062816,1.4283500885978047,0.08575380359612725,0.8939498209948719,1.0,10/27,16.82%,CD44;DDX5;PMAIP1;YJU2;SPRED3;TWIST1;EEF1E1;MDM2;ATR;KDM1A
prerank,regulation of wound healing (GO:0061041),0.535226665626126,1.4277374446857176,0.07865168539325842,0.8933073193162386,1.0,12/42,17.28%,CD109;KANK1;OCLN;CAV1;ALOX5;DMTN;CASK;ACTG1;ARFGEF1;HRAS;CRK;F2R
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.4720934947810009,-1.4264818897173204,0.07371794871794872,0.5651034585187574,1.0,7/25,9.23%,ERRFI1;CBLB;SLC6A9;EPHB2;ZFYVE28;SOCS5;PPARG
prerank,N-terminal protein amino acid modification (GO:0031365),0.6354675036560581,1.4263410078465322,0.11879699248120301,0.89679261393122,1.0,8/14,21.53%,PDF;NAA40;NTMT1;AANAT;NAA15;NAA10;NAA35;METAP1D
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.356876688372366,-1.4261722248239979,0.006134969325153374,0.5619063939435555,1.0,26/75,19.38%,PTPRJ;NR2F2;SLC8A1;SLC8A3;LYN;PKIG;DAB2IP;IRAK3;SH2B3;APC;PIK3CB;LRP6;IPO5;LRP5;PRKAR2B;NF1;RASIP1;CD300A;SORL1;MYOCD;HHEX;INCA1;PRKAR1B;SPRY4;SPRY1;PAQR3
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.5243779593421455,1.425515678147601,0.07878017789072427,0.8972488753480832,1.0,6/43,6.56%,PRKCB;SORBS1;KANK1;OGT;TSC2;ZBTB7B
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.6035386250160053,-1.4253960736743854,0.08695652173913043,0.5601395299599499,1.0,7/10,24.28%,PDE3A;PDE4D;PDE3B;PDE2A;PDE11A;APLNR;RNF157
prerank,lipoprotein localization (GO:0044872),0.6724211785281834,1.4253493609442094,0.1166936790923825,0.8944397465015483,1.0,2/11,5.89%,PRKCB;UNC119
prerank,negative regulation of stress fiber assembly (GO:0051497),0.5766884966751652,1.425111226998378,0.09248554913294797,0.8920853442532531,1.0,7/24,10.78%,PHLDB2;TJP1;ARAP1;TMEFF2;ARHGEF18;RHPN2;DLC1
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.40589069447820325,-1.4246597019461154,0.046413502109704644,0.558271133593503,1.0,10/40,8.35%,BMP6;ADGRV1;WNT4;SLC8A1;KL;BMPR1B;FBN2;TGFB1;PKDCC;ACVR2A
prerank,regulation of endocytic recycling (GO:2001135),0.6599323384379873,1.4242780519336304,0.10652920962199312,0.8925510286393075,1.0,3/11,10.93%,ACTN2;EHD1;ATP9A
prerank,Rho protein signal transduction (GO:0007266),0.5200810673137083,1.424227949084286,0.08962868117797695,0.8892387877104382,1.0,15/53,16.30%,AGTR1;CDH13;CELSR1;EPS8L2;CDC42EP4;CDC42EP5;ARHGAP29;CDC42;GNA13;RHOA;PDPN;RHOU;ARHGDIB;RIPOR1;ARHGEF1
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.444580843336419,-1.4229011439520654,0.04428044280442804,0.5598403593601042,1.0,6/27,5.61%,SLC1A3;SLC47A1;SLC6A9;SLC1A2;SLC7A5;SLC1A1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.5977045674545263,1.422841070073393,0.08083832335329341,0.8891146882047472,1.0,6/21,7.89%,EYA2;GDNF;BCL2L1;MAPK7;EYA1;UNC5B
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.5977045674545263,1.422841070073393,0.08083832335329341,0.8891146882047472,1.0,6/21,7.89%,EYA2;GDNF;BCL2L1;MAPK7;EYA1;UNC5B
prerank,embryonic appendage morphogenesis (GO:0035113),0.6641462435078613,1.4227058985690497,0.11267605633802817,0.8862200145106982,1.0,2/12,7.38%,MBNL1;TGFB2
prerank,regulation of glucose transmembrane transport (GO:0010827),0.6245248853428653,1.4226629785154323,0.10371517027863777,0.8829379861198544,1.0,2/18,2.01%,PRKCB;OCLN
prerank,regulation of multicellular organism growth (GO:0040014),-0.5315631990355331,-1.4224993932044157,0.08256880733944955,0.5569958681173064,1.0,3/15,2.23%,IGF1;GHR;STAT5B
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.41368100342355824,-1.4221061172707643,0.06276150627615062,0.5542143219013203,1.0,11/39,14.19%,ERRFI1;PTPRJ;TGFA;ITGA1;DAB2IP;SH3KBP1;ZFYVE28;PTPN12;PTPN3;GRB2;EPS15
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.39323954416700124,-1.421587116566329,0.039473684210526314,0.5518878488354438,1.0,21/48,22.82%,ROBO1;GAS6;IRAK3;NR1H3;PARP14;SH2B3;SLIT2;RFFL;SAMHD1;PPARG;NLRC5;PADI2;SLIT3;NR1H2;PELI3;CCDC3;CNOT7;TRAIP;SIGIRR;GPS2;YTHDF2
prerank,nuclear migration (GO:0007097),0.6496142373760699,1.4213058279157718,0.10815047021943573,0.8859342909743173,1.0,9/13,24.59%,DOCK7;SYNE3;PAFAH1B1;DYNC1H1;SUN2;TMEM201;HOOK3;CEP120;PCM1
prerank,melanosome transport (GO:0032402),0.622667899870129,1.4209928520958808,0.10534124629080119,0.8805261795583228,1.0,5/18,13.35%,RAB17;BLOC1S6;MLPH;MYO5A;MKKS
prerank,pigment granule transport (GO:0051904),0.622667899870129,1.4209928520958808,0.10534124629080119,0.8805261795583228,1.0,5/18,13.35%,RAB17;BLOC1S6;MLPH;MYO5A;MKKS
prerank,lipoprotein transport (GO:0042953),0.6920030656539885,1.4205853352276694,0.10945273631840796,0.879101465192126,1.0,2/10,5.89%,PRKCB;UNC119
prerank,response to UV-A (GO:0070141),0.649019059647006,1.4195894782796759,0.11661341853035144,0.8803271441495029,1.0,4/14,9.74%,OPN1SW;MMP9;TIMP1;CCND1
prerank,actin polymerization or depolymerization (GO:0008154),0.5160427959902651,1.419465618100476,0.08939974457215837,0.8775899945058355,1.0,14/50,12.08%,COBL;VILL;GSN;MICAL2;DIAPH1;CORO7;ENAH;TWF1;AVIL;ANG;MICAL1;MSRB2;ABI1;WASF1
prerank,negative regulation of cholesterol transport (GO:0032375),0.6996713497913787,1.419283179289108,0.10998307952622674,0.8750372795040674,1.0,2/10,11.06%,SREBF2;ABCA2
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.5937741783031355,1.4192466691976138,0.09226190476190477,0.8719019348087665,1.0,1/22,0.15%,CD55
prerank,negative regulation of protein metabolic process (GO:0051248),0.5214344212198259,1.4191935909822102,0.06607369758576874,0.8688168405016107,1.0,11/48,12.16%,CLU;LDLR;PFDN1;HMGCR;FLOT2;CRYAB;AZIN1;CYP51A1;BANP;SF3B3;SNX12
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.3428524847710298,-1.4191464551711297,0.02197802197802198,0.5553533812693681,1.0,47/107,21.37%,GRIK2;CDH2;NRG3;SLC8A3;GRID2;GRM3;SNCAIP;GRM7;LRRC4C;LGI1;GRM8;SLC12A2;MCTP2;DLGAP1;SYT1;LRRK2;GRM5;GRIK3;CLSTN2;NLGN1;LRP8;DGKI;CNTNAP4;GRIK1;GRIK4;TMEM108;NLGN3;DRD2;BDNF;CAMK2A;MCTP1;CLN3;KCNMB4;BAIAP3;CPLX2;GRM1;NPTX1;FMR1;PXK;KCTD13;STX1B;GRIK5;CX3CR1;CACNA1B;TPRG1L;RIMS1;DGKZ
prerank,blood circulation (GO:0008015),0.5108762947801853,1.4187067262300452,0.08964646464646464,0.8677995815973393,1.0,7/49,4.45%,AGTR1;SGCG;F5;COL4A3;SGCD;CYB5R3;EPO
prerank,artery development (GO:0060840),-0.47131147838173754,-1.4185746043195109,0.07560137457044673,0.5533964850106988,1.0,9/23,14.37%,ENG;ROBO1;ACVRL1;PKD2;ROBO2;PDE2A;NF1;TBX1;BMPR2
prerank,artery morphogenesis (GO:0048844),-0.4372397056176134,-1.4183492142289362,0.0756578947368421,0.5502470876804711,1.0,11/30,14.37%,PDGFRB;JAG1;ENG;ADAMTS9;NOTCH1;PKD2;TBX2;NF1;HPGD;TBX1;BMPR2
prerank,detection of visible light (GO:0009584),0.6397207931431373,1.418330387925147,0.10076335877862595,0.8662433727586669,1.0,8/16,20.91%,RP1;CACNA2D4;GNAQ;CNGB1;PDE6B;GNA11;ABCA4;TULP1
prerank,regulation of developmental growth (GO:0048638),-0.46382003039870834,-1.4174029364445258,0.0449438202247191,0.5494083773437051,1.0,5/29,2.23%,PLCB1;IGF1;GHR;INSR;STAT5B
prerank,negative regulation of complement activation (GO:0045916),0.6977682007020692,1.4168607225306666,0.08644067796610169,0.8699730108424776,1.0,1/10,0.15%,CD55
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.6516724337653484,1.4168287993849384,0.11682242990654206,0.8668707560308937,1.0,2/13,6.56%,SORBS1;ZBTB7B
prerank,regulation of lipid biosynthetic process (GO:0046890),0.5474242335925152,1.4165980300437948,0.07340720221606649,0.8647319889010948,1.0,6/32,7.24%,SORBS1;PRKAA2;CREBL2;AVIL;CREB1;EIF6
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.6884685355520677,1.4164839791588604,0.09615384615384616,0.8620079223666685,1.0,2/12,4.26%,CD44;GCNT2
prerank,melanocyte differentiation (GO:0030318),-0.5542845033277326,-1.415990836625302,0.11671087533156499,0.5500586584383858,1.0,6/11,21.22%,ENPP1;MITF;KIT;LRMDA;MREG;SLC24A5
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.500778040757984,-1.4159819656096209,0.08708708708708708,0.5463400435031655,1.0,7/19,11.38%,PTPRJ;TEK;KDR;TSC1;ROCK1;MAP4K4;MYOC
prerank,positive regulation of positive chemotaxis (GO:0050927),0.6308616743746183,1.4158272166582377,0.11603053435114503,0.8619204128522955,1.0,3/15,2.86%,CDH13;NTRK3;IL16
prerank,estrogen metabolic process (GO:0008210),0.6253088475011728,1.4142127444813997,0.0984375,0.8664722002612001,1.0,3/15,11.12%,SULT1A1;HSD17B14;HSD17B11
prerank,positive regulation of ossification (GO:0045778),-0.4165753403904151,-1.413491618257165,0.05909090909090909,0.550319492757171,1.0,11/39,8.35%,BMP6;ADGRV1;WNT4;SLC8A1;WNT5A;KL;BMPR1B;FBN2;TGFB1;PKDCC;ACVR2A
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.49644733749577147,1.4133973772122008,0.07446808510638298,0.867386621197928,1.0,17/66,15.76%,CDH1;LIMK2;ZC3H12A;MAVS;SESN2;ORMDL3;LARP7;BAG3;ZIC1;HDAC3;EIF2AK3;PINX1;UBR5;ZPR1;FLNA;TESK1;MEPCE
prerank,antibacterial humoral response (GO:0019731),0.6380679911084302,1.4133113973540237,0.09545454545454546,0.8645728116326608,1.0,6/16,19.32%,SLPI;ANG;RNASE3;PLA2G6;RNASE7;JCHAIN
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.659974329168447,1.413310698901037,0.08139534883720931,0.8614174364077241,1.0,6/13,12.85%,CLU;NUPR1;ALOX5;USP19;EIF2AK3;LPCAT3
prerank,response to cadmium ion (GO:0046686),0.5804112187106232,1.4132285307835226,0.08726752503576538,0.8586530127919781,1.0,5/26,8.53%,DAXX;MMP9;FOS;JUN;MAPK9
prerank,actin filament bundle assembly (GO:0051017),0.5406840245495976,1.4128496582486714,0.10364145658263306,0.8574364132313823,1.0,8/33,9.58%,BAIAP2L1;PAWR;CALD1;ESPN;ADD1;DMTN;MICAL1;EZR
prerank,cellular response to organonitrogen compound (GO:0071417),0.475805252160209,1.4127009825888452,0.056818181818181816,0.8550071947517629,1.0,21/99,14.09%,CDH1;CFTR;RAP1B;RAP1A;DIAPH1;CTNNA1;SESN2;SH3BP4;DMTN;AANAT;GOLPH3;CAPN2;ACTB;EZR;HTR1B;AQP1;RAPGEF3;CPEB3;TRPM2;MEF2C;SFRP1
prerank,protein localization to membrane (GO:0072657),0.44925377111536813,1.4106664799056328,0.030927835051546393,0.8617926182633907,1.0,36/187,10.18%,CDH1;FGF13;ANK2;TSPAN5;ACTN2;SLMAP;TTC7A;ANK1;EMP2;MAGI2;CAV1;ITGB7;RAP1A;CD81;S100A10;CACNB3;EHD1;ARL3;FYB2;RAMP1;FLOT2;FRMPD1;NPC1;SYNE3;ANK3;CPE;ZFYVE27;PACS1;RAB3B;STXBP1;NDC1;TNFRSF1A;MYO5A;EZR;KCNB1;SYNJ2BP
prerank,regulation of neuron apoptotic process (GO:0043523),0.4800290824242703,1.4101792351458695,0.05803571428571429,0.8610294785155475,1.0,18/96,10.70%,EGLN3;CRLF1;PPARGC1A;NRBP2;NUPR1;NGF;PTK2B;FOXO3;GDNF;CLCF1;EGLN2;ERBB3;TGFB2;UNC5B;SIX1;KCNB1;SRPK2;SOD2
prerank,sensory perception of pain (GO:0019233),-0.4816113122317868,-1.4097904877124225,0.08024691358024691,0.5581740270606764,1.0,16/21,38.45%,RETREG1;PTGES;MME;OPRM1;OPRK1;NIPSNAP1;TRPA1;CHRNA4;CCR2;KCNA2;CCL2;KCNK4;OPRL1;CHRNB2;ALOXE3;PROK2
prerank,epiboly involved in wound healing (GO:0090505),0.6273045939357016,1.409270632404795,0.109717868338558,0.8619903631870389,1.0,7/16,15.66%,CD44;TMEFF2;TOR1A;RHOA;PDPN;DDR1;FLNA
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.6510719179988216,1.4086906666988999,0.12557427258805512,0.8615885661813696,1.0,5/12,12.85%,SOAT1;DGAT1;ACSL3;SOAT2;LPCAT3
prerank,membrane raft organization (GO:0031579),0.6306013120821744,1.4086572744050836,0.1136,0.8586916119553576,1.0,5/15,6.89%,EMP2;S100A10;FLOT2;NPC1;ANXA2
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.6810395636489346,1.4071889756268012,0.12082670906200318,0.8622940105881242,1.0,2/10,6.81%,CAV1;ANK3
prerank,basement membrane organization (GO:0071711),-0.5420581235541767,-1.406946758858046,0.10761154855643044,0.5632940833273722,1.0,8/14,9.67%,FLRT2;NID1;NID2;COL4A1;LAMB1;NTN4;NTNG1;RAMP2
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.6521643158827595,1.4068987431844453,0.1072,0.8606621681977348,1.0,5/12,11.67%,PPARGC1A;ABCD1;MTLN;TWIST1;IRS2
prerank,dendritic cell differentiation (GO:0097028),-0.4828882690657702,-1.4066900842044554,0.08852459016393442,0.5603412880973349,1.0,5/22,4.50%,LYN;GAS6;AXL;CAMK4;LGALS9
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.6603297247520292,1.406285591423446,0.1029641185647426,0.8604760665704557,1.0,3/12,11.15%,VSIG1;MUC6;TLR4
prerank,regulation of stress fiber assembly (GO:0051492),0.4927012250431416,1.4042321926034387,0.06107784431137724,0.8668929869336339,1.0,27/74,16.86%,PHLDB2;LPAR1;TJP1;ARAP1;CCN2;WNT11;S100A10;TMEFF2;ARHGEF18;PXN;CDC42;ARHGEF5;RHPN2;ACTG1;DLC1;RAPGEF3;RHOA;ASAP3;ARHGEF10L;SFRP1;CCDC88A;ITGB1BP1;TESK1;PPFIA1;PFN2;ABL1;SLC9A1
prerank,positive regulation of intracellular protein transport (GO:0090316),0.4565040857777938,1.4041263509801356,0.03118279569892473,0.8643564373409452,1.0,42/144,16.87%,CDH1;SREBF2;BBC3;ZC3H12A;MAVS;PMAIP1;CD81;PPP1R13B;ANK3;BAD;PLK3;FZD5;TCF7L2;CHP1;YWHAB;BAG3;MIEF2;ZIC1;YWHAQ;MYO1C;KCNB1;AKAP5;BCAS3;HDAC3;RAPGEF3;SAE1;VPS11;YWHAZ;NPEPPS;RHOU;GSK3A;UBR5;GSK3B;HRAS;ZPR1;ITGB1BP1;RNF31;ITGB2;FLNA;RIPOR1;E2F1;UBE2D3
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.35079721521507296,-1.4038842424555966,0.04430379746835443,0.5653116183527227,1.0,30/75,17.33%,PTPRM;DCN;SULF1;SEMA6A;TEK;WNT4;CLDN5;PDE3B;DAB2IP;THBS1;COL4A2;SEMA3E;RGCC;THBS2;GTF2I;SERPINF1;ROCK1;MECP2;PPARG;ISM1;NPR1;SPARC;AMOT;AGO1;HSPG2;NAXE;STAB1;HHEX;MINAR1;SPRED1
prerank,macrophage differentiation (GO:0030225),0.6356563205701706,1.4035372141807485,0.12277867528271405,0.8642455724782795,1.0,4/13,8.48%,MMP9;IL15;BMP4;CDC42
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.5889160680231608,-1.4031896650796762,0.09653465346534654,0.5638072089328724,1.0,6/10,12.35%,DCN;KDR;BCL2;LRRK2;MYOC;RACK1
prerank,regulation of T cell chemotaxis (GO:0010819),0.6416855770436819,1.4023050681267033,0.1344,0.8670948076394573,1.0,4/11,8.45%,CCL5;ADAM10;STK39;OXSR1
prerank,"phototransduction, visible light (GO:0007603)",0.6327355494548663,1.4019365156345591,0.1187214611872146,0.865918094621266,1.0,5/14,15.14%,RP1;GNAQ;CNGB1;PDE6B;GNA11
prerank,regulation of cell morphogenesis (GO:0022604),0.5682271542721676,1.4012052184595263,0.08840579710144927,0.8662973844721179,1.0,12/30,18.38%,CD44;FMNL2;ZMYM6;CAPZB;EFNA5;MOV10;STRIP1;ZMYM4;PDPN;CAMSAP1;NTNG2;WTIP
prerank,presynapse organization (GO:0099172),-0.5892612094257976,-1.4008211497042609,0.10256410256410256,0.5673030773097958,1.0,5/10,16.06%,WNT5A;NLGN1;FZD1;NLGN3;LRRTM3
prerank,water-soluble vitamin metabolic process (GO:0006767),0.49033165910361703,1.4004115964037958,0.07793764988009592,0.8670444398197761,1.0,15/68,18.99%,CUBN;AMN;CYB5R3;GSTO1;NNMT;SHMT1;ALDH1L2;PCCA;SLC19A2;ALDH1L1;VNN1;MMAB;PDXK;SLC19A1;MCCC2
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.5225333337746733,1.4001412312226442,0.08439897698209718,0.8653110599151543,1.0,14/46,15.66%,CDH1;ZC3H12A;MAVS;TCF7L2;BAG3;ZIC1;HDAC3;RAPGEF3;UBR5;GSK3B;NEDD4;ZPR1;DHX9;FLNA
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.6538507263886087,1.3999972650685046,0.12400635930047695,0.8630798898026768,1.0,2/12,6.56%,SORBS1;ZBTB7B
prerank,cellular response to exogenous dsRNA (GO:0071360),0.6501473506792963,1.3999322451432117,0.09693053311793215,0.8604938860270026,1.0,6/12,19.46%,CAV1;MAVS;MUL1;DHX9;COLEC12;FLOT1
prerank,positive regulation of glucose metabolic process (GO:0010907),0.6457395062572006,1.3993068072151715,0.10551181102362205,0.8604661049217397,1.0,7/14,19.42%,PPARGC1A;PMAIP1;NNMT;IRS2;PTPN2;DDB1;GPLD1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.6056611852622436,1.3991596724867068,0.11349693251533742,0.8582838067406671,1.0,12/18,18.79%,KANK1;RAP1B;PTK2B;RIPOR2;KRIT1;LLGL2;BCAS3;ARFGEF1;CDH5;SHTN1;KIF20B;ROCK2
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.5890866117827303,1.3985360165983651,0.09821428571428571,0.8581570871331735,1.0,4/20,6.34%,ACTN2;MMP9;EPO;STK39
prerank,nucleotide biosynthetic process (GO:0009165),-0.49479777386746154,-1.3982995616154184,0.10909090909090909,0.571256983314581,1.0,5/18,11.72%,ME1;HPRT1;PRPSAP2;RRM1;PNP
prerank,cellular response to organic cyclic compound (GO:0071407),0.4559051387585575,1.3978917133496962,0.0457516339869281,0.8581871743680161,1.0,25/141,11.18%,CDH1;CFTR;ADTRP;NCOA3;CCL5;RORC;RAP1B;ZC3H12A;ATP1A2;RAP1A;DIAPH1;CTNNA1;FAM210B;INSIG1;LCOR;DMTN;AANAT;MSN;GOLPH3;ADCY6;ACTB;EZR;ARL6IP5;AQP1;RAPGEF3
prerank,filopodium assembly (GO:0046847),0.6148513422661075,1.3970566094046157,0.13122171945701358,0.8590637094256026,1.0,2/16,0.86%,RAB17;SRGAP2
prerank,positive regulation of phospholipase activity (GO:0010518),0.5774507484729946,1.3961708912100428,0.10533910533910534,0.8605178535508714,1.0,4/22,1.51%,AGTR1;FGFR1;NTRK3;CCL5
prerank,cardiac muscle cell development (GO:0055013),0.5898942676269051,1.395922389435884,0.11526946107784432,0.8588248886940062,1.0,3/20,3.66%,CXADR;PDLIM5;CSRP3
prerank,actin filament bundle organization (GO:0061572),0.5386048985196927,1.3955850680678057,0.10533910533910534,0.8575393100670702,1.0,8/33,9.58%,BAIAP2L1;PAWR;CALD1;ESPN;ADD1;DMTN;MICAL1;EZR
prerank,transepithelial transport (GO:0070633),0.6231284649113148,1.3952584621832818,0.11297709923664122,0.8561838602917218,1.0,1/15,0.07%,CXADR
prerank,Wnt signaling pathway (GO:0016055),0.46616215531030875,1.3947019663841478,0.07093821510297482,0.8559335609257055,1.0,16/92,8.41%,WNT16;WNT1;NXN;WNT10A;WNT11;DIXDC1;GPC4;WNT6;RARG;CPE;WLS;DVL3;WNT5B;FZD5;RBX1;TCF7L2
prerank,tRNA aminoacylation (GO:0043039),0.5306657464753705,1.3946556738476548,0.10144927536231885,0.8533795703913404,1.0,19/37,21.35%,QARS1;EPRS1;VARS1;FARS2;HARS1;LARS2;AARS1;EEF1E1;HARS2;TARS1;SARS1;SARS2;YARS1;GATB;FARSA;DARS2;FARSB;NARS1;YARS2
prerank,cell junction organization (GO:0034330),0.4828784504562759,1.3942084298119302,0.07491082045184304,0.8525001374783209,1.0,13/71,9.26%,CXADR;SDK1;TJP2;TJP1;OCLN;LIMS2;MYOT;TGFB2;ILK;CDC42;GRHL2;OPHN1;ACTB
prerank,cellular response to starvation (GO:0009267),0.45219827797669165,1.3941895632962926,0.05307855626326964,0.8497902636221524,1.0,11/147,3.80%,DAPL1;RNF152;PRKAA2;ATP6V1B1;MAP3K5;SREBF2;CDKN1A;ZC3H12A;PMAIP1;FOXO3;SESN2
prerank,signal transduction by p53 class mediator (GO:0072331),0.5510606957981733,1.3938593872967362,0.09322033898305085,0.8485717295299371,1.0,12/30,17.98%,FHIT;NDRG1;DDX5;PMAIP1;SESN2;PPP1R13B;USP10;ATRX;PDK2;POU4F1;NBN;TRIAP1
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.4788529643097327,-1.3937174654799793,0.08463949843260188,0.5821559570793673,1.0,9/21,10.37%,ENPP1;NOS3;GAS6;NOTCH1;ECM1;ASPN;TGFB1;ROCK1;BCOR
prerank,negative regulation of TORC1 signaling (GO:1904262),0.6472003688266649,1.3935340959673432,0.14035087719298245,0.8472298349800881,1.0,2/13,3.80%,RNF152;SESN2
prerank,ketone body metabolic process (GO:1902224),-0.5825390175610199,-1.3934745698359454,0.10669975186104218,0.5793527638208562,1.0,4/10,9.40%,ACSS3;HMGCLL1;HMGCS2;BDH1
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.6608395767136452,1.3933910571509145,0.13071895424836602,0.8452170478580697,1.0,5/10,14.44%,CCL5;ADAM10;STK39;OXSR1;WNK1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.5644101799393191,-1.3932842764923181,0.09898477157360407,0.5726131816083418,1.0,4/12,10.90%,IGF1;STIMATE;LMCD1;CHERP
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.5644101799393191,-1.3932842764923181,0.09898477157360407,0.5726131816083418,1.0,4/12,10.90%,IGF1;STIMATE;LMCD1;CHERP
prerank,leukocyte cell-cell adhesion (GO:0007159),0.5803682807308593,1.3927255319707914,0.10661268556005399,0.8455735577022526,1.0,5/24,9.58%,NT5E;CCL5;GFUS;MSN;EZR
prerank,lamellipodium organization (GO:0097581),0.5516192654370689,1.392649826374603,0.09349593495934959,0.8432143895903298,1.0,10/29,18.37%,CDH13;ABLIM2;ABLIM1;DMTN;GOLPH3;ARFIP2;WASF1;CCDC88A;VCL;ARHGEF6
prerank,regulation of lymphocyte migration (GO:2000401),0.6696388798550925,1.3920138604531302,0.15347334410339256,0.8433948999789325,1.0,5/10,21.66%,ADTRP;MSN;SLC8B1;JAM2;MIA3
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.6735840448010794,1.3916627183680577,0.12376237623762376,0.842295472409154,1.0,3/10,11.15%,ADTRP;TLR6;TLR4
prerank,regulation of cellular protein localization (GO:1903827),0.5155090511824069,1.391613362886815,0.09256844850065189,0.8398089470775796,1.0,12/45,11.21%,GPC6;PRKAA2;GPC1;NDEL1;GPC4;GPC3;DVL3;SUMO3;TOR1A;RAB11FIP5;ABCA2;CSNK1E
prerank,platelet degranulation (GO:0002576),0.46546731669646174,1.3914218196146462,0.04550499445061043,0.8380955360885057,1.0,16/118,8.78%,FN1;CD109;CLU;F5;ACTN2;PHACTR2;SYTL4;SCCPDH;TIMP1;CD9;ANXA5;TEX264;TGFB2;SRGN;STXBP1;VEGFB
prerank,nitrogen compound transport (GO:0071705),0.44839317213818847,1.3912106022764252,0.05644302449414271,0.8364178614226035,1.0,21/141,13.26%,CUBN;SLC7A14;SCAMP5;AMN;RAMP1;SLC48A1;SLC3A1;RAB7A;ARRDC3;NDC1;SLC25A47;ARL6IP5;TOM1;SLC7A6;SLC1A4;AQP1;SCAMP2;SLC25A45;SLC18A1;PDPN;CHMP1A
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.5236908030601316,1.391026460591458,0.09174311926605505,0.8346107443582241,1.0,6/39,6.34%,UTRN;ANK2;FHL1;WWP2;AHCYL1;STK39
prerank,regulation of inclusion body assembly (GO:0090083),-0.5627928489403937,-1.3907564971561424,0.12531328320802004,0.5766852370374572,1.0,7/11,31.24%,SNCAIP;SACS;DNAJB2;BAG5;DNAJB1;HSPA1B;HSPA2
prerank,negative regulation of defense response to virus (GO:0050687),0.6749047199648951,1.3904951940500887,0.11935483870967742,0.8343620807858132,1.0,6/10,24.21%,PPM1B;TARBP2;MUL1;ILRUN;PCBP2;C1QBP
prerank,positive regulation of vascular permeability (GO:0043117),0.6488277656787392,1.3904532872134756,0.1260229132569558,0.8319606370149017,1.0,4/12,2.01%,ANGPT1;TJP2;TJP1;OCLN
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.6862708569248609,1.390251724517329,0.12627986348122866,0.830282799114381,1.0,1/10,0.09%,PRKCB
prerank,cholesterol transport (GO:0030301),0.5176515902535086,1.3898560059004894,0.10025380710659898,0.8295061495867796,1.0,12/45,18.13%,CLU;LDLR;SOAT1;CAV1;STARD3;NPC1;SOAT2;STARD4;VPS4A;OSBPL5;RELCH;OSBPL2
prerank,intraciliary retrograde transport (GO:0035721),-0.5619315005860629,-1.3891923007136968,0.1189873417721519,0.5778691679667335,1.0,7/12,28.12%,IFT122;TTC21B;WDR19;IFT43;DYNC2LI1;DYNC2I2;IFT140
prerank,aerobic respiration (GO:0009060),0.580221693507151,1.388943876385034,0.12721893491124261,0.830905423093451,1.0,9/20,17.73%,SDHB;ME3;UQCRC2;MTFR1L;UQCRC1;MDH2;SLC25A14;UQCRH;MTFR2
prerank,positive regulation of protein sumoylation (GO:0033235),0.6768751117120355,1.3885410818162374,0.10945273631840796,0.8301499540940618,1.0,5/10,12.88%,HDAC4;MUL1;SAE1;PIAS1;PIAS3
prerank,proton transmembrane transport (GO:1902600),0.5261668370884728,1.388474791080824,0.08970976253298153,0.8278682623655389,1.0,14/36,22.82%,SLC36A3;ATP6V1B1;ATP1A2;SLC25A14;SLC25A27;HVCN1;ATP6V0D1;ATP5F1B;SLC9A1;ATP1A3;ATP1A4;ATP1A1;SLC4A11;ATP6V0E1
prerank,postsynaptic membrane organization (GO:0001941),-0.49285687615620355,-1.388412018661699,0.11384615384615385,0.5766559869865299,1.0,5/17,12.76%,GPHN;NRXN1;SHANK3;NLGN1;NLGN3
prerank,response to cAMP (GO:0051591),0.5290101023780818,1.3881964241430533,0.09831460674157304,0.8266169652136369,1.0,8/37,11.18%,CFTR;RAP1B;RAP1A;DMTN;AANAT;EZR;AQP1;RAPGEF3
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.6802015543232905,1.3880589894076274,0.1369150779896014,0.8247804181804513,1.0,9/10,30.13%,ACADL;ACADM;IVD;GCDH;ACAD11;ETFB;ETFA;ETFDH;ACADVL
prerank,circulatory system development (GO:0072359),0.45883636466632893,1.3869837575624462,0.05292171995589857,0.8270111553325312,1.0,16/118,8.24%,FN1;CXADR;NTRK3;PDLIM5;NXN;CDKN1A;MICAL2;AKAP13;CRB2;STRA6;FOXC2;TSC2;RBM20;ERBB3;TGFB2;PKD1
prerank,protein K11-linked ubiquitination (GO:0070979),0.567581475772063,1.3864440264499567,0.11477761836441894,0.8268892661234882,1.0,1/27,0.05%,FZR1
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.5319485818206464,1.3852638987495238,0.10695876288659793,0.8294448636354316,1.0,7/37,11.34%,PHLDB2;MAPRE2;PRKAA2;MAP6;EFNA5;GAS2L1;EPHA3
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.604539639952586,1.3843186887645471,0.12576687116564417,0.8310735880896705,1.0,1/15,0.18%,AGTR1
prerank,positive regulation of insulin secretion (GO:0032024),0.5249760161792196,1.3838806887885062,0.10204081632653061,0.8305175116399078,1.0,14/36,20.22%,CFTR;MCU;GLUD1;BAD;TCF7L2;TRPM4;IRS2;AACS;PLA2G6;NLGN2;STX4;GPER1;GPLD1;SOX4
prerank,cation transmembrane transport (GO:0098655),0.5219793548172127,1.383415697321543,0.09498680738786279,0.830062793376253,1.0,13/44,15.33%,TRPM3;ATP1A2;TRPM8;ABCC8;SFXN3;SLC36A4;SFXN1;TRPM6;SLC25A38;TRPM4;PKD2L1;TRPM2;SLC7A3
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.46577250047845936,-1.382768473211221,0.10179640718562874,0.5916349575487242,1.0,10/21,13.02%,SULF1;HS6ST2;NDST3;HS6ST3;XYLT1;EXTL3;XYLT2;EXT2;HS3ST3B1;B3GAT3
prerank,triglyceride catabolic process (GO:0019433),-0.47174339191057013,-1.3825228957460203,0.08038585209003216,0.5887187571782829,1.0,9/19,43.54%,LPL;PNPLA3;FABP7;PNPLA2;LIPH;LIPC;FABP4;FABP12;FABP5
prerank,cell chemotaxis (GO:0060326),0.4970222161694627,1.382192375319142,0.0925700365408039,0.8328123765732848,1.0,10/60,5.94%,AGTR1;LPAR1;CCR4;PARVA;CXCR4;ACKR2;ACKR4;CCR10;ACKR3;CCRL2
prerank,regulation of transmembrane transport (GO:0034762),0.536632711710384,1.3819904630412025,0.10109289617486339,0.8312727826531808,1.0,4/31,4.49%,PRKCB;OCLN;WWP2;KCNJ13
prerank,negative regulation of blood pressure (GO:0045776),-0.5469561706713214,-1.38168176155946,0.10991957104557641,0.5874927138858707,1.0,8/13,38.52%,NOS3;DRD2;BMPR2;PRCP;GPR37L1;APLN;NOS2;DRD3
prerank,transport along microtubule (GO:0010970),0.6325057986470175,1.3811640587814495,0.14285714285714285,0.8325539537544245,1.0,4/13,9.27%,DYNC1I1;ARHGAP21;CDC42;BAG3
prerank,myoblast fusion (GO:0007520),0.6731488168513963,1.3810901378732148,0.12950819672131147,0.8304136706689618,1.0,3/12,5.40%,ADAM12;CD81;CD9
prerank,regulation of tau-protein kinase activity (GO:1902947),0.6619224619551202,1.3807717573707967,0.13592233009708737,0.8293425690815452,1.0,1/10,0.40%,CLU
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.4645062393231748,1.3805803541648312,0.06451612903225806,0.827720404195023,1.0,17/100,8.31%,FN1;WNT16;FGFR1;NTRK3;PIK3IP1;CCL5;PLXNB1;PDGFC;GAB1;EPO;TSC2;HAX1;MYDGF;ERBB3;TGFB2;UNC5B;MAZ
prerank,regulation of cell adhesion (GO:0030155),0.44986464931562203,1.3805289858669756,0.04787812840043525,0.8254821942015539,1.0,20/129,7.84%,GPR4;CDH13;ANGPT1;CCL5;PLXNB1;PODXL;EPHA4;ADAM10;PKP4;PLXNA2;CXCR4;PTK2B;PPP2CA;RIPOR2;DUSP1;FBLN1;EFNA5;CBLL1;ERBB3;ZFHX3
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.3215554082973456,-1.37987406630737,0.0125,0.5897746884440653,1.0,40/138,13.71%,FLT1;PTPRG;ROR1;PDGFRB;EPHA7;TEK;IL31RA;INSR;MERTK;MPZL1;LIFR;LYN;PTK2;AXL;TIE1;PDGFRA;KDR;ACVR1B;EPHB2;EPHB4;ROR2;PIK3CB;NTRK2;JAK2;ACVR2A;ERBB4;FGFR2;RYK;AHI1;KIT;NPR1;BLNK;PTPRT;IGF1R;IL6ST;FGFR4;BDNF;FLT4;RET;EPHA5
prerank,positive regulation of calcium ion import (GO:0090280),-0.548245427741763,-1.379673206360047,0.105,0.5867933449201745,1.0,2/12,2.67%,PDGFRB;CXCL12
prerank,negative regulation of interleukin-8 production (GO:0032717),0.6010488984239666,1.3794651392085218,0.13260530421216848,0.8276347884860847,1.0,4/17,9.18%,KLF4;ANXA4;OTUD7B;TLR6
prerank,protein localization to cell junction (GO:1902414),0.5758956597196199,1.3788565166618787,0.1199421965317919,0.8278454586409694,1.0,6/22,11.60%,TJP2;TJP1;BSN;ARHGEF18;PCLO;JAK1
prerank,steroid hormone biosynthetic process (GO:0120178),0.5543796374384241,1.3779332712088295,0.11328671328671329,0.8295114268760408,1.0,6/29,11.12%,STARD3;HSD17B14;DHCR7;SRD5A3;FDX1;HSD17B11
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.6717370757177258,1.3776545014219532,0.13651877133105803,0.8259438668660243,1.0,3/10,14.44%,KLF4;MAPK7;WNK1
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.6717370757177258,1.3776545014219532,0.13651877133105803,0.8259438668660243,1.0,3/10,14.44%,KLF4;MAPK7;WNK1
prerank,canonical Wnt signaling pathway (GO:0060070),0.4800222892174937,1.3774621527398416,0.09436274509803921,0.8244185463953474,1.0,17/68,14.35%,WNT16;WNT1;WNT10A;WNT11;CAV1;DIXDC1;WNT6;RARG;DVL3;WNT5B;FZD5;TCF7L2;CSNK1E;WNT3;GATA3;SFRP1;GSK3B
prerank,maturation of LSU-rRNA (GO:0000470),0.5556465950902588,1.377201929199048,0.11657303370786516,0.8231756931270447,1.0,8/26,15.14%,NSA2;NOP2;PES1;EIF6;MAK16;RPL10A;RPF1;DDX18
prerank,response to ATP (GO:0033198),-0.48230980011192687,-1.3766737980183164,0.11246200607902736,0.5925523690707316,1.0,8/18,27.99%,TRPC3;ABCC9;SSH1;P2RY1;P2RY12;DGKQ;CIB2;TAF1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.5728984112496788,-1.3745038723360687,0.12949640287769784,0.5959596955792126,1.0,6/10,34.35%,LGALS9;CX3CR1;ARRB2;FCGR2B;CEACAM1;LILRB1
prerank,regulation of blood circulation (GO:1903522),0.5284268017822852,1.374117082711694,0.10107816711590296,0.8342667020677195,1.0,2/34,0.75%,AGTR1;CELF2
prerank,regulation of pH (GO:0006885),0.6467297636522322,1.3740461382118163,0.11658456486042693,0.8321892370294414,1.0,7/11,21.07%,ATP6V1B1;SLC9A7;PDK2;SLC26A4;SLC9A1;ATP6AP1;ATP1A4
prerank,cell-cell junction maintenance (GO:0045217),0.6802117642186778,1.373687816249933,0.13311148086522462,0.8312231894911911,1.0,4/11,17.28%,TJP1;NLGN2;PRTN3;F2R
prerank,tricarboxylic acid metabolic process (GO:0072350),0.6464320339422679,1.3735169757509287,0.12480252764612954,0.829631252432899,1.0,10/12,26.17%,IDH3G;GLUD1;ACO2;IDH3A;ASS1;SIRT4;ACO1;ACLY;IDH1;IDH2
prerank,negative regulation of macrophage activation (GO:0043031),0.6059139318501737,1.3721245116414882,0.12406576980568013,0.8332649362060213,1.0,3/16,2.55%,LDLR;CD200;ZC3H12A
prerank,primary neural tube formation (GO:0014020),0.5380872908494225,1.3715885683620113,0.1219195849546044,0.833242951059116,1.0,8/30,13.00%,CELSR1;COBL;LMO4;TSC2;TGFB2;GRHL2;DLC1;PLXNB2
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.5624775006175741,1.3707281561452278,0.11477761836441894,0.8345486359607286,1.0,8/23,16.86%,ATP6V1B1;SLC12A8;SLC9A7;PDK2;SLC12A4;SLC26A4;SLC12A6;SLC9A1
prerank,regulation of mast cell activation (GO:0033003),-0.5692422520387183,-1.3703188529420907,0.13212435233160622,0.6055319586102482,1.0,6/10,30.58%,LYN;PLSCR1;CD84;CRLF2;MILR1;CD300LF
prerank,tube closure (GO:0060606),0.5340352454749363,1.3698873920884946,0.12982005141388175,0.8358720684047172,1.0,8/31,13.00%,CELSR1;COBL;LMO4;TSC2;TGFB2;GRHL2;DLC1;PLXNB2
prerank,extracellular matrix organization (GO:0030198),0.43872895266831446,1.3696052129362437,0.031762295081967214,0.8346951651189819,1.0,26/276,3.20%,FN1;CDH1;ADAM12;ITGB4;THSD4;ITGA10;ADAMTS14;COL23A1;COL25A1;CD44;ITGB8;LAMA4;TMPRSS6;LAMC2;MMP9;COL4A3;SH3PXD2A;COL4A4;DAG1;ADAMTS7;ADAMTSL5;ADAM10;GSN;COL5A2;ITGB7;LAMA5
prerank,tight junction assembly (GO:0120192),0.4991937687695531,1.369472722511145,0.10137672090112641,0.8328846401509802,1.0,8/49,10.71%,CLDN11;POF1B;OCLN;LSR;PATJ;PARD6B;GRHL2;ACTG1
prerank,regulation of response to oxidative stress (GO:1902882),0.656706817053208,1.3687513506470035,0.13957307060755336,0.8337843305825985,1.0,3/11,5.07%,ABCD1;SELENON;ALOX5
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.5791681564694877,1.3668157765330684,0.11386861313868613,0.8399402590746218,1.0,3/21,7.53%,PRKCB;CD81;NFAM1
prerank,regulation of sequestering of calcium ion (GO:0051282),0.6348302088881442,1.3666857524807505,0.14756671899529042,0.8381714764125215,1.0,4/12,9.51%,ANK2;DIAPH1;PTK2B;MTLN
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.4611924243818241,1.36591581814662,0.06987399770904926,0.8393067406168768,1.0,16/95,7.21%,UST;ANGPT1;GPC6;ST3GAL4;GPC1;CHST12;HEXA;B4GAT1;GPC4;GCNT2;DSE;CHST11;SDC4;PRELP;CHPF;GPC3
prerank,aminoglycan biosynthetic process (GO:0006023),0.4991693110443967,1.3658612744595962,0.1095360824742268,0.8372132600308908,1.0,9/49,7.21%,B3GALT1;GPC6;GPC1;HEXA;B4GAT1;GPC4;GCNT2;SDC4;GPC3
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.6099487495557091,1.3651732120745377,0.13050075872534142,0.8377479838845202,1.0,3/15,4.40%,UST;CHST12;DSE
prerank,fatty acid beta-oxidation (GO:0006635),0.490412713666335,1.364884002167282,0.0962962962962963,0.8366895937230666,1.0,24/51,23.42%,ACOT8;ABCD1;ECHDC1;ACADL;EHHADH;MTLN;ACAT2;HADHA;SLC25A17;CPT2;ECI2;ACADM;AUH;HADHB;IVD;ECHS1;PEX2;DECR2;HSD17B10;CRAT;MECR;GCDH;ACAD11;DECR1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.6132917048017195,1.3647793470910163,0.11329305135951662,0.834802049523068,1.0,7/16,19.29%,PIGZ;PIGA;PIGX;DPM2;PIGN;PIGP;PIGQ
prerank,cellular response to chemokine (GO:1990869),0.49196086657807836,1.3645696210275724,0.11395646606914213,0.8334492609404188,1.0,9/46,8.45%,CCL5;ZC3H12A;PTK2B;ACKR3;RIPOR2;DUSP1;GPR75;STK39;OXSR1
prerank,negative regulation of protein secretion (GO:0050709),0.5245977173847987,1.364316953621705,0.11972789115646258,0.8322979439237447,1.0,12/38,17.28%,ADTRP;CD200;HMGCR;RAB11FIP3;CYP51A1;KCNB1;RAB11FIP5;SERGEF;RHBDF2;SFRP1;RAB11FIP1;F2R
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.4195412299297081,-1.3639456695340122,0.08196721311475409,0.6229365835338417,1.0,13/33,18.09%,IGF1;PIK3R1;NYAP2;PIK3CB;PIK3CD;NF1;IGF1R;HTR2A;EDN1;PIK3R5;SIRT2;MYO16;PIK3R2
prerank,regulation of cellular component movement (GO:0051270),0.5023737199569156,1.3632003787319402,0.1089238845144357,0.8347397223266708,1.0,22/49,20.15%,PRAG1;ARAP1;YTHDF1;ARHGAP18;CDK6;DIAPH1;DAPK3;CD9;ERBB3;RAF1;RHOA;ZSWIM8;PDPN;TGFBR3;MEMO1;IGBP1;ACTN4;ABL1;HDAC6;ROCK2;ADAM17;HBEGF
prerank,regulation of RNA splicing (GO:0043484),0.4723857922436247,1.3628717762268867,0.09518072289156626,0.8338432047314409,1.0,18/69,15.46%,MBNL1;AHNAK;AHNAK2;CELF1;SNRNP70;SON;POLR2A;RBM20;LARP7;HNRNPH2;SRPK2;SRRM4;HABP4;RPS26;SRPK1;ZPR1;GRSF1;MBNL2
prerank,positive regulation of cell death (GO:0010942),0.4836612240300119,1.3624742085719792,0.09348093480934809,0.8331520927766434,1.0,16/59,15.65%,CLU;DAXX;MAP3K5;EFNB2;ZC3H12A;CELF1;PRR7;FOS;RARG;BMP4;HP;HPR;MARK4;GSK3B;EIF4G1;ITGB2
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.5441705631501969,1.3618908612127303,0.10903873744619799,0.8333901847470964,1.0,8/29,14.69%,PLB1;MBOAT2;PLA2G12A;MBOAT7;LPCAT2;TMEM86B;LPCAT3;PLA2G6
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.410040251138456,-1.3613233641982245,0.08203125,0.6280512474159597,1.0,7/34,5.29%,FLT1;PRKD1;SEMA6A;VEGFC;KDR;NOTCH1;DAB2IP
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.5881452196504602,1.360995406506191,0.14069591527987896,0.8348505829414288,1.0,4/17,7.38%,CCL5;PODXL;FOXC2;TGFB2
prerank,glycosaminoglycan catabolic process (GO:0006027),0.4831621962156626,1.3609629018152165,0.09348093480934809,0.8327669217611919,1.0,15/55,11.10%,CD44;GPC6;GPC1;HEXA;GPC4;NAGLU;SDC4;PRELP;GLB1;GPC3;ARSB;STAB2;CHP1;GUSB;HEXB
prerank,positive regulation of cartilage development (GO:0061036),-0.49008848421700274,-1.3608074060569095,0.12058823529411765,0.6260248701831101,1.0,6/17,15.14%,SOX5;ACVRL1;BMPR1B;PKDCC;BMPR2;SOX6
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.568656806618642,1.3602788850598617,0.12324929971988796,0.8333824821242648,1.0,4/24,5.85%,CLU;CD44;ACKR3;BCL2L1
prerank,nucleic acid metabolic process (GO:0090304),0.4755626437032343,1.3599776256876,0.09188544152744631,0.832459021768647,1.0,21/69,19.73%,NT5E;GTF2F1;FEN1;RBFOX2;POLR2H;POLR2A;XRN2;HNRNPH2;POLG;DNASE1L2;TOPBP1;DNASE1L1;DUSP11;WTAP;POLR2C;RAD50;HNRNPA3;POLR2E;PTBP1;PCBP2;DXO
prerank,sensory perception of chemical stimulus (GO:0007606),-0.5141539300139814,-1.3598172330188067,0.09006211180124224,0.6256140225235354,1.0,7/15,22.43%,GNAS;UBR3;DRD2;GNAL;BBS4;SYT10;ADCY3
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.6328642174385744,1.3584805905175341,0.1573208722741433,0.8367118301261675,1.0,5/13,16.82%,CD44;YJU2;TWIST1;MDM2;KDM1A
prerank,melanosome localization (GO:0032400),0.5695772753714298,1.357102484701146,0.1370851370851371,0.8403016910106132,1.0,5/21,13.35%,RAB17;BLOC1S6;MLPH;MYO5A;MKKS
prerank,membrane protein proteolysis (GO:0033619),0.523231365296655,1.3569639775846158,0.12467532467532468,0.8386185780637652,1.0,16/37,20.73%,TMPRSS6;DAG1;ADAM10;AFG3L2;NAPSA;SPPL2B;CTSH;HM13;BACE1;PRTN3;SPPL3;PRKCQ;SPPL2A;ADAM17;RHBDD1;APH1A
prerank,positive regulation of biosynthetic process (GO:0009891),0.516409434097202,1.3563459461052665,0.11802853437094682,0.8389939298891584,1.0,8/40,11.15%,SORBS1;CCL5;VIM;CREBL2;CREB1;BMP4;TLR6;TLR4
prerank,L-glutamate transmembrane transport (GO:0015813),-0.565153250893562,-1.356303589961458,0.15037593984962405,0.6334509796170816,1.0,3/10,5.61%,SLC1A3;SLC1A2;SLC1A1
prerank,negative regulation of cytokine production (GO:0001818),0.4381911566477423,1.3562958681155353,0.052854122621564484,0.8370001749233179,1.0,22/163,10.20%,FN1;KLF4;TRIB2;CD200;ZC3H12A;TWSG1;ABCD1;IKBKE;MAVS;HOMER2;HOMER3;ANXA4;TRIM25;IRF3;OTUD7B;SRGN;LGR4;FOXP3;TLR6;PTPN6;EZR;PPP1R11
prerank,regulation of insulin secretion (GO:0050796),0.4580383813065191,1.3560837931249294,0.08095781071835804,0.8356921547627647,1.0,20/101,14.09%,DPP4;ITPR2;CCL5;CACNA1A;RAP1A;MCU;ALOX5;EFNA5;ABCC8;GLUD1;BAD;CDK16;TCF7L2;KCNB1;ITPR3;RAPGEF3;IRS2;KCNA5;AACS;SFRP1
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.5608779524043833,-1.3559291158289726,0.13262599469496023,0.6311195323989119,1.0,2/10,1.18%,ZEB2;RAPGEF2
prerank,regulation of autophagy (GO:0010506),0.43280776175806124,1.355598254918199,0.03730569948186528,0.8353339113653557,1.0,54/216,15.53%,DAPL1;RNF152;PRKAA2;ATP6V1B1;SREBF2;TPCN1;NUPR1;ZC3H12A;EEF1A1;EP300;FOXO3;DAPK3;DAPK1;HSPB1;MTDH;ORMDL3;SH3BP4;USP10;RHEB;HAX1;MAPK15;TRIM21;BAD;TAB3;EXOC7;EXOC4;RUBCN;FZD5;CAPNS1;SMCR8;MTMR3;OSBPL7;EIF4G2;WDR6;FOXK1;TFEB;EXOC8;VDAC1;PIP4K2C;GSK3A;VPS26B;ULK1;GSK3B;EIF4G1;ATP6V1E1;GAPDH;NEDD4;DNM1L;FLCN;ATP6V1D;WASHC1;PLK2;RB1CC1;ATP6V0D1
prerank,regulation of fibroblast migration (GO:0010762),-0.4645426232780328,-1.3545968633982233,0.11728395061728394,0.6318865474746095,1.0,9/20,17.77%,PTK2;FGF2;THBS1;APPL2;TGFB1;RFFL;GNA12;CLN3;PRR5L
prerank,manganese ion transport (GO:0006828),-0.5215311204336567,-1.3545717898315404,0.11733333333333333,0.6283914914458189,1.0,6/14,10.97%,SLC30A10;TRPC3;TRPC4;SLC39A8;TRPC6;TRPC5
prerank,respiratory system development (GO:0060541),-0.41851425767570416,-1.3544881352491036,0.09454545454545454,0.6251190990422945,1.0,14/32,18.01%,GLI2;FGF2;CHD7;FGFR2;LOXL3;SPEF2;BASP1;SMCHD1;NPHP3;ZIC3;RBP4;ABCA3;FGF9;DISP1
prerank,receptor-mediated endocytosis (GO:0006898),0.4466748671739046,1.3539879563598711,0.0570801317233809,0.8399771208012092,1.0,34/132,16.81%,CUBN;LDLR;CAV1;AMN;CD81;CLTB;FCHSD2;AP2A2;ASGR1;GPR107;ACKR3;RAMP1;CD9;CAV2;STAB2;GRK2;HP;HPR;HYOU1;FCER1G;AP2A1;WASF1;LMBR1L;PDLIM7;NEDD4;ARHGAP27;HSP90AA1;HSPH1;ITGB2;AP4E1;LRP3;CANX;COLEC12;LRP2
prerank,neural tube closure (GO:0001843),0.5292965971152072,1.353009994056279,0.12696335078534032,0.8417434100026645,1.0,9/34,13.00%,CELSR1;COBL;LMO4;TSC2;TGFB2;DVL3;GRHL2;DLC1;PLXNB2
prerank,endothelial cell development (GO:0001885),-0.43661222525332677,-1.352868946925225,0.0944055944055944,0.62704658602234,1.0,8/25,4.00%,COL22A1;RAPGEF2;PECAM1;PDE4D;RDX;PPP1R16B;COL18A1;COL15A1
prerank,regulation of calcium ion transport (GO:0051924),0.48938181686463467,1.352752949672068,0.08939974457215837,0.8406268642899716,1.0,6/54,3.43%,ANK2;STIM2;CCL5;IL16;HOMER2;HOMER3
prerank,negative regulation of leukocyte migration (GO:0002686),0.6641463724404101,1.3525228265510423,0.15248796147672553,0.8394391767386775,1.0,3/10,4.13%,ADTRP;CD200;BMP5
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.5593789645246305,1.3514901203857599,0.14032496307237813,0.8416330217273796,1.0,3/22,8.98%,NFATC2;DUSP10;FOXP3
prerank,protein polymerization (GO:0051258),0.48529896449776444,1.3509574736198233,0.10580645161290322,0.8416297612234109,1.0,10/56,9.61%,FGF13;COBL;GSN;DIAPH1;CORO7;ANG;MSRB2;CHMP4A;CHMP4B;HDGFL3
prerank,release of cytochrome c from mitochondria (GO:0001836),0.5855293026528476,1.350240287953276,0.13704819277108435,0.8425169229132575,1.0,5/17,10.70%,CLU;BBC3;BCL2L1;BAD;SOD2
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.42557246722560765,-1.350133273901294,0.07116104868913857,0.6325004259748498,1.0,11/29,15.56%,GRIK2;SLC4A10;SHISA6;EPHB2;NETO1;SHISA9;DRD2;CAMK2A;MCTP1;CLN3;NCDN
prerank,regulation of cell differentiation (GO:0045595),0.44206902821613225,1.349642694170942,0.06878306878306878,0.842876819795604,1.0,25/148,10.28%,PRKCB;PHLDB2;FGFR1;KLF4;MBOAT2;DAG1;RORC;EMP2;CCN2;DDX5;CDK6;NGF;GDNF;PPP2CA;PPP1R13L;FLOT2;LTBP4;ALOX5;PLEKHB2;ZFHX3;SIX1;LGALS3;CDK5RAP1;RAF1;FADS1
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.437417996477803,-1.3493114317500847,0.09210526315789473,0.6316041684597176,1.0,9/22,15.83%,APPL2;LRRK2;PTPRZ1;ID2;NES;GATA2;TAFA1;TOX;KDM2B
prerank,blood vessel morphogenesis (GO:0048514),-0.3697955350640236,-1.3486902541353172,0.07177033492822966,0.630000309087833,1.0,21/54,14.10%,FLT1;ENG;LAMA1;CCBE1;CDH2;GLMN;KDR;COL4A1;CYP1B1;SLC1A1;ID1;TGFB1;SOX17;LRP5;RAMP2;NF1;LOX;RASIP1;FLT4;TBX1;EGFL7
prerank,chondrocyte differentiation (GO:0002062),-0.4137750486383275,-1.348279814801363,0.0703125,0.6278175114617034,1.0,10/32,15.14%,SOX5;SULF1;RUNX1;BMPR1B;RUNX2;TGFB1;HMGA2;CCN3;BMPR2;SOX6
prerank,extracellular matrix disassembly (GO:0022617),0.49367487519772035,1.348061571574634,0.10824108241082411,0.847499676072627,1.0,15/53,13.09%,CD44;TMPRSS6;MMP9;ADAM10;HPN;GSN;TIMP1;TIMP2;KLKB1;CAPN2;LAMC1;CAPNS1;ADAM15;MMP12;EXOC8
prerank,response to glucocorticoid (GO:0051384),-0.43597607889013035,-1.3473120309579767,0.11870503597122302,0.6276044400066411,1.0,8/26,21.48%,SLIT2;BCL2L11;SLIT3;ADAM9;PDCD7;ZFP36;NR3C1;GOT1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.6045404044769168,1.347052440577104,0.14088820826952528,0.8496249026056859,1.0,3/16,5.85%,CLU;ACKR3;BCL2L1
prerank,sodium ion transmembrane transport (GO:0035725),0.4544899069203489,1.3458359253693284,0.09918319719953325,0.8525930069418588,1.0,6/84,2.79%,SLC9A2;SLC9A4;ASIC5;SCN3A;NALCN;ATP1A2
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.47020179342398827,-1.3455056172008422,0.0949367088607595,0.6303106792909334,1.0,8/17,8.73%,IL34;NOTCH1;SERPINE2;BIN1;TGFB1;PTPRZ1;ID2;TENM4
prerank,tRNA metabolic process (GO:0006399),0.5918024978774994,1.3451985860518116,0.1591240875912409,0.8529865455480332,1.0,10/17,21.35%,FARS2;TRPT1;POP1;THG1L;AARS1;RPP21;DTD1;SARS1;DARS2;YARS2
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.5043366821051198,-1.3450157936860792,0.11204481792717087,0.6285343684971151,1.0,3/14,12.36%,OSMR;PTGS2;IL6ST
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.6463676068248336,1.3445952120028568,0.14802631578947367,0.8532603394980057,1.0,2/11,10.50%,ACTN2;SNX33
prerank,negative regulation of immune effector process (GO:0002698),0.6127097505766199,1.3445118902209423,0.1695447409733124,0.8514634505318416,1.0,1/13,0.15%,CD55
prerank,cardiac muscle tissue development (GO:0048738),0.4858538117740369,1.343839496395953,0.12167300380228137,0.8521609921647623,1.0,8/50,6.80%,SGCG;NOTCH2;SGCD;AKAP13;GJB6;CSRP3;BMP5;BMP4
prerank,positive regulation of lipid catabolic process (GO:0050996),0.5760793008416412,1.3438187008830211,0.16666666666666666,0.8501073091800395,1.0,5/19,11.67%,ABCD1;ABHD5;MTLN;TWIST1;IRS2
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.4437219495830058,-1.3433766582258813,0.13398692810457516,0.6305957069610953,1.0,8/22,14.77%,CACNA1C;STIM1;ADGRV1;GRM3;CAP2;NF1;DRD2;EDNRB
prerank,positive regulation of protein metabolic process (GO:0051247),0.44911701231732076,1.3430726675349594,0.08453837597330367,0.8510205495846644,1.0,26/110,19.51%,FZR1;AGTR1;CLU;KLF4;WWP2;NFKBIA;MAPK7;EGLN2;GPC3;RAB7A;ABCA2;GSK3A;RAB1B;GSK3B;EIF4G1;NEDD4;PLK2;DDB1;NSF;PRMT1;ROCK2;RNF41;IDE;APP;KLF2;ASB5
prerank,bicellular tight junction assembly (GO:0070830),0.4938193017093666,1.3417984121664632,0.11772151898734177,0.8542748049041347,1.0,6/46,8.89%,CLDN11;POF1B;OCLN;PATJ;PARD6B;GRHL2
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.49760600052795995,1.3404073258153686,0.11853720050441362,0.8581076759429379,1.0,15/49,18.46%,CLU;SMAD6;EP300;CRYAB;PPM1A;NLRP2B;CDC42;PYDC1;RAF1;LDLRAD4;ULK1;GSK3B;PRKCZ;HDAC6;PARK7
prerank,positive regulation of locomotion (GO:0040017),-0.43379277031251606,-1.3403974439550719,0.08098591549295775,0.6369706493008916,1.0,14/27,32.92%,PDGFRB;SPOCK2;THBS1;TGFB1;CFAP20;RARRES2;P2RY12;CCL19;AKT2;PPM1F;AIF1;TRIM32;TREM2;CAVIN1
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.4589758656934077,-1.3395397162551854,0.11280487804878049,0.6364395134190313,1.0,7/20,10.04%,IGF1;PDGFRB;IGFBP5;VTN;ACE;SLIT2;CCN4
prerank,negative regulation of cellular catabolic process (GO:0031330),0.4819866766301694,1.3390036824847218,0.10059880239520957,0.8619756882028232,1.0,14/63,14.87%,DAPL1;NUPR1;TIMP4;TIMP1;TIMP2;TAB3;RUBCN;HP;EIF4G2;WDR6;FOXK1;GSK3A;EIF4G1;WASHC1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5539760317060988,-1.3383338410210335,0.12652068126520682,0.6369394629360593,1.0,3/11,6.51%,CAMK2D;NOS1AP;BIN1
prerank,histone H3-K4 trimethylation (GO:0080182),0.6390244767843549,1.3381678830450472,0.16943521594684385,0.8633932537737684,1.0,3/11,9.03%,OGT;BEND3;KMT2A
prerank,regulation of cytoplasmic translation (GO:2000765),0.5996074665616768,1.3378289094464149,0.15723270440251572,0.862699446974316,1.0,6/14,15.31%,CPEB2;YBX3;UNK;PKM;CPEB3;DHX9
prerank,fatty acid oxidation (GO:0019395),0.4759284995940461,1.337480136863292,0.11613691931540342,0.8619430764530199,1.0,17/57,14.62%,PPARGC1A;ABCD1;ADH7;ECHDC1;ACADL;EHHADH;PECR;MTLN;ACAT2;HADHA;SLC25A17;CPT2;ECI2;ACADM;AUH;ILVBL;HADHB
prerank,negative regulation of macroautophagy (GO:0016242),0.5356639873418292,1.3374516148841027,0.15130674002751032,0.8599447301689612,1.0,8/26,9.88%,NRBP2;NUPR1;TSC2;TMEM39A;RUBCN;CHMP4A;CHMP4B;SMCR8
prerank,neutrophil migration (GO:1990266),0.4747582904027986,1.337222668837675,0.11995104039167687,0.8588753924092029,1.0,2/58,1.51%,CXADR;CCL5
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.6232956140062645,1.3371712279696237,0.15599343185550082,0.8570083326367716,1.0,4/12,10.28%,ACOT8;ABCD1;ELOVL1;FADS1
prerank,muscle cell development (GO:0055001),0.5227836671547085,1.3364381089403088,0.14540466392318244,0.8579453849708253,1.0,3/30,1.59%,CXADR;ANK2;NEBL
prerank,apical junction assembly (GO:0043297),0.48188704355377726,1.336201424193689,0.11685116851168512,0.8567607736228455,1.0,7/53,8.89%,CLDN11;POF1B;OCLN;CTNNA1;PATJ;PARD6B;GRHL2
prerank,neuron apoptotic process (GO:0051402),-0.4491668411499844,-1.3350581730396913,0.10778443113772455,0.6437845916044351,1.0,7/19,12.14%,FAS;FAM162A;BCL2;CIT;TNFRSF21;TRPC5;BID
prerank,regulation of macrophage cytokine production (GO:0010935),-0.5153002343465629,-1.335038927645441,0.1320754716981132,0.6404846783884612,1.0,6/13,16.64%,WNT5A;SEMA7A;IRAK3;TGFB1;GPRC5B;CD74
prerank,eye photoreceptor cell development (GO:0042462),0.5876868072299024,1.3339503791081284,0.15748031496062992,0.8640225491656176,1.0,2/15,3.12%,RP1;CRB2
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.5756999973064999,1.333511913254706,0.1524390243902439,0.8639148170795236,1.0,1/17,0.15%,CD55
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.4289996627667937,-1.3331606279070025,0.10774410774410774,0.6432974286555827,1.0,6/26,7.47%,ERRFI1;TGFA;CBLB;NCK2;ZFYVE28;SOCS5
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.5428561219214233,1.3331138991118106,0.15138888888888888,0.8634864695512386,1.0,6/24,9.84%,EPHA4;PTK2B;NUB1;LATS1;PKD1;ATP5IF1
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.45617817644887354,1.332887428997284,0.1031390134529148,0.8623716469834408,1.0,28/101,17.30%,AGTR1;CYFIP2;KLF4;OGT;VIM;SAMD4A;YTHDF1;NFKBIA;RPS4X;PERP;EIF4A3;MSN;UPF3A;EIF6;BAD;EZR;VPS11;POLDIP3;CPEB3;PLXNB2;FXR1;UPF3B;EIF4G1;PYM1;HSP90AA1;EEF2;TBC1D10A;STUB1
prerank,peptidyl-tyrosine modification (GO:0018212),-0.3612162086321453,-1.3328500156282361,0.06666666666666667,0.6409752960501292,1.0,17/56,10.13%,FLT1;PDGFRB;TEK;INSR;LYN;PTK2;TPST1;PDGFRA;KDR;EPHB2;ABI2;PKDCC;JAK2;ERBB4;FGFR2;KIT;ABL2
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.3737018404880411,-1.3324195539333945,0.09523809523809523,0.638949013633012,1.0,16/46,12.83%,CDH2;NRXN1;SHANK3;GRM3;GRM7;GRM8;SYT1;LRRK2;GRM5;GRIK3;NLGN1;CACNG8;DGKI;GRIK1;NLGN3;DRD2
prerank,positive regulation of response to stimulus (GO:0048584),0.4995981980789441,1.3320454807418969,0.10756972111553785,0.864016876072493,1.0,13/40,15.31%,IL15;MAVS;SELENON;YPEL3;NSMCE4A;TGFB2;ILK;CDKN2AIP;GATA3;FXR1;MYC;EEF1E1;DHX9
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.39388712570596573,-1.3313094830363874,0.0931174089068826,0.6392751227985045,1.0,16/36,25.34%,SGMS1;FAS;DAB2IP;DEPTOR;BCL2;TPD52L1;DAPK2;TMBIM6;BDNF;NR4A2;CX3CL1;CX3CR1;TRAF1;CYLD;ASAH2;PYCARD
prerank,regulation of cell death (GO:0010941),0.44866346417852554,1.3310892402974848,0.10159817351598173,0.8658897645994422,1.0,23/94,15.42%,WNT16;CLU;SRGAP2;CCL5;CCN2;ZC3H12A;WNT11;CELF1;PRR7;CRYAB;CTSZ;GPR75;BMP4;CHMP4B;CHP1;HP;HPR;VPS4B;BNIP3L;DUS2;EIF4G1;SNCB;CHMP2A
prerank,regulation of protein secretion (GO:0050708),0.4435018120313313,1.3303305470024713,0.07222222222222222,0.8670605998299715,1.0,20/119,10.23%,DPP4;ITPR2;ADTRP;CCL5;SYTL4;CACNA1A;RAP1A;HMGCR;ALOX5;ABCC8;GOLPH3;TGFB2;ANG;CYP51A1;EZR;LLGL2;APBB1;KCNB1;IER3IP1;ITPR3
prerank,T cell differentiation in thymus (GO:0033077),0.5951613873390834,1.330105361009572,0.16927899686520376,0.8659265783722055,1.0,4/14,19.53%,GLI3;RABL3;MR1;ADAM17
prerank,protein homotrimerization (GO:0070207),-0.4997669690650304,-1.3300315817182098,0.12467532467532468,0.6370734730316128,1.0,11/14,37.95%,SLC1A5;SCARA5;SLC1A2;DISP1;MIF;MLKL;PNPT1;STEAP4;ASIC1;ALOX5AP;P2RX3
prerank,protein trimerization (GO:0070206),-0.4997669690650304,-1.3300315817182098,0.12467532467532468,0.6370734730316128,1.0,11/14,37.95%,SLC1A5;SCARA5;SLC1A2;DISP1;MIF;MLKL;PNPT1;STEAP4;ASIC1;ALOX5AP;P2RX3
prerank,negative regulation of lymphocyte migration (GO:2000402),0.6592046951317801,1.329860691548143,0.1826086956521739,0.8649396950307335,1.0,3/10,5.13%,ADTRP;CD200;RIPOR2
prerank,digestive tract morphogenesis (GO:0048546),-0.502121549986548,-1.3296685139709052,0.14402173913043478,0.6350255069263905,1.0,9/14,17.30%,PDGFRA;GLI1;SOX17;ID2;FGFR2;NIPBL;BBS7;SOX11;EPHB3
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.5613659103414446,-1.3289399879148645,0.1329923273657289,0.6341354603185448,1.0,5/11,7.45%,SEMA6A;ADAMTS9;EPN2;THBS1;PIK3CB
prerank,alanine transport (GO:0032328),0.6326454965855526,1.3287815616101715,0.17096774193548386,0.8673841258800882,1.0,3/10,10.87%,SLC36A3;SLC36A4;SLC1A4
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.5277562197860501,-1.3285353112215108,0.13447432762836187,0.6323559505016595,1.0,7/12,19.94%,ABCA1;NR1H3;PPARG;ITGAV;NR1H2;PPARA;ABCG1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.5901849278149567,1.327476603887912,0.17147435897435898,0.8708726176694013,1.0,8/15,20.40%,REEP3;RTN3;ZFYVE27;TMEM33;ATL2;REEP4;ARL6IP1;RAB10
prerank,regulation of neuron differentiation (GO:0045664),-0.3411306675193829,-1.3268066575851423,0.05982905982905983,0.6346291101165322,1.0,22/76,13.09%,TCF4;ZEB1;VWC2;NREP;MOSMO;BRINP3;NRCAM;BIN1;LRRK2;DTX1;ZFHX2;NLGN1;ROCK1;ID2;TIAM1;HEYL;IMPACT;BEND6;NEPRO;ARHGEF2;MMD;BDNF
prerank,negative regulation of hormone secretion (GO:0046888),0.6445356465556353,1.3263211577279859,0.18612521150592218,0.8735400930155304,1.0,3/10,15.60%,RAB11FIP3;RAB11FIP5;RAB11FIP1
prerank,lipid phosphorylation (GO:0046834),-0.5485266323781146,-1.3255535326390988,0.1588089330024814,0.6355029560240377,1.0,7/10,23.01%,DGKH;DGKB;DGKI;DGKG;DGKZ;DGKQ;DGKK
prerank,heart process (GO:0003015),0.586670871948866,1.3254165063256678,0.18,0.875331520623099,1.0,2/14,2.23%,SGCG;SGCD
prerank,actin filament polymerization (GO:0030041),0.5165920874662785,1.3252038060183062,0.1475177304964539,0.8741730373137195,1.0,6/29,7.83%,COBL;GSN;DIAPH1;CORO7;ANG;MSRB2
prerank,negative regulation of axonogenesis (GO:0050771),0.5290139052738774,1.3248905368876958,0.14245014245014245,0.8734555212040919,1.0,2/27,0.73%,FGF13;RTN4R
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.2942563247492682,-1.3245336813917403,0.0,0.6357781622715588,1.0,70/224,20.93%,PDE7B;SLC1A3;GRIK2;UNC13B;KCND2;NRXN1;NOVA1;CACNA1E;GRM3;GABRG3;GRM7;DLG2;SLC1A2;GRIN2A;GRIA3;CAMK4;GRIA2;CACNB4;PTCHD1;DLGAP1;SLC1A1;SYT1;RIT2;GRIN2B;GABRB1;GRM5;GLRA1;NLGN1;GABRG2;HTR7;GABRG1;LRP6;SLC6A1;CHRM3;PRKAR2B;APBA1;PLP1;SNAP25;DTNA;HCRTR2;MBP;GRIK1;GABRA3;GRIK4;NLGN3;GLRA3;HTR2A;AMPH;KCNMB4;GLRA2;GABRB2;CHRM2;MPZ;KCNQ3;GRM1;PRKAR1B;GABRA1;NPTX1;GLRB;RPS6KA1;RPS6KA3;GABRE;OPRK1;HRH1;KCNK3;SYT10;GRIA4;CACNA1B;KCNIP2;PCDHB16
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.32040853343682413,-1.3244446074968608,0.02608695652173913,0.6329455213450741,1.0,34/101,19.60%,FLT1;PDGFRB;PDGFD;CEMIP;IL34;RAPGEF2;ROBO1;WNT5A;PKD2;FGF2;DAB2IP;LRRK2;RGCC;DIPK2A;TGFB1;EZH2;TPD52L1;CCNY;PIK3R6;ETAA1;KIT;IRGM;HMGA2;SPDYA;EDN1;PIK3R5;EDN3;INCENP;EGF;MAP2K1;TCIM;CD40;CIB1;MST1R
prerank,regulation of macrophage differentiation (GO:0045649),-0.5005470085440185,-1.3243012438090878,0.13411078717201166,0.6303236081960722,1.0,6/15,18.79%,IL34;ID2;HSF1;RIPK1;C1QC;CSF1
prerank,heart development (GO:0007507),0.4287388002102056,1.3240112278093947,0.07783783783783783,0.875183442101626,1.0,20/150,7.38%,FN1;CXADR;SGCG;NTRK3;PDLIM5;CDKN1A;SGCD;MICAL2;AKAP13;STRA6;CSRP3;FOXC2;BMP5;TSC2;BMP4;MEF2D;RBM20;GPC3;ERBB3;TGFB2
prerank,regulation of leukocyte migration (GO:0002685),0.5870478157903473,1.3235814188787587,0.1579754601226994,0.8750070459182875,1.0,2/16,3.22%,ADTRP;CD81
prerank,positive regulation of stress fiber assembly (GO:0051496),0.4937789929468282,1.3235085281088987,0.13240857503152584,0.8733166264194543,1.0,18/44,18.79%,LPAR1;CCN2;WNT11;S100A10;PXN;CDC42;ARHGEF5;RAPGEF3;RHOA;ARHGEF10L;SFRP1;CCDC88A;ITGB1BP1;TESK1;PFN2;ABL1;FHOD1;ROCK2
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.49346688345737255,-1.3219944179265575,0.13675213675213677,0.6343060972385974,1.0,4/16,3.60%,PDGFRB;PDGFD;PTPRJ;PDGFRA
prerank,regulation of phosphorylation (GO:0042325),0.43689890802063047,1.321032971873219,0.09340659340659341,0.8814772799821982,1.0,18/120,9.57%,FN1;CCL5;OGT;CDKN1A;EMP2;EP300;SESN2;PPP2CA;KDM4D;HSPB1;NUP93;BMP4;EIF6;ILK;ANG;PML;NDC1;JMJD8
prerank,positive regulation of glucose import (GO:0046326),0.5616750894477069,1.3208605631287949,0.15859030837004406,0.8801065778637901,1.0,4/21,5.14%,SORBS1;OCLN;CREBL2;RHOQ
prerank,positive regulation of telomere maintenance (GO:0032206),0.5320317819874951,1.3207702973907527,0.13067400275103164,0.878475806617549,1.0,13/31,19.54%,NEK7;NABP2;MRE11;MAPK15;MAP3K4;ATRX;PML;TNKS2;NBN;PRKCQ;RAD50;PPP1R10;PNKP
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.47185352567522043,1.3205571471440074,0.10948905109489052,0.8773200086430114,1.0,19/62,18.86%,CLU;MMP9;YBX3;NFE2L2;EPO;HSPB1;ACKR3;BCL2L1;MAPK7;NDUFS3;SOD2;HYOU1;CREB3;OPA1;VNN1;MDM2;ARMC10;PARK7;CDKN2D
prerank,SNARE complex assembly (GO:0035493),0.6502401039192971,1.3204348859515005,0.16412859560067683,0.8758311945701481,1.0,5/10,21.67%,STXBP6;STXBP1;VAMP1;UVRAG;VAMP2
prerank,regulation of amyloid-beta clearance (GO:1900221),0.5777775344533534,1.3202711110932852,0.17709923664122137,0.8745043228486967,1.0,3/16,7.74%,CLU;HMGCR;CYP51A1
prerank,response to interleukin-6 (GO:0070741),-0.5481077521955238,-1.3198378936927329,0.12935323383084577,0.6380982551950115,1.0,3/10,11.17%,PID1;PTGIS;PTPRT
prerank,catecholamine metabolic process (GO:0006584),-0.5002257823844862,-1.3196419230944794,0.136986301369863,0.6356308714364194,1.0,4/14,24.06%,SNCAIP;DRD2;RNF180;DDC
prerank,regulation of calcium ion import (GO:0090279),-0.4411811241159776,-1.3191503798497222,0.14912280701754385,0.6339787982014342,1.0,3/21,4.78%,PDGFRB;CXCL12;PKD2
prerank,regulation of macrophage migration (GO:1905521),0.6410322796952816,1.319003168036291,0.1713810316139767,0.8778758461712096,1.0,4/10,12.19%,CD200;CD81;PTK2B;CD200R1
prerank,oligodendrocyte differentiation (GO:0048709),-0.47186430307173044,-1.318805361574467,0.11009174311926606,0.6321538304419654,1.0,7/19,15.62%,SLC8A3;SOX13;EIF2B3;PTPRZ1;TPPP;SOX6;MYRF
prerank,dendritic spine morphogenesis (GO:0060997),-0.4867971957773215,-1.318627625330682,0.15053763440860216,0.6297830856169819,1.0,4/15,6.15%,SHANK3;DOCK10;PAK3;EPHB2
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.5080322161527498,1.318249167021537,0.1335149863760218,0.8789252097613979,1.0,2/33,3.88%,DPP4;FOXC2
prerank,dicarboxylic acid catabolic process (GO:0043649),0.6146342558650056,1.3181477558364632,0.15822784810126583,0.8773262706929563,1.0,4/13,10.61%,GLUL;ACOT8;GLUD1;ACSF3
prerank,protein K63-linked ubiquitination (GO:0070534),0.4970527283016966,1.3179303209234017,0.13378378378378378,0.8763222315421113,1.0,19/41,22.38%,RNF152;WWP2;RNF5;TRIM21;MAGEL2;UBE2B;RNF126;PELI1;NEDD4;BFAR;UBE2N;PRPF19;STUB1;ZFP91;TRIM5;ARIH2;TRAF3IP2;UBE2V1;RNF168
prerank,positive regulation of chromosome organization (GO:2001252),0.604454402226215,1.3176876053131934,0.1674347158218126,0.8753362857432991,1.0,7/15,18.15%,FEN1;MRE11;ATRX;PML;NBN;RAD50;PPP1R10
prerank,cellular response to oxidative stress (GO:0034599),0.4354692543536756,1.317251721554095,0.09429824561403509,0.8751512440047428,1.0,20/118,11.20%,WNT16;PRKAA2;PPARGC1A;MMP9;CPEB2;ZC3H12A;FOXO3;FOS;SESN2;MGAT3;NFE2L2;DAPK1;NUDT2;PXN;ROMO1;JUN;MAPK9;SOD2;AGAP3;PDK2
prerank,arachidonic acid secretion (GO:0050482),-0.5614616695915099,-1.3169239608218697,0.1534526854219949,0.6289359192202217,1.0,7/10,41.10%,PNPLA8;ACE;DRD2;NMUR2;PLA2G5;DRD3;BDKRB2
prerank,arachidonate transport (GO:1903963),-0.5614616695915099,-1.3169239608218697,0.1534526854219949,0.6289359192202217,1.0,7/10,41.10%,PNPLA8;ACE;DRD2;NMUR2;PLA2G5;DRD3;BDKRB2
prerank,regulation of microtubule-based process (GO:0032886),0.5051508290377138,1.3166305017534568,0.14864864864864866,0.8757077970537004,1.0,11/36,17.34%,PHLDB2;PRKAA2;DIAPH1;MAP6;EFNA5;EPHA3;MARK4;GSK3B;MEMO1;IGBP1;HDAC6
prerank,cellular response to interleukin-6 (GO:0071354),-0.4284957045165109,-1.3164602291636425,0.14388489208633093,0.6275431963803103,1.0,15/26,28.01%,PID1;PTGIS;ST18;IL6R;JAK2;STAT3;PTPRT;IL6ST;YAP1;SMAD4;SOCS3;CBL;SPI1;FER;CEBPA
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.4896115609122262,1.316367505514864,0.15374507227332457,0.8748329390933297,1.0,11/43,12.94%,KLF5;KLF4;DDX5;FOXO3;FOS;BMP4;TGFB2;JUN;NFIB;SMARCA4;GATA3
prerank,positive regulation of telomere capping (GO:1904355),0.5675341938160527,1.3160475255902018,0.15922619047619047,0.8741877173759763,1.0,7/17,19.54%,NEK7;NABP2;MAPK15;MAP3K4;TNKS2;PRKCQ;PNKP
prerank,DNA catabolic process (GO:0006308),0.6225328177524064,1.3158641205876318,0.17109634551495018,0.8729211112446245,1.0,4/11,13.77%,XRN2;DNASE1L2;DNASE1L1;REXO4
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.3709982392387042,-1.3157452326917882,0.07327586206896551,0.626616758195025,1.0,15/44,20.88%,PTPRJ;LYN;DAB2IP;IRAK3;SH2B3;PIK3CB;DNAJA1;NF1;CD300A;SORL1;PDCD4;SPRY4;SPRY1;PAQR3;BMP7
prerank,regulation of filopodium assembly (GO:0051489),0.4989414174376166,1.3155732491167718,0.1306122448979592,0.8721562680107952,1.0,11/38,13.38%,RAB17;ARAP1;PALM;RIPOR2;RHOQ;CAPZB;DMTN;CDC42;BCAS3;FXR1;TRPM2
prerank,peripheral nervous system development (GO:0007422),0.540895940077159,1.3153821945453668,0.14890510948905109,0.8709553639244049,1.0,6/23,10.47%,GPC1;NGF;GDNF;GFRA3;ERBB3;ADGRG6
prerank,positive regulation of reproductive process (GO:2000243),-0.4071561346944157,-1.315124661928783,0.1079136690647482,0.6256048378350656,1.0,5/31,7.24%,PLCB1;PDE3A;LHFPL2;ACVR1B;GLRA1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.37882609441073856,-1.3150719296764766,0.07725321888412018,0.6229175903731433,1.0,9/43,7.47%,ERRFI1;PTPRJ;TGFA;ITGA1;CBLB;DAB2IP;SH3KBP1;ZFYVE28;SOCS5
prerank,cellular response to dsRNA (GO:0071359),0.5835420771379496,1.3149027971787342,0.15015479876160992,0.8709313742898851,1.0,6/15,19.46%,CAV1;MAVS;MUL1;DHX9;COLEC12;FLOT1
prerank,calcium-mediated signaling (GO:0019722),0.44490368985072576,1.3143643481411216,0.10686164229471316,0.8714002599767495,1.0,14/93,6.37%,AGTR1;NUDT4;ANK2;CCR4;CXCR4;MCU;PTGFR;RCAN1;ACKR2;ACKR4;CCR10;ACKR3;CCRL2;DMTN
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.5275642759579745,1.3139307304760117,0.14949201741654572,0.8711725454580678,1.0,7/27,10.78%,PHLDB2;TJP1;ARAP1;TMEFF2;ARHGEF18;RHPN2;DLC1
prerank,regulation of platelet aggregation (GO:0090330),-0.467386066885524,-1.3132593581903984,0.1329639889196676,0.625923800095925,1.0,4/17,7.16%,PRKG1;LYN;SERPINE2;SH2B3
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.5281373426090499,-1.3129994445253779,0.15544041450777202,0.6239597093164496,1.0,4/12,17.23%,LYN;RUNX1;CD300A;RC3H1
prerank,barbed-end actin filament capping (GO:0051016),0.5703949442143766,1.3129607650576718,0.16812865497076024,0.8713237800584964,1.0,6/18,6.22%,VILL;GSN;CAPZB;TWF1;AVIL;ADD1
prerank,actin filament capping (GO:0051693),0.5703949442143766,1.3129607650576718,0.16812865497076024,0.8713237800584964,1.0,6/18,6.22%,VILL;GSN;CAPZB;TWF1;AVIL;ADD1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.42156159720528885,-1.3125240813752306,0.12292358803986711,0.6224472926114124,1.0,12/25,25.51%,GRID2;GRIN2A;GRIN2B;LRRK2;GLRA1;NLGN3;DRD2;MPP2;RAB3GAP1;INSYN2A;ARRB2;CHRNA4
prerank,renal filtration (GO:0097205),-0.5518161843780316,-1.312406091609802,0.15968586387434555,0.6199789226230877,1.0,2/10,3.25%,SULF1;CD34
prerank,macrophage chemotaxis (GO:0048246),0.6366445312062585,1.3123666831131837,0.1762652705061082,0.8719168817526743,1.0,3/10,16.75%,CCL5;LGALS3;TAFA4
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.5540765804687542,1.311914018508127,0.17251908396946564,0.8717577826202516,1.0,6/20,12.11%,CNOT6;CELF1;MOV10;EIF6;MOV10L1;AJUBA
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.5537164675143762,1.311875484166965,0.17142857142857143,0.8699966529727673,1.0,8/22,17.68%,PPP2CA;DUSP10;PPM1B;DUSP1;PPM1A;PPM1D;PPP2CB;PDP1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.5879844992442033,1.3114408300479459,0.17477203647416414,0.86987074810861,1.0,1/14,0.18%,AGTR1
prerank,B cell homeostasis (GO:0001782),-0.5428789763587684,-1.311351681245747,0.15212527964205816,0.620245400663134,1.0,5/10,21.74%,LYN;DOCK10;NCKAP1L;TNFAIP3;DOCK11
prerank,negative regulation of cellular protein localization (GO:1903828),0.5057547818149706,1.3112149120724759,0.13770053475935828,0.8689507929546664,1.0,12/34,20.09%,ACTN2;CTNNA1;RIPOR2;OTUD7B;NSFL1C;LATS1;SNX33;GSK3B;FLCN;ROCK2;ILRUN;MAPT
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.4666427095607939,1.310449124397479,0.13924050632911392,0.8702748108497775,1.0,17/52,16.87%,SREBF2;BBC3;PMAIP1;PPP1R13B;BAD;FZD5;YWHAB;YWHAQ;SAE1;VPS11;YWHAZ;NPEPPS;RHOU;GSK3A;RNF31;E2F1;UBE2D3
prerank,regulation of telomere capping (GO:1904353),0.543733245082062,1.3103710528058317,0.16115107913669063,0.86866195452754,1.0,10/23,20.96%,NEK7;NABP2;MAPK15;MAP3K4;TNKS2;NBN;PRKCQ;RAD50;PNKP;TERF2
prerank,regulation of potassium ion transport (GO:0043266),0.5156562941328752,1.3093206935883577,0.1464088397790055,0.8709341859407086,1.0,5/31,6.81%,ANK2;ACTN2;FHL1;PTK2B;ANK3
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.4860805018492397,-1.3083474060307096,0.1661721068249258,0.6267987547759493,1.0,5/16,8.12%,HIF1A;NPR3;NOS1AP;PIK3CB;GCH1
prerank,bile acid and bile salt transport (GO:0015721),-0.42284196058273105,-1.3076600284759372,0.12380952380952381,0.6262663262241926,1.0,4/24,3.43%,ABCC4;SLCO2B1;SLCO1C1;NCOA1
prerank,mRNA splice site selection (GO:0006376),0.5234036543477322,1.307652729640869,0.14972527472527472,0.8759104889108411,1.0,13/30,20.95%,CELF2;CELF1;LUC7L3;KHDC4;SF3A2;SRSF9;ISY1;LUC7L2;SRSF1;SRSF5;SF3A3;SFSWAP;PUF60
prerank,regulation of intracellular protein transport (GO:0033157),0.5141709219847317,1.3076409158057531,0.13802435723951287,0.8740704149490619,1.0,13/32,24.59%,PTPN14;NDEL1;BMP4;PLK3;GCC2;BCAS3;RIPOR1;KIF20B;VAMP2;SIRT7;TPR;ICE1;PCM1
prerank,sterol biosynthetic process (GO:0016126),0.5130066836219603,1.306936121468305,0.16411682892906815,0.8750133544772815,1.0,13/33,18.18%,FDFT1;DHCR7;FDPS;HMGCR;INSIG1;PMVK;CYP51A1;MSMO1;ACAT2;SQLE;PLPP6;TM7SF2;HMGCS1
prerank,positive regulation of angiogenesis (GO:0045766),0.43552208433878126,1.306861455272489,0.10307017543859649,0.8734440166069045,1.0,24/108,12.27%,PRKCB;ADAM12;ITGB8;KLF4;ANXA3;TJP1;NINJ1;ZC3H12A;GAB1;FOXC2;HSPB1;MTDH;PKM;AGGF1;MYDGF;VEGFB;JMJD8;EMC10;TWIST1;AQP1;RAPGEF3;S100A1;JAK1;SP1
prerank,regulation of RNA metabolic process (GO:0051252),0.4590905497249311,1.3067376346995283,0.13277511961722488,0.8721161345356863,1.0,19/59,20.54%,MBNL1;AHNAK;AHNAK2;CELF1;SNRNP70;SON;RBM20;HNRNPH2;SRRM4;RASA1;GRSF1;MBNL2;OAS2;BRDT;IGF2BP3;PTBP1;IGF2BP2;PCBP2;IGF2BP1
prerank,nuclear membrane organization (GO:0071763),0.5521919372216305,1.3064063759107858,0.1607669616519174,0.8715902393423511,1.0,9/19,24.70%,NSFL1C;CHMP4B;TOR1A;VPS4A;TOR1AIP1;CHMP2A;GPER1;TMEM43;UBXN2A
prerank,vesicle transport along microtubule (GO:0047496),0.5475766029221577,1.3054334447135727,0.14756446991404013,0.8736904189293258,1.0,5/23,10.55%,DYNC1I1;NDEL1;KIF13A;KIF1C;PAFAH1B1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.5447693110116104,-1.3046201149866132,0.1561712846347607,0.632847890520888,1.0,4/10,16.47%,ESR1;PSMC6;TP53;HMGB1
prerank,response to muscle stretch (GO:0035994),-0.5021682135604238,-1.3044271190978631,0.1447721179624665,0.6306262513649886,1.0,4/15,2.51%,DMD;CDH2;SLC8A1;PTK2
prerank,positive regulation of T cell cytokine production (GO:0002726),0.5492019154478606,1.3040584014282388,0.17256637168141592,0.8775009539585072,1.0,3/20,8.35%,CD55;CD81;FZD5
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.621720633900257,1.3037006900516261,0.1782178217821782,0.877153104570826,1.0,4/11,5.26%,MMP9;GSN;PRR7;PIH1D1
prerank,negative regulation of cell death (GO:0060548),0.45061658159840334,1.303696970044656,0.11866359447004608,0.8753079312866071,1.0,21/88,15.46%,WNT16;CLU;SRGAP2;PPARGC1A;CD200;CCN2;WNT11;KANK2;BMP4;CHMP4A;CHMP4B;TIGAR;VPS4B;CD200R1;BNIP3L;DUS2;GSK3B;EIF4G1;NENF;CHMP2A;IKBKG
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.3887884135899518,-1.3022184382302553,0.12403100775193798,0.6346477601425522,1.0,11/35,9.95%,PDE7B;IRAG1;KSR1;PDE3A;RAPGEF2;PDE4D;GUCY1B1;CAP2;ADCY1;PDE9A;PDE2A
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.5356516742737709,1.301995384301845,0.18155619596541786,0.8804389274321095,1.0,5/23,9.73%,UACA;ZC3H12A;PPM1B;PPM1A;NMI
prerank,positive regulation of protein kinase B signaling (GO:0051897),-0.29056565728909417,-1.3014607056791698,0.0,0.634237361492516,1.0,34/150,12.69%,PDGFRB;HIP1;PTPRJ;TGFA;ENG;PIK3R1;TEK;INSR;KITLG;SEMA5A;PTK2;ESR1;GAS6;AXL;PDGFRA;MFHAS1;KL;FGF2;THBS1;IL18;IGF2;TGFB1;PIK3CB;GAB2;ERBB4;FGFR2;PIK3AP1;PIK3CD;KIT;MYOC;IGF1R;GRB2;TXN;FGFR4
prerank,axonal transport of mitochondrion (GO:0019896),-0.530214635216808,-1.301460180126374,0.16927083333333334,0.6314798077468964,1.0,5/11,15.90%,HIF1A;SYBU;ACTR10;NEFL;TRAK2
prerank,regulation of cell population proliferation (GO:0042127),0.40198107665795857,1.301368185194574,0.004,0.8811969451521735,1.0,94/691,9.08%,FN1;DPP4;EGLN3;AGTR1;CDH13;CLU;FGFR1;ZBTB7C;PTPN14;CRLF1;CHRM1;IGFBP6;NTRK3;CNOT6;WNT1;KLF4;TFAP2C;LAMC2;TJP1;TFAP2D;COL4A3;PDGFC;EFNB2;GRK5;CDKN1A;ADAM10;SMAD6;EMP2;NIBAN2;CD200;MAGI2;NUPR1;IL15;CDK10;PDF;CELF1;CDK6;CD81;SULT2B1;NGF;RBFOX2;PTGFR;TNFSF13;KANK2;PTK2B;SGK3;TNFRSF8;GDNF;NOP2;HDAC4;BMP5;CLCF1;GCNT2;EPO;TIMP1;PTPRU;CIAO1;DOT1L;NACC1;S100A11;CDK4;RPS4X;RARG;SH3BP4;TSC2;JUND;FOXM1;ZBTB17;KRAS;TES;SHC1;CGREF1;DDRGK1;MAPK15;BMP4;CCND2;ERBB3;TGFB2;STAT4;TGFB1I1;SLURP1;ROMO1;FGF22;SIX1;MAZ;JUN;TCF7L2;FBXO5;SSR1;ADAMTS1;PML;IL7R;FOXP3;BRD7
prerank,apoptotic process (GO:0006915),0.4135766923300512,1.3012143011738215,0.07572614107883817,0.8799443518955109,1.0,49/203,17.53%,EGLN3;RNF152;NOTCH2;CYFIP2;PAWR;OGT;BBC3;EP300;CXCR4;PMAIP1;PTK2B;DAPK3;PPP2CA;DAPK1;ZBTB16;AHCYL1;PPP1R15A;NUDT2;NFKBIA;IRF3;TSC2;BCL2L1;EFNA5;ERBB3;BAD;PLK3;TNFRSF10B;DPF2;RAF1;ADAM15;DLC1;FEM1B;PLSCR3;TGFBR2;FXR1;VDAC1;MYC;ING4;PAX3;YARS1;GAPDH;MDM2;IKBKG;ITGB2;PAK6;PDE1B;ERCC2;SIAH1;PIDD1
prerank,synapse assembly (GO:0007416),0.46033218058839515,1.3009878080381285,0.14200477326968974,0.8790047409237363,1.0,4/67,1.61%,CDH1;FGF13;SDK1;PLXNB1
prerank,Golgi ribbon formation (GO:0090161),0.5948601178620754,1.3005036927658076,0.17420435510887772,0.8791009389514371,1.0,7/13,19.43%,GOLPH3;GCC2;STX16;FHDC1;TMED5;VTI1A;MYO18A
prerank,metal ion transport (GO:0030001),-0.32754735801233703,-1.3003012766293593,0.03278688524590164,0.6322481178999354,1.0,20/86,14.11%,ITPR1;CACNA1C;CALCRL;SLC8A1;SLC8A3;CACNA1E;TRPC3;TUSC3;PKD2;TRPC4;SLC39A8;PANX1;SELENOK;RAMP2;TPT1;CACNG8;TRPC5;SLC30A1;CAMK2A;RYR2
prerank,DNA methylation (GO:0006306),0.5392724297325391,1.299646151801234,0.17045454545454544,0.8808642388341473,1.0,11/23,26.57%,FOS;BEND3;ATRX;ZFP57;DNMT3A;PPM1D;KMT2E;N6AMT1;TEX15;BAZ2A;EHMT1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.37077457390737933,-1.2993427444441645,0.09871244635193133,0.6324513739674072,1.0,11/40,8.90%,LEF1;JAG1;COL1A1;DAB2;NOTCH1;RGCC;TGFB1;EZH2;GLIPR2;AXIN2;TIAM1
prerank,regulation of phospholipase activity (GO:0010517),0.6280362314221005,1.2990856817144905,0.19686411149825783,0.8812078167444244,1.0,1/10,0.51%,FGFR1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.5188374541908335,1.298804734637516,0.1744186046511628,0.880451932265401,1.0,4/26,7.52%,CFTR;EFNA5;KLF7;CDK16
prerank,response to sterol (GO:0036314),0.6197872423213722,1.2985161228945519,0.19117647058823528,0.8797282024718497,1.0,5/11,12.14%,RORC;INSIG1;PMVK;ABCA2;TGFBR2
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.5412231150276383,1.297810425540111,0.17310443490701002,0.8808946708195305,1.0,5/23,8.17%,SMO;GDNF;BMP4;WNT5B;SIX1
prerank,protein oxidation (GO:0018158),-0.5213691002519126,-1.296575101568012,0.1868421052631579,0.6383489504260632,1.0,4/11,12.30%,LOXL1;TMX3;LOXL3;LOX
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.5533191055678812,1.2955388720503598,0.18125960061443933,0.8882279334102763,1.0,5/18,13.52%,CLU;EPHA4;ABCA2;SP1;GSK3A
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.5106928248007001,-1.2954688186987569,0.15873015873015872,0.6388905961947889,1.0,7/13,15.20%,LTBP1;FBN1;GREM2;FBN2;CD46;NRROS;CHRDL1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.3935558845485335,-1.2939755988211072,0.10112359550561797,0.6408471258731183,1.0,11/33,19.94%,LEF1;IL34;RUNX1;ID2;HSF1;TRAF6;RIPK1;CTNNBIP1;CD74;CSF1;FES
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.42618397315919343,-1.2938939065369004,0.13712374581939799,0.6384169612605504,1.0,7/26,7.58%,SHANK3;RDX;SYNPO;TSC1;ALMS1;SYNPO2;ROCK1
prerank,inositol lipid-mediated signaling (GO:0048017),0.46573180940824327,1.293087926174539,0.1559748427672956,0.896652615085388,1.0,13/50,11.75%,PITPNM2;FGFR1;PLCL2;PLCB3;PLCD3;OGT;NGF;PIK3C2B;PLCL1;PI4KA;EZR;IRS2;RHOA
prerank,GPI anchor metabolic process (GO:0006505),0.5293469017739987,1.292956692428516,0.1732394366197183,0.8953241141998936,1.0,9/26,19.42%,PIGU;PIGZ;PGAP2;PIGA;DPM2;PIGN;PIGP;PIGQ;GPLD1
prerank,positive regulation of gene expression (GO:0010628),0.4033395555222471,1.292177553890908,0.02710843373493976,0.8966537123508002,1.0,86/442,14.62%,FN1;WNT16;CLU;ANGPT1;ANK2;ITGB8;NTRK3;ADTRP;KLF4;PPARGC1A;SMO;VIM;SCAMP5;HPN;OCLN;GSN;SAMD4A;DDX5;YTHDF1;IL15;ZC3H12A;WNT11;EP300;CELF1;NGF;WNT6;NFE2L2;POLR2H;OLFM1;RPS4X;TAF1C;OVOL2;POLR2A;HOXA5;KRAS;MOV10;FOXD1;HCFC1;ZBTB7B;DDRGK1;EIF4A3;BMP4;ANK3;RBMS3;MSN;UPF3A;RBM20;EIF6;NFAM1;FGF22;MAZ;POU3F1;MAPK9;TENT4A;TLR6;TXK;ACTB;MAP2K2;EZR;POLR1C;MYO1C;MUSK;TWIST1;SRPK2;HABP4;ACTG1;POLR1E;TLR4;CALCOCO1;POLR1F;POLDIP3;SP1;EIF2AK3;WNT3;CPEB3;PLXNB2;FXR1;MYC;GSK3A;MEF2C;UBR5;UPF3B;GSK3B;PYM1;GAPDH;ZPR1
prerank,regulation of mitochondrial fusion (GO:0010635),-0.5332670268384035,-1.2921481961611232,0.18324607329842932,0.6412370612341596,1.0,3/11,11.56%,PID1;TFRC;ZDHHC6
prerank,response to estrogen (GO:0043627),0.5066739355777907,1.2921236606587674,0.1650485436893204,0.8950320148757815,1.0,9/31,18.34%,KRT19;CAV1;EP300;TRIM25;BCAS3;GATA3;SFRP1;SFR1;RARA
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.6083901451896108,1.2920459923005103,0.19902912621359223,0.8934802773678677,1.0,2/11,1.30%,TJP2;TJP1
prerank,cell junction assembly (GO:0034329),0.43777789101209297,1.291778951726553,0.11920529801324503,0.892762057131265,1.0,13/100,9.26%,FN1;CDH1;SDK1;TJP1;PKP4;LIMS2;ILK;PARD6B;FZD5;CDC42;GRHL2;OPHN1;ACTB
prerank,atrial septum morphogenesis (GO:0060413),0.6200193989511683,1.2908089824453273,0.189419795221843,0.8949561855173179,1.0,2/10,7.38%,NOTCH2;TGFB2
prerank,ribosomal large subunit biogenesis (GO:0042273),0.4662801845382351,1.2907626325914192,0.15834348355663824,0.8933309351910632,1.0,14/54,15.88%,NSA2;NLE1;NOP2;PES1;PPAN;EIF6;MAK16;SDAD1;NIP7;RPL10A;RPF1;HEATR3;PAK1IP1;RPL14
prerank,regulation of protein localization to nucleus (GO:1900180),0.48251886087091544,1.2906304753073226,0.1346153846153846,0.8919613724786961,1.0,20/43,23.72%,LIMK2;GLUL;CTNNA1;SESN2;ORMDL3;OTUD7B;BMP4;LATS1;SUMO3;EIF2AK3;GSK3B;FLCN;TESK1;PARK7;CDK5RAP3;ILRUN;BYSL;TPR;LATS2;WWTR1
prerank,cholesterol metabolic process (GO:0008203),0.45833621931941443,1.2903378101270517,0.14478527607361963,0.8913672769945725,1.0,19/68,18.18%,FDFT1;SOAT1;STARD3;SULT2B1;DHCR7;FDPS;HMGCR;INSIG1;PMVK;CYP51A1;MSMO1;FDX1;SOAT2;ACAT2;SQLE;OSBPL5;PLPP6;TM7SF2;HMGCS1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.4198723279043526,1.290229224043522,0.08713692946058091,0.8900052561877387,1.0,44/173,19.30%,CD55;ANK2;DYNC1I1;F5;NRBP2;ANK1;PEF1;ERGIC1;COPA;SPTBN2;TMED1;TFG;CAPZB;CTSZ;ANK3;ERGIC2;IER3IP1;BCAP31;ZW10;HYOU1;TRAPPC1;SPTAN1;MCFD2;VTI1B;ERGIC3;NAPA;GOLGB1;ARF4;COG8;PREB;VAMP7;RAB1B;CNIH1;ATL2;SEC23A;DYNC1LI2;NSF;DYNC1H1;COPG1;YKT6;TMED5;BET1L;SEC24B;VTI1A
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.5288956637569042,1.290175561591067,0.18349928876244664,0.8884052474370082,1.0,4/26,5.14%,SORBS1;OCLN;CREBL2;RHOQ
prerank,regulation of cation channel activity (GO:2001257),0.4466581215044611,1.2892869667079403,0.12958715596330275,0.8900191845917129,1.0,11/89,4.45%,FGF13;ANK2;ACTN2;SLMAP;AHNAK;MMP9;CACNB3;PTK2B;SELENON;DAPK1;EPO
prerank,positive regulation of calcium ion transport (GO:0051928),0.4958814309205246,1.2891113677683799,0.16036505867014342,0.8889347238777353,1.0,4/36,2.65%,ANK2;STIM2;CCL5;CAV1
prerank,synaptic membrane adhesion (GO:0099560),0.5812763201032539,1.2886527109295915,0.17480314960629922,0.8889128131389454,1.0,4/14,6.85%,GPC6;GPC4;PTPRD;PTPRF
prerank,negative regulation of cell motility (GO:2000146),0.42965666537473396,1.2882893693732143,0.11074197120708748,0.8886773853959421,1.0,18/108,8.39%,CDH1;SRGAP3;SRGAP2;KANK1;EPHA4;DAG1;MAGI2;WNT11;SPINT2;FOXO3;DUSP10;PTPRU;TMEFF2;FBLN1;MAPK15;CCDC125;SLURP1;PIP5KL1
prerank,negative regulation of cell activation (GO:0050866),0.5921151293129944,1.2879707462850667,0.1765601217656012,0.8881400733325946,1.0,3/14,6.08%,LDLR;CD200;THBD
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.5700292320223079,1.287333439948531,0.1933028919330289,0.8890106491569787,1.0,6/16,13.91%,EP300;NAA40;AANAT;NAA15;NAA20;NAA10
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.5711333301139813,1.2867858115055737,0.19148936170212766,0.8894193619404198,1.0,3/16,7.30%,RAET1E;LAMP1;PVR
prerank,inorganic cation import across plasma membrane (GO:0098659),0.44666750413460327,1.28645230136444,0.1292270531400966,0.8890461767827551,1.0,12/75,14.06%,SLC9A2;SLC9A4;SLC12A8;ATP1A2;KCNJ13;SLC39A6;SLC9A7;SLC9A6;TRPM4;SLC12A4;TRPM2;ATP2B4
prerank,positive regulation of cell differentiation (GO:0045597),-0.27710899671850847,-1.2863888467121085,0.041666666666666664,0.6562963990597606,1.0,50/237,10.04%,TCF4;PLCB1;BMP6;SOX5;IGF1;ZEB1;LEF1;PRKD1;PRKCH;COL1A1;RAPGEF2;CDH2;DAB2;KITLG;WNT4;BOC;ZHX3;MEDAG;VWC2;AR;ACVRL1;CD34;KDR;TMEM100;SLC6A6;BMPR1B;RUNX2;BRINP3;IL18;NRCAM;CTNNA2;RGCC;FBN2;PPARD;TGFB1;PKDCC;IL6R;EZH2;GLIPR2;ID2;ACVR2A;AXIN2;NUDT21;TIAM1;HEYL;LRP5;PPARG;BTG1;IMPACT;CCN4
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.40581012722411514,-1.2860314988580621,0.1474820143884892,0.6546900270363708,1.0,6/26,8.12%,POR;HIF1A;NPR3;NOS1AP;PIK3CB;GCH1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.6178961659050553,1.2858709845780618,0.19627749576988154,0.8896310688404976,1.0,3/10,11.20%,OGT;ZNF692;PDK2
prerank,sensory perception (GO:0007600),-0.36268139134762784,-1.2858353247418535,0.125,0.6526082313524237,1.0,26/45,36.58%,GNAS;ADGRV1;PCDH15;TTC8;RETREG1;ADORA2A;PTGES;MME;GNAL;OPRM1;BBS4;OPRK1;NIPSNAP1;NTSR2;WHRN;TRPA1;CHRNA4;CDH23;CCR2;KCNA2;CCL2;KCNK4;OPRL1;CHRNB2;ALOXE3;CLRN1
prerank,positive regulation of ERAD pathway (GO:1904294),0.5885612280043284,1.2858328413462734,0.21166666666666667,0.888000493409236,1.0,4/13,10.39%,CAV1;NFE2L2;TMEM259;BCAP31
prerank,protein hydroxylation (GO:0018126),0.5803786385671459,1.2855951861305837,0.20030581039755352,0.8871697276777346,1.0,1/15,0.09%,EGLN3
prerank,steroid catabolic process (GO:0006706),0.612445237933223,1.284797091752641,0.20240137221269297,0.8886232517921134,1.0,3/10,19.55%,HSD17B14;HSD17B11;YWHAH
prerank,neuromuscular synaptic transmission (GO:0007274),0.553656310601589,1.2847096006685121,0.2055800293685756,0.887204337399231,1.0,4/18,6.66%,FCHSD2;STAC3;FCHSD1;KIF1B
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.5569202007210262,1.283762134028866,0.1831831831831832,0.8891804319055739,1.0,4/19,5.96%,CLU;RTN1;FLOT2;RTN3
prerank,regulation of platelet activation (GO:0010543),-0.43632342186714307,-1.2836329384743344,0.16307692307692306,0.6566940946624094,1.0,4/21,3.60%,PLA2G4A;LYN;NOS3;PDGFRA
prerank,negative regulation of T cell differentiation (GO:0045581),0.6297788484334947,1.2835100377113042,0.2124600638977636,0.8884710698952487,1.0,2/10,6.80%,GLI3;BMP4
prerank,dendritic cell chemotaxis (GO:0002407),0.577721139414094,1.283132609422991,0.20153846153846153,0.8882479081138489,1.0,4/14,13.38%,CCL5;CXCR4;TRPM4;TRPM2
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.40780004262047737,-1.282616864362741,0.1461794019933555,0.6572179055016362,1.0,12/28,31.06%,CD47;SH3KBP1;NCKAP1L;CYRIB;HSPD1;TYROBP;NOD2;PYCARD;TNIP2;CCR2;PRKDC;CCL2
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.5572591240888156,1.2824658931513582,0.21225710014947682,0.8891675852021713,1.0,1/17,0.66%,ANK2
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.5627302948643039,1.2824561537852188,0.20726172465960666,0.8874721884019174,1.0,3/17,7.30%,RAET1E;LAMP1;PVR
prerank,respiratory tube development (GO:0030323),-0.41310523310202396,-1.2823005433675532,0.1368421052631579,0.6555838070448585,1.0,10/28,15.71%,PCSK5;GLI2;FGF2;FGFR2;LOXL3;NPHP3;ZIC3;RBP4;ABCA3;FGF9
prerank,regulation of stem cell population maintenance (GO:2000036),0.5573915942608496,1.2806088805213138,0.1936416184971098,0.8929708049884789,1.0,5/18,13.47%,NCOA3;ESRRB;WDR43;PTN;MYC
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.5284637778896155,1.2802859747584032,0.17372262773722627,0.8924988559744911,1.0,9/22,15.28%,NTRK3;MAGI2;RAP1A;NGF;EHD1;RAB35;WASF1;SH3GL2;RAPGEF1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.45032007553148695,-1.2801978836999754,0.17352941176470588,0.6595236225110029,1.0,12/18,28.01%,ST18;IL6R;JAK2;STAT3;IL6ST;YAP1;SMAD4;SOCS3;CBL;SPI1;FER;CEBPA
prerank,defense response to bacterium (GO:0042742),0.4344375664026268,1.2794090929778101,0.1281767955801105,0.8941964525382862,1.0,23/105,15.49%,ANXA3;GALP;MAVS;SLPI;PGLYRP3;EPX;CFP;SHC1;ANG;ROMO1;STAB2;LBP;TLR6;RNASE3;PPP1R11;AQP1;TLR4;ANKRD17;FCER1G;PLA2G6;TLR3;MR1;OAS2
prerank,motor neuron axon guidance (GO:0008045),0.5688918678167287,1.2788171637321817,0.19906687402799378,0.8947585063311599,1.0,2/15,1.67%,LAMC2;EPHA4
prerank,plasma membrane invagination (GO:0099024),0.508300399383986,1.2780777597733262,0.15568022440392706,0.895899067981111,1.0,9/29,15.65%,GSN;GULP1;CDC42;SNX33;SNX18;RHOA;DOCK1;VAMP7;ITGB2
prerank,in utero embryonic development (GO:0001701),0.5203637106757671,1.2775936669399848,0.19146005509641872,0.8961677917201194,1.0,4/25,8.24%,MBNL1;ADAM10;FUT8;PKD1
prerank,aerobic electron transport chain (GO:0019646),0.44942351639026057,1.2774426000338803,0.15995260663507108,0.8950180977745908,1.0,25/68,21.43%,NDUFV1;NDUFB11;UQCRC2;COX5A;NDUFB8;COX8A;UQCRC1;NDUFB6;NDUFS3;COX7A2L;COX5B;AFG1L;NDUFAB1;NDUFB7;NDUFV2;NDUFA1;UQCR11;NDUFB4;UQCRH;NDUFB5;NDUFB9;COX4I1;COX10;NDUFA2;NDUFA12
prerank,positive regulation of chromatin organization (GO:1905269),0.5968200424629677,1.2771774400570157,0.20945945945945946,0.8943832549586782,1.0,6/12,23.34%,DAXX;ATRX;UBE2N;H3-3A;TERF2;TINF2
prerank,establishment of spindle orientation (GO:0051294),0.5131254299607239,1.2765221397629096,0.1807909604519774,0.8952162068533622,1.0,11/28,22.94%,NDEL1;NSFL1C;MAP4;LLGL2;PAFAH1B1;ZW10;INSC;NUMA1;MISP;LLGL1;ITGB1
prerank,signal transduction in response to DNA damage (GO:0042770),0.45898334976234645,1.2759700938773155,0.16666666666666666,0.8957222218179399,1.0,17/49,17.98%,WNT1;NDRG1;SESN2;DOT1L;USP10;ATRX;DONSON;USP28;CDC5L;PRPF19;ATR;E2F1;HINFP;ABL1;NBN;CHEK2;TRIAP1
prerank,cellular component disassembly (GO:0022411),0.46890831671747835,1.2759634527422437,0.15945611866501855,0.8940328886830073,1.0,14/53,13.09%,CD44;TMPRSS6;MMP9;ADAM10;GSN;TIMP1;TIMP2;KLKB1;CAPN2;LAMC1;CAPNS1;ADAM15;MMP12;EXOC8
prerank,plasma membrane organization (GO:0007009),0.44824000950634274,1.2759035812660642,0.14642857142857144,0.8925283400214153,1.0,20/61,18.13%,ANK2;AHNAK2;SYTL4;ABCD1;CXCR4;OTOF;A4GALT;CAVIN2;ANK3;CHMP4A;TLCD2;SNX33;PLSCR3;ANO6;FER1L6;SYT11;NSF;PACSIN1;STX4;OSBPL2
prerank,inner mitochondrial membrane organization (GO:0007007),0.47393963623923824,1.2759005689421097,0.15077319587628865,0.8908364023431166,1.0,25/47,26.35%,TIMM10;CHCHD3;MICOS13;AGK;ROMO1;MICOS10;AFG3L2;LETM1;ATP5PF;OPA1;APOO;IMMT;ATP5F1B;MTX1;SPG7;TIMM9;ATP5PD;MTX3;ATP5ME;MAIP1;ATP5F1D;MTX2;ATP5F1C;ATP5MC3;NDUFA13
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.4346108764521199,1.2758636185105734,0.1548311990686845,0.889286978635237,1.0,19/74,14.09%,PHLDB2;DAG1;HPN;CRB2;PPP2CA;BMP5;GCNT2;OLFM1;OVOL2;SPRED3;TGFB2;TGFB1I1;TWIST1;EPHA3;LDLRAD4;TGFBR2;PDPN;GATA3;SFRP1
prerank,spliceosomal complex assembly (GO:0000245),0.46849758435530375,1.275771468003721,0.18434343434343434,0.8879924309206225,1.0,18/46,21.94%,CELF2;CELF1;DDX39B;LUC7L3;USP39;SRPK2;KHDC4;SF3A2;SRPK1;SRSF9;LUC7L2;PRPF19;PRPF6;SRSF1;SRSF5;SF3A3;PUF60;DDX23
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.3786269402590134,-1.2757671586424593,0.13229571984435798,0.6707137225392115,1.0,11/35,11.59%,FLT1;PTPRM;SULF1;NR2F2;XDH;THBS1;RGCC;ATOH8;PPARG;NF1;ATP5F1A
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.421952828443387,1.2755015001794752,0.133032694475761,0.8873014845624551,1.0,17/108,10.78%,EGLN3;NLRP2;COL4A3;MAP3K5;UACA;GSN;BBC3;PMAIP1;PRR7;NGF;DAPK1;MUL1;BAD;TNFRSF10B;ARL6IP5;BCAP31;DLC1
prerank,neurotransmitter transport (GO:0006836),-0.3203520942190254,-1.2754685202832174,0.07692307692307693,0.6689036981241635,1.0,14/73,10.46%,SLC1A3;UNC13B;NRXN1;LIN7A;SLC1A2;BRSK1;SLC1A1;SYT1;PPFIA2;SLC29A1;SNAPIN;APBA1;SLC17A6;SNAP25
prerank,microtubule-based transport (GO:0099111),0.5841962044406285,1.2752526767857113,0.2082018927444795,0.8866544956794579,1.0,3/13,15.23%,DYNC1I1;SPAG17;ADCY10
prerank,positive regulation of blood coagulation (GO:0030194),0.5672801137291256,1.2747957719961152,0.20211161387631976,0.8867245375363639,1.0,6/17,19.93%,ST3GAL4;THBD;DMTN;ANO6;F2R;USF1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.42581771359138965,-1.2746024175472523,0.12693498452012383,0.6686901436779172,1.0,12/23,22.21%,IFNGR1;IFNGR2;NR1H3;PARP14;JAK2;PPARG;NLRC5;IRGM;NR1H2;CDC37;HSP90AB1;SOCS3
prerank,carboxylic acid catabolic process (GO:0046395),0.5853572573092751,1.2745056627005324,0.2300469483568075,0.8861578311719384,1.0,3/12,11.29%,ACOT8;NAGK;PON3
prerank,axon development (GO:0061564),-0.32051290056055265,-1.2743001941571164,0.0759493670886076,0.6668288344654659,1.0,28/78,17.78%,MAP1B;SEMA5A;DCC;PAK3;GRM7;NREP;ZDHHC17;BRSK1;NRCAM;EPHB2;CTNNA2;SLITRK1;S100B;DSCAML1;FGFR2;RYK;NTNG1;PLP1;MAPK8IP3;DRD2;CAMSAP2;DHFR;MTR;MAP1A;SLITRK3;EPHB3;ARHGAP35;ATL1
prerank,reticulophagy (GO:0061709),0.5847935368636623,1.273881477590274,0.2178060413354531,0.8870338620483857,1.0,5/12,16.23%,DDRGK1;TEX264;ULK1;RB1CC1;UFM1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.4424636479875875,1.273667910836077,0.1519434628975265,0.8862169332495218,1.0,21/80,14.69%,CLU;VIM;EPHA4;SAMD4A;YTHDF1;RPS4X;EIF4A3;UPF3A;EIF6;TNFRSF1A;ABCA2;POLDIP3;SP1;CPEB3;PLXNB2;FXR1;GSK3A;UPF3B;SMPD2;PYM1;PLA2G6
prerank,phospholipid homeostasis (GO:0055091),-0.5156351145819617,-1.2730778424943943,0.1925,0.6676782286291929,1.0,2/11,6.55%,ABCA1;RCN3
prerank,microtubule nucleation (GO:0007020),-0.44193846307596674,-1.2730271425435213,0.19090909090909092,0.665195218790805,1.0,9/20,15.97%,CLASP2;CCDC57;RANBP9;TUBGCP2;NDE1;TPPP;GOLGA2;CSNK1D;SLAIN2
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.49692690031152953,1.2730194825483645,0.20162381596752368,0.8870914275448593,1.0,8/33,9.08%,KLF4;CDKN1A;CDK6;FHL1;KANK2;CDK4;PLK3;BRD7
prerank,glycolipid biosynthetic process (GO:0009247),0.4838416275623925,1.2727840157279138,0.18626155878467635,0.8863684920623669,1.0,12/38,19.29%,ST3GAL4;PIGU;SCCPDH;A4GALT;LARGE1;PIGZ;PGAP2;PIGA;DPM2;PIGN;PIGP;PIGQ
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.5230859186917182,-1.272744740099546,0.19477434679334918,0.6634188512416581,1.0,6/10,31.24%,SACS;DNAJB2;SORL1;DNAJB1;HSPA1B;HSPA2
prerank,regulation of synapse organization (GO:0050807),0.5145105374304846,1.2718624788015287,0.19350282485875706,0.8881444377760422,1.0,3/26,1.67%,RAB17;PDLIM5;EPHA4
prerank,positive regulation of wound healing (GO:0090303),0.49412232561495845,1.270761233913141,0.16191709844559585,0.8907874553315202,1.0,9/36,14.36%,KANK1;ST3GAL4;OCLN;FOXC2;DMTN;ACTG1;RREB1;ARFGEF1;HRAS
prerank,cellular response to ketone (GO:1901655),0.4868186875439822,1.2698385364311506,0.18707015130674004,0.8928386323725981,1.0,7/35,11.04%,CFTR;PTGFR;MSN;GOLPH3;ADCY6;ADAM15;AQP1
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.4298538150029919,-1.2694514523564855,0.1447811447811448,0.6706879302526736,1.0,10/19,30.54%,ZMIZ1;GAS6;AXL;NCKAP1L;CD27;RHOH;BTK;IL7;XBP1;PRKDC
prerank,reverse cholesterol transport (GO:0043691),0.5809683537927799,1.2693256059597857,0.20952380952380953,0.8930619835891448,1.0,1/13,0.40%,CLU
prerank,regulation of endocytosis (GO:0030100),0.44957405232536085,1.2681986889730874,0.15764139590854392,0.8959296687232099,1.0,17/61,17.28%,RAB17;CDH13;SCAMP5;TSC2;STON1;CBLL1;GPC3;RUBCN;LGALS3;OPHN1;SNX33;EPHA3;SNX12;RAB5C;SYT11;ABL1;PACSIN1
prerank,regulation of oxidative phosphorylation (GO:0002082),0.5584799371706831,1.267113365517361,0.2222222222222222,0.8986728174343238,1.0,3/16,9.89%,NUPR1;ABCD1;COX7A2L
prerank,intestinal absorption (GO:0050892),0.5837147545349992,1.2668318381375663,0.22445820433436534,0.8981157216377308,1.0,1/13,1.20%,TJP2
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.3963565522997324,1.2661635973279015,0.046464646464646465,0.8991331366722491,1.0,47/348,10.71%,FN1;WNT16;CLU;ANGPT1;ANK2;ITGB8;NTRK3;ADTRP;KLF4;PPARGC1A;ANKRD31;SMO;HPN;OCLN;GSN;MAGI2;ZC3H12A;WNT11;CELF1;NGF;WNT6;NFE2L2;OLFM1;OVOL2;HOXA5;KRAS;MOV10;FOXD1;HCFC1;ZBTB7B;DDRGK1;BMP4;ANK3;MAPK7;ANXA2;RBMS3;MSN;FGF22;MAZ;POU3F1;MAPK9;TLR6;EZR;MUSK;TWIST1;SRPK2;ACTG1
prerank,cardiac muscle cell contraction (GO:0086003),-0.4392427060391012,-1.2654360364026251,0.15625,0.68052848598993,1.0,7/19,15.43%,CACNA1C;CAMK2D;KCNJ2;CACNA1G;FGF12;SCN1A;SCN1B
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.5941045553308063,1.2650824325594976,0.208130081300813,0.9002612423943782,1.0,6/12,14.35%,HOMER2;HOMER3;RCAN1;CHP1;ATP2B4;GSK3B
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.5941045553308063,1.2650824325594976,0.208130081300813,0.9002612423943782,1.0,6/12,14.35%,HOMER2;HOMER3;RCAN1;CHP1;ATP2B4;GSK3B
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.5818875426876016,1.264292689825148,0.20754716981132076,0.9018298306262732,1.0,3/13,8.61%,BMP5;ERLIN2;ERLIN1
prerank,anion transmembrane transport (GO:0098656),-0.32951691403778993,-1.2641758396661318,0.06470588235294118,0.6815843448434414,1.0,10/67,6.08%,SLC1A3;SLC6A13;SLC13A3;SLC16A12;LRRC8C;SLC6A9;SLC1A2;SLC7A5;SLC1A1;SLC39A8
prerank,negative regulation of cell migration (GO:0030336),0.4141728386056663,1.2632290602397271,0.12686567164179105,0.9042812614329837,1.0,15/137,4.94%,CDH1;PHLDB2;SRGAP3;SRGAP2;ADTRP;KANK1;EPHA4;DAG1;MAGI2;WNT11;FOXO3;DUSP10;TIMP1;PTPRU;TMEFF2
prerank,cGMP metabolic process (GO:0046068),-0.5004417176292706,-1.2629016444104273,0.17585301837270342,0.6827239337628708,1.0,5/12,10.43%,GUCY1B1;GUCY1A1;PDE9A;PDE2A;NPR1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.6093347519089326,1.262796525239576,0.22019867549668873,0.9043748166280685,1.0,7/11,30.33%,UQCRC2;UQCRC1;UQCR11;UQCRH;UQCRFS1;UQCRB;UQCC3
prerank,positive regulation of GTPase activity (GO:0043547),0.4096795395137554,1.2624642134267787,0.10684647302904564,0.9039755683755917,1.0,44/188,17.28%,ARHGAP42;MAPRE2;RTN4R;NTRK3;SRGAP2;ARAP1;NGEF;CCL5;PLXNB1;PKP4;SIPA1L1;WNT11;NDEL1;RAP1A;S100A10;GRTP1;TBC1D16;TIAM2;CAV2;DOCK7;ARHGAP29;CCDC125;DVL3;BCR;ARHGEF5;BCAS3;SNX18;SGSM2;RAPGEF3;TBC1D1;RGS6;ASAP3;SFRP1;GSK3B;HRAS;ARHGAP27;FLCN;USP6NL;RAPGEF1;TBC1D22A;TBC1D10A;PRTN3;RAP1GAP;F2R
prerank,regulation of osteoblast differentiation (GO:0045667),-0.30641888878481477,-1.2622512748556733,0.05303030303030303,0.6819259450335076,1.0,26/82,16.84%,BMP6;IGF1;PRKD1;SMOC1;WNT4;ZHX3;PTK2;NOTCH1;RORB;BMPR1B;RUNX2;FBN2;IL6R;ACVR2A;LRP5;FGFR2;PPARG;TWIST2;CCN4;IL6ST;CCN1;TMEM64;BMPR2;CTNNBIP1;SOX11;SUCO
prerank,central nervous system neuron differentiation (GO:0021953),-0.3849421606035239,-1.2619668910607365,0.14232209737827714,0.6801378570769421,1.0,13/33,20.22%,MAP2;GRID2;NTRK2;LRP6;RYK;KNDC1;GBA2;TOX;MDGA2;FAIM2;NR4A2;SPOCK1;CHD5
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.5847203283815335,1.2608799683483094,0.2213375796178344,0.9086633035448416,1.0,2/12,3.61%,NOTCH2;PTK2B
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.44313051902297,1.2608282318185233,0.17514792899408285,0.9071915822836328,1.0,25/69,21.43%,NDUFV1;NDUFB11;UQCRC2;COX5A;NDUFB8;COX8A;UQCRC1;NDUFB6;NDUFS3;COX7A2L;COX5B;AFG1L;NDUFAB1;NDUFB7;NDUFV2;NDUFA1;UQCR11;NDUFB4;UQCRH;NDUFB5;NDUFB9;COX4I1;COX10;NDUFA2;NDUFA12
prerank,positive regulation of T cell proliferation (GO:0042102),-0.33224888934226116,-1.2603306896886994,0.05521472392638037,0.6825785670543459,1.0,11/55,12.36%,IGF1;IGFBP2;NCK2;VCAM1;IL18;TFRC;IGF2;CD46;NCKAP1L;PNP;IL6ST
prerank,regulation of dendritic spine development (GO:0060998),-0.43869723968300023,-1.260253754024236,0.18840579710144928,0.6802936735978551,1.0,6/19,10.79%,SHANK3;TANC2;PPFIA2;NLGN1;KIF1A;DLG5
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.4420318843521762,1.2602331162223301,0.1816009557945042,0.907911209636699,1.0,20/65,21.17%,FBXL7;FHL1;NABP2;PSMD11;AVEN;PSMD4;PSMF1;ZFYVE19;RBX1;PSMD7;PSMB5;PINX1;VPS4A;INTS3;PSMD1;PSMC4;CDK5RAP3;PSMD8;NABP1;CHFR
prerank,smooth muscle cell differentiation (GO:0051145),-0.49974322058666243,-1.2601905704466652,0.20266666666666666,0.6778811845513814,1.0,9/12,22.26%,MRTFB;TBX18;TMEM204;GATA6;EDNRB;MYOCD;HEY2;APLNR;HEY1
prerank,cellular component assembly (GO:0022607),0.3943991572582525,1.2592894964892747,0.09193054136874361,0.9100787333430722,1.0,44/253,12.08%,REPS2;BAIAP2L1;RP1;PAWR;PPARGC1A;CALD1;PARVA;OCLN;GSN;YTHDF1;LIMS2;EPRS1;PTK2B;BSN;RHOQ;ESPN;ELOB;RTN3;SYCP2;ADD1;DMTN;ANK3;ZFYVE27;ILK;MICAL1;GPAA1;AFG3L2;CFAP206;PARD6B;CDC42;LAMC1;PML;PCLO;GRHL2;KMT2A;OPHN1;ACTB;EZR;TLCD2;ACTG1;ZW10;RHOA;YWHAZ;WASF1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.5229941001233442,1.2592788720311252,0.21518987341772153,0.9084742868456569,1.0,2/24,2.09%,PRKCB;NIBAN2
prerank,positive regulation by host of viral transcription (GO:0043923),0.5648853647803354,1.2585425239348063,0.21826625386996903,0.9096264757647606,1.0,6/15,12.27%,HPN;EP300;SMARCB1;JUN;SMARCA4;SP1
prerank,regulation of cellular component organization (GO:0051128),0.41439777845648557,1.258360262925585,0.14502164502164502,0.9086739808209308,1.0,36/135,18.79%,AGTR1;RAB17;CDH13;TJP1;RAP1B;MLLT3;RAP1A;SGK3;LTBP4;TSC2;ROS1;STON1;HCFC1;SSRP1;EGLN2;LATS1;DCUN1D5;OPHN1;SOCS2;MARK4;CHPT1;SNX12;OGFR;BCAR1;RAB5C;NEDD4;RAPGEF1;HSP90AA1;RAB33B;ABL1;PACSIN1;PRKCQ;PTPN11;STK38L;PARK7;ROCK2
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.484767715629736,1.2581641422466492,0.16137931034482758,0.907744541303314,1.0,9/35,14.55%,NR3C2;DAXX;DDX5;RBFOX2;EGLN2;KDM3A;CALCOCO1;UBR5;NEDD4
prerank,fatty acid catabolic process (GO:0009062),0.44286907976321394,1.2579361085210723,0.16,0.9069805344500168,1.0,18/67,14.62%,ADTRP;ACOT8;ABCD1;ECHDC1;ACADL;EHHADH;PECR;MTLN;ACAT2;HADHA;PCCA;SLC25A17;CPT2;ECI2;ACADM;AUH;ILVBL;HADHB
prerank,positive regulation of phagocytosis (GO:0050766),-0.34917289414958774,-1.2579149864510475,0.09302325581395349,0.6825616149568976,1.0,10/47,13.19%,PTPRJ;CD47;MERTK;GAS6;IL15RA;APPL2;GATA2;NCKAP1L;LMAN2;CAMK1D
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.609894234293144,1.2577757856068859,0.21565495207667731,0.9059650011837772,1.0,4/12,10.71%,CELSR1;LAMA5;ACTB;ACTG1
prerank,rRNA transcription (GO:0009303),0.5514201348692958,1.2577094636689623,0.22257551669316375,0.9045856981216179,1.0,10/17,24.49%,ANG;POLR1E;GTF3C3;SPIN1;GTF3C2;GTF3C5;GTF3C4;SIRT7;POLR1G;TCOF1
prerank,establishment of apical/basal cell polarity (GO:0035089),0.579645437346466,1.2575208988590398,0.2113323124042879,0.9037640993968694,1.0,7/14,15.73%,MSN;PATJ;CDC42;OPHN1;EZR;RHOA;FSCN1
prerank,positive regulation of coagulation (GO:0050820),0.6108184516117224,1.257218716782013,0.23519736842105263,0.9017342193605701,1.0,2/10,6.37%,ST3GAL4;DMTN
prerank,positive regulation of hemostasis (GO:1900048),0.6108184516117224,1.257218716782013,0.23519736842105263,0.9017342193605701,1.0,2/10,6.37%,ST3GAL4;DMTN
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.527601592420407,1.2569646199889788,0.19219653179190752,0.9010912426969585,1.0,6/22,12.28%,SMARCB1;PIH1D1;UBTF;WDR43;SMARCA4;EIF2AK3
prerank,positive regulation of phosphorylation (GO:0042327),-0.2757920769913056,-1.256900902164738,0.037037037037037035,0.6830284750198251,1.0,67/240,13.83%,FLT1;IGF1;ROR1;PDGFRB;EPHA7;IL34;LEPR;ENG;TEK;INSR;PECAM1;LIMCH1;DAB2;PDE8A;MERTK;PELI2;ZBTB20;TNIK;LYN;HIF1A;VEGFC;AR;PTK2;GAS6;AXL;TIE1;GLMN;PDGFRA;KDR;SLCO3A1;FAS;FGF2;PRKAA1;THBS1;FNIP1;EPHB2;TFRC;LRRK2;EPHB4;ROR2;IGF2;TGFB1;CRKL;NTRK2;ACVR2A;BRAT1;AXIN2;ERBB4;FGFR2;ARRB1;RYK;KIT;IRGM;KNDC1;NCKAP1L;BTBD10;IGF1R;RIPK1;RACK1;CCN1;FGFR4;FLT4;PIK3R3;TBX1;RET;EPHA5;CSNK1D
prerank,modulation by symbiont of entry into host (GO:0052372),0.5460727241503439,1.2568222672989813,0.21225710014947682,0.9000441801902695,1.0,5/16,10.46%,CAV1;TRIM25;TRIM21;EXOC7;EXOC2
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.5281058218266292,1.2567621643734608,0.21313868613138687,0.8986900039234491,1.0,3/21,7.53%,PRKCB;CD81;NFAM1
prerank,response to organophosphorus (GO:0046683),-0.4650621964100635,-1.2566708098406254,0.18313953488372092,0.6812188057573544,1.0,6/16,21.61%,TRPC3;ABCC9;TYMS;RFC3;DGKQ;VGF
prerank,positive regulation of hydrolase activity (GO:0051345),0.41383720038971133,1.2564009273385943,0.13568376068376067,0.8985115790815971,1.0,32/137,17.28%,MAPRE2;RTN4R;SRGAP2;ARAP1;CCL5;PLXNB1;PKP4;CD200;WNT11;NDEL1;RAP1A;S100A10;CAV2;DVL3;BCAS3;SNX18;SGSM2;RAPGEF3;RHOA;RGS6;ASAP3;SFRP1;GSK3B;HRAS;ARHGAP27;FLCN;USP6NL;RAPGEF1;CTSH;PRTN3;RAP1GAP;F2R
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.33709386486199966,-1.2562782600463849,0.07471264367816093,0.6798788112575606,1.0,21/67,13.19%,FLT1;GHR;PDGFRB;TEK;INSR;LYN;PTK2;PDGFRA;KDR;EPHB2;ABI2;BMX;PKDCC;JAK2;ERBB4;FGFR2;KIT;ABL2;IGF1R;FGFR4;FLT4
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.503417531639334,-1.2555758496165188,0.20215633423180593,0.679615249695905,1.0,10/12,34.24%,PIK3R1;DAB2IP;BCL2L11;BAX;BOK;ERN1;BAK1;XBP1;PTPN1;ATF6
prerank,mitochondrial transport (GO:0006839),0.45072601691486536,1.2554568790069585,0.16666666666666666,0.9004616036680068,1.0,25/53,26.59%,STARD3;PMAIP1;TIMM10;TIMM44;BCL2L1;TOMM5;BAD;PITRM1;BCAP31;TOMM20;TIMM17B;HSP90AA1;SLC25A4;TMEM14C;SPG7;TIMM9;TOMM40;TSPO;FLVCR1;TIMM23;AIP;MAIP1;ABCB10;MTX2;FBXO7
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.43303907462688684,1.2550560264065724,0.16167664670658682,0.9005165021946002,1.0,10/74,8.40%,EGLN3;EP300;NFE2L2;EPO;PSMD11;ELOB;PSMD4;PSMF1;EGLN2;RBX1
prerank,acylglycerol homeostasis (GO:0055090),-0.4356624857421303,-1.254900467526381,0.1656441717791411,0.679196432424324,1.0,4/20,6.77%,IL18;NR1H3;RORA;PNPLA8
prerank,cellular respiration (GO:0045333),0.46550972240741706,1.2546931252910647,0.17979002624671916,0.9003549887821704,1.0,21/41,28.56%,PPARGC1A;SDHB;ME3;UQCRC2;MTFR1L;UQCRC1;MTLN;MDH2;SLC25A14;UQCRH;MTFR2;COX10;UQCRFS1;SURF1;ATP5F1D;MTFR1;ETFB;ETFA;ETFDH;NDUFS4;LYRM7
prerank,regulation of myeloid cell differentiation (GO:0045637),0.44132735076887375,1.2544639386194452,0.16056670602125148,0.8996318146274815,1.0,10/62,9.03%,PRKCB;EP300;CDK6;PTK2B;ZBTB16;HOXA5;MOV10;EIF6;LGALS3;KMT2A
prerank,regulation of protein localization to membrane (GO:1905475),0.5006199772517754,1.2539896778210016,0.20054570259208732,0.8998929140176813,1.0,8/28,13.86%,GPC6;GPC1;GSN;GPC4;GPC3;ACTB;VTI1B;VPS4A
prerank,endocardial cushion morphogenesis (GO:0003203),-0.4432709603348256,-1.2539513692456652,0.20055710306406685,0.6794914015254003,1.0,6/18,9.62%,ENG;NOS3;ACVRL1;NOTCH1;HEYL;TBX2
prerank,ureteric bud morphogenesis (GO:0060675),0.5512724316848628,1.2537486941909004,0.19811320754716982,0.8992372548432888,1.0,7/16,13.47%,WNT11;GDNF;BMP4;SIX1;NPNT;GATA3;MYC
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.4961361939615504,-1.2526725505813618,0.19270833333333334,0.6810250681887093,1.0,4/13,7.47%,ERRFI1;CBLB;ZFYVE28;SOCS5
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.507095822001417,1.2523503331046852,0.21190130624092887,0.902983699290885,1.0,1/25,0.15%,CD55
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.4820573968938001,-1.2502913469541697,0.20424403183023873,0.6830419728624497,1.0,6/13,12.27%,PLCB1;STAT5B;IL15RA;STAT5A;STAT3;GRB2
prerank,cellular response to interleukin-15 (GO:0071350),-0.4820573968938001,-1.2502913469541697,0.20424403183023873,0.6830419728624497,1.0,6/13,12.27%,PLCB1;STAT5B;IL15RA;STAT5A;STAT3;GRB2
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.4556795337228214,-1.25018199480363,0.1977077363896848,0.6808716027171203,1.0,11/15,50.30%,PLTP;ABCG1;LCAT;ABCA5;APOC1;LIPC;PLA2G3;APOM;SCARB1;APOA1;APOE
prerank,regulation of TORC1 signaling (GO:1903432),0.4917489015073748,1.2493705376912971,0.1800818553888131,0.9129155352740234,1.0,8/33,16.16%,RNF152;SESN2;PIH1D1;SIK3;SMCR8;KPTN;FLCN;SESN1
prerank,nucleosome assembly (GO:0006334),0.4941674976829523,1.2492473387402179,0.19973009446693657,0.911807546822184,1.0,9/31,18.28%,DAXX;GRWD1;ASF1A;KAT6B;ATRX;UBN1;IPO4;SPTY2D1;H3-3A
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.49276634265547015,-1.2492209803957195,0.1945945945945946,0.6812675047101605,1.0,11/12,38.06%,EPHB2;B4GALT5;ARHGAP35;HSP90AB1;MYCBP2;PTEN;EPHB6;EPHB1;CHRNB2;SPTBN4;B4GALT6
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.3649552693857451,-1.2488154860396918,0.13043478260869565,0.680076135716338,1.0,12/41,14.11%,ITPR1;SLC8A1;SLC8A3;GRIN2A;PKD2;FGF2;GRIN2B;SLC24A2;CHERP;DRD2;HTR2A;RYR2
prerank,regulation of neurogenesis (GO:0050767),-0.3360725805037177,-1.2482008602281391,0.07920792079207921,0.6793514023571073,1.0,19/55,22.82%,TGM2;NOTCH1;APPL2;B2M;SERPINF1;HEYL;PRUNE1;MME;BHLHE40;SORL1;SOX11;NUMB;OPRM1;YAP1;CX3CL1;CX3CR1;HEY2;HEY1;YTHDF2
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.45211613746495316,-1.2479990513858061,0.18597560975609756,0.6774819802286323,1.0,4/17,15.38%,PDE3B;PRKAA1;MFSD2A;SORL1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.5342923807428067,1.2478938496697052,0.2217453505007153,0.9153214564394182,1.0,10/20,19.86%,MCU;MCUB;PMPCA;MICU1;AFG3L2;MCUR1;LETM1;SLC8B1;SPG7;STOML2
prerank,protein tetramerization (GO:0051262),-0.31872997480748544,-1.2476995113330487,0.07792207792207792,0.6759254892696148,1.0,21/67,15.50%,ALDH1A2;PKD2;OXA1L;APPL2;GBP5;GRIN2B;HPRT1;KCNJ2;B2M;UPB1;MCOLN1;NUDT21;SAMHD1;AQP4;ALDH9A1;CPSF6;KCNJ12;GOLGA2;CBY1;KCNC1;ACACB
prerank,intestinal lipid absorption (GO:0098856),0.5937550693493168,1.2471355309511238,0.24110032362459546,0.9166497061465698,1.0,2/11,8.94%,LDLR;SOAT2
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.3033686085695853,-1.2461223964517132,0.07692307692307693,0.6783870829029125,1.0,15/86,8.56%,BMP6;RBPMS;ZEB2;SULF1;ENG;DAB2;ACVRL1;NOTCH1;BMPR1B;THBS1;ACVR1B;TGFB1;JAK2;ACVR2A;ING2
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.3102099423148306,-1.245601490308904,0.056451612903225805,0.6775430810039043,1.0,29/88,14.37%,PTPRM;SULF1;PRKD1;NR2F2;TEK;SEMA5A;HIF1A;VEGFC;PPP1R16B;AKT3;WNT5A;XDH;ACVRL1;TIE1;KDR;FGF2;THBS1;RGCC;ECM1;ATOH8;STAT5A;PIK3CD;NF1;ATP5F1A;PDCD6;FLT4;SPARC;EGFL7;BMPR2
prerank,prostanoid biosynthetic process (GO:0046457),-0.4595879030717592,-1.2450899614320643,0.1907514450867052,0.6767636311135621,1.0,8/15,19.88%,PLA2G4A;PTGIS;PTGS2;PNPLA8;PTGES;EDN1;CD74;MIF
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.47141163975376893,1.2450715878221148,0.19920844327176782,0.9230148681941386,1.0,9/36,10.43%,NECTIN3;AMN;KIF13A;ANK3;GOLPH3;GCC2;RAB7A;GOLGA7;GGA1
prerank,cellular response to growth factor stimulus (GO:0071363),-0.28052246971394773,-1.2450624020683463,0.07575757575757576,0.6744194842462812,1.0,45/151,15.14%,FLT1;BMP6;SOX5;ADAMTS12;PDE3A;PRKD1;SEMA6A;RAPGEF2;PDE8A;WNT4;WWOX;STAT5B;WNT5A;ACVRL1;STMN2;NDNF;KDR;NOTCH1;TMEM100;CLEC3B;BMPR1B;RUNX2;DAB2IP;APPL2;ACVR1B;MTSS2;TGFB1;CRKL;PTPN12;NTRK2;ACVR2A;RPS6KB1;RAMP2;PDE2A;GAREM1;ACAP2;RACK1;VSTM2A;FLT4;HYAL1;TBX1;SMAD3;BMPR2;DUSP22;SOX6
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.5183439770050065,-1.244508279691826,0.22193877551020408,0.6736131339700793,1.0,4/10,27.18%,LYN;KIT;CD40;FGR
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.44267683691878734,1.2441241029699508,0.17625,0.9251134918119621,1.0,10/57,10.39%,CYFIP2;NLRP2;MAP3K5;UACA;PMAIP1;DAPK1;PERP;BAD;ARL6IP5;BCAP31
prerank,dendrite morphogenesis (GO:0048813),-0.3676415806505229,-1.244092378160497,0.14545454545454545,0.672425433627501,1.0,9/35,8.24%,FARP1;MAP2;SHANK3;DOCK10;PAK3;DCDC2;EPHB2;CTNNA2;SDC2
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.4110692351806761,-1.2440205445081989,0.16568047337278108,0.6702404202469389,1.0,5/24,4.78%,DMD;PDE4D;CAMK2D;JPH1;PKD2
prerank,connective tissue development (GO:0061448),0.4801706255223166,1.2438592728193132,0.20689655172413793,0.9245602429539571,1.0,7/35,8.24%,CD44;ITGB8;RORC;ZBTB16;DDRGK1;DYRK1B;PKD1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.3464744268190349,-1.2431674581893848,0.13392857142857142,0.6702978286384976,1.0,7/45,8.35%,BMP6;RBPMS;ENG;DAB2;ACVRL1;TGFB1;ACVR2A
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.48313985536868354,1.243147303685274,0.20527045769764216,0.9257507392224444,1.0,8/33,12.94%,KLF5;KLF4;FOXO3;FOS;TGFB2;JUN;SMARCA4;GATA3
prerank,postreplication repair (GO:0006301),0.4558937042430404,1.24288804301625,0.18998716302952504,0.9251795443562245,1.0,18/45,22.42%,TRIM25;USP10;REV1;POLK;WDR33;UBE2B;PCLAF;RPA3;POLH;POLD2;PCNA;UBE2N;RPS27A;UBC;RFC1;POLN;UBE2V1;NSMCE1
prerank,regulation of glucose metabolic process (GO:0010906),0.48454810769071366,1.242617381418022,0.18664850136239783,0.9245592541328319,1.0,8/34,12.61%,OGT;RORC;PMAIP1;ZNF692;RUBCNL;PDK2;IRS2;FOXK1
prerank,regulation of MAPK cascade (GO:0043408),0.40430812844639585,1.2424827519399753,0.15360169491525424,0.9235231552110523,1.0,20/157,9.94%,FN1;ADRA1B;FGFR1;LPAR1;NTRK3;JCAD;DAG1;LBH;GDF15;CAV1;DUSP1;CAV2;ROS1;SHC1;MYDGF;IQGAP1;ARHGEF5;PTPN6;MAP2K2;PRDM15
prerank,phosphate-containing compound metabolic process (GO:0006796),0.39757385047441635,1.242392624886211,0.1108786610878661,0.9222684211420946,1.0,19/198,8.03%,PLPPR2;PLB1;NUDT4;PLCB3;LIMK2;PLCD3;DUSP10;PTPRD;PFKP;HKDC1;DUSP12;IP6K1;INPP4A;AGK;SLC20A1;PFKFB2;NADK;PPIP5K2;PPM1A
prerank,negative regulation of cellular process (GO:0048523),0.38500955111593627,1.2422062765430981,0.04504504504504504,0.9214751108185533,1.0,113/521,15.42%,WNT16;CDH13;CLU;ZBTB7C;ANGPT1;PTPN14;IGFBP6;SRGAP2;WNT1;KLF4;COL4A3;PLXNB1;PODXL;CDKN1A;ADAM10;SMAD6;NIBAN2;CD200;PLXNA2;CCN2;MAGI2;NUPR1;WNT11;CDK10;CELF1;CDK6;FHL1;SULT2B1;NGF;KANK2;PTK2B;TNFRSF8;SESN2;PPP2CA;BMP5;EPO;PPP1R13B;PTPRU;ALOX5;RIPOR2;CRYAB;S100A11;CD9;DUSP1;RARG;SH3BP4;TSC2;FBLN1;FOXM1;ZBTB17;TES;CGREF1;MUL1;BMP4;OSGIN2;CBLL1;ERBB3;TGFB2;TGFB1I1;SLURP1;NLRP2B;PSRC1;CHMP4B;FBXO5;NDUFS3;ADAMTS1;PML;FOXP3;BRD7;PTPN6;APBB1;NMI;DACT2;RAF1;ABI1;CASK;ADAM15;SOD2;DLC1;GSDME;SMARCA4;VPS4B;EIF2AK3;WDR6;PTPN2;CDKN2AIP;RASA1;PDPN;LPCAT3;PPM1D;GATA3;PLXNB2;CHMP1A;CAPRIN2;MYC;EEF1E1;BTG2;PRDM11;ING4;PINX1;MYBL1;SFRP1;BNIP3L;TGFBR3;DUS2;HRAS;P3H3;FLCN;ITGB1BP1;LMNA;SYT11;ARHGDIB;CHMP2A
prerank,diol metabolic process (GO:0034311),-0.4262461516016611,-1.2418770551013294,0.19169329073482427,0.671836700554642,1.0,9/19,27.72%,NOS3;DEGS2;GCH1;SPR;SGPP1;SPHK1;PLPP3;ASAH2;PLPP2
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.5824391001033177,1.2415955922723765,0.2159090909090909,0.9222547288194277,1.0,5/13,18.47%,DCTPP1;UPP2;MBD4;NEIL1;NT5M
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.42355009841215574,1.2411911433290481,0.16972477064220184,0.9222403244795898,1.0,25/87,20.23%,FBXL7;KLF4;CDKN1A;CDK6;FHL1;KANK2;CDK4;PSMD11;AVEN;PSMD4;PSMF1;RBX1;FBXO5;BRD7;PSMD7;PSMB5;PINX1;PSMD1;PSMC4;WEE1;GPNMB;CDKN2D;PSMD8;RB1;PRMT2
prerank,positive regulation of vasculogenesis (GO:2001214),-0.5196685478610348,-1.2411898192718065,0.21621621621621623,0.6716455787880699,1.0,4/10,4.75%,RAPGEF2;CD34;KDR;TMEM100
prerank,divalent inorganic cation homeostasis (GO:0072507),0.5106118950150247,1.2411527952031525,0.20251396648044692,0.9208042573575662,1.0,5/25,7.98%,ATP6V1B1;CAV1;SELENON;ANK3;JPH2
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.42091835820131157,1.2411069302842983,0.1780821917808219,0.9193898746342408,1.0,8/86,5.14%,CLU;BAIAP2L1;OCLN;CDC42EP4;PTK2B;FCHSD2;CDC42EP5;FCHSD1
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.5514055979790801,1.24100879189079,0.20212765957446807,0.9182102728262829,1.0,2/18,3.81%,AGTR1;GDNF
prerank,regulation of Ras protein signal transduction (GO:0046578),0.4232453325069544,1.2408255898489815,0.18128654970760233,0.9173162168092278,1.0,23/86,12.78%,STK19;NOTCH2;KANK1;OGT;AKAP13;EPS8L2;NGF;KANK2;EPO;DENND3;RASAL3;FOXM1;ARHGEF18;SHC1;TGFB2;BCR;OPHN1;RAF1;DLC1;IRS2;RABL3;MAPKAP1;SYNGAP1
prerank,positive regulation of cell population proliferation (GO:0008284),0.38780365733750644,1.2407825817680689,0.052104208416833664,0.9159215640236991,1.0,56/423,8.79%,FN1;DPP4;CDH13;FGFR1;CRLF1;NTRK3;CNOT6;WNT1;LAMC2;TJP1;CCL5;PDGFC;EFNB2;GRK5;CDKN1A;ADAM10;EMP2;S100A6;IL15;PDF;CDK6;CD81;PTGFR;TNFSF13;PTK2B;GDNF;NOP2;HDAC4;BMP5;CLCF1;GCNT2;EPO;TIMP1;CIAO1;DOT1L;NACC1;CDK4;RPS4X;FOXM1;KRAS;SHC1;DDRGK1;MAPK15;BMP4;CCND2;ERBB3;TGFB2;BAD;ROMO1;FGF22;MAZ;TCF7L2;FBXO5;SSR1;LAMC1;IL7R
prerank,neuron remodeling (GO:0016322),-0.5266278855198583,-1.2407393838143435,0.24484536082474226,0.6706489301037742,1.0,8/10,32.35%,ADGRB3;ANKS1A;C1QA;EPHA8;CX3CL1;C3;RND1;FARP2
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.5065122901797061,1.2405190864869284,0.2166172106824926,0.9138199946217653,1.0,7/23,11.77%,BBC3;PMAIP1;PPP1R13B;BAD;YWHAB;YWHAQ;YWHAZ
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.5065122901797061,1.2405190864869284,0.2166172106824926,0.9138199946217653,1.0,7/23,11.77%,BBC3;PMAIP1;PPP1R13B;BAD;YWHAB;YWHAQ;YWHAZ
prerank,respiratory electron transport chain (GO:0022904),0.5568562776787334,1.240294350224484,0.2138364779874214,0.9132223056165704,1.0,2/14,4.01%,PPARGC1A;SDHB
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.470663490477291,1.240288400057622,0.20433017591339647,0.9117158868892112,1.0,5/39,6.81%,FGF13;UTRN;SLMAP;STK39;ANK3
prerank,linoleic acid metabolic process (GO:0043651),0.546920633852579,1.2402084632896382,0.2492354740061162,0.9105264247906634,1.0,6/17,19.38%,ABCD1;ELOVL1;ALOX5;FADS1;GSTM2;FADS2
prerank,positive regulation of autophagy (GO:0010508),0.4309662302526566,1.2398826755882049,0.16666666666666666,0.9102502817446001,1.0,24/81,17.03%,RNF152;PRKAA2;TPCN1;ZC3H12A;FOXO3;SESN2;DAPK1;MTDH;ORMDL3;SH3BP4;TSC2;TRIM21;BAD;PLK3;TFEB;GSK3A;BNIP3L;ULK1;GSK3B;FLCN;PLK2;IKBKG;SESN1;EIF2AK4
prerank,positive regulation of lipid localization (GO:1905954),0.5954820104726798,1.239810063566599,0.24600638977635783,0.9090391158221558,1.0,2/11,2.72%,ZC3H12A;IKBKE
prerank,regulation of macromolecule metabolic process (GO:0060255),0.39875403225955064,1.2396005909985572,0.12461059190031153,0.9083520009029841,1.0,40/170,19.56%,CDH1;PRDM6;TRIM60;LDLR;ZC3H12A;CDK6;AFF3;TBC1D16;GDNF;CGGBP1;YBX3;TRIM44;CDK4;TOB2;TRIM21;NKAP;TXK;TRIM26;TRIM11;MTMR3;KDM6A;TFEB;RASA1;CDK2;CIAO3;TCF19;MYC;PRDM11;FOXP1;ADNP;HINFP;HMG20B;CAVIN4;ZNF462;IGF2BP3;ROCK2;IGF2BP2;APP;FLOT1;PCBP2
prerank,positive regulation of protein polymerization (GO:0032273),0.43428971062218924,1.239333970348094,0.2048780487804878,0.9079028494090063,1.0,7/65,5.14%,BAIAP2L1;OCLN;CDC42EP4;PTK2B;FCHSD2;CDC42EP5;FCHSD1
prerank,zymogen activation (GO:0031638),0.46727569486368425,1.2388679874216162,0.2073490813648294,0.9082712977292785,1.0,8/39,10.78%,CYFIP2;PRSS12;PERP;KLKB1;BAD;KLK1;HP;HPR
prerank,regulation of kinase activity (GO:0043549),-0.2974537664093224,-1.2384173844751805,0.10236220472440945,0.6752521818558332,1.0,27/89,13.71%,FLT1;ROR1;PDGFRB;EPHA7;TEK;INSR;MERTK;PLCE1;AXL;TIE1;PDGFRA;KDR;RBL1;EPHB2;EPHB4;ROR2;NTRK2;ERBB4;FGFR2;RYK;NLRC5;KIT;IGF1R;FGFR4;FLT4;RET;EPHA5
prerank,carbohydrate derivative transport (GO:1901264),-0.433745372251754,-1.2381856892848158,0.16825396825396827,0.6736534068718077,1.0,7/18,19.94%,PLTP;SLC29A1;MFSD2A;CLN3;SLC10A7;SLC15A2;ABCG1
prerank,positive regulation of B cell proliferation (GO:0030890),0.4959203531279167,1.238080120431297,0.21568627450980393,0.9098590217362523,1.0,4/29,4.18%,NFATC2;SASH3;CD81;CLCF1
prerank,regulated exocytosis (GO:0045055),0.4023152634425789,1.237552477175475,0.14149947201689547,0.9104148921467591,1.0,33/173,15.66%,FN1;CD109;CLU;F5;ACTN2;PHACTR2;SYTL4;OTOF;SCCPDH;TIMP1;CD9;ANXA5;TEX264;TGFB2;SRGN;STXBP1;DNAJC5;SYNGR3;VEGFB;PCLO;STEAP2;HABP4;RAB11FIP5;VTI1B;OLA1;SYT6;VAMP7;ALDOA;SYT11;SYT12;RAB11FIP1;ACTN4;FLNA
prerank,lipid oxidation (GO:0034440),0.5861224798696412,1.237517638910283,0.26129032258064516,0.9090500853153273,1.0,2/12,5.07%,PPARGC1A;ALOX5
prerank,negative regulation of type I interferon production (GO:0032480),0.4636662638875637,1.2374943554210314,0.206266318537859,0.907671795430479,1.0,6/40,5.68%,IKBKE;MAVS;RELB;TRIM25;PPM1B;IRF3
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.5790776439241668,1.237296521026905,0.2257001647446458,0.9068855061629624,1.0,6/12,22.75%,PTPN14;BMP4;NEDD4;AAAS;SIRT7;TPR
prerank,protein import into mitochondrial matrix (GO:0030150),0.5378588154810053,1.2363127130174716,0.21571648690292758,0.9088339215362052,1.0,9/18,22.76%,TIMM44;DNLZ;ROMO1;TOMM20;TIMM17B;TOMM40L;TOMM40;TIMM50;TIMM23
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.4698938908771269,-1.2361543228252818,0.1925287356321839,0.677426592855071,1.0,13/14,53.05%,IL18;IL17D;PAEP;CD84;CD80;RASGRP1;ISL1;CARD9;IL23A;IL23R;IL12B;IL17F;IL1B
prerank,nerve growth factor signaling pathway (GO:0038180),0.5958873620683173,1.2358602919986543,0.21617161716171618,0.9089851701790789,1.0,3/10,3.27%,MAGI2;RAP1A;NGF
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.4397508117750716,-1.2350277422461777,0.17484662576687116,0.6784640286088136,1.0,4/17,16.49%,N4BP2L2;KAT7;HMGA2;SOX11
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.4764156859905044,-1.2348870465354982,0.20810810810810812,0.6765702320241618,1.0,6/12,25.08%,DKC1;CCT7;GNL3L;CCT2;CCT4;WRAP53
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.5255399771692403,1.2346605424021626,0.22290076335877862,0.9104809990382876,1.0,4/19,8.07%,DAXX;POLR2H;POLR2A;ATRX
prerank,regulation of DNA recombination at telomere (GO:0072695),0.5255399771692403,1.2346605424021626,0.22290076335877862,0.9104809990382876,1.0,4/19,8.07%,DAXX;POLR2H;POLR2A;ATRX
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.43492009346056437,1.2337411457680174,0.1866151866151866,0.9124982362956527,1.0,5/52,3.48%,MBNL1;CELF2;DDX5;CELF1;RBFOX2
prerank,positive regulation of DNA replication (GO:0045740),-0.44618390464256374,-1.2336583908951408,0.17955801104972377,0.6779412297385069,1.0,9/16,27.16%,GLI2;KAT7;GLI1;BCAR3;EGF;CTC1;STN1;FAF1;EGFR
prerank,import into cell (GO:0098657),-0.3573392587617017,-1.2331373762694684,0.15841584158415842,0.6772140727096464,1.0,9/41,10.60%,SLC1A3;SLC6A13;LRRC8C;SLC47A1;SLC7A5;SLC6A6;SLC29A1;SNAP25;LRRC8A
prerank,chordate embryonic development (GO:0043009),0.4483580054592277,1.2330891956954237,0.18865598027127004,0.9135118889317241,1.0,9/55,8.89%,MBNL1;KIAA1217;FGFR1;ADAM10;WNT11;BMP5;FUT8;PKD1;GRHL2
prerank,regulation of protein autophosphorylation (GO:0031952),-0.36557658891097056,-1.23218866079675,0.16728624535315986,0.6778197376229393,1.0,5/36,1.90%,ERRFI1;EPHA7;PDGFD;ENG;ENPP1
prerank,regulation of cellular protein metabolic process (GO:0032268),0.4529734402095622,1.2321683264033283,0.19536019536019536,0.9155692626943793,1.0,4/47,5.36%,AGTR1;KLF4;FOXO3;NFKBIA
prerank,endocardial cushion development (GO:0003197),-0.4129331575834147,-1.2319912020012722,0.1896551724137931,0.6761191352855316,1.0,6/21,9.62%,ENG;NOS3;ACVRL1;NOTCH1;HEYL;TBX2
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.4173604893956825,-1.2319585491950575,0.17229729729729729,0.6739456828516149,1.0,7/21,18.73%,IGF1;KDR;LGALS9;ITGAV;EGF;MAP2K1;PTGER4
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.5836885740524885,1.2318502288898456,0.2431561996779388,0.9153022180094721,1.0,6/11,27.43%,NAGK;UAP1L1;GFPT1;GNPDA2;UAP1;PGM3
prerank,muscle organ development (GO:0007517),0.44796223346103925,1.2314413381634908,0.18696186961869618,0.9154251867528945,1.0,14/54,13.82%,UTRN;SGCG;MRAS;SGCA;SGCD;FHL1;LARGE1;COL6A3;MEF2D;EVC;MEF2B;ZBTB42;FXR1;MEF2C
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.6037820066739905,1.2312945363557826,0.25671140939597314,0.9145684350145132,1.0,1/10,1.06%,ACTN2
prerank,positive regulation of exosomal secretion (GO:1903543),0.5572404255055323,1.2310088640494559,0.221875,0.9141696617503416,1.0,8/15,17.99%,SDC4;RAB7A;VPS4B;VPS4A;CHMP2A;PDCD6IP;STAM;TSG101
prerank,detection of calcium ion (GO:0005513),-0.47157636719451146,-1.2308837863781377,0.2154696132596685,0.6748711562655209,1.0,6/13,22.16%,STIM1;SYT1;RYR2;KCNMB4;KCNIP2;CASQ2
prerank,fatty acid elongation (GO:0030497),0.5548839038678237,1.2305667186884064,0.2289348171701113,0.914447487905883,1.0,4/13,9.23%,ABCD1;ELOVL1;ELOVL6;HACD4
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.5092765098124368,1.23038602634134,0.22320117474302498,0.913641184806517,1.0,8/23,17.29%,NUPR1;EP300;HDAC4;TIGAR;NCOR1;GSK3A;PGP;GIT1
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.523142528189872,-1.2302017676906518,0.24358974358974358,0.6747054897851177,1.0,4/10,16.47%,SH3RF1;RUNX1;NCKAP1L;HMGB1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.5160947441374713,1.2294892238904724,0.24147727272727273,0.9156464847717577,1.0,14/23,25.43%,NABP2;ZFYVE19;PLK3;ZW10;VPS4A;PLK2;INTS3;ZWINT;WEE1;CDK5RAP3;NABP1;CHFR;PLK5;PABIR1
prerank,sulfur compound biosynthetic process (GO:0044272),0.40946192435126966,1.2285605037981036,0.18008948545861297,0.917839639735591,1.0,18/104,12.31%,UST;ANGPT1;ST3GAL4;CHST12;B4GAT1;HAGH;DSE;CHST11;PRELP;CHPF;MGST3;GSTO1;MAT2B;HPGDS;CHST13;CDO1;CHPF2;ST3GAL6
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.5157934992879654,1.2285549336991504,0.23065476190476192,0.916387822994325,1.0,4/19,15.52%,EP300;PHLDA3;PML;USP28
prerank,gland development (GO:0048732),0.43530659723732235,1.2281251215946198,0.19374247894103488,0.9165027183725817,1.0,11/59,9.58%,COBL;IGSF3;WNT10A;WNT11;CAV1;STRA6;NKX2-8;MSN;LSR;SIX1;EZR
prerank,regulation of cytoskeleton organization (GO:0051493),0.41505786144232143,1.2279961332316025,0.17951541850220265,0.9155553436598599,1.0,19/108,11.75%,PHLDB2;PRKAA2;CELSR1;TJP1;PLXNB1;ARHGAP18;CDK10;DIAPH1;MAP6;RHOQ;EFNA5;DMTN;CAPN2;IQGAP1;ARHGEF5;EZR;DLC1;EPHA3;RHOA
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.5076372141999344,-1.2275259412287511,0.23056994818652848,0.6802706321551122,1.0,5/10,13.02%,XYLT1;CSGALNACT1;XYLT2;PXYLP1;B3GAT3
prerank,regulation of viral release from host cell (GO:1902186),0.5171709170783879,1.227396223498443,0.2345679012345679,0.9162740954531416,1.0,10/21,17.99%,TRIM25;VPS37B;TRIM21;PML;TRIM26;TRIM11;VPS4A;CHMP2A;DDB1;TSG101
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.5508510107032333,1.2272631305165311,0.24624624624624625,0.9152890249661781,1.0,6/17,17.54%,CD44;YJU2;TWIST1;MDM2;KDM1A;ARMC10
prerank,positive regulation of cellular metabolic process (GO:0031325),0.41366445954379333,1.2271401091416898,0.18171296296296297,0.9142345276118522,1.0,20/98,14.92%,AGTR1;ANGPT1;KLF4;CCL5;CDKN1A;HPN;MAGI2;ZC3H12A;DHRS4;NFKBIA;ANXA2;ROMO1;ACACA;STARD4;FASN;TGFBR2;GATA3;RAB1B;EIF4G1;DCXR
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.4832765836869882,1.2270481343552375,0.23108108108108108,0.9131172334615881,1.0,7/31,11.49%,FDFT1;MOCS3;ALOX5;CYP51A1;NFS1;PYCR3;NOXRED1
prerank,negative regulation of neuron death (GO:1901215),0.4233859659307503,1.226545951938421,0.18771331058020477,0.913509812070359,1.0,27/93,18.76%,CRLF1;PPARGC1A;NRBP2;CD200;NGF;PTK2B;GDNF;CLCF1;ERBB3;UNC5B;SIX1;CHMP4A;CHMP4B;SOD2;CD200R1;RASA1;MEF2C;SET;GSK3B;EIF4G1;NENF;IKBKG;POU4F1;F2R;PARK7;GPNMB;TOX3
prerank,cytoplasmic sequestering of protein (GO:0051220),0.5714473237162212,1.2265421643523748,0.23547400611620795,0.912087933398542,1.0,9/13,20.64%,NFKBIA;LATS1;PKD1;YWHAB;GET4;FLNA;KEAP1;SUFU;DBN1
prerank,regulation of primary metabolic process (GO:0080090),0.40302523246360206,1.2261633833710925,0.15673289183222958,0.9120686707100949,1.0,39/126,20.65%,LDLR;FDFT1;SREBF2;DHCR7;FDPS;HMGCR;PSMD11;PMVK;RUBCNL;PSMD4;PSMF1;AZIN1;CYP51A1;ELOVL6;NFYC;PSMD7;HDAC3;NCOR1;CERS2;ACACA;GPAM;IRS2;FASN;SP1;PSMB5;NCOR2;SQLE;PSMD1;TM7SF2;PSMC4;HMGCS1;ROCK2;PSAP;PSMD8;PRKAB1;SREBF1;OPA3;PRKAB2;ABCA7
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.4291151272984265,-1.2259952393029,0.18322981366459629,0.6822775001409874,1.0,8/18,25.39%,RUVBL1;DKC1;PARN;CCT7;CCT2;CCT4;NOP10;DCP2
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.5386227111218886,1.2258011884950581,0.23993808049535603,0.911938358703607,1.0,1/17,0.66%,ANK2
prerank,establishment of vesicle localization (GO:0051650),0.5263793070288244,1.225731821385425,0.2571001494768311,0.910750667445348,1.0,7/18,19.21%,LIMK2;TOR1A;TMEM230;SYT11;IKBKG;TESK1;RAB27A
prerank,positive regulation of transmembrane transport (GO:0034764),-0.4655460723244952,-1.2255818399156349,0.22772277227722773,0.6813694626090555,1.0,8/13,23.46%,AZIN2;ACSL1;ACSL5;CA2;SLC26A6;C2CD5;NR4A3;C3
prerank,DNA methylation or demethylation (GO:0044728),0.5337524386052211,1.2254806027733112,0.24336283185840707,0.908852182591453,1.0,5/19,12.89%,FOS;BEND3;ATRX;DNMT3A;PPM1D
prerank,DNA alkylation (GO:0006305),0.5337524386052211,1.2254806027733112,0.24336283185840707,0.908852182591453,1.0,5/19,12.89%,FOS;BEND3;ATRX;DNMT3A;PPM1D
prerank,cellular biogenic amine catabolic process (GO:0042402),0.5932292489713876,1.224653793661284,0.23283082077051925,0.9105409981826851,1.0,2/10,4.89%,SMOX;DMGDH
prerank,sodium ion export across plasma membrane (GO:0036376),0.5544337676962101,1.2244068637505094,0.24644549763033174,0.9100367939548379,1.0,7/13,21.08%,ATP1A2;SLC4A4;SLC9A1;ATP1B3;ATP1A3;ATP1A4;ATP1A1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.5919018006121357,1.2241839801314438,0.25662251655629137,0.9079898601867816,1.0,5/10,17.29%,NUPR1;HDAC4;TIGAR;NCOR1;GIT1
prerank,negative regulation of glycolytic process (GO:0045820),0.5919018006121357,1.2241839801314438,0.25662251655629137,0.9079898601867816,1.0,5/10,17.29%,NUPR1;HDAC4;TIGAR;NCOR1;GIT1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.4293880725503295,1.2240785981349052,0.20772946859903382,0.9069387218270172,1.0,9/72,6.27%,FGF13;CLU;KANK1;LDLR;SSH3;PFDN1;CRYAB;TWF1;EML2
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.48447120989822484,1.2239843078364798,0.24162011173184358,0.9058399330713881,1.0,7/31,9.08%,KLF4;CDKN1A;CDK6;FHL1;KANK2;CDK4;BRD7
prerank,regulation of actin filament polymerization (GO:0030833),0.4223119224576034,1.2238765525676047,0.19523809523809524,0.9048031006655507,1.0,12/69,7.59%,BAIAP2L1;KANK1;ARHGAP18;SSH3;CDC42EP4;PTK2B;FCHSD2;CDC42EP5;FCHSD1;TWF1;HAX1;LATS1
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.5163524550938612,1.2231444775653895,0.2300469483568075,0.9061691407852007,1.0,4/21,8.35%,WNT1;CAV1;DVL3;FZD5
prerank,negative regulation of translation (GO:0017148),0.41726920461851164,1.2231109702073844,0.1850574712643678,0.9048754482963921,1.0,25/87,19.00%,SAMD4A;CPEB2;YTHDF1;SAMD4B;CELF1;EPRS1;DAPK3;DAPK1;UNK;EIF4A3;EIF4EBP1;SHMT1;EIF2AK3;CPEB3;SYNCRIP;FXR1;BTG2;GAPDH;MEX3D;EIF2AK4;IGF2BP3;YTHDF3;ROCK2;EIF4EBP2;IGF2BP2
prerank,mitochondrial membrane organization (GO:0007006),0.4828465439082413,1.2220695664327086,0.2024623803009576,0.9074194723948746,1.0,12/32,18.44%,PMAIP1;CHCHD3;MICOS13;BCL2L1;BAD;MICOS10;OPA1;APOO;IMMT;SLC25A4;MTX1;SPG7
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.4141684276919835,1.2219377589934566,0.19226260257913247,0.9064769387392363,1.0,13/86,10.46%,EGLN3;EP300;NFE2L2;EPO;PSMD11;ELOB;MAPK7;PSMD4;PSMF1;EGLN2;RBX1;BAG3;PSMD7
prerank,regulation of tube diameter (GO:0035296),0.5652552686151946,1.2217610437368525,0.26540284360189575,0.9043120803652834,1.0,1/13,0.18%,AGTR1
prerank,vascular process in circulatory system (GO:0003018),0.5652552686151946,1.2217610437368525,0.26540284360189575,0.9043120803652834,1.0,1/13,0.18%,AGTR1
prerank,iron ion transmembrane transport (GO:0034755),-0.5088804766920757,-1.22148225465521,0.2334152334152334,0.6913824239762048,1.0,3/10,6.08%,SCARA5;SLC40A1;SLC39A8
prerank,collagen fibril organization (GO:0030199),0.4236376816399017,1.2213757908013436,0.19336384439359267,0.9044409365158818,1.0,12/88,7.38%,ITGB4;ADAMTS14;COL23A1;COL25A1;LAMC2;COL4A3;COL4A4;COL5A2;COL6A1;COL6A3;PXDN;TGFB2
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.5465440586091341,1.2211022870588164,0.24508320726172467,0.9040961402599954,1.0,3/15,4.29%,NAGK;MGAT3;LARGE1
prerank,regulation of T cell migration (GO:2000404),0.5175311476579582,1.220969098887912,0.2556053811659193,0.9031917426290011,1.0,5/18,12.19%,CCL5;CD200;RIPOR2;RHOA;CD200R1
prerank,negative regulation of immune system process (GO:0002683),0.5526069705689683,1.2207988147838504,0.24274809160305344,0.9024463693151911,1.0,3/16,8.98%,ADTRP;CD200;FOXP3
prerank,urogenital system development (GO:0001655),-0.505266911117143,-1.2207304616558001,0.23017902813299232,0.6913866434892175,1.0,4/11,23.87%,EPHB2;EPHB3;PAX8;PAX2
prerank,retina homeostasis (GO:0001895),0.5117171834992368,1.2205312572456506,0.23760932944606414,0.9020546956678683,1.0,9/23,20.91%,CRB2;HSPB1;POTEF;ACTB;ACTG1;CNGB1;CDH3;JCHAIN;TULP1
prerank,steroid biosynthetic process (GO:0006694),0.43768725631066574,1.219448796384638,0.20174346201743462,0.904734486239842,1.0,11/56,11.13%,FDFT1;OSBPL9;ACOT8;DHCR7;HMGCR;INSIG1;PMVK;CYP39A1;CYP51A1;MSMO1;OSBPL7
prerank,regulation of neuroblast proliferation (GO:1902692),-0.45127104857013567,-1.2192362693113465,0.21212121212121213,0.6936317665700414,1.0,7/15,20.54%,SMARCD3;LRRK2;NF1;TAFA1;DRD2;CX3CL1;CX3CR1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.4155989246183432,1.2186786367849562,0.18728323699421964,0.9062795500373124,1.0,14/80,11.04%,CD44;NLRP2;KLF4;MAP3K5;UACA;PMAIP1;NGF;DAPK1;BAD;RAF1;ARL6IP5;BCAP31;CARD16;AQP1
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.46192385859860835,1.218368644791954,0.2108667529107374,0.9060557316718787,1.0,7/38,13.01%,DSG2;ANK2;CAV1;DSC2;TRPM4;KCNA5;CACNB2
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.4814155650719373,-1.218226229122188,0.22955145118733508,0.6941320029322551,1.0,3/12,3.43%,PDE4D;GJD3;CAMK2D
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.4556492473978151,-1.2181766135533054,0.2046783625730994,0.6920338079561678,1.0,6/15,19.85%,RUVBL1;DKC1;CCT7;CCT2;CCT4;NOP10
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.5500778727795411,1.2180105804945283,0.26080246913580246,0.905927443049928,1.0,6/14,20.07%,ACOT8;ABCD1;EHHADH;ECI2;DECR2;CRAT
prerank,embryonic digestive tract development (GO:0048566),-0.43462197154454923,-1.2179465444038646,0.2063953488372093,0.6904791729026493,1.0,8/18,9.11%,PCSK5;GLI2;RARB;PDGFRA;SALL1;PKDCC;ID2;FGFR2
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.5220075136697998,1.2179044294733772,0.24514200298953662,0.9049471823055898,1.0,11/18,23.60%,CTNNA1;OTUD7B;LATS1;CHP1;GSK3B;FLCN;UFM1;SUFU;ILRUN;RAB23;LATS2
prerank,spinal cord development (GO:0021510),-0.47942185889189975,-1.2172984104380429,0.24128686327077747,0.6902584522860834,1.0,7/12,18.78%,GLI2;PKD2;LOXL3;VIT;NF1;SOX11;SOX12
prerank,chemical synaptic transmission (GO:0007268),-0.2597617865141132,-1.2169798969290622,0.0,0.6889630878983525,1.0,83/284,21.33%,PDE7B;SLC1A3;GRIK2;UNC13B;KCND2;NRXN1;NOVA1;GRID2;LIN7A;CACNA1E;GRM3;GABRG3;GRM7;DLG2;SLC1A2;GRIN2A;GRIA3;CAMK4;GRIA2;CACNB4;SHISA6;BRSK1;PTCHD1;DLGAP1;SLC1A1;SYT1;CDH8;RIT2;GRIN2B;GABRB1;GRM5;GRIK3;GLRA1;NLGN1;GABRG2;HTR7;GABRG1;LRP6;SLC6A1;TBC1D24;CHRM3;SNAPIN;PRKAR2B;APBA1;PLP1;SLC17A6;SNAP25;DTNA;HCRTR2;MBP;GRIK1;GABRA3;GRIK4;NLGN3;DRD2;GLRA3;HTR2A;AMPH;KCNMB4;GLRA2;GABRB2;CHRM2;MPZ;KCNQ3;GRM1;PRKAR1B;GABRA1;NPTX1;GLRB;RPS6KA1;RPS6KA3;GABRE;OPRK1;HRH1;KCNK3;SYT10;GRIA4;GRIK5;CACNA1B;KCNIP2;PCDHB16;RIMS1;GABARAP
prerank,negative regulation of chemokine production (GO:0032682),0.558577148888127,1.2169730816223825,0.2566510172143975,0.9070499553830765,1.0,2/14,6.65%,KLF4;MUL1
prerank,brain morphogenesis (GO:0048854),-0.4787968454455029,-1.21678156920501,0.24175824175824176,0.6873808406859866,1.0,7/12,25.04%,SHANK3;CTNNA2;SPEF2;BBS4;VPS51;PAX2;PTEN
prerank,establishment of epithelial cell polarity (GO:0090162),0.5202834657679175,1.2164899043527393,0.24357034795763993,0.9074183280707274,1.0,8/19,19.68%,MSN;GOLPH3;CDC42;OPHN1;EZR;RHOA;MYO18A;PARD3
prerank,regulation of protein catabolic process (GO:0042176),0.4078712812124717,1.2162834808962861,0.19369369369369369,0.906779955111668,1.0,26/99,19.51%,FZR1;EEF1A1;WWP2;HMGCR;EGLN2;GPC3;AZIN1;CYP51A1;RAB7A;BANP;SF3B3;SNX12;WDR91;GSK3A;GSK3B;NEDD4;MDM2;PLK2;FLNA;CENATAC;DDB1;NSF;CHEK2;RNF41;IDE;ASB5
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.3621453211481653,-1.2162586975473089,0.1709090909090909,0.686688267290037,1.0,16/32,23.00%,SNCAIP;MCTP2;LRRK2;DTNBP1;PREPL;SNAPIN;SLC30A1;CAMK2A;MCTP1;KCNMB4;BAIAP3;CPLX2;FMR1;STX1B;RIMS1;RIMS3
prerank,bicarbonate transport (GO:0015701),0.4967687415741056,1.2154589374306606,0.2338235294117647,0.9085028878994811,1.0,3/25,6.78%,CFTR;SLC4A2;CYB5RL
prerank,cellular response to reactive oxygen species (GO:0034614),0.4294800766933721,1.215321433457269,0.20693928128872366,0.9076678627013958,1.0,17/59,18.46%,MMP9;MAP3K5;FOS;NFE2L2;PXN;MAPK7;ROMO1;JUN;MAPK9;AGAP3;AQP1;PDK2;TRPM2;CHUK;ABL1;HDAC6;PARK7
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.47535055228283407,-1.2151364742804598,0.20565552699228792,0.6877828943672815,1.0,3/12,4.92%,DMD;ATP1B1;WNK2
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.4420033680284187,1.215090411245468,0.20496894409937888,0.9071541492083245,1.0,18/51,18.79%,LPAR1;CCN2;WNT11;S100A10;PXN;CDC42;ARHGEF5;RAPGEF3;RHOA;ARHGEF10L;SFRP1;CCDC88A;ITGB1BP1;TESK1;PFN2;ABL1;FHOD1;ROCK2
prerank,protein polyglutamylation (GO:0018095),-0.4945206475880884,-1.2145427099546575,0.23232323232323232,0.6873143707205203,1.0,7/11,29.38%,TTLL4;TTLL11;CFAP20;TTLL5;CEP41;TTLL7;TTLL6
prerank,negative regulation of interferon-beta production (GO:0032688),0.572267901545819,1.2143505506927494,0.23491027732463296,0.9084165700223815,1.0,2/10,4.64%,RELB;PPM1B
prerank,regulation of protein kinase A signaling (GO:0010738),-0.42722447778167594,-1.2134357253689936,0.18770226537216828,0.6883320517937217,1.0,8/20,22.76%,ADGRV1;LRRK2;PRKAR2B;TCIM;PRKAR1B;AKAP7;MIF;IAPP
prerank,regulation of sensory perception of pain (GO:0051930),-0.501743253351235,-1.2131042833474392,0.24154589371980675,0.6870092707267863,1.0,4/11,13.64%,TMEM100;MGLL;ZFHX2;CCN3
prerank,carboxylic acid transport (GO:0046942),-0.31654555049375077,-1.213083223136808,0.12903225806451613,0.6848967560936848,1.0,13/55,7.94%,SLC6A13;SLC13A3;SLC16A12;SLC1A5;SLC6A12;SLC6A9;SLC7A5;SLC16A9;SLC6A6;SLC16A6;SLC1A1;SLC16A1;SLC16A4
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.5503188357250197,1.2127325892406318,0.23190546528803546,0.912971044326871,1.0,6/16,20.02%,ST3GAL4;ALOX5;RHOA;IRAK1;ITGB2;NFAT5
prerank,protein homooligomerization (GO:0051260),-0.283981232974548,-1.2126317751244124,0.08080808080808081,0.6840550408047779,1.0,40/114,21.03%,ALDH1A2;SLC1A5;SCARA5;SLC1A2;PKD2;EHD4;IKZF4;APPL2;GBP5;HPRT1;KCNJ2;EHD3;B2M;UPB1;MCOLN1;GSDMD;SAMHD1;AQP11;JMJD6;AQP4;ALDH9A1;TRMT61B;ALS2;KCNJ12;G3BP2;GLRA3;GOLGA2;CBY1;MPP2;ACACB;TIFA;BLM;ATL1;DISP1;HCN1;CBR4;RNF135;MIF;CRYZ;MLKL
prerank,negative regulation of response to external stimulus (GO:0032102),0.40757569042976927,1.2124618506301486,0.17800453514739228,0.9125955641229437,1.0,28/105,20.24%,CD109;RTN4R;KLF4;EPHA4;PPM1B;ALOX5;MUL1;MAPK7;TRIM21;FEM1A;TNFRSF1A;NMI;CASK;CARD16;CERS2;PTPN2;LPCAT3;GATA3;CRK;CDH5;DUSP3;FNDC4;OTULIN;ILRUN;GPER1;PCBP2;RB1;RTN4RL1
prerank,glycosaminoglycan metabolic process (GO:0030203),0.4370038972453939,1.2123474982062987,0.21551724137931033,0.9116481177700201,1.0,11/54,10.08%,GPC6;GPC1;HEXA;GPC4;GCNT2;NAGLU;SDC4;GLB1;GPC3;EXT1;GUSB
prerank,dendritic cell migration (GO:0036336),0.5370716720873331,1.2122589832394917,0.24849397590361447,0.9105763325321619,1.0,5/16,13.38%,CCL5;CXCR4;ALOX5;TRPM4;TRPM2
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.5919254316618004,1.2116548830316085,0.27597955706984667,0.9115334095830376,1.0,4/10,14.28%,EMC9;EMC10;EMC6;EMC2
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.5307354740452369,1.2108597020679093,0.23652694610778444,0.9131038763444581,1.0,9/16,27.67%,DDX5;SRSF9;DHX9;SRSF1;PUF60;SFPQ;CELF4;CDK13;HNRNPM
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.4235406823330111,1.2108194695888936,0.19544364508393286,0.9118933843583127,1.0,14/69,11.75%,PITPNM2;FGFR1;PLCL2;PLCB3;PLCD3;OGT;NGF;PIK3C2B;PLCL1;ERBB3;PI4KA;EZR;IRS2;RHOA
prerank,negative regulation of reproductive process (GO:2000242),-0.4318660239824713,-1.210655302886907,0.21739130434782608,0.6877276210141676,1.0,2/17,0.61%,IGF1;SULF1
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.5691426080771702,1.2100663558370879,0.25967741935483873,0.9133043276402192,1.0,3/13,4.29%,NAGK;MGAT3;LARGE1
prerank,regulation of mitochondrion organization (GO:0010821),0.44466716557230435,1.209935529318407,0.24875,0.9124214824595638,1.0,22/47,22.36%,PPARGC1A;SREBF2;EP300;HAX1;MUL1;GOLPH3;FZD5;MIEF2;PLSCR3;VDAC1;GSK3A;GSK3B;DNM1L;FLCN;HDAC6;PISD;RHOT2;SREBF1;MAPT;FBXW7;SIRT7;INF2
prerank,cellular response to drug (GO:0035690),-0.399274617031376,-1.2098631385999201,0.22525597269624573,0.6879438880016171,1.0,6/25,10.36%,ACER2;GAS6;AIM2;TFRC;PDE4B;TP53
prerank,response to thyroid hormone (GO:0097066),0.5442524286187009,1.209710291330111,0.26644736842105265,0.9118607316657616,1.0,2/13,2.00%,THRB;HPN
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.4354673270421527,1.2096786567660993,0.2283653846153846,0.9106445810537095,1.0,6/63,4.18%,NFATC2;CCL5;SASH3;IL15;CD81;CLCF1
prerank,chemokine-mediated signaling pathway (GO:0070098),0.4480646681921393,1.209501996053059,0.23803191489361702,0.9099595118303037,1.0,6/42,8.45%,CCL5;PTK2B;ACKR3;GPR75;STK39;OXSR1
prerank,regulation of blood coagulation (GO:0030193),0.48998713460414517,1.2092392330791564,0.22911051212938005,0.9095463850579637,1.0,5/27,6.37%,ADTRP;ST3GAL4;CAV1;THBD;DMTN
prerank,protein-containing complex assembly (GO:0065003),0.3824882985342852,1.2090330354076906,0.131551901336074,0.9089159327918274,1.0,53/259,15.46%,FN1;REPS2;FBXL7;F5;PPARGC1A;ADAM10;OCLN;ZC3H12A;CAND2;EP300;PEF1;EPRS1;MCU;PTK2B;PPP6R3;PYGO2;TFG;ELOB;CTSZ;DMTN;BAD;TRAPPC9;GPAA1;AFG3L2;PARD6B;RBX1;TCF7L2;LAMC1;PML;TNFRSF1A;KMT2A;TLE2;ZW10;SMARCA4;TLE4;TRAPPC1;MCFD2;WASF1;ANO6;NAPA;OPA1;MYC;PREB;RAB1B;GSK3B;CNIH1;DNM1L;ITGB1BP1;SEC23A;ANKRD28;MDM2;DHX9;IKBKG
prerank,xenobiotic transport (GO:0042908),-0.433373754940138,-1.2085374354320406,0.22888283378746593,0.6893886783571161,1.0,9/17,31.40%,SLC47A1;SLC7A5;ABCA3;SLC15A2;ABCC3;SLC22A2;ABCG2;SLC22A3;ABCC1
prerank,protein homotetramerization (GO:0051289),-0.3326362981993843,-1.208031679678535,0.1414141414141414,0.6886987055656181,1.0,18/49,18.47%,ALDH1A2;PKD2;APPL2;GBP5;HPRT1;KCNJ2;B2M;UPB1;MCOLN1;SAMHD1;AQP4;ALDH9A1;KCNJ12;GOLGA2;CBY1;ACACB;HCN1;CBR4
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.401478931312295,-1.2072862831223332,0.19292604501607716,0.68873625186183,1.0,8/22,15.91%,MAP2;MAP1B;AEBP1;PRUNE1;GBA2;CAMSAP2;GPX1;MAP1A
prerank,protein targeting to lysosome (GO:0006622),0.5117870375548779,1.2070865159374178,0.2485207100591716,0.9145749274223858,1.0,10/20,23.29%,CLU;GCC2;RAB7A;VPS4A;NEDD4;SNX16;AP3M1;M6PR;AP4M1;NCOA4
prerank,Golgi to plasma membrane transport (GO:0006893),0.4399725777273055,1.2068223212904734,0.22905759162303665,0.9141655736534393,1.0,17/47,17.50%,STXBP6;AMN;KIF13A;ARL3;ANK3;GOLPH3;GCC2;EXOC4;GOLGA7;STEAP2;GGA1;EXOC2;EXOC8;OSBPL5;CCDC22;NSF;ARFRP1
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.4683882541379554,-1.205970999653491,0.23333333333333334,0.6906437963159783,1.0,6/13,16.00%,IRAK2;PIK3AP1;TRAF6;UNC93B1;PIK3C3;TLR7
prerank,glutamate metabolic process (GO:0006536),0.5142118558488019,1.2058541877255795,0.2481089258698941,0.9163683802432323,1.0,6/19,20.89%,GLUL;GLUD1;PRODH;DGLUCY;ALDH18A1;GAD1
prerank,neuromuscular process controlling balance (GO:0050885),-0.4833620402927895,-1.205604014343002,0.2526595744680851,0.689598501996015,1.0,4/12,15.15%,NRXN1;PCDH15;TPP1;CLN3
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.4305580514407674,-1.2050465842320337,0.1989100817438692,0.6890947169839968,1.0,7/16,33.20%,PDS5B;NIPBL;BOD1;NAA50;RAD21;SGO1;DSCC1
prerank,prostaglandin metabolic process (GO:0006693),-0.3823586375555186,-1.2042902284565522,0.19078947368421054,0.6891555501508715,1.0,9/26,16.64%,PLA2G4A;PTGIS;PTGS2;PNPLA8;PTGES;ACOX1;HPGD;EDN1;CD74
prerank,calcium ion import across plasma membrane (GO:0098703),-0.4685752675222191,-1.2042347394820458,0.226775956284153,0.687222413633162,1.0,3/14,8.59%,SLC8A1;SLC8A3;SLC24A2
prerank,response to nutrient levels (GO:0031667),0.5252056231419456,1.2040538923764343,0.23738872403560832,0.9216600238256617,1.0,4/17,14.38%,PRKAA2;KCNB1;ULK1;EIF4G1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.5546558143357713,1.2039216360534375,0.26283048211508553,0.9208125791435373,1.0,4/12,11.34%,DSG2;CAV1;DSC2;TRPM4
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.5301376549660017,1.2035839754477489,0.2730015082956259,0.9207503585005888,1.0,3/17,5.96%,CLU;RTN1;RTN3
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.40954326641049177,1.2032800981568499,0.19542857142857142,0.9205109401994044,1.0,17/84,14.52%,CLU;RTN1;SAMD4A;SAMD4B;EPRS1;DAPK3;DAPK1;ORMDL3;RTN3;EIF4A3;SHMT1;EIF2AK3;CPEB3;SYNCRIP;FXR1;BTG2;GAPDH
prerank,peptidyl-lysine trimethylation (GO:0018023),0.4803090363950647,1.203123752588837,0.24571428571428572,0.9197091734105152,1.0,4/26,9.03%,OGT;EEF2KMT;BEND3;KMT2A
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.42484727506690145,1.2031046626034665,0.21908127208480566,0.9184366542840501,1.0,19/69,18.76%,CRLF1;PPARGC1A;NRBP2;NGF;PTK2B;GDNF;CLCF1;ERBB3;UNC5B;SIX1;SOD2;RASA1;MEF2C;SET;ZPR1;POU4F1;F2R;PARK7;TOX3
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.46896013985739304,1.2030162606057013,0.24027777777777778,0.9174248338116198,1.0,11/31,16.64%,BBC3;PMAIP1;PPP1R13B;BAD;YWHAB;YWHAQ;ZNF205;YWHAZ;GSK3A;GSK3B;E2F1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.5107786581471998,1.2027238230635764,0.2620481927710843,0.9171944726348447,1.0,3/19,6.84%,KLF4;HPN;MAPK7
prerank,protein stabilization (GO:0050821),0.38782854874983524,1.2026373023954622,0.1689401888772298,0.9161945232346914,1.0,30/168,12.25%,CLU;ANK2;PPARGC1A;EPHA4;PARVA;CDKN1A;EP300;CREBL2;BAG1;LAMP1;FLOT2;TRIM44;CRYAB;FKBPL;CREB1;HCFC1;MUL1;DNLZ;IFT46;DVL3;CHP1;USP19;GOLGA7;BAG3;UBE2B;GNAQ;HYPK;RABL3;COA8;NAA15
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.5867839134545465,1.2024371967350258,0.27980132450331124,0.9155877456555366,1.0,5/10,11.75%,MSN;CDC42;OPHN1;EZR;RHOA
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.4695321123989807,-1.2019724777637766,0.24396782841823056,0.6916171243520232,1.0,7/13,27.99%,DDIT3;TMSB4X;SOX11;HEY2;HEY1;SIN3A;TAF1
prerank,eosinophil migration (GO:0072677),0.5539285048341441,1.2017549131618253,0.26582278481012656,0.9153644598072063,1.0,2/14,8.27%,CCL5;LGALS3
prerank,eosinophil chemotaxis (GO:0048245),0.5539285048341441,1.2017549131618253,0.26582278481012656,0.9153644598072063,1.0,2/14,8.27%,CCL5;LGALS3
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.4560179214233416,1.2015143437472628,0.23609226594301222,0.9149280320554897,1.0,10/40,14.73%,CLU;MMP9;BBC3;PMAIP1;BCL2L1;BAD;PLSCR3;HRK;OPA1;DNM1L
prerank,regulation of lymphocyte activation (GO:0051249),0.5590761019861324,1.2014597889080352,0.28391167192429023,0.9138347274438291,1.0,1/12,1.51%,CCL5
prerank,cell projection assembly (GO:0030031),0.5005248137227802,1.2011253580928902,0.26495726495726496,0.9136870378519487,1.0,5/22,13.41%,PARVA;GSN;RHOQ;CDC42;RHOU
prerank,chondroitin sulfate metabolic process (GO:0030204),0.4724792157666712,1.2010556897775204,0.24142661179698216,0.9126454033612699,1.0,9/30,11.88%,CHST12;HEXA;DSE;CHST11;CHPF;ARSB;HEXB;CHST13;CHPF2
prerank,negative regulation of heart contraction (GO:0045822),0.5792125668393324,1.2009355725278354,0.2724252491694352,0.9117709222749311,1.0,3/11,10.66%,ZC3H12A;ATP1A2;GRK2
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.4373863905004065,-1.2006722426705394,0.22546419098143236,0.6933236005173351,1.0,6/14,16.64%,WNT5A;SEMA7A;CAMK4;KIT;GPRC5B;CD74
prerank,nucleotide-sugar metabolic process (GO:0009225),0.5583361040471944,1.1998683153493823,0.26547231270358307,0.9143192202787181,1.0,3/12,5.86%,B4GALNT2;GFUS;FUT8
prerank,cellular response to alkaloid (GO:0071312),-0.4328323972553247,-1.1998641717048286,0.24107142857142858,0.6934448892543881,1.0,8/17,23.83%,SLC8A1;TGM2;CASP7;RYR2;BLM;SPIDR;CASQ2;RAD51
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.5032247686938437,1.1997869214528012,0.2695139911634757,0.9133418188794954,1.0,8/21,24.62%,ANK2;KCNA5;FLNA;SCN4B;SNTA1;GJA5;KCNH2;CACNA2D1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.4120477187416102,-1.1990355164551136,0.22955974842767296,0.6936975720134798,1.0,5/21,6.00%,PLA2G4A;OSBPL10;MBOAT1;PLA1A;PLAAT3
prerank,negative regulation of ion transport (GO:0043271),0.4918486566164655,1.1988256313865342,0.2547864506627393,0.9154648945938534,1.0,6/24,15.26%,ACTN2;PTK2B;HTR1B;WNK1;NEDD4;SYT11
prerank,receptor signaling pathway via STAT (GO:0097696),-0.39091137420433386,-1.1985809272316945,0.19141914191419143,0.6929224848652971,1.0,9/25,13.69%,GHR;IL31RA;STAT5B;PKD2;IFNAR2;JAK2;STAT5A;STAT3;STAT6
prerank,dephosphorylation (GO:0016311),0.39440113453714354,1.1984292373700296,0.1832797427652733,0.9156496863293728,1.0,16/147,8.03%,PLPPR2;PTPN14;PPM1L;PPP2CA;DUSP10;PPM1B;PTPRU;PTPRD;DUSP12;DUSP1;UBLCP1;PTPRF;PTPN9;PTPRA;PP2D1;PPM1A
prerank,regulation of phagocytosis (GO:0050764),-0.33409105979903836,-1.1983193419396152,0.15048543689320387,0.691586999431946,1.0,21/53,27.64%,CD47;MERTK;TGM2;GAS6;IL15RA;DYSF;GATA2;PLSCR1;RACK1;LMAN2;CAMK1D;ITGAV;SPHK1;DOCK2;PIP4P2;LYAR;HCK;PYCARD;SLC11A1;FGR;FCGR2B
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.5035027560582029,1.1982147847179616,0.243531202435312,0.9152029594220705,1.0,4/20,9.08%,PRKAA2;PPARGC1A;FOXP3;BRD7
prerank,regulation of ossification (GO:0030278),0.4617898983258342,1.197749486095418,0.23025435073627845,0.9155475804177936,1.0,10/36,14.09%,ANKH;SMAD6;SGMS2;ZBTB16;BMP4;TGFB2;TWIST1;PTN;MEF2C;SFRP1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.3933842186596614,1.1973528482458276,0.19422863485016648,0.9156277713731698,1.0,16/114,10.46%,TNFRSF11B;EDA2R;EDA;TNFSF13;PTK2B;FOXO3;TNFRSF8;NFKBIA;PSMD11;PSMD4;COMMD7;PSMF1;ILK;TNFRSF1A;PYDC1;PSMD7
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.45947405012654796,-1.19693645491432,0.25139664804469275,0.6935117077679834,1.0,6/14,23.19%,ENTPD1;NUDT1;ENTPD3;ENTPD5;ENTPD6;NUDT16
prerank,autophagosome maturation (GO:0097352),-0.3623668629068918,-1.1968318026269382,0.19434628975265017,0.6918029070704835,1.0,13/32,17.60%,ATP2A2;VMP1;LAMP2;UBQLN1;SNX14;CHMP3;VPS16;VPS33B;LIX1;MAP1LC3A;CLN3;VPS33A;TECPR1
prerank,DNA modification (GO:0006304),0.48845034297688067,1.1967799792006495,0.25441176470588234,0.9163416588882715,1.0,13/22,29.98%,PARP3;EXOSC3;MUTYH;MBD4;NEIL1;PARP2;TERF2;TINF2;EXOSC4;PARP1;TERF1;TERF2IP;TDG
prerank,engulfment of apoptotic cell (GO:0043652),-0.44645178693218296,-1.19672063920507,0.23577235772357724,0.6900315977423165,1.0,4/15,9.85%,RHOBTB1;MEGF10;THBS1;XKR6
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.5791319931690907,1.1963265057030557,0.2838063439065108,0.9166846173539177,1.0,1/10,0.09%,PRKCB
prerank,secretory granule organization (GO:0033363),-0.5017668116132735,-1.1962445391076153,0.246684350132626,0.6893029674382819,1.0,4/10,10.87%,ABCA1;LYST;DTNBP1;VPS33B
prerank,regulation of embryonic development (GO:0045995),0.4622291846798777,1.1958392628689147,0.2398427260812582,0.9171242927112443,1.0,5/34,4.23%,PHLDB2;DAG1;NIBAN2;CRB2;RBM19
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.4796181826925093,1.195592055596031,0.2390998593530239,0.9167154900646592,1.0,2/27,1.19%,UTRN;SLMAP
prerank,regulation of neuron projection development (GO:0010975),0.3876129245083203,1.1954775776744646,0.18716577540106952,0.9158124468488182,1.0,24/163,7.81%,RAB17;LPAR1;RTN4R;NTRK3;TBR1;KANK1;PDLIM5;PRAG1;EPHA4;EFNB2;PTK7;MAGI2;SIPA1L1;NDEL1;ITM2C;EP300;RAP1A;PTK2B;TWF1;AVIL;PTPN9;SRCIN1;ADCY6;ARSB
prerank,hyaluronan catabolic process (GO:0030214),0.5191355967312545,1.1954561816337896,0.2586466165413534,0.9146090029003349,1.0,6/18,11.10%,CD44;HEXA;STAB2;CHP1;GUSB;HEXB
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.538224397244566,1.195425270000002,0.26905829596412556,0.9134366781264988,1.0,3/16,4.13%,IGFBP6;WNT1;BMP5
prerank,positive regulation of protein localization to membrane (GO:1905477),0.3968859564022292,1.195070119798004,0.21773288439955107,0.9134565644732187,1.0,29/98,19.55%,SORBS1;BBC3;PMAIP1;CD81;PPP1R13B;STAC3;ANK3;PTPN9;BAD;LGALS3;CHP1;YWHAB;MIEF2;YWHAQ;MYO1C;KCNB1;AKAP5;CNPY4;EPHA3;YWHAZ;ATP2B4;HRAS;ITGB1BP1;ITGB2;E2F1;STX4;NECAB2;GPER1;YWHAH
prerank,early endosome to late endosome transport (GO:0045022),0.5029698733676393,1.194894726642804,0.2774480712166172,0.9127997297669307,1.0,6/20,14.67%,EMP2;RAB7A;LMTK2;HOOK1;WDR91;SNX16
prerank,regulation of programmed necrotic cell death (GO:0062098),0.5048158163966819,1.1946276876500703,0.24817518248175183,0.9124929501112141,1.0,8/20,19.46%,OGT;NUPR1;FLOT2;PELI1;HSP90AA1;STUB1;PDCD6IP;FLOT1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.4453901847419993,-1.1944016053047786,0.23333333333333334,0.6923792800786913,1.0,10/14,37.29%,FIP1L1;NUDT21;CPSF6;CPSF1;CPSF4;NCBP1;ERN1;NCBP2;CPSF4L;CPSF2
prerank,negative regulation of autophagosome assembly (GO:1902902),0.551733467242506,1.1941925391300083,0.2805071315372425,0.9127748718705185,1.0,5/13,9.88%,NUPR1;TMEM39A;CHMP4A;CHMP4B;SMCR8
prerank,peptidyl-lysine methylation (GO:0018022),0.47998486412512675,1.1941752688269454,0.27880512091038406,0.9115608713232722,1.0,13/26,27.17%,EEF2KMT;SMYD3;EEF1AKMT3;TRMT112;SETD7;SMYD1;ATPSCKMT;ANTKMT;KMT5A;N6AMT1;SMYD2;EHMT1;EEF1AKMT2
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.4379458323272202,-1.194055341530795,0.23770491803278687,0.6913929995337845,1.0,7/15,25.53%,KCNN2;ATP1B1;KCNJ2;KCNJ8;KCNIP2;YWHAE;KCNJ3
prerank,regulation of exocytosis (GO:0017157),0.44399685350719864,1.1939969054898838,0.229404309252218,0.9109818669486248,1.0,14/46,20.40%,CFTR;STXBP6;SYTL4;UNC13D;RAB3B;CPLANE2;NSF;RAB8B;STX4;RAB2B;RAB27A;RAB9A;ATP6AP1;RAB10
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.5511060800878766,1.193747764335833,0.26101141924959215,0.9106449499369125,1.0,1/12,0.14%,SORBS1
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.4649448281705928,-1.1936820989583323,0.24725274725274726,0.6905261832903793,1.0,3/13,5.93%,GAS6;AXL;IL18
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.5179866728817948,1.1934658489655159,0.24300441826215022,0.910402280682796,1.0,1/20,0.14%,NT5E
prerank,positive regulation of response to wounding (GO:1903036),0.49231997225547547,1.19334147526542,0.27285513361462727,0.9095929381878026,1.0,7/24,14.36%,KANK1;OCLN;DMTN;ACTG1;PTN;ARFGEF1;HRAS
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.4789917686491645,-1.1926023609177048,0.23142857142857143,0.6916450305183566,1.0,10/12,49.70%,IL18;IL17D;PAEP;CD80;RASGRP1;ISL1;CARD9;IL23A;IL23R;IL12B
prerank,negative regulation of phagocytosis (GO:0050765),-0.4264479881142048,-1.1924334446684783,0.24293785310734464,0.6901252518407381,1.0,6/17,16.47%,CD47;DYSF;PLSCR1;RACK1;CD300A;HMGB1
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.5408935665381245,1.191870573336621,0.2840909090909091,0.9135276980615427,1.0,1/13,0.14%,SORBS1
prerank,sprouting angiogenesis (GO:0002040),0.4356180006899509,1.1918482844119354,0.23391089108910892,0.9123486594054392,1.0,7/51,3.61%,CDH13;ANGPT1;ADTRP;EFNB2;PARVA;RSPO3;PTK2B
prerank,ameboidal-type cell migration (GO:0001667),0.4379116349996176,1.1917618310624072,0.22762148337595908,0.9114048701497598,1.0,6/51,3.81%,SEMA3D;SRGAP2;FAT2;SEMA3B;ITGB7;GDNF
prerank,neutrophil degranulation (GO:0043312),0.37554670340984464,1.1917543827854904,0.092,0.9101747462313958,1.0,92/425,17.07%,CD55;CD44;ANXA3;MMP9;ADAM10;GSN;CPPED1;RAP1B;NBEAL2;SLPI;EEF1A1;RAP1A;CYB5R3;DIAPH1;RAB9B;TMC6;DGAT1;MGAM;AP2A2;UNC13D;EPX;IMPDH2;LAMP1;ORMDL3;ALOX5;S100A11;MOSPD2;PSMD11;TIMP2;RAB44;PLEKHO2;DPP7;PKM;CTSZ;NRAS;CFP;PGM2;MLEC;DDOST;ANXA2;GLB1;NFAM1;GLIPR1;ARSB;LGALS3;DNAJC5;IQGAP1;RAB7A;MANBA;NAPRT;GOLGA7;PTPN6;DERA;ILF2;RNASE3;GUSB;STOM;PSMD7;TOM1;HP;HEXB;PTGES2;TRAPPC1;SPTAN1;FCER1G;MVP;RHOA;COMMD3;ANO6;AP1M1;TRPM2;DNASE1L1;RAB5C;LTA4H;VAMP7;ALDOA;COMMD9;DNAJC3;ATP6V1D;VNN1;HVCN1;HSP90AA1;RAP2C;ITGB2;ARL8A;EEF2;CTSH;ARMC8;CAND1;VCL;DYNC1H1;PRTN3
prerank,regulation of epithelial cell differentiation (GO:0030856),0.5186303534223464,1.1909399700601042,0.29154078549848944,0.9118278647175551,1.0,4/17,12.94%,CAV1;KLF7;MAFG;GATA3
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3861888532261441,1.190749636867499,0.1743810548977395,0.9112991252211802,1.0,19/152,11.35%,ADRA1B;GPR4;LPAR1;GRK5;ADCY9;PTGFR;ADGRL2;ADGRD1;CRHR2;RAMP1;ADCY6;LGR4;ADGRG2;HTR1B;AKAP5;ADGRG6;GNAO1;GNAQ;GNA13
prerank,positive regulation of epithelial cell migration (GO:0010634),0.4069152285712092,1.1904905412528333,0.21729237770193402,0.9109591359308616,1.0,21/92,14.84%,ANGPT1;MAPRE2;DOCK5;ANXA3;MMP9;ZC3H12A;GFUS;PTK2B;FOXC2;BMP4;TGFB2;EMC10;NRP2;BCAS3;BCAR1;GATA3;DOCK1;RREB1;FOXP1;AAMP;ITGB1BP1
prerank,DNA damage checkpoint signaling (GO:0000077),0.4706676851042045,1.1903402409072492,0.26170798898071623,0.910216160959038,1.0,14/28,27.28%,DOT1L;DONSON;USP28;CDC5L;PRPF19;ATR;E2F1;HINFP;NBN;CHEK2;TIPRL;RAD9A;STK33;CEP63
prerank,neutrophil activation involved in immune response (GO:0002283),0.37497682011531186,1.190242427375414,0.096,0.9092978956611584,1.0,92/428,17.07%,CD55;CD44;ANXA3;MMP9;ADAM10;GSN;CPPED1;RAP1B;NBEAL2;SLPI;EEF1A1;RAP1A;CYB5R3;DIAPH1;RAB9B;TMC6;DGAT1;MGAM;AP2A2;UNC13D;EPX;IMPDH2;LAMP1;ORMDL3;ALOX5;S100A11;MOSPD2;PSMD11;TIMP2;RAB44;PLEKHO2;DPP7;PKM;CTSZ;NRAS;CFP;PGM2;MLEC;DDOST;ANXA2;GLB1;NFAM1;GLIPR1;ARSB;LGALS3;DNAJC5;IQGAP1;RAB7A;MANBA;NAPRT;GOLGA7;PTPN6;DERA;ILF2;RNASE3;GUSB;STOM;PSMD7;TOM1;HP;HEXB;PTGES2;TRAPPC1;SPTAN1;FCER1G;MVP;RHOA;COMMD3;ANO6;AP1M1;TRPM2;DNASE1L1;RAB5C;LTA4H;VAMP7;ALDOA;COMMD9;DNAJC3;ATP6V1D;VNN1;HVCN1;HSP90AA1;RAP2C;ITGB2;ARL8A;EEF2;CTSH;ARMC8;CAND1;VCL;DYNC1H1;PRTN3
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.4924309511713044,1.1901895549179369,0.27405247813411077,0.908265884104558,1.0,6/23,8.22%,PMAIP1;TIMM10;AGK;BAD;ROMO1;HSPA4
prerank,endoplasmic reticulum organization (GO:0007029),0.41349482021578166,1.1899026114265407,0.22690058479532163,0.9080574113386833,1.0,29/72,23.97%,SPTSSB;OTOF;REEP3;CAV2;RTN3;MAPK15;GET4;TMEM33;EIF2AK3;LPCAT3;DNM1L;ATL2;CCDC47;REEP4;SHTN1;RNF112;TLE6;SEC31B;APP;SMPD4;RAB10;TMCC1;MIA3;VAMP2;SEC16A;SGTA;SEC31A;VAPA;TOR1AIP2
prerank,negative regulation of anoikis (GO:2000811),-0.4578981393832812,-1.1894548648093974,0.2553763440860215,0.6966596586423127,1.0,4/14,6.45%,PTK2;TLE1;NOTCH1;BCL2
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.4157954541581747,1.1893358344990088,0.21919431279620852,0.9088902010372182,1.0,12/75,10.16%,AGTR1;CDH13;FGFR1;JCAD;NRAS;AGGF1;MYDGF;BMP4;ANG;VEGFB;EMC10;NRP2
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.30629385751934796,-1.1891613750692245,0.13636363636363635,0.6954830675822394,1.0,14/67,7.58%,FLT1;SULF1;PRKD1;PIK3R1;VAV3;VEGFC;PTK2;AXL;KDR;NCK2;CLEC14A;DAB2IP;PIK3CB;ROCK1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.4689331401159613,1.1888971202352714,0.2360335195530726,0.9092468604152988,1.0,8/29,14.09%,HPN;PPP2CA;BMP5;OVOL2;SPRED3;LDLRAD4;GATA3;SFRP1
prerank,calcium ion import into cytosol (GO:1902656),-0.45143953068528125,-1.1888535442424206,0.25,0.6943604510560968,1.0,3/15,8.59%,SLC8A1;SLC8A3;SLC24A2
prerank,response to organic cyclic compound (GO:0014070),-0.32874355426821744,-1.1884541104543231,0.16037735849056603,0.6936852813458444,1.0,15/52,14.59%,STAT5B;ESR1;IGFBP5;GGT5;CYP1B1;ALPL;SLC1A1;IL18;LRRK2;TGFB1;PAQR8;STAT3;FGFR4;DRD2;DHFR
prerank,mitochondrion organization (GO:0007005),0.38360386314138656,1.1881423771252213,0.19406150583244963,0.9107143708027988,1.0,69/165,26.87%,CXADR;PPARGC1A;GABPB1;TIMM10;TIMM44;CHCHD3;AGTPBP1;CAV2;BCL2L1;HCFC1;HAX1;NRF1;MUL1;SLIRP;TOMM5;MTFR1L;AFG3L2;PITRM1;MIEF2;THG1L;COX7A2L;AFG1L;BCAP31;NIPSNAP2;WASF1;TOMM20;OPA1;BNIP3L;TIMM17B;DNM1L;VPS13D;ATP5F1B;SLC25A4;MTX1;CLUH;MTFR2;SPG7;PARK7;PISD;RHOT2;TIMM9;STOML2;HSD17B10;TOMM40;TSPO;TWNK;TIMM50;SIRT4;MIEF1;GABPA;LONP1;TFAM;TIMM23;MTX3;IFIT2;AIP;AIFM2;ADCK1;DNAJA3;ATP5F1D;MTX2;RAB32;MTFR1;RHOT1;FANCG;FBXO7;COX7A2;PARP1;ESRRA
prerank,proteasome assembly (GO:0043248),0.5597659626893945,1.1877726634281602,0.2876712328767123,0.9107708864780968,1.0,3/11,6.99%,PSMD11;POMP;PSMD4
prerank,pore complex assembly (GO:0046931),0.5017713728901112,1.1876736997725754,0.26988636363636365,0.9098994400294487,1.0,5/19,12.23%,ADAM10;NUP93;BAD;NDC1;ANO6
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.3723646094153382,-1.1868923294238682,0.21476510067114093,0.6962062809315333,1.0,12/25,20.36%,SULF1;ENG;ACVRL1;NOTCH1;BMPR1B;ACVR2A;ZNF423;CCN1;BMPR2;SOX11;UBE2O;SMAD4
prerank,positive regulation of actin nucleation (GO:0051127),0.5603889453039502,1.1864914219410088,0.3027823240589198,0.912926706455841,1.0,3/11,12.08%,GSN;FCHSD2;WASF1
prerank,ribonucleoprotein complex assembly (GO:0022618),0.3900946217531192,1.1861716974272525,0.19313304721030042,0.9128449597879343,1.0,56/132,28.18%,CELF2;NLE1;CELF1;NOP2;PPAN;SNRPB;TARBP2;MRPS7;EIF6;LSM4;DDX39B;RPSA;EIF4B;LUC7L3;USP39;SRPK2;KHDC4;PWP2;SF3A2;SRPK1;SRSF9;GEMIN6;ISY1;DHX9;HSP90AA1;LUC7L2;PRPF19;CLP1;PRPF6;SRSF1;SNUPN;SRSF5;RPL6;RPS28;DDX20;PUF60;PTGES3;DDX23;GEMIN5;SHQ1;EIF2S2;CELF4;CLNS1A;CPSF7;GEMIN8;GEMIN2;RPS27;NOP53;RRS1;MDN1;XRCC5;SNRPD2;SNRPD1;SF1;RSL24D1;RPL24
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.39353274257530185,1.186170868130494,0.21034870641169853,0.9116190370051748,1.0,14/110,11.35%,ADRA1B;GPR4;LPAR1;ADCY9;PTGFR;ADGRL2;ADGRD1;RAMP1;ADCY6;LGR4;ADGRG2;ADGRG6;GNAQ;GNA13
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.46167876190278495,-1.185920393448009,0.24,0.6971490309598458,1.0,6/13,24.80%,KDR;IL33;JAK2;EDN1;NOD2;NAMPT
prerank,negative regulation of stem cell differentiation (GO:2000737),-0.4682577952832408,-1.1855239192939793,0.2236180904522613,0.696235594880204,1.0,3/12,5.69%,JAG1;NOTCH1;N4BP2L2
prerank,skeletal muscle tissue development (GO:0007519),0.45959762856867875,1.184999607045971,0.2530949105914718,0.9145371029083551,1.0,6/32,8.17%,CAV1;CSRP3;SELENON;LMOD3;CAV2;SIX1
prerank,metal ion homeostasis (GO:0055065),0.4538355760360817,1.184892185751676,0.24453024453024452,0.9136624544697962,1.0,8/40,11.71%,ATP6V1B1;SLC12A8;CAV1;SELENON;ANK3;JPH2;LETM1;SLC12A4
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3738286825197523,1.1848855624312276,0.14845360824742268,0.9124563256104309,1.0,60/234,19.55%,PRKCB;CLU;WNT1;ANXA3;PPARGC1A;SMO;EDA2R;EDA;TSSK4;CD200;CAV1;IKBKE;MAVS;EP300;HDAC5;HDAC4;TRIM25;MTDH;FLOT2;SMARCB1;NFKBIA;ZIC2;DDRGK1;TRIM41;TRIM21;LPAR5;NFAM1;TAB3;RAB7B;ARHGEF5;TLR6;TRIM26;CARD16;SMARCA4;TLR4;COPS5;MAP3K13;IRAK1;CHUK;DHX9;IKBKG;RNF31;UBE2N;RPS27A;UBC;PRKCZ;RELN;KDM1A;PIDD1;TAB2;TRIM37;PRKCQ;PARK7;ATF2;FZD2;PRKD2;NFKB2;APP;FLOT1;ZBTB7A
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.4085658339884963,1.1845612188801016,0.2339930151338766,0.9123226277647908,1.0,21/72,17.98%,CNOT6;CDKN1A;NDRG1;EP300;SESN2;USP10;FOXM1;PLK3;ATRX;PML;BTG2;ING4;MDM2;PLK2;PCNA;E2F1;NBN;PRMT1;CHEK2;PIDD1;TRIAP1
prerank,modified amino acid transport (GO:0072337),-0.4342282716737702,-1.1844581433821013,0.24857142857142858,0.6973763334126669,1.0,2/15,1.07%,SLC6A13;SLC16A12
prerank,mesonephros development (GO:0001823),0.5612034799664896,1.1844365802796744,0.3032258064516129,0.9115844374788277,1.0,3/11,12.94%,ZBTB16;BMP4;GATA3
prerank,regulation of lamellipodium assembly (GO:0010591),0.45775770639353647,1.1843061423801022,0.2560646900269542,0.9108045047353365,1.0,7/34,8.48%,WNT1;OCLN;CAPZB;TWF1;AVIL;DMTN;CDC42
prerank,negative regulation of interleukin-2 production (GO:0032703),0.5138920180513162,1.184002347059314,0.28100470957613816,0.910649732122541,1.0,4/18,9.58%,HOMER2;HOMER3;FOXP3;EZR
prerank,histone H3-K9 demethylation (GO:0033169),0.5587770051402775,1.1836569052982908,0.29187396351575456,0.9106354111098766,1.0,5/11,16.82%,KDM4D;KDM4B;KDM3A;KDM4C;KDM1A
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.5113350150032249,1.1833277153267048,0.25107604017216645,0.9106000182680158,1.0,4/17,12.23%,CCL5;MOSPD2;CREB3;ANO6
prerank,protein targeting to mitochondrion (GO:0006626),0.42398683526358594,1.1832973500376578,0.24783147459727387,0.9095014019785489,1.0,18/52,20.94%,TIMM10;TIMM44;PMPCA;AGK;TOMM5;DNLZ;ROMO1;HSPA4;PITRM1;BCAP31;TOMM20;TIMM17B;HSP90AA1;TOMM40L;TIMM9;TOMM40;TSPO;TIMM50
prerank,regulation of interleukin-12 production (GO:0032655),-0.3362131366151679,-1.1831182105623093,0.1989795918367347,0.6994611618844568,1.0,5/47,5.53%,PLCB1;CD47;LGALS9;THBS1;IRAK3
prerank,regulation of bone mineralization (GO:0030500),-0.3207653885337465,-1.182415784603798,0.2205128205128205,0.6995025970905084,1.0,14/55,10.37%,BMP6;ADGRV1;WNT4;SLC8A1;ENPP1;KL;BMPR1B;FBN2;ECM1;TGFB1;PKDCC;ACVR2A;NOTUM;BCOR
prerank,positive regulation of synaptic transmission (GO:0050806),-0.30481796340539236,-1.181958437048281,0.125,0.6988781231412299,1.0,16/72,10.17%,GRIK2;NRXN1;SHANK3;SLC8A3;GRIN2A;LGI1;SYT1;EPHB2;GRIN2B;CLSTN2;NLGN1;ADCY1;DTNBP1;SLC24A2;NFATC4;CACNG8
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.5768564601713156,1.181471086321173,0.2988313856427379,0.9135707742475908,1.0,1/10,0.33%,NFATC2
prerank,calcineurin-mediated signaling (GO:0097720),0.5768564601713156,1.181471086321173,0.2988313856427379,0.9135707742475908,1.0,1/10,0.33%,NFATC2
prerank,hyaluronan metabolic process (GO:0030212),0.4875177067624492,1.181018887361992,0.26945244956772335,0.9139844601257245,1.0,6/23,11.10%,CD44;HEXA;STAB2;CHP1;GUSB;HEXB
prerank,sterol homeostasis (GO:0055092),0.41641348719820326,1.1807334916758936,0.2494061757719715,0.9137705597859155,1.0,13/65,11.06%,LDLR;SOAT1;CAV1;ABCD1;TTC39B;EHD1;INSIG1;NPC1;CYP39A1;RALY;SOAT2;ACSM3;ABCA2
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.4824471137387588,-1.1802612945254993,0.2661290322580645,0.7017974335796443,1.0,5/11,26.65%,HIF1A;NONO;RACK1;NR4A3;ATF4
prerank,response to axon injury (GO:0048678),-0.4102254918327862,-1.180108356114711,0.24641833810888253,0.7002874413269284,1.0,8/18,21.76%,NREP;MAPK8IP3;DHFR;MTR;SARM1;SOD1;P2RY12;TYROBP
prerank,regulation of GTPase activity (GO:0043087),0.3811236153941847,1.1799060815629547,0.20167189132706373,0.9154329151456578,1.0,47/177,17.28%,MAPRE2;RTN4R;SRGAP2;ARAP1;NGEF;CCL5;PLXNB1;EPHA4;PKP4;PLXNA2;CPEB2;SIPA1L1;WNT11;NDEL1;RAP1A;S100A10;ADAP1;SH3BP4;CAV2;EFNA5;DVL3;ARHGEF5;BCAS3;SNX18;SGSM2;RAPGEF3;EPHA3;RGS6;PLXNB2;ASAP3;OCRL;ARFGEF1;SFRP1;GSK3B;HRAS;WNK1;ARHGAP27;FLCN;ITGB1BP1;USP6NL;RAPGEF1;PLXNA3;CRK;FICD;PRTN3;RAP1GAP;F2R
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.39837462887792013,-1.1798797808534132,0.2260061919504644,0.69902593792368,1.0,5/21,3.43%,CACNA1C;DMD;SLC8A1;PDE4D;CAMK2D
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.479924743095461,1.1797974866007535,0.2922437673130194,0.9145732196266017,1.0,5/25,11.15%,CLU;KLF4;DDAH2;TLR6;TLR4
prerank,regulation of establishment of protein localization (GO:0070201),-0.44650266665632443,-1.1797224227255005,0.2507042253521127,0.6975207249405351,1.0,10/14,34.82%,CORO2B;DNAJA1;SPIDR;CENPJ;CTSD;CEP135;SCFD1;GAPVD1;TREM2;CEP295
prerank,regulation of actin filament-based movement (GO:1903115),0.5675974329560469,1.1795295899924625,0.2903225806451613,0.914324140940544,1.0,1/10,0.66%,ANK2
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.4008507430216331,1.1786707156257554,0.21816037735849056,0.9161004658140245,1.0,22/85,17.30%,CLU;TRIB2;NUPR1;ZYG11B;SH3RF2;TMEM259;NUB1;ELOB;DDRGK1;RBX1;SUMO2;COP1;HSPBP1;OSBPL7;CSNK1E;PIAS1;DDA1;GSK3A;GSK3B;MDM2;KEAP1;STUB1
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.40201155965635815,-1.1784813770663483,0.22916666666666666,0.6991780457602368,1.0,11/22,34.35%,WNT5A;SLC7A5;TNFRSF1B;TRIL;NOD2;TRIM6;BTK;CCR2;LACC1;TNFRSF14;LILRB1
prerank,bone development (GO:0060348),-0.3517296698183373,-1.178441342367118,0.2032520325203252,0.6973520654719126,1.0,13/39,11.38%,SULF1;GNAS;TGM2;SH3PXD2B;CYP26B1;LRP6;LRP5;FGFR2;NOTUM;SFRP4;TP53;DYM;MYOC
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.4758266108060109,1.1784042833478459,0.2590448625180897,0.9158174852365162,1.0,5/23,9.65%,DYNC1I1;MAP6;KIF1C;KIF1B;HOOK1
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.4530805593494517,-1.1783635617570811,0.2454780361757106,0.6956520605368851,1.0,4/13,10.88%,TBX3;NOTCH1;TGFB1;SRA1
prerank,dopaminergic neuron differentiation (GO:0071542),-0.4044560830129599,-1.1780304560575412,0.21492537313432836,0.6946180479534388,1.0,12/19,46.75%,LRP6;RYK;MANF;NR4A2;LMX1A;WNT2;SHH;VEGFA;FOXA1;EN1;FOXA2;CDNF
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.3547862103967765,-1.1779230522103412,0.2033898305084746,0.6930333003651596,1.0,11/36,14.59%,HIF1A;NPR3;NOS3;NOSTRIN;NOS1AP;NOSIP;PIK3CB;GCH1;CYGB;SPR;DHFR
prerank,regulation of membrane repolarization (GO:0060306),0.5444221826196487,1.1773450476885816,0.2857142857142857,0.9182646784500121,1.0,2/13,3.47%,CAV1;CACNB3
prerank,glycine transport (GO:0015816),0.5705716858609016,1.1772633238102164,0.2991735537190083,0.9173614500786429,1.0,2/10,10.51%,SLC36A3;SLC25A38
prerank,purine ribonucleotide transport (GO:0015868),-0.4224100994163302,-1.1772157308568556,0.25474254742547425,0.693166811011936,1.0,2/16,1.29%,LRRC8C;ABCC4
prerank,lipid biosynthetic process (GO:0008610),0.4129053629262084,1.1771952465668227,0.24649532710280375,0.9163801722414137,1.0,14/77,11.78%,PRKAA2;FDFT1;OLAH;HMGCR;ALOX5;CYP51A1;PDSS2;ACSM3;FADS1;NDUFAB1;ACSF3;ACACA;GPAM;SCD5
prerank,cardiac conduction system development (GO:0003161),0.47302796510416806,1.1767657839735703,0.2727272727272727,0.9166630358348707,1.0,3/24,6.80%,NOTCH2;GJB6;BMP4
prerank,N-glycan processing (GO:0006491),-0.4184213212788921,-1.176658048967013,0.27977839335180055,0.6928663861507021,1.0,7/18,17.07%,MAN1C1;ST8SIA4;MGAT4A;ST8SIA6;MAN2A1;ST8SIA5;ST8SIA2
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.4809631830259192,-1.176581831625345,0.28391959798994976,0.6912130101928639,1.0,7/11,42.44%,JAK2;TMEM106A;HDAC2;XBP1;TAF7;PF4;IL4
prerank,cellular response to estradiol stimulus (GO:0071392),0.5051941048181946,1.1762474874110382,0.28417818740399386,0.9171818846550471,1.0,6/18,19.14%,NCOA3;FAM210B;LCOR;SFRP1;POU4F1;GPER1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.4223563834162277,-1.176103686961194,0.2598187311178248,0.6907277515359711,1.0,8/17,10.34%,TMEM100;FGF2;VEZF1;ATOH8;BTG1;AHI1;SFRP4;RFX3
prerank,limb morphogenesis (GO:0035108),0.5016056496959478,1.1757850353366626,0.29178885630498536,0.9176709608817153,1.0,3/20,7.38%,MBNL1;GLI3;TGFB2
prerank,RNA splicing (GO:0008380),0.4033031752546013,1.1754071437057851,0.22853957636566333,0.9178181515394155,1.0,32/95,23.23%,MBNL1;PPARGC1A;SRSF2;YJU2;PPP2CA;SNRPB;LSM4;DDX39B;RBM8A;DBR1;LUC7L3;SF3B3;USP39;SRPK2;SRSF7;DDX47;SRPK1;SYNCRIP;RNPS1;MAGOHB;MAGOH;PRPF6;PTBP1;ZMAT5;WBP4;SF3A3;PRPF8;SFPQ;DDX23;U2AF1;NRDE2;SRRM1
prerank,acylglycerol catabolic process (GO:0046464),-0.36382947094759366,-1.1751654224427133,0.23048327137546468,0.6915507798007824,1.0,8/30,26.69%,MGLL;LIPE;ABHD12;ABHD2;LPL;PNPLA3;FABP7;PNPLA2
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.3905581616448824,1.1751610767207563,0.2286036036036036,0.9175075326563502,1.0,13/104,8.03%,CD109;WNT1;VEPH1;SMAD6;MAGI2;NBL1;CRIM1;TRIM33;CAV1;IGSF1;SPRED3;TGFB1I1;PPM1A
prerank,regulation of chemokine production (GO:0032642),-0.350416861096833,-1.1751215605814052,0.22270742358078602,0.6897706537418841,1.0,17/36,31.92%,HIF1A;WNT5A;LGALS9;IL18;IL6R;IL33;TLR7;CD74;LPL;SIGIRR;PYCARD;ACKR1;IL7;AIF1;SNAI2;HMOX1;TREM2
prerank,muscle cell differentiation (GO:0042692),-0.35149665792586554,-1.1748153672772461,0.1918819188191882,0.6888079790298633,1.0,12/32,13.45%,DMD;SYNE1;MRTFB;GLMN;MEGF10;TBX18;RORA;SPEG;TMEM204;GATA6;SGCZ;TBX1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.5479574112396107,1.1745284182110707,0.3184,0.9184678465583453,1.0,6/13,19.24%,PMAIP1;VDAC2;BAD;BLOC1S2;BNIP3L;RHOT2
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.3036787833789962,-1.1741048747812752,0.17261904761904762,0.6889366112931875,1.0,15/66,10.65%,FLT1;PDGFRB;SASH1;PDGFD;IL34;ROBO1;FGF2;DAB2IP;LRRK2;TGFB1;EZH2;TPD52L1;PIK3R6;KIT;TRAF6
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.5208234119560224,1.1738547973421571,0.29721362229102166,0.9196081694735863,1.0,7/16,16.85%,IMPDH2;NUDT2;PAICS;GMPS;GART;AMPD2;ADSS2
prerank,neurogenesis (GO:0022008),0.4406704183947432,1.1738313129610192,0.26376440460947503,0.9184916692124713,1.0,5/43,8.17%,LPAR1;CXCR4;CDK6;TGFB2;SIX1
prerank,response to fatty acid (GO:0070542),-0.4261174994012199,-1.1737603496235227,0.24431818181818182,0.6880745915702531,1.0,2/17,3.91%,PID1;FOXO1
prerank,response to purine-containing compound (GO:0014074),-0.4256477363481237,-1.173518766967034,0.26865671641791045,0.6869601113930394,1.0,6/17,21.61%,TRPC3;ABCC9;RYR2;P2RY1;DGKQ;VGF
prerank,photoreceptor cell development (GO:0042461),0.5397355489898743,1.173202291364953,0.28923076923076924,0.9195803037811502,1.0,2/14,4.77%,RP1;ARL3
prerank,regulation of synapse maturation (GO:0090128),-0.4857011353590652,-1.173036090060946,0.27638190954773867,0.686500761720707,1.0,3/10,7.33%,NRXN1;DAB2IP;ARHGEF15
prerank,monocarboxylic acid transport (GO:0015718),-0.326996503741922,-1.1724698004596597,0.20095693779904306,0.6862125226483657,1.0,12/51,7.94%,SLC6A13;SLC16A12;ABCC4;SLCO2B1;SLCO1C1;SLC6A12;NCOA1;SLCO3A1;SLC16A9;SLC16A6;SLC16A1;SLC16A4
prerank,cristae formation (GO:0042407),0.4742007361873428,1.1723846573721066,0.28091397849462363,0.9211385280547577,1.0,14/27,26.14%,CHCHD3;MICOS13;AFG3L2;LETM1;ATP5PF;APOO;IMMT;ATP5F1B;SPG7;ATP5PD;ATP5ME;ATP5F1D;ATP5F1C;ATP5MC3
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.4436709822224838,-1.1719507167095216,0.26216216216216215,0.6858118665833849,1.0,6/13,22.02%,FIP1L1;NUDT21;CPSF6;CPSF1;CPSF4;NCBP1
prerank,neutrophil mediated immunity (GO:0002446),0.3693819844617746,1.1719436332449475,0.115,0.9214908855997325,1.0,92/432,17.07%,CD55;CD44;ANXA3;MMP9;ADAM10;GSN;CPPED1;RAP1B;NBEAL2;SLPI;EEF1A1;RAP1A;CYB5R3;DIAPH1;RAB9B;TMC6;DGAT1;MGAM;AP2A2;UNC13D;EPX;IMPDH2;LAMP1;ORMDL3;ALOX5;S100A11;MOSPD2;PSMD11;TIMP2;RAB44;PLEKHO2;DPP7;PKM;CTSZ;NRAS;CFP;PGM2;MLEC;DDOST;ANXA2;GLB1;NFAM1;GLIPR1;ARSB;LGALS3;DNAJC5;IQGAP1;RAB7A;MANBA;NAPRT;GOLGA7;PTPN6;DERA;ILF2;RNASE3;GUSB;STOM;PSMD7;TOM1;HP;HEXB;PTGES2;TRAPPC1;SPTAN1;FCER1G;MVP;RHOA;COMMD3;ANO6;AP1M1;TRPM2;DNASE1L1;RAB5C;LTA4H;VAMP7;ALDOA;COMMD9;DNAJC3;ATP6V1D;VNN1;HVCN1;HSP90AA1;RAP2C;ITGB2;ARL8A;EEF2;CTSH;ARMC8;CAND1;VCL;DYNC1H1;PRTN3
prerank,microtubule polymerization or depolymerization (GO:0031109),0.4765868344854948,1.1718134329506558,0.28486646884273,0.9207620626625003,1.0,2/25,3.02%,FGF13;KIF2A
prerank,positive regulation of kinase activity (GO:0033674),-0.2830906516038697,-1.17180041264258,0.14285714285714285,0.6844554463689733,1.0,32/107,13.71%,FLT1;PRKAG2;ROR1;PDGFRB;EPHA7;TEK;RAPGEF2;INSR;MERTK;PTK2;GAS6;AXL;TIE1;PDGFRA;KDR;EPHB2;EPHB4;ROR2;NTRK2;ERBB4;FGFR2;RYK;KIT;ALS2;IGF1R;CCN1;FGFR4;SPDYA;MMD;FLT4;RET;EPHA5
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.31476594966355825,-1.171513975785886,0.1977401129943503,0.6834624372525591,1.0,9/56,8.35%,BMP6;RBPMS;ENG;DAB2;ACVRL1;SNX25;BMPER;TGFB1;ACVR2A
prerank,regulation of gene expression (GO:0010468),0.36274522262758846,1.1714190674431166,0.061,0.9209086785730219,1.0,148/903,14.36%,FN1;CDH1;WNT16;MBNL1;BNC2;NFATC2;CLU;ANGPT1;ANK2;NOTCH2;ITGB8;PRDM6;PRKAA2;NTRK3;FOXN3;DAXX;TRIM60;ADTRP;KLF4;TFAP2C;PPARGC1A;AHNAK;SMO;AHNAK2;ADAM10;HPN;OCLN;GSN;ZC3H12A;WNT11;EP300;CELF1;HDAC5;CDK6;NGF;AFF3;DAPK3;GDNF;ZNF219;PPP2CA;CREBL2;CGGBP1;WNT6;HDAC4;YBX3;NFE2L2;GCNT2;WWP2;OLFM1;FLOT2;SNRNP70;TRIM44;SON;IGSF1;MLF2;CDK4;ESRRB;PRRX2;OVOL2;PATZ1;PHF1;POLR2A;HOXA5;KRAS;MOV10;FOXD1;HCFC1;ZBTB7B;KAT6B;DDRGK1;EFEMP1;BMP4;ANK3;RBMS3;MSN;RBM20;TOB2;TRIM21;TGFB2;NKAP;ZFHX3;FGF22;ATRX;SIX1;MAZ;POU3F1;MAPK9;PML;FOXP3;HNRNPH2;TLR6;TXK;MYCBP;TRIM26;MAP2K2;TRIM11;EZR;APBB1;SMCR8;MUSK;FADS1;NFYC;TWIST1;SRPK2;ZNF205;SRRM4;ACTG1;GON4L;MYT1;TLR4;CALCOCO1;KDM6A;AJUBA;SNX12;SFMBT2;SP1;EIF2AK3;ZNF148;TAF5;WNT3;TFEB;SPIN1;SH3GL2;CHD3;GATA3;RREB1;SBNO2;GPBP1;CDK2;CIAO3;NFIA;TCF19;MYC;GSK3A;PRDM11;REXO4;MEF2C;TLE5;MYBL1;ATP2B4;SFRP1;SRRT;FOXP1;UBR5;PTP4A3;IRF2;GSK3B;HRAS
prerank,post-translational protein modification (GO:0043687),0.36738622752333305,1.1711222295171146,0.15252525252525254,0.9207135823573568,1.0,69/332,17.60%,FN1;MSLN;FBXL7;F5;FAM20C;FBXW8;PRSS23;ADAM10;PENK;ASB14;FBXL20;SPSB4;SERPINC1;ZBTB16;TIMP1;PSMD11;NUB1;ANO8;ELOB;KLHL21;BMP4;PSMD4;PSMF1;GPC3;FEM1C;FEM1A;SUMF1;WSB2;FBXL18;RBX1;FBXO31;LAMC1;LAMB2;COP1;PSMD7;FBXW9;FEM1B;SUMF2;DCUN1D1;SOCS2;CALU;KLHL13;COPS5;DCAF6;CP;PSMB5;UBXN7;LGALS1;DDA1;ASB7;CHML;SOCS6;DCAF17;TULP4;RAB1B;DNAJC3;PRKCSH;ASB6;CCDC22;FBXL15;ASB8;DDB1;CAND1;ASB3;CUL9;KEAP1;PTP4A2;UBE2F;PSMD1
prerank,ventricular septum morphogenesis (GO:0060412),-0.373313274186772,-1.1709518235955654,0.24414715719063546,0.6832148648301088,1.0,13/27,22.26%,ZFPM2;ROBO1;NOTCH1;ROBO2;SLIT2;HEYL;SLIT3;BMPR2;SOX11;SMAD4;HEY2;APLNR;HEY1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.4453247060635587,1.1709224446079374,0.26710526315789473,0.9203103771060871,1.0,16/38,22.70%,SREBF2;HAX1;FZD5;ATP5IF1;SIAH3;SAE1;VPS11;NPEPPS;RHOU;GSK3A;RNF31;UBE2D3;SREBF1;FBXW7;ARIH2;MICALL2
prerank,carnitine metabolic process (GO:0009437),0.5456121326456932,1.1708994854344763,0.30063291139240506,0.9192069551121345,1.0,5/12,13.28%,ACADL;CPT1B;SHMT1;CPT2;ACADM
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.4128528026666512,1.1708893939840719,0.24588235294117647,0.9180556049852356,1.0,18/67,17.01%,RAB17;PODXL;RABEP2;CAV1;TBC1D16;CAPZB;TWF1;DMTN;MAPK15;CDC42;TBC1D1;ODAD3;FXR1;TRPM2;USP6NL;FSCN1;TBC1D22A;TBC1D10A
prerank,myelination (GO:0042552),-0.32654249046167627,-1.1705148264575795,0.2,0.6826410814717855,1.0,20/46,16.99%,SLC8A3;MAL;EPB41L3;TNFRSF21;NFASC;CMTM8;GAL3ST1;PLP1;NF1;PLLP;MBP;MYOC;TPPP;CNTNAP1;ABCD2;B4GALT5;MYRF;SIRT2;ACSBG1;MPZ
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.5373224642657453,1.170512087063894,0.3086816720257235,0.9181819327582684,1.0,4/12,5.45%,ADTRP;NBL1;BMP5;DUSP1
prerank,recombinational repair (GO:0000725),0.40074302967838293,1.1704910932239352,0.25317919075144507,0.9171006341106365,1.0,29/77,22.42%,FEN1;RECQL4;KDM4D;NABP2;RNF138;MRE11;RMI1;HUS1B;NSMCE2;MMS22L;ERCC5;RPA3;MCM8;FAN1;UBE2N;LIG3;SFR1;SMC6;NBN;RAD50;ZFYVE26;NUCKS1;ERCC4;NABP1;POLN;YY1;SFPQ;SWI5;NSMCE1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.5605189725249713,1.1704690848046035,0.2899505766062603,0.9160246181757341,1.0,3/11,11.01%,SMARCB1;PIH1D1;SMARCA4
prerank,epithelial to mesenchymal transition (GO:0001837),-0.32956789381624585,-1.1704165618303124,0.2018348623853211,0.6810930245982393,1.0,15/47,11.92%,LEF1;ENG;WNT4;HIF1A;WNT5A;TBX3;NOTCH1;TGFB1;ROCK1;TASOR;HEYL;LOXL3;NOTCH4;DLG5;HMGA2
prerank,regulation of B cell activation (GO:0050864),-0.37555259782593237,-1.1702201221868513,0.21754385964912282,0.6798948948626679,1.0,12/25,38.37%,SH3KBP1;TNFAIP3;NOD2;AHR;TNIP2;FCGR2B;BANK1;FOXJ1;SAMSN1;IL4I1;IKZF3;THEMIS2
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.26966166446575274,-1.1699234117228139,0.11904761904761904,0.6789054486542913,1.0,35/124,17.39%,PTPRM;CNTNAP2;RAPGEF2;MAP2;LYN;FRY;STMN2;LIMA1;LGI1;PKD2;LAMB1;LRP12;CEP78;NLGN1;ROCK1;DTNBP1;ARMC2;TBC1D24;RYK;FAM161A;SNAPIN;PLP1;MYOC;TBC1D23;MANF;TMEM108;KIFAP3;ATXN10;PPP1R9A;STMN3;NCDN;ATCAY;HMGB1;RASGRF1;WDPCP
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.45397161454777674,1.169264894011251,0.2603305785123967,0.9191194476480932,1.0,12/30,22.70%,SREBF2;FZD5;SAE1;VPS11;NPEPPS;RHOU;GSK3A;RNF31;UBE2D3;FBXW7;ARIH2;MICALL2
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.39751377355835094,-1.168913293660898,0.24285714285714285,0.6799534369092762,1.0,6/18,7.62%,RDX;RIC1;DAB2IP;DACT1;VPS35;AMER1
prerank,fatty acid derivative biosynthetic process (GO:1901570),-0.34110020470789804,-1.1684279969918456,0.2277992277992278,0.6795095126094033,1.0,8/35,12.20%,PAM;ACSS3;GGT5;HMGCLL1;FAR2;HMGCS2;BDH1;HPGD
prerank,negative regulation of apoptotic process (GO:0043066),0.36711589158930424,1.1680465170297598,0.12650602409638553,0.9220412613416877,1.0,95/444,17.28%,ANGPT1;CD44;CRLF1;NOTCH2;PRKAA2;WNT1;KLF4;PPARGC1A;TJP1;NRBP2;MMP9;GRK5;ADAM10;HPN;SMAD6;NIBAN2;NUPR1;ZC3H12A;TNFAIP8;WNT11;CAV1;QARS1;NGF;PTK2B;GDNF;CLCF1;SH3RF2;ANXA4;HSPB1;MTDH;BAG1;SON;CRYAB;NFKBIA;ANXA5;AVEN;BCL2L1;MRE11;HAX1;SHC1;MYDGF;DDRGK1;DDAH2;BMP4;GOLPH3;CCND2;ERBB3;ARHGAP10;PLK3;UNC5B;SIX1;MAZ;BAG3;RAF1;CARD16;HDAC3;SOD2;PTMA;AQP1;SOCS2;HYPK;YWHAZ;NAA15;COPS5;OPA1;ERCC5;RASA1;PDPN;ARF4;CBX4;VDAC1;MYC;IRAK1;MEF2C;ZFAND6;SFRP1;BNIP3L;SET;GSK3B;DNAJC3;PLK2;BFAR;DSTYK;IGBP1;FLNA;MAEA;CTSH;UFM1;RPS27A;UBC;POU4F1;LRP2;CIAPIN1;XIAP;F2R
prerank,response to interleukin-4 (GO:0070670),-0.48176309222027786,-1.1680325943927155,0.30617283950617286,0.6789146053421795,1.0,1/10,0.48%,LEF1
prerank,negative regulation of programmed cell death (GO:0043069),0.3674419946286843,1.168019034181501,0.15477386934673368,0.9209555175184363,1.0,79/355,17.26%,ANGPT1;CD44;NOTCH2;PRKAA2;WNT1;TJP1;MMP9;GRK5;ADAM10;HPN;SMAD6;NIBAN2;NUPR1;TNFAIP8;WNT11;NGF;KANK2;PTK2B;GDNF;SH3RF2;ANXA4;HSPB1;MTDH;BAG1;SON;CRYAB;NFKBIA;ANXA5;AVEN;BCL2L1;MRE11;HAX1;SHC1;MYDGF;DDRGK1;DDAH2;BMP4;GOLPH3;CCND2;ARHGAP10;PLK3;RAB7A;BAG3;RAF1;TIGAR;HDAC3;PTMA;AQP1;SOCS2;HYPK;YWHAZ;NAA15;COPS5;OPA1;ERCC5;RASA1;PDPN;ARF4;CBX4;VDAC1;MYC;IRAK1;ZFAND6;SFRP1;BNIP3L;GSK3B;DNAJC3;PLK2;BFAR;DSTYK;FLNA;CTSH;UFM1;RPS27A;UBC;POU4F1;LRP2;CIAPIN1;XIAP
prerank,negative regulation of endopeptidase activity (GO:0010951),0.4269349717126798,1.1679620211025985,0.2572145545796738,0.9199592932749868,1.0,8/47,8.76%,ANXA8;ANXA8L1;CRB2;TIMP4;SERPINC1;TIMP1;TIMP2;SERPINB8
prerank,diol biosynthetic process (GO:0034312),-0.4328292858809808,-1.1678281871174114,0.26988636363636365,0.6776743207177297,1.0,9/15,33.30%,ACER2;GCH1;SPR;DHFR;SPHK1;ASAH2;SPTLC2;ACER3;SPTLC3
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.39052963015593506,1.1677773011821058,0.23076923076923078,0.9194541387289045,1.0,18/84,15.97%,MBNL1;CELF2;DDX5;CELF1;RBFOX2;SON;LARP7;RBM8A;SRPK2;SRRM4;SRSF7;SRPK1;FXR1;DAZAP1;RNPS1;SRSF9;MBNL2;MAGOH
prerank,keratan sulfate catabolic process (GO:0042340),0.5439149826609685,1.1669994979801408,0.3232830820770519,0.9210223959455397,1.0,4/11,11.10%,HEXA;PRELP;GLB1;HEXB
prerank,plasma membrane repair (GO:0001778),0.541583898710417,1.1669634791344254,0.30618892508143325,0.9200060588718202,1.0,2/13,2.30%,AHNAK2;SYTL4
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.4221737414371056,1.1667762009150602,0.2604298356510746,0.9195140168010604,1.0,10/55,13.84%,FBXL7;FHL1;PSMD11;AVEN;PSMD4;PSMF1;RBX1;PSMD7;PSMB5;PINX1
prerank,Rap protein signal transduction (GO:0032486),0.564006296265599,1.1657576761472568,0.306368330464716,0.9219222385002718,1.0,6/10,15.44%,RAP1B;RAP1A;RAPGEF3;RAPGEF1;PLK2;RAP2C
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.4886883390643483,-1.1656656443112605,0.2871287128712871,0.6818749634114691,1.0,6/10,26.61%,ADGRV1;PLS1;SOD1;TSKU;WHRN;IFT88
prerank,sulfur compound transport (GO:0072348),-0.3699450628996159,-1.1654306366877099,0.25735294117647056,0.6807934136492764,1.0,4/27,4.99%,SLC6A13;SLC26A7;SLC35F3;SLC6A6
prerank,regulation of monocyte chemotaxis (GO:0090025),0.47338229699548195,1.1648718283559232,0.2775453277545328,0.9238376787882501,1.0,6/24,12.23%,CCL5;NBL1;MOSPD2;DUSP1;CREB3;ANO6
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.47484719462310354,1.1647585537799812,0.2821997105643994,0.9230584892749895,1.0,7/27,13.01%,ANK2;AHNAK;CACNB3;SELENON;JPH2;JPH3;CACNB2
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.5606105827126664,1.1645426139212463,0.31239388794567063,0.9226920641176014,1.0,3/10,14.01%,KLF4;MAPK7;TLE5
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.5060080087023535,1.1645317952793643,0.2981651376146789,0.9204122491715891,1.0,8/15,23.88%,BLOC1S6;AP3B1;AP3S1;BLOC1S2;AP3S2;AP3M1;AP3D1;BLOC1S5
prerank,anterograde synaptic vesicle transport (GO:0048490),0.5060080087023535,1.1645317952793643,0.2981651376146789,0.9204122491715891,1.0,8/15,23.88%,BLOC1S6;AP3B1;AP3S1;BLOC1S2;AP3S2;AP3M1;AP3D1;BLOC1S5
prerank,secretion (GO:0046903),-0.4460998594016307,-1.1638749204507353,0.28225806451612906,0.6834055560227328,1.0,7/14,30.33%,FBLN5;NPR1;RIMS1;SLC22A6;SLC22A2;GUCA1B;PRKCI
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.4002194469702606,1.1638001014294952,0.24910607866507747,0.9217967182425584,1.0,19/80,15.73%,WNT1;ARAP1;OCLN;EPS8L2;NDEL1;CDC42EP4;PALM;CDC42EP5;RIPOR2;RHOQ;AVIL;CDC42;BCAS3;PLEKHM1;MARK4;HRAS;CCDC88A;WASHC1;FSCN1
prerank,actin filament organization (GO:0007015),0.37471063288354006,1.1635861621146655,0.21018418201516792,0.9213754811813233,1.0,22/151,10.16%,BAIAP2L1;POF1B;COBL;NEBL;TMOD3;MYO1H;VILL;EMP2;GSN;MPRIP;TMOD2;MCU;CORO7;LMOD3;ENAH;AVIL;DMTN;CDC42;MYO5A;GAS2L1;MYO1C;ABI1
prerank,triglyceride homeostasis (GO:0070328),-0.3787633472952056,-1.1634419415933897,0.25539568345323743,0.6828396001567565,1.0,10/26,29.69%,IL18;NR1H3;RORA;PNPLA8;LPL;NR1H4;DGAT2;FITM2;ANGPTL4;XBP1
prerank,positive regulation of JNK cascade (GO:0046330),0.4045098715338034,1.1631265327745268,0.2651331719128329,0.9217631305747498,1.0,6/70,4.38%,WNT16;MAP3K5;EDA2R;CCN2;PTK2B;SH3RF2
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.45661220731382907,1.1629634595629768,0.2845303867403315,0.921158883940749,1.0,10/27,18.32%,PRKCB;KANK1;TSC2;PTPRE;PTPN2;PIP4K2C;GSK3A;PRKCZ;PRKCQ;SLC27A4
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.49715039361523494,1.162923840970813,0.3105022831050228,0.9201563122784604,1.0,9/19,27.43%,NAGK;NANS;UAP1L1;GFPT1;GNPDA2;PMM1;UAP1;PMM2;PGM3
prerank,response to nitric oxide (GO:0071731),-0.45011381350440616,-1.1627498221395947,0.27071823204419887,0.6830416258810166,1.0,5/13,15.60%,GUCY1B1;FOXO1;EGLN1;TXN;MTR
prerank,negative regulation of axon extension (GO:0030517),0.4597675395343732,1.1625792101902412,0.28551724137931034,0.9202667180054183,1.0,3/30,2.81%,SEMA3D;RTN4R;SEMA3B
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.5279048504618629,1.1618270661400676,0.30218068535825543,0.9216238277604537,1.0,6/14,15.66%,EMP2;LIMS2;TIMP1;DMTN;ITGB1BP1;FLNA
prerank,telomere maintenance via telomerase (GO:0007004),0.47742888270134193,1.16161521745622,0.2863013698630137,0.92118995396262,1.0,13/28,23.34%,PPP6R3;MRE11;GAR1;CDK2;PINX1;ANKRD28;HSP90AA1;RAD50;RFC1;TERF2;PTGES3;SHQ1;TINF2
prerank,regulation of apoptotic process (GO:0042981),0.36137906516398904,1.1616146041395312,0.08808808808808809,0.9200498673859335,1.0,143/676,17.31%,EGLN3;CLU;ANGPT1;CD44;NOTCH2;PRKAA2;DAXX;WNT1;PAWR;ACTN2;TJP1;MMP9;NGEF;MAP3K5;GRK5;ADAM10;HPN;SMAD6;NIBAN2;NDRG1;ARHGEF17;NUPR1;AKAP13;TNFAIP8;WNT11;PMAIP1;ARHGEF12;PRR7;NGF;PHLDA3;PTK2B;FOXO3;TNFRSF8;DAPK3;GDNF;TIAM2;DAPK1;SH3RF2;ANXA4;HSPB1;PPP1R13B;OLFM1;MTDH;BAG1;UTP11;SON;CRYAB;NFKBIA;ANXA5;RARG;AVEN;IRF3;PERP;BCL2L1;HOXA5;ARHGEF18;MRE11;HAX1;SHC1;MYDGF;DDRGK1;DDAH2;BMP4;PNMA2;EGLN2;GOLPH3;CCND2;ARHGAP10;BAD;PLK3;LATS1;TNFRSF10B;NLRP2B;JUN;PIP5KL1;ADAMTSL4;ARHGEF5;BAG3;PTPN6;TRIO;APBB1;RAF1;IER3IP1;ARL6IP5;HDAC3;PTMA;USP42;AQP1;GNA13;SOCS2;PLSCR3;HYPK;YWHAZ;GADD45B;ANKRD13C;BCAR1;ANO6;NAA15;COPS5;HRK;OPA1;ERCC5;RASA1;PDPN;SOS2;ARF4;LGALS1;CBX4;RNPS1;VDAC1;MYC;EEF1E1;ING4;IRAK1;MEF2C;ZFAND6;SFRP1;BNIP3L;GSK3B;DNM1L;FLCN;DNAJC3;PLK2;HSP90AA1;BFAR;DSTYK;ACTN4;FLNA;IP6K2;CTSH;UFM1;ARHGEF1;FRZB;RPS27A;UBC;E2F1;ABL1;LRP2;SIGMAR1;CIAPIN1;SIAH1;XIAP;PLEKHG2
prerank,regulation of necroptotic process (GO:0060544),0.47439731675909874,1.1612990218742092,0.29148629148629146,0.9200274064668029,1.0,10/23,20.54%,OGT;YBX3;FLOT2;PELI1;HSP90AA1;SLC25A4;STUB1;PDCD6IP;FLOT1;ZBP1
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.49738538284727996,1.1612725905820998,0.2942073170731707,0.9189626141547826,1.0,4/16,9.55%,KDM4D;SHLD2;PARP3;RIF1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.5131530110739034,1.1612077931405314,0.3257918552036199,0.9180362435709878,1.0,5/17,12.85%,SREBF2;ERLIN2;ERLIN1;ABCA2;LPCAT3
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.4094928848871883,1.161138760568097,0.2447058823529412,0.917147589191667,1.0,17/73,12.89%,TFAP2C;EP300;HDAC5;CGGBP1;HDAC4;POLR2H;TAF1C;PHF1;ZFP57;ACTB;DNMT3A;POLR1C;MYO1C;POLR1E;AEBP2;POLR1F;PPM1D
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.4117797148490683,1.1606970274454547,0.27175208581644816,0.917488819688301,1.0,18/63,17.98%,CNOT6;CDKN1A;EP300;PLK3;FBXO31;PML;SDE2;CCND1;CDK2;BTG2;MDM2;PLK2;PCNA;E2F1;PRMT1;CHEK2;PIDD1;TRIAP1
prerank,amino sugar biosynthetic process (GO:0046349),0.5414525769407212,1.1606706373578048,0.31121642969984203,0.9164470049551655,1.0,6/12,27.43%,NAGK;UAP1L1;GFPT1;GNPDA2;UAP1;PGM3
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.5613281228551037,1.1605303065744974,0.31209150326797386,0.9157291355957102,1.0,2/10,8.98%,ZC3H12A;FOXP3
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.518076495575642,1.1602573516875636,0.29754601226993865,0.9155139723286869,1.0,4/16,10.39%,ANK2;PPP1R15A;DDRGK1;BCAP31
prerank,regulation of exosomal secretion (GO:1903541),0.49857966998401526,1.15973231051059,0.28378378378378377,0.9161943497487501,1.0,9/19,17.99%,SDC4;RAB7A;ATP9A;VPS4B;VPS4A;CHMP2A;PDCD6IP;STAM;TSG101
prerank,positive regulation of T cell migration (GO:2000406),0.4800952677348138,1.1597281245738245,0.28901734104046245,0.9150973531792249,1.0,8/20,19.53%,CCL5;ADAM10;STK39;OXSR1;RHOA;WNK1;APP;ADAM17
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.4234547177772744,-1.1596824234915226,0.25,0.6895372904777457,1.0,5/16,8.01%,ST6GALNAC3;ST3GAL5;ST8SIA4;ST6GALNAC5;ST8SIA6
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.47519033514781506,1.1592862385893745,0.2763337893296854,0.9154846217281022,1.0,13/29,23.34%,PPP6R3;MRE11;GAR1;CDK2;PINX1;ANKRD28;HSP90AA1;RAD50;RFC1;TERF2;PTGES3;SHQ1;TINF2
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.5127723646859376,1.1592748799449304,0.29357798165137616,0.9144105256204557,1.0,3/15,6.80%,NCOA3;SULT2B1;BMP4
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.388948297771757,-1.1587523162231075,0.2641509433962264,0.6903167961598524,1.0,4/20,7.35%,PID1;DAB2;TGFB1;PKDCC
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.2604288088544361,-1.158666778560098,0.12244897959183673,0.6888274182996361,1.0,42/161,16.15%,BICC1;MCC;FZD6;DAB2;IGFBP2;SOX13;WNT5A;DKK3;STK3;ANKRD6;TLE1;TMEM131L;ZNRF3;SHISA6;DAB2IP;HECW1;CHD8;PSMC6;TBX18;JADE1;DACT1;PSMA6;GLI1;APC;AMER1;SOX17;FZD4;LRP6;AXIN2;IGFBP4;NOTUM;SFRP4;INVS;NPHP3;DDIT3;CCDC88C;NKD2;TMEM64;PSME1;PSMB10;APC2;PSMD5
prerank,leukocyte tethering or rolling (GO:0050901),0.5048795548918333,1.1584683892577414,0.2986627043090639,0.9159952958677149,1.0,3/17,7.16%,PODXL2;ITGB7;GOLPH3
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.5536813329092463,1.158244437293526,0.30287648054145516,0.9156063622053195,1.0,5/11,14.09%,RSPO3;MLLT3;WNT5B;CSNK1E;SFRP1
prerank,neuron differentiation (GO:0030182),0.376358154656468,1.1578509598733688,0.2238648363252376,0.915810297828265,1.0,15/165,9.20%,WNT16;WNT1;PBX3;PBX1;NRBP2;WNT10A;WNT11;ITM2C;WNT6;PTPRD;TGFB2;WNT5B;FZD5;ACSL3;OPHN1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.4263110755947862,1.1577060439390956,0.28035043804755944,0.9151841238476681,1.0,15/50,20.19%,CD44;KLF4;MMP9;NGF;PIH1D1;RAF1;CARD16;AQP1;IGBP1;XIAP;TRIAP1;PARK7;CDKN2D;BEX3;ARL6IP1
prerank,mammary gland development (GO:0030879),-0.3967298583217117,-1.1576768162951419,0.2483221476510067,0.6898520828214735,1.0,6/21,9.87%,GLI2;WNT4;TBX3;JAK2;ERBB4;NOTCH4
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.48386418428787353,1.1571443082679427,0.28995756718529,0.9159220426402852,1.0,3/21,2.93%,CNOT6;SAMD4A;SAMD4B
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.4032409674213269,1.156939912500826,0.26153846153846155,0.9154606086022863,1.0,17/76,15.63%,NR3C2;UACA;ZC3H12A;EP300;PPM1B;TRIM44;NFKBIA;ILK;PPM1A;EZR;NMI;TLR4;RHOA;IRAK1;PTP4A3;TLR3;ACTN4
prerank,neuron projection development (GO:0031175),-0.2641972944027765,-1.1564069597726192,0.07692307692307693,0.6917478139353583,1.0,44/168,13.82%,PTPRM;CNTNAP2;RAPGEF2;MAP2;ADGRV1;DCLK1;SHANK3;TNIK;LYN;NRK;DOCK10;PAK3;GRM7;FRY;STMN2;NYAP2;SGK1;LGI1;LAMB1;DAB2IP;EPB41L3;LRP12;EPHB2;LRRK2;NLGN1;ROCK1;DTNBP1;TBC1D24;RYK;SNAPIN;PLP1;MAP4K4;NCKAP1L;ALS2;MYOC;MAPK8IP3;TBC1D23;MANF;TMEM108;BDNF;CNTNAP1;ATXN10;PPP1R9A;STMN3
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.5399879126145292,1.1563573806588399,0.30198019801980197,0.9162791889891928,1.0,3/13,7.48%,CYFIP2;PERP;BAD
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.3906519905630617,-1.15619834461026,0.260233918128655,0.6905864581669088,1.0,6/20,4.54%,CACNA1C;DMD;SLC8A1;CAMK2D;ATP2A2;ATP1B1
prerank,positive regulation of translation (GO:0045727),0.38970089342001607,1.1558766501015123,0.2675086107921929,0.9168189921664414,1.0,27/94,20.71%,CCL5;VIM;SAMD4A;YTHDF1;YBX3;RPS4X;PKM;EIF4A3;UPF3A;EIF6;MRPS27;HABP4;POLDIP3;CPEB3;PLXNB2;FXR1;BOLL;UPF3B;PYM1;DHX9;JMJD4;EEF2;USP16;YTHDF3;TRUB2;SOX4;ZCCHC4
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.5077186793670698,1.1557660190138572,0.2995391705069124,0.9160804831195959,1.0,2/16,3.17%,LDLR;ABHD5
prerank,response to chemokine (GO:1990868),0.5179643997885479,1.155296403975026,0.30198019801980197,0.9165463067396017,1.0,7/13,14.44%,ZC3H12A;RIPOR2;DUSP1;STK39;OXSR1;RHOA;WNK1
prerank,regulation of mitotic nuclear division (GO:0007088),-0.31511296199230704,-1.1552144407697422,0.1711229946524064,0.691642473813059,1.0,14/55,17.58%,IGF1;PDGFRB;TGFA;INSR;RGCC;IGF2;LRP5;RCC1;ANAPC15;TOM1L1;EDN1;BORA;EDN3;EGF
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.46096349223934907,1.1550912933602469,0.3058984910836763,0.9161788314208545,1.0,10/30,17.60%,B4GALNT2;ASGR1;MGAT1;FUT8;DDOST;MCFD2;DPM2;ALG5;UBE2J1;RPN2
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.2923061670719646,-1.1548127573103502,0.16981132075471697,0.6910329552701102,1.0,17/75,9.51%,FARP1;MAP2;MAP1B;DCC;PAK3;DCDC2;ZDHHC17;BRSK1;NRCAM;CTNNA2;SLITRK1;S100B;DSCAML1;SDC2;FGFR2;RYK;NTNG1
prerank,cellular response to hypoxia (GO:0071456),0.37915243160712064,1.1541619828717706,0.244173140954495,0.9182151417267702,1.0,32/126,18.09%,EGLN3;NDRG1;CPEB2;EP300;PMAIP1;EPO;PSMD11;ELOB;PSMD4;PSMF1;EGLN2;BAD;PLK3;RBX1;TWIST1;CARD16;TIGAR;PSMD7;AQP1;HYOU1;PSMB5;NPEPPS;MYC;SFRP1;BNIP3L;LMNA;MDM2;RPS27A;UBC;STUB1;PSMD1;PSMC4
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.3944996629768031,1.1536388572013863,0.25578703703703703,0.9188839722756162,1.0,16/84,19.72%,FZR1;PSMD11;PSMD4;PSMF1;FBXO31;FBXO5;PSMD7;PSMB5;ANAPC4;CDK2;RPS27A;UBC;PSMD1;PSMC4;PSMD8;RB1
prerank,regulation of response to biotic stimulus (GO:0002831),0.45895353891830715,1.1533066597965942,0.2943661971830986,0.9188421689443874,1.0,1/28,0.15%,CD55
prerank,excitatory postsynaptic potential (GO:0060079),-0.3965748619808539,-1.1532651149882398,0.2653061224489796,0.6937005450677456,1.0,6/19,14.94%,GRID2;GRIN2A;GRIN2B;LRRK2;DRD2;MPP2
prerank,positive regulation of histone acetylation (GO:0035066),0.47565311225284646,1.1531369743032607,0.29678362573099415,0.9183061650258072,1.0,5/23,9.08%,PPARGC1A;SMARCB1;PIH1D1;FOXP3;BRD7
prerank,central nervous system myelination (GO:0022010),0.5548479958110684,1.1522020829942963,0.30948419301164726,0.9204583621305765,1.0,1/11,0.40%,CLU
prerank,morphogenesis of an epithelium (GO:0002009),0.47478609006961414,1.1517007842263363,0.3004172461752434,0.9211106478317663,1.0,5/25,10.71%,DAG1;WNT10A;LAMA5;ACTB;ACTG1
prerank,regulation of myoblast differentiation (GO:0045661),-0.34694838506555037,-1.1516831670900858,0.2099236641221374,0.6962381325056114,1.0,8/32,10.88%,PLCB1;BOC;TBX3;NOTCH1;TGFB1;BTG1;LRRC8A;SRA1
prerank,long-chain fatty acid import into cell (GO:0044539),-0.48914889220010505,-1.1515683027555996,0.291970802919708,0.6948015972452515,1.0,3/10,9.55%,SLC2A1;ACSL1;RPS6KB1
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.386953774426968,-1.1513176149268658,0.2719033232628399,0.6938014342394885,1.0,3/20,7.31%,PID1;DAB2;TGFB1
prerank,response to exogenous dsRNA (GO:0043330),0.49592112640723207,1.1510617190297905,0.3086053412462908,0.9220715766671842,1.0,7/18,19.46%,CAV1;MAVS;MUL1;TLR3;DHX9;COLEC12;FLOT1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.4023063735195303,1.1506527136668134,0.2647754137115839,0.9223407835797519,1.0,20/73,19.37%,CD44;NTRK3;CAV1;NGF;CREBL2;DOCK7;HAX1;LATS1;RAF1;RAPGEF3;CAPRIN2;ATP2B4;EIF4G1;HSP90AA1;PFN2;HDAC6;MTCP1;PARK7;PRKD2;APP
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.46410199414797343,1.150609303337153,0.2902777777777778,0.9213774099508037,1.0,6/27,16.56%,MAP3K8;MAP3K5;CHUK;IKBKG;RPS27A;UBC
prerank,macrophage migration (GO:1905517),0.5220181758015545,1.1505351595548428,0.31561996779388085,0.9205248639417691,1.0,2/13,8.27%,CCL5;LGALS3
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.4377651502644156,1.1501565819188233,0.2956636005256242,0.9207242479636714,1.0,14/38,21.43%,NDUFV1;NDUFB11;NDUFB8;NDUFB6;NDUFS3;NDUFAB1;NDUFB7;NDUFV2;NDUFA1;NDUFB4;NDUFB5;NDUFB9;NDUFA2;NDUFA12
prerank,positive regulation of cell migration (GO:0030335),0.36581829088615186,1.1500299100648235,0.2158859470468432,0.920021617751025,1.0,29/253,8.60%,FN1;SEMA3D;CDH13;DOCK5;NTRK3;LAMC2;TJP1;SMO;MMP9;CCL5;PODXL;PDGFC;ADAM10;GAB1;WNT11;CAV1;SEMA3B;PTK2B;GCNT2;SH3RF2;S100A11;DMTN;DDRGK1;CBLL1;TGFB2;WNT5B;MAZ;ELP5;FBXO5
prerank,cellular response to decreased oxygen levels (GO:0036294),0.4036625684147857,1.1497427512045186,0.25961538461538464,0.9199425196790071,1.0,17/65,15.22%,EGLN3;NDRG1;CPEB2;PMAIP1;EGLN2;BAD;TWIST1;CARD16;TIGAR;AQP1;HYOU1;NPEPPS;MYC;SFRP1;BNIP3L;LMNA;MDM2
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.5216020840567093,1.1491296433698754,0.3161189358372457,0.9209332695503631,1.0,5/13,16.50%,DDX5;PMAIP1;SPRED3;EEF1E1;ATR
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.44877326409477025,1.1487836136080316,0.288,0.920996359195128,1.0,5/32,9.97%,GALP;PGLYRP3;ANG;ROMO1;RNASE3
prerank,positive regulation of cell adhesion (GO:0045785),-0.284220606357547,-1.1487135110863642,0.16778523489932887,0.6993652388964431,1.0,18/74,15.07%,FRMD5;PTPRJ;CD47;TGM2;CXCL12;NDNF;MEGF10;JAK2;VIT;NCKAP1L;RSU1;PPP3CA;HYAL1;RET;FBLN2;ADAM9;ITGAV;TFE3
prerank,regulation of ERBB signaling pathway (GO:1901184),0.5088021955474745,1.148032354849805,0.32,0.9224778513975758,1.0,1/15,0.37%,CDH13
prerank,cellular response to calcium ion (GO:0071277),-0.28878529513743434,-1.1480275412351664,0.18181818181818182,0.6995623092836447,1.0,13/67,7.83%,CPNE8;ADGRV1;WNT5A;CAMK2D;RASGRP2;CPNE4;PKD2;SYT9;PRKAA1;SYT1;NLGN1;ADCY1;MCOLN1
prerank,neural tube development (GO:0021915),-0.42778260408344027,-1.1476109265337513,0.27485380116959063,0.6989237632002049,1.0,4/15,7.31%,ALDH1A2;PKD2;DACT1;TGFB1
prerank,endomembrane system organization (GO:0010256),0.36844702854559125,1.1475801497506553,0.229800629590766,0.922980063516528,1.0,53/178,19.57%,SPTSSB;FBXW8;ANXA8;ANXA8L1;SYP;OTOF;TJAP1;A4GALT;REEP3;TMED1;CAV2;NUP93;MAPK15;ATP8B2;ANK3;NSFL1C;GOLPH3;ARHGAP21;SRGN;CDC42;HOOK1;TLCD2;TOR1A;BCAS3;SNX33;ZW10;VPS11;EIF2AK3;PHETA2;GOLGB1;EXOC8;ARFGEF1;NPLOC4;VPS18;PLEKHJ1;FER1L6;VPS4A;PHETA1;DNM1L;ATL2;USP6NL;REEP4;PI4K2A;WASHC4;SUN2;SEC23IP;OSBPL2;TMED5;RNF112;SEC31B;HOOK3;MYO18A;SMPD4
prerank,regulation of metal ion transport (GO:0010959),0.49568236023356294,1.1475359751658392,0.31797235023041476,0.9220471846726235,1.0,2/16,2.86%,ANK2;IL16
prerank,peptide hormone secretion (GO:0030072),0.4700567896282766,1.1474400523084967,0.30704225352112674,0.9212822509389748,1.0,3/26,7.52%,GAL;LTBP4;CDK16
prerank,positive regulation of intracellular transport (GO:0032388),0.4378230896293505,1.147298547077333,0.2870493991989319,0.920638034960373,1.0,13/38,24.59%,ACTN2;EHD1;PLK3;BCAS3;NEDD4;RIPOR1;DYNC1H1;NUMA1;KIF20B;VAMP2;TPR;ICE1;PCM1
prerank,response to UV (GO:0009411),0.3880395820739107,1.147032549056296,0.2420814479638009,0.920423872451625,1.0,33/95,24.75%,SCARA3;FEN1;EP300;MAP3K4;REV1;POLK;SDE2;UBE2B;CCND1;PCLAF;AQP1;ERCC5;MYC;POLH;NEDD4;USP28;PCNA;ATR;ERCC2;KDM1A;EIF2AK4;TRIAP1;COPS9;CDKN2D;ERCC4;USF1;RHBDD1;YY1;MEN1;RPL26;CDC25A;EIF2S1;PTPRK
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.33655034272572937,-1.1470276547421383,0.23348017621145375,0.6988809200952556,1.0,9/41,8.02%,TGFA;IL34;DOCK3;GAS6;NOX4;GRM5;ACE;LRP8;NTRK2
prerank,clathrin coat assembly (GO:0048268),-0.4327555740667576,-1.146722866738784,0.2845303867403315,0.697975295310733,1.0,7/15,21.13%,HIP1;CLTA;SGIP1;EPS15;FCHO2;CALY;HIP1R
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.41463513766014115,1.1463213270329196,0.2641025641025641,0.9216583325900324,1.0,8/55,7.90%,AGTR1;CDKN1A;ZC3H12A;DHRS4;ALOX5;FOXM1;EIF6;ROMO1
prerank,regulation of cell-matrix adhesion (GO:0001952),0.40379423933214703,1.1457870946516633,0.2555012224938875,0.9223752300796748,1.0,20/64,17.84%,CDH13;UTRN;EMP2;CDK6;PTK2B;DAPK3;EFNA5;PTPRA;CASK;ADAM15;ACTG1;EPHA3;RHOA;RASA1;SFRP1;GSK3B;VCL;SLC9A1;DUSP3;PEAK1
prerank,glycoprotein catabolic process (GO:0006516),-0.41853647464536425,-1.1456510787209178,0.26443768996960487,0.6991889823585309,1.0,2/17,1.30%,ADAMTS12;ADAMTS9
prerank,response to cytokine (GO:0034097),-0.2671256367360786,-1.1456449059277565,0.1511627906976744,0.6975026849622388,1.0,35/141,14.03%,PID1;LEF1;ALDH1A2;OSMR;IL1R1;SP100;IL1RAPL1;TIMP3;LIFR;IRAK2;GGT5;LGALS9;XAF1;ADAR;PTPN4;IRAK3;IFNAR2;BCL2;IL6R;PTPN12;IFITM3;GCH1;JAK2;CXCL16;TBK1;PLSCR1;TRAF6;STAT3;RIPK1;IL6ST;KLHL20;MME;SMAD3;YTHDC2;ADAM9
prerank,insulin receptor signaling pathway (GO:0008286),0.4001117687048605,1.144839083410202,0.27040194884287455,0.9244551141625448,1.0,17/69,15.53%,SORBS1;ATP6V1B1;GAB1;FOXC2;RHOQ;CAV2;SHC1;AP3S1;PDK2;IRS2;BCAR1;PTPN2;GSK3A;GSK3B;ATP6V1E1;ATP6V1D;ATP6V0D1
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.42915171070435304,1.1448100113397455,0.28174603174603174,0.9234875732716814,1.0,14/42,20.26%,TRIM25;USP10;REV1;POLK;PCLAF;RPA3;POLH;POLD2;PCNA;RPS27A;UBC;RFC1;CDKN2D;POLN
prerank,positive regulation of catabolic process (GO:0009896),0.39916068725566606,1.1445827558381247,0.27837514934289126,0.9231185161878936,1.0,14/65,19.51%,FZR1;WWP2;EGLN2;GPC3;RAB7A;GSK3A;GSK3B;NEDD4;PLK2;DDB1;NSF;RNF41;IDE;ASB5
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.4736238945629725,-1.144525849127438,0.30183727034120733,0.6988230489029282,1.0,8/11,37.00%,TP53;DDIT3;ATF3;ATF4;HSPA5;ATF6;CREB3L1;ATF6B
prerank,regulation of myoblast fusion (GO:1901739),0.5333768450880868,1.1435374120810275,0.3487603305785124,0.9255406419835603,1.0,2/11,5.13%,EHD1;RIPOR2
prerank,regulation of cholesterol metabolic process (GO:0090181),0.4828760714284051,1.143177255642796,0.31149927219796214,0.9256909701803482,1.0,5/20,12.85%,SREBF2;TTC39B;ACADL;ABCA2;LPCAT3
prerank,nervous system development (GO:0007399),0.3589881551228035,1.1431321143521553,0.16950852557673018,0.9247449513419576,1.0,48/429,9.49%,FN1;CDH1;MBNL1;FGF13;SDK1;LPAR1;NOTCH2;CHRM1;CELSR1;SMO;ZIC4;PDGFC;PCDHA8;SREBF2;GSN;NBL1;CRIM1;NINJ1;EP300;CXCR4;TMOD2;NGF;RBFOX2;GDNF;GLIS2;HDAC4;ZBTB16;UTP11;HMGCR;PCDHB12;NAGLU;GFRA3;UNC119;AVIL;EFNA5;EIF2B2;ZIC2;LRCH4;ERBB3;CYP51A1;PKD1;FZD5;POU3F1;GRHL2;OPHN1;DPF2;ZIC1;PCDHA4
prerank,organic substance transport (GO:0071702),0.38020643170276874,1.1428659119088325,0.2472885032537961,0.9244821638648533,1.0,15/121,11.49%,CUBN;SLCO2A1;SCAMP5;ABCD1;AMN;RAMP1;SLC48A1;SLC22A18;RAB7A;ARRDC3;NDC1;ARL6IP5;TOM1;ABCA2;SCAMP2
prerank,mitochondrion transport along microtubule (GO:0047497),-0.44341430841565554,-1.142635521498491,0.26666666666666666,0.7023081816348998,1.0,4/13,11.82%,HIF1A;SYBU;NEFL;LRPPRC
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.4661033525898757,1.1426071498567054,0.32083333333333336,0.9241969660083733,1.0,5/26,11.15%,CLU;KLF4;DDAH2;TLR6;TLR4
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.4521014345314988,-1.1423169338465775,0.28804347826086957,0.7015703086984543,1.0,4/12,10.70%,SDK2;PROM1;RORB;STAT3
prerank,regulation of microglial cell activation (GO:1903978),0.5092557357975206,1.142014740177275,0.324031007751938,0.9251000392709818,1.0,1/15,1.18%,LDLR
prerank,blood vessel endothelial cell migration (GO:0043534),0.46967745379946424,1.1420030356576898,0.3078055964653903,0.9240821452909748,1.0,3/22,2.06%,ADTRP;EFNB2;EMP2
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.4480260131423622,-1.1417199749372062,0.2889447236180904,0.7014775646267314,1.0,3/12,2.85%,PRKG1;DOCK4;IGFBP5
prerank,response to X-ray (GO:0010165),-0.4389824021083132,-1.1413554571866698,0.29365079365079366,0.7008359681402607,1.0,4/14,16.81%,BRCC3;NIPBL;IKBIP;BLM
prerank,cellular response to sterol (GO:0036315),0.5254271730035591,1.1408005527326195,0.32018927444794953,0.9270042998718233,1.0,4/13,11.13%,SMO;RORC;INSIG1;OSBPL7
prerank,regulation of protein kinase C signaling (GO:0090036),-0.4237247762682924,-1.1407169597924847,0.28732394366197184,0.7010292057872333,1.0,6/14,18.30%,ADGRV1;WNT5A;GPD1L;FLT4;DGKG;CD40
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.4513686010547101,-1.1406011354862602,0.3022113022113022,0.6996620448345018,1.0,6/11,13.26%,CD34;LGALS9;THBS1;PTGS2;CD46;GATA6
prerank,embryonic limb morphogenesis (GO:0030326),0.4373135575317605,1.1405745180797926,0.3096514745308311,0.9266900104091629,1.0,6/34,10.33%,MBNL1;GLI3;AFF3;RARG;TGFB2;TWIST1
prerank,retrograde axonal transport (GO:0008090),-0.40799445839323467,-1.1405406598934293,0.2857142857142857,0.6981139403615964,1.0,7/16,18.91%,DLG2;ACTR10;NEFL;KIF1A;TMEM108;MAP1A;SOD1
prerank,calcium ion transport into cytosol (GO:0060402),-0.3894032825800644,-1.1403622679532308,0.265625,0.696956969279923,1.0,5/21,6.26%,CACNA1C;SLC8A1;GRIN2A;JPH1;GRIN2B
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.5459390726571317,1.1399852381723077,0.3446054750402576,0.9276455488386531,1.0,1/11,0.58%,SCARA3
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.35540894966089126,1.1398651419589907,0.14744232698094284,0.9269368930463526,1.0,93/509,15.75%,FN1;ADRA1B;WNT16;PRKCB;CDH13;FGFR1;NR3C2;ANGPT1;LPAR1;NTRK3;CCL5;JCAD;EDA2R;PLXNB1;PDGFC;NUPR1;BBC3;GDF15;AKAP13;GAB1;WNT11;CAV1;IKBKE;MAVS;EP300;PMAIP1;GCNT2;EPO;TRIM25;MTDH;TRIM44;TFG;CAV2;BCL2L1;SLC20A1;RHEB;HAX1;SHC1;MYDGF;MUL1;CC2D1A;WLS;GOLPH3;ERBB3;TRIM21;TGFB2;BAD;TAB3;ILK;TNFRSF10B;UNC5B;FGF22;PPM1A;MAZ;TCF7L2;IQGAP1;TNFRSF1A;TLR6;PTPN6;JMJD8;NMI;SMCR8;BCAP31;CARD16;HDAC3;GSDME;TLR4;ANKRD17;IRS2;RHOA;MIB2;GATA3;EEF1D;PELI1;LGALS1;IRAK1;CHUK;PTP4A3;HRAS;GAPDH;NEDD4;DNM1L;FLCN;ITGB1BP1;GPR89A;TLR3;PLK2;HSP90AA1;IKBKG;RNF31;ACTN4;FLNA;UBE2N
prerank,kidney development (GO:0001822),0.40311125080128335,1.1395940215246871,0.2811004784688995,0.9268212859891076,1.0,11/65,8.24%,AGTR1;STRA6;KANK2;GDNF;ZBTB16;PYGO2;ARL3;BMP4;TGFB2;SIX1;PKD1
prerank,neuron projection extension (GO:1990138),0.44962194404476674,1.1393344196383222,0.2876712328767123,0.9266090089269389,1.0,11/32,17.93%,ALCAM;FLRT1;IQGAP1;SLC9A6;NRP2;SH3GL2;FLRT3;ULK1;HSP90AA1;EIF2AK4;SEMA3A
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.5121395576283938,1.1393330523030893,0.33634992458521873,0.9255474421339087,1.0,6/15,19.18%,CD44;MDM2;KDM1A;ARMC10;TRIAP1;TAF9B
prerank,peptidyl-asparagine modification (GO:0018196),0.4500722956766395,1.1392920836182383,0.3216216216216216,0.9246066418636552,1.0,10/31,17.60%,B4GALNT2;ASGR1;MGAT1;FUT8;DDOST;MCFD2;DPM2;ALG5;UBE2J1;RPN2
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.39213604656027057,-1.1391996014984023,0.2719033232628399,0.6984878670228999,1.0,6/20,9.13%,TGM2;CAMK2D;ATP2A2;BCL2;SELENOK;FIS1
prerank,regulation of organelle organization (GO:0033043),0.3958146970377663,1.1390959636304465,0.2840909090909091,0.9241862417555932,1.0,23/80,15.45%,TJP1;PLXNB1;MAVS;EP300;DIAPH1;MUL1;MAPK15;MSN;GOLPH3;CAPN2;ARHGEF5;MIEF2;MYO5A;EZR;TMEM33;VPS11;ARMH3;CPLANE2;PREB;DNM1L;USP6NL;SYT11;RAB33B
prerank,chromatin assembly (GO:0031497),0.4331699503798101,1.139010729746805,0.3134715025906736,0.9233740239473383,1.0,5/38,8.07%,DAXX;GRWD1;ASF1A;KAT6B;ATRX
prerank,positive regulation of receptor internalization (GO:0002092),0.476115154917545,1.1387539177389965,0.30858806404657935,0.9231646318167752,1.0,2/22,2.29%,ANGPT1;MAGI2
prerank,negative regulation of cilium assembly (GO:1902018),0.5441652811679111,1.1386762237455754,0.30629139072847683,0.9223735563636986,1.0,3/12,6.96%,LIMK2;CDK10;MAP4
prerank,positive regulation of response to external stimulus (GO:0032103),0.3804494702094752,1.1381246268164742,0.2549234135667396,0.9232111205924697,1.0,22/128,15.83%,AGTR1;GPR4;NAPEPLD;CCL5;IL17RA;NINJ1;IL15;IL16;NFKBIA;THBD;FEM1A;POLR3B;TNFRSF1A;NMI;TLR4;ANKRD17;PTN;POLR3C;TNIP1;TLR3;DHX9;POLR3G
prerank,supramolecular fiber organization (GO:0097435),0.3582334429689642,1.1375963497738555,0.21068548387096775,0.923907783273849,1.0,40/334,10.69%,ITGB4;FGF13;PGM5;ADAMTS14;COL23A1;TNXB;COL25A1;POF1B;TSPAN5;LAMC2;COL4A3;COL4A4;VIM;TMOD3;MYO1H;ADAM10;EMP2;GSN;COL5A2;MPRIP;TMOD2;KIF2A;CORO7;COL6A1;LMOD3;COL6A3;AVIL;PXDN;CLIP4;TGFB2;PLK3;CDC42;CHP1;MYO5A;HDGFL3;HOOK1;MYO1C;KLHL24;GGA1;PLEC
prerank,positive regulation of potassium ion transport (GO:0043268),0.43068641994318013,1.1374727930227708,0.2982456140350877,0.9232201492585358,1.0,3/38,3.11%,ANK2;ACTN2;FHL1
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.37311512068850117,1.1373950422047696,0.2622415669205658,0.9224427536682543,1.0,37/158,15.94%,PRKCB;LPAR1;EDA2R;AKAP13;IKBKE;MAVS;TRIM25;MTDH;TFG;SLC20A1;MUL1;CC2D1A;WLS;TRIM21;TAB3;TNFRSF10B;PPM1A;TNFRSF1A;TLR6;JMJD8;CARD16;ANKRD17;RHOA;MIB2;EEF1D;PELI1;LGALS1;IRAK1;CHUK;GAPDH;GPR89A;PLK2;IKBKG;RNF31;FLNA;UBE2N;CCDC22
prerank,regulation of muscle cell differentiation (GO:0051147),-0.34415800239444017,-1.1373812343719294,0.25660377358490566,0.7019792393898141,1.0,7/31,9.11%,CDH2;BOC;MEGF10;CTNNA2;IGF2;ID2;FGFR2
prerank,negative regulation of TOR signaling (GO:0032007),0.43843486308674917,1.137238097691192,0.3050397877984085,0.921934027949251,1.0,5/36,5.70%,RNF152;PRKAA2;SESN2;SH3BP4;TSC2
prerank,positive regulation of vasculature development (GO:1904018),0.38623536767961075,1.13700550968363,0.2834285714285714,0.921685183924309,1.0,16/94,11.18%,PRKCB;ADAM12;ITGB8;ANXA3;NINJ1;ZC3H12A;GAB1;HSPB1;MTDH;AGGF1;MYDGF;VEGFB;EMC10;TWIST1;AQP1;RAPGEF3
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.4430708282866396,1.1369003553854586,0.3095890410958904,0.9209818330115251,1.0,12/31,22.76%,PEX26;TIMM44;DNLZ;ROMO1;TOMM20;TIMM17B;PEX6;PEX2;TOMM40L;TOMM40;TIMM50;TIMM23
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.5141310018105419,1.1367249588763284,0.3291139240506329,0.9204809758018083,1.0,2/13,3.24%,SULT1A1;SULT2B1
prerank,regulation of interferon-beta production (GO:0032648),0.4158885649016145,1.1362573865815075,0.2811704834605598,0.9209431470973903,1.0,18/46,24.53%,MAVS;RELB;PPM1B;IRF3;POLR3B;TLR4;POLR3C;TLR3;DHX9;HSP90AA1;OAS2;POLR3G;PTPN11;FLOT1;YY1;POLR3F;SIRPA;POLR3D
prerank,embryonic eye morphogenesis (GO:0048048),-0.46190877748994863,-1.1361409487525063,0.3325242718446602,0.703585079982768,1.0,5/11,9.62%,FBN1;MFAP5;FBN2;LRP6;TBX2
prerank,regulation of lipid metabolic process (GO:0019216),0.38802734041648596,1.1358047976868972,0.2590909090909091,0.9214143535535795,1.0,21/88,12.27%,FDFT1;SREBF2;RORC;CAV1;DHCR7;FDPS;HMGCR;PMVK;RUBCNL;CYP51A1;ELOVL6;NFYC;HDAC3;NCOR1;CERS2;ACACA;GPAM;MBOAT7;IRS2;FASN;SP1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.49067803292538353,1.135794860715104,0.32872503840245776,0.9204135861283321,1.0,7/17,22.90%,EMC9;EMC10;GET4;EMC6;EMC2;SGTA;MMGT1
prerank,homologous chromosome segregation (GO:0045143),0.4894311588979891,1.1357437564601738,0.31378299120234604,0.9195279204044693,1.0,1/20,1.16%,ANKRD31
prerank,regulation of acute inflammatory response (GO:0002673),-0.39790478709975985,-1.1355982533795885,0.2903225806451613,0.7033644429955888,1.0,3/18,12.36%,OSMR;PTGES;IL6ST
prerank,translesion synthesis (GO:0019985),0.42798985118024563,1.135495385389692,0.28859060402684567,0.9193038311663638,1.0,15/42,21.90%,TRIM25;USP10;REV1;POLK;PCLAF;NPLOC4;RPA3;POLH;POLD2;PCNA;RPS27A;UBC;RFC1;POLN;RCHY1
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.3791285133006631,-1.135226547164821,0.2867132867132867,0.7027007897082491,1.0,6/24,7.35%,SOX5;ADAMTS12;TRPS1;ACVRL1;BMPR1B;PKDCC
prerank,organelle fusion (GO:0048284),0.4686403200154062,1.1349160432837266,0.32200886262924666,0.9201805465552156,1.0,10/22,21.29%,CHCHD3;AFG3L2;MIEF2;THG1L;VPS11;OPA1;VPS18;STX4;SPG7;MIEF1
prerank,acyl-CoA biosynthetic process (GO:0071616),0.5006173155450667,1.1338214760110599,0.31703470031545744,0.9227044500041626,1.0,8/16,22.87%,SLC25A1;ACACA;SCD5;FASN;PPT2;ACLY;GCDH;MLYCD
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.49609018536566696,1.1335369509761457,0.3333333333333333,0.9225921195623474,1.0,3/17,6.80%,ADTRP;ATP1A2;BMP4
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.4552369696161614,1.1333647261513287,0.2928870292887029,0.9221378378354856,1.0,7/28,12.66%,DAXX;NGF;TNFRSF10B;TNFRSF1A;BAG3;DDX47;BLOC1S2
prerank,intracellular pH reduction (GO:0051452),0.42941691650527397,1.1332264135926118,0.2953020134228188,0.9215691526289579,1.0,10/33,19.74%,ATP6V1B1;RAB7A;DMXL2;ATP6V1E1;ATP6V1D;GPR89B;GPR89A;ATP6V0D1;ATP6V1B2;ATP6V0B
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.388592940783541,1.1328916061816043,0.2926829268292683,0.921649140463896,1.0,24/72,19.87%,ZC3H12A;FEN1;MRE11;RBX1;POLK;XRN2;DNASE1L2;ERCC5;RPA3;DNASE1L1;REXO4;DCP1A;POLD2;PCNA;FAN1;DDB1;RPS27A;UBC;ERCC2;RNASE4;RAD50;RFC1;DXO;ERCC4
prerank,defense response to protozoan (GO:0042832),-0.45729806006941304,-1.1324581350276806,0.3087071240105541,0.7086471207474213,1.0,6/12,26.82%,LYST;GBP6;CD40;GBP2;GBP4;SLC11A1
prerank,peptide metabolic process (GO:0006518),-0.2826005421913546,-1.1323384307318856,0.16901408450704225,0.7072957133882306,1.0,17/75,13.31%,DMD;PCSK5;AEBP1;CPD;GSTZ1;ACE;GSTT1;CPXM2;TPP1;CPXM1;SPCS2;NLN;CPQ;BACE2;ETHE1;ENPEP;MME
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.44774948729014974,1.1323277582184699,0.330567081604426,0.9224896842521889,1.0,4/31,3.00%,RANBP3L;SMAD6;CRIM1;CDK6
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.49783208534114176,1.1323230585936133,0.3286384976525822,0.9214767529713986,1.0,6/16,13.47%,GDNF;FOXD1;BMP4;SIX1;NPNT;MYC
prerank,regulation of neurotransmitter transport (GO:0051588),-0.4014833330283515,-1.1322460595611814,0.2881844380403458,0.7058981846636566,1.0,8/16,21.20%,SNCAIP;MCTP2;CAMK2A;MCTP1;KCNMB4;CPLX2;FMR1;RIMS1
prerank,adenine nucleotide transport (GO:0051503),-0.3984838599159271,-1.131317830070933,0.2896174863387978,0.7068755742829944,1.0,2/17,1.29%,LRRC8C;ABCC4
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.45477019235077937,1.1311419899630035,0.3240611961057024,0.9243717649220329,1.0,5/28,11.13%,CLU;NUPR1;DDRGK1;ATP5IF1;OSBPL7
prerank,"base-excision repair, gap-filling (GO:0006287)",0.43199580952893685,1.1308546397523114,0.29362880886426596,0.9242816307941775,1.0,12/35,19.54%,FEN1;MUTYH;POLG;MBD4;RPA3;POLD2;PCNA;LIG3;NEIL1;PARG;RFC1;PNKP
prerank,positive regulation of cellular process (GO:0048522),0.3530285525537051,1.1307588947294085,0.15130260521042085,0.9235897828644452,1.0,83/565,12.14%,FN1;DPP4;FGFR1;CRLF1;PRKAA2;NTRK3;CNOT6;WNT1;LAMC2;TJP1;CCL5;EPHA4;PDGFC;EFNB2;GRK5;ADAM10;HPN;EMP2;CCN2;NUPR1;IL15;ZC3H12A;CAV1;PDF;CELF1;CD81;PRR7;PTGFR;TNFSF13;PTK2B;GDNF;NOP2;PPP1R13L;HDAC4;BMP5;CLCF1;GCNT2;EPO;TIMP1;CIAO1;DOT1L;NACC1;CDK4;RPS4X;NSMCE4A;FOXM1;KRAS;HCFC1;SHC1;DDRGK1;MAPK15;BMP4;CCND2;ERBB3;TRIM21;TGFB2;ZFHX3;ROMO1;FGF22;MAZ;CDC42;FBXO5;SSR1;IL7R;LBP;PTPN6;MTLN;CAPNS1;CCND1;SRPK2;HP;HPR;KDM4C;TLR4;TBRG4;TRPM4;ANKRD17;ACACA;FCER1G;IRS2;FASN;EIF4G2;TGFBR2
prerank,actin crosslink formation (GO:0051764),0.516168388194181,1.1305124420373094,0.31085526315789475,0.9233366404142724,1.0,1/12,0.43%,BAIAP2L1
prerank,nucleosome organization (GO:0034728),0.40793594655451043,1.1304263303581843,0.2838002436053593,0.9225879762061634,1.0,16/55,18.28%,DAXX;GRWD1;SMARCB1;ASF1A;KAT6B;ATRX;SMARCA4;SRCAP;SMARCD2;SET;SMARCC1;SPTY2D1;LIN54;BRDT;ZNHIT1;H3-3A
prerank,epithelium development (GO:0060429),-0.26699521722351865,-1.1303311490926358,0.10638297872340426,0.7079006103671313,1.0,22/107,9.79%,ERRFI1;ALDH1A2;WNT4;PPP2R3A;CD34;CTSB;KDR;CNN3;PKD2;IFT122;DACT1;RCN3;SALL1;TGFB1;SOX17;JAK2;FGFR2;PPARG;TPP1;TBX2;LOXL3;AHI1
prerank,negative regulation of secretion by cell (GO:1903531),0.4356313240686633,1.1302618338301509,0.3165562913907285,0.9220958788456046,1.0,10/38,15.36%,ADTRP;STXBP6;HMGCR;CYP51A1;TNFRSF1A;HTR1B;SERGEF;RHBDF2;SYT11;PNKD
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.516980426553417,1.1297786469259032,0.3395931142410016,0.9225871585349873,1.0,4/13,12.14%,GLI3;ZBTB7B;NKAP;TGFBR2
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.5294687685040816,1.1295634250411353,0.3338557993730408,0.9222847159604902,1.0,4/12,21.66%,ADTRP;WNK1;ASS1;MIA3
prerank,negative regulation of multicellular organismal process (GO:0051241),0.364049051756806,1.1293154551353248,0.258298755186722,0.9220738348333988,1.0,47/199,15.60%,PLCL2;LAMA4;HPN;SMAD6;IL15;GDF15;WNT11;TWSG1;FOXC2;PPP2CA;DUSP10;BMP5;TIMP1;HMGCR;PROCR;RAB11FIP3;IP6K1;OVOL2;DOCK7;SPRED3;RHEB;BMP4;KLF7;PARP3;PLCL1;CYP51A1;SRGN;LGR4;ARRDC3;GRHL2;FOXP3;NFIB;PPP1R11;RAB11FIP5;TLR4;LDLRAD4;GATA3;GSK3A;MEF2C;ATP2B4;SFRP1;GSK3B;FLCN;SYT11;ARHGDIB;ABHD6;RAB11FIP1
prerank,keratan sulfate metabolic process (GO:0042339),0.4405366336347677,1.1293021777078707,0.3168044077134986,0.9210976896413614,1.0,7/31,12.31%,ST3GAL4;HEXA;B4GAT1;PRELP;GLB1;HEXB;ST3GAL6
prerank,cardiac muscle cell action potential (GO:0086001),-0.34750774489578856,-1.1292069270576917,0.24045801526717558,0.7093161589151358,1.0,10/30,15.43%,CACNA1C;DMD;SLC8A1;ATP1B1;KCNJ2;CACNA1G;FGF12;HCN2;SCN1A;SCN1B
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.441469605140386,1.1288216785302414,0.31241473396998637,0.9216447245153082,1.0,4/35,2.81%,SEMA3D;PLXNB1;PLXNA2;SEMA3B
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.5045825018807215,1.1287328785922748,0.3126934984520124,0.9208993209243176,1.0,4/15,11.15%,NLRP2B;PYDC1;TLR6;TLR4
prerank,regulation of defense response to virus by host (GO:0050691),0.4456331721118748,1.1284885247685223,0.32083333333333336,0.9206941600366119,1.0,8/30,17.03%,ZC3H12A;MAVS;TRIM44;TARBP2;MUL1;DHX9;HSP90AA1;EIF2AK4
prerank,embryonic organ morphogenesis (GO:0048562),-0.3259295751556749,-1.1284574035673103,0.24714828897338403,0.7097097513867379,1.0,16/42,17.95%,FBN1;MFAP5;PDGFRA;FBN2;DSCAML1;SOX17;ID2;FGFR2;MEGF8;RBP4;TBX1;NIPBL;RYR2;SOX11;HOXC4;HOXD3
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.3496205932534728,-1.1281114582361182,0.28668941979522183,0.7090295696130822,1.0,4/29,9.11%,ENG;NOTCH1;TGFB1;FGFR2
prerank,glycolipid metabolic process (GO:0006664),0.4155244902402547,1.1277138370226956,0.30632911392405066,0.922155765837094,1.0,13/47,14.98%,ST3GAL4;HEXA;SCCPDH;GLB1;SUMF1;ABCA2;HEXB;SUMF2;ST3GAL6;ESYT2;SMPD2;NAGA;ST6GALNAC4
prerank,regulation of ruffle assembly (GO:1900027),0.4736372987445941,1.1275578539077287,0.33821376281112736,0.9216526800940046,1.0,4/23,2.87%,KANK1;EPS8L2;CAV1;NDEL1
prerank,tryptophan metabolic process (GO:0006568),0.5307609432111853,1.1273694654817905,0.34796747967479674,0.9212854484229167,1.0,4/11,24.53%,TDO2;HAAO;KYAT1;KMO
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.49851042744582996,1.1272250676683295,0.32532051282051283,0.9207529356251611,1.0,3/15,6.97%,SMOX;TPH2;AANAT
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.462785654005825,-1.1267421304856173,0.28756476683937826,0.7110814753253802,1.0,6/10,32.06%,DKC1;CCT7;CCT2;CCT4;WRAP53;CCT3
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.43905907808836253,1.1266884552774852,0.32142857142857145,0.9215032702092384,1.0,10/28,18.32%,PRKCB;KANK1;TSC2;PTPRE;PTPN2;PIP4K2C;GSK3A;PRKCZ;PRKCQ;SLC27A4
prerank,positive regulation of mitochondrion organization (GO:0010822),0.40083355657423864,1.126321450620962,0.31234866828087166,0.9217742970217668,1.0,14/57,15.11%,PPARGC1A;MMP9;BBC3;PMAIP1;MCU;MUL1;BAD;MIEF2;ZNF205;HRK;GSK3A;GSK3B;DNM1L;DDHD1
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.4405383236880708,-1.1262256772694426,0.29743589743589743,0.710806972485486,1.0,6/12,35.49%,MAOA;HNMT;DDC;SMS;SLC22A3;SLC29A4
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.45782679678287463,-1.1260885772305391,0.3385012919896641,0.7095674173744992,1.0,5/10,12.51%,PDE8A;LRRK2;GPR37;RIPK1;TXN
prerank,negative regulation of DNA recombination (GO:0045910),0.4226869047930579,1.1258504350685417,0.3178191489361702,0.9222589626935507,1.0,8/43,9.55%,DAXX;POLR2H;SHLD2;POLR2A;PARP3;ATRX;KLHL15;RIF1
prerank,ribosomal large subunit assembly (GO:0000027),0.4656064598698588,1.1257896745570648,0.2935103244837758,0.9214531888367811,1.0,3/24,4.65%,NLE1;NOP2;PPAN
prerank,cellular response to light stimulus (GO:0071482),0.39789037788278336,1.1256596049525096,0.288135593220339,0.9208694100092485,1.0,23/66,24.75%,OPN1SW;EP300;POLK;SDE2;AQP1;CNGB1;MYC;PDE6B;NEDD4;USP28;PCNA;ATR;KDM1A;EIF2AK4;TRIAP1;COPS9;ERCC4;RHBDD1;YY1;RPL26;CDC25A;EIF2S1;PTPRK
prerank,skeletal muscle organ development (GO:0060538),0.45306917434000543,1.1255107228195833,0.30834512022630833,0.9202879787075354,1.0,7/26,13.82%,CAV1;STRA6;CSRP3;LARGE1;SIX1;FXR1;MEF2C
prerank,mitochondrion morphogenesis (GO:0070584),-0.4571140463334724,-1.125060551846159,0.30617283950617286,0.7107799687711224,1.0,3/11,9.13%,PID1;MTM1;FIS1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.38322374736956877,1.1250341977248757,0.2852233676975945,0.9208260167577851,1.0,9/87,7.99%,FGFR1;CD44;CCL5;FLRT1;GTF2F1;RBFOX2;POLR2H;POLR2A;FGF22
prerank,toxin transport (GO:1901998),0.5463653341830725,1.1247187435794814,0.3712948517940718,0.9208571197293619,1.0,2/10,5.63%,ADAM10;ANTXR1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.5309223054104096,1.1244838692312982,0.34290540540540543,0.9205989974717725,1.0,3/11,7.90%,TIMM10;AGK;ROMO1
prerank,negative regulation of locomotion (GO:0040013),0.5304289499229362,1.1244413237447437,0.3490566037735849,0.9197411949060511,1.0,7/12,17.80%,SPINT2;FBLN1;CCDC125;PTPN2;GATA3;CRK;DUSP3
prerank,positive regulation of filopodium assembly (GO:0051491),0.45036016987206773,1.1244124690530761,0.32432432432432434,0.9188283986126488,1.0,6/24,10.44%,ARAP1;PALM;RIPOR2;RHOQ;CDC42;BCAS3
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.44930137032955353,1.1244094707820769,0.3178621659634318,0.9178457864056039,1.0,14/30,20.23%,DDX5;EP300;KDM4C;SMARCA4;NCOR1;SFRP1;FOXP1;NCOR2;KDM1A;HDAC6;H3-3A;PARK7;ZBTB7A;PRMT2
prerank,cellular response to hydrogen peroxide (GO:0070301),0.43342825305043386,1.1242211387970076,0.3245492371705964,0.9174528876965691,1.0,13/33,23.90%,MAP3K5;NFE2L2;MAPK7;AQP1;TRPM2;ABL1;SIGMAR1;HDAC6;PARK7;RNF112;SIRPA;RHOB;IL6
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.5071877033750318,1.1242022290733291,0.33064516129032256,0.9165241252114789,1.0,6/13,17.93%,PLXNB1;PLXNA2;NRP2;PLXNB2;PLXNA3;SEMA3A
prerank,response to zinc ion (GO:0010043),-0.36155037950634855,-1.1240026487482124,0.27241379310344827,0.7120824745950748,1.0,14/25,36.67%,PAM;GLRA1;CRIP1;GLRA2;D2HGDH;SLC30A3;MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F
prerank,regulation of cell motility (GO:2000145),0.3723913742805955,1.123287925710651,0.29418221734357847,0.9184232734071149,1.0,30/121,17.08%,PRAG1;PLXNB1;PLXNA2;ARHGAP18;CDK6;KIF2A;SPINT2;DIAPH1;LMO4;SGK3;DAPK3;MGAT3;FBLN1;CCDC125;ERBB3;SRCIN1;FGF22;PARD6B;RAF1;TWIST1;RHOA;GATA3;PLXNB2;MEMO1;LMNA;FLNA;PLXNA3;CRK;ABL1;TBCCD1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.4472209268157343,-1.1232185441443416,0.31758530183727035,0.7127957856798528,1.0,4/12,16.81%,KAT7;TIPIN;WRNIP1;BLM
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.39028855570399046,-1.1231006036553326,0.3122923588039867,0.7114934252162235,1.0,4/21,3.83%,DMD;PDE4D;GPD1L;NCK2
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.4584427183528158,-1.1230470658721372,0.3308457711442786,0.7100211672230764,1.0,5/11,25.53%,ATP1B1;KCNJ2;KCNIP2;YWHAE;KCNJ3
prerank,regulation of axonogenesis (GO:0050770),0.40457678428765986,1.1225422948121855,0.3030690537084399,0.9198393238879635,1.0,8/51,4.76%,RTN4R;PLXNB1;EPHA4;PLXNA2;SIPA1L1;NGF;TIAM2;MAP6
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.4710704785254344,1.1223921195515427,0.3245227606461087,0.9193394020290617,1.0,5/20,13.79%,CCL5;MTDH;LBP;TLR4;IRAK1
prerank,indolalkylamine catabolic process (GO:0046218),0.5360248340975885,1.1218977777771546,0.347682119205298,0.9200339201277484,1.0,4/10,24.53%,TDO2;HAAO;KYAT1;KMO
prerank,positive regulation of type I interferon production (GO:0032481),0.3902453896258892,1.1212418786222904,0.2930622009569378,0.9211119056343325,1.0,23/73,20.54%,MAVS;EP300;POLR2H;IRF3;MRE11;POLR3B;POLR1C;TLR4;POLR3C;IRAK1;CHUK;GAPDH;TLR3;DHX9;HSP90AA1;OAS2;POLR3G;PTPN11;POLR3H;POLR2E;NFKB2;FLOT1;ZBP1
prerank,myotube cell development (GO:0014904),0.5331685854527752,1.1211979374390817,0.3338815789473684,0.9202542398873523,1.0,4/10,8.17%,SELENON;LMOD3;CAV2;SIX1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.363448968181241,1.1207404559151486,0.2783068783068783,0.9208192754642086,1.0,47/166,20.71%,SORBS1;CLU;KLF4;PPARGC1A;LDLR;CCL5;VIM;SAMD4A;YTHDF1;RPS4X;EIF4A3;DDAH2;UPF3A;EIF6;NNMT;CHP1;TLR6;ZNF205;TLR4;STARD4;IRS2;POLDIP3;SP1;PTPN2;CPEB3;PLXNB2;FXR1;MYC;UPF3B;PYM1;DHX9;HSP90AA1;PCNA;EEF2;DDB1;PRMT1;ASS1;CDH3;PARK7;YTHDF3;PRKD2;GPLD1;KLF2;SREBF1;SOX4;PAOX;ZCCHC4
prerank,smooth muscle tissue development (GO:0048745),0.5379477175066861,1.1206585102475977,0.34925864909390447,0.9200973157964089,1.0,3/10,6.80%,SMO;STRA6;BMP4
prerank,regulation of neuroinflammatory response (GO:0150077),0.4756822653587617,1.1202078068527406,0.34268833087149186,0.9204537732490093,1.0,3/19,2.39%,MMP9;CD200;NUPR1
prerank,mammary gland epithelium development (GO:0061180),-0.42763797205440984,-1.1199901397219618,0.3100558659217877,0.7167188823168037,1.0,4/14,8.78%,WNT4;JAK2;ID2;ERBB4
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.4466319994103738,1.1199181639919231,0.3132530120481928,0.9203683904264448,1.0,10/29,16.87%,IKBKE;IRF3;TLR6;TLR4;CHUK;TLR3;IKBKG;RPS27A;UBC;UBE2D3
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.4634787244117462,1.1197980129850804,0.34894259818731116,0.9197612192256461,1.0,4/22,7.98%,ANK2;STAC3;GSTO1;JPH2
prerank,polarized epithelial cell differentiation (GO:0030859),0.5232172455865772,1.1195920492905789,0.35590551181102364,0.9194244913201617,1.0,5/13,11.75%,MSN;CDC42;OPHN1;EZR;RHOA
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.5248572107838941,1.1194855790958576,0.35648148148148145,0.9187890368299289,1.0,1/11,0.58%,CD44
prerank,positive regulation of isotype switching (GO:0045830),0.5112141325359252,1.1192200713169007,0.343801652892562,0.9186246831773238,1.0,4/15,9.55%,TNFSF13;CLCF1;SHLD2;RIF1
prerank,sensory perception of smell (GO:0007608),-0.4692231294508253,-1.1186311921312218,0.35555555555555557,0.7188706349578464,1.0,6/11,28.82%,UBR3;DRD2;BBS4;SYT10;ADCY3;SLC24A4
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.46245192788756073,1.1182150166862947,0.32850940665701883,0.9208164149992876,1.0,6/24,12.85%,CLU;ALOX5;BCL2L1;CREB3;OPA1;LPCAT3
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.5178422377008243,1.1179110546255973,0.3333333333333333,0.9208142215591281,1.0,5/12,13.17%,PLK3;FBXO31;SDE2;CCND1;CDK2
prerank,positive regulation of axonogenesis (GO:0050772),0.4158315114446168,1.1178424073322555,0.31208499335989376,0.9200350984615806,1.0,10/43,13.17%,ISLR2;PLXNB1;PLXNA2;NGF;TIAM2;MAP6;ZFYVE27;RHOA;PLXNB2;MAP3K13
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.515156657279844,1.1177991424961455,0.33699059561128525,0.9192471345450133,1.0,6/14,16.85%,IMPDH2;ADK;PAICS;GMPS;GART;ADSS2
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.381089657520653,1.117664373116431,0.2932061978545888,0.9187038997337834,1.0,20/76,17.30%,CLU;TRIB2;ZYG11B;SH3RF2;NUB1;ELOB;DDRGK1;RBX1;SUMO2;COP1;HSPBP1;CSNK1E;PIAS1;DDA1;GSK3A;GSK3B;MDM2;CCDC22;KEAP1;STUB1
prerank,embryonic hemopoiesis (GO:0035162),-0.44608583003479907,-1.1169948851134441,0.296195652173913,0.7217502181226046,1.0,8/12,26.65%,KITLG;KDR;SH2B3;KIT;FLT3LG;TAL1;THOC5;ATF4
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.3351652008746895,-1.1167213549851556,0.2804878048780488,0.7208756353512742,1.0,16/37,28.20%,PRKAG2;CEMIP;TGFB1;IRGM;S1PR2;SIRT2;SPRED1;EGF;SPHK1;BMP7;DGKQ;STOX1;TRIM6;CADM4;RIPK2;CALM3
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.3846087138373325,1.11645099044932,0.3114754098360656,0.9215841560751888,1.0,20/76,18.96%,NLRP2;KLF4;CD200;ZC3H12A;ANXA4;NFKBIA;COMMD7;TRIM21;NLRP2B;CHP1;FOXP3;PYDC1;COMMD6;IRAK1;CHUK;CCDC22;MTURN;TRIM37;OTULIN;CDK5RAP3
prerank,renal water homeostasis (GO:0003091),-0.37133193148111476,-1.1163710780193818,0.313588850174216,0.7202680112977087,1.0,12/23,22.44%,ADCY5;ADCY7;RAB11FIP2;ADCY1;ADCY4;AQP4;PRKAR2B;MYO5B;ADCY2;PRKAR1B;ADCY3;ADCY8
prerank,lytic vacuole organization (GO:0080171),-0.33920154177216183,-1.11606997238953,0.29056603773584905,0.7195102012159245,1.0,10/32,17.80%,ABCA1;CLVS2;LRRK2;GAA;TPP1;SNAPIN;LAMTOR1;CLN3;TMEM106B;CLVS1
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.33327451383119955,-1.1153758380452754,0.2908366533864542,0.7197872849568849,1.0,15/33,20.63%,GRIK2;NRG3;GRID2;LRRC4C;GRIK3;NLGN1;LRP8;GRIK1;GRIK4;NLGN3;BDNF;PXK;GRIK5;CX3CR1;CACNA1B
prerank,establishment of mitotic spindle orientation (GO:0000132),0.46490687328763197,1.115203879829215,0.34011627906976744,0.9244949343352196,1.0,7/23,18.67%,NDEL1;NSFL1C;PAFAH1B1;ZW10;INSC;NUMA1;MISP
prerank,regulation of anoikis (GO:2000209),-0.3962681981496455,-1.1151097117462658,0.29239766081871343,0.7189498572942453,1.0,5/19,6.45%,PTK2;TLE1;NOTCH1;SIK1;BCL2
prerank,positive regulation of immune response (GO:0050778),0.4009993276161515,1.1147222775927803,0.3142857142857143,0.9251008924479039,1.0,13/64,17.88%,CCL5;SASH3;IL15;CD81;TGFB2;POLR3B;NMI;POLR3C;DHX9;ITGB2;POLR3G;EIF2AK4;STX4
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.48424215508803264,1.114721667150892,0.34788937409024745,0.9241291692866536,1.0,5/17,10.35%,COX5A;COX8A;COX7A2L;COX5B;AFG1L
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.37500408357562665,1.114605980464193,0.2964244521337947,0.9235065372569399,1.0,16/94,11.20%,MAP3K5;CDKN1A;FHIT;DDX5;BBC3;IKBKE;PMAIP1;TMEM117;PPP1R13B;PPP1R15A;BCL2L1;BAD;TNFRSF10B;PML;ARL6IP5;PDK2
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.47333488088135756,1.1142873150914006,0.32238805970149254,0.9235421445476901,1.0,6/18,14.54%,DDX5;ZC3H12A;BMP4;MAP2K2;NCOR1;NCOR2
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.4661457794942679,-1.1141026050903768,0.3167082294264339,0.7201632031959079,1.0,3/10,8.18%,KDR;IL33;JAK2
prerank,regulation of AMPA receptor activity (GO:2000311),-0.36566484355587725,-1.1140759940334735,0.2996742671009772,0.7186455561588462,1.0,6/25,12.76%,SHANK3;SHISA6;NLGN1;CACNG8;SHISA9;NLGN3
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.4868815389644348,1.1137140193075183,0.333843797856049,0.9244221623810442,1.0,1/17,0.15%,CD55
prerank,positive regulation of interferon-alpha production (GO:0032727),0.47421809597994957,1.113712535119041,0.3391304347826087,0.9234583367287029,1.0,6/19,15.31%,MAVS;IRF3;TLR4;CHUK;TLR3;DHX9
prerank,positive regulation of neuron differentiation (GO:0045666),-0.32607563389500804,-1.1131683707168367,0.2753623188405797,0.7195404953720611,1.0,14/40,17.95%,TCF4;ZEB1;VWC2;BRINP3;NRCAM;HEYL;IMPACT;BEND6;ARHGEF2;MMD;GPRC5B;BRINP2;SOX11;HOXD3
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.45463041625659717,-1.1129289408317447,0.32839506172839505,0.7186029142444671,1.0,4/11,9.56%,NOVA1;NOVA2;ZNF445;PCBP3
prerank,protein depolymerization (GO:0051261),0.4456857740397653,1.1129168511523528,0.3356741573033708,0.9250661961306854,1.0,6/27,11.69%,GSN;MICAL2;KIF2A;TWF1;MICAL1;VPS4B
prerank,negative regulation of cell growth (GO:0030308),0.36885149325277794,1.1127758767504101,0.2969094922737307,0.924553659615684,1.0,28/121,16.35%,FGF13;RTN4R;OSTN;CDKN1A;WNT11;FHL1;SESN2;PPP2CA;SH3BP4;MUL1;OSGIN2;TGFB2;PSRC1;NDUFS3;PML;APBB1;ADAM15;SMARCA4;CDKN2AIP;CAPRIN2;GSK3A;PRDM11;SFRP1;ULK1;FLCN;IP6K2;CCDC85B;FRZB
prerank,positive regulation of histone deacetylation (GO:0031065),-0.43888913333722496,-1.1127560731597888,0.339572192513369,0.7174829647312222,1.0,4/12,13.56%,PRKD1;SAP30BP;ING2;NIPBL
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.26782229290355386,-1.1127492514652606,0.22580645161290322,0.7159217733315848,1.0,30/95,23.56%,CEP250;IQCB1;CCP110;CEP78;ALMS1;TMEM67;NDE1;AHI1;CEP162;PRKAR2B;TCTN1;C2CD3;NEDD1;SCLT1;CSNK1D;SDCCAG8;TCTN2;TCTN3;CKAP5;B9D1;NPHP4;CEP41;CENPJ;MAPRE1;HAUS4;RPGRIP1L;HAUS7;CEP72;YWHAE;SSNA1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.4436657394806693,1.1124009500806502,0.3242506811989101,0.9248147984480051,1.0,4/31,2.48%,PDLIM5;NGEF;EPHA4;SIPA1L1
prerank,cell cycle checkpoint signaling (GO:0000075),0.5238446593787863,1.1122912370727294,0.34455128205128205,0.9242042729082152,1.0,7/12,21.17%,NABP2;ZW10;PLK2;ZWINT;WEE1;NABP1;CHFR
prerank,negative regulation of endocytosis (GO:0045806),0.4519304147757146,1.1117110052654915,0.34104046242774566,0.9250832684448331,1.0,7/24,11.34%,SCAMP5;CAV1;UNC119;RUBCN;LGALS3;SNX33;EPHA3
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.4649397366872916,1.1116421362131803,0.35276967930029157,0.9243178370779507,1.0,4/25,5.61%,LIMK2;KANK1;CDK10;CAPZB
prerank,protein kinase A signaling (GO:0010737),0.5113878465015267,1.1114985227789216,0.3538961038961039,0.9238087423941633,1.0,2/12,9.58%,GAL;EZR
prerank,myelination in peripheral nervous system (GO:0022011),-0.42504294653249597,-1.1112675987953597,0.34782608695652173,0.7184367453319461,1.0,8/13,25.76%,NF1;MYOC;CNTNAP1;SIRT2;SOD1;DICER1;PRX;NCMAP
prerank,cAMP metabolic process (GO:0046058),-0.4169988266154034,-1.111233492361828,0.3,0.7169740525528246,1.0,9/13,22.44%,ADCY5;PDE4D;ADCY7;ADCY1;ADCY4;PTHLH;ADCY2;ADCY3;ADCY8
prerank,protein localization to lysosome (GO:0061462),0.4478485173564784,1.111116891357683,0.34210526315789475,0.9239961485474034,1.0,13/28,23.29%,CD81;SH3BP4;GCC2;RAB7A;KPTN;VPS4A;NEDD4;SNX16;AP3M1;M6PR;SZT2;AP4M1;NCOA4
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.39008621345448935,-1.1096810146767415,0.3130699088145897,0.7196984793963135,1.0,6/19,9.13%,PTPRJ;KDR;VCAM1;STIMATE;GRM5;FIS1
prerank,regulation of cellular respiration (GO:0043457),-0.3977341900105992,-1.1096228545360274,0.30409356725146197,0.7182794160484367,1.0,12/17,42.44%,PRDM16;CBFA2T3;NOA1;SHMT2;PNPT1;TRAP1;IL10RB;IFNLR1;IFNAR1;NOS2;VCP;IL4
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.3631982858740093,1.1095830143132983,0.3080260303687636,0.9278636492618488,1.0,21/138,12.35%,NR3C2;THRB;NOTCH2;PPARGC1A;RORC;CCN2;GTF2F1;HDAC5;NR6A1;POLR2H;ESRRB;RARG;POLR2A;RXRB;MAZ;NR2C1;HDAC3;NCOR1;DR1;GTF2E1;TAF5
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.44032716999642374,1.1091803576840626,0.31398416886543534,0.9281873217740126,1.0,10/30,16.87%,IKBKE;IRF3;TLR6;TLR4;CHUK;TLR3;IKBKG;RPS27A;UBC;UBE2D3
prerank,positive regulation of interferon-beta production (GO:0032728),0.4324134020069406,1.1091110728894125,0.32754010695187163,0.9274616682697179,1.0,12/33,19.46%,MAVS;IRF3;POLR3B;TLR4;POLR3C;TLR3;DHX9;HSP90AA1;OAS2;POLR3G;PTPN11;FLOT1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.4531653974379226,-1.1086390887935116,0.3380281690140845,0.7194722776741355,1.0,5/11,16.45%,WNT5A;LRP5;FGFR2;TBX1;CTNNBIP1
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.3955211190679338,-1.108456020245769,0.29900332225913623,0.7168103321210385,1.0,5/20,5.29%,IGF1;INSR;ZBTB20;HIF1A;PRKAA1
prerank,positive regulation of glycolytic process (GO:0045821),-0.3955211190679338,-1.108456020245769,0.29900332225913623,0.7168103321210385,1.0,5/20,5.29%,IGF1;INSR;ZBTB20;HIF1A;PRKAA1
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.49463204163539565,1.1081052338583122,0.3643410852713178,0.9286818179864412,1.0,4/16,10.78%,PHLDB2;DMTN;BCAS3;DLC1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.49463204163539565,1.1081052338583122,0.3643410852713178,0.9286818179864412,1.0,4/16,10.78%,PHLDB2;DMTN;BCAS3;DLC1
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.40310172276246725,1.107626920394625,0.31572164948453607,0.9292541673153574,1.0,11/49,12.28%,MMP9;NUPR1;BBC3;CAV1;PMAIP1;BCL2L1;BAD;NDUFS3;BCAP31;GSDME;EIF2AK3
prerank,cellular response to lipid (GO:0071396),0.3567250336760562,1.107624859401402,0.288135593220339,0.9283033332899719,1.0,31/191,14.09%,CFTR;ADTRP;NCOA3;VIM;RORC;PTK7;ZC3H12A;WNT11;ATP1A2;FAM210B;PTK2B;WNT6;INSIG1;LCOR;CREB1;MSN;TRIM41;ADCY6;WNT5B;LBP;CARD16;ADAM15;AQP1;TLR4;EPHA3;RHOA;WNT3;SBNO2;IRAK1;MEF2C;SFRP1
prerank,cellular response to tumor necrosis factor (GO:0071356),0.35087682025428285,1.1071315104687804,0.27205882352941174,0.9289484629949457,1.0,28/175,14.20%,TNFRSF11B;CCL5;EDA2R;EDA;ADAMTS7;ZC3H12A;TNFSF13;PTK2B;FOXO3;TNFRSF8;YBX3;NFE2L2;NFKBIA;PSMD11;PSMD4;COMMD7;PSMF1;ILK;TNFRSF1A;PYDC1;PSMD7;GSDME;NPNT;PSMB5;GATA3;ZFAND6;SFRP1;CHUK
prerank,regulation of cell division (GO:0051302),0.3908106114654871,1.1070283496642515,0.32009345794392524,0.9283296012147081,1.0,21/72,20.46%,NCOA3;MLLT3;KIF13A;ESRRB;RAB11FIP3;BCL2L1;KLHL21;PLK3;AURKC;PRDM15;INSC;KLHL13;MYC;FLCN;PLK2;GIT1;ZFYVE26;TLE6;UVRAG;CSPP1;PIK3R4
prerank,negative regulation of cell population proliferation (GO:0008285),0.3452557538766793,1.1067339705509158,0.2665995975855131,0.9282810029562494,1.0,67/351,14.96%,CDH13;ZBTB7C;PTPN14;IGFBP6;KLF4;COL4A3;PLXNB1;CDKN1A;HPN;SMAD6;NIBAN2;CD200;MAGI2;NUPR1;CDK10;CELF1;CDK6;SULT2B1;NGF;KANK2;PTK2B;TNFRSF8;DUSP10;BMP5;PTPRU;S100A11;RARG;SH3BP4;TSC2;FBLN1;SLC16A2;ZBTB17;TES;CGREF1;BMP4;TGFB2;ANG;TGFB1I1;SLURP1;ADAMTS1;PML;FOXP3;BRD7;PTPN6;NMI;RAF1;ABI1;SOD2;DLC1;GSDME;WDR6;PTPN2;PDPN;PPM1D;GATA3;MYC;EEF1E1;BTG2;ING4;PINX1;SFRP1;TGFBR3;HRAS;P3H3;FLCN;ITGB1BP1;LMNA
prerank,T cell proliferation (GO:0042098),-0.4255632285233659,-1.1061547362330049,0.33608815426997246,0.7215261122919951,1.0,4/13,8.64%,CADM1;DOCK8;CTPS1;PPP3CB
prerank,negative regulation of actin filament polymerization (GO:0030837),0.46311874693196237,1.1058681413203315,0.3455571227080395,0.9300660763347072,1.0,4/22,6.02%,KANK1;GSN;SSH3;TWF1
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.36984354105566514,-1.1055411232384535,0.3136094674556213,0.7216332000085864,1.0,5/24,13.29%,PLA2G4A;PNPLA8;SERAC1;CDS2;ABCA3
prerank,triglyceride biosynthetic process (GO:0019432),0.480342740030162,1.1054361791167444,0.35724743777452417,0.9304340329357396,1.0,7/18,24.21%,DGAT1;MOGAT3;MOGAT1;GPAM;PCK2;GPAT3;LPIN1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.3871131376395174,-1.1053176066883454,0.31952662721893493,0.7207065388105399,1.0,9/18,11.93%,GRIK2;UNC13B;GRID2;GRIA2;CDH8;GRIK3;SLC17A6;GRIK1;GRIK4
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.42893323607618977,-1.1049793792626954,0.3315068493150685,0.7200990865866893,1.0,8/14,31.83%,THBS1;RGCC;ITGA4;PDCD4;CD40;PRKCI;CCL2;PLCG1
prerank,membrane depolarization (GO:0051899),0.43640901178136393,1.104906669064607,0.33550913838120106,0.9311956622141614,1.0,4/32,3.47%,SCN3A;CACNA1A;CAV1;CACNB3
prerank,cholesterol homeostasis (GO:0042632),0.39057728669008396,1.1045812842728613,0.32662721893491126,0.9312793939691876,1.0,12/64,11.06%,LDLR;SOAT1;CAV1;TTC39B;EHD1;INSIG1;NPC1;CYP39A1;RALY;SOAT2;ACSM3;ABCA2
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.46812021956120864,-1.1045204674803126,0.355,0.7198306369713274,1.0,3/10,1.90%,ERRFI1;ENG;ENPP1
prerank,regulation of proteolysis (GO:0030162),0.41290028495943515,1.1042152628878472,0.3197452229299363,0.9314390408509008,1.0,6/48,7.48%,CYFIP2;OGT;CAV1;LTBP4;PERP;BAD
prerank,regulation of vacuole organization (GO:0044088),-0.37853900764055515,-1.104169666737187,0.3281733746130031,0.7192363713029081,1.0,6/20,10.44%,TBC1D12;SCARB2;MTM1;LAPTM4B;TBC1D14;NPRL3
prerank,negative regulation of protein ubiquitination (GO:0031397),0.4008561567292106,1.1038503177902128,0.3440721649484536,0.9315993750383703,1.0,7/50,8.65%,NXN;OGT;CAV1;PRR7;SH3RF2;FBXO5;CHP1
prerank,endocytic recycling (GO:0032456),0.39608843292815665,1.1037821434512487,0.32578616352201256,0.9308573207948135,1.0,11/50,16.17%,RAB17;EHD1;RAB11FIP3;RAB7A;LMTK2;RAB35;SNX12;VPS52;WASHC1;CCDC22;VPS50
prerank,positive regulation of dendrite development (GO:1900006),0.5360390868323661,1.1036779238964038,0.3536184210526316,0.930224997316862,1.0,4/10,17.28%,COBL;BMP5;PTN;PACSIN1
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.3397821386124826,-1.1033778369052496,0.28888888888888886,0.719832248507071,1.0,11/30,28.86%,CD34;LGALS9;CD46;STAT3;HMGB1;HSPD1;NOD2;PYCARD;PIBF1;ISG15;PLCG2
prerank,regulation of axon extension (GO:0030516),0.4176617472320016,1.1031209478045743,0.3382352941176471,0.9310579623563414,1.0,11/37,20.64%,ISLR2;RTN4R;OLFM1;ZFYVE27;MAP3K13;GSK3B;ABL1;SHTN1;SEMA3A;MAPT;DBN1
prerank,regulation of interferon-gamma production (GO:0032649),-0.28838748465153236,-1.102937757836807,0.275,0.7195031362319796,1.0,9/71,8.36%,IL1R1;CD47;PDE4D;GAS6;AXL;SLC7A5;LGALS9;IL18;PDE4B
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.3330291229875688,-1.102133175445144,0.2762237762237762,0.7201803857754175,1.0,7/30,13.19%,FLT1;KDR;ACE;TGFB1;KIT;TP53;FLT4
prerank,retinol metabolic process (GO:0042572),-0.41465660630311907,-1.1020970657804485,0.3543307086614173,0.7187756117021002,1.0,6/14,16.82%,CYP1B1;RDH10;DHRS3;RBP4;ADH1A;RDH11
prerank,regulation of inflammatory response (GO:0050727),0.3521247677725126,1.1019523337413593,0.30325288562434416,0.9338261265957373,1.0,29/190,15.31%,AGTR1;GPR4;NAPEPLD;KLF4;MMP9;CCL5;CD200;IL17RA;NINJ1;IL15;IL16;CELF1;ALOX5;NFKBIA;AKNA;MAPK7;FEM1A;TNFRSF1A;NMI;TLR4;CD200R1;PTPN2;LPCAT3;GATA3;SBNO2;FOXP1;TNIP1;TLR3;DHX9
prerank,protein ADP-ribosylation (GO:0006471),-0.3522569599548904,-1.10167007742847,0.32413793103448274,0.7184680744311108,1.0,6/28,9.01%,ZC3HAV1;PARP12;ART3;PARP14;PARP8;TNKS
prerank,proteolysis (GO:0006508),0.35106860281383695,1.1016580418531807,0.28907048008171604,0.9337886184928099,1.0,49/252,18.59%,DPP4;CPB1;TMPRSS6;CPA4;CPA3;MMP9;OGT;ADAMTS7;ADAM10;HPN;TINAGL1;ADAM33;DPP7;NAALAD2;CTSZ;KLKB1;CPE;DESI2;DESI1;CAPN2;SRGN;AFG3L2;PITRM1;SDE2;SPCS3;MMP12;RNF123;NAPSA;PSMB5;NPEPPS;PGPEP1;TRABD2B;TASP1;PGPEP1L;MDM2;SPPL2B;CTSH;HM13;BACE1;ATG4B;PRTN3;FBXL2;SPPL3;USP25;PSMC4;SPPL2A;SUFU;SPG7;CAPN15
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.3614055748472411,-1.1015558493273299,0.32558139534883723,0.717264382681241,1.0,7/23,10.12%,GHR;NOTCH1;CYP1B1;ERBB4;OCIAD1;MGAT5;KIT
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.41567057934912177,1.1013602313303743,0.3229426433915212,0.933813637612554,1.0,10/46,8.88%,PLCL2;LAMA4;IL15;FOXC2;IP6K1;DOCK7;RHEB;PLCL1;LGR4;ARRDC3
prerank,sensory perception of light stimulus (GO:0050953),-0.26455941760342394,-1.1012533001317382,0.2702702702702703,0.7165296477163574,1.0,11/87,4.93%,COL1A1;ADGRV1;PCDH15;SLC4A10;COL18A1;RP2;ATXN7;EYA4;MYO9A;GRM8;COL11A1
prerank,response to insulin (GO:0032868),0.37964402882723164,1.1012402270690684,0.3119047619047619,0.9332237850034885,1.0,10/80,7.24%,SORBS1;OGT;CPEB2;HDAC5;EPRS1;RHOQ;INSIG1;PKM;ZBTB7B;EIF6
prerank,regulation of sprouting angiogenesis (GO:1903670),0.4324903036418419,1.1008732514180957,0.34965986394557824,0.9334614301030669,1.0,9/33,11.60%,KLF4;TJP1;GLUL;ALOX5;PKM;JMJD8;SYNJ2BP;S100A1;JAK1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.4129237342983338,-1.1008106913419293,0.3557951482479784,0.7161151817245073,1.0,3/14,4.92%,DMD;ATP1B1;WNK2
prerank,positive regulation of B cell activation (GO:0050871),0.4057699634056894,1.1005842178590326,0.3346055979643766,0.9333913038297389,1.0,5/50,4.72%,NFATC2;SASH3;CD81;CLCF1;SHLD2
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.4000920999021658,1.1005112169702425,0.345088161209068,0.9326582033008393,1.0,17/46,23.63%,TIMM10;TIMM44;TOMM5;DNLZ;ROMO1;PITRM1;HK1;BCAP31;TOMM20;TIMM17B;TOMM40L;TIMM9;TOMM40;TSPO;TIMM50;TIMM23;AIP
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.5205214578813825,1.100473985122478,0.36082474226804123,0.9308830724895071,1.0,4/10,14.87%,CDC42EP4;CDC42EP5;CDC42;WASHC1
prerank,regulation of pseudopodium assembly (GO:0031272),0.5205214578813825,1.100473985122478,0.36082474226804123,0.9308830724895071,1.0,4/10,14.87%,CDC42EP4;CDC42EP5;CDC42;WASHC1
prerank,negative regulation of organelle assembly (GO:1902116),0.43586910321846806,1.1004562617714002,0.34257975034674065,0.930002692006887,1.0,12/35,20.14%,LIMK2;NUPR1;CDK10;TMEM39A;CHMP4A;CHMP4B;SMCR8;TESK1;FEZ1;TRIM37;NBDY;PHF23
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.4422634064055144,1.1004386199050218,0.3351724137931035,0.9291060998134781,1.0,2/27,1.38%,NAPEPLD;ETNK2
prerank,O-glycan processing (GO:0016266),-0.29487250864062486,-1.1004206806088375,0.3111111111111111,0.7156254629382941,1.0,15/54,18.27%,ST3GAL1;GALNT7;ST3GAL3;GALNT13;GALNT15;C1GALT1;GXYLT2;POMGNT1;GALNT2;GALNT14;B4GALT5;GCNT1;C1GALT1C1;POFUT1;GALNT9
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.4533497076990173,1.1003019148745783,0.3249630723781389,0.9286045847099226,1.0,5/22,13.52%,CLU;EPHA4;ABCA2;SP1;GSK3A
prerank,phagosome acidification (GO:0090383),0.4323892228978975,1.0995767555398621,0.3376251788268956,0.9299926832961501,1.0,7/26,19.74%,ATP6V1B1;RAB7A;ATP6V1E1;ATP6V1D;ATP6V0D1;ATP6V1B2;ATP6V0B
prerank,regulation of lipid kinase activity (GO:0043550),-0.43510911036233957,-1.0991473243057661,0.3641160949868074,0.7173679836812333,1.0,4/11,18.09%,PIK3R1;RBL1;PIK3R3;PIK3R2
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.5200208364328801,1.0990814697707705,0.3867768595041322,0.930643831468735,1.0,4/11,16.54%,NUPR1;YBX3;PELI1;SLC25A4
prerank,cell differentiation in spinal cord (GO:0021515),-0.4646513434079582,-1.0988826706509318,0.3278301886792453,0.7166093522300598,1.0,3/10,16.02%,SOX13;SOX6;MDGA2
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.4196014829851845,1.0988803988083766,0.33695652173913043,0.9303482794505424,1.0,12/36,19.01%,QARS1;DUSP10;SH3RF2;DUSP1;FOXM1;EZR;HDAC3;NCOR1;MYC;IGBP1;DUSP3;TAOK3
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.3197390393101864,-1.0987426052852838,0.2979591836734694,0.7154415810552114,1.0,9/39,11.91%,ABCA1;STEAP3;MTTP;RCN3;SEL1L;TVP23B;PPY;TMEM167A;TANGO2
prerank,negative regulation of cartilage development (GO:0061037),0.5106156733837908,1.0987150324351247,0.3644859813084112,0.9299807464492076,1.0,3/13,6.71%,ADAMTS7;WNT11;EFEMP1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.44718260699274426,1.0987114439675745,0.3489736070381232,0.9290567869059067,1.0,6/25,14.73%,MMP9;BBC3;PMAIP1;BAD;HRK;DNM1L
prerank,oligosaccharide metabolic process (GO:0009311),0.4014932162107476,1.0982331702076782,0.3432642487046632,0.9295316451488027,1.0,8/46,14.98%,B3GALT1;ST3GAL4;B4GALNT2;FUT8;MANBA;ST3GAL6;NAGA;ST6GALNAC4
prerank,negative regulation of viral release from host cell (GO:1902187),0.5048115412805753,1.0977749753496377,0.38283828382838286,0.9300491663206313,1.0,4/13,9.40%,TRIM21;PML;TRIM26;TRIM11
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.35107475166016405,1.09723872444602,0.3119747899159664,0.9308290439195428,1.0,45/208,15.94%,PRKCB;LPAR1;EDA2R;AKAP13;ZC3H12A;IKBKE;MAVS;TRIM59;HSPB1;TRIM25;PPM1B;MTDH;TFG;USP10;SLC20A1;OTUD7B;MUL1;CC2D1A;WLS;TRIM21;TAB3;TNFRSF10B;PPM1A;TNFRSF1A;TLR6;JMJD8;CARD16;ANKRD17;RHOA;MIB2;EEF1D;PELI1;LGALS1;IRAK1;ZFAND6;CHUK;GAPDH;TNIP1;GPR89A;PLK2;IKBKG;RNF31;FLNA;UBE2N;CCDC22
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.44962070531630755,1.0966812397583572,0.3590844062947067,0.9316360531851215,1.0,4/25,9.20%,EPHA4;PSMF1;PML;OPHN1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.3350248373842465,-1.0964216388576289,0.29615384615384616,0.7201491585032169,1.0,9/30,15.43%,CACNA1C;GJC1;GPD1L;KCNJ2;CACNA1G;FGF12;SCN1A;RYR2;SCN1B
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.3777374071768035,-1.0962927595886818,0.3137931034482759,0.7190021697259364,1.0,5/23,5.29%,IGF1;INSR;ZBTB20;HIF1A;PRKAA1
prerank,lung development (GO:0030324),-0.3374036448182573,-1.0961508877565525,0.308,0.7178472580191986,1.0,12/33,16.49%,ERRFI1;GLI2;FGF2;RCN3;FGFR2;LOXL3;NPHP3;ZIC3;RBP4;ABCA3;FGF9;SOX11
prerank,regulation of translational initiation (GO:0006446),0.38937021051390647,1.096042238310354,0.33729216152019004,0.9326746731885346,1.0,21/63,18.94%,CCL5;YTHDF1;HSPB1;EIF2B2;EIF4B;EIF4EBP1;HABP4;EIF4G2;EIF2AK3;BOLL;EIF4G1;PAIP1;DNAJC3;EIF5B;EIF3B;EIF1;EIF2AK4;CTIF;EIF4A2;YTHDF3;EIF4EBP2
prerank,negative regulation of phosphatase activity (GO:0010923),0.44339009955378683,1.09582590410297,0.3431372549019608,0.9323863636948369,1.0,8/25,15.09%,SH3RF2;PPP1R15A;TGFB2;CRY2;CHP1;PPP1R11;GSK3B;PPP1R1B
prerank,apical protein localization (GO:0045176),0.5346591075459235,1.0958141445223741,0.3709150326797386,0.9314930707362528,1.0,3/10,11.03%,CELSR1;ACTB;INSC
prerank,gliogenesis (GO:0042063),0.49017996835736694,1.0955272406470569,0.3645833333333333,0.9314419865842164,1.0,4/15,10.01%,CDK6;CD9;TGFB2;NFIB
prerank,positive regulation of protein catabolic process (GO:0045732),0.3748671894440142,1.095479914307576,0.34467120181405897,0.9306636121755242,1.0,21/84,19.51%,FZR1;WWP2;MSN;EGLN2;GPC3;PLK3;RAB7A;EZR;SNX33;VPS11;GSK3A;GSK3B;NEDD4;PLK2;HSP90AA1;DDB1;NSF;RNF41;IDE;GPLD1;ASB5
prerank,cellular response to UV (GO:0034644),0.38009146156774276,1.0953378150668098,0.33649289099526064,0.9301817755056399,1.0,19/76,18.17%,OPN1SW;MMP9;CDKN1A;EP300;TIMP1;POLK;SDE2;CARD16;AQP1;MYC;NEDD4;USP28;PCNA;DDB1;ATR;KDM1A;EIF2AK4;TRIAP1;COPS9
prerank,positive regulation of translational initiation (GO:0045948),0.4667232731310268,1.09514762831484,0.34977578475336324,0.9298315445431619,1.0,4/18,13.46%,CCL5;YTHDF1;HABP4;BOLL
prerank,positive regulation of developmental growth (GO:0048639),-0.2954458586962519,-1.0950347454081837,0.32057416267942584,0.7193907556144816,1.0,9/49,13.09%,PLCB1;GHR;INSR;SEMA7A;SYT1;CDKL5;ITSN2;MACF1;BDNF
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.4395008041982722,1.0947439644878374,0.3587994542974079,0.9301198975828052,1.0,2/29,6.12%,ANKRD31;SYCP2
prerank,cell part morphogenesis (GO:0032990),-0.42548489202952455,-1.0945053507636395,0.33687002652519893,0.7193945451235588,1.0,3/13,9.13%,PID1;MTM1;FIS1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.45531351189891756,-1.0944855672337175,0.3671875,0.7179415967393101,1.0,2/10,7.75%,PTPRJ;PTPN12
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.4172243356388836,1.0944710343595594,0.3409090909090909,0.9300812071274096,1.0,8/37,10.83%,NUPR1;BBC3;CAV1;PMAIP1;BCL2L1;BAD;BCAP31;GSDME
prerank,regulation of telomerase activity (GO:0051972),0.41353856643796005,1.0943793502414962,0.3554987212276215,0.9294637478827937,1.0,15/45,22.08%,KLF4;NEK7;NABP2;MAPK15;MAP3K4;GRHL2;MYC;PINX1;HSP90AA1;HMBOX1;PRKCQ;PNKP;ERCC4;PTGES3;MEN1
prerank,regulation of interferon-alpha production (GO:0032647),0.44926472881566737,1.09431498049253,0.34965034965034963,0.9287780353102436,1.0,6/23,15.31%,MAVS;IRF3;TLR4;CHUK;TLR3;DHX9
prerank,glycerolipid metabolic process (GO:0046486),-0.4463448565301994,-1.0942165075524735,0.36486486486486486,0.717236143823714,1.0,8/11,26.56%,DGKB;GAL3ST1;DGKG;PNPLA3;PIP5K1A;DGKZ;DGKQ;PLA2G15
prerank,regulation of nuclear division (GO:0051783),0.4665930282507192,1.093777831375547,0.3520710059171598,0.9295550416961671,1.0,6/20,18.48%,DAPK3;CAV2;FBXO5;PKMYT1;CUL9;KIF20B
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.5101878300306856,1.0933361926366678,0.37209302325581395,0.930036579569777,1.0,4/11,19.14%,EFNB2;TGFB2;MEF2C;GPER1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.3753513976790666,-1.0932247060427418,0.3366013071895425,0.7185989179872371,1.0,4/19,4.00%,PARD3B;DLG2;ERBIN;LRRC7
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.43230506844906613,-1.0931630911615282,0.3155080213903743,0.7173150575451839,1.0,2/13,0.18%,PLCB1;IGF1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.4171583419921502,-1.0931599755961803,0.3518005540166205,0.7158573949302778,1.0,5/13,12.51%,PDE8A;LRRK2;GPR37;RACK1;TXN
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.5083863450724194,1.0930626426586967,0.3857791225416036,0.929997185677008,1.0,1/12,0.58%,CD44
prerank,regulation of coagulation (GO:0050818),0.5327654682212234,1.0927376359084269,0.38333333333333336,0.930065077696472,1.0,2/11,5.19%,CAV1;PROCR
prerank,generation of neurons (GO:0048699),0.35370030632773725,1.0925828827869801,0.29656607700312176,0.9296411349132543,1.0,19/190,9.20%,WNT16;FGF13;FGFR1;CELSR1;WNT1;NRBP2;WNT10A;WNT11;ITM2C;CDK6;WNT6;PTPRD;DOCK7;TGFB2;WNT5B;SIX1;FZD5;ACSL3;OPHN1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.4819767423084004,1.092498360248592,0.3682678311499272,0.9290069449164353,1.0,5/18,14.83%,KANK1;RIPOR2;CCDC125;DLC1;FLCN
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.47347792076795403,1.0922710775155904,0.37910447761194027,0.9287928254079383,1.0,3/18,7.16%,PODXL2;ITGB7;GOLPH3
prerank,cellular response to radiation (GO:0071478),0.4118562636000887,1.0922260344590975,0.3488681757656458,0.9280170269051278,1.0,3/40,4.50%,OPN1SW;CDKN1A;KDM4D
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.36853888889755404,-1.0920888523786763,0.3212121212121212,0.7171294670254493,1.0,5/21,8.18%,BMP6;RBPMS;DAB2;TGFB1;JAK2
prerank,negative regulation by host of viral process (GO:0044793),0.5314281727595618,1.0918657152478086,0.38605442176870747,0.9281573224670033,1.0,6/10,32.63%,ZC3H12A;EIF2AK4;VAPA;PRKN;PSMC3;CCNK
prerank,regulation of NMDA receptor activity (GO:2000310),-0.3379275314581688,-1.0914429382016222,0.29571984435797666,0.7174135643435782,1.0,10/32,8.60%,SLC6A9;DLG2;GRIN2A;GRIA3;GRIA2;LRRC7;EPHB2;GRIN2B;NLGN1;NEFL
prerank,myoblast differentiation (GO:0045445),0.5053518776322357,1.0913038652054199,0.3890675241157556,0.9289813960314464,1.0,2/14,2.31%,MBNL1;DDX5
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.42816042823547085,-1.0909673734263505,0.34203655352480417,0.7172019655795143,1.0,5/13,15.15%,GRIK2;SLC4A10;SHISA6;SHISA9;CLN3
prerank,carbohydrate catabolic process (GO:0016052),0.41573259108664895,1.090734465639161,0.34656084656084657,0.9298638755968618,1.0,11/38,16.08%,HKDC1;PKM;PFKFB2;MANBA;DERA;ENO2;HK1;ALDOA;GAPDH;NAGA;TPI1
prerank,oligodendrocyte development (GO:0014003),-0.41769236688584843,-1.0906217544427492,0.3573407202216066,0.7167578749647927,1.0,6/15,15.62%,EIF2B3;PLP1;TPPP;CNTNAP1;B4GALT5;MYRF
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.4150344095742269,1.0903469948390667,0.3412384716732543,0.9301673219068052,1.0,12/38,19.43%,CLU;KLF4;ZC3H12A;CAV1;DDAH2;TLR6;TLR4;ATP2B4;HSP90AA1;ASS1;ROCK2;KLF2
prerank,regulation of cell migration (GO:0030334),0.34071135136979974,1.0902585281629265,0.28169014084507044,0.929524383111252,1.0,47/382,8.51%,CDH1;SEMA3D;CDH13;PHACTR1;NTRK3;SRGAP3;SRGAP2;KANK1;LAMC2;TJP1;SMO;MMP9;CCL5;PLXNB1;PODXL;EPHA4;PDGFC;DAG1;ADAM10;PLXNA2;MAGI2;WNT11;CAV1;SEMA3B;KIF2A;PTK2B;FOXO3;LMO4;SGK3;DUSP10;MGAT3;GCNT2;SH3RF2;PTPRU;TMEFF2;DDRGK1;MAPK15;CBLL1;SRCIN1;SLURP1;ARSB;WNT5B;FGF22;PARD6B;MAZ;PIP5KL1;ELP5
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.3200960486477954,-1.0898490229122102,0.2839506172839506,0.7174119558679319,1.0,13/36,15.44%,PLCB1;LEF1;FZD6;WNT5A;NFATC1;FZD4;PPP3R1;PPP3CB;TNRC6A;PPP3CA;CAMK2A;AGO1;GNB1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.5188609670751935,1.089353122954862,0.3839869281045752,0.9314017161011646,1.0,5/12,16.85%,IMPDH2;PAICS;GMPS;GART;ADSS2
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.42677337253276404,1.0892614634492834,0.353494623655914,0.9307858250550409,1.0,12/33,20.23%,DDX5;EP300;DDRGK1;LATS1;KDM4C;GPAM;UFM1;KDM1A;HDAC6;H3-3A;PARK7;PRMT2
prerank,positive chemotaxis (GO:0050918),0.4813831876359839,1.0890668852736163,0.3939393939393939,0.9304909349088143,1.0,3/17,8.27%,ANGPT1;TSC2;LGALS3
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.391704106977774,1.0890291047930483,0.34143377885783716,0.9296952409243895,1.0,14/54,17.98%,CNOT6;CDKN1A;EP300;PLK3;PML;BTG2;MDM2;PLK2;PCNA;E2F1;PRMT1;CHEK2;PIDD1;TRIAP1
prerank,double-strand break repair via homologous recombination (GO:0000724),0.37007021910273097,1.089009980450718,0.33032694475760993,0.9288453277095755,1.0,33/95,22.42%,FEN1;RECQL4;KDM4D;NABP2;RNF138;MRE11;RAD54L;RMI1;HUS1B;NSMCE2;MMS22L;ERCC5;RPA3;MCM8;FAN1;UBE2N;LIG3;SFR1;MCM6;SMC6;NBN;MCM7;RAD50;ZFYVE26;NUCKS1;ERCC4;NABP1;POLN;YY1;SFPQ;MCM4;SWI5;NSMCE1
prerank,Ras protein signal transduction (GO:0007265),0.35941301722334223,1.0884802950622454,0.3286486486486486,0.9295808759888087,1.0,34/137,16.30%,AGTR1;CDH13;CELSR1;CDKN1A;MRAS;RAP1B;EPS8L2;RAP1A;CDC42EP4;CDC42EP5;NRAS;KRAS;SHC1;ARHGAP29;JUN;RALGDS;RAPGEF3;GNA13;RHOA;WASF1;PDPN;RREB1;CDK2;SHC2;BRAP;HRAS;SETDB1;RAPGEF1;ARHGDIB;PLK2;RAP2C;USP28;RIPOR1;ARHGEF1
prerank,regulation of epithelial cell migration (GO:0010632),-0.29517527173542124,-1.0882467243916385,0.29444444444444445,0.7201488976737528,1.0,9/51,5.29%,PTPRG;SASH1;MCC;CLASP2;HIF1A;PTK2;BMPER;ENPP2;DAB2IP
prerank,inner ear morphogenesis (GO:0042472),0.45394654837369147,1.0882144826787974,0.3787425149700599,0.9294840384478107,1.0,4/22,9.45%,ATP6V1B1;HPN;SIX1;ZIC1
prerank,activation of GTPase activity (GO:0090630),0.3763188057697359,1.0877467961018132,0.3414071510957324,0.9300593768588326,1.0,15/89,11.86%,ARHGAP42;NTRK3;NGEF;SIPA1L1;GRTP1;TBC1D16;TIAM2;DOCK7;ARHGAP29;CCDC125;BCR;ARHGEF5;BCAS3;SGSM2;TBC1D1
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.38260573549197374,1.0875958920849293,0.34261501210653755,0.9296347346541496,1.0,27/69,24.81%,GTF2F1;POLR2H;NABP2;POLR2A;INTS2;RPRD2;GTF2E1;SP1;TAF5;ELL;SRRT;INTS3;POLR2C;INTS13;POLR2E;INTS6;TAF8;TBP;NABP1;SNAPC3;GTF2E2;TAF6;INTS1;CDK9;ICE1;ELL2;POLR2K
prerank,acylglycerol metabolic process (GO:0006639),-0.3176071973483001,-1.0870606179570537,0.2982456140350877,0.7218936989737764,1.0,18/37,27.41%,DGKH;DGKB;PLAAT3;MGLL;SEL1L;DGKI;ABHD12;DGKG;ABHD2;LPL;PNPLA3;DGAT2;DGKZ;DGKQ;DGKK;GK5;PNPLA2;AWAT2
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.4548403536352551,1.0865021064668834,0.3586800573888092,0.9320419813315863,1.0,6/21,11.24%,HKDC1;PGM2;PGD;DERA;HK1;RPIA
prerank,negative regulation of hippo signaling (GO:0035331),-0.4345415886666002,-1.0864253476460686,0.3449197860962567,0.7220890142514121,1.0,6/12,22.14%,WWC2;CIT;DLG5;LIMD1;MAPK14;WWC1
prerank,response to ethanol (GO:0045471),-0.40556948555416644,-1.08614891462047,0.34806629834254144,0.7213267958132413,1.0,8/14,25.90%,GRIN2A;ADCY7;GRIN2B;GLRA1;GLRA2;SOD1;GRIN3A;GOT2
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.44325433075324827,-1.086065341849871,0.35501355013550134,0.7200820465518812,1.0,4/11,14.59%,NOS3;GCH1;SPR;DHFR
prerank,Rac protein signal transduction (GO:0016601),0.4731259839229759,1.0851694581290903,0.3713872832369942,0.9352102208334778,1.0,1/18,0.37%,CDH13
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.4068848524776197,1.0848072615495619,0.34346103038309117,0.935457933470556,1.0,6/40,8.79%,CLU;PTK2B;NUB1;DESI1;LATS1;PML
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.3741069779685192,1.084686352149109,0.34015927189988626,0.9349171608933236,1.0,24/87,16.81%,NOTCH2;CELSR1;ARHGAP18;CDK10;PTK2B;DAPK3;RHOQ;TWF1;EFNA5;DMTN;IQGAP1;ARHGEF5;EZR;DLC1;RAPGEF3;EPHA3;RHOA;TRPM2;CCDC88A;ARHGDIB;TESK1;FSCN1;CRK;ABL1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.4331613093116705,-1.0846109064902048,0.36519607843137253,0.722653992446312,1.0,3/12,12.17%,CYP26B1;EZH2;DHRS3
prerank,ribosome assembly (GO:0042255),0.39449687005361234,1.0844658283019744,0.3501259445843829,0.9347005245818428,1.0,19/47,28.53%,NLE1;NOP2;PPAN;MRPS7;EIF6;RPSA;PWP2;RPL6;RPS28;EFL1;C1QBP;EIF2A;RPS27;NOP53;RRS1;MDN1;RSL24D1;RPL24;DDX3X
prerank,sphingosine metabolic process (GO:0006670),-0.39839683868599407,-1.0838777202507666,0.32840236686390534,0.723012870929812,1.0,9/17,33.30%,ACER2;SGPP1;SPHK1;PLPP3;ASAH2;PLPP2;SPTLC2;ACER3;SPTLC3
prerank,cellular response to chemical stress (GO:0062197),0.36964723958169,1.0837096296394626,0.3546576879910213,0.9361972664703275,1.0,10/96,5.23%,PRKAA2;PPARGC1A;CPEB2;ZC3H12A;CAV1;FOXO3;SESN2;MGAT3;NFE2L2;NUDT2
prerank,pulmonary valve morphogenesis (GO:0003184),0.4714548520192553,1.0829706202278175,0.38382352941176473,0.9375360826082072,1.0,5/17,7.38%,NOTCH2;SMAD6;STRA6;BMP4;TGFB2
prerank,telomere organization (GO:0032200),0.4101514340974149,1.0828487743745772,0.3605263157894737,0.9370191501589835,1.0,24/43,28.15%,RECQL4;DOT1L;MRE11;PARP3;RIF1;HUS1B;RPA3;POLD2;PCNA;ATR;NBN;RAD50;H3-3A;ERCC4;TERF2;PTGES3;TINF2;APEX1;RPA2;PARP1;POLD1;XRCC5;TERT;TERF1
prerank,histone lysine demethylation (GO:0070076),0.44267651908204486,1.0827175652835108,0.37175792507204614,0.9365041564954033,1.0,7/25,12.09%,KDM4D;KDM4B;KDM5C;KDM3A;RIOX2;KDM4C;KDM6A
prerank,granulocyte differentiation (GO:0030851),0.469197003950725,1.0827135409318047,0.37574850299401197,0.9356192709032344,1.0,7/18,18.34%,CDKN1A;EP300;CDK4;PML;CDK2;E2F1;RARA
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.500716871751117,1.0826986899065674,0.3729903536977492,0.9347550281889646,1.0,3/12,8.61%,ERLIN2;ACADL;ERLIN1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.48664982109292043,1.0823687999159235,0.3524451939291737,0.934874186934508,1.0,5/14,18.02%,KLF4;HDAC5;RHOA;ITGB1BP1;MEOX2
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.3688569982804237,1.0823574437766428,0.3448687350835322,0.9340123022463558,1.0,10/76,10.44%,BAIAP2L1;NTRK3;CDC42EP4;PTK2B;FCHSD2;CDC42EP5;FCHSD1;HAX1;CDC42;BCAS3
prerank,cytoskeleton organization (GO:0007010),-0.2559840944657138,-1.0823445779379073,0.24468085106382978,0.7256377185099298,1.0,26/114,13.42%,MAST4;MARK1;RHOBTB1;SEMA6A;FGD5;TNIK;PLCE1;RND3;FMNL3;PALLD;MICAL3;LRCH3;EPB41L3;SH3KBP1;RANBP9;BIN1;ABI2;RHOBTB3;FGD3;ARAP3;ZMYM3;CNN2;KLHL20;DES;CNTNAP1;CECR2
prerank,negative regulation of viral process (GO:0048525),0.3838929412418674,1.082294069211631,0.3515527950310559,0.9333117507392258,1.0,14/57,16.62%,CCL5;MAVS;SLPI;RNASEL;TRIM21;LARP7;PML;TRIM26;TRIM11;SRPK2;SRPK1;TNIP1;OAS2;HEXIM1
prerank,cellular protein modification process (GO:0006464),0.3338886051398528,1.0822126165390238,0.191,0.9326644535027412,1.0,205/983,17.75%,FN1;EGLN3;PRKCB;MSLN;UST;FGFR1;PTPN14;STK19;FBXL7;B3GALT1;PRKAA2;F5;LIMK2;FAM20C;PRAG1;FBXW8;ST3GAL4;NRBP2;MAP3K5;TRIB2;PRSS23;GRK5;ADAM10;TSSK6;TSSK4;PENK;PIGU;WNT11;IKBKE;NEK7;CDK10;PDF;ASB14;CDK6;PPM1L;FBXL20;MKNK2;PTK2B;SGK3;DAPK3;PPP2CA;SPSB4;ATE1;DUSP10;SERPINC1;GCNT2;LARGE1;DAPK1;ZBTB16;TIMP1;WWP2;PPM1B;PTPRU;PTPRD;CDKL2;CDK4;DUSP12;DUSP1;PSMD11;NUB1;ANO8;UBLCP1;MGAT1;ROS1;ELOB;CREB1;RNASEL;PHKA2;KLHL21;STK39;NPC1;MACROD1;SIK3;DDOST;CSK;BMP4;PTPRF;PTPN9;PSMD4;PARP3;PTPRA;CPE;PSMF1;TGM5;GPC3;TGFB2;PP2D1;FEM1C;FEM1A;CDK16;ILK;LATS1;SUMF1;WSB2;DYRK1B;PPM1A;GPAA1;FBXL18;RBX1;OXSR1;MAPK9;AURKC;FBXO31;LAMC1;MANBA;BCR;LMTK2;TXK;PTPN6;LAMB2;MTMR3;SRPK2;PIGT;COP1;PSMD7;CDKL4;GRK2;FBXW9;FEM1B;PDK2;CSNK1E;SUMF2;DCUN1D1;PARP6;PTPRE;SOCS2;JAK1;ALG1;CALU;YWHAZ;KLHL13;MARK4;TGFBR2;EIF2AK3;COPS5;ST3GAL6;PPP1CB;DCAF6;CDK18;SRPK1;CP;PPM1D;PSMB5;UBXN7;ARF4;MAP3K13;CDK2;LGALS1;DDA1;GSK3A;ASB7;ALG5;IRAK1;CHML;SOCS6;DCAF17;CHUK;TULP4;ULK1;SERP2;RAB1B;GSK3B;WNK1;NUS1;NTAQ1;DNAJC3;PIGS;CDC42BPA;PPP2CB;PLK2;JMJD4;PRKCSH;ASB6;DUSP11;CCDC22;TNKS2;AAK1;FBXL15;ASB8;DDB1;PAK6;CAND1;ASB3;PRKCZ;ATG4B;CUL9;ABL1;UBE2D3;PRKAG1;MAP3K6;MAPK6;CDC25B;EIF2AK4;PTPN13;KEAP1;PTP4A2;MAPKAPK2;UBE2F;CHEK2;FBXL2;PSMD1;RPN2;PDP1;USP25;BMPR1A
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.4699706709556451,1.081594135284516,0.3873343151693667,0.9336047208790461,1.0,4/18,7.48%,PMAIP1;BCL2L1;MUL1;BAD
prerank,histone H4-K16 acetylation (GO:0043984),0.4680231919352293,1.081326070240074,0.38636363636363635,0.9335293650292721,1.0,7/19,16.02%,OGT;HCFC1;KMT2A;JADE2;ING4;MSL2;MEAF6
prerank,axon guidance (GO:0007411),0.3432456512275396,1.0805405804369121,0.3193717277486911,0.934994174691202,1.0,35/201,11.67%,ALCAM;SEMA3D;NOTCH2;LAMC2;SMO;GPC1;PLXNB1;EPHA4;EFNB2;DAG1;NIBAN2;PLXNA2;GAB1;SEMA3B;CXCR4;LAMA5;DOK6;GDNF;SPTBN2;ENAH;GFRA3;EFNA5;SHC1;MAPK7;KLF7;PTPRA;UNC5B;OPHN1;EZR;NFIB;NRP2;SEMA4F;EPHA3;SPTAN1;IRS2
prerank,regulation of biomineral tissue development (GO:0070167),-0.34298199013379294,-1.0804894291449838,0.31864406779661014,0.7292884679088504,1.0,8/26,9.83%,ENPP1;NOS3;GAS6;NOTCH1;ECM1;TGFB1;ROCK1;NOTUM
prerank,androgen receptor signaling pathway (GO:0030521),0.5148943662610388,1.0802775874290087,0.3819672131147541,0.9349082402602897,1.0,2/11,2.31%,DAXX;DDX5
prerank,cellular response to copper ion (GO:0071280),0.4842349424358108,1.079789748190959,0.3901345291479821,0.9355478021334828,1.0,2/16,11.04%,DAXX;AQP1
prerank,negative regulation of coagulation (GO:0050819),0.48607667638453417,1.0797462261815423,0.3976083707025411,0.9348035042268475,1.0,3/14,6.08%,ADTRP;PROCR;THBD
prerank,regulation of vasculogenesis (GO:2001212),-0.40578378892089384,-1.079049841201522,0.3283208020050125,0.7318238314675961,1.0,5/14,4.75%,RAPGEF2;XDH;CD34;KDR;TMEM100
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.3830631330608299,1.0785803305314041,0.36991368680641185,0.9373822128587403,1.0,7/54,8.65%,NXN;OGT;CAV1;PRR7;SH3RF2;TRIM21;CHP1
prerank,ganglioside metabolic process (GO:0001573),-0.3719810420483921,-1.0785445555140825,0.3667711598746082,0.7317262821994678,1.0,9/20,19.52%,ST6GALNAC3;ST3GAL5;ST8SIA4;ST6GALNAC5;ST8SIA6;NEU1;ST8SIA2;GM2A;NEU3
prerank,glycolytic process (GO:0006096),0.43662043427872105,1.0784623825816035,0.38741258741258744,0.9368221556570641,1.0,8/28,16.08%,HKDC1;PKM;PFKFB2;ENO2;HK1;ALDOA;GAPDH;TPI1
prerank,phosphate ion transmembrane transport (GO:0035435),0.49950629637393895,1.078042238850758,0.38030560271646857,0.9371804408056023,1.0,4/12,14.51%,SLC25A3;SLC20A1;SLC25A14;SLC37A1
prerank,negative regulation of B cell activation (GO:0050869),-0.3628765410425831,-1.0779773083547357,0.3464052287581699,0.7318766037881969,1.0,11/21,32.51%,LYN;TNFRSF21;ID2;CD300A;RC3H1;TNFAIP3;TYROBP;FCGR2B;BANK1;FOXJ1;SAMSN1
prerank,cellular glucan metabolic process (GO:0006073),-0.43977503224039416,-1.0778923232738433,0.3765281173594132,0.7306648275940604,1.0,4/11,17.90%,PRKAG2;PHKA1;UGP2;GBE1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.40622775876143485,1.0778234714040638,0.36133333333333334,0.936980716938889,1.0,3/40,2.29%,CLU;ANGPT1;MAGI2
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.44289735158636145,1.0778088329416167,0.37155297532656023,0.9361404784807976,1.0,1/23,0.32%,DSG2
prerank,metanephric mesenchyme development (GO:0072075),-0.4584425356948718,-1.0776315200972575,0.38137472283813745,0.7298726771622681,1.0,3/10,10.69%,WNT4;PKD2;BASP1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.2934747681304853,-1.0773454743169693,0.36464088397790057,0.7291536418095828,1.0,8/51,7.48%,IL34;VEGFC;PTK2;CXCL12;GAS6;LGALS9;THBS1;IL6R
prerank,sensory perception of sound (GO:0007605),0.3652396991563846,1.0772759244766543,0.3486238532110092,0.9367868032777458,1.0,17/88,14.01%,ATP6V1B1;USP53;COL4A3;HPN;EPS8L2;TIMM10;HOMER2;TPRN;RIPOR2;EML2;EYA1;TMC2;PDZD7;GSDME;MKKS;SLC26A4;PAX3
prerank,ion transport (GO:0006811),0.36247681317719493,1.0772155937411598,0.3723756906077348,0.9360788746358288,1.0,21/111,16.86%,SLC9A2;SLC9A4;TRPM3;SLC4A2;CTNS;SLC20A1;VDAC2;CNGB3;SLC9A7;SLC9A6;PKD2L1;SLC12A4;ANO6;CNGB1;VDAC1;SLC26A4;WNK1;SLC9A8;SLC12A6;SLC8B1;SLC9A1
prerank,establishment of endothelial barrier (GO:0061028),0.4286270745025251,1.077082976289865,0.37347767253044656,0.9355762983252929,1.0,10/29,15.44%,TJP2;TJP1;RAP1B;RAP1A;MSN;EZR;RAPGEF3;RAB1B;RAPGEF1;RAP2C
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.3375562682452374,-1.0766233842440942,0.3373493975903614,0.7295972893063899,1.0,13/30,19.51%,NOS3;FAS;RFFL;TNFSF10;CFLAR;ARHGEF2;RIPK1;GPX1;ICAM1;RNF34;FAIM2;TRADD;TNFAIP3
prerank,microglial cell activation (GO:0001774),0.4506914771793653,1.0756924477069545,0.3695652173913043,0.9389344330507275,1.0,1/21,0.40%,CLU
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.3834002312533965,-1.075501543775847,0.37209302325581395,0.7310712838135989,1.0,4/18,7.31%,CLASP2;RUNX1;RGCC;TGFB1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.44369758995039144,-1.0754850024589875,0.38929440389294406,0.7296978958544249,1.0,5/11,37.35%,NOS1AP;KCNIP2;TREM2;RNF207;ALG10B
prerank,negative regulation of catabolic process (GO:0009895),0.39630750281767513,1.075363357287983,0.3572327044025157,0.9390168674267418,1.0,10/47,12.16%,NUPR1;HDAC4;HMGCR;AZIN1;CYP51A1;BANP;SF3B3;TIGAR;NCOR1;SNX12
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3481350207142223,1.074854126350954,0.34893617021276596,0.9396704790331025,1.0,25/166,12.35%,NR3C2;THRB;NOTCH2;PPARGC1A;RORC;CCN2;GTF2F1;HDAC5;NR6A1;POLR2H;ESRRB;TAF1C;RARG;POLR2A;RXRB;MAZ;UBTF;NR2C1;POLR1C;HDAC3;POLR1E;NCOR1;GTF2E1;POLR1F;TAF5
prerank,outer dynein arm assembly (GO:0036158),0.48367881041259314,1.0748097591638273,0.3858858858858859,0.9389297515024084,1.0,6/15,26.69%,LRRC49;ODAD3;DNAAF5;ODAD2;DNAH5;DNAAF4
prerank,negative regulation of calcium ion transport (GO:0051926),0.4787130069247883,1.074237150127356,0.3851239669421488,0.9397185297529141,1.0,2/15,4.45%,ATP1A2;EPO
prerank,regulation of mRNA catabolic process (GO:0061013),0.3545957248651563,1.0741480637900205,0.35476718403547675,0.9391069827320015,1.0,31/121,19.44%,VIM;SAMD4A;YTHDF1;ZC3H12A;SAMD4B;TNFSF13;HSPB1;PSMD11;MOV10;PSMD4;PSMF1;EXOSC3;YWHAB;PSMD7;YWHAZ;PSMB5;FXR1;CARHSP1;DCP1A;TNPO1;SET;EIF4G1;RPS27A;UBC;MAPKAPK2;PSMD1;PSMC4;IGF2BP3;YTHDF3;IGF2BP2;PSMD8
prerank,cell proliferation in forebrain (GO:0021846),0.5216965224227039,1.0737628593744255,0.40266222961730447,0.9393924878357907,1.0,6/10,26.73%,DOCK7;AKNA;HOOK3;CEP120;PCM1;NUMBL
prerank,phosphate ion transport (GO:0006817),0.46918592973685314,1.0737483322471917,0.38351822503961963,0.9385632388302961,1.0,4/16,14.51%,SLC25A3;SLC20A1;SLC25A14;SLC37A1
prerank,pentose-phosphate shunt (GO:0006098),0.5121326456309679,1.0736043717236512,0.375,0.9381383128388495,1.0,5/11,16.40%,PGM2;PGD;DERA;RPIA;RBKS
prerank,negative regulation of response to stimulus (GO:0048585),0.3831442410856564,1.0735249596914505,0.3800738007380074,0.9375055917903371,1.0,14/60,14.20%,CLU;KLF4;CDK6;ALOX5;MAPK7;KLF7;ERBB3;FBXO5;FOXP3;CASK;TWIST1;LPCAT3;TLE5;BRAP
prerank,protein import (GO:0017038),0.36422269326773027,1.0734963195830731,0.34831460674157305,0.9367043827120085,1.0,23/84,18.71%,CLU;PEX26;ABCD1;IPO7;TSC2;NUP93;HSPA4;TNPO2;SNX33;MMP12;SLC25A17;TNPO1;NXT2;RANBP6;HEATR3;PXMP4;HSP90AA1;IPO4;RAB8B;CSE1L;PPP1R10;PEX3;PEX2
prerank,negative regulation of cell aging (GO:0090344),0.4767590595348342,1.0726694301771436,0.39813374805598756,0.9383625065675285,1.0,9/16,21.55%,WNT1;CDK6;FOXM1;FBXO5;TWIST1;MAP3K3;ZKSCAN3;TERF2;YBX1
prerank,cartilage development (GO:0051216),0.3959513782838185,1.072021696611784,0.3686176836861768,0.9395481620018064,1.0,8/49,10.01%,CD44;ITGB8;ZBTB16;DDRGK1;BMP4;WNT5B;PKD1;NFIB
prerank,protein K48-linked ubiquitination (GO:0070936),0.3879928957542339,1.0717571460767967,0.37218045112781956,0.9394691136691512,1.0,12/54,16.87%,RNF152;RNF5;UBE2G2;RBX1;RNF146;UBE2B;RNF126;PELI1;UBR5;UBE2H;BFAR;UBE2D3
prerank,response to reactive oxygen species (GO:0000302),0.38580029446495223,1.0716241628831142,0.38209331651954603,0.9389869145765812,1.0,14/54,14.94%,MMP9;FOS;PXN;PLK3;ROMO1;JUN;MAPK9;SOD2;HP;AGAP3;PDK2;COA8;CHUK;APTX
prerank,regulation of B cell proliferation (GO:0030888),0.3993495048867224,1.0714291670634801,0.3592356687898089,0.9386955968722042,1.0,4/44,4.18%,NFATC2;SASH3;CD81;CLCF1
prerank,positive regulation of phospholipase C activity (GO:0010863),0.4051452278562337,1.0714175027136963,0.3858267716535433,0.9378491312746075,1.0,3/40,0.84%,FGFR1;LPAR1;NTRK3
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.48922036548735515,1.0707156148804846,0.4105754276827372,0.9390893350879652,1.0,2/14,2.15%,LDLR;CD200
prerank,potassium ion transport (GO:0006813),0.34883946364865437,1.0706285447479598,0.3318777292576419,0.9384683121907238,1.0,17/120,14.03%,SLC9A2;SLC9A4;HPN;NALCN;ATP1A2;KCNJ13;ABCC8;CHP1;KCNA4;SLC9A7;SLC9A6;KCNB1;AQP1;PKD2L1;KCNA5;KCNQ5;TMEM175
prerank,chromatin remodeling (GO:0006338),0.36226861225362156,1.070500565464662,0.3490460157126824,0.9379837709786593,1.0,32/100,19.72%,DAXX;HDAC5;HDAC4;KDM4D;SMARCB1;PIH1D1;KDM4B;HCFC1;KDM5C;ATRX;FOXP3;ACTB;KDM4C;SMARCA4;DR1;SRCAP;KDM6A;ACTL6B;MPND;MYSM1;BAZ2B;CHD3;SMARCD2;MYC;GATAD2B;SMARCC1;GATAD1;BRDT;ARID1B;PBRM1;ZBTB7A;RB1
prerank,protein localization to microtubule organizing center (GO:1905508),-0.39465871535351815,-1.0701264267608153,0.36772486772486773,0.7429251870170231,1.0,8/15,27.82%,CCDC14;C2CD3;NEDD1;CSNK1D;BBS4;CEP131;SPAG5;PIBF1
prerank,regulation of protein transport (GO:0051223),0.4215661370410151,1.0701053694816582,0.3986394557823129,0.9383104824480495,1.0,6/27,13.93%,NDEL1;WWP2;CHP1;LLGL2;SNX12;RHBDF2
prerank,regulation of cholesterol efflux (GO:0010874),0.42101918353783324,1.0700079954288932,0.38812154696132595,0.9377338768110441,1.0,4/30,5.36%,SREBF2;CAV1;TTC39B;NFKBIA
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.5096468330714632,1.0699563254455895,0.3956228956228956,0.9370151600837467,1.0,5/11,22.06%,MAP3K5;ARL6IP5;PRODH;STK24;DIABLO
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.4748643443645849,1.0699328260456504,0.396875,0.9362166771954408,1.0,3/15,11.18%,EHD1;RIPOR2;RAPGEF3
prerank,anion transport (GO:0006820),-0.32256760937235784,-1.0699193652580812,0.35772357723577236,0.7420372451312586,1.0,4/33,1.71%,SLC13A3;LRRC8C;SLC26A7;SLCO2B1
prerank,regulation of Notch signaling pathway (GO:0008593),0.3688233031172021,1.0696618355192855,0.3706293706293706,0.9361642391095152,1.0,8/76,4.47%,TSPAN5;WNT1;PRAG1;ELF3;SREBF2;NIBAN2;EP300;WWP2
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.3943781554057943,1.0695726974331805,0.38149556400506973,0.9355771641858973,1.0,8/47,12.14%,AGTR1;CDKN1A;ZC3H12A;DHRS4;ROMO1;TLR6;TLR4;TGFBR2
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.3943555487646909,1.0692657791431834,0.3680104031209363,0.9356271684005644,1.0,14/44,20.00%,OSBPL9;ACOT8;DHCR7;HMGCR;INSIG1;PMVK;CYP39A1;MSMO1;OSBPL7;SQLE;TM7SF2;OSBPL2;PARK7;HSD17B10
prerank,membrane lipid biosynthetic process (GO:0046467),0.38328914869491554,1.0691761347343338,0.3492063492063492,0.9350380281120436,1.0,6/58,4.19%,SPTSSB;ST3GAL4;SGMS2;PPM1L;SCCPDH;ELOVL1
prerank,organelle transport along microtubule (GO:0072384),0.4250122523461463,1.068686065096372,0.3789764868603043,0.935628955656262,1.0,9/31,20.09%,DYNC1I1;NDEL1;ARHGAP21;CDC42;PAFAH1B1;COPG1;TMEM201;RHOT2;MAPT
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.48188566091182267,1.0683076966014018,0.397341211225997,0.9359143583929141,1.0,4/15,10.60%,ZC3H12A;KHNYN;POP1;LACTB2
prerank,positive regulation of telomerase activity (GO:0051973),0.4201987789871726,1.0682206542404828,0.3878378378378378,0.9353247581579294,1.0,10/33,19.54%,KLF4;NEK7;MAPK15;MAP3K4;GRHL2;MYC;HSP90AA1;HMBOX1;PRKCQ;PNKP
prerank,myotube differentiation (GO:0014902),0.48338012247734974,1.068088331751012,0.3978658536585366,0.9348311986165124,1.0,1/17,0.10%,ADAM12
prerank,cytoplasmic microtubule organization (GO:0031122),0.3839756043987154,1.0679661949548913,0.3834771886559803,0.9343168513999695,1.0,20/54,24.68%,LIMK2;CLIP4;PLK3;CHP1;EZR;HOOK1;VPS4B;RHOA;CCDC88A;CAMSAP1;DYNC1H1;NUMA1;KATNAL2;TUBGCP5;HOOK3;MAPT;TRPV4;PCM1;SLK;CEP126
prerank,activation of protein kinase B activity (GO:0032148),-0.3322284329199946,-1.0679049585837568,0.35471698113207545,0.7459746167491624,1.0,5/29,5.93%,IGF1;INSR;WNT5A;GAS6;IL18
prerank,regulation of protein export from nucleus (GO:0046825),0.4370081371878093,1.0675361892876747,0.38653001464128844,0.9347775505119419,1.0,9/23,22.75%,PTPN14;TCF7L2;BAG3;RAPGEF3;GSK3B;PARK7;XPO4;SIRT7;TPR
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.4355694662366516,1.0671131215210736,0.39660056657223797,0.935177882023237,1.0,2/25,2.17%,B3GALT1;B4GAT1
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.36415877805851365,1.0670086092332602,0.3586698337292161,0.9346727317668505,1.0,15/85,12.89%,CELSR1;WNT1;MAGI2;WNT11;AP2A2;PSMD11;PSMD4;PSMF1;DVL3;FZD5;CDC42;PSMD7;AP2A1;RHOA;PSMB5
prerank,protein deacylation (GO:0035601),0.4437984045875789,1.0664253233001766,0.38968481375358166,0.9355829202053164,1.0,8/23,22.26%,HDAC5;HDAC4;ABHD10;HDAC3;HDAC6;LYPLAL1;ABHD17C;SIRT7
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.34106346741942983,1.0661447367056507,0.355601233299075,0.9355370718280945,1.0,17/214,6.52%,FN1;ANGPT1;CD44;NOTCH2;NTRK3;CCL5;PDGFC;CCN2;RAP1A;PTK2B;DUSP10;GCNT2;ACKR3;ROS1;FBLN1;SPRED3;SHC1
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.2998509467966622,-1.066045017671554,0.2971698113207547,0.7495060704267237,1.0,6/48,8.36%,IL1R1;PDE4D;SLC7A5;LGALS9;IL18;PDE4B
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.4876320822706529,1.0657941667315125,0.40483870967741936,0.9357240701142272,1.0,4/13,16.44%,CRLF1;JAK1;OAS2;CANX
prerank,negative regulation of ossification (GO:0030279),0.43689950163119606,1.0656664874325623,0.4043478260869565,0.9352606591224384,1.0,6/23,14.09%,SMAD6;PTK2B;SRGN;TRPM4;MEF2C;SFRP1
prerank,membrane assembly (GO:0071709),0.41496493624724323,1.0655280616472975,0.3855755894590846,0.9348178217980613,1.0,14/34,19.46%,EMP2;S100A10;PTPRD;FLOT2;ANK3;ANXA2;NSFL1C;CHMP4B;TLCD2;VPS4A;CHMP2A;NLGN2;STX4;FLOT1
prerank,tryptophan catabolic process (GO:0006569),0.5013821607884125,1.065117751182003,0.40826446280991735,0.9351501580816441,1.0,4/11,24.53%,TDO2;HAAO;KYAT1;KMO
prerank,pulmonary valve development (GO:0003177),0.4609261820795641,1.0649675988053589,0.39642324888226527,0.9347377699061385,1.0,6/18,9.00%,NOTCH2;SMAD6;STRA6;BMP4;TGFB2;TNFRSF1A
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.4274344389099194,1.0648977707414462,0.36149584487534625,0.9341006738130979,1.0,4/27,7.78%,CPA4;EP300;KAT6B;MORF4L2
prerank,brain development (GO:0007420),-0.24413463828983423,-1.0644373291744371,0.2911392405063291,0.7526812215379788,1.0,35/136,15.58%,EPHA7;ARNT2;CNTNAP2;RAPGEF2;CDH2;ADGRL3;SHANK3;EML1;GRIN2A;AFF2;COL4A1;SYNJ2;CHD8;ROBO2;GRIN2B;CTNNA2;ZFHX2;DSCAML1;TUBGCP2;UBE3A;NES;SPEF2;NNAT;NF1;PAFAH1B2;EEF1AKMT4-ECE2;MEIS1;TBC1D23;PCDH18;NIPBL;MFSD2A;TMX2;SOX6;MEIS2;HSPG2
prerank,negative regulation of metabolic process (GO:0009892),0.3921454394438456,1.0643278356233297,0.3674698795180723,0.9349261594891779,1.0,10/54,8.88%,PLCL2;LAMA4;IL15;FOXC2;IP6K1;DOCK7;RHEB;PLCL1;LGR4;ARRDC3
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.49298208328633764,1.0642358706771224,0.3950413223140496,0.9343534464705007,1.0,3/13,7.66%,CD81;INSIG1;GCC2
prerank,mitotic recombination (GO:0006312),-0.4036657374595245,-1.064151657106395,0.36127167630057805,0.7520093302900108,1.0,10/15,27.74%,MSH3;RAD51D;RAD54B;SMC5;RAD51;ERCC1;TEP1;TPRKB;GEN1;RAD52
prerank,regulation of mRNA metabolic process (GO:1903311),0.5082164519910658,1.0637965351946381,0.4033057851239669,0.934879213422652,1.0,5/11,19.77%,SLTM;SRPK2;SRPK1;DHX9;CDK11B
prerank,histone H4 acetylation (GO:0043967),0.3922314956073867,1.0635640110226088,0.38817480719794345,0.9347479401388454,1.0,16/47,18.46%,OGT;EP300;NAA40;BEND3;HCFC1;MORF4L2;KMT2A;APBB1;ACTL6B;JADE2;ING4;MSL2;MEAF6;TRRAP;TRIM16;ATF2
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.35857448445861656,1.0635088411745648,0.37414187643020597,0.9340780690604191,1.0,12/93,10.22%,WNT16;MAP3K5;EDA2R;CCN2;ZC3H12A;PTK2B;SH3RF2;MAP3K4;TGFB2;RELL1;EMC10;ARL6IP5
prerank,translational termination (GO:0006415),0.3619623357339323,1.0629025182410332,0.38558352402745993,0.935057374087046,1.0,43/95,28.37%,MRPS16;MRPL38;MRPL24;MRPL37;MRPL2;MRPL49;MRPL33;MRPS7;MRPS34;GSPT2;MRPS23;MRPS33;MRPS27;MRPL9;MRPL57;MRPS15;MRPL50;MRPS18C;MRPS28;MRPS35;GADD45GIP1;TRMT112;MTRF1L;ETF1;MRPL19;MRPL14;MRPL32;AURKAIP1;N6AMT1;MRPL39;MRPS25;MRPS30;MRPL54;MRPS21;MRPS22;MRPS12;MRPL35;GFM2;PTCD3;MRPL44;MRPL18;MRPS6;MRPS24
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.3940276772735139,1.0623865349332655,0.3788265306122449,0.9357779921848142,1.0,12/44,20.19%,CD44;KLF4;NGF;RAF1;CARD16;AQP1;IGBP1;XIAP;TRIAP1;CDKN2D;BEX3;ARL6IP1
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.48659526251703406,1.062271410721647,0.409967845659164,0.935241346092879,1.0,3/13,11.83%,NR3C2;BMP4;CALCOCO1
prerank,positive regulation of developmental process (GO:0051094),0.3468239114586719,1.0622184529889753,0.36947368421052634,0.9345450320477248,1.0,28/164,13.17%,PHLDB2;FGFR1;NCOA3;COBL;DAG1;NIBAN2;CCN2;MCU;GDNF;PPP1R13L;BMP5;RBM19;ZBTB16;SHLD2;ESRRB;FOXD1;MUL1;BMP4;DVL3;FBXO5;MIEF2;RIF1;RAPGEF3;TRPM4;PTN;CPEB3;RREB1;MAP3K13
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.44199519332485127,-1.0620361232039275,0.3775,0.7564151471725262,1.0,2/10,4.05%,LYN;FAS
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.2553586545409099,-1.061768046331164,0.30392156862745096,0.7557308362608468,1.0,20/109,8.54%,PLCB1;PDGFRB;PLA2G4A;PIK3R1;INPP4B;PIP5K1B;INPP5D;PIP4K2A;SYNJ2;FGF2;ARF3;PLAAT3;MTMR14;MTM1;PLEKHA8;BMX;PLEKHA2;PIK3CB;PLEKHA4;PIK3R6
prerank,cellular response to oxygen-containing compound (GO:1901701),0.3331911993101794,1.061708755312404,0.3550356052899288,0.9351755106261597,1.0,51/291,14.20%,CFTR;NCOA3;MMP9;VIM;RORC;PTK7;RAP1B;ZC3H12A;WNT11;RAP1A;FAM210B;PTK2B;FOS;SESN2;WNT6;DAPK1;SH3BP4;INSIG1;LCOR;CREB1;DMTN;PXN;AANAT;TRIM41;CAPN2;ADCY6;ROMO1;WNT5B;JUN;MAPK9;LBP;SHMT1;ACTB;EZR;CARD16;AGAP3;AQP1;TLR4;RAPGEF3;PDK2;EPHA3;RHOA;WNT3;CPEB3;SBNO2;CDK2;IRAK1;MEF2C;ATP2B4;SFRP1;CHUK
prerank,carnitine shuttle (GO:0006853),0.500590451526961,1.0610323364290712,0.4065180102915952,0.9363930761085644,1.0,4/11,12.63%,PRKAA2;CPT1B;ACACA;CPT2
prerank,snRNA transcription (GO:0009301),0.37268007868734204,1.0607900153079557,0.37484885126964934,0.9362631593419587,1.0,27/70,24.81%,GTF2F1;POLR2H;NABP2;POLR2A;INTS2;RPRD2;GTF2E1;SP1;TAF5;ELL;SRRT;INTS3;POLR2C;INTS13;POLR2E;INTS6;TAF8;TBP;NABP1;SNAPC3;GTF2E2;TAF6;INTS1;CDK9;ICE1;ELL2;POLR2K
prerank,long-chain fatty acid metabolic process (GO:0001676),0.38075138667975594,1.0607776523271297,0.3916256157635468,0.9354614186880492,1.0,13/64,13.94%,ADTRP;ACOT8;ABCD1;EPHX1;ELOVL1;ALOX5;SLC27A3;ACADL;ELOVL6;ACSL3;FADS1;CPT2;LTA4H
prerank,translation (GO:0006412),0.34076207353136106,1.0607657168135056,0.35958549222797925,0.934661105889267,1.0,88/208,28.37%,MRPS16;EEF1A1;QARS1;EPRS1;MRPL24;MRPL37;MRPL2;VARS1;FARS2;HARS1;TMA7;RPS4X;MRPS7;ABCF1;RPL31;RPSA;MRPS34;LARS2;GSPT2;RPL22;AARS1;MRPS33;RPL28;SRBD1;RPS26;MRPL9;COPS5;MRPL57;EEF1D;EEF1E1;HARS2;TARS1;RPL10A;MRPS15;SARS1;SARS2;EIF4G1;YARS1;TNIP1;MRPS18C;MRPS28;RPL14;RRBP1;EEF2;RPS27A;GATB;FARSA;HBS1L;IGF2BP3;DARS2;EIF4EBP2;RPL6;FARSB;TRMT112;RPS28;ETF1;RPL41;NARS1;EEF2K;RPLP2;YARS2;RPLP1;RPL7;IGHMBP2;MRPL32;RPL21;N6AMT1;RPL26;KARS1;MRPS21;RPS27;RPS12;MRPS12;FTSJ1;RPL18;MRPL35;RPS17;GFM2;PTCD3;RPS3;LARS1;RPL22L1;MRPL18;MRPS6;RSL24D1;RPL24;EEF1A2;MRPS24
prerank,activation of phospholipase C activity (GO:0007202),0.42378818640995647,1.0604916092907435,0.3881019830028329,0.9346319403002277,1.0,4/29,11.30%,LPAR1;ANG;TXK;GNAQ
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.48907209378835226,1.0604551856673137,0.38863287250384027,0.9338822934920405,1.0,4/13,13.10%,NAPEPLD;ZBTB7B;SIX1;RREB1
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.44632496964544016,1.0602592767184966,0.4148471615720524,0.9336441595300536,1.0,5/20,15.67%,CLU;HSPA4;MKKS;HSP90AA1;PTGES3L
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.3951404425231097,1.0599395101319815,0.38552631578947366,0.9336943259959563,1.0,8/43,9.63%,CDH13;MMP9;CCL5;BMP4;MEF2D;JUN;ADAMTS1;HTR1B
prerank,histone H3-K4 methylation (GO:0051568),0.4203977785653722,1.059609756232517,0.4,0.9338455551998289,1.0,10/26,23.66%,OGT;BEND3;KMT2A;KDM6A;DYDC2;MEN1;KMT2B;CTR9;KMT2C;CXXC1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.40857653123798077,-1.0594529586143686,0.3783068783068783,0.7606715625851149,1.0,3/14,9.87%,RAPGEF2;PKIG;PRKAR2B
prerank,mitochondrial gene expression (GO:0140053),0.4019170853231411,1.0586430799009134,0.3854166666666667,0.9359518482756432,1.0,11/42,17.40%,MRPS16;FOXO3;MRPL2;HARS1;MRPS7;MRPS34;LARS2;MRPL57;MRPS15;MRPS28;GATB
prerank,positive regulation of programmed cell death (GO:0043068),0.3331815669157424,1.0580137447528037,0.36863543788187375,0.9370051757990526,1.0,70/272,20.73%,CLU;PAWR;NGEF;MAP3K5;ARHGEF17;AKAP13;TNFAIP8;PMAIP1;ARHGEF12;PRR7;NGF;PHLDA3;FOXO3;TNFRSF8;DAPK3;TIAM2;DAPK1;OLFM1;UTP11;RARG;HOXA5;ARHGEF18;BMP4;PNMA2;BAD;LATS1;TNFRSF10B;NLRP2B;JUN;PIP5KL1;ADAMTSL4;ARHGEF5;TRIO;APBB1;ARL6IP5;GNA13;GADD45B;MARK4;ANO6;HRK;SOS2;RNPS1;EEF1E1;ING4;SFRP1;BNIP3L;DNM1L;FLCN;IP6K2;ARHGEF1;FRZB;RPS27A;UBC;E2F1;ABL1;SIAH1;PLEKHG2;HDAC6;PIDD1;SLC27A4;ARHGEF6;GPER1;MTCH1;GPLD1;UBE2Z;DDX20;SOX4;PRMT2;ZBP1;APH1A
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.34031843603321077,-1.0577829316116856,0.37583892617449666,0.7636565222009774,1.0,7/24,10.12%,GHR;NOTCH1;CYP1B1;JAK2;ERBB4;OCIAD1;KIT
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.3518867297680171,1.0571564599207555,0.3790322580645161,0.9386838721160917,1.0,20/100,15.22%,CLU;OGT;TRIB2;FHIT;ZYG11B;SH3RF2;NUB1;ELOB;DDRGK1;DESI1;RBX1;SUMO2;COP1;HSPBP1;CSNK1E;PIAS1;DDA1;GSK3A;GSK3B;MDM2
prerank,regulation of synapse assembly (GO:0051963),0.3927974303653232,1.056982340185648,0.40152477763659467,0.9383261879191291,1.0,5/46,4.84%,RAB17;GPC6;PDLIM5;GPC4;PTPRD
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.3861828335357346,1.0567906580879702,0.38017565872020076,0.9380969870573992,1.0,5/48,4.59%,FGFR1;ANGPT1;JCAD;FOXC2;HSPB1
prerank,fatty acid transmembrane transport (GO:1902001),0.44570102403802714,1.0565031357580623,0.4008941877794337,0.9381472918281567,1.0,5/19,12.63%,PRKAA2;ABCD1;CPT1B;ACACA;CPT2
prerank,pharyngeal system development (GO:0060037),0.47056566642481906,1.055681378729483,0.3934169278996865,0.9397220345432009,1.0,5/15,17.75%,BMP5;BMP4;TGFB2;GATA3;BMPR1A
prerank,activation of protein kinase A activity (GO:0034199),-0.3826270599433856,-1.0549393106431575,0.391812865497076,0.7698325817908414,1.0,10/16,22.44%,ADCY5;ADCY7;ADCY1;ADCY4;PRRC1;PRKAR2B;ADCY2;PRKAR1B;ADCY3;ADCY8
prerank,carboxylic acid metabolic process (GO:0019752),-0.3107977559407065,-1.0543638184227015,0.34523809523809523,0.7698954505886045,1.0,5/33,5.08%,PLA2G4A;ST3GAL1;SLC2A1;PTGIS;CSGALNACT1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.2702215607409303,-1.0537330229319233,0.36419753086419754,0.7701287477111087,1.0,24/74,20.11%,IGF1;SH3RF1;AR;NOS3;EYA4;FAS;THBS1;BCL2;RFFL;TNFSF10;CFLAR;ARHGEF2;RIPK1;ITGA6;ITGAV;GPX1;PELI3;ICAM1;ZMYND11;RNF34;FAIM2;TRADD;TNFAIP3;SIAH2
prerank,response to endoplasmic reticulum stress (GO:0034976),0.35226807753304334,1.0534964997047471,0.383668903803132,0.9453203126720107,1.0,31/107,22.33%,CFTR;MAP3K5;SCAMP5;BBC3;TMEM117;RNF5;TMEM259;PPP1R15A;DDRGK1;TNFRSF10B;JUN;USP19;BCAP31;TMEM33;HYOU1;EIF2AK3;GSK3B;DNAJC10;CCDC47;CREB3L2;UFM1;FICD;ERP27;CDK5RAP3;FLOT1;RHBDD1;GORASP2;TMX1;PPP1R15B;SEC16A;THBS4
prerank,cellular response to metal ion (GO:0071248),0.3553168665307993,1.053481526729691,0.39035087719298245,0.9445264189425264,1.0,22/123,15.27%,CDH1;PRKAA2;DAXX;MMP9;FOS;ADD1;DMTN;ANK3;JUN;IQGAP1;MAPK9;TIGAR;AQP1;SLC41A1;CPNE2;TRPM2;MEF2C;SYT6;CHUK;HVCN1;SYT11;SYT12
prerank,regulation of response to external stimulus (GO:0032101),0.3477854464654595,1.0533216072204505,0.3809001097694841,0.9441689739571197,1.0,9/121,6.42%,CD55;AGTR1;EFNB2;GUCY2F;CAV1;CELF1;CXCR4;ALOX5;AKNA
prerank,cell projection organization (GO:0030030),0.41969593922615334,1.0531334479407817,0.3967168262653899,0.943863550648447,1.0,6/30,16.15%,PARVA;GSN;RHOQ;CDC42;RHOU;KIF17
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.4766127729314313,1.0530640498982744,0.41362916006339145,0.9432288114583461,1.0,3/14,6.26%,MMP9;CAV1;SPRED3
prerank,apoptotic mitochondrial changes (GO:0008637),0.40939578859405135,1.0528695223120605,0.3779310344827586,0.9429360517503749,1.0,5/32,10.70%,CLU;BBC3;BCL2L1;BAD;SOD2
prerank,regulation of mast cell degranulation (GO:0043304),-0.4058268922303925,-1.0524297647797582,0.4027777777777778,0.7722794598066212,1.0,8/14,27.18%,LYN;LGALS9;GAB2;CD300A;CD84;FES;FER;FGR
prerank,cellular zinc ion homeostasis (GO:0006882),-0.3374122311291222,-1.0524030229099757,0.38405797101449274,0.7708902274314614,1.0,5/26,12.48%,SLC30A10;SLC39A12;SLC39A8;SLC39A10;SLC30A1
prerank,mitochondrial translational termination (GO:0070126),0.3615753675336936,1.052208551126073,0.3927738927738928,0.9440277982725299,1.0,39/88,28.37%,MRPS16;MRPL38;MRPL24;MRPL37;MRPL2;MRPL49;MRPL33;MRPS7;MRPS34;MRPS23;MRPS33;MRPS27;MRPL9;MRPL57;MRPS15;MRPL50;MRPS18C;MRPS28;MRPS35;GADD45GIP1;MTRF1L;MRPL19;MRPL14;MRPL32;AURKAIP1;MRPL39;MRPS25;MRPS30;MRPL54;MRPS21;MRPS22;MRPS12;MRPL35;GFM2;PTCD3;MRPL44;MRPL18;MRPS6;MRPS24
prerank,positive regulation of protein processing (GO:0010954),0.45890091373561454,1.052133073628714,0.40873634945397813,0.9434162822866429,1.0,5/19,13.97%,HPN;GSN;KLKB1;LPCAT3;PLGRKT
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.4261202625370655,1.0520425081707792,0.40472673559822747,0.9428413937850412,1.0,1/24,0.14%,SORBS1
prerank,mononuclear cell differentiation (GO:1903131),-0.34757963642579237,-1.051959676652989,0.4019607843137255,0.7706227929377913,1.0,4/24,2.88%,IL31RA;LYN;GAS6;AXL
prerank,protein destabilization (GO:0031648),0.4167258299709419,1.0518399171720987,0.4147018030513176,0.9425742577515431,1.0,8/32,18.71%,GSN;EP300;MUL1;TRIM21;SERF2;MDM2;CTSH;PEX2
prerank,regulation of tissue remodeling (GO:0034103),-0.37757482475920323,-1.0511507945167706,0.39570552147239263,0.7714419350523077,1.0,6/18,16.84%,LEPR;RUNX1;IL18;TGFB1;FLT4;SUCO
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.44834328939410384,1.0509711788712277,0.40707964601769914,0.9442382427236214,1.0,8/20,16.85%,IMPDH2;PAICS;NT5C2;GMPS;AK3;GART;AMPD2;ADSS2
prerank,activation of protein kinase activity (GO:0032147),-0.2513414462181186,-1.050878246341086,0.2828282828282828,0.7707191586345495,1.0,24/106,12.51%,IGF1;GHR;INSR;ADCY5;TNIK;NRK;PAK3;WNT5A;GAS6;STK3;ADCY7;CARD10;IL18;ADCY1;ADCY4;JAK2;PRRC1;STRADA;PRKAR2B;MAP4K4;TRAF6;TIRAP;TOM1L1;TXN
prerank,regulation of amyloid-beta formation (GO:1902003),0.4051835263421911,1.050799218698741,0.3921832884097035,0.9439201841002349,1.0,7/34,13.52%,CLU;RTN1;EPHA4;RTN3;ABCA2;SP1;GSK3A
prerank,gonad development (GO:0008406),-0.29679369561340646,-1.0506887393610294,0.3574144486692015,0.7697728310025314,1.0,8/41,10.69%,NR2F2;KITLG;WNT4;AR;WNT5A;SALL1;KIT;BASP1
prerank,maintenance of blood-brain barrier (GO:0035633),0.42187792687171116,1.0505470746584749,0.39808481532147744,0.9438023227643653,1.0,8/30,10.71%,TJP2;TJP1;OCLN;GJB6;LSR;LAMC1;ACTB;ACTG1
prerank,translational elongation (GO:0006414),0.35433574064480233,1.0503427414868949,0.4034090909090909,0.9435810461028349,1.0,23/101,16.09%,MRPS16;MRPL38;EEF1A1;MRPL24;MRPL37;MRPL2;MRPL49;MRPL33;MRPS7;MRPS34;MRPS23;LTN1;MRPS33;MRPS27;MRPL9;MRPL57;EEF1D;MRPS15;MRPL50;MRPS18C;MRPS28;MRPS35;EEF2
prerank,positive regulation of cellular catabolic process (GO:0031331),0.3489554743453984,1.0501919497319272,0.39312567132116005,0.9431720740880737,1.0,31/132,15.37%,RNF152;PRKAA2;TPCN1;ZC3H12A;ABCD1;ABHD5;FOXO3;DAPK1;MTDH;ORMDL3;SH3BP4;MOV10;PFKFB2;MSN;TRIM21;BAD;MTLN;EZR;TWIST1;SNX33;VPS11;IRS2;ZSWIM8;TFEB;GSK3A;ULK1;GSK3B;FLCN;GRSF1;PLK2;HSP90AA1
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.31713433462504337,-1.0501013271665587,0.3671875,0.7700013803094913,1.0,8/32,11.59%,ADGRB3;IL1RAPL1;RAPGEF2;TNIK;HECW1;SDC2;KNDC1;CDKL5
prerank,nucleic acid-templated transcription (GO:0097659),0.38785647232409215,1.0497252383855613,0.39510939510939513,0.9437464967706728,1.0,10/42,18.69%,THRB;CREBL2;POLR2H;NKX2-8;POLR2A;PTMA;RNPS1;E2F1;POLR2C;POLR2E
prerank,regulation of isotype switching (GO:0045191),0.4831904465681673,1.0496416085406686,0.4157303370786517,0.9431934002669909,1.0,3/14,9.55%,SHLD2;PARP3;RIF1
prerank,negative regulation of viral genome replication (GO:0045071),0.3975254067851559,1.049504541400135,0.3864864864864865,0.9427625948413126,1.0,9/40,15.49%,CCL5;MAVS;SLPI;RNASEL;SRPK2;SRPK1;SETDB1;TNIP1;OAS2
prerank,cell-cell junction assembly (GO:0007043),0.37513523718473624,1.0492609867635656,0.40530759951749096,0.9426738618177791,1.0,11/63,11.75%,CLDN11;TJP1;PKP4;CTNNA1;GJB6;CD9;PATJ;PARD6B;ACTB;ACTG1;RHOA
prerank,glucose catabolic process to pyruvate (GO:0061718),0.4365136468125206,1.0492463650081314,0.41509433962264153,0.9410755526379511,1.0,8/24,16.08%,PFKP;PKM;ENO2;HK1;FOXK1;ALDOA;GAPDH;TPI1
prerank,canonical glycolysis (GO:0061621),0.4365136468125206,1.0492463650081314,0.41509433962264153,0.9410755526379511,1.0,8/24,16.08%,PFKP;PKM;ENO2;HK1;FOXK1;ALDOA;GAPDH;TPI1
prerank,protein kinase B signaling (GO:0043491),0.43757566632833217,1.0489696728731415,0.41797432239657634,0.9410776912786777,1.0,4/23,7.56%,ADTRP;CCL5;TSC2;PLK3
prerank,positive regulation of immune effector process (GO:0002699),-0.3353205799757106,-1.0489489894288557,0.36551724137931035,0.7718834343162421,1.0,5/27,9.92%,PTPRJ;LGALS9;APPL2;DDX60;CD46
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.2683217315722582,-1.0485456981710013,0.3375796178343949,0.7715675664381231,1.0,29/72,25.34%,LIFR;GAS6;AXL;IRAK2;RUNX1;IRAK3;IFNGR1;IFNGR2;IFNAR2;JAK2;CFLAR;RBCK1;RIPK1;RACK1;CD74;CDC37;VRK2;TRADD;TNFAIP3;AGPAT2;HSP90AB1;TRAF1;SPHK1;SOCS3;CYLD;SIGIRR;BIRC2;AGPAT1;PYCARD
prerank,cellular response to osmotic stress (GO:0071470),0.43198374735583844,1.0477332094027567,0.4043795620437956,0.9437144641823824,1.0,5/21,11.04%,YBX3;EPO;STK39;OXSR1;AQP1
prerank,"wound healing, spreading of cells (GO:0044319)",0.4363592873342414,1.0475709156590671,0.40512048192771083,0.9433701887070234,1.0,8/24,15.66%,CD44;TMEFF2;TOR1A;RHOA;MMP12;PDPN;DDR1;FLNA
prerank,regulation of nervous system development (GO:0051960),-0.3051840406330074,-1.047141931147559,0.3445692883895131,0.7740011254876207,1.0,14/37,22.82%,PTPRZ1;TENM4;HEYL;PRUNE1;NPHP3;TNFRSF1B;BHLHE40;SIRT2;YAP1;CX3CL1;CX3CR1;HEY2;HEY1;YTHDF2
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.332557117774471,1.0462778925874445,0.4110429447852761,0.9461817660673743,1.0,56/260,18.72%,RAB17;CDH13;CYS1;SRGAP2;ABLIM2;ACTN2;ABLIM1;PARVA;EMP2;GSN;RAP1B;RAP1A;EHD1;CNGA2;ARL3;INPP5E;CCDC28B;RAB11FIP3;AVIL;DMTN;GOLPH3;IFT46;EXOC7;CFAP54;EXOC4;PKD1;CC2D2A;IFT80;OPHN1;EZR;EXOC2;ARFIP2;ANO6;CPLANE2;CNGB1;EXOC8;ARF4;OCRL;MKKS;CCDC88A;ATP6V1D;RAP2C;ATP6V0D1;FLNA;FSCN1;TMEM138;PTPDC1;VCL;RAB8B;HDAC6;RILPL1;SHTN1;FHDC1;ARHGEF6;WDR35;GALNT11
prerank,copper ion homeostasis (GO:0055070),0.46390945905421055,1.0461569124357908,0.42990654205607476,0.9457180266190878,1.0,7/17,23.37%,COX19;SLC31A2;CCDC22;XIAP;ABCB6;APP;MT2A
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.47355670727937743,1.0460863110583631,0.4211332312404288,0.9451031012097946,1.0,5/16,23.02%,RAET1E;VAMP7;ULBP1;VAMP2;ARL8B
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.446074993854177,1.0456574684840407,0.42342342342342343,0.9455274672820646,1.0,6/20,11.91%,DGAT1;SLC25A1;ACSL3;ACACA;SCD5;FASN
prerank,RNA processing (GO:0006396),0.34150164680917966,1.045396815844838,0.39308176100628933,0.945488263832176,1.0,47/176,20.31%,MBNL1;CELF2;PPARGC1A;SRSF2;CELF1;YJU2;PPP2CA;SON;SNRPB;RNASEL;LSM4;DDX39B;RBM8A;TENT4A;XRN2;LUC7L3;SF3B3;USP39;SRPK2;SRRM4;SRSF7;DDX47;SF3A2;ZCCHC8;SRPK1;HNRNPUL1;SYNCRIP;TUT7;RNPS1;SRSF9;PABPN1;DUSP11;MAGOHB;MAGOH;CLP1;PRPF6;TSEN2;RBMS2;SRSF1;PTBP1;SRSF5;ZMAT5;CSTF3;WBP4;SF3A3;DDX20;THOC1
prerank,regulation of cell cycle phase transition (GO:1901987),0.3543981951098233,1.04522125354882,0.38646788990825687,0.9451970408472271,1.0,14/91,18.09%,FZR1;CDKN1A;PSMD11;PSMD4;PSMF1;FBXO5;PSMD7;PSMB5;ANAPC4;ATP2B4;DDB1;ERCC2;PSMD1;PSMC4
prerank,determination of bilateral symmetry (GO:0009855),-0.3431929308629598,-1.0451116524819963,0.367003367003367,0.7781220306756178,1.0,8/25,18.26%,NOTCH1;PKD2;NPHP3;ZIC3;TBX1;BBS7;DNAH11;KIF3B
prerank,organic anion transport (GO:0015711),0.361326053577389,1.0450587581837094,0.3793103448275862,0.9448884481863735,1.0,7/76,7.91%,CFTR;SLCO2A1;SLC4A2;SLC35A2;SLC16A2;CYB5RL;SLC2A8
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.42586057827407775,1.0449821555678367,0.39774330042313116,0.944299823282776,1.0,4/24,8.48%,WNT1;OCLN;AVIL;CDC42
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.41656274344146477,1.0449489322438696,0.4021887824897401,0.9436085725108166,1.0,10/30,19.01%,CAV1;PPP2CA;DMTN;SRCIN1;PTPN6;MVP;PTPN2;SFRP1;PRKCZ;SH3BP5L
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.4440348172299588,1.044521797397452,0.41389728096676737,0.9440634419859276,1.0,6/18,21.66%,ADTRP;WNK1;ASS1;DUSP3;GPNMB;MIA3
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.5040197293636626,1.0442951963396314,0.432520325203252,0.9439027301272094,1.0,2/11,12.20%,HPN;BCAR1
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.366914361078958,1.044291993850145,0.4090909090909091,0.9431051374123168,1.0,13/66,9.74%,KLF4;LSM10;CDKN1A;CDK6;FHL1;KANK2;CDK4;CCND2;PKD1;ADAMTS1;BRD7;PTPN6;CCND1
prerank,neuropeptide signaling pathway (GO:0007218),0.36957430471023167,1.0439530290947827,0.41405269761606023,0.9432689026679609,1.0,5/58,8.83%,SORCS2;GAL;PENK;CPE;HCRTR1
prerank,histone H4-K5 acetylation (GO:0043981),0.4657143100506849,1.043952522084618,0.4341692789968652,0.9416645063246563,1.0,5/15,16.02%,OGT;HCFC1;JADE2;ING4;MEAF6
prerank,histone H4-K8 acetylation (GO:0043982),0.4657143100506849,1.043952522084618,0.4341692789968652,0.9416645063246563,1.0,5/15,16.02%,OGT;HCFC1;JADE2;ING4;MEAF6
prerank,organic hydroxy compound transport (GO:0015850),-0.30898815722131023,-1.0439199036334306,0.3625,0.779938970836171,1.0,5/36,7.18%,ABCC4;SLCO2B1;SLCO1C1;NCOA1;SLC16A1
prerank,organophosphate catabolic process (GO:0046434),-0.4103420609307931,-1.0433874756351553,0.41160949868073876,0.7799549596561857,1.0,2/11,12.70%,ENPP2;ABHD12
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.3383167500898944,-1.0431927948708375,0.38408304498269896,0.7790338851746131,1.0,8/26,12.76%,NRXN1;SHANK3;SLC8A3;LRRK2;NLGN1;MTMR2;TMEM108;NLGN3
prerank,cellular response to retinoic acid (GO:0071300),0.393596638294154,1.0430968315832647,0.40341655716162944,0.9432594875008856,1.0,9/42,12.42%,PTK7;WNT11;PTK2B;WNT6;CREB1;WNT5B;AQP1;EPHA3;WNT3
prerank,positive regulation of protein acetylation (GO:1901985),0.4936922968316081,1.0430779757954247,0.408,0.9425080168192761,1.0,1/12,0.82%,PRKAA2
prerank,positive regulation of behavior (GO:0048520),-0.43708554185357895,-1.0428439690690894,0.41309823677581864,0.7785461392388757,1.0,5/10,9.37%,NLGN1;NPAS2;AGRP;SGIP1;CFAP20
prerank,error-prone translesion synthesis (GO:0042276),0.4369189578123635,1.0425675561278072,0.4107692307692308,0.9431748419349869,1.0,8/21,18.64%,REV1;POLK;RPA3;POLH;PCNA;RPS27A;UBC;RFC1
prerank,cellular response to organic substance (GO:0071310),-0.2532489970209865,-1.042258963791673,0.30434782608695654,0.7786210738661773,1.0,26/116,10.70%,PID1;GHR;LEF1;IL1RAPL1;STAT5B;IGFBP5;ACVRL1;NCOA1;CYP1B1;CLEC3B;BMPR1B;PTPN4;SLC1A1;ACVR1B;ROBO2;IL18;LRRK2;SLIT2;TGFB1;PTPN12;ACVR2A;TBK1;RPS6KB1;RAMP2;TRAF6;STAT3
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.49291890161873997,1.040841994196762,0.4154351395730706,0.9472524745345745,1.0,2/11,8.98%,ZC3H12A;FOXP3
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.3820944397164422,-1.040769953755257,0.4005235602094241,0.7812958311516133,1.0,2/14,5.53%,THBS1;IRAK3
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.2937930269980431,-1.0407669079762145,0.3776824034334764,0.7798690017323433,1.0,5/41,5.53%,IGF1;GAS6;CD34;LGALS9;IRAK3
prerank,protein-DNA complex disassembly (GO:0032986),0.4574369529080617,1.040695731554854,0.4008941877794337,0.9468925246274777,1.0,7/16,16.26%,GRWD1;SMARCB1;SMARCA4;SMARCD2;MYC;SET;SMARCC1
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.49094381721748087,1.0406605436585377,0.4350547730829421,0.9461783593018392,1.0,3/12,8.44%,PODXL;MAGI2;IQGAP1
prerank,negative regulation of binding (GO:0051100),0.35606763082080617,1.0405527965431076,0.4168618266978923,0.9457123947922027,1.0,23/81,19.05%,CFHR1;SMO;CDKN1A;GTF2F1;CAV1;SLPI;NFKBIA;CTSZ;JUN;SUMO3;ACTB;CARD16;HABP4;CSNK1E;TLE5;GSK3B;ITGB1BP1;E2F1;KDM1A;BTAF1;WAPL;PARK7;ILRUN
prerank,cellular response to interleukin-4 (GO:0071353),-0.43373650789559437,-1.0404724752068923,0.4086294416243655,0.7792953291410813,1.0,1/10,0.48%,LEF1
prerank,glycoprotein biosynthetic process (GO:0009101),0.3599451507292675,1.0401486587770195,0.4101057579318449,0.9460832571551754,1.0,17/79,14.89%,B3GALT1;ST3GAL4;CHST12;GCNT2;LARGE1;CHST11;MGAT1;NPC1;DDOST;GOLPH3;CHST13;ALG1;ST3GAL6;ALG5;SERP2;NUS1;TNIP1
prerank,regulation of defense response (GO:0031347),-0.2647188912654222,-1.039388292863112,0.38028169014084506,0.7807770872730562,1.0,18/76,11.65%,ADAMTS12;IL1R1;WNT5A;SEMA7A;NR1D2;APPL2;MGLL;PTGS2;PSMA6;ELMOD2;LRP8;BRD4;JAK2;SAMHD1;PIK3AP1;PTGES;TIRAP;CASP4
prerank,positive regulation of apoptotic process (GO:0043065),0.3272667158059892,1.039228563121076,0.3977619532044761,0.9479715150499334,1.0,65/293,17.53%,CLU;PAWR;NGEF;MAP3K5;ARHGEF17;NUPR1;AKAP13;ZC3H12A;TNFAIP8;PMAIP1;ARHGEF12;PRR7;NGF;PHLDA3;FOXO3;TNFRSF8;DAPK3;TIAM2;DAPK1;OLFM1;UTP11;RARG;HOXA5;ARHGEF18;BMP4;PNMA2;TGFB2;BAD;LATS1;TNFRSF10B;NLRP2B;JUN;PIP5KL1;ADAMTSL4;ARHGEF5;TRIO;APBB1;ARL6IP5;SRPK2;DLC1;GNA13;GADD45B;ANO6;HRK;SOS2;RNPS1;EEF1E1;PRDM11;ING4;TLE5;SFRP1;BNIP3L;DNM1L;FLCN;IP6K2;ARHGEF1;FRZB;BACE1;RPS27A;UBC;E2F1;ABL1;SIAH1;PLEKHG2;PIDD1
prerank,cytosolic transport (GO:0016482),0.3468494146966013,1.039046296350064,0.40311804008908686,0.9477121973005879,1.0,35/108,19.79%,EMP2;RAB9B;CORO7;VPS13A;LAMP1;GCC2;MAGEL2;MON2;RAB7A;LMTK2;HOOK1;GGA1;VPS54;AP2A1;VTI1B;RNF126;PHETA2;WDR91;VPS26B;VPS52;PLEKHJ1;PHETA1;STX16;SNX16;WASHC1;VPS50;TBC1D10A;ARFRP1;YKT6;TMEM87B;BET1L;HOOK3;RAB9A;VTI1A;TBC1D17
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.4154198349421434,1.0389976129866225,0.40730337078651685,0.9470313326497263,1.0,5/30,6.52%,STK19;NOTCH2;NGF;EPO;SHC1
prerank,positive regulation of MAPK cascade (GO:0043410),0.33057525436769963,1.0389894029492501,0.39858012170385393,0.9462512283677059,1.0,19/245,6.62%,ADRA1B;FGFR1;ANGPT1;CD44;LPAR1;NOTCH2;NTRK3;CCL5;JCAD;PDGFC;CCN2;GDF15;RAP1A;PTK2B;GCNT2;ACKR3;CAV2;SHC1;MYDGF
prerank,regulation of type I interferon production (GO:0032479),0.3528548871232978,1.0388705577669346,0.4134275618374558,0.9458168129157358,1.0,22/84,20.54%,IKBKE;MAVS;EP300;POLR2H;TRIM25;IRF3;MRE11;TRIM21;POLR3B;POLR1C;POLR3C;NPLOC4;IRAK1;GAPDH;DHX9;POLR3G;POLR3H;POLR2E;ILRUN;NFKB2;PCBP2;ZBP1
prerank,positive regulation of viral process (GO:0048524),0.3659504810114894,1.03861080228792,0.40763546798029554,0.9457372352220106,1.0,16/60,18.96%,CCL5;GTF2F1;POLR2H;TARBP2;POLR2A;TMEM39A;RAB7A;SRPK2;SRPK1;VPS4A;DHX9;DDB1;NELFB;POLR2C;POLR2E;NELFA
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.4685266022605496,1.0385787047313204,0.421875,0.9450411296968089,1.0,2/15,5.85%,CLU;BCL2L1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.3649386633853471,1.0381256505537524,0.3904109589041096,0.944712068865402,1.0,18/78,17.02%,DYNC1I1;KIF2A;AP2A2;SPTBN2;CAPZB;RAB7A;KLC1;AP1S3;FCER1G;AP2A1;SH3GL2;AP1M1;AP1S2;SEC23A;DYNC1LI2;AP1B1;CANX;DYNC1H1
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.3649386633853471,1.0381256505537524,0.3904109589041096,0.944712068865402,1.0,18/78,17.02%,DYNC1I1;KIF2A;AP2A2;SPTBN2;CAPZB;RAB7A;KLC1;AP1S3;FCER1G;AP2A1;SH3GL2;AP1M1;AP1S2;SEC23A;DYNC1LI2;AP1B1;CANX;DYNC1H1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.4525488097779465,1.0380212534519484,0.42511346444780634,0.9442133461842033,1.0,5/17,14.97%,NFE2L2;HSPB1;MAPK7;SOD2;VNN1
prerank,response to cholesterol (GO:0070723),0.45199905552097663,1.0379400289125422,0.41140215716486905,0.9436289673178301,1.0,5/17,12.14%,SMO;PMVK;ABCA2;OSBPL7;TGFBR2
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.44810734469369995,1.0379282536677301,0.43684992570579495,0.942871065735364,1.0,2/17,1.77%,ADTRP;EFNB2
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.34333450713984426,1.0378585483211438,0.4147665580890337,0.9422921092142434,1.0,15/121,7.63%,ANGPT1;CD44;CRLF1;CCL5;EPHA4;IL15;CD81;PTK2B;CLCF1;EPO;UNC119;EFNA5;HAX1;ERBB3;SRCIN1
prerank,pyruvate metabolic process (GO:0006090),0.3786445208615105,1.0376959903945133,0.41903584672435107,0.941984560771092,1.0,13/52,16.08%,HAGH;ME3;HKDC1;PKM;LDHB;PFKFB2;LDHAL6B;ENO2;HK1;VDAC1;ALDOA;GAPDH;TPI1
prerank,cytosolic calcium ion transport (GO:0060401),0.4183976355802756,1.0372935040753146,0.4211267605633803,0.9423373125046584,1.0,9/28,11.88%,MCU;CACNB3;MCUB;MICU1;JPH2;AFG3L2;ITPR3;MCUR1;JPH3
prerank,regulation of cell aging (GO:0090342),0.4954980347104906,1.037085583549559,0.4535073409461664,0.9421039482655046,1.0,2/11,6.11%,WNT1;FOXM1
prerank,regulation of protein phosphorylation (GO:0001932),0.3286219095222658,1.0367157673168406,0.4,0.9423186479028554,1.0,33/256,10.49%,FN1;ANGPT1;NTRK3;LIMK2;DAXX;ADTRP;MMP9;OCLN;ZC3H12A;MAVS;SESN2;PPP2CA;KDM4D;HSPB1;FBLN1;TWF1;EFNA5;KRAS;WDFY2;MYDGF;BMP4;CCND2;ILK;DVL3;FGF22;PIP5KL1;CHP1;VEGFB;PML;FKBP8;CCND1;MUSK;HDAC3
prerank,ethanol metabolic process (GO:0006067),0.48931274895773175,1.0367107584802921,0.41533546325878595,0.9415490916595006,1.0,2/12,2.95%,SULT1A1;ADH7
prerank,regulation of establishment of protein localization to telomere (GO:0070203),-0.41750388161721863,-1.0364132890935467,0.43915343915343913,0.7875051153297818,1.0,6/11,32.06%,DKC1;CCT7;CCT2;CCT4;WRAP53;CCT3
prerank,positive regulation of myelination (GO:0031643),-0.42248122604760213,-1.0363411979293105,0.40298507462686567,0.7862635241858281,1.0,6/11,25.76%,TENM4;TPPP;TNFRSF1B;MYRF;DICER1;NCMAP
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.33581582373329083,1.0360629026044452,0.416135881104034,0.9424966612277148,1.0,32/152,14.44%,SCEL;KANK1;RSPO3;PTK7;CAV1;TMEM198;RNF220;DAPK3;PPM1B;PSMD11;PSMD4;WLS;PSMF1;GPC3;ILK;WNT5B;LGR4;PPM1A;RNF146;UBE2B;ADGRA2;PRDM15;PSMD7;SMARCA4;CSNK1E;TRPM4;SPIN1;PSMB5;CAPRIN2;SFRP1;UBR5;WNK1
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.33939539283015896,1.0359715105398983,0.43263964950711936,0.9419841204500753,1.0,28/129,14.44%,SCEL;KANK1;PTK7;CAV1;TMEM198;RNF220;DAPK3;PPM1B;PSMD11;PSMD4;WLS;PSMF1;GPC3;ILK;LGR4;PPM1A;RNF146;UBE2B;ADGRA2;PRDM15;PSMD7;CSNK1E;TRPM4;PSMB5;CAPRIN2;SFRP1;UBR5;WNK1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.2888678736547503,-1.035644504601704,0.3869565217391304,0.7867582537484265,1.0,5/43,5.53%,IGF1;GAS6;CD34;LGALS9;IRAK3
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.46103594932011066,1.0354670125607937,0.4270353302611367,0.9426130516559735,1.0,6/16,23.67%,SHOC1;CENPS;RMI1;ERCC4;TOP2B;FANCM
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.41319804381378683,1.035321688766621,0.4223776223776224,0.9422520682597356,1.0,9/26,14.54%,KANK2;CRY2;SMARCA4;NCOR1;VPS11;VPS18;SFRP1;FOXP1;NCOR2
prerank,modification-dependent protein catabolic process (GO:0019941),0.33413895457772663,1.0348919199991595,0.4222689075630252,0.9426533052852258,1.0,34/193,17.30%,FZR1;FBXL7;PCYOX1;RNF43;SPSB4;RNF5;TRIM25;PSMD11;NUB1;PSMF1;FEM1C;FEM1A;KLHL15;UBE2G2;RBX1;RNF146;UBE2B;PPP1R11;RNF126;WDR91;ANAPC4;NPLOC4;UBE4A;NEDD4;UBE2H;MDM2;BFAR;UBA6;DDB1;RPS27A;UBC;SIAH1;KEAP1;STUB1
prerank,regulation of brown fat cell differentiation (GO:0090335),0.4701590689738648,1.0348234689901767,0.4071207430340557,0.9420658242686683,1.0,5/16,14.83%,NAPEPLD;ZBTB7B;SIX1;RREB1;FLCN
prerank,positive regulation of cytokine production (GO:0001819),-0.2185337450304483,-1.0346058979741384,0.375,0.7881730067137623,1.0,51/292,14.06%,PLCB1;SULF1;IL1R1;CCBE1;AFAP1L2;PDE4D;NOD1;PLA2R1;CADM1;HIF1A;WNT5A;TMED10;SLC7A5;CD34;GLMN;LGALS9;CYP1B1;RUNX1;SPTBN1;RFTN1;GBP5;IL18;PTGS2;RGCC;RORA;TGFB1;LRRFIP1;IL6R;IL33;PDE4B;TBK1;CRCP;PIK3CD;CD46;TRAF6;STAT3;MBP;TIRAP;ARHGEF2;PNP;POLR3A;RIPK1;IL6ST;DDIT3;DRD2;IL17D;POLR2F;FLT4;POU2F2;STAT6;CYRIB
prerank,regulation of interleukin-4 production (GO:0032673),-0.3532391071735419,-1.03428491063594,0.4,0.7876571608837728,1.0,3/21,4.50%,LEF1;SLC7A5;LGALS9
prerank,membrane organization (GO:0061024),0.32599982808550737,1.0342587006478496,0.409375,0.9428824878193722,1.0,54/227,18.13%,CFTR;REPS2;ANK2;LDLR;SYP;OTOF;CLTB;A4GALT;AP2A2;REEP3;NUP93;NPC1;ANK3;NSFL1C;SLC2A8;CHMP4A;CHMP4B;CHP1;IL7R;ACTB;AGFG1;TLCD2;TOR1A;TMEM33;ACTG1;VPS4B;AP2A1;LPCAT2;VTI1B;NAPA;OPA1;SH3GL2;LPCAT3;STX11;CHMP1A;OCRL;FER1L6;VPS4A;VAMP7;TOR1AIP1;CCDC88A;DNM1L;CHMP2A;REEP4;CERT1;AAK1;RPS27A;UBC;LRP2;ARPC2;PDCD6IP;STAM;SUN2;OSBPL2
prerank,mitochondrial fusion (GO:0008053),0.44733863029548593,1.0341199345166405,0.4332298136645963,0.942510156745932,1.0,8/18,21.29%,CHCHD3;AFG3L2;MIEF2;THG1L;OPA1;SPG7;STOML2;MIEF1
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.4863345995575496,1.0340546020309869,0.44426494345718903,0.9419144040986079,1.0,6/11,21.64%,ASF1A;ATRX;UBN1;IPO4;H3-3A;HAT1
prerank,blood vessel diameter maintenance (GO:0097746),0.40248837737847964,1.0339116758944946,0.4124668435013263,0.9415205293021109,1.0,1/34,0.18%,AGTR1
prerank,regulation of chromatin binding (GO:0035561),0.4978033623180709,1.0338726452402194,0.43350604490500866,0.9408774200625578,1.0,4/10,18.45%,KDM4D;HMBOX1;BTAF1;WAPL
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.31210335028169695,-1.0333159420639604,0.40816326530612246,0.7888526333497489,1.0,17/32,34.20%,ABHD3;SLC44A2;PCYT1A;LPIN2;MFSD2A;SLC44A1;STARD10;PCTP;SLC44A5;LCAT;CHAT;SLC44A3;CSNK2B;PEMT;LPIN3;CSNK2A1;CSNK2A2
prerank,membrane repolarization during action potential (GO:0086011),-0.40613153764690146,-1.0331647850387384,0.4225352112676056,0.7878098367000365,1.0,4/13,23.55%,ATP1B1;KCNJ2;KCNIP2;YWHAE
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.399418646828544,-1.0322906484166854,0.42587601078167114,0.7887687037095503,1.0,6/14,32.79%,MRNIP;FANCB;WDR48;ERCC6;WRAP53;RAD51AP1
prerank,positive regulation of fat cell differentiation (GO:0045600),0.3885990056207451,1.0322524742928914,0.41740226986128626,0.9446821098883184,1.0,12/47,14.09%,NAPEPLD;ZC3H12A;CREBL2;ZBTB16;CREB1;WDFY2;ZBTB7B;AAMDC;SIX1;TRPM4;RREB1;SFRP1
prerank,regulation of cell cycle (GO:0051726),0.32367352994169,1.0319876006295086,0.41624365482233505,0.9446517305565078,1.0,68/271,20.01%,NOTCH2;GRK5;CDKN1A;ADAM10;MAGI2;NUPR1;NEK7;CDK10;EP300;CDK6;DAPK3;PES1;PPP1R13B;PPP1R15A;SON;CDK4;DUSP1;TSC2;JUND;FOXM1;ZBTB17;HCFC1;BMP4;TRIM21;TGFB2;NLRP2B;PKD1;JUN;TCF7L2;IQGAP1;FBXO5;PML;GAS2L1;APBB1;CCND1;PCLAF;SRPK2;TBRG4;ANKRD17;GADD45B;EIF4G2;WDR6;GATA3;CHMP1A;MYC;PRDM11;ING4;SFRP1;HRAS;MDM2;MAEA;POU4F1;ABL1;LIN54;NBN;XIAP;INTS13;CAMK2N1;GADD45GIP1;RARA;KIF20B;RNF112;CDKN2D;CDK5RAP3;GPER1;RB1;CDK11B;CENPF
prerank,peptide catabolic process (GO:0043171),-0.3433225432320915,-1.0318967863517572,0.37254901960784315,0.7884246042298105,1.0,6/23,12.62%,ECE1;GGT5;ACE;TPP1;CPQ;ENPEP
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.43058540137009893,-1.0313412543918172,0.40932642487046633,0.7885312582128886,1.0,7/10,31.46%,NUDT21;CPEB1;HSF1;PAF1;NCBP1;DHX36;NCBP2
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.42119749708889165,-1.0312590341569028,0.4101876675603217,0.7873390213049243,1.0,3/12,12.09%,INSR;IRGM;IGF1R
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.31544902568550637,-1.0310319288790293,0.4043321299638989,0.7865459449044591,1.0,5/31,9.11%,ENG;ZFPM2;NOTCH1;TGFB1;FGFR2
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.31302311865717464,-1.0308067329531483,0.37218045112781956,0.7857064333816862,1.0,11/31,28.86%,PLCB1;LGALS9;TIRAP;HMGB1;CD40;HSPD1;MAPK14;CCL19;RIPK2;MAPK11;PLCG2
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.32199875426901536,-1.030783555808572,0.3902439024390244,0.7843780739327251,1.0,8/29,10.70%,GHR;IL31RA;STAT5B;PKD2;IFNAR2;JAK2;STAT5A;STAT3
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.4135842257216285,1.0305568627426103,0.40368271954674223,0.9479019241071076,1.0,3/27,8.53%,AGTR1;NFKBIA;MAPK9
prerank,sterol metabolic process (GO:0016125),0.36611208273978657,1.0301506889187504,0.41656210790464243,0.9482494792168489,1.0,12/60,8.94%,SOAT1;STARD3;SULT2B1;DHCR7;HMGCR;INSIG1;PMVK;CYP39A1;CYP51A1;MSMO1;FDX1;SOAT2
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.4113628480021305,1.02998727027205,0.4177215189873418,0.9479420899832868,1.0,10/28,20.33%,EPHA4;YTHDF1;AKAP5;PTN;GSK3B;RELN;ABL1;EIF2AK4;APP;AGER
prerank,protein autoprocessing (GO:0016540),-0.37238394371918565,-1.0299825367936972,0.3816568047337278,0.7851619819943293,1.0,7/17,22.35%,FAM111A;CASP4;CTSL;FXN;MYRF;HTRA2;SPRTN
prerank,macromolecule catabolic process (GO:0009057),-0.33541612162953405,-1.0298884674364035,0.4204946996466431,0.7840172052158881,1.0,16/26,36.18%,SNX25;TGFB1;SH3GLB1;TPP1;MVB12A;CLPX;USE1;SMURF1;CLN6;CLN8;TRIM24;PPT1;UCHL3;CAPN3;BECN1;LGMN
prerank,nuclear envelope organization (GO:0006998),0.43099403580024875,1.0298254112882956,0.4233687405159332,0.9475928126160594,1.0,7/20,17.81%,REEP3;NUP93;TOR1A;VPS4A;TOR1AIP1;REEP4;SUN2
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.4484755603655265,1.0297539834860088,0.42272727272727273,0.9469940307844665,1.0,4/16,11.26%,ERLIN2;ACADL;ERLIN1;NCOR1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.37776977190613337,1.0295060919519676,0.43908629441624364,0.9468723734249501,1.0,15/53,16.50%,DDX5;EYA2;PMAIP1;NSMCE4A;SPRED3;EYA1;TIGAR;ABRAXAS1;FXR1;MYC;EEF1E1;DHX9;PCNA;UBE2N;ATR
prerank,synaptic vesicle endocytosis (GO:0048488),-0.3172471179344946,-1.0294560498775753,0.38076923076923075,0.7837734082480333,1.0,10/33,14.77%,DNAJC6;DNM3;SYNJ2;SYT1;NLGN1;ITSN2;STON2;NLGN3;AMPH;FCHO2
prerank,lymphocyte chemotaxis (GO:0048247),-0.3135699132111631,-1.029068766538786,0.4279835390946502,0.7833550287071334,1.0,15/34,32.57%,CYP7B1;GAS6;SLC12A2;CXCL16;PIK3CD;CCL13;CX3CL1;GPR183;CCL19;ADAM8;HSD3B7;PIK3CG;CCL2;CXCL10;CCL14
prerank,regulation of lipid storage (GO:0010883),0.44296986828226576,1.0287772302216769,0.4407027818448023,0.9480797674753993,1.0,8/22,23.90%,ZC3H12A;IKBKE;NFKBIA;PTPN2;HILPDA;FBXW7;FTO;IL6
prerank,COPII-coated vesicle budding (GO:0090114),0.3602185389415514,1.0279744897088925,0.4216725559481743,0.9495005187970043,1.0,24/68,23.84%,F5;PEF1;PPP6R3;TFG;CTSZ;TRAPPC9;TRAPPC1;MCFD2;NAPA;PREB;RAB1B;CNIH1;SEC23A;ANKRD28;NSF;SEC23IP;SEC24B;SEC31B;MIA3;SEC16A;SEC31A;VAPA;GRIA1;SEC24D
prerank,RNA interference (GO:0016246),0.4592019197428717,1.0278003823936979,0.4341906202723147,0.9492033581141841,1.0,5/17,16.63%,CELF1;TARBP2;TSNAX;DHX9;CLP1
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.3984317967270648,-1.0273322920644008,0.4128686327077748,0.786574471011122,1.0,3/13,3.43%,SLC8A1;PDE4D;CAMK2D
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.4385017942921951,1.0271687663076077,0.4316860465116279,0.9501260011663288,1.0,7/21,11.62%,MCU;MCUB;MICU1;AFG3L2;BCAP31;MCUR1;LETM1
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.3364916227523965,1.0266625329855887,0.42701525054466233,0.9507334370564312,1.0,37/140,17.31%,SRGAP3;SRGAP2;ARAP1;NGEF;ARHGEF17;ARHGAP18;AKAP13;ARHGEF12;ARAP2;TIAM2;RHOQ;FOXM1;ARHGEF18;ARHGAP29;ARHGAP21;ARHGAP10;CDC42;BCR;ARHGEF5;OPHN1;TRIO;DLC1;GNA13;RHOA;RABL3;SOS2;INPP5B;OCRL;ARHGAP31;RHOU;FLCN;ARHGDIB;ARHGEF1;TAGAP;RELN;ARHGAP33;PLEKHG2
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.4842003500195964,1.0266572525864195,0.45145631067961167,0.9499702870323694,1.0,3/11,9.39%,DDX5;BMP4;MAP2K2
prerank,cation transport (GO:0006812),0.3333599936725378,1.0262460687853139,0.4468980021030494,0.950356737329878,1.0,24/167,13.38%,FGF13;TRPM3;SLC36A3;SCN3A;ATP1A2;TRPM8;SLC66A1;KCNJ13;ABCC8;SLC36A4;CNGB3;SLC22A18;CHP1;KCNA4;TRPM6;SLC7A6;AQP1;TRPM4;PKD2L1;SLC41A1;ANO6;KCNA5;CNGB1;TRPM2
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.2928228067960769,-1.0261505177238468,0.4247787610619469,0.788428978561878,1.0,8/40,10.92%,SLC7A11;SLC13A3;SLC7A5;SLC16A1;SLC7A7;SLC16A7;SLC38A11;SLC38A9
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.45847189935264665,1.025940763146499,0.45085803432137284,0.950432859578132,1.0,3/16,13.52%,PLCB3;KLK1;GSK3A
prerank,protein autophosphorylation (GO:0046777),-0.23291886297186815,-1.0259387068926533,0.4426229508196721,0.7876285767226294,1.0,33/157,13.62%,FLT1;PDGFRB;PRKD1;TEK;INSR;TNIK;LYN;PTK2;CAMK2D;PDGFRA;CAMK4;KDR;SIK1;WNK2;CDK12;ACVR1B;LRRK2;EPHB4;BMX;NTRK2;JAK2;ERBB4;DAPK2;FGFR2;KIT;STK17B;CDKL5;IGF1R;RIPK1;NEK6;FGFR4;FLT4;CAMK2A
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.39588563914460384,1.0258854834993492,0.4238845144356955,0.9498196740684276,1.0,5/36,9.20%,OGT;FHIT;DDRGK1;PSMF1;OPHN1
prerank,glucan catabolic process (GO:0009251),0.4605307382585267,1.0257481951365792,0.44178628389154706,0.9494149613483174,1.0,4/15,10.99%,MGAM;PHKA2;PGM2;PHKB
prerank,cellular response to insulin stimulus (GO:0032869),0.33882623845343296,1.025626980350278,0.43078626799557035,0.9489689614642253,1.0,33/124,20.40%,SORBS1;ATP6V1B1;CPEB2;GAB1;HDAC5;EPRS1;FOXC2;RHOQ;CAV2;INSIG1;PKM;SHC1;AP3S1;MYO5A;PDK2;IRS2;BCAR1;PTPN2;GSK3A;GSK3B;ATP6V1E1;ATP6V1D;ATP6V0D1;RAB8B;ATP6V1B2;PCK2;SLC27A4;IDE;GPLD1;ATP6V0B;USF1;ATP6AP1;RAB10
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.39610159978636866,1.0254851882122915,0.4155124653739612,0.9486067025289103,1.0,4/32,3.88%,KLF4;JCAD;HDAC5;FOXC2
prerank,error-free translesion synthesis (GO:0070987),0.430675250143661,1.0253304499962854,0.4362017804154303,0.9482361730504004,1.0,11/22,27.14%,REV1;NPLOC4;RPA3;POLH;PCNA;RPS27A;UBC;RFC1;RCHY1;RPA2;POLD1
prerank,organic acid transport (GO:0015849),0.3417369134676598,1.0252208911081415,0.4199772985244041,0.9477986517686934,1.0,11/94,13.16%,SLC7A14;SLC10A5;SLC27A3;SLC3A1;SLC25A47;SLC7A6;SLC1A4;SLC25A45;SLC25A17;PDPN;SLC25A14
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.4020643782119532,1.0250202271729374,0.44105409153952846,0.9475781221588992,1.0,6/33,8.41%,ANGPT1;NUPR1;NFE2L2;MAPK7;KRIT1;TCF7L2
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.43442738090156996,1.0249361277253914,0.4442793462109955,0.9470446340719291,1.0,8/20,19.72%,NIBAN2;EP300;DDRGK1;TWIST1;GATA3;POU4F1;PARK7;RB1
prerank,phosphorylation (GO:0016310),0.3178188792190626,1.024892746120612,0.44120603015075377,0.9464092606415347,1.0,97/385,20.02%,PRKCB;FGFR1;STK19;PRKAA2;LIMK2;FAM20C;PRAG1;NRBP2;MAP3K5;TRIB2;GRK5;ADAM10;TSSK6;TSSK4;WNT11;IKBKE;NEK7;CDK10;CDK6;MKNK2;PTK2B;SGK3;DAPK3;DAPK1;CDKL2;CDK4;ROS1;AGK;CREB1;RNASEL;STK39;SIK3;CSK;NADK;TGFB2;CDK16;ILK;LATS1;DYRK1B;OXSR1;MAPK9;AURKC;PI4KA;BCR;LMTK2;TXK;HK1;SRPK2;CDKL4;DGKA;GRK2;PDK2;CSNK1E;JAK1;YWHAZ;MARK4;TGFBR2;EIF2AK3;CDK18;SRPK1;MAP3K13;CDK2;GSK3A;IRAK1;CHUK;ULK1;GSK3B;WNK1;CDC42BPA;PLK2;AAK1;PAK6;PRKCZ;ABL1;PRKAG1;MAP3K6;MAPK6;CDC25B;EIF2AK4;MAPKAPK2;CHEK2;BMPR1A;PEAK1;RSKR;RARA;STK38L;STK24;ROCK2;TAOK3;PRKD2;APP;PNKP;MAP3K1;CDK11B;PRKAB1;TBCK;CDC42BPG
prerank,intracellular lipid transport (GO:0032365),0.4317753540233643,1.0248568105799465,0.45007451564828616,0.9457388211419526,1.0,6/21,15.82%,PRKAA2;ABCD1;CPT1B;ACACA;CPT2;CERT1
prerank,hippo signaling (GO:0035329),0.4182437961357733,1.0247994863093195,0.43847241867043846,0.9451135432049174,1.0,4/26,8.93%,TJP2;TJP1;LATS1;YWHAB
prerank,natural killer cell mediated immunity (GO:0002228),0.46123048082899976,1.0246264238565368,0.43146417445482865,0.9448448207995538,1.0,1/15,1.91%,RAET1E
prerank,cellular protein metabolic process (GO:0044267),0.3227544947160517,1.024604816694758,0.4271356783919598,0.9441380584124713,1.0,89/396,19.53%,FN1;MSLN;IGFBP6;F5;FAM20C;PRSS23;ADAM10;PENK;MRPS16;EEF1A1;MRPL24;MRPL37;SFTPC;SERPINC1;TIMP1;WWP2;RNF5;DENND3;HARS1;RPS4X;DUSP12;ANO8;MRPS7;PHKA2;BMP4;CPE;TGM5;GPC3;MSRB2;AFG3L2;UBE2G2;ABCF1;LAMC1;FDX1;MANBA;RPL31;RPSA;GSPT2;RPL22;LAMB2;MRPS33;SPCS3;RPL28;CALU;SRBD1;RPS26;MRPL9;COPS5;ST3GAL6;NAPSA;CP;LGALS1;HARS2;RPL10A;LTA4H;MRPS15;SARS1;EIF4G1;NTAQ1;DNAJC3;TNIP1;MRPS18C;PRKCSH;RPL14;RRBP1;CTSH;HM13;RPS27A;ABL1;UBE2D3;SEC11A;CHEK2;FBXL2;RPN2;SPPL3;USP25;HBS1L;IGF2BP3;YES1;SPG7;GALNT11;EIF4EBP2;RPL6;FARSB;IDE;APP;SFTPA1;SFTPA2;ADAM17
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.43729896942703805,1.0243010596099564,0.44411326378539495,0.9442055411038043,1.0,11/21,18.79%,DAPK3;EFNA5;PTPRA;ACTG1;EPHA3;RHOA;VCL;SLC9A1;DUSP3;PEAK1;ROCK2
prerank,DNA integrity checkpoint signaling (GO:0031570),0.3943955711181696,1.024125274677853,0.4524765729585007,0.9439342046395224,1.0,11/36,17.48%,DOT1L;HUS1B;DONSON;USP28;CDC5L;PRPF19;ATR;E2F1;HINFP;NBN;CHEK2
prerank,cellular copper ion homeostasis (GO:0006878),0.4773329462744523,1.023984424182666,0.46485623003194887,0.943566722217858,1.0,6/14,23.37%,COX19;SLC31A2;CCDC22;ABCB6;APP;MT2A
prerank,mitotic cytokinetic process (GO:1902410),0.4429896196884733,1.0239660514442503,0.43902439024390244,0.9428696402784608,1.0,12/20,26.58%,CHMP4A;CHMP4B;VPS4B;RHOA;CHMP1A;VPS4A;CHMP2A;PDCD6IP;MITD1;KLHDC8B;CHMP5;CHMP1B
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.35340022966615975,1.0239241549606353,0.4169653524492234,0.9422310564298204,1.0,7/73,7.62%,EGLN3;COL4A3;BBC3;NGF;MUL1;BAD;TNFRSF10B
prerank,regulation of muscle contraction (GO:0006937),0.4240959385008315,1.0238335577725575,0.4490934449093445,0.941718513708956,1.0,3/26,3.76%,CAV1;ATP1A2;DAPK3
prerank,regulation of mRNA stability (GO:0043488),0.3333210413151582,1.023516427612789,0.4316469321851453,0.9418210289782402,1.0,36/145,19.44%,VIM;SAMD4A;YTHDF1;SAMD4B;CELF1;TNFSF13;GDNF;HSPB1;PSMD11;PSMD4;PSMF1;EXOSC3;YWHAB;PSMD7;TBRG4;YWHAZ;PSMB5;FXR1;CARHSP1;DCP1A;TNPO1;SET;EIF4G1;PAIP1;MEX3D;RPS27A;UBC;E2F1;MAPKAPK2;PSMD1;PSMC4;IGF2BP3;YTHDF3;ROCK2;IGF2BP2;PSMD8
prerank,protein modification by small protein conjugation (GO:0032446),0.3193304880107093,1.0234897596695562,0.4342105263157895,0.9411426851613384,1.0,116/361,25.46%,RNF152;FBXL7;TRIM60;FBXW8;TRIM33;CAND2;RNF43;RNF220;SPSB4;NFE2L2;WWP2;MOCS3;TRIM44;NUB1;ELOB;RNF138;NUP93;KLHL21;DDRGK1;MUL1;EYA1;CBLL1;TRIM41;TRIM21;UBE2G2;RBX1;DCUN1D5;NDC1;SDE2;SUMO2;SUMO3;TRIM47;TRIM26;TRIM11;UBE2B;RNF182;PCNP;KLHL24;SAE1;TRPM4;DCUN1D1;VPS11;KLHL13;NSMCE2;MIB2;ZSWIM8;PIAS1;PIAS3;DTX3;VPS18;BRAP;NEDD4;UBE2H;MDM2;PCNA;UBE2N;CCDC22;MSL2;FBXL15;UFM1;UBA6;DDB1;CAND1;RPS27A;UBC;CUL9;DTX2;UBE2D3;KEAP1;STUB1;UBE2F;FBXL2;AAAS;PDZRN3;OTULIN;RAE1;PEX2;CDK5RAP3;RNF41;UBE2Z;ASB5;FBXO9;CHFR;VHL;FBXW7;CUL2;TRIM5;UBE2E1;RCHY1;ARIH2;POM121;SMURF2;RNF168;DET1;TPR;RNF213;CTR9;RNF14;RNF7;CDC23;URM1;RANBP2;LEO1;FBXO4;NUP42;GAN;ATG3;UBA7;TMEM129;RANGAP1;UBE2M;NUP62;FBH1;TRIM39;TSPAN17;SEH1L
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.33894923947382255,-1.022910652183431,0.4266666666666667,0.7944208699576066,1.0,8/24,11.38%,PTPRJ;PIK3R1;TEK;KDR;TSC1;ROCK1;MAP4K4;MYOC
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.37339215678681237,1.0228415996937883,0.4307496823379924,0.9421558434628354,1.0,8/52,11.34%,SORBS1;STAC3;PTPN9;LGALS3;ACSL3;AKAP5;CNPY4;EPHA3
prerank,mitochondrial translational elongation (GO:0070125),0.3512973131313739,1.0226752845806335,0.43676814988290397,0.9418831209127633,1.0,38/88,28.37%,MRPS16;MRPL38;MRPL24;MRPL37;MRPL2;MRPL49;MRPL33;MRPS7;MRPS34;MRPS23;MRPS33;MRPS27;MRPL9;MRPL57;MRPS15;MRPL50;MRPS18C;MRPS28;MRPS35;GADD45GIP1;MRPL19;MRPL14;MRPL32;AURKAIP1;MRPL39;MRPS25;MRPS30;MRPL54;MRPS21;MRPS22;MRPS12;MRPL35;GFM2;PTCD3;MRPL44;MRPL18;MRPS6;MRPS24
prerank,positive regulation of cellular respiration (GO:1901857),0.48068975729676633,1.022248400626212,0.434991974317817,0.9422849680102373,1.0,1/11,2.39%,NUPR1
prerank,ESCRT III complex disassembly (GO:1904903),0.4944401323063488,1.022138091936012,0.44336569579288027,0.9410762752878366,1.0,7/10,26.58%,VPS4B;CHMP1A;VPS4A;CHMP2A;IST1;CHMP5;CHMP1B
prerank,ESCRT complex disassembly (GO:1904896),0.4944401323063488,1.022138091936012,0.44336569579288027,0.9410762752878366,1.0,7/10,26.58%,VPS4B;CHMP1A;VPS4A;CHMP2A;IST1;CHMP5;CHMP1B
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.4875841495141628,1.0220161647797497,0.45234248788368336,0.9406573289721342,1.0,2/11,9.98%,RNF5;TOR1A
prerank,exit from mitosis (GO:0010458),-0.40644593938127616,-1.021980042381314,0.4196185286103542,0.7956171449634345,1.0,5/12,16.69%,CLASP2;EPS8;UBE2S;CTDP1;CHMP7
prerank,positive regulation of cellular component organization (GO:0051130),-0.24248688694122492,-1.021913550460749,0.3894736842105263,0.7944235607999076,1.0,29/107,16.12%,FRMPD4;INSR;NRXN1;DAB2;SHANK3;ASAP1;AR;SLF1;RUNX1;DAB2IP;FNIP1;TFRC;TGFB1;SH3GLB1;TIRAP;TPPP;BCL2L11;IGF1R;BID;RACK1;HYAL1;BMF;SLF2;SURF4;FNIP2;CDC42EP2;BAX;GPX1;GNL3L
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.32889008383257584,1.0218684975359174,0.44742489270386265,0.9403094110830651,1.0,36/149,19.55%,PRKCB;CLU;EDA2R;EDA;CAV1;EP300;TRIM25;MTDH;FLOT2;NFKBIA;DDRGK1;TRIM21;TAB3;RAB7B;TLR6;CARD16;TLR4;MAP3K13;IRAK1;CHUK;DHX9;IKBKG;RNF31;UBE2N;RPS27A;UBC;PRKCZ;PIDD1;TAB2;TRIM37;PRKCQ;PRKD2;NFKB2;APP;FLOT1;ZBTB7A
prerank,regulation of protein targeting to membrane (GO:0090313),0.41368173096751043,1.0217231155741675,0.4345991561181435,0.9399699466149881,1.0,9/28,15.65%,DMTN;ANK3;CHP1;MIEF2;MYO1C;KCNB1;HRAS;ITGB1BP1;ITGB2
prerank,zinc ion homeostasis (GO:0055069),-0.32141326355721067,-1.0214643321844252,0.4444444444444444,0.7942578558489939,1.0,5/28,12.48%,SLC30A10;SLC39A12;SLC39A8;SLC39A10;SLC30A1
prerank,cardiac atrium morphogenesis (GO:0003209),0.45251619035487867,1.0212906671152922,0.43423137876386686,0.9403958662986003,1.0,2/16,7.38%,NOTCH2;TGFB2
prerank,neuron projection regeneration (GO:0031102),-0.4230398958249608,-1.0211543099608587,0.42,0.7936611387648215,1.0,4/10,15.60%,NREP;MAPK8IP3;DHFR;MTR
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.3483902540679572,-1.0210342054595918,0.4179566563467492,0.7926160825959911,1.0,5/20,12.08%,PLOD2;GATM;PTDSS1;PLSCR1;CNDP2
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.48106228125147776,1.0209663687040527,0.46141732283464565,0.9405324500271028,1.0,3/12,14.16%,KLF4;TLR4;FOXP1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.35160236648512266,1.0207710096739,0.4119047619047619,0.9403189186520913,1.0,17/76,17.30%,ANGPT1;ZC3H12A;CAV1;HDAC4;MUL1;CENPS;DCUN1D5;HDAC3;HSPBP1;SAE1;DCUN1D1;PIAS1;PIAS3;GSK3A;TNIP1;XIAP;STUB1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.2963414959141745,-1.0205555682808292,0.41732283464566927,0.7925610259340695,1.0,6/33,7.53%,PLCB1;RDX;UBE2E2;RGCC;GLI1;EZH2
prerank,development of primary male sexual characteristics (GO:0046546),-0.3052607774888066,-1.0204476928038548,0.4151624548736462,0.7914452303432871,1.0,5/34,2.84%,KITLG;WNT4;AR;WNT5A;LHFPL2
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.4192926460710383,-1.0198423241141308,0.4271604938271605,0.7916474289333715,1.0,3/11,11.44%,LYN;MFHAS1;TIRAP
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.4269004543739533,-1.0197960024486923,0.43658536585365854,0.790425701431179,1.0,1/10,0.68%,TGFA
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.4403483089539989,1.019775665942997,0.44377811094452774,0.9422877041997183,1.0,8/19,20.64%,FBXW8;PTPRD;CAPRIN2;SS18L2;RELN;SS18L1;CAMK2B;DBN1
prerank,ceramide metabolic process (GO:0006672),0.3807649179320186,1.0196690943423183,0.4389937106918239,0.9418606811212186,1.0,5/49,5.85%,SPTSSB;SGMS2;PPP2CA;ORMDL3;AGK
prerank,immunoglobulin mediated immune response (GO:0016064),0.49819589702148154,1.019303439250404,0.45648604269293924,0.9421167437954253,1.0,2/10,11.64%,CD81;FCER1G
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.42846919510719933,1.0189343644169722,0.46153846153846156,0.9423747576754496,1.0,1/21,0.23%,FGF13
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.4342969068345699,1.01886853771776,0.45180722891566266,0.9418018951628393,1.0,2/20,2.81%,SEMA3D;SEMA3B
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.41219826776330315,1.018616718857575,0.44428772919605075,0.9417483745603729,1.0,4/26,7.16%,ST3GAL4;SCCPDH;LARGE1;GOLPH3
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.48938453792273373,1.018328143383074,0.4444444444444444,0.9418211144500958,1.0,3/10,13.95%,PFKP;HK1;GFPT1
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.378976452702792,1.0180302528582577,0.43924050632911393,0.9418929564346266,1.0,4/39,2.90%,TSPAN5;WNT1;ELF3;EP300
prerank,regulation of axon guidance (GO:1902667),0.48592979721896307,1.0179808851436754,0.4546952224052718,0.9412862876213431,1.0,3/10,13.79%,YTHDF1;ZSWIM8;TUBB2B
prerank,regulation of ATP metabolic process (GO:1903578),0.36733449694077197,1.0176683231287127,0.44106463878326996,0.9413662563228542,1.0,10/54,9.89%,OGT;ABCD1;EP300;BEND3;NUP93;EIF6;NDC1;JMJD8;ATP5IF1;COX7A2L
prerank,ventricular septum development (GO:0003281),-0.30005987374924054,-1.01759708669679,0.421875,0.7951065735617485,1.0,15/37,22.26%,ZFPM2;ROBO1;NOTCH1;ROBO2;SALL1;SLIT2;HEYL;PDE2A;SLIT3;BMPR2;SOX11;SMAD4;HEY2;APLNR;HEY1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.4395570712403829,1.017509727506765,0.42857142857142855,0.94105626374822,1.0,9/17,29.98%,MUTYH;ERCC5;MBD4;NEIL1;TERF2;TINF2;TERF1;TERF2IP;TDG
prerank,cellular glucose homeostasis (GO:0001678),-0.28930946249941025,-1.0174507912983515,0.42342342342342343,0.7941403255427729,1.0,12/41,12.35%,PIK3R1;UNC13B;ZBTB20;HIF1A;GAS6;FOXO1;FOXK2;PRKAA1;HK2;LRRC8A;IGF1R;RACK1
prerank,regulation of monooxygenase activity (GO:0032768),-0.33369737488213913,-1.0167184553586828,0.41414141414141414,0.7946196556881211,1.0,7/23,12.79%,POR;NOS3;NOSTRIN;NOS1AP;NOSIP;CYGB;SPR
prerank,megakaryocyte differentiation (GO:0030219),-0.4098600976905284,-1.016688558527785,0.44923857868020306,0.7933169448182766,1.0,6/11,40.44%,SH2B3;KIT;TAL1;CDKN2B;IL11;THPO
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.39329423101782607,-1.0166086366714522,0.4301369863013699,0.7921554284570435,1.0,3/13,12.79%,NOS3;GCH1;SPR
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.3957373640121515,-1.016500961435614,0.42780748663101603,0.791090635388522,1.0,2/13,2.50%,PID1;NOS3
prerank,stress granule assembly (GO:0034063),0.43373527408102375,1.016357349913854,0.4523809523809524,0.9435007809939757,1.0,7/20,20.09%,YTHDF1;PRRC2C;ATXN2L;DYNC1H1;UBAP2L;YTHDF3;MAPT
prerank,cellular response to glucagon stimulus (GO:0071377),-0.36580563727325643,-1.0158593993708585,0.45294117647058824,0.7914636035371593,1.0,10/17,22.44%,ADCY5;ADCY7;ADCY1;ADCY4;PRKAR2B;CYSLTR2;ADCY2;PRKAR1B;ADCY3;ADCY8
prerank,snRNA metabolic process (GO:0016073),0.44638457312512403,1.0155728026143283,0.4525316455696203,0.944918868373365,1.0,8/17,22.45%,INTS2;MTREX;ZCCHC8;MEPCE;INTS3;INTS6;TUT1;INTS1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.45623483952104216,1.015340506253614,0.4494047619047619,0.9448032223993366,1.0,3/16,12.57%,ZC3H12A;MOV10;CPEB3
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.3602738014613898,1.0150024800288358,0.42839951865222625,0.9434574303617588,1.0,17/61,19.07%,F5;PEF1;PPP6R3;TFG;CTSZ;TRAPPC9;TRAPPC1;MCFD2;NAPA;PREB;RAB1B;CNIH1;SEC23A;ANKRD28;NSF;SEC23IP;SEC24B
prerank,COPII vesicle coating (GO:0048208),0.3602738014613898,1.0150024800288358,0.42839951865222625,0.9434574303617588,1.0,17/61,19.07%,F5;PEF1;PPP6R3;TFG;CTSZ;TRAPPC9;TRAPPC1;MCFD2;NAPA;PREB;RAB1B;CNIH1;SEC23A;ANKRD28;NSF;SEC23IP;SEC24B
prerank,vesicle coating (GO:0006901),0.3602738014613898,1.0150024800288358,0.42839951865222625,0.9434574303617588,1.0,17/61,19.07%,F5;PEF1;PPP6R3;TFG;CTSZ;TRAPPC9;TRAPPC1;MCFD2;NAPA;PREB;RAB1B;CNIH1;SEC23A;ANKRD28;NSF;SEC23IP;SEC24B
prerank,positive regulation of dendrite extension (GO:1903861),-0.3684615040214312,-1.0149502461218831,0.4246987951807229,0.7926688349532706,1.0,10/17,36.55%,SYT1;ITSN2;SMURF1;RIMS1;CPNE9;RNF157;CPNE5;RASAL1;SYT17;SYT4
prerank,amino acid transmembrane transport (GO:0003333),-0.28382780590720036,-1.014687309868349,0.40611353711790393,0.7920681956081922,1.0,8/45,10.92%,SLC7A11;SLC6A13;SLC47A1;SLC7A5;SLC6A6;SLC7A7;SLC38A11;SLC38A9
prerank,sensory organ development (GO:0007423),0.36640032367746844,1.0145674215448417,0.41975308641975306,0.9439104651034952,1.0,4/51,3.16%,PBX3;PBX1;WNT10A;STRA6
prerank,negative regulation of vascular permeability (GO:0043116),-0.40899019126893443,-1.0139875923116075,0.47733333333333333,0.7926687280078728,1.0,6/12,9.95%,PTPRJ;PDE3A;CLDN5;SLIT2;RAMP2;PDE2A
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.33269574153137876,-1.013916071019811,0.42388059701492536,0.7915028171922864,1.0,7/21,10.43%,ADCY5;GUCY1B1;ADCY7;GUCY1A1;ADCY1;ADCY4;NPR1
prerank,amyloid precursor protein catabolic process (GO:0042987),0.46197860506883326,1.0138537900563405,0.450920245398773,0.9450933294457693,1.0,6/14,23.98%,ADAM10;BACE1;ADAM17;ABCA7;APH1A;PSEN1
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.43669501348721806,1.0137300263723317,0.4604519774011299,0.9446740011449559,1.0,4/20,6.12%,CDK6;PTK2B;ZBTB16;HOXA5
prerank,negative regulation of protein catabolic process (GO:0042177),0.3899431965054059,1.0135232079371364,0.44823066841415465,0.9444948431419011,1.0,10/40,12.16%,TIMP4;TIMP1;HMGCR;SNRNP70;TIMP2;AZIN1;CYP51A1;BANP;SF3B3;SNX12
prerank,RNA 3'-end processing (GO:0031123),0.3574146913008659,1.0133879839296531,0.4423305588585018,0.9441285298852136,1.0,24/69,21.00%,SRSF2;EIF4A3;DDX39B;RBM8A;TENT4A;WDR33;RPRD2;SRSF7;POLDIP3;THOC7;TUT7;RNPS1;CSTF1;SRSF9;UPF3B;PABPN1;MAGOHB;MAGOH;CLP1;SRSF1;SRSF5;CSTF3;THOC1;TUT1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.460606778866528,1.013380108814723,0.4628482972136223,0.9434044629021369,1.0,4/14,11.67%,ABCD1;MTLN;TWIST1;IRS2
prerank,calcium ion transmembrane transport (GO:0070588),0.3485994372283688,1.013035757136991,0.44280860702151753,0.9436241984197642,1.0,20/86,14.06%,TRPM3;CACNA1A;NALCN;TRPM8;MCU;CACNB3;MCUB;PMPCA;CACNA2D4;TMEM165;MICU1;AFG3L2;PKD1;TRPM6;MCUR1;TRPM4;LETM1;ANO6;TRPM2;ATP2B4
prerank,heart contraction (GO:0060047),0.38259058356701925,1.0130338900464562,0.44036697247706424,0.9428908340379711,1.0,4/41,3.66%,SGCG;SGCD;ATP1A2;CSRP3
prerank,positive regulation of viral genome replication (GO:0045070),0.3966065431141467,1.0128205313545082,0.4271708683473389,0.9427515943975339,1.0,13/29,28.53%,CCL5;TARBP2;TMEM39A;SRPK2;SRPK1;DDB1;TOP2B;PABPC1;PPID;PDE12;PPIE;LARP1;DDX3X
prerank,renal system development (GO:0072001),0.36951128721740023,1.0127171460326632,0.4602203182374541,0.9422792775600508,1.0,8/52,8.24%,AGTR1;STRA6;PYGO2;ARL3;BMP4;TGFB2;SIX1;PKD1
prerank,cellular polysaccharide catabolic process (GO:0044247),0.4463035795009672,1.0126088465782357,0.4489795918367347,0.9418508658781294,1.0,4/16,10.99%,MGAM;PHKA2;PGM2;PHKB
prerank,regulation of astrocyte differentiation (GO:0048710),0.47142215082439515,1.0125440125942387,0.4576547231270358,0.941283692363507,1.0,2/12,4.18%,EPHA4;CLCF1
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.408162296751177,1.011994769966083,0.45755968169761274,0.9420220703496566,1.0,14/33,24.25%,PPP6R3;MRE11;GAR1;CDK2;PINX1;ANKRD28;HSP90AA1;RAD50;RFC1;TERF2;PTGES3;SHQ1;TINF2;ZBTB48
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.3504320177002493,1.0119285327782648,0.4268440145102781,0.9414702567563015,1.0,28/71,21.78%,ADAMTS7;PMAIP1;ATE1;ZYG11B;CTSZ;OTUD7B;CAPN2;CHMP4B;VPS4B;RNF123;VPS4A;SOCS6;MDM2;PRPF19;CTSH;HM13;DDB1;RPS27A;UBC;STUB1;HDAC6;PDCD6IP;RNF41;IDE;RHBDD1;CHFR;CTSK;LONP1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.3545345022339816,1.0118168253738602,0.4412770809578107,0.9410507158431024,1.0,18/79,17.02%,DYNC1I1;KIF2A;AP2A2;SPTBN2;CAPZB;RAB7A;KLC1;AP1S3;FCER1G;AP2A1;SH3GL2;AP1M1;AP1S2;SEC23A;DYNC1LI2;AP1B1;CANX;DYNC1H1
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.3946271201050145,-1.0117505006985312,0.4427083333333333,0.7959628128531752,1.0,6/13,20.53%,RCL1;UTP20;NOP9;RPS21;TBL3;KRI1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.38287687284739363,1.0117343935726586,0.4583333333333333,0.9405304575589938,1.0,12/39,15.63%,WNT1;KANK1;GCNT2;FBLN1;EFNA5;DMTN;CASK;ADAM15;RHOA;RASA1;ITGB1BP1;ACTN4
prerank,regulation of angiogenesis (GO:0045765),0.3235601616070626,1.0110949765877757,0.44723092998955066,0.9415034735043778,1.0,29/192,11.18%,PRKCB;ADAM12;ITGB8;KLF4;ANXA3;COL4A3;EMP2;NIBAN2;GLUL;NINJ1;ZC3H12A;GAB1;HSPB1;MTDH;ALOX5;HOXA5;AGGF1;MYDGF;TGFB2;KRIT1;VEGFB;ADAMTS1;PML;EMC10;ADGRA2;SYNJ2BP;TWIST1;AQP1;RAPGEF3
prerank,inorganic cation transmembrane transport (GO:0098662),0.31667765820941984,1.0110273105249328,0.46303901437371664,0.9409591336466567,1.0,39/268,15.07%,SLC9A2;SLC9A4;TRPM3;SLC36A3;ATP6V1B1;ASIC5;SCN3A;HPN;CACNA1A;NALCN;ATP1A2;TRPM8;CACNA2D4;TMEM165;ABCC8;SLC39A3;PKD1;SLC39A6;KCNA4;TRPM6;SLC9A7;SLC9A6;KCNB1;TRPM4;PKD2L1;SLC41A1;ANO6;KCNA5;SLC25A14;TRPM2;SLC39A13;KCNQ5;SLC6A7;TMEM175;ATP2B4;SLC25A27;SLC30A6;HVCN1;SLC9A8
prerank,ureteric bud development (GO:0001657),0.43857366811468435,1.0106219810701298,0.4421052631578947,0.941341911544275,1.0,5/17,12.03%,WNT11;BMP4;GPC3;SIX1;NPNT
prerank,fatty acid biosynthetic process (GO:0006633),0.3596794350791187,1.0103052093209184,0.4405339805825243,0.9415166319044165,1.0,13/63,13.94%,ABCD1;OLAH;ELOVL1;ALOX5;ELOVL6;ACSM3;HACD4;FADS1;NDUFAB1;ACSF3;ACACA;SCD5;LTA4H
prerank,multivesicular body organization (GO:0036257),0.3989458308645209,1.010183486072842,0.45081967213114754,0.9411181203071781,1.0,13/31,20.09%,VPS37B;CHMP4A;CHMP4B;VPS4B;CHMP1A;VPS4A;CHMP2A;PDCD6IP;STAM;TSG101;RAB27A;VPS37A;IST1
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.42244702231686443,1.0101257752113155,0.43615494978479197,0.9405467083391902,1.0,3/23,7.30%,RAET1E;LAMP1;PVR
prerank,fat cell differentiation (GO:0045444),0.3607537406120739,1.0099235194577578,0.4638922888616891,0.9403481429563073,1.0,6/57,8.41%,KLF4;PPARGC1A;SMAD6;EP300;WNT5B;TCF7L2
prerank,phosphatidylserine metabolic process (GO:0006658),-0.30703993103161026,-1.0097317957085716,0.43006993006993005,0.7999322077003329,1.0,6/32,6.00%,PLA2G4A;OSBPL10;MBOAT1;PLA1A;PTDSS1;PLAAT3
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.48037662653486657,1.0096594628842377,0.44939965694682676,0.9403216041141903,1.0,1/10,0.76%,CHRM1
prerank,response to histamine (GO:0034776),-0.4133319715540116,-1.0096087678434542,0.43349753694581283,0.7989135480092431,1.0,6/10,22.04%,GABRB1;GABRG2;DRD2;GABRB2;HRH1;GABRB3
prerank,L-serine metabolic process (GO:0006563),0.48462787194796025,1.0094873936392426,0.4521880064829822,0.9400701337413574,1.0,3/10,9.12%,SERINC5;PHGDH;SHMT1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.4270495408648378,1.009411194666838,0.4744744744744745,0.9395378597205124,1.0,5/18,17.36%,COX19;COX16;COX20;COA8;SMIM20
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.41590824859052605,-1.0093800695085446,0.43112244897959184,0.7982102261885416,1.0,4/10,20.54%,SMARCD3;DRD2;CX3CL1;CX3CR1
prerank,axoneme assembly (GO:0035082),0.3934012268756691,1.0091626889531293,0.44959128065395093,0.939467839885327,1.0,2/31,8.13%,RP1;CFAP206
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.45427395132775794,1.0091348096956008,0.45592705167173253,0.9388113016279755,1.0,6/15,16.60%,USP46;ZDHHC12;NPS;STXBP1;NLGN2;SYN3
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.31910019296939945,1.0091247384817477,0.4923702950152594,0.9381147144106086,1.0,72/306,19.16%,THRB;ST3GAL4;MRPS16;FEN1;GRWD1;EEF1A1;MRPL24;MRPL37;CREBL2;LARGE1;RECQL4;POLR2H;HARS1;RPS4X;NKX2-8;MRPS7;POLR2A;MRE11;GOLPH3;PTMS;REV1;ABCF1;RPL31;RPSA;GSPT2;RPL22;EXT1;PCLAF;MRPS33;PTMA;RMI1;RPL28;SRBD1;TOPBP1;RPS26;EIF4G2;MRPL9;COPS5;EEF1D;CDK2;RNPS1;ING4;RPA3;HARS2;RPL10A;MRPS15;SET;SARS1;EIF4G1;DONSON;TNIP1;POLD2;MCM8;MRPS18C;RPL14;RRBP1;EEF2;MCM6;ATR;RPS27A;E2F1;NBN;MCM7;POLR2C;RAD50;HBS1L;IGF2BP3;NT5M;POLR2E;EIF4EBP2;RPL6;FARSB
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.4118122366210978,-1.0087071570818642,0.44607843137254904,0.7985741291144657,1.0,5/11,25.33%,GRK3;ARRB1;ADM;SAG;ARRB2
prerank,neurotrophin signaling pathway (GO:0038179),0.4191411977329259,1.0086422536944775,0.46008708272859217,0.9386734559861616,1.0,10/21,23.94%,MAGI2;RAP1A;NGF;ZFYVE27;BCAR1;RAPGEF1;KIDINS220;CASP3;SOS1;FRS2
prerank,L-amino acid transport (GO:0015807),0.4022453176253331,1.0083986169567702,0.4599728629579376,0.9386202532673876,1.0,8/28,15.33%,SLC36A3;CTNS;SLC36A4;SFXN1;ARL6IP5;SLC1A4;SLC25A12;SLC7A3
prerank,regulation of JUN kinase activity (GO:0043506),0.3920756692680543,1.0082607069887637,0.4574898785425101,0.938269785483406,1.0,6/33,9.18%,MAP3K5;DUSP10;MAP3K4;DVL3;ARHGEF5;TLR6
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.4208979760086866,1.0077912975609797,0.48104956268221577,0.9387839244894928,1.0,7/22,18.96%,DDX5;PMAIP1;SPRED3;EEF1E1;ATR;HEXIM1;CDK5RAP3
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.32311082408263503,1.0076286010051916,0.47101449275362317,0.9385292965473389,1.0,54/182,22.01%,NOTCH2;ITGB8;PRKAA2;KLF4;LDLR;SMO;ADAM10;OCLN;ZC3H12A;CELF1;WWP2;OLFM1;FLOT2;OVOL2;MOV10;DDRGK1;BMP4;RBMS3;TGFB2;MAP2K2;SMCR8;SNX12;SFMBT2;ZNF148;SH3GL2;MEF2C;TLE5;ATP2B4;SFRP1;FOXP1;HRAS;SETDB1;FLCN;TET1;RIN3;LRP3;POU4F1;HINFP;BMPR1A;PARK7;ROCK2;GPER1;APP;RB1;MAPT;SLC2A10;TERF2;VHL;WDR54;YY1;FBXW7;AP1AR;DLG4;PGR
prerank,mesonephric tubule development (GO:0072164),0.4484736058877079,1.0075093617612978,0.4549689440993789,0.9381259672584427,1.0,5/15,12.03%,WNT11;BMP4;SIX1;PKD1;NPNT
prerank,regulation of response to cytokine stimulus (GO:0060759),0.423656778873517,1.0074732342981612,0.47032640949554894,0.9375213409498804,1.0,6/19,15.31%,KLF4;MAVS;MAPK7;IRAK1;TLE5;DHX9
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.4950560361024563,1.0074253884622626,0.4639344262295082,0.936929725997143,1.0,2/10,6.89%,EPHA4;ANXA2
prerank,regulation of cell development (GO:0060284),0.38523419970256,1.0073899266644442,0.44399460188933876,0.9363080535252691,1.0,5/36,12.42%,NOTCH2;DOCK7;RHEB;ADGRA2;WNT3
prerank,regulation of neuron migration (GO:2001222),0.40384600936741155,1.0073350018207277,0.4524822695035461,0.935739386989335,1.0,2/26,0.86%,PHACTR1;SRGAP2
prerank,response to copper ion (GO:0046688),0.4357436580662273,1.0070346822573846,0.46971935007385524,0.9357973429420604,1.0,1/20,0.93%,DAXX
prerank,response to interferon-beta (GO:0035456),-0.34137263114784355,-1.0064599515849815,0.44891640866873067,0.8033315894947981,1.0,11/22,26.70%,XAF1;AIM2;IFNAR2;IFITM3;PLSCR1;IRGM;SHFL;HTRA2;BST2;TRIM6;IFITM1
prerank,positive regulation of defense response to virus by host (GO:0002230),0.41478300652441075,1.0063853020220057,0.47430249632892807,0.9367984090267463,1.0,3/24,5.02%,ZC3H12A;MAVS;TRIM44
prerank,glutamine family amino acid metabolic process (GO:0009064),0.38695329433302134,1.0062006271458563,0.45013123359580054,0.9365648998443582,1.0,12/33,26.31%,GLUL;DDAH2;GLUD1;PYCR3;PRODH;DGLUCY;KYAT1;ALDH18A1;SIRT4;PYCR2;DDAH1;ALDH5A1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.3560400355820513,-1.0059626758639353,0.43352601156069365,0.8032364638029759,1.0,2/17,0.77%,PDGFRB;ITGA1
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.3470975269008848,1.0058620285319635,0.4827188940092166,0.9367567438569562,1.0,28/80,19.79%,RAB9B;SNX8;GCC2;MAGEL2;RAB7A;RAB7B;GGA1;VPS54;SGSM2;VTI1B;RNF126;SNX12;PHETA2;VPS26B;VPS52;PLEKHJ1;PHETA1;STX16;WASHC1;VPS50;TBC1D10A;ARFRP1;YKT6;TMEM87B;BET1L;RAB9A;VTI1A;TBC1D17
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.23850795163243996,-1.0055880979016174,0.41284403669724773,0.802890049211092,1.0,16/112,7.44%,SOX5;COL1A2;PDE3A;ENG;WNT4;CLDN5;ZMIZ1;WWOX;PTK2;WNT5A;ACVRL1;CLEC3B;APPL2;ID1;TGFB1;CRKL
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.4127223366247815,1.0042672778471022,0.45942028985507244,0.9402472494753176,1.0,2/24,2.81%,SEMA3D;SEMA3B
prerank,negative regulation of DNA replication (GO:0008156),0.4617586772729861,1.0040131358969837,0.4664429530201342,0.940234728194854,1.0,6/13,28.66%,S100A11;ATR;WAPL;GTPBP4;TERF1;CDC6
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.3641552699151734,-1.0038462615215324,0.4341317365269461,0.8060272333166851,1.0,6/16,27.60%,SOX5;NUDT21;SOX6;SP7;DHX36;RBM24
prerank,membrane depolarization during action potential (GO:0086010),-0.3129991291546766,-1.0038119316143308,0.46258503401360546,0.804768068246782,1.0,8/26,15.43%,CACNA1C;SLC8A1;SCN7A;KCNJ2;CACNA1G;HCN2;SCN1A;SCN1B
prerank,regulation of urine volume (GO:0035809),-0.4129978577579338,-1.0035615805388618,0.45390070921985815,0.8041330166672673,1.0,5/10,27.62%,NPR3;NPR1;ADM;HYAL2;HAS2
prerank,lysosome organization (GO:0007040),-0.3005000644857295,-1.0031306508722095,0.45660377358490567,0.8039897421249481,1.0,11/36,17.80%,ABCA1;CLVS2;LRRK2;GAA;TPP1;SNAPIN;LAMTOR1;CLN3;TMEM106B;VPS33A;CLVS1
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.3372414625158528,-1.0029766017887487,0.46,0.8030831233445255,1.0,9/24,18.58%,ERRFI1;PRKCH;RUNX1;ROCK1;HOXA7;CTSL;SGPP1;ZFP36;NME2
prerank,potassium ion transmembrane transport (GO:0071805),0.3260262523494478,1.002747702273016,0.45217391304347826,0.9428662509451264,1.0,17/135,14.03%,SLC9A2;SLC9A4;HPN;SLC12A8;NALCN;ATP1A2;KCNJ13;ABCC8;KCNA4;SLC9A7;SLC9A6;KCNB1;PKD2L1;SLC12A4;KCNA5;KCNQ5;TMEM175
prerank,protein deubiquitination (GO:0016579),0.31392010279969396,1.0026971935903801,0.478844169246646,0.9422810672609622,1.0,72/242,24.42%,CFTR;OGT;MINDY2;ZC3H12A;EP300;USP46;USP29;OTUD1;NFKBIA;PSMD11;USP10;USP32;OTUD7B;HCFC1;PSMD4;PSMF1;DESI2;USP19;ACTB;USP20;ENY2;USP24;PSMD7;USP42;USP3;RHOA;RNF123;COPS5;ABRAXAS1;TOMM20;FOXK1;MYSM1;PSMB5;GATA3;MYC;TNIP1;MDM2;IKBKG;USP28;RPS27A;UBC;OTUD6B;KEAP1;TRRAP;PSMD1;USP25;STAM;OTULIN;PSMC4;USP16;USP21;TAF9B;PSMD8;INO80D;USP22;INO80C;USP2;YY1;USP11;INO80E;SMURF2;WDR20;MDM4;PSMA7;TADA3;USP13;TFPT;MBD6;BIRC3;CDC25A;STAM2;USP34
prerank,positive regulation of endothelial cell migration (GO:0010595),0.34281268098178624,1.0026888899958402,0.4648711943793911,0.9415903569766008,1.0,19/84,14.84%,FGFR1;ANGPT1;ANXA3;ZC3H12A;GFUS;PTK2B;FOXC2;HSPB1;BMP4;EMC10;NRP2;BCAS3;BCAR1;SP1;GATA3;FOXP1;NUS1;AAMP;ITGB1BP1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.32673352024796143,1.002234853895561,0.4753410283315845,0.9420635828220544,1.0,11/151,4.60%,ANGPT1;CD44;NOTCH2;NTRK3;CCL5;PDGFC;CCN2;RAP1A;PTK2B;GCNT2;ACKR3
prerank,negative regulation of interleukin-6 production (GO:0032715),0.40795584494963955,1.0013130486065052,0.47109826589595377,0.943773683686908,1.0,6/27,15.26%,CD200;ZC3H12A;PTPN6;TLR4;CD200R1;SYT11
prerank,response to interleukin-1 (GO:0070555),-0.2552911671639949,-1.000863078955534,0.4294478527607362,0.8073733444821856,1.0,9/73,5.53%,ADAMTS12;IL1R1;CD47;HIF1A;PTGIS;IRAK2;LGALS9;DAB2IP;IRAK3
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.258611752762977,-1.0007511392699349,0.4110429447852761,0.8063101721736584,1.0,20/63,20.74%,IGF1;SH3RF1;SP100;WWOX;AR;FAS;THBS1;DEPTOR;TNFSF10;CFLAR;RIPK1;BID;ITGA6;ITGAV;PELI3;ZMYND11;TRADD;SIAH2;TNFSF12;TRAF1
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.4567280130831122,1.000378152209474,0.4682274247491639,0.9455664422258636,1.0,1/12,0.55%,THRB
prerank,negative regulation of interleukin-10 production (GO:0032693),0.4399224728791581,1.0000888249619375,0.45481927710843373,0.945614233250151,1.0,2/16,8.98%,TRIB2;FOXP3
prerank,production of siRNA involved in RNA interference (GO:0030422),0.48992906559113036,0.999914664937279,0.478476821192053,0.9453192855073972,1.0,2/10,7.97%,TARBP2;TSNAX
prerank,regulation of protein ubiquitination (GO:0031396),0.3272008012395998,0.999828554711847,0.48180815876515987,0.9448375379185432,1.0,27/108,22.26%,ANGPT1;DAXX;NXN;OGT;CAV1;PRR7;SH3RF2;CENPS;CHP1;HDAC3;HSPBP1;DCUN1D1;GSK3A;PINX1;WASHC1;HSP90AA1;UBE2N;XIAP;STUB1;PARK7;CDK5RAP3;PHF23;SOX4;FBXW7;SPOPL;RCHY1;SIRT7
prerank,vesicle organization (GO:0016050),0.3688565937861321,0.999793508062471,0.47066326530612246,0.9442208461262303,1.0,13/46,13.88%,ANXA8;ANXA8L1;CAV1;CAV2;SRGN;HOOK1;SNX33;VPS11;PHETA2;EXOC8;VPS18;PLEKHJ1;PHETA1
prerank,regulation of presynapse assembly (GO:1905606),0.43757287693659586,0.9997470654009982,0.4490106544901065,0.9429150629727934,1.0,7/18,19.37%,GPC6;GPC4;PTPRD;IL1RAPL2;EIF4G1;MDGA1;APP
prerank,regulation of presynapse organization (GO:0099174),0.43757287693659586,0.9997470654009982,0.4490106544901065,0.9429150629727934,1.0,7/18,19.37%,GPC6;GPC4;PTPRD;IL1RAPL2;EIF4G1;MDGA1;APP
prerank,cellular response to hormone stimulus (GO:0032870),0.3433265502539905,0.9996983372160554,0.45639187574671447,0.9423354118033197,1.0,6/69,4.95%,THRB;ADTRP;NCOA3;CAV1;ATP1A2;RAMP1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.3541348863021175,-0.9993824470921434,0.46226415094339623,0.8085997068851166,1.0,5/19,9.87%,BMP6;NEXMIF;NOTCH1;RGCC;NOTCH4
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.3091936252738404,-0.9993516160591543,0.4357142857142857,0.8073458001717089,1.0,12/28,20.57%,CLASP2;MAP2;MAP1B;STMN2;PRUNE1;GBA2;STMN3;CAMSAP2;MAP1A;FKBP4;STMN4;MAPRE1
prerank,negative regulation of protein binding (GO:0032091),0.3450889179548364,0.999236999509442,0.4536702767749699,0.9428966910442564,1.0,14/71,14.84%,CFHR1;CDKN1A;GTF2F1;CAV1;SLPI;CTSZ;PTPRF;ACTB;CARD16;ADAM15;CSNK1E;TLE5;GSK3B;ITGB1BP1
prerank,microtubule polymerization (GO:0046785),0.3991480850288098,0.9990758521007042,0.4783861671469741,0.9426016095783823,1.0,2/29,2.87%,FGF13;NDEL1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.47038933533108407,0.999009235322071,0.4864864864864865,0.9420643081039997,1.0,3/11,14.16%,TGFB2;TGFBR2;TGFBR3
prerank,nuclear export (GO:0051168),0.3473479430865778,0.9983390817800459,0.4766355140186916,0.9431547248835151,1.0,29/80,23.23%,RANBP3L;SRSF2;EIF4A3;DESI1;PKD1;DDX39B;CHP1;RBM8A;SRSF7;POLDIP3;THOC7;RNPS1;SRSF9;UPF3B;MAGOHB;MAGOH;RITA1;WASHC4;CSE1L;SRSF1;RAE1;SRSF5;XPO4;THOC1;RANBP3;POM121;U2AF1;TPR;SRRM1
prerank,substrate-dependent cell migration (GO:0006929),-0.38471671983602884,-0.9978243089351396,0.4563953488372093,0.8101176152848045,1.0,5/14,19.69%,VEGFC;ITGA11;ANKS1A;EPHA8;P2RY12
prerank,regulation of vasculature development (GO:1901342),-0.3244735744824913,-0.9977182740724103,0.4607142857142857,0.8090552474128796,1.0,7/26,13.51%,SP100;BMPER;FGF2;TSPAN12;NF1;EGLN1;RNH1
prerank,protein localization to cilium (GO:0061512),-0.3083461135679709,-0.99733890997494,0.44609665427509293,0.8088101255301157,1.0,13/32,19.18%,IFT122;TTC21B;TULP3;RAB29;TCTN1;ZNF423;INVS;WDR19;BBS1;CSNK1D;TCTN2;NPHP4;BBS4
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.3534043438200735,-0.9972166779037547,0.4470588235294118,0.807815371559352,1.0,9/20,22.26%,ENG;ACVRL1;TBX3;NOTCH1;HEYL;PDCD4;SPRY1;HEY2;HEY1
prerank,sensory perception of mechanical stimulus (GO:0050954),0.33801028501285885,0.9971583100792655,0.4668192219679634,0.945535774107204,1.0,10/85,6.89%,ATP6V1B1;USP53;COL4A3;EPS8L2;TIMM10;HOMER2;TPRN;RIPOR2;EML2;EYA1
prerank,regulation of cholesterol storage (GO:0010885),0.44318345602816644,0.9971327044671155,0.473015873015873,0.9448908650370507,1.0,3/15,3.69%,SREBF2;TTC39B;EHD1
prerank,nuclear pore complex assembly (GO:0051292),0.47539167667992166,0.9971253699947167,0.45307443365695793,0.9442084445433347,1.0,2/10,8.96%,NUP93;NDC1
prerank,protein O-linked mannosylation (GO:0035269),0.4274433002208393,0.9963536701935807,0.45440729483282677,0.9454640568512904,1.0,3/18,4.29%,B4GAT1;TMTC1;LARGE1
prerank,positive regulation of integrin activation (GO:0033625),0.47931566016532684,0.9961192883199991,0.4900332225913621,0.9453621590952745,1.0,1/11,2.26%,RAP1B
prerank,positive regulation of cell projection organization (GO:0031346),0.3317850040625914,0.9958815455371275,0.47433035714285715,0.9452663187234123,1.0,17/115,7.81%,NTRK3;FBXW8;PLXNB1;PTK7;PLXNA2;MAGI2;EP300;RAP1A;NGF;PTK2B;TIAM2;MAP6;PTPRD;TWF1;AVIL;DVL3;ARSB
prerank,positive regulation of JUN kinase activity (GO:0043507),0.4117432762980968,0.9957901009336699,0.47067238912732473,0.9447877701548707,1.0,5/23,9.18%,MAP3K5;MAP3K4;DVL3;ARHGEF5;TLR6
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.46351028430133057,0.9953592004067521,0.48031496062992124,0.9451871077339586,1.0,4/12,19.21%,TLR6;ZNF205;TLR4;RAB27A
prerank,positive regulation of innate immune response (GO:0045089),0.3975260834521082,0.9951487736336933,0.4676753782668501,0.9450393139689724,1.0,8/30,15.83%,CCL5;MAVS;POLR3B;LBP;NMI;POLR3C;DHX9;POLR3G
prerank,calcium ion homeostasis (GO:0055074),0.3369532635414745,0.9948877574375374,0.4814398200224972,0.9450146562025245,1.0,11/95,8.09%,ANK2;ATP6V1B1;STIM2;CCL5;CAV1;CSRP3;SELENON;ATP13A3;TMEM165;JPH2;ATP13A4
prerank,negative regulation of developmental process (GO:0051093),0.34984247914706185,0.9947374945581478,0.4845605700712589,0.9447098161024147,1.0,9/69,7.02%,WNT1;KANK1;WNT11;CDK6;FOXM1;MUL1;BMP4;KLF7;PARP3
prerank,cellular response to nitrogen compound (GO:1901699),0.4238564238138318,0.9944357175349354,0.4675324675324675,0.944823607254466,1.0,7/20,23.79%,DAXX;ATRX;ATP2B4;ROCK2;DDI2;EPG5;RTF2
prerank,regulation of immune response (GO:0050776),0.3292730575275135,0.9941335152876929,0.5043196544276458,0.9449203388931371,1.0,9/135,7.38%,CXADR;RAET1E;CD200;IL15;ITGB7;CD81;CSK;PVR;TGFB2
prerank,long-chain fatty acid transport (GO:0015909),0.38876721384639185,0.9941070776216089,0.4679399727148704,0.9442779398182217,1.0,6/30,12.63%,PRKAA2;ABCD1;CPT1B;ACSL3;ACACA;CPT2
prerank,positive regulation of embryonic development (GO:0040019),0.4222309318073817,0.9939114844869043,0.4657534246575342,0.9441307401141422,1.0,3/19,4.23%,WNT1;NIBAN2;RBM19
prerank,homocysteine metabolic process (GO:0050667),-0.40620289952390565,-0.9939107073579805,0.4755784061696658,0.8153494517971258,1.0,7/11,43.28%,NOX4;MTHFR;CTH;MMUT;CBS;DPEP1;TST
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.32068440611056925,-0.9931122175378979,0.45017182130584193,0.8161604365841367,1.0,2/24,1.46%,PID1;DAB2
prerank,lung epithelium development (GO:0060428),0.4900160105743292,0.993010330817573,0.4886731391585761,0.9457284753293028,1.0,4/10,8.89%,STRA6;BMP4;PKD1;GRHL2
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.3593580384062434,0.9929066749401793,0.4706601466992665,0.9445823687827933,1.0,19/56,23.39%,NDUFV1;NDUFB11;NDUFB8;NDUFB6;NDUFS3;NDUFAB1;NDUFB7;NDUFV2;NDUFA1;NDUFB4;NDUFAF4;NDUFB5;NDUFB9;DMAC2;NDUFA2;NDUFA12;TMEM126A;NDUFAF5;NDUFB10
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.3593580384062434,0.9929066749401793,0.4706601466992665,0.9445823687827933,1.0,19/56,23.39%,NDUFV1;NDUFB11;NDUFB8;NDUFB6;NDUFS3;NDUFAB1;NDUFB7;NDUFV2;NDUFA1;NDUFB4;NDUFAF4;NDUFB5;NDUFB9;DMAC2;NDUFA2;NDUFA12;TMEM126A;NDUFAF5;NDUFB10
prerank,regulation of autophagosome maturation (GO:1901096),0.4403720321461477,0.99270836781214,0.48083067092651754,0.9444032081807806,1.0,5/13,20.14%,TMEM39A;RUBCN;SMCR8;UVRAG;PHF23
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.31277312391723755,-0.9923452461668788,0.47547169811320755,0.8167654127599538,1.0,14/29,32.28%,UTP6;NGDN;UTP20;RRP36;NOP9;RPS21;DHX37;TBL3;KRI1;WDR46;NOL10;ABT1;MRPS11;HELB
prerank,peptidyl-lysine acetylation (GO:0018394),0.4798456085825817,0.9919444246727186,0.46808510638297873,0.9457695480354439,1.0,1/10,2.90%,EP300
prerank,positive regulation of ruffle assembly (GO:1900029),0.46414420762003133,0.9918912658869288,0.48925619834710743,0.9452064904062653,1.0,4/13,14.36%,EPS8L2;NDEL1;PLEKHM1;HRAS
prerank,regulation of histone acetylation (GO:0035065),0.38880444537165976,0.9918280159227202,0.48324022346368717,0.9446945986418479,1.0,8/33,14.83%,PPARGC1A;HDAC5;FOXP3;KMT2A;BRD7;RAPGEF3;SET;FLCN
prerank,negative regulation of gene expression (GO:0010629),0.31107429582250656,0.9917493090257967,0.499496475327291,0.9442067870381143,1.0,57/302,14.83%,NOTCH2;ITGB8;PRKAA2;KLF4;SMO;ADAM10;OCLN;SAMD4A;ZC3H12A;TWSG1;SAMD4B;CELF1;EPRS1;DAPK3;DAPK1;WWP2;OLFM1;FLOT2;OVOL2;PHF1;MOV10;DDRGK1;EIF4A3;BMP4;RBMS3;TGFB2;SRGN;LGR4;FOXP3;SHMT1;MAP2K2;DNMT3A;SMCR8;PPP1R11;NCOR1;AEBP2;RPS26;SNX12;SFMBT2;EIF2AK3;ZNF148;CPEB3;SH3GL2;SYNCRIP;PPM1D;FXR1;BTG2;MEF2C;TLE5;ATP2B4;SFRP1;FOXP1;HRAS;GAPDH;NCOR2;SETDB1;FLCN
prerank,DNA metabolic process (GO:0006259),0.3135063923598749,0.9913076344050583,0.5061224489795918,0.9446288131102322,1.0,74/270,22.45%,NT5E;FEN1;RECQL4;DOT1L;SMARCB1;NABP2;ASF1A;NSMCE4A;MRE11;PARP3;DCTPP1;CENPS;INIP;RAD54L;TCF7L2;POLK;RIF1;UBE2B;MUTYH;POLG;DNASE1L2;SRPK2;POLE4;USP3;CSNK1E;HUS1B;TOPBP1;ERCC5;CDK2;MBD4;PWWP3A;BTG2;RPA3;DNASE1L1;REXO4;POLH;ENDOV;POLD2;MCM8;PRIM2;PCNA;FAN1;UBE2N;LIG3;DDB1;MCM6;ATR;RPS27A;UBC;HINFP;NEIL1;NBN;MCM7;INTS3;TRRAP;PARG;RAD50;PARP2;PARK7;RFC1;PNKP;UVRAG;ERCC4;NABP1;ORC2;TERF2;TOP2B;MCM4;PTGES3;LONP1;DDX23;MEN1;SIRT7;IGHMBP2
prerank,regulation of translation (GO:0006417),0.32161856955595625,0.9908727514201826,0.5042462845010616,0.9450436685682392,1.0,47/173,20.71%,VIM;SAMD4A;YTHDF1;SAMD4B;EPRS1;FOXO3;DAPK3;DAPK1;HSPB1;RPS4X;EIF2B2;EIF4A3;UPF3A;EIF6;EIF4B;SHMT1;LTN1;POLDIP3;EIF4G2;EIF2AK3;CPEB3;SYNCRIP;PLXNB2;FXR1;BTG2;UPF3B;EIF4G1;PYM1;GAPDH;PAIP1;DHX9;EIF5B;EIF3B;EEF2;EIF1;EIF2B4;EIF2AK4;CTIF;EIF4A2;IGF2BP3;YTHDF3;IGF2BP2;APP;ETF1;SOX4;IGF2BP1;ZCCHC4
prerank,regulation of actomyosin structure organization (GO:0110020),0.4691241249267479,0.990562848978068,0.4697986577181208,0.9451524100435393,1.0,7/13,18.79%,AKAP13;CDC42;ACTG1;ASAP3;SLC9A1;FHOD1;ROCK2
prerank,regulation of fatty acid oxidation (GO:0046320),0.43280422226196297,0.9904238849042938,0.4857142857142857,0.9448088842687263,1.0,3/16,7.48%,PPARGC1A;ABCD1;ACADL
prerank,microtubule bundle formation (GO:0001578),0.372473287171892,0.9901298906934842,0.49107142857142855,0.9448900378886783,1.0,6/42,12.06%,RP1;CFAP206;PSRC1;CHP1;GAS2L1;MARK4
prerank,hematopoietic stem cell differentiation (GO:0060218),0.4824424627575489,0.9896587048155897,0.4924114671163575,0.9454225192381209,1.0,3/10,14.09%,MLLT3;LMBR1L;SFRP1
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.386421178543346,0.9889965956139558,0.49115646258503404,0.9463901079433237,1.0,14/30,23.99%,AMN;KIF13A;ANK3;GOLPH3;GCC2;GOLGA7;GGA1;NSF;ARFRP1;RAB10;VAMP2;SEC16A;RAB31;GOLPH3L
prerank,positive regulation of immunoglobulin production (GO:0002639),0.3914874359782015,0.9889297243353671,0.47229916897506924,0.945872744726208,1.0,4/31,9.55%,SASH3;CLCF1;SHLD2;RIF1
prerank,positive regulation of cell motility (GO:2000147),0.31459955444727133,0.9889293212213697,0.49742002063983487,0.9451830508731952,1.0,17/205,4.38%,SEMA3D;CDH13;NTRK3;LAMC2;TJP1;SMO;MMP9;CCL5;PODXL;PDGFC;ADAM10;WNT11;CAV1;SEMA3B;PTK2B;GCNT2;SH3RF2
prerank,myelin assembly (GO:0032288),0.48942387283802774,0.9887056811696874,0.4772727272727273,0.9450848865054683,1.0,3/10,11.06%,GPC1;CD9;ABCA2
prerank,regulation of cell size (GO:0008361),-0.33078562474217954,-0.9885235768671524,0.4772727272727273,0.8258339583115677,1.0,8/23,18.19%,VAV3;RDX;DEPTOR;PRR16;MTPN;EDN1;AKT1S1;VAV1
prerank,synapse organization (GO:0050808),0.3261503523802961,0.9884241691011925,0.49295774647887325,0.9451690998240628,1.0,12/125,8.48%,CDH1;SDK1;GPC6;UNC13C;GPC4;CACNB3;PTPRD;MYOT;ANK3;PTPRF;FZD5;CDC42
prerank,protein localization to vacuole (GO:0072665),0.45762970847634427,0.9883632743701298,0.48615384615384616,0.9446317317358072,1.0,9/13,30.45%,CD81;SH3BP4;KPTN;SZT2;GLMP;LAMTOR5;RTN4;ATP13A2;RNF128
prerank,cellular response to fatty acid (GO:0071398),-0.3901451666118325,-0.9875287846400181,0.49206349206349204,0.8272851588213713,1.0,1/12,0.08%,PID1
prerank,positive regulation of signal transduction (GO:0009967),0.3150922240178519,0.9875029443897431,0.49793388429752067,0.9461394123825437,1.0,23/238,7.58%,PRKCB;SORBS1;TSPAN5;NTRK3;WNT1;KANK1;SMO;JCAD;ELF3;RSPO3;EMP2;EP300;LIMS2;PTK2B;TRIM44;SMARCB1;PIH1D1;CAV2;DMTN;ZBTB7B;WLS;TGFB2;ILK
prerank,inositol phosphate-mediated signaling (GO:0048016),0.43134703721178913,0.9866570665648144,0.4798136645962733,0.9476557236694174,1.0,1/19,0.33%,NFATC2
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.47462189092829543,0.9863093215156647,0.49328859060402686,0.9478120920881125,1.0,1/10,1.24%,NCOA3
prerank,cytokine-mediated signaling pathway (GO:0019221),0.3055551071839252,0.9862808074522632,0.5467336683417086,0.9471943870667574,1.0,70/532,11.77%,FN1;TNFRSF11B;CD44;CRLF1;MAP3K8;MMP9;CCL5;IL17RE;EDA2R;VIM;EDA;CDKN1A;RORC;IL17RA;RAP1B;IL15;IL16;LAMA5;TNFSF13;PTK2B;FOXO3;TNFRSF8;FOS;CLCF1;EPO;TIMP1;ACKR3;IL3RA;TRIM25;ALOX5;NFKBIA;PSMD11;IRF3;BCL2L1;RNASEL;GPR75;SHC1;CSK;GSTO1;ANXA2;PSMD4;MSN;COMMD7;PSMF1;MTAP;TRIM21;STAT4;TAB3;ILK;RBX1;NDN;CDC42;PML;IL7R;LBP;TNFRSF1A;PYDC1;TRIM26;PTPN6;CCND1;TWIST1;PSMD7;SOD2;SMARCA4;IL1R2;SOCS2;JAK1;FCER1G;IRS2;YWHAZ
prerank,positive regulation of RNA metabolic process (GO:0051254),0.3662591574607243,0.98582528288516,0.4758800521512386,0.9476856653807406,1.0,11/45,14.96%,DDX5;BUD23;POLR2A;BMP4;RBM20;MAP2K2;WDR43;HABP4;HRAS;ZPR1;GRSF1
prerank,peroxisomal membrane transport (GO:0015919),0.3904942107809686,0.9857960685995308,0.4856361149110807,0.9470840570416372,1.0,8/27,18.71%,PEX26;ABCD1;SLC25A17;PXMP4;PEX6;RAB8B;PEX3;PEX2
prerank,glycoprotein metabolic process (GO:0009100),-0.2659345689878632,-0.9857925530434409,0.4585152838427948,0.8304932224017058,1.0,15/53,18.35%,ST6GALNAC3;MAN1C1;ADAMTS9;HIF1A;ST8SIA4;MGAT4A;ST8SIA6;MAN2A1;MAN2B1;B4GALT5;GCNT1;ST8SIA5;B4GALT7;ST8SIA2;PCSK6
prerank,positive regulation of nervous system process (GO:0031646),-0.3526384167434327,-0.9855919557092017,0.48546511627906974,0.8296997951146967,1.0,8/18,25.76%,UNC13B;TENM4;TPPP;TNFRSF1B;MYRF;RIMS1;DICER1;NCMAP
prerank,regulation of viral genome replication (GO:0045069),0.35195973235342415,0.9853971815058702,0.49236641221374045,0.9474215646268904,1.0,11/56,16.36%,CCL5;MAVS;SLPI;TARBP2;RNASEL;TMEM39A;SRPK2;SRPK1;TNIP1;OAS2;DDB1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.39179863177550156,0.9851979413648161,0.4783216783216783,0.94724489858737,1.0,11/29,23.01%,FEM1A;FBXO5;ARRDC3;DCUN1D5;FEM1B;DCUN1D1;UBE2N;ABL1;PARK7;FBXW7;TRIB3
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.36118712866599473,-0.9849000859236551,0.4586894586894587,0.83031760560254,1.0,4/16,10.60%,PLCB1;BOC;BTG1;LRRC8A
prerank,heterocycle biosynthetic process (GO:0018130),0.444685120184984,0.9839902004956894,0.4682170542635659,0.9496716678635714,1.0,5/14,11.49%,MOCS3;ALOX5;NFS1;PYCR3;NOXRED1
prerank,negative regulation of centrosome duplication (GO:0010826),-0.4010950397184554,-0.9838439900886616,0.4883116883116883,0.8317389526291071,1.0,6/11,27.51%,TMEM67;RBM14;CCNF;KAT2B;BRCA1;NPM1
prerank,peptidyl-methionine modification (GO:0018206),0.4567907640479808,0.9836670040179227,0.4903536977491961,0.9498214827611399,1.0,3/12,13.23%,PDF;NAA15;NAA20
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.4501222523230295,0.983160819024381,0.4843260188087774,0.9504291694125652,1.0,3/13,8.79%,PIGU;DOT1L;IL7R
prerank,triglyceride metabolic process (GO:0006641),0.36143939894928806,0.9831362047126078,0.4747847478474785,0.9497988154676511,1.0,4/48,5.71%,CAV1;DGAT1;MOGAT3;MOGAT1
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.344446256915767,-0.9828741671998277,0.49096385542168675,0.8331178027597628,1.0,9/18,25.90%,MSRA;ASPG;FOLH1;MTHFR;ADI1;ASNS;GOT1;SMS;GOT2
prerank,inflammatory response (GO:0006954),0.3150117439473828,0.9827425470269018,0.5165631469979296,0.9501357666751681,1.0,20/195,11.32%,AGTR1;CD44;CCL5;ELF3;HDAC5;CXCR4;PTGFR;FOS;RELB;HDAC4;CCRL2;NFAM1;ABCF1;TNFRSF1A;TLR6;TAC4;HP;HPR;TLR4;CDO1
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.4729422702389856,0.9826350100081009,0.4909983633387889,0.9497125489574216,1.0,6/11,20.65%,SOAT1;ITM2C;ABCA2;NECAB3;NECAB2;ABCA7
prerank,maintenance of protein location in nucleus (GO:0051457),-0.3387497852222994,-0.982453232984245,0.47796610169491527,0.8329126559590384,1.0,3/20,8.37%,SP100;SYNE1;TOPORS
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.34128882607458266,0.9824524788144382,0.4970414201183432,0.9495115343564355,1.0,7/72,7.99%,FGFR1;FLRT1;GTF2F1;RBFOX2;POLR2H;POLR2A;FGF22
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.32866352559738604,-0.9821124159058292,0.46788990825688076,0.8324535491816172,1.0,3/21,6.26%,EPHA7;AIM2;GRIN2B
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.47168755084140246,0.9819745298196418,0.5090016366612111,0.9500615410650541,1.0,1/10,0.82%,PRKAA2
prerank,ear morphogenesis (GO:0042471),0.4101980375684934,0.981741162032654,0.4841628959276018,0.9499997533895073,1.0,4/20,10.33%,ATP6V1B1;SIX1;ZIC1;TWIST1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.3582498852548185,-0.9815374666422698,0.4868421052631579,0.8326158662304823,1.0,2/17,9.18%,PLA2G4A;SERAC1
prerank,Notch signaling pathway (GO:0007219),0.35066216245251464,0.9810742854824083,0.48194271481942713,0.9510072543965282,1.0,5/59,2.90%,NOTCH2;PBX1;ADAM10;NLE1;EP300
prerank,neural crest cell development (GO:0014032),0.3606225613384969,0.980963755485123,0.48148148148148145,0.9506234199907089,1.0,4/44,3.81%,SEMA3D;SEMA3B;PEF1;GDNF
prerank,macrophage activation (GO:0042116),0.3789032195701881,0.9807043075309674,0.48064085447263016,0.9506397096697699,1.0,10/34,20.33%,CLU;LBP;NMI;TLR4;SBNO2;FOXP1;ITGB2;APP;MAPT;AGER
prerank,protein-containing complex subunit organization (GO:0043933),0.3257193027645513,0.9804970881555612,0.48995535714285715,0.9504965461311198,1.0,14/109,9.03%,REPS2;PPARGC1A;OCLN;EPRS1;PTK2B;ELOB;DMTN;GPAA1;AFG3L2;PARD6B;LAMC1;PML;NDC1;KMT2A
prerank,regulation of vesicle-mediated transport (GO:0060627),0.3340421554752555,0.9802919293663697,0.492622020431328,0.9503507429241415,1.0,17/91,17.88%,RAB17;CDH13;TSC2;STON1;RAB3B;OPHN1;MAP2K2;ATP9A;SNX12;CPLANE2;RAB5C;RAB33B;ABL1;NSF;RAB8B;PACSIN1;STX4
prerank,negative regulation of viral entry into host cell (GO:0046597),0.4582618015727163,0.9790114908335765,0.4786184210526316,0.9529606127626226,1.0,3/12,9.40%,GSN;TRIM26;TRIM11
prerank,regulation of protein neddylation (GO:2000434),-0.4197110698577063,-0.9789655592441008,0.49878934624697335,0.8382598128959072,1.0,5/10,17.57%,HIF1A;EPAS1;RPL11;DCUN1D3;DCUN1D2
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.46556802444210815,0.9789025571617195,0.5,0.9525618394345328,1.0,8/13,30.36%,DESI2;DESI1;SAE1;UBA6;UBA7;UBA3;UBA2;SENP6
prerank,regulation of immunoglobulin production (GO:0002637),0.40707779702488245,0.9785657419942003,0.4851063829787234,0.9527399161914799,1.0,2/23,4.18%,SASH3;CLCF1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.37858037813459233,0.9778766043094177,0.48221343873517786,0.953809198547196,1.0,8/31,11.75%,ANK1;CRB2;MSN;CDC42;OPHN1;EZR;SYNJ2BP;RHOA
prerank,protein complex oligomerization (GO:0051259),-0.23775264451434558,-0.9778356452646957,0.5289256198347108,0.8398166120482883,1.0,26/85,18.12%,LRRC8C;PKD2;EHD4;IKZF4;OXA1L;EHD3;MAT2A;UPB1;GSDMD;NUDT21;AQP11;JMJD6;TRMT61B;LRRC8A;WDCP;ALS2;CPSF6;G3BP2;CLDN1;GLRA3;KCNC1;MPP2;TIFA;BLM;ATL1;BOK
prerank,nuclear membrane reassembly (GO:0031468),0.3529691252989982,0.977742855869889,0.4856115107913669,0.9534850860580873,1.0,12/54,15.81%,CC2D1B;PPP2CA;REEP3;NUP93;NSFL1C;CHMP4A;CHMP4B;NDC1;VPS4A;LMNA;CHMP2A;REEP4
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.3351370373422528,-0.977637568060657,0.4688427299703264,0.8390588655066654,1.0,4/20,6.35%,SLC8A1;ATP1B1;SLC12A2;KCNJ2
prerank,regulation of signal transduction (GO:0009966),0.3137654714802194,0.9775899311488419,0.5129802699896158,0.9531933045464407,1.0,31/190,12.94%,CD55;CLU;IGFBP6;PRAG1;OGT;SREBF2;GRK5;VEPH1;RSPO3;GDNF;PPP2CA;TIMP1;TSC2;FRMPD1;OVOL2;CSK;PXN;ERBB3;ILK;UBTF;FOXP3;ZIC1;LLGL2;USP20;SYNJ2BP;GRK2;SOCS2;PTPN2;CDKN2AIP;RGS6;GATA3
prerank,sodium-independent organic anion transport (GO:0043252),0.47586125052939643,0.9775238541270589,0.5085910652920962,0.952673358921464,1.0,2/10,6.03%,SLCO2A1;SLC16A2
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.4188592542320418,0.977327053217061,0.4745269286754003,0.9525126920586692,1.0,10/20,26.04%,ADAM10;SPPL2B;HM13;SPPL2A;ADAM17;RHBDD1;APH1A;PSEN1;MBTPS2;RELA
prerank,calcium ion transport (GO:0006816),0.3275119478994642,0.9770728450411731,0.5233949945593036,0.9524116144309347,1.0,21/113,14.06%,TRPM3;ANK2;STIM2;CCL5;CACNA1A;CAV1;NALCN;TRPM8;CACNB3;RAMP1;CACNA2D4;TMEM165;MICU1;PKD1;TRPM6;MCUR1;TRPM4;ANO6;CACNB2;TRPM2;ATP2B4
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.264863090100671,-0.9762549301631138,0.47804878048780486,0.8414763580603184,1.0,15/54,15.44%,DPP10;KCNN2;NOS1AP;KCNIP4;KCNIP3;KCNJ2;BIN1;KCNIP1;KCNJ12;DPP6;KCNJ6;KCNJ10;KCNMB4;KCNMA1;GNB1
prerank,positive regulation of protein maturation (GO:1903319),-0.41006591122066416,-0.9759188518099257,0.49869451697127937,0.841030764352045,1.0,4/11,25.78%,CCBE1;NKD2;BAG2;ADAM8
prerank,prostaglandin biosynthetic process (GO:0001516),-0.3436898418182911,-0.97561513000983,0.4906832298136646,0.8404403934147582,1.0,8/18,19.88%,PLA2G4A;PTGIS;PTGS2;PNPLA8;PTGES;EDN1;CD74;MIF
prerank,sympathetic nervous system development (GO:0048485),0.4436175311420517,0.9755968181821129,0.48632218844984804,0.9555272761165734,1.0,5/15,20.22%,GDNF;NRP2;GATA3;SEMA3A;SOX4
prerank,regulation of calcium-mediated signaling (GO:0050848),0.3966975552710714,0.9754056928831223,0.47126436781609193,0.9553663335891919,1.0,1/25,0.37%,CDH13
prerank,negative regulation of phosphorylation (GO:0042326),0.3384723638179579,0.9753500890980501,0.4988235294117647,0.9548227156484528,1.0,22/85,18.96%,NTRK3;CDKN1A;OCLN;NUPR1;ZC3H12A;HDAC4;FBLN1;BMP4;PIP5KL1;CHP1;FKBP8;TIGAR;NCOR1;IRS2;SH3GL2;DNAJC10;TESK1;PTPN13;GIT1;PARK7;CDKN2D;CDK5RAP3
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.42671926640923974,0.9748754978771449,0.4831288343558282,0.955312201806168,1.0,2/16,2.68%,ZC3H12A;ABCD1
prerank,neuron migration (GO:0001764),0.3625667116762732,0.9747101128151379,0.5,0.955048242589907,1.0,3/48,0.88%,FGF13;FGFR1;CELSR1
prerank,cochlea morphogenesis (GO:0090103),0.4666955592990875,0.9746502082712319,0.5017123287671232,0.9545031922239386,1.0,1/10,2.00%,HPN
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.4628364410164015,0.9746287124150127,0.49921259842519683,0.9538780504330019,1.0,3/12,12.85%,SREBF2;ABCA2;LPCAT3
prerank,polyamine metabolic process (GO:0006595),0.45207652476556026,0.9743948632446726,0.4876847290640394,0.9538032798692915,1.0,1/13,1.39%,SMOX
prerank,melanosome organization (GO:0032438),0.39098643411517686,0.9738963759816068,0.4736111111111111,0.9543486311784529,1.0,6/26,14.30%,KIF13A;BLOC1S6;AP3B1;BLOC1S2;AP1M1;PMEL
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.46286964057733443,0.9737785138857218,0.49328859060402686,0.9539592839161,1.0,1/11,1.18%,LDLR
prerank,glucose import (GO:0046323),-0.38448015119687395,-0.9736690804578345,0.49056603773584906,0.8442129763398432,1.0,2/13,8.80%,SLC2A1;SORT1
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.3729545815113354,-0.9736286152713193,0.48055555555555557,0.8429765875305413,1.0,3/13,7.66%,SHANK3;EPHB2;ADCY1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.4197213562582094,0.9729789754206389,0.4824961948249619,0.9552547152147667,1.0,6/18,14.35%,RAP1B;RAP1A;SYN1;RIMS4;VPS18;GSK3B
prerank,alpha-amino acid metabolic process (GO:1901605),0.3640145999266013,0.9729144568352431,0.484394506866417,0.9547440599548122,1.0,15/45,24.62%,GLUL;NAALAD2;DDAH2;GLUD1;PYCR3;THAP4;SLC25A12;ASS1;KYAT1;ALDH18A1;PYCR2;GPT2;KMO;DDAH1;KYAT3
prerank,cortical actin cytoskeleton organization (GO:0030866),0.40819107114710307,0.972846425286053,0.5038759689922481,0.9542460286427754,1.0,4/20,9.59%,FMNL2;RHOQ;STRIP1;LLGL2
prerank,organelle organization (GO:0006996),0.30726918289049365,0.9720900505086327,0.5735887096774194,0.9554566528383512,1.0,94/388,20.18%,CXADR;SPTSSB;PPARGC1A;FMNL2;FBXW8;ANK1;MICAL2;YTHDF1;GABPB1;CAV1;ABCD1;DIAPH1;TJAP1;ZMYM6;NCKIPSD;TMED1;AGTPBP1;CAPZB;CAV2;DMTN;HCFC1;HAX1;NRF1;SYNE3;MAPK15;ATP8B2;NSFL1C;GOLPH3;ARHGAP21;ARHGAP10;MICAL1;STRIP1;CHMP4A;CHMP4B;CDC42;RAB7A;CENPT;PCLO;MIEF2;TOR1A;AFG1L;BCAS3;NIPSNAP2;ZW10;VPS11;VPS4B;MARK4;AJUBA;EIF2AK3;ZMYM4;OPA1;GOLGB1;CHMP1A;RHOU;MYC;ARFGEF1;NPLOC4;VPS18;VPS4A;DNM1L;ATL2;VPS13D;USP6NL;CHMP2A;PEX6;ATP5F1B;PAK6;MTX1;CAMSAP1;PI4K2A;CFAP61;PACSIN1;CLUH;NUMA1;PDCD6IP;MTFR2;STX4;SEC23IP;PEX3;ODF2;WTIP;PARK7;TMED5;RNF112;PEX2;YTHDF3;SEC31B;RHOT2;MYO18A;SMPD4;STOML2;HSD17B10;MNS1;HILPDA
prerank,polyol metabolic process (GO:0019751),0.36164971770191817,0.9720462713699901,0.5019255455712451,0.9548944948093667,1.0,11/46,15.85%,NUDT4;PLCB3;PLCD3;IP6K1;INPP4A;PPIP5K2;INPP5B;OCRL;PLCD4;PLCD1;IP6K2
prerank,RNA destabilization (GO:0050779),0.4192031319622341,0.9720213622384166,0.493730407523511,0.9542807254132328,1.0,7/18,23.12%,YTHDF1;CELF1;MEX3D;YTHDF3;ROCK2;DXO;FTO
prerank,regulation of JNK cascade (GO:0046328),0.3274736703795314,0.9717463572322008,0.507514450867052,0.954328332982797,1.0,7/101,4.38%,WNT16;MAP3K5;EDA2R;CCN2;PTK2B;DUSP10;SH3RF2
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.3134947751123318,-0.9716312216661016,0.5266903914590747,0.8470888633733089,1.0,9/27,14.37%,PDGFRB;DACH1;ACVRL1;FGF2;RGCC;TNKS;TOM1L1;FGFR4;BMPR2
prerank,gastrulation (GO:0007369),-0.3558387190477766,-0.9715332740327643,0.5027624309392266,0.8459987218792535,1.0,4/15,12.12%,TASOR;LRP5;MEGF8;NPHP3
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.28016771760698744,-0.9714584523873862,0.4810126582278481,0.8448878511621049,1.0,18/37,28.73%,IFT81;IFT122;TTC21B;IFT74;WDR19;KIFAP3;IFT43;KIF3B;CLUAP1;DYNC2LI1;DYNLL2;DYNC2I2;IFT27;KIF3C;IFT88;CEP131;IFT140;IFT22
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.3413821019305009,-0.9713213078171432,0.49158249158249157,0.8438963349737003,1.0,6/18,16.50%,LYN;SLIT2;IL6R;MTUS1;CAMK1D;EDN3
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.3294431059535088,0.9713210571477692,0.5218855218855218,0.9547449705461206,1.0,11/95,8.03%,CD109;VEPH1;SMAD6;TRIM33;CAV1;EP300;LTBP4;SPRED3;LATS1;TGFB1I1;PPM1A
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.339019246599292,0.971298488368767,0.4970344009489917,0.9541235361276166,1.0,10/65,12.26%,CD109;VEPH1;SMAD6;CAV1;SPRED3;TGFB1I1;PPM1A;LDLRAD4;TGFBR2;DAND5
prerank,multivesicular body assembly (GO:0036258),0.3863642270048047,0.9712536162113928,0.502770083102493,0.9535782230626991,1.0,12/30,20.09%,VPS37B;CHMP4A;CHMP4B;VPS4B;CHMP1A;VPS4A;CHMP2A;PDCD6IP;STAM;TSG101;VPS37A;IST1
prerank,cellular response to glucose starvation (GO:0042149),0.3672004246668575,0.9711676572924206,0.49550706033376124,0.9531325438308759,1.0,5/41,3.80%,PRKAA2;ZC3H12A;PMAIP1;FOXO3;SESN2
prerank,regulation of protein metabolic process (GO:0051246),0.36776982115916684,0.9710384141334809,0.5201560468140443,0.9527758522940116,1.0,12/44,21.81%,KLF4;LDLR;LTBP4;MAPK7;MDM2;CENATAC;CHEK2;ROCK2;APP;KLF2;ABCA7;SPOPL
prerank,bile acid metabolic process (GO:0008206),0.38748497187024855,0.9707748661520995,0.502906976744186,0.9527506144685015,1.0,5/27,11.13%,OSBPL9;ACOT8;NPC1;CYP39A1;OSBPL7
prerank,negative regulation of fat cell differentiation (GO:0045599),-0.2921195892353461,-0.97058050728857,0.4878048780487805,0.8446076151949303,1.0,9/34,9.53%,RUNX1T1;ZFPM2;ENPP1;WNT5A;FOXO1;RORA;TGFB1;BBS12;GATA2
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.36842353831317465,-0.9704480261626214,0.4849315068493151,0.8436004099552352,1.0,5/13,18.91%,GLI2;CAMK4;TOX;CLPTM1;SOD1
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3037807620508364,0.9703045787254492,0.5691220988900101,0.9531853657417709,1.0,44/308,13.17%,ADRA1B;PPARGC1A;NCOA3;SMO;OGT;PDGFC;SCAMP5;NIBAN2;IL15;CAV1;TRPM8;CXCR4;CRB2;GDNF;RBM19;GCNT2;ZBTB16;OLFM1;SHLD2;ESRRB;FOXD1;ZBTB7B;BMP4;TGFB2;BAD;ACADL;NFAM1;TGFB1I1;ELOVL6;SIX1;FBXO5;LBP;TXK;RIF1;TWIST1;KDM3A;HDAC3;TRPM4;TGFBR2;PTN;CPT2;PDPN;RREB1;MAP3K13
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.44674064035227407,0.969580339491006,0.49922958397534667,0.9543450603815194,1.0,1/13,0.51%,FGFR1
prerank,regulation of phospholipase C activity (GO:1900274),0.43492425464496576,0.9692758205023507,0.5239567233384853,0.9544575426435262,1.0,2/15,0.84%,FGFR1;NTRK3
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.34339991177879786,0.9692204864274987,0.501207729468599,0.9539326904475867,1.0,23/64,24.81%,MLLT3;GTF2F1;POLR2H;ELOB;POLR2A;SSRP1;ELP4;POLR1E;ELL;TCEA2;ELP2;ERCC2;NELFB;POLR2C;POLR2E;NELFA;ELOF1;AFF4;CTR9;CDK9;LEO1;MNAT1;POLR2K
prerank,positive regulation of cellular protein localization (GO:1903829),0.33858759319596904,0.9691484684958793,0.5047058823529412,0.953453606757802,1.0,26/69,25.05%,PRKAA2;LIMK2;SESN2;ORMDL3;DDRGK1;SNX33;MARK4;EIF2AK3;GSK3B;CCDC88A;SYT11;TESK1;NUMA1;STX4;PARK7;NECAB2;CDK5RAP3;CROCC;MAPT;ABCA7;TM9SF4;WWTR1;GAS8;FYN;STX3;NUP62
prerank,histone H3 deacetylation (GO:0070932),0.4299349420127643,0.9690581644453781,0.5,0.9530125796881951,1.0,7/15,25.07%,HDAC4;HDAC3;SFPQ;SIRT7;PER1;PER2;HDAC8
prerank,regulation of protein sumoylation (GO:0033233),0.424179632196365,0.9688988749790838,0.5196374622356495,0.9527368368484722,1.0,5/17,12.88%,HDAC4;MUL1;SAE1;PIAS1;PIAS3
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.35554173134921024,-0.9688316002523686,0.48760330578512395,0.846654448371594,1.0,14/16,51.52%,CYRIB;STX7;CEACAM1;LILRB1;FADD;IL12A;IL12RB1;IL23A;KLRD1;IL23R;IL12B;RIPK3;XCL1;KLRC1
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.2162233846920162,-0.9687397631246251,0.5,0.8455320684414804,1.0,54/172,21.50%,PLA2G4A;PIK3R1;INPP4B;ETNK1;PIP5K1B;DGKH;GPD1L;INPP5D;DGKB;PIP4K2A;SYNJ2;FGF2;PLD1;ARF3;ABHD3;PTDSS1;MTMR14;MTM1;PLEKHA8;BMX;PLEKHA2;PIK3CB;PLEKHA4;PIK3R6;CDS2;PIK3CD;SLC44A2;PLSCR1;PCYT1A;LPIN2;MTMR7;MTMR2;DGKG;PIK3R3;MFSD2A;SLC44A1;PI4K2B;PIK3C3;CLN3;PIK3R5;RUFY1;AGPAT3;STARD10;PCTP;FIG4;PIK3R2;INPPL1;PNPLA3;AGPAT2;PLA2G4C;PIP4K2B;PIP5K1A;DGKZ;DGKQ
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.45838655679965096,0.9685683083308789,0.49589490968801314,0.9528991376507143,1.0,1/11,1.03%,WNT1
prerank,metal ion export (GO:0070839),-0.29759211682811226,-0.9683231174588822,0.4784172661870504,0.8453263653447345,1.0,4/31,5.94%,KCNT2;KCNK5;ATP1B1;SLC40A1
prerank,response to retinoic acid (GO:0032526),0.34619009592264377,0.968232377131027,0.4932182490752158,0.9530460120909938,1.0,11/59,12.42%,PTK7;WNT11;PTK2B;WNT6;RARG;CREB1;RXRB;WNT5B;AQP1;EPHA3;WNT3
prerank,regulation of programmed cell death (GO:0043067),0.31109426676375884,0.9679592235218206,0.5338894681960376,0.9530725450907226,1.0,21/161,12.20%,CLU;DAXX;ACTN2;NDRG1;PMAIP1;KANK2;DAPK3;DAPK1;PPP1R13B;RARG;IRF3;PERP;HAX1;TNFRSF10B;PTPN6;RAF1;TIGAR;USP42;PLSCR3;MARK4;BCAR1
prerank,sodium ion transport (GO:0006814),0.3267165209453894,0.9671541784501286,0.5134818288393904,0.9543747818809115,1.0,5/85,2.79%,FGF13;ASIC5;SCN3A;NALCN;ATP1A2
prerank,response to lipid (GO:0033993),-0.23251958080828716,-0.9664773874711774,0.5092592592592593,0.8488909872631412,1.0,21/105,13.26%,ACER2;STAT5B;NOS3;ESR1;ERBIN;FOXO1;GGT5;LGALS9;ALPL;IRAK3;PPARD;TGFB1;GCH1;JAK2;PAQR8;PPARG;STAT3;TIRAP;FGFR4;RBP4;GATA6
prerank,myeloid leukocyte differentiation (GO:0002573),0.3417957821001636,0.9661487654079076,0.5282555282555282,0.9562061106950721,1.0,17/65,18.81%,MMP9;CDKN1A;IL15;EP300;CDK4;BMP4;CDC42;PML;TGFBR2;SBNO2;CDK2;FOXP1;E2F1;PDE1B;PRTN3;RARA;BATF2
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.44209086787922075,0.96603044566137,0.5039370078740157,0.9558369724864549,1.0,10/14,29.46%,NABP2;ATRX;PINX1;TNKS2;ATR;TERF2;TINF2;XRCC5;TERT;TERF2IP
prerank,negative regulation of viral life cycle (GO:1903901),0.428557595467387,0.9658817592087118,0.4796875,0.9555172319665486,1.0,3/15,9.40%,GSN;TRIM26;TRIM11
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.39961637587358084,0.9657263913576929,0.515850144092219,0.9552275210050944,1.0,8/25,16.08%,PFKP;PKM;ENO2;HK1;FOXK1;ALDOA;GAPDH;TPI1
prerank,secondary alcohol metabolic process (GO:1902652),0.36308068357797263,0.9657174023450891,0.5006802721088436,0.9545875499684738,1.0,9/42,16.03%,SOAT1;STARD3;SULT2B1;IDH3G;FDX1;SOAT2;SQLE;OSBPL5;IDH3A
prerank,"DNA-templated transcription, termination (GO:0006353)",0.3403167754480683,0.9656775826882871,0.519208381839348,0.9540137394037779,1.0,18/68,19.84%,LSM10;POLR2H;SNRPB;TAF1C;POLR2A;MAZ;UBTF;WDR33;POLR1C;POLR1E;POLR1F;CSTF1;PABPN1;CLP1;ERCC2;POLR2E;CSTF3;TBP
prerank,nucleosome disassembly (GO:0006337),0.4385516538033313,0.965428644267704,0.5139318885448917,0.953330275015659,1.0,6/14,16.26%,GRWD1;SMARCB1;SMARCA4;SMARCD2;SET;SMARCC1
prerank,chromatin disassembly (GO:0031498),0.4385516538033313,0.965428644267704,0.5139318885448917,0.953330275015659,1.0,6/14,16.26%,GRWD1;SMARCB1;SMARCA4;SMARCD2;SET;SMARCC1
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.31689641168782734,-0.9652700852860824,0.4936708860759494,0.8508148327891757,1.0,5/23,7.47%,ERRFI1;CBLB;SH3BP5;ZFYVE28;SOCS5
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.41583023608535863,0.965191386969716,0.511380880121396,0.9532192939775976,1.0,3/20,10.82%,FKBP5;NKTR;PPIC
prerank,histone H3-K36 demethylation (GO:0070544),0.4703618995143902,0.9649688692713605,0.5165876777251185,0.9531009290548607,1.0,3/10,10.85%,KDM4B;RIOX2;KDM4C
prerank,protein localization to mitochondrion (GO:0070585),-0.3867869106518731,-0.964958006302052,0.5238095238095238,0.8502999560418549,1.0,3/11,7.96%,LRRK2;HK2;DNAJA1
prerank,icosanoid metabolic process (GO:0006690),-0.2768633062370315,-0.9645265509467271,0.4840182648401826,0.8501690294939231,1.0,7/40,6.77%,PLA2G4A;PTGIS;GGT5;CYP1B1;MGLL;PTGS2;PNPLA8
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.35541600264549256,-0.964461517951534,0.5145348837209303,0.8490247203191276,1.0,8/16,21.33%,ARHGAP24;AUTS2;PIK3CB;ALS2;STMN3;RASGRF1;ARF6;GABARAP
prerank,organic cation transport (GO:0015695),-0.33282542439704116,-0.9642052713312907,0.5205047318611987,0.8483821601732916,1.0,10/20,36.92%,SLC47A1;SLC44A2;SLC44A1;SLC5A7;SLC22A2;SLC25A26;SLC22A3;SLC22A5;SLC29A4;PDZK1
prerank,amide transport (GO:0042886),-0.29973589793736544,-0.9641567927885367,0.4901315789473684,0.84718415242566,1.0,12/26,32.98%,PLTP;TAP2;PLEKHA8;AQP11;DISP1;SLC5A6;SLC14A1;PLEKHA3;ABCG2;ABCA13;SLC38A5;CPTP
prerank,regulation of T cell differentiation (GO:0045580),0.37155739060639265,0.9640161482395713,0.5220293724966623,0.9548218980667145,1.0,1/33,0.33%,NFATC2
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.3400547917780995,-0.9639613638905395,0.5391849529780565,0.846398213453384,1.0,11/19,34.74%,AQP4;SPEF2;RFX3;NPHP3;CFAP53;CCDC39;ROPN1L;SPA17;DNAAF2;ODAD4;NEK10
prerank,ribosomal small subunit assembly (GO:0000028),0.4251932163461508,0.9637419006732763,0.5170876671619614,0.9548613377375486,1.0,8/16,30.80%,MRPS7;RPSA;PWP2;RPS28;RPS27;XRCC5;RPS15;ERAL1
prerank,digestive tract development (GO:0048565),0.3766561716198414,0.9636686017352669,0.5127175368139224,0.954392673831022,1.0,6/33,8.24%,COBL;SMO;GLI3;STRA6;TGFB2;PKD1
prerank,anterior/posterior pattern specification (GO:0009952),-0.2573849764459126,-0.9635443858744587,0.5102040816326531,0.8461877336301004,1.0,20/53,26.32%,PCSK5;HEYL;LRP5;BASP1;HOXA7;DDIT3;TBX1;BHLHE40;BMPR2;HOXB7;HHEX;HOXC4;HOXB6;HOXD3;HEY2;HEY1;BHLHE41;HOXC5;SMAD2;HOXB9
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),-0.23229982951274147,-0.9635145668271426,0.5333333333333333,0.8449719235985744,1.0,51/116,33.67%,ADCY5;CALCRL;LYN;GGT5;ADCY7;ADCY1;ADCY4;HTR7;ADORA2A;RAMP2;PRKAR2B;GPR45;CYSLTR1;PTHLH;GNB1;ADM;CYSLTR2;MC5R;ADCY2;PTGDR;PRKAR1B;PTGER4;GLP2R;RXFP1;MAPK14;VIPR2;ADCY3;ADCY8;IAPP;ADCYAP1R1;GPR27;HCK;NPSR1;CALCA;GNG2;HRH2;FGR;TSHR;FCGR2B;CD247;ADRB1;PLCG2;LHCGR;PLCG1;TREM2;PTH2R;GPR20;CD163;HTR6;GIPR;CRHR1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.3501398023014955,0.9634415994935829,0.5130111524163569,0.9543018425790069,1.0,11/50,15.63%,NR3C2;EP300;TRIM44;ILK;NMI;TLR4;RHOA;IRAK1;PTP4A3;TLR3;ACTN4
prerank,regulation of establishment of planar polarity (GO:0090175),0.32653330219906884,0.9633834100552857,0.5226480836236934,0.9537911899310813,1.0,14/88,12.89%,CELSR1;WNT1;WNT11;AP2A2;PSMD11;PSMD4;PSMF1;DVL3;FZD5;CDC42;PSMD7;AP2A1;RHOA;PSMB5
prerank,receptor clustering (GO:0043113),0.38665334401496887,0.9633195738600292,0.4928774928774929,0.9532805573238692,1.0,8/27,15.66%,MAGI2;ITGB7;SYNJ2BP;MUSK;PTN;ITGB1BP1;ITGB2;FLNA
prerank,positive regulation of growth (GO:0045927),-0.25515742677826075,-0.9631644891555301,0.543859649122807,0.8445869408179808,1.0,14/64,13.67%,PLCB1;INSR;LGI1;RFTN1;BCL2;SLC25A33;BRAT1;CXCL16;FXN;EXOSC2;HYAL1;KLHL22;MTPN;MFSD2A
prerank,peptidyl-proline modification (GO:0018208),0.3953955327614713,0.9628126852990105,0.4978540772532189,0.9538466665511042,1.0,4/25,10.82%,FKBP5;NTMT1;NKTR;PPIC
prerank,ncRNA transcription (GO:0098781),0.4457568426958681,0.9627137385237281,0.5306451612903226,0.953415062027653,1.0,5/13,22.26%,ANG;SPIN1;SNAPC3;SIRT7;POLR1G
prerank,B cell activation (GO:0042113),0.34509511104697765,0.9625162094651768,0.5318892900120337,0.9532346451043429,1.0,11/68,16.18%,PRKCB;HDAC5;HDAC4;CLCF1;NFAM1;CR2;RABL3;PTPN2;MEF2C;KLF6;TPD52
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.39579070116424053,-0.9623951074571218,0.5096952908587258,0.8452640085299612,1.0,6/10,26.67%,DNAJC19;MTMR2;ABCA3;MFSD2A;MTMR4;PHB2
prerank,microtubule anchoring at centrosome (GO:0034454),-0.3927413879948992,-0.9620994526719222,0.5132530120481927,0.8447686714184688,1.0,4/10,21.12%,NIN;BBS4;CCDC68;CEP19
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.2297192358251606,-0.9617887850840512,0.5463917525773195,0.8442592292841364,1.0,31/113,17.68%,ABCA1;UNC13B;ASAP1;SLF1;ESR1;CUL4B;DAB2IP;PSMC6;GBP5;FNIP1;TFRC;TGFB1;SH3GLB1;TP53;TIRAP;TPPP;BCL2L11;BID;RACK1;RASIP1;BMF;SLF2;FNIP2;CDC42EP2;BAX;TTBK1;ERCC3;GNL3L;SKAP1;GTF2H3;SPIDR
prerank,negative regulation of myotube differentiation (GO:0010832),0.4464165121877093,0.9615511222178176,0.5149501661129569,0.9549142767282666,1.0,3/12,10.49%,HDAC5;HDAC4;HDAC3
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.4024199131947242,0.9614106054133497,0.49784791965566716,0.9546439954185295,1.0,3/23,5.09%,EFNB2;NIBAN2;LMOD3
prerank,negative regulation of leukocyte activation (GO:0002695),0.43249321760575554,0.9613626070833128,0.5110759493670886,0.9540995397654393,1.0,2/15,2.55%,CD200;ZC3H12A
prerank,actin-myosin filament sliding (GO:0033275),0.3656250432793198,0.9610383649894815,0.5181695827725438,0.9535903822786822,1.0,2/38,1.66%,ACTN2;VIM
prerank,muscle filament sliding (GO:0030049),0.3656250432793198,0.9610383649894815,0.5181695827725438,0.9535903822786822,1.0,2/38,1.66%,ACTN2;VIM
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.38117870264026077,0.9609309090492965,0.5214814814814814,0.9532349388083452,1.0,2/25,1.44%,ARAP1;MMP9
prerank,negative regulation of cell communication (GO:0010648),-0.3223977242122332,-0.9607421435598351,0.5076452599388379,0.8456122160532676,1.0,4/21,12.47%,UBASH3B;GLRA1;SOCS5;KIF26A
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.32945172200887346,0.9606005483530013,0.532258064516129,0.9533841964749261,1.0,34/87,28.56%,COX19;NDUFV1;NDUFB11;COX16;NDUFB8;NDUFB6;NDUFS3;NDUFAB1;COX20;COA8;NDUFB7;NDUFV2;NDUFA1;NDUFB4;NDUFAF4;SMIM20;NDUFB5;SDHAF3;NDUFB9;DMAC2;NDUFA2;NDUFA12;TMEM126A;NDUFAF5;NDUFB10;UQCRFS1;SURF1;TIMMDC1;NDUFA13;COX14;NDUFAF7;NDUFB3;NDUFS4;LYRM7
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.37111676577454966,0.9603164956292134,0.500651890482399,0.9534316634042009,1.0,4/37,8.79%,OGT;FHIT;DDRGK1;PML
prerank,glucose homeostasis (GO:0042593),0.3286872686447915,0.9600203617463362,0.5040276179516686,0.9534939548357373,1.0,15/83,12.61%,PRKAA2;PPARGC1A;MCU;ALOX5;HKDC1;HECTD4;KLF7;BAD;TCF7L2;CRY2;HK1;KCNB1;PDK2;PTPN2;FOXK1
prerank,negative regulation of protein processing (GO:0010955),-0.38237276794741387,-0.9599836118384217,0.5297297297297298,0.8462010391957647,1.0,3/12,6.54%,THBS1;SERPINE2;LRRK2
prerank,response to hydrogen peroxide (GO:0042542),0.3515051085687447,0.9598821795072059,0.49226804123711343,0.9531760677189516,1.0,18/45,27.52%,MAP3K5;NFE2L2;MAPK7;HP;AQP1;TRPM2;APTX;ABL1;HDAC6;PARK7;STK24;SIRPA;RHOB;IL6;FYN;RELA;RPS3;STK25
prerank,cellular response to virus (GO:0098586),0.38715073264415506,0.959521086743162,0.5137362637362637,0.9534148484996764,1.0,7/30,15.37%,CCL5;ZC3H12A;IRF3;LGALS8;GSDME;CHUK;HSP90AA1
prerank,regulation of mitochondrial fission (GO:0090140),-0.30712900981768376,-0.9594021344246664,0.5173501577287066,0.846439731638622,1.0,7/24,14.17%,DCN;KDR;LRRK2;VPS35;FIS1;CYRIB;SPIRE1
prerank,regulation of viral transcription (GO:0046782),0.36035708051883636,0.9593816315496175,0.5065616797900262,0.953110280672507,1.0,13/39,18.96%,GTF2F1;POLR2H;TARBP2;POLR2A;TRIM21;LARP7;TRIM11;DHX9;HEXIM1;NELFB;POLR2C;POLR2E;NELFA
prerank,regulation of glucose import (GO:0046324),0.38349150131008736,0.9590725076123708,0.5138888888888888,0.9532077182633244,1.0,4/30,5.14%,SORBS1;OCLN;CREBL2;RHOQ
prerank,mesenchymal cell development (GO:0014031),-0.3475228724166681,-0.958985321753504,0.5168195718654435,0.8462010178609239,1.0,9/18,25.44%,CDH2;NOTCH1;HEYL;PDCD6;SOX11;NOLC1;HEY2;KBTBD8;KLHL12
prerank,positive regulation of protein ubiquitination (GO:0031398),0.32601675852777984,0.9589123145290682,0.5365566037735849,0.9529529426802767,1.0,24/80,24.12%,ANGPT1;CAV1;PEF1;SPSB4;CENPS;RBX1;ARRDC3;DCUN1D5;HDAC3;HSPBP1;DCUN1D1;GSK3A;UBE2N;KDM1A;XIAP;STUB1;CDK5RAP3;PHF23;FBXW7;RCHY1;TRIB3;FBXO4;FANCM;BIRC3
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.38409216760634457,0.9588976753221085,0.5164383561643836,0.952335887335009,1.0,3/29,7.30%,RAET1E;LAMP1;PVR
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.359945503167098,0.95883773763993,0.522911051212938,0.9518200314869657,1.0,2/41,1.06%,ANK2;ACTN2
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.3476266833463708,-0.9584988152104967,0.5289256198347108,0.8461831783025372,1.0,2/17,6.00%,PLA2G4A;PLAAT3
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3300629700114689,0.9584866466035294,0.5334114888628371,0.9520183735876495,1.0,7/79,2.47%,WNT1;GPC1;SMAD6;NIBAN2;NBL1;CRIM1;TRIM33
prerank,protein sumoylation (GO:0016925),0.34900334785355663,0.95842248607425,0.499359795134443,0.9515357199078679,1.0,19/49,25.46%,NUP93;EYA1;NDC1;SUMO2;SUMO3;SAE1;TRPM4;NSMCE2;PIAS1;PIAS3;AAAS;RAE1;POM121;TPR;RANBP2;NUP42;RANGAP1;NUP62;SEH1L
prerank,response to peptide hormone (GO:0043434),0.35463472926312467,0.9580565441732266,0.5220883534136547,0.9517931394096846,1.0,7/43,7.41%,OGT;CAV1;CREB1;EIF2B2;ZBTB7B;EIF6;STAT4
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.3897196954888299,0.9579537393686984,0.5292439372325249,0.9513912293367375,1.0,1/25,0.66%,ANK2
prerank,mRNA destabilization (GO:0061157),0.3705538224853263,0.9577717560117305,0.5220293724966623,0.9511791668010079,1.0,9/38,18.79%,YTHDF1;ZC3H12A;CELF1;MOV10;CPEB3;TUT7;MEX3D;YTHDF3;ROCK2
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.4547289663649885,0.9572620646839832,0.5127334465195246,0.951754281384253,1.0,1/10,1.03%,WNT1
prerank,heart looping (GO:0001947),0.358890139369667,0.9561893164226144,0.5133333333333333,0.953681450668993,1.0,3/40,2.24%,TBR1;SMO;MICAL2
prerank,regulation of striated muscle contraction (GO:0006942),0.3870201598763229,0.9561858915383911,0.5067934782608695,0.9530448756361893,1.0,2/27,2.79%,ANK2;ATP1A2
prerank,mRNA metabolic process (GO:0016071),0.3269410065294987,0.9560294444908095,0.5223713646532439,0.9527934399358935,1.0,23/90,21.54%,PPARGC1A;LSM10;DDX5;SRSF2;CELF1;SON;SNRPB;USP39;SRRM4;TBRG4;SRSF7;SF3A2;SRSF9;RNASE4;SRSF1;PTBP1;SRSF5;PCBP2;DXO;CSTF3;SF3A3;PRPF8;SFPQ
prerank,gluconeogenesis (GO:0006094),0.3667884009521907,0.9558943864427278,0.5096774193548387,0.9524988566125221,1.0,9/39,18.21%,PPARGC1A;SLC25A1;ENO2;MDH2;ALDOA;GAPDH;SLC25A12;TPI1;PCK2
prerank,inositol phosphate metabolic process (GO:0043647),0.3566437172991912,0.9556505070838924,0.5198973042362003,0.9524500375242626,1.0,11/46,15.85%,NUDT4;PLCB3;PLCD3;IP6K1;INPP4A;PPIP5K2;INPP5B;OCRL;PLCD4;PLCD1;IP6K2
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.3842968617812741,0.9555628807973447,0.5190615835777126,0.9519977364929064,1.0,8/24,18.64%,POLK;RPA3;POLD2;PCNA;LIG3;RPS27A;UBC;RFC1
prerank,mismatch repair (GO:0006298),0.38401775564914076,0.9554779600112695,0.5140845070422535,0.9515861047536033,1.0,7/27,16.81%,MLH1;MUTYH;MLH3;RPA3;POLD2;PCNA;ABL1
prerank,telomere maintenance (GO:0000723),0.3538699760460326,0.9552762975139497,0.5364916773367477,0.9514465879206149,1.0,25/50,28.15%,RECQL4;MRE11;PARP3;RIF1;HUS1B;NSMCE2;RPA3;POLD2;PCNA;ATR;SMC6;NBN;RAD50;ERCC4;TERF2;PTGES3;TINF2;APEX1;ZBTB48;RPA2;PARP1;POLD1;XRCC5;TERT;TERF1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.370552933628973,0.954992794895591,0.5272727272727272,0.951455283391121,1.0,9/35,14.83%,KANK1;RIPOR2;RASAL3;CCDC125;TGFB2;DLC1;MAPKAP1;SYNGAP1;FLCN
prerank,protein transport (GO:0015031),0.298956223676731,0.9548412018903952,0.6028368794326241,0.9511694491056762,1.0,69/332,18.12%,PRKCB;RAB17;CLU;ATP6V1B1;SCAMP5;AMN;GRTP1;KIF13A;TBC1D16;EHD1;ARL4A;COPA;AP3B1;SNX8;RAMP1;SIL1;TMED1;UNC119;ANK3;WLS;GOLPH3;GCC2;RAB3B;STXBP1;RAB7A;ARRDC3;NDC1;LMTK2;GOLGA7;MON1A;ARL6IP5;GGA1;SNX33;TOM1;SGSM2;SCAMP2;AP2A1;ARFIP2;RABL3;TBC1D1;NAPA;VIPAS39;STX11;ARF4;CHMP1A;NAPB;VPS26B;PREB;RAB5C;RAB1B;ATP6V1E1;STX16;ATP6V1D;USP6NL;NECAB3;CHMP2A;ATP6V0D1;TBC1D22A;CANX;LRP2;NSF;TBC1D10A;RAB8B;HDAC6;ARFRP1;COPG1;STX4;SEC23IP;ATP6V1B2
prerank,nuclear transport (GO:0051169),-0.3507187162635079,-0.9544580527318044,0.5180722891566265,0.8555152525197649,1.0,8/16,28.54%,XPO1;NUTF2;NXT1;NUP205;BANF1;RSRC1;NPM1;PSIP1
prerank,regulation of focal adhesion assembly (GO:0051893),0.35003038356690674,0.9540895346654124,0.5280199252801993,0.952372913521901,1.0,19/54,18.79%,PHLDB2;S100A10;DAPK3;EFNA5;DMTN;PTPRA;BCAS3;ACTG1;DLC1;EPHA3;RHOA;SFRP1;ITGB1BP1;VCL;ABL1;SLC9A1;DUSP3;PEAK1;ROCK2
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.3188887867540914,-0.9536218040626919,0.5277777777777778,0.8552138839238932,1.0,4/23,8.56%,ZEB2;DAB2;THBS1;ING2
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.3188887867540914,-0.9536218040626919,0.5277777777777778,0.8552138839238932,1.0,4/23,8.56%,ZEB2;DAB2;THBS1;ING2
prerank,mesoderm development (GO:0007498),-0.34529110084815223,-0.9532883412003207,0.5342857142857143,0.8547680152958291,1.0,6/18,13.64%,TBX3;TIE1;BMX;JAK2;TBX1;MEST
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.431034839693177,0.9531813024915667,0.5119236883942766,0.9538841916920557,1.0,2/15,4.59%,FGFR1;HSPB1
prerank,Notch signaling involved in heart development (GO:0061314),0.4547418239393289,0.9523527462332513,0.5421686746987951,0.9551706721414074,1.0,1/11,0.72%,NOTCH2
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.3298304127834902,0.9521728843945463,0.5291319857312723,0.954959537822308,1.0,10/77,8.68%,CLU;MMP9;QARS1;PIH1D1;BCL2L1;BMP4;LGALS3;MAZ;TCF7L2;NDUFS3
prerank,endosome organization (GO:0007032),0.3608473540937324,0.9521459138448757,0.5173333333333333,0.954376789884273,1.0,14/41,19.21%,ANXA8;ANXA8L1;HOOK1;SNX33;VPS11;PHETA2;EXOC8;VPS18;PLEKHJ1;PHETA1;PI4K2A;WASHC4;HOOK3;RAB27A
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.2992531400312042,0.9520600588294924,0.6016177957532861,0.9539560900117127,1.0,60/314,17.60%,FZR1;FBXL7;FBXL20;SPSB4;NFE2L2;WWP2;RNF5;TRIM25;ERLIN2;PSMD11;NSFL1C;PSMD4;PSMF1;FEM1C;FEM1A;KLHL15;UBE2G2;RMND5B;FBXL18;RBX1;FBXO31;FBXO5;ERLIN1;USP19;PML;RNF121;UBE2B;LTN1;PCNP;SIAH3;COP1;PSMD7;AGAP3;FEM1B;RNF126;ZSWIM8;PSMB5;ANAPC4;CDK2;PELI1;GSK3A;NPLOC4;RHBDD2;UBE4A;DNAJC10;NEDD4;MDM2;BFAR;MAEA;FBXL15;DDB1;ARMC8;RPS27A;UBC;UBE2D3;SIAH1;STUB1;UBE2J1;FBXL2;PSMD1
prerank,negative regulation of hemostasis (GO:1900047),0.445023009061734,0.9519507349327053,0.52099533437014,0.9535982945596283,1.0,2/12,6.08%,ADTRP;THBD
prerank,regulation of keratinocyte proliferation (GO:0010837),0.39221677870499577,0.9518795545528287,0.5180555555555556,0.9531316201393423,1.0,1/22,0.72%,NOTCH2
prerank,positive regulation of cell cycle (GO:0045787),0.3364741512903873,0.9517183980431747,0.5301062573789846,0.952886786056733,1.0,21/62,21.45%,NUPR1;CDK4;HCFC1;CCND2;TRIM21;TGFB2;PSRC1;PKD1;USP19;EIF4EBP1;CCND1;SRPK2;ANKRD17;MDM2;CDC25B;DUSP3;RARA;APP;ADAM17;USP22;USP2
prerank,cellular sodium ion homeostasis (GO:0006883),-0.3563185164207183,-0.9517075033151535,0.525,0.8575146532218539,1.0,3/15,4.92%,SLC8A1;ATP1B1;SLC12A2
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.34578464661471753,0.9515220747212287,0.5307692307692308,0.9527084671696177,1.0,5/51,2.47%,WNT1;SMAD6;NBL1;CRIM1;TRIM33
prerank,regulation of cartilage development (GO:0061035),0.4139822983446819,0.9510398316212115,0.5310136157337367,0.9532143192051246,1.0,4/18,6.80%,MBOAT2;WNT11;ZBTB16;BMP4
prerank,mitochondrial translation (GO:0032543),0.32102815321746414,0.950885667017027,0.5683371298405467,0.9529381912054199,1.0,39/104,27.04%,MRPS16;MRPL38;MRPL24;MRPL37;MRPL2;HARS1;MRPL49;MRPL33;MRPS7;MRPS34;LARS2;MRPS23;MRPS33;MRPS27;MRPL9;MRPL57;MRPS15;MRPL50;MRPS18C;MRPS28;MRPS35;GATB;GADD45GIP1;MTRF1L;MRPL19;MRPL14;MRPL32;AURKAIP1;MRPL39;MRPS25;MRPS30;MRPL54;MRPS21;MRPS22;MRPS12;MRPL35;GFM2;PTCD3;MRPL44
prerank,regulation of cellular component biogenesis (GO:0044087),0.3656381603116638,0.9508753039314859,0.5228426395939086,0.952330828102121,1.0,13/39,18.79%,TJP1;RAP1B;RAP1A;HCFC1;MSN;LATS1;EZR;VPS11;RAPGEF1;HSP90AA1;SPTY2D1;PTPN11;ROCK2
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.35493815572051357,-0.9508675033957954,0.5094850948509485,0.8583648643265785,1.0,3/14,5.34%,IL34;PTK2;THBS1
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.41528895724944315,0.9506806148208647,0.509009009009009,0.9521738175201061,1.0,3/17,10.07%,SCAMP5;UNC13D;KCNB1
prerank,positive regulation of cell cycle process (GO:0090068),-0.22847276632749894,-0.9506738467277194,0.5923076923076923,0.8575296949785414,1.0,12/91,10.25%,IGF1;SVIL;PDGFRB;TGFA;INSR;CDC14A;RGCC;CIT;IGF2;LRP5;PLSCR1;GPSM2
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.37691060103654683,0.950571594669911,0.5162200282087447,0.9518283458456092,1.0,8/29,11.91%,ELOVL1;SLC25A1;ELOVL6;ACSL3;ACSF3;ACACA;SCD5;FASN
prerank,amyloid precursor protein metabolic process (GO:0042982),0.4140500245302349,0.950542722050221,0.5138461538461538,0.9512585301868319,1.0,5/18,23.98%,ADAM10;BACE1;ADAM17;APH1A;PSEN1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.25318616811315153,-0.9503769592200816,0.5752688172043011,0.8570202265329007,1.0,17/65,14.78%,ERRFI1;HIP1;PTPRJ;TGFA;ITGA1;AFAP1L2;MVB12B;DAB2IP;SH3KBP1;ZFYVE28;PTPN12;PTPN3;GRB2;CNOT9;BCAR3;EPS15;MVB12A
prerank,protein neddylation (GO:0045116),0.4429321306392256,0.9503015654944098,0.53198127925117,0.9512040009520126,1.0,8/13,29.63%,RBX1;DCUN1D5;DCUN1D1;UBE2F;RNF7;UBE2M;UBA3;NEDD8
prerank,regulation of phosphate metabolic process (GO:0019220),0.41844469003239226,0.950208715294944,0.5061728395061729,0.9508025822177918,1.0,6/16,23.98%,SMG7;TIGAR;IGBP1;MCM7;IKBKB;PSEN1
prerank,regulation of macroautophagy (GO:0016241),0.3154464301528048,0.9500702494252373,0.5403314917127072,0.9504938067801894,1.0,35/105,23.16%,PRKAA2;ATP6V1B1;NRBP2;SESN2;TSC2;RHEB;EXOC7;EXOC4;CAPNS1;SMCR8;EXOC8;VPS26B;BNIP3L;ULK1;ATP6V1E1;GAPDH;NEDD4;ATP6V1D;IKBKG;RB1CC1;ATP6V0D1;SESN1;PRKAG1;HDAC6;LZTS1;ATP6V1B2;ATP6V0B;PRKAB1;PRKAB2;CDK5R1;GNAI3;VPS26A;UBQLN2;ATP6V0E1;CASP3
prerank,modulation by host of viral genome replication (GO:0044827),0.43792555880913614,0.9498586081578065,0.5443234836702955,0.9504109627692027,1.0,5/13,23.47%,ZC3H12A;EIF2AK4;FBXL2;NUCKS1;VAPA
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.2834933926237635,-0.9497618828289676,0.5735849056603773,0.8573534686036776,1.0,13/36,19.67%,HIF1A;WNT5A;GAS6;AXL;PARP14;NLRC5;IRGM;CASP4;RIPK1;EDN1;CD74;CSF1;AGPAT2
prerank,mRNA 3'-end processing (GO:0031124),0.33047112578435767,0.9493365046728146,0.5375446960667462,0.9509550671994593,1.0,29/78,23.48%,SRSF2;AHCYL1;EIF4A3;DDX39B;RBM8A;WDR33;RPRD2;SRSF7;POLDIP3;THOC7;RNPS1;CSTF1;SRSF9;UPF3B;GRSF1;PABPN1;MAGOHB;MAGOH;CLP1;SRSF1;SRSF5;APP;CSTF3;THOC1;TUT1;U2AF1;PABPC1;SRRM1;LEO1
prerank,response to calcium ion (GO:0051592),-0.22333243056995283,-0.9492903179565723,0.5555555555555556,0.8572978209450645,1.0,16/102,7.83%,CPNE8;STIM1;ADGRV1;TRPC3;WNT5A;CAMK2D;RASGRP2;CPNE4;PKD2;SYT9;PRKAA1;THBS1;SYT1;NLGN1;ADCY1;MCOLN1
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.3964319681505656,0.9490947115126056,0.5224312590448625,0.9508648046580399,1.0,5/21,11.88%,CHST12;CHST11;CHPF;CHST13;CHPF2
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.4038368499764069,0.9490438582354286,0.5370919881305638,0.9503645399428989,1.0,2/19,2.01%,TJP1;OCLN
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.34419352808513887,0.9490087439238767,0.5411622276029056,0.949814442934184,1.0,19/56,21.71%,ARL3;SON;UNC119;ANK3;CHMP4B;RAB35;SNX33;SNX18;RHOA;EFHC2;JTB;RASA1;SEPTIN9;VPS4A;PDCD6IP;ROCK2;IST1;MITD1;RHOC
prerank,regulation of store-operated calcium entry (GO:2001256),0.46349309914430376,0.9487017337825475,0.5440931780366056,0.9499125363479469,1.0,2/10,3.43%,HOMER2;HOMER3
prerank,protein heterooligomerization (GO:0051291),-0.34336285302088243,-0.9486847716155808,0.5015873015873016,0.8575869560051707,1.0,5/17,11.71%,PKD2;GRIN2B;MAT2A;NUDT21;CPSF6
prerank,regulation of protein binding (GO:0043393),0.3146334883287787,0.9485291116144888,0.5544217687074829,0.9496902565543566,1.0,28/114,19.46%,CFHR1;CDKN1A;GTF2F1;CAV1;SLPI;HDAC5;PPP2CA;HDAC4;CTSZ;ADD1;BMP4;TRIM21;PKD1;TCF7L2;ACTB;CARD16;CSNK1E;CAPRIN2;TLE5;GSK3B;ITGB1BP1;CRK;KDM1A;SPPL3;PARK7;IDE;APP;FLOT1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.42890093761527537,0.9480495013000405,0.5071542130365659,0.9501934151493264,1.0,6/13,25.49%,PPP1R15A;DDRGK1;BFAR;ABCA7;PPP1R15B;NCK1
prerank,tRNA processing (GO:0008033),0.3403778477459942,0.9479500380898742,0.5266272189349113,0.9498070812950814,1.0,23/61,24.31%,FARS2;LCMT2;TRPT1;ELP5;TRIT1;POP1;THG1L;AARS1;ANKRD16;RPP21;SARS1;TRNT1;CTU1;CLP1;TSEN2;TRMT10B;CTU2;TYW5;RPP40;NSUN6;FAM98B;URM1;KARS1
prerank,cardiac ventricle development (GO:0003231),-0.32215792917537883,-0.9478730367145084,0.5120481927710844,0.8583380908498411,1.0,5/20,9.95%,ENG;NOTCH1;SALL1;HEYL;PDE2A
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.4246578080344734,0.9476952308738262,0.5117739403453689,0.9497591680869417,1.0,2/15,4.06%,EDA;WNT6
prerank,pre-miRNA processing (GO:0031054),-0.3567876964998816,-0.9476661489486431,0.5303867403314917,0.8575925259159727,1.0,6/14,21.85%,TUT4;ADAR;DROSHA;AGO1;AGO4;DICER1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.4490883123967561,0.9472760710474561,0.5351014040561622,0.9501430637120629,1.0,3/11,11.60%,CCL5;ANK3;JAK1
prerank,response to glucagon (GO:0033762),-0.33128760953752256,-0.9469857338340103,0.5443425076452599,0.8580575427666399,1.0,11/19,22.44%,ADCY5;ADCY7;ADCY1;ADCY4;CRY1;PRKAR2B;CYSLTR2;ADCY2;PRKAR1B;ADCY3;ADCY8
prerank,catecholamine biosynthetic process (GO:0042423),-0.38743001550019074,-0.946019260861228,0.5346534653465347,0.8592563349396909,1.0,2/11,8.12%,MOXD1;GCH1
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.37804402386713243,-0.9459908672303023,0.5229591836734694,0.8580541237897206,1.0,2/12,3.31%,MAP2;STMN2
prerank,base-excision repair (GO:0006284),0.3427932950481758,0.9457209159015477,0.5152671755725191,0.9531818040073603,1.0,14/48,20.43%,FEN1;MUTYH;POLG;ERCC5;MBD4;RPA3;POLD2;PCNA;LIG3;NEIL1;PARG;RFC1;PNKP;APEX2
prerank,protein-containing complex disassembly (GO:0032984),0.3387362281330208,0.9456731060692228,0.5332480818414322,0.9526855853457907,1.0,16/54,19.79%,WNT1;CAV1;RUBCNL;DVL3;FZD5;VTI1B;VIPAS39;MYC;VPS4A;VAMP7;GSK3B;PYM1;MAP1LC3B;TSG101;FZD2;UVRAG
prerank,regulation of interleukin-1 production (GO:0032652),-0.35413909687102607,-0.9452694465963786,0.5487465181058496,0.8586100904585008,1.0,2/15,3.04%,GAS6;TMED10
prerank,regulation of BMP signaling pathway (GO:0030510),0.3267325852260816,0.9452227163273618,0.5516014234875445,0.9531228634810055,1.0,19/73,17.75%,WNT1;SMAD6;NBL1;CRIM1;TRIM33;TWSG1;CRB2;FOXD1;BMP4;DAND5;RBPMS2;FBXL15;LRP2;UBE2D3;XIAP;SMAD5;CDH5;NUMA1;BMPR1A
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.36021107527233875,0.9451472773253524,0.5413929040735874,0.9526664224581605,1.0,6/37,11.15%,IL17RA;ZC3H12A;ABCD1;ALOX5;TLR6;TLR4
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.26116665712625053,-0.9447909386968842,0.5555555555555556,0.8586241683233492,1.0,20/50,20.46%,DCDC2;IFT81;MOSMO;IFT122;RORA;TULP3;GLI1;ARMC9;FGFR2;MEGF8;DLG5;RACK1;KCTD21;BTRC;KIF7;INTU;ULK3;PTCH2;GAS1;FUZ
prerank,cellular response to ATP (GO:0071318),-0.3546035853461185,-0.9447271497446459,0.5376044568245125,0.8575065736011205,1.0,5/14,27.99%,SSH1;P2RY1;P2RY12;CIB2;TAF1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.45152731148282554,0.9447153260015013,0.5406779661016949,0.9530569163503322,1.0,3/10,14.55%,ATP1A2;STK39;NEDD4
prerank,regulation of receptor binding (GO:1900120),0.4574650094056452,0.9442010333668046,0.5296167247386759,0.9536297169218341,1.0,3/10,10.43%,MMP9;PTPRF;ADAM15
prerank,positive regulation of proteolysis (GO:0045862),0.3410233802473351,0.9439993703082115,0.54125,0.9534631686798498,1.0,14/55,20.35%,CYFIP2;OGT;ZC3H12A;PERP;BAD;ATP5IF1;SNX33;TNIP1;CTSH;TBC1D10A;STUB1;GPLD1;IST1;RHBDD1
prerank,regulation of cellular biosynthetic process (GO:0031326),0.3734993029578396,0.9439598191055409,0.5405405405405406,0.9529388271019424,1.0,5/28,7.24%,PRKAA2;CCL5;CTNS;AVIL;EIF6
prerank,positive regulation of secretion by cell (GO:1903532),0.3288270396014142,0.9438001074195007,0.5545134818288394,0.9526963288512184,1.0,11/70,10.66%,CFTR;SYTL4;UNC13D;GOLPH3;TGFB2;ANG;EZR;APBB1;KCNB1;IER3IP1;GRK2
prerank,electron transport chain (GO:0022900),0.425668104164469,0.9437478134994667,0.562111801242236,0.952195237221214,1.0,3/15,9.43%,PPARGC1A;SDHB;CYB561
prerank,mitotic chromosome condensation (GO:0007076),0.3859845614692635,0.9433133363759628,0.5443213296398892,0.9526013680679299,1.0,10/26,23.00%,TENT4A;NCAPD3;CHMP1A;SET;NCAPH2;RB1;PHF13;NCAPH;SMC4;KMT5A
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.2802285214888808,-0.9431756072658294,0.5642023346303502,0.8601944244688253,1.0,6/34,7.85%,PTPRB;PTPRJ;UBASH3B;TNS2;PTPN12;PTPRZ1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.3791217849525688,0.9429693238909379,0.5329428989751098,0.9527445077117017,1.0,5/26,8.61%,PRKAA2;ERLIN2;EIF6;ACADL;ERLIN1
prerank,regulation of cytokinesis (GO:0032465),0.32834759316193224,0.9426208989161761,0.5619930475086906,0.9529204895171911,1.0,21/78,20.46%,PKP4;KIF13A;RAB11FIP3;BCL2L1;KLHL21;ZFYVE19;PLK3;CDC42;AURKC;RHOA;KLHL13;VPS4A;FLCN;PLK2;CDC25B;GIT1;ZFYVE26;KIF20B;UVRAG;CSPP1;PIK3R4
prerank,sodium ion homeostasis (GO:0055078),-0.31566884298837256,-0.942562954379144,0.5384615384615384,0.8605065855665809,1.0,3/21,4.92%,SLC8A1;ATP1B1;SLC12A2
prerank,protein targeting to peroxisome (GO:0006625),0.36798643129429404,0.9424368743403234,0.5338753387533876,0.952719568104734,1.0,9/29,18.71%,PEX26;ABCD1;SLC25A17;ZFAND6;PXMP4;PEX6;RAB8B;PEX3;PEX2
prerank,mitochondrial protein processing (GO:0034982),0.4543462465948048,0.9419472001537091,0.5409836065573771,0.9532814665575373,1.0,4/11,19.86%,PMPCA;AFG3L2;SPG7;STOML2
prerank,negative regulation of dephosphorylation (GO:0035305),0.4112194971170159,0.9418976706400485,0.54,0.9527599760771839,1.0,4/18,8.93%,SH3RF2;PPP1R15A;CHP1;YWHAB
prerank,positive regulation of ATP metabolic process (GO:1903580),0.3740967808118222,0.9416621034405724,0.536813922356091,0.9526822804697066,1.0,5/32,6.59%,PRKAA2;PPARGC1A;NUPR1;BEND3;PFKFB2
prerank,cellular amino acid catabolic process (GO:0009063),0.32054323441623445,0.9412341357020777,0.5538990825688074,0.9530352486092133,1.0,26/87,22.69%,GLUL;CARNMT1;TDO2;PIPOX;GLUD1;ABAT;SHMT1;CARNS1;AMT;SLC25A44;SLC25A21;AUH;OGDH;BCAT2;IVD;DLST;HAAO;PRODH;ECHS1;MCCC2;KYAT1;HSD17B10;GAD1;SARDH;BLMH;GCDH
prerank,negative regulation of proteolysis (GO:0045861),0.36149061519870185,0.9411879980200413,0.5472972972972973,0.9525259021555629,1.0,5/34,7.36%,EPHA4;TIMP4;TIMP1;TIMP2;TRIM21
prerank,DNA strand elongation (GO:0022616),0.41528086175697315,0.9409406305298398,0.5384615384615384,0.9525310294339792,1.0,7/18,21.59%,MRE11;POLD2;NBN;MCM7;RAD50;GINS3;MCM4
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.3557539154874326,0.9407233564047396,0.5491480996068152,0.9524491744540223,1.0,7/41,11.78%,ACOT8;ABCD1;EPHX1;ELOVL1;ALOX5;FADS1;SCD5
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.34431096069158973,0.9405664259016044,0.5508155583437893,0.9521961627756091,1.0,6/57,4.45%,CRLF1;CCL5;IL15;PPP2CA;CLCF1;EPO
prerank,cGMP biosynthetic process (GO:0006182),-0.398125713245972,-0.9403903228920081,0.5561097256857855,0.8649538370224195,1.0,3/10,10.43%,GUCY1B1;GUCY1A1;NPR1
prerank,regulation of cation transmembrane transport (GO:1904062),-0.2921249887502358,-0.9403174794077841,0.5538461538461539,0.8638604757328444,1.0,7/29,13.20%,DPP10;KCNN2;KCNIP4;KCNIP3;FGF12;KCNIP1;DPP6
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.3206630034704652,-0.9402937085296498,0.5508982035928144,0.862656641116487,1.0,5/22,6.31%,LYN;MFHAS1;DAB2IP;APPL2;NR1H3
prerank,response to steroid hormone (GO:0048545),0.36324850979453505,0.9400090840762036,0.5203804347826086,0.9528500694218174,1.0,5/31,11.06%,ADTRP;CAV1;ATP1A2;TGFB2;ABCA2
prerank,regulation of fat cell differentiation (GO:0045598),0.32778259591371894,0.9397368577195221,0.5475372279495991,0.9528684765522718,1.0,21/74,19.14%,WNT1;TRIB2;RORC;ZC3H12A;CREBL2;ZBTB16;ALOX5;CREB1;WDFY2;AAMDC;TRIO;TRPM4;GATA3;SFRP1;CCDC85B;LRP3;FRZB;E2F1;CDS1;TAF8;GPER1
prerank,receptor catabolic process (GO:0032801),-0.3144178045899991,-0.9393433335073925,0.5794701986754967,0.8638012758541719,1.0,7/24,8.81%,SNX25;ZNRF3;CLTA;MYLIP;TGFB1;AP2B1;SH3GLB1
prerank,photoperiodism (GO:0009648),-0.2947049431206148,-0.9388853249738615,0.5740740740740741,0.8637136406936103,1.0,7/28,13.93%,PPP1CC;SIK1;ID2;CRY1;TP53;PER3;BHLHE40
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.3483443519692293,0.9388243498652395,0.5475285171102662,0.9543494052025501,1.0,5/49,4.45%,CRLF1;CCL5;IL15;CLCF1;EPO
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.2776957169908888,-0.9386140370231097,0.5,0.8630990725021818,1.0,15/38,19.51%,SP100;NOS3;FAS;THBS1;RFFL;TNFSF10;CFLAR;ARHGEF2;RIPK1;GPX1;ICAM1;RNF34;FAIM2;TRADD;TNFAIP3
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.26169797568174646,-0.9385080894793343,0.5594713656387665,0.8621576550686908,1.0,7/46,6.41%,TIMP3;SEMA6A;LYN;WNK2;DAB2IP;EPHB2;RANBP9
prerank,protein mannosylation (GO:0035268),0.3919634140926087,0.9383473165864357,0.5207715133531158,0.9548901937054838,1.0,3/22,4.29%,B4GAT1;TMTC1;LARGE1
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.33935825911460316,-0.9379734707855683,0.5390835579514824,0.8623267127349377,1.0,8/17,23.42%,SULF1;ZDHHC17;SLIT2;SFRP4;TMEM204;PCSK6;FSTL3;DOK5
prerank,lipoprotein biosynthetic process (GO:0042158),-0.37717818202072284,-0.9379651047080555,0.5459459459459459,0.8610955719914366,1.0,3/11,18.16%,UGCG;PIK3C3;ATG10
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.2952259744368386,-0.937949387581389,0.5836298932384342,0.8598872526004256,1.0,7/27,13.93%,PPP1CC;SIK1;ID2;CRY1;TP53;PER3;BHLHE40
prerank,mRNA modification (GO:0016556),-0.3128852878667566,-0.9378273516904311,0.532051282051282,0.858966296569155,1.0,6/22,16.23%,METTL8;PUS7;METTL16;TRMT61B;DKC1;TRMT6
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.4471342541842348,0.9376805205289911,0.5639344262295082,0.9557684918831018,1.0,1/12,0.83%,UNC13C
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.2803289637624291,-0.9374196060299668,0.5780590717299579,0.8588333993398729,1.0,9/36,17.61%,TGFA;SHANK3;HIF1A;EPHB2;JAK2;NLGN3;EDN1;EGF;HDAC2
prerank,skeletal system development (GO:0001501),0.3081211073192392,0.9371941507316477,0.5786096256684492,0.9562499425627786,1.0,11/148,4.37%,TNFRSF11B;KIAA1217;FGFR1;CD44;ITGB8;WNT1;ANKH;AKAP13;WNT11;BMP5;ZBTB16
prerank,positive regulation of phosphatase activity (GO:0010922),-0.31734804335388145,-0.9370151567122815,0.5629139072847682,0.8585917976508247,1.0,2/21,0.77%,PDGFRB;ITGA1
prerank,microtubule depolymerization (GO:0007019),-0.33606430003122173,-0.9368755866496795,0.5246376811594203,0.8576708096157856,1.0,11/17,34.31%,STMN2;NCKAP5;KIF18A;STMN3;CKAP5;STMN4;KIF18B;KIF14;NCKAP5L;CCSAP;KIF19
prerank,regulation of receptor internalization (GO:0002090),0.36327610088873685,0.9368681860189575,0.5383580080753702,0.9564109450611502,1.0,2/35,2.29%,ANGPT1;MAGI2
prerank,toll-like receptor signaling pathway (GO:0002224),0.3170368832785456,0.9367347030654918,0.5572082379862701,0.9560983951050285,1.0,34/84,25.96%,SCARA3;TAB3;LBP;TLR6;NMI;CNPY3;TLR4;S100A1;IRAK1;CHUK;TNIP1;TLR3;IKBKG;ITGB2;RPS27A;UBC;COLEC12;UBE2D3;MAPKAPK2;TAB2;SFTPA1;SFTPA2;IRAK4;MAP3K1;PIK3R4;CTSK;TLR1;EPG5;TLR5;IKBKB;BIRC3;LY96;CASP8;TAB1
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.3487752628181446,-0.9361921260250664,0.5377643504531722,0.8581665400592646,1.0,7/15,20.98%,ENTPD1;CMPK2;NME2;AK4;ENTPD3;ENTPD5;ENTPD6
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.3801336876315072,0.9359057807299788,0.5610795454545454,0.957439645234786,1.0,5/28,7.62%,MAP3K5;BBC3;TMEM117;PPP1R15A;TNFRSF10B
prerank,eye morphogenesis (GO:0048592),-0.3358408182051721,-0.9357763305194005,0.5544554455445545,0.857912262701454,1.0,8/19,13.56%,FBN1;MFAP5;COL5A1;IFT122;FBN2;NF1;STAT3;NIPBL
prerank,embryonic digit morphogenesis (GO:0042733),-0.33079372163058834,-0.9356523304084937,0.5210084033613446,0.8570020835754801,1.0,7/18,17.61%,ECE1;TBX3;SALL1;TBX2;INTU;WDPCP;HDAC2
prerank,vasculogenesis (GO:0001570),-0.28947607768815237,-0.9349140122838374,0.5551724137931034,0.8576444628015962,1.0,13/32,17.33%,PDGFRB;ENG;GLMN;KDR;NOTCH1;TGFB1;SOX17;RAMP2;RASIP1;EGFL7;ADM;SOX18;SPRED1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.395038531594584,0.9348884624669656,0.5311572700296736,0.9591860115080489,1.0,2/19,3.24%,SULT1A1;SULT2B1
prerank,leukotriene biosynthetic process (GO:0019370),-0.35404240783768126,-0.9347966189442043,0.5313351498637602,0.8567211988312108,1.0,2/14,3.96%,PLA2G4A;GGT5
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.4216045976653816,0.934604997321308,0.5375,0.9592443399365427,1.0,6/14,23.84%,SEC23A;SEC24B;SEC31B;MIA3;SEC31A;SEC24D
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.4123135387343426,0.9340724603291188,0.5491679273827534,0.9598980206813432,1.0,2/18,1.46%,FGFR1;COL4A3
prerank,peptidyl-lysine monomethylation (GO:0018026),0.46269598871136225,0.9337037446028924,0.5622950819672131,0.9601160692029956,1.0,7/10,30.75%,SETD7;KMT5A;SMYD2;EHMT1;EEF1AKMT2;METTL18;SETD6
prerank,nuclear pore organization (GO:0006999),0.41486770189356204,0.9336576971319975,0.5403726708074534,0.9596007190464715,1.0,8/14,28.93%,NUP93;NDC1;TPR;SEH1L;NUP133;TMEM170A;RTN4;NUP35
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.381860802417047,-0.9336472698029225,0.5443037974683544,0.8583487009557289,1.0,2/11,1.33%,JAG1;ZFPM2
prerank,positive regulation of DNA binding (GO:0043388),0.3708080949859737,0.933536643013979,0.5578512396694215,0.9592824240690885,1.0,9/31,19.72%,MMP9;NIBAN2;NGF;TWIST1;GATA3;PINX1;POU4F1;PARK7;RB1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.3317109873336476,0.9335282719336373,0.5578313253012048,0.958685431492913,1.0,10/59,11.51%,OSBPL9;ACOT8;ALOX5;GAMT;CYP39A1;ACSM3;NDUFAB1;ACSF3;OSBPL7;ACACA
prerank,protein acetylation (GO:0006473),0.35941916555850617,0.9326683799251784,0.5402777777777777,0.960072900651599,1.0,9/30,21.64%,EP300;NAA40;AANAT;NAA15;ING4;NAA10;MAPT;NAA35;HAT1
prerank,histone monoubiquitination (GO:0010390),-0.3039415645242276,-0.9326612942769108,0.5589225589225589,0.8595226978921294,1.0,8/24,23.37%,CUL4B;WAC;BCOR;DTX3L;KDM2B;PAF1;RYBP;RNF2
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.30957192962971936,-0.9326523630809718,0.5358255451713395,0.8583212990820602,1.0,2/24,0.85%,PID1;LEPR
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.31839335761013626,0.9321341194531678,0.5755813953488372,0.9606694391490733,1.0,26/88,16.31%,STXBP6;CORO7;BLOC1S6;VPS13A;ARL3;EXOC4;MON2;GOLGA7;MYO5A;STEAP2;EXOC2;AP1S3;SCAMP2;AP2A1;NAPA;SH3GL2;GOLGB1;AP1M1;EXOC8;AP1S2;VAMP7;OSBPL5;CHMP2A;AP4E1;CCDC22;AP1B1
prerank,double-strand break repair (GO:0006302),0.3007529215086318,0.9319958723194751,0.5985010706638115,0.9603932514936954,1.0,44/158,22.42%,FEN1;RECQL4;KDM4D;NABP2;KDM4B;RNF138;MRE11;EYA1;PARP3;TENT4A;RIF1;APBB1;RMI1;HUS1B;MDC1;NSMCE2;ABRAXAS1;MMS22L;ERCC5;PAXX;RPA3;APTX;MCM8;FAN1;UBE2N;PRPF19;DCLRE1C;LIG3;SFR1;SMC6;NBN;CHEK2;RAD50;PARP2;ZFYVE26;NUCKS1;ERCC4;NABP1;POLN;YY1;SFPQ;SWI5;RNF168;NSMCE1
prerank,endocrine system development (GO:0035270),-0.3213937506554351,-0.9318920062059577,0.5625,0.8589485047125643,1.0,6/21,13.45%,GLI2;WNT4;DKK3;SALL1;NF1;TBX1
prerank,cellular response to glucose stimulus (GO:0071333),-0.28638019913285084,-0.931733768707004,0.5807692307692308,0.8581126652464809,1.0,8/30,12.35%,UNC13B;ZBTB20;GAS6;PRKAA1;RAB11FIP2;RAB11B;IGF1R;RACK1
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.37139200866551164,0.9317071926863315,0.5345997286295794,0.9604155124453946,1.0,4/29,6.02%,KANK1;TJP1;SSH3;TWF1
prerank,wound healing (GO:0042060),-0.24597944437620772,-0.9315492864777235,0.6,0.8573531014551605,1.0,22/62,24.28%,IGF1;WNT5A;PDGFRA;DYSF;FGF2;MYOF;CFLAR;NF1;PPP3CA;MACF1;CLDN1;SMAD3;ANXA6;DCBLD2;PRCP;TSKU;EPB41L4B;JAML;SRF;CORO1B;DSP;PAK1
prerank,mRNA processing (GO:0006397),0.2938933365248294,0.9311096833063838,0.6378433367243134,0.9611732944089421,1.0,93/287,25.55%,PPARGC1A;DDX5;GTF2F1;SRSF2;CELF1;RBM19;POLR2H;SNRNP70;SON;SNRPB;POLR2A;SRRM2;EIF4A3;RALY;LSM4;DDX39B;RBM8A;HNRNPH2;WDR33;PHF5A;DBR1;RPRD2;SF3B3;USP39;MTREX;SRRM4;TBRG4;SRSF7;SF3A2;POLDIP3;ZCCHC8;THOC7;FRG1;HNRNPUL1;GPATCH1;SYNCRIP;RBM10;RNPS1;PNN;CSTF1;SRSF9;SRRT;UPF3B;GEMIN6;PLRG1;ISY1;DHX9;PABPN1;CWC15;CDC5L;MAGOHB;MAGOH;PRPF19;CLP1;ERCC2;PRPF40B;PRPF6;POLR2C;HNRNPA3;SRSF1;PPIL1;POLR2E;PTBP1;SRSF5;ZMAT5;PCBP2;CSTF3;WBP4;SF3A3;THOC1;PUF60;PRPF8;SFPQ;YBX1;DDX23;GEMIN5;U2AF1;PABPC1;RBM15;SPEN;SRRM1;AURKAIP1;PRKACA;CMTR2;DDX46;CWF19L1;SNRPB2;MNAT1;POLR2K;CPSF7;GEMIN2;RBM15B;LSM5
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.30974658720276194,0.9310133245045294,0.5980176211453745,0.960774801347702,1.0,14/118,8.32%,PHLDB2;PDLIM5;FMNL2;EPHA4;DAG1;EMP2;SIPA1L1;CRB2;GDNF;ZMYM6;CAPZB;EFNA5;SRCIN1;STRIP1
prerank,atrioventricular valve morphogenesis (GO:0003181),0.39611167109493256,0.9306761141968255,0.5375191424196019,0.9609458543073994,1.0,9/19,24.29%,SMAD6;OLFM1;TGFB2;TGFBR2;BMPR1A;SOX4;EFNA1;MDM4;ZFPM1
prerank,regulation of neuron projection arborization (GO:0150011),-0.3523542440554369,-0.930467456218649,0.5432835820895522,0.8588674611066207,1.0,6/15,13.67%,WNT5A;MYO9A;FZD4;NTNG1;MACF1;MFSD2A
prerank,mitochondrial genome maintenance (GO:0000002),-0.36792339776463906,-0.9302939817849323,0.5592783505154639,0.8580569622116567,1.0,3/11,12.36%,AKT3;SLC25A33;TOP3A
prerank,midbody abscission (GO:0061952),0.4147614220494506,0.9302856390944335,0.5567651632970451,0.9611832557236173,1.0,10/17,26.58%,CHMP4A;CHMP4B;VPS4B;CHMP1A;VPS4A;CHMP2A;PDCD6IP;MITD1;CHMP5;CHMP1B
prerank,insulin secretion (GO:0030073),0.4054149661231815,0.9302809164516566,0.5486725663716814,0.9605827782219258,1.0,7/19,27.58%,GAL;RAB11FIP5;PARK7;ADCYAP1;CYB5R4;PTPRN;PTPRN2
prerank,negative regulation of cellular component movement (GO:0051271),0.41746949913731213,0.9300963879724508,0.5297805642633229,0.9603844923358327,1.0,7/15,16.37%,SPINT2;CD9;FBLN1;CCDC125;GATA3;TGFBR3;CRK
prerank,positive regulation of lamellipodium organization (GO:1902745),0.36144824410335136,0.9300882351736537,0.5446194225721784,0.9597916177546636,1.0,7/32,17.04%,WNT1;OCLN;AVIL;CDC42;RREB1;FSCN1;ARPC2
prerank,striated muscle cell differentiation (GO:0051146),-0.33798532955097166,-0.9298381506694984,0.5272727272727272,0.8579427876756754,1.0,6/16,16.09%,MYEF2;KDM6B;SIK1;SORT1;CBY1;MYOCD
prerank,synaptic vesicle transport (GO:0048489),0.4367272972045159,0.9293934860835159,0.5466237942122186,0.9607645792752743,1.0,7/11,30.76%,TOR1A;TMEM230;RAB27A;KIF5A;SYNJ1;KIF5C;DNM2
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.43548357170775354,0.92895438495092,0.5632530120481928,0.9610980288959936,1.0,2/12,8.74%,STARD3;FDX1
prerank,glutathione derivative metabolic process (GO:1901685),0.3919548994843784,0.9287839411650536,0.546242774566474,0.9602564718132223,1.0,5/20,15.84%,MGST3;GSTO1;HPGDS;GSTK1;GSTM2
prerank,glutathione derivative biosynthetic process (GO:1901687),0.3919548994843784,0.9287839411650536,0.546242774566474,0.9602564718132223,1.0,5/20,15.84%,MGST3;GSTO1;HPGDS;GSTK1;GSTM2
prerank,regulation of DNA binding (GO:0051101),0.3474197602914026,0.9287336837185053,0.5597402597402598,0.9597746825012972,1.0,8/44,10.68%,SMO;MMP9;NGF;DOT1L;NFKBIA;JUN;SUMO3;HABP4
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.2883648493858952,0.9287130078245894,0.6966966966966966,0.9592147120053022,1.0,107/572,16.87%,THRB;PRDM6;TMPRSS6;KLF4;TFAP2C;SREBF2;RORC;FOXP2;GLI3;DDX5;TRIM33;HIVEP1;KLF12;CAV1;FOXP4;ZNF436;EP300;HDAC5;ZMYM5;ZNF692;MXD4;KANK2;FOXO3;FOXC2;ZNF219;GLIS2;CGGBP1;HDAC4;NR6A1;ZBTB16;EPO;WWP2;MTDH;BEND3;RARG;PHF21A;LCOR;FOXM1;OTUD7B;HCFC1;ZBTB7B;BMP4;CC2D1A;KLF7;NKAP;PLK3;ZFHX3;LARP7;PPM1A;ATRX;MAZ;JUN;TCF7L2;CRY2;ZFP57;FOXP3;DPF2;BAG3;NR2C1;DNMT3A;RIF1;EZR;APBB1;CCND1;NFIB;SAP130;TWIST1;HDAC3;ZNF205;NFIC;SP2;SMARCA4;NCOR1;DR1;ZNF148;MIER2;MAFK;CPEB3;CHD3;GATA3;RREB1;CBX4;MYC;ZNF177;MEF2C;TLE5;PCGF2;FOXP1;SARS1;IRF2;NCOR2;NEDD4;GATAD2B;FLCN;MDM2;IGBP1;HMBOX1;TCF25;ZGPAT;IRF2BP2;RPS27A;UBC;HEXIM1;E2F1;POU4F1;KDM1A;UBE2D3
prerank,regulation of cell cycle process (GO:0010564),0.3153772460728348,0.9284819904830364,0.5980066445182725,0.9591348420440238,1.0,37/104,26.81%,KIF13A;DAPK3;RAB11FIP3;CAV2;BCL2L1;KLHL21;PLK3;CDC42;AURKC;FBXO5;USP19;PKMYT1;KLHL13;MARK4;SFRP1;FLCN;PLK2;MAD1L1;CUL9;DYNC1H1;GIT1;NUMA1;ZFYVE26;KIF20B;GPER1;UVRAG;PIK3R4;PLK5;CCDC8;PLK4;E4F1;RACGAP1;IHO1;CALM2;CDK13;PRPF40A;SND1
prerank,genitalia development (GO:0048806),-0.3599387608619856,-0.9283826592529252,0.5311720698254364,0.8604311199847413,1.0,4/12,7.99%,WNT5A;TBX3;CHD7;DNAJC19
prerank,epithelial tube morphogenesis (GO:0060562),-0.2838384691837105,-0.9281785992918138,0.5968992248062015,0.8597009803783001,1.0,9/32,14.11%,GLI2;ACVRL1;COL4A1;PKD2;SLIT2;SOX17;MEGF8;RASIP1;RYR2
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.40140601742236004,0.9281420552495332,0.5616835994194485,0.9592401602635638,1.0,6/18,18.46%,NFE2L2;HSPB1;MAPK7;SOD2;VNN1;PARK7
prerank,negative regulation of cellular component organization (GO:0051129),0.32258705361031037,0.928080015581963,0.5699052132701422,0.9587784827370938,1.0,17/74,17.34%,CLU;SCAMP5;EP300;TMEFF2;CRYAB;RUBCN;LGALS3;CDC42;RAF1;SNX33;RAPGEF3;EPHA3;ULK1;GSK3B;SYT11;PRKCZ;HDAC6
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.4111643134130054,0.9280744947753766,0.5605095541401274,0.9581840955414903,1.0,3/16,7.16%,DDX5;RBFOX2;EGLN2
prerank,RNA stabilization (GO:0043489),-0.2732062752417991,-0.9280441440601164,0.6162790697674418,0.8587861139766846,1.0,14/33,29.03%,TENT5A;ZCCHC17;EIF4ENIF1;AXIN2;DKC1;PARN;TENT5D;NOCT;TENT2;PHAX;SLC11A1;DHX36;RBM24;ELAVL1
prerank,regulation of chromatin organization (GO:1902275),0.41722443531354125,0.9277146905207697,0.5510835913312694,0.9584060607022095,1.0,2/14,7.01%,MLLT3;SSRP1
prerank,protein modification by small protein removal (GO:0070646),0.2908181473987903,0.9271763941355913,0.6529351184346035,0.9589869341402655,1.0,72/252,24.42%,CFTR;OGT;ZC3H12A;EP300;USP46;USP29;OTUD1;NFKBIA;PSMD11;USP10;USP32;OTUD7B;HCFC1;PSMD4;PSMF1;DESI2;DESI1;USP19;ACTB;USP20;TOR1A;USP24;PSMD7;USP42;USP3;RHOA;RNF123;COPS5;ABRAXAS1;TOMM20;FOXK1;MYSM1;PSMB5;GATA3;SENP3;MYC;TNIP1;MDM2;IKBKG;USP28;RPS27A;UBC;OTUD6B;KEAP1;TRRAP;PSMD1;USP25;STAM;PSMC4;USP16;USP21;TAF9B;PSMD8;INO80D;USP22;INO80C;USP2;YY1;USP11;INO80E;SMURF2;WDR20;MDM4;PSMA7;TADA3;USP13;TFPT;MBD6;BIRC3;CDC25A;STAM2;USP34
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.38353645773807277,0.9270469249403037,0.5496402877697841,0.9586884943049527,1.0,8/24,15.65%,ANK3;CHP1;MIEF2;MYO1C;KCNB1;HRAS;ITGB1BP1;ITGB2
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.33425921628174227,0.9266959732027616,0.5760869565217391,0.9588419864992268,1.0,6/57,10.21%,LPAR1;CHRM1;ADCY9;ADCY6;HTR1B;AKAP5
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.3159239206786352,-0.9265934594248016,0.5700325732899023,0.8611537179388126,1.0,11/23,19.13%,ENPP1;MOSMO;IFT122;TULP3;MEGF8;RACK1;KCTD21;BTRC;KIF7;ULK3;PTCH2
prerank,regulation of lipase activity (GO:0060191),-0.3538342514402031,-0.9263063460899689,0.5775401069518716,0.8606634781070157,1.0,1/13,0.56%,PCSK5
prerank,monosaccharide transmembrane transport (GO:0015749),0.40053672274582086,0.9260952456770261,0.5395569620253164,0.9595844421480074,1.0,3/16,12.58%,SLC2A12;SLC2A8;SLC2A9
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.3044907812678598,-0.9260585564421208,0.5644171779141104,0.8601316908940846,1.0,10/22,27.32%,ESR1;PSMC6;MED4;TP53;PAXIP1;MED16;SRF;SUB1;MED14;DHX36
prerank,protein import into peroxisome membrane (GO:0045046),0.3801325714509146,0.9257456693481187,0.5430183356840621,0.9597722514946182,1.0,7/22,18.71%,PEX26;ABCD1;SLC25A17;PXMP4;RAB8B;PEX3;PEX2
prerank,positive regulation of protein kinase activity (GO:0045860),0.29953297643006943,0.925743602010452,0.6175213675213675,0.9591742286187135,1.0,17/148,9.39%,CLU;DAXX;CCL5;EPHA4;CDKN1A;EMP2;RAP1A;PTK2B;PPP2CA;PIH1D1;UNC119;CAMKK1;ERBB3;TGFB2;SRCIN1;IQGAP1;MAP2K2
prerank,anterograde axonal transport (GO:0008089),0.3486609202042985,0.9256449804219057,0.5797101449275363,0.958795912035578,1.0,6/37,6.67%,BLOC1S6;AP3B1;HSPB1;KIF1C;KIF1B;AP3S1
prerank,magnesium ion transport (GO:0015693),0.41549381690610765,0.9254884574795659,0.5090016366612111,0.9585599888598738,1.0,5/12,22.90%,NIPAL3;SLC41A1;NIPA2;CNNM4;MMGT1
prerank,epithelial cell morphogenesis (GO:0003382),0.407778982726534,0.9253247399191038,0.5553869499241275,0.958321238867959,1.0,5/17,17.42%,POF1B;GRHL2;DACT2;CNMD;RILPL1
prerank,hepaticobiliary system development (GO:0061008),0.3862398643178704,0.9250613834645685,0.5508720930232558,0.9582944598058597,1.0,6/20,18.96%,COBL;NKX2-8;LSR;TGFBR3;PRKCSH;CDK5RAP3
prerank,dorsal/ventral pattern formation (GO:0009953),-0.32208096964618277,-0.925020631830925,0.5825825825825826,0.8613373209810479,1.0,4/20,7.55%,GLI2;ACVRL1;BMPR1B;DSCAML1
prerank,protein localization to organelle (GO:0033365),0.30697035342612344,0.9247860493352382,0.6032967032967033,0.9582633464012653,1.0,47/133,25.36%,ANK2;LAMP5;OTOF;CSRP3;EHD1;ARL3;LAMP1;PPP1R15A;DDRGK1;BMP4;GCC2;SIX1;BANP;GET4;TOR1A;RAB35;DCP1A;TOR1AIP1;ATP6V1D;LMNA;MDM2;DHX9;RAB33B;CCDC47;RIPOR1;FAM83H;ARFRP1;WDR35;APP;ZBTB7A;CROCC;ABCA7;TULP1;TULP2;YBX1;VAMP2;SGTA;MTCH2;VAPA;ARL6;ARL1;SIX4;GABARAPL2;TIA1;CYB5A;SNX10;TSPAN17
prerank,establishment of protein localization to membrane (GO:0090150),0.3307465887277084,0.924613823003667,0.572139303482587,0.9580458122319117,1.0,8/66,9.72%,NECTIN3;ZDHHC12;VPS37B;FRMPD1;NPC1;SYNE3;GOLGA7;MYO1C
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.4005382506066566,0.9244486054465697,0.5625942684766214,0.9577961439113023,1.0,4/18,15.47%,NUP93;ENY2;POLDIP3;PABPN1
prerank,maturation of SSU-rRNA (GO:0030490),-0.2790971885182446,-0.9240664798768192,0.5570175438596491,0.8624725214811304,1.0,16/34,32.78%,UTP6;NGDN;NAT10;RRP36;LSM6;DHX37;TSR3;NOB1;WDR3;SNU13;RIOK2;WDR46;NOL10;MRPS11;HELB;NOL11
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.2848888419357321,0.924049628809914,0.83,0.9580562629136433,1.0,255/1645,14.33%,CDH1;PRKCB;BNC2;NFATC2;ZBTB7C;NR3C2;KLF5;FOXN3;DAXX;TMPRSS6;TBR1;WNT1;KLF4;TFAP2C;PBX3;PPARGC1A;PBX1;KLF3;ZIC4;TFAP2D;DMRT2;MAP3K5;ELF3;OGT;LBH;SREBF2;CDKN1A;RORC;SMAD6;NIBAN2;FOXP2;GLI3;DDX5;MLLT3;HOXA4;TRIM33;HIVEP1;CAND2;WNT11;KLF12;FOXP4;ZNF436;EP300;ZFHX4;TOX4;HDAC5;ZNF692;MXD4;QARS1;RBFOX2;CC2D1B;FOXO3;FOS;DAPK3;PCGF6;RELB;MGA;FOXC2;SP5;ZNF219;GLIS2;NOP2;PPP2CA;KLF16;CREBL2;PPP1R13L;HDAC4;NFE2L2;NR6A1;ZBTB16;ZBTB8A;ANXA4;EPO;WWP2;MTDH;CIAO1;TRIM44;SMARCB1;IGSF1;FOXD2;POU2F3;NFE2L1;NACC1;MLF2;CRYAB;ESRRB;RFX7;IRF3;PRRX2;BICRA;SLTM;JUND;OVOL2;NKX2-8;PATZ1;PHF1;POLR2A;LCOR;CREB1;ZBTB46;ZIK1;FOXM1;HOXA5;ZBTB17;RXRB;PCGF3;FOXD1;HCFC1;ZIC2;NRF1;SHC1;KDM5C;ZBTB7B;KAT6B;EFEMP1;PHF10;BMP4;MEF2D;CC2D1A;KLF7;COMMD7;MED30;STAT4;NKAP;CDK16;ILK;TGFB1I1;DVL3;ZNF471;ZFHX3;DYRK1B;ZNF418;MAGEL2;CIC;PPM1A;L3MBTL3;ATRX;SIX1;PSRC1;MAZ;JUN;POU3F1;TCF7L2;FBXO5;CRY2;ELP4;ZFP57;PML;GRHL2;FOXP3;KMT2A;POU5F2;BRD7;SCML2;DPF2;NR2C1;MYCBP;MAP2K2;ZIC1;YWHAQ;HDGFL3;PHF5A;APBB1;MED29;ILF2;PRDM15;ENY2;NFIB;ZNF467;FADS1;NFYC;TWIST1;KDM3A;HDAC3;ARID4A;ZNF205;NFE2L3;NFIC;SOD2;GON4L;TLE2;BCL7A;SP2;KDM4C;MYT1;SMARCA4;ABCA2;MAMLD1;ARID3B;CREB3L4;CREB3;NCOR1;AEBP2;CALCOCO1;MEF2B;SRCAP;AJUBA;MED8;HOXB5;SFMBT2;NAA15;MAFG;SP1;ZBTB42;ZNF148;ACTL6B;TAF5;CDK18;MAFK;FOXK1;CCNL2;MED12;TFEB;SPIN1;BAZ2B;PIAS1;PIAS3;ZFP30;CHD3;GATA3;SMARCD2;ZSCAN20;TSC22D4;RREB1;SBNO2;GPBP1;NFIA;CHMP1A;BEND5;MED21;TCEA2;CBX4;MYC;POLR3C;ZNF177;PRDM11;MED24;ING4;REXO4;ZFP1;MEF2C;TLE5;PAX3;ZFP92;MYBL1;ATP2B4;SFRP1;SRRT;FOXP1;CHUK;SET;TASP1;ZXDC;PTP4A3;IRF2
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.29223992185302095,0.9238880360074251,0.6490335707019329,0.9577932076619083,1.0,103/264,28.40%,DDX5;GTF2F1;SRSF2;RBM19;POLR2H;SNRNP70;SNRPB;POLR2A;SRRM2;EIF4A3;RALY;LSM4;DDX39B;RBM8A;HNRNPH2;WDR33;PHF5A;DBR1;SF3B3;USP39;SRPK2;MTREX;SRSF7;SF3A2;ZCCHC8;FRG1;SRPK1;HNRNPUL1;GPATCH1;SYNCRIP;RBM10;RNPS1;PNN;CSTF1;SRSF9;SRRT;UPF3B;GEMIN6;PLRG1;ISY1;DHX9;PABPN1;CWC15;CDC5L;MAGOHB;MAGOH;PRPF19;CLP1;PRPF40B;PRPF6;POLR2C;HNRNPA3;SRSF1;SNUPN;PPIL1;POLR2E;PTBP1;SRSF5;ZMAT5;PCBP2;CSTF3;WBP4;SF3A3;DDX20;PUF60;PRPF8;SFPQ;YBX1;DDX23;GEMIN5;U2AF1;PABPC1;RBM15;SPEN;DCPS;SRRM1;CELF4;DDX46;CWF19L1;SNRPB2;CLNS1A;POLR2K;CPSF7;GEMIN8;GEMIN2;RBM15B;LSM5;PPIL3;CDK13;PRPF40A;DDX42;PPIE;GPKOW;RBM6;SNRPD2;SNRPD1;SF1;HNRNPM;HNRNPR;CSTF2;SF3B2;HNRNPH1;HSPA8
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.4454156762754323,0.9235415109803863,0.5486577181208053,0.9579659156576116,1.0,2/10,8.88%,NINJ1;LBP
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.25246225436511305,-0.923511684605351,0.5549738219895288,0.8625787265916937,1.0,13/57,11.50%,DLG2;GRIN2A;GRIA3;GRIA2;LRRC7;SHISA6;DLGAP1;GRIN2B;NLGN1;NEFL;NETO1;CACNG8;SHISA9
prerank,regulation of glycolytic process (GO:0006110),0.3252700145250417,0.9234423308726396,0.59375,0.9575838883299306,1.0,12/68,11.26%,PRKAA2;OGT;NUPR1;EP300;HDAC4;NUP93;PFKFB2;EIF6;NDC1;JMJD8;TIGAR;NCOR1
prerank,positive regulation of catalytic activity (GO:0043085),-0.2717586387184676,-0.9234239634245062,0.576,0.8616033309705045,1.0,13/37,23.34%,AZIN2;MSH3;IGF2;ABL2;NHEJ1;FGFR4;FXN;B3GAT3;SLC5A3;SOD1;CIB1;MAPK14;NOD2
prerank,sphingolipid biosynthetic process (GO:0030148),0.32270458245664024,0.9234156058273391,0.5980975029726516,0.9570383244991639,1.0,9/71,9.23%,SPTSSB;SGMS2;PPM1L;A4GALT;ELOVL1;LARGE1;AGK;ELOVL6;HACD4
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.30012338529128874,0.9233687242054012,0.6163655685441021,0.9565424929897158,1.0,18/136,9.13%,NLRP2;KLF4;CD200;NUPR1;ZC3H12A;GLIS2;HDAC4;ANXA4;WWP2;NFKBIA;COMMD7;TRIM21;NLRP2B;PKD1;TCF7L2;CHP1;FOXP3;PYDC1
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.4327264699355025,0.9233053727278592,0.5470494417862839,0.9560702398471682,1.0,3/12,12.07%,INSIG1;GPAA1;ANKRD13C
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.4003456718460765,0.922621937144734,0.5557299843014128,0.9569745873793223,1.0,6/17,17.80%,UBASH3A;LGALS3;EZR;PTPN2;SH2D1A;DUSP3
prerank,regulation of protein-containing complex assembly (GO:0043254),0.31124216555866346,0.9222738540103269,0.5958149779735683,0.957165750937344,1.0,27/110,18.46%,CLU;GSN;EP300;PIH1D1;CRYAB;HCFC1;MAPK15;LATS1;STXBP1;LGALS3;CDC42;MTLN;RAF1;AJUBA;HRK;NAPA;NAPB;PREB;TRABD2B;ULK1;GSK3B;HSP90AA1;PRKCZ;HDAC6;CDH5;PTPN11;PARK7
prerank,regulation of steroid metabolic process (GO:0019218),0.377059637259782,0.9222448750197051,0.5606694560669456,0.9566382534456006,1.0,4/23,11.06%,RORC;TTC39B;ACADL;ABCA2
prerank,phospholipid biosynthetic process (GO:0008654),0.3548199578721668,0.9221719750890247,0.5607476635514018,0.9561999229826232,1.0,8/36,14.45%,SGMS2;FDPS;AGK;SRD5A3;FADS1;GPAM;DOLK;NUS1
prerank,mitotic cytokinesis (GO:0000281),0.3463037217514648,0.9220577105217971,0.5799256505576208,0.9558765721887255,1.0,11/47,12.78%,ARL3;SON;UNC119;ANK3;CHMP4B;RAB35;SNX33;SNX18;EFHC2;JTB;RASA1
prerank,icosanoid biosynthetic process (GO:0046456),0.4560345644304688,0.9220199715607696,0.5688524590163935,0.9553589001365511,1.0,4/10,13.94%,ALOX5;MGST3;FADS1;LTA4H
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.4131839435084249,0.9215760149201785,0.5523076923076923,0.9557426063634269,1.0,3/13,9.23%,ELOVL1;ELOVL6;HACD4
prerank,positive regulation of axon extension (GO:0045773),0.37569242932988056,0.9215599043198117,0.5659025787965616,0.955184295967326,1.0,6/22,20.64%,ISLR2;ZFYVE27;MAP3K13;SHTN1;MAPT;DBN1
prerank,cellular response to DNA damage stimulus (GO:0006974),0.2899559421053415,0.9214846974533212,0.6777442094662638,0.954756253917954,1.0,76/336,18.46%,NFATC2;WNT1;SUSD6;CDKN1A;ZC3H12A;IKBKE;FEN1;RECQL4;DOT1L;PPP1R15A;NABP2;USP10;IRF3;BCL2L1;PHF1;ASF1A;NSMCE4A;MRE11;MACROD1;MAPK15;PARP3;CENPS;PLK3;INIP;RAD54L;FBXO31;POLK;PML;DCUN1D5;RIF1;UBE2B;APBB1;CCND1;MUTYH;PCLAF;TIGAR;MTREX;USP3;CSNK1E;TOPBP1;CDKN2AIP;MBD4;PAXX;MYC;PWWP3A;BTG2;REXO4;FOXP1;UBR5;POLH;ENDOV;APTX;MCM8;IKBKG;USP28;FAN1;UBA6;DDB1;ATR;E2F1;HINFP;ABL1;SMC6;NBN;MCM7;XIAP;INTS3;MAPKAPK2;TRRAP;CHEK2;PIDD1;RAD50;PARP2;USP16;PARK7;ATF2
prerank,intracellular cholesterol transport (GO:0032367),0.4060569452734664,0.9213572592825441,0.5345622119815668,0.9544440547179134,1.0,6/15,18.13%,LDLR;NPC1;STARD4;VPS4A;RELCH;OSBPL2
prerank,ephrin receptor signaling pathway (GO:0048013),0.3158174719959653,0.9211404540890948,0.5912322274881516,0.9543362228328437,1.0,22/82,18.79%,MMP9;NGEF;EPHA4;EFNB2;SIPA1L1;AP2A2;EFNA5;CDC42;ACTB;ACTG1;EPHA3;AP2A1;RHOA;RASA1;HRAS;EFNA4;CRK;ARPC2;GIT1;PTPN11;YES1;ROCK2
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.39554948140764945,0.9211117326653782,0.5780089153046062,0.9538115810252926,1.0,3/19,5.38%,MCU;RIPOR2;MOSPD2
prerank,Golgi to endosome transport (GO:0006895),0.40314242333702405,0.9207228669483819,0.568075117370892,0.9540797227492369,1.0,4/16,11.70%,CORO7;VPS13A;MON2;AP2A1
prerank,lymphocyte migration (GO:0072676),0.3503721134061785,0.9205265649530225,0.5646437994722955,0.9539261843360914,1.0,3/32,12.94%,CCL5;MSN;GATA3
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.4030120387706939,0.9203769725323119,0.56752655538695,0.9536677182116272,1.0,3/17,5.38%,MCU;RIPOR2;MOSPD2
prerank,regulation of protein kinase activity (GO:0045859),0.30748015352296953,0.9203543018716671,0.5932017543859649,0.9531220590209156,1.0,25/106,19.79%,DAXX;TRIB2;CDKN1A;RAP1A;QARS1;PTK2B;HSPB1;TARBP2;TSC2;CAMKK1;IQGAP1;CHP1;PYDC1;SMCR8;GNAQ;JTB;ITGB1BP1;RAP2C;RELN;PRKAG1;TAB2;CAMK2N1;PARK7;RB1;UVRAG
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.36264673309464485,0.9203128233662063,0.5525238744884038,0.9526243503920785,1.0,5/29,12.23%,CCL5;MOSPD2;LGALS3;CREB3;ANO6
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.3503198089805834,0.920169371666701,0.5811170212765957,0.9523352624959257,1.0,5/38,6.65%,DAG1;MAGI2;PHLDA3;TSC2;MUL1
prerank,positive regulation of viral transcription (GO:0050434),0.3741990359648364,0.9201195743950046,0.53601108033241,0.9518582779270046,1.0,8/25,18.96%,GTF2F1;POLR2H;POLR2A;DHX9;NELFB;POLR2C;POLR2E;NELFA
prerank,ruffle organization (GO:0031529),-0.336803054450218,-0.9193615563210461,0.5617647058823529,0.8702877448597045,1.0,5/16,22.78%,LIMA1;AIF1L;ARF6;PIP5K1A;CORO1B
prerank,transcription by RNA polymerase III (GO:0006383),0.3696271693267119,0.919317889778978,0.5521557719054242,0.9530965711305232,1.0,13/27,28.24%,GTF3C3;ELL;POLR3G;GTF3C2;GTF3C5;POLR3H;TBP;SNAPC3;GTF3C4;ICE1;POLR2K;ZC3H8;BRF1
prerank,cognition (GO:0050890),-0.269172380149338,-0.919062403505844,0.5798319327731093,0.8698293008046623,1.0,12/42,13.67%,SOBP;RP9;TUSC3;SETD5;PTCHD1;GRM5;TTC8;CHD7;NF1;CHMP2B;NIPBL;MFSD2A
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.2532320186128348,-0.9188966614739195,0.6526315789473685,0.8689910000160267,1.0,11/49,16.64%,AFAP1L2;NOD1;LGALS9;STAT3;TIRAP;RIPK1;DDIT3;IL17D;TLR7;HMGB1;CD74
prerank,positive regulation of chemokine production (GO:0032722),-0.2555094178344778,-0.9188904710432199,0.583732057416268,0.8677956461712005,1.0,12/44,17.63%,HIF1A;WNT5A;LGALS9;IL18;IL6R;IL33;MBP;TIRAP;TLR7;HMGB1;CD74;LPL
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.36752149084990243,0.9186788689599051,0.557510148849797,0.9539278948625527,1.0,3/30,6.64%,OGT;FHIT;DDRGK1
prerank,clathrin-dependent endocytosis (GO:0072583),0.37609631216549627,0.9185668433357128,0.5830945558739254,0.9535940350243284,1.0,4/26,4.41%,CLTB;FCHSD2;AP2A2;GPR107
prerank,secondary palate development (GO:0062009),-0.34335155538975454,-0.9185464921014858,0.5440414507772021,0.8674343982141455,1.0,4/14,8.72%,LEF1;WNT5A;CHD7;LRRC32
prerank,amyloid fibril formation (GO:1990000),0.33813412786010366,0.9184638275898105,0.5660377358490566,0.9532471296037998,1.0,13/51,20.73%,TSPAN5;ADAM10;GSN;GGA1;MDM2;BACE1;RPS27A;UBC;SIAH1;H3-3A;APP;MAPT;APH1A
prerank,positive regulation of organelle organization (GO:0010638),0.35412266815448423,0.9182472915798668,0.5603799185888738,0.9531366197008179,1.0,4/32,14.35%,PPARGC1A;ANXA2;SMCR8;GSK3B
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.4490083204849441,0.9181961028539879,0.5818181818181818,0.9526517398478614,1.0,3/10,9.42%,PCGF3;ZFP57;DNMT3A
prerank,neurotransmitter uptake (GO:0001504),0.4314473573944093,0.9180033268827545,0.5795275590551181,0.9524977717605398,1.0,2/12,2.79%,GLUL;ATP1A2
prerank,transcription by RNA polymerase II (GO:0006366),0.2903311470943716,0.91797874015721,0.6798378926038501,0.9519589642684411,1.0,65/305,20.17%,NR3C2;THRB;NOTCH2;PPARGC1A;LSM10;RORC;CCN2;DDX5;MLLT3;GTF2F1;HDAC5;NR6A1;POLR2H;NABP2;ESRRB;SNRPB;TAF1C;RARG;ELOB;NKX2-8;POLR2A;RXRB;ZBTB7B;SSRP1;MAZ;ELP4;NR2C1;WDR33;INTS2;RPRD2;HDAC3;NFE2L3;NFIC;NCOR1;GTF2E1;SP1;TAF5;ELL;RREB1;RPAP1;CSTF1;SRRT;NCOR2;PABPN1;ELP2;TBPL1;CLP1;MED27;ERCC2;NELFB;INTS3;POLR2C;INTS13;RARA;POLR2E;INTS6;NELFA;TAF8;TAF9B;CSTF3;TBP;MED7;TEAD1;MNT;NABP1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.4281260901485111,0.9178835325265039,0.5518945634266886,0.951601933633335,1.0,2/11,5.45%,NBL1;DUSP1
prerank,regulation of hydrolase activity (GO:0051336),0.3217111701056673,0.9170801789825742,0.5885167464114832,0.9528000195702863,1.0,20/71,17.96%,NGEF;PLXNB1;EPHA4;PLXNA2;SIPA1L1;CAV1;ADAP1;EFNA5;ARHGEF5;ATP5IF1;PAFAH1B1;EPHA3;PLXNB2;OCRL;ARHGAP27;ITGB1BP1;PLXNA3;CRK;RAP1GAP;ARHGAP44
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.3072202225417562,0.9164710795679154,0.6020293122886133,0.9535629806243525,1.0,10/102,7.65%,SORBS1;CPEB2;ADCY9;CAV1;HDAC5;EPRS1;RHOQ;INSIG1;PKM;ADCY6
prerank,mitotic nuclear membrane organization (GO:0101024),0.3356976048827229,0.9163263952974088,0.5779141104294478,0.952694190980918,1.0,11/51,15.81%,CC2D1B;PPP2CA;REEP3;NUP93;CHMP4A;CHMP4B;NDC1;VPS4A;LMNA;CHMP2A;REEP4
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.3356976048827229,0.9163263952974088,0.5779141104294478,0.952694190980918,1.0,11/51,15.81%,CC2D1B;PPP2CA;REEP3;NUP93;CHMP4A;CHMP4B;NDC1;VPS4A;LMNA;CHMP2A;REEP4
prerank,isotype switching (GO:0045190),0.44836780429274875,0.9159503596234188,0.5563139931740614,0.952944532706759,1.0,5/10,30.42%,EXOSC3;RNF168;RNF8;MSH2;MSH6
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.3587736102910609,-0.9158755618936567,0.5855614973262032,0.8727109421295954,1.0,5/13,17.82%,EIF4ENIF1;TNRC6A;POLR2G;CNOT7;ZFP36
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.23554547323936165,-0.915802965546513,0.6490066225165563,0.871704211109165,1.0,29/75,24.28%,PLCB1;PLCE1;RGS5;KCTD8;RGS3;NMT2;MGLL;TULP3;GIT2;ROCK1;RIC8B;CRY1;RGS12;CAMK2A;FNTB;EDN1;MRAP2;RGS16;SAG;RGS4;DGKQ;RPGRIP1L;METAP2;PDE6H;GNG7;RGS20;C3;PDE6A;RNF157
prerank,positive regulation of macroautophagy (GO:0016239),0.3351366972807291,0.9153302581098504,0.569811320754717,0.9537225484414217,1.0,13/48,16.54%,PRKAA2;SESN2;TSC2;HSPB8;BAG3;SMCR8;VDAC1;PIP4K2C;BNIP3L;VPS13D;IKBKG;SESN1;SLC25A4
prerank,negative regulation of catalytic activity (GO:0043086),-0.30259245384756417,-0.915244711302332,0.5718475073313783,0.871747117012688,1.0,7/24,15.15%,NOTCH1;OXA1L;NOSIP;NES;TP53;CAMK2A;CLN3
prerank,potassium ion homeostasis (GO:0055075),0.37693717481006583,0.9151948000855147,0.5791788856304986,0.953430938493491,1.0,8/23,21.08%,SLC12A8;ATP1A2;SLC12A4;SLC12A6;ATP1B3;ATP1A3;ATP1A4;ATP1A1
prerank,protein localization to phagophore assembly site (GO:0034497),0.4340238543628374,0.915027118055305,0.5830618892508144,0.953210077467491,1.0,11/11,56.63%,PACS2;WIPI2;TRAPPC8;WDR45;WIPI1;ATG13;STX17;WDR45B;MFN2;ATG9A;ATG9B
prerank,gene expression (GO:0010467),0.2864102731059336,0.9149435548873983,0.6784630940343782,0.9528178586884908,1.0,78/348,19.16%,THRB;TSPAN5;CELF2;MRPS16;SRSF2;EEF1A1;MRPL24;MRPL37;CREBL2;POLR2H;HARS1;RPS4X;NKX2-8;MRPS7;POLR2A;RNASEL;NUP93;EIF4A3;GOLPH3;SMG7;ABCF1;DDX39B;RBM8A;XRN2;RPL31;RPSA;NDC1;GSPT2;WDR33;RPL22;AGFG1;MRPS33;PTMA;RPL28;SRSF7;SRBD1;RPS26;POLDIP3;MRPL9;COPS5;THOC7;HNRNPUL1;SYNCRIP;DNAJB11;RNPS1;HARS2;RPL10A;SRSF9;MRPS15;SARS1;TASP1;UPF3B;EIF4G1;TNIP1;PABPN1;MRPS18C;RPL14;DUSP11;RRBP1;MAGOHB;MAGOH;RPS27A;CLP1;E2F1;LMF2;STUB1;AAAS;POLR2C;HBS1L;IGF2BP3;RBMS2;SRSF1;RAE1;POLR2E;SRSF5;EIF4EBP2;RPL6;FARSB
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.2695327569357875,-0.9149286681795503,0.6081081081081081,0.8712531445142039,1.0,5/38,10.18%,BMP6;SASH1;GBP5;DDX60;PLSCR1
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.3078648453301759,-0.9145323656335858,0.5993589743589743,0.8710692346512363,1.0,8/21,18.73%,ERRFI1;RUNX1;ROCK1;SFRP4;CTSL;SGPP1;ZFP36;MAFF
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.3576499634065932,0.9145132286905233,0.5727636849132176,0.9532006995990597,1.0,15/32,30.05%,NEK7;MAPK15;MAP3K4;HMBOX1;TNKS2;ATR;PRKCQ;PNKP;FBXO4;CCT5;XRCC5;NAF1;CTNNB1;CCT8;CCT6A
prerank,intracellular protein transmembrane transport (GO:0065002),0.33994942074251244,0.9143797190117301,0.550761421319797,0.9529143603784341,1.0,12/42,22.76%,PEX26;TIMM44;DNLZ;ROMO1;TOMM20;TIMM17B;PEX6;PEX2;TOMM40L;TOMM40;TIMM50;TIMM23
prerank,neuromuscular junction development (GO:0007528),0.37566959729120314,0.9142598983694934,0.5718475073313783,0.9525932603553137,1.0,8/24,17.70%,UNC13C;CACNB3;ANK3;MUSK;CACNB2;NEDD4;F2R;PDZRN3
prerank,UV-damage excision repair (GO:0070914),-0.3657783295079954,-0.9141303896219458,0.5651105651105651,0.8708395880864451,1.0,7/12,38.22%,CUL4B;ACTR5;ERCC1;POLA1;DDB2;POLD3;INO80
prerank,termination of RNA polymerase I transcription (GO:0006363),0.36307291551508053,0.9140993608100451,0.581267217630854,0.952377213341424,1.0,14/30,26.38%,POLR2H;TAF1C;UBTF;POLR1C;POLR1E;POLR1F;ERCC2;POLR2E;TBP;POLR1G;MNAT1;POLR2K;POLR1B;TTF1
prerank,purine-containing compound biosynthetic process (GO:0072522),0.37188928162691676,0.9139236928669134,0.5655270655270656,0.9521801725695154,1.0,10/25,22.63%,ADK;PAICS;GMPS;SHMT1;GART;AMPD2;DGUOK;PRPS1L1;PRPS1;APRT
prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.27528961448435235,-0.9139076999823325,0.6470588235294118,0.8701557831316168,1.0,14/31,34.56%,LYN;GLMN;TNFRSF21;DLG5;CD300A;SOX11;RC3H1;TYROBP;FCGR2B;CD86;LST1;CD80;LILRB1;IL4I1
prerank,negative regulation of mitochondrion organization (GO:0010823),0.3564953475029473,0.9137989125141509,0.5779944289693594,0.9518601063392561,1.0,3/33,6.65%,CLU;BCL2L1;MUL1
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.34136379061086725,0.9137789263126338,0.5633245382585752,0.9513236387109394,1.0,13/39,19.87%,RBX1;POLK;ERCC5;RPA3;POLD2;PCNA;FAN1;DDB1;RPS27A;UBC;ERCC2;RFC1;ERCC4
prerank,regulation of microtubule depolymerization (GO:0031114),0.37110706846398644,0.9132279425188411,0.5600578871201157,0.9519706981439999,1.0,1/25,0.23%,FGF13
prerank,regulation of nervous system process (GO:0031644),-0.31902616709104975,-0.913073618269573,0.5945121951219512,0.8709928602790475,1.0,3/18,5.51%,SLC8A3;NOS3;DLGAP1
prerank,regulation of dendrite extension (GO:1903859),0.40046009547537886,0.9122740198011199,0.5544117647058824,0.9535144439212236,1.0,1/18,0.95%,OSTN
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.31005024682202276,0.9121391914142903,0.5997732426303855,0.9532335251939968,1.0,22/93,19.37%,CD44;NTRK3;CAV1;NGF;CREBL2;DOCK7;DMTN;HAX1;LATS1;NLRP2B;RAF1;RAPGEF3;CAPRIN2;ATP2B4;EIF4G1;HSP90AA1;PFN2;HDAC6;MTCP1;PARK7;PRKD2;APP
prerank,spermatid development (GO:0007286),-0.27860507269043927,-0.9120021747796098,0.6259842519685039,0.8722839823731259,1.0,7/32,20.00%,ING2;YTHDC2;ZMYND15;BBS4;CIB1;RFX2;NME5
prerank,phagosome maturation (GO:0090382),0.3413360209268168,0.9119518178815603,0.5831099195710456,0.9530469232541819,1.0,12/35,27.01%,ATP6V1B1;RAB7A;ATP6V1E1;ATP6V1D;ATP6V0D1;ATP6V1B2;ATP6V0B;ATP6V0E1;RAB31;RAB32;ATP6V0E2;ATP6V0D2
prerank,regulation of actin filament-based process (GO:0032970),0.32126715886131013,0.9119263978479191,0.6025492468134415,0.9525203937403728,1.0,19/70,18.79%,CELSR1;ARHGAP18;CDK10;RHOQ;EFNA5;DMTN;IQGAP1;ARHGEF5;EZR;DLC1;EPHA3;RHOA;CCDC88A;TESK1;FSCN1;CRK;ABL1;ARHGAP44;ROCK2
prerank,regulation of histone deacetylation (GO:0031063),-0.35901054089214945,-0.9115797316671534,0.5754189944134078,0.8721361544394116,1.0,6/13,22.66%,CAMK2D;SAP30BP;ING2;NIPBL;APLNR;PRMT6
prerank,determination of heart left/right asymmetry (GO:0061371),0.3373275049471149,0.9115639757219065,0.582901554404145,0.9527111006624025,1.0,3/43,2.24%,TBR1;SMO;MICAL2
prerank,heme biosynthetic process (GO:0006783),0.3898610616157321,0.9115334952066313,0.5574018126888217,0.9522016483402828,1.0,10/22,21.23%,NFE2L1;UROS;ATP5IF1;SLC25A38;HMBS;PPOX;ABCB6;TSPO;FLVCR1;COX10
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.3322021122958942,-0.9113868491529261,0.6167664670658682,0.8713833348288742,1.0,6/15,25.78%,TNFRSF1B;ADAM9;PACSIN3;SNX9;SH3D19;ADAM8
prerank,GTP metabolic process (GO:0046039),0.4120304884732302,0.9113623254540952,0.5824345146379045,0.9519860760671383,1.0,7/15,22.61%,IMPDH2;RHOQ;AK3;OPA1;GNAI3;RAB23;EFL1
prerank,lymphocyte proliferation (GO:0046651),-0.3005645546488529,-0.9111246306717332,0.610223642172524,0.8708340899107265,1.0,8/22,21.32%,ELF4;BCL2;CTPS1;PPP3CB;HELLS;CD40;HSPD1;FLT3
prerank,protein maturation (GO:0051604),0.3102270233654443,0.9111198929553285,0.5931428571428572,0.9519371267685179,1.0,20/95,17.30%,TSPAN5;OGT;ADAM10;NAA40;CIAO1;AANAT;CPE;SRGN;AFG3L2;PITRM1;SDE2;NDUFAB1;ISCA1;NAA15;DNAJB11;NAA10;TASP1;BACE1;LMF2;STUB1
prerank,gene silencing by miRNA (GO:0035195),0.35823898862596343,0.9108598772466132,0.5665294924554184,0.9519404559630573,1.0,4/32,7.24%,CNOT6;TARBP2;MOV10;EIF6
prerank,positive regulation of neuron projection development (GO:0010976),0.3121739952592005,0.9107254353397725,0.6231386025200458,0.9516510501427212,1.0,11/85,7.81%,NTRK3;COBL;PTK7;MAGI2;EP300;RAP1A;PTK2B;BMP5;TWF1;AVIL;ARSB
prerank,cellular lipid catabolic process (GO:0044242),-0.28068976114949284,-0.9102135325607966,0.5971223021582733,0.8717880751796634,1.0,7/27,15.80%,CYP1B1;ENPP2;PPARD;ACOX1;LPIN2;ABHD12;SIRT2
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.3365322345908752,0.91015504737788,0.5779467680608364,0.9523493641872582,1.0,9/47,14.06%,ZC3H12A;CAV1;EP300;ERLIN2;ACADL;ERLIN1;ABCA2;PGP;ATP2B4
prerank,cardiocyte differentiation (GO:0035051),-0.3773376109963187,-0.910142246743375,0.5558510638297872,0.8707435705486967,1.0,6/10,16.09%,KDM6B;SIK1;EEF1AKMT4-ECE2;GATA6;CBY1;MYOCD
prerank,regulation of glycogen metabolic process (GO:0070873),0.41736010439262006,0.9101378745153885,0.5607321131447587,0.9518168125138446,1.0,5/12,28.46%,RUBCNL;PPP1R3F;PPP1R3C;PPP1R3B;AKT1
prerank,cellular protein localization (GO:0034613),0.2895165180002976,0.9101066816955437,0.6898669396110543,0.9513178361203233,1.0,56/285,18.07%,RAB17;ANGPT1;ANK2;CELSR1;OCLN;EMP2;PIGU;WNT11;GRTP1;KIF13A;TBC1D16;CSRP3;EHD1;ARL4A;COPA;AP3B1;PTPRU;SNX8;SIL1;TMED1;ARMCX3;CPE;WLS;UNC50;STXBP1;GGA1;TM9SF1;SGSM2;AP2A1;ARFIP2;RABL3;TBC1D1;MESD;NAPA;CPLANE2;VIPAS39;STX11;ARF4;SEPTIN9;NAPB;VPS26B;RAB5C;RAB1B;STX16;USP6NL;FLNA;PRPF19;TBC1D22A;VCL;NSF;TBC1D10A;PACSIN1;HDAC6;ARFRP1;STX4;SEC23IP
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.23033042552064434,-0.9099700391356578,0.6792452830188679,0.8699219817251209,1.0,22/73,25.54%,KITLG;TCF12;LMO2;RUNX1;PSMC6;PSMA6;PUS7;GATA2;PSME1;PSMB10;PSMD5;PSMD3;TAL1;PSMA4;YAP1;PSMB9;PSMA8;PSMB7;YTHDF2;PSMA3;SPI1;PSMD10
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.3740332224957743,-0.909613593011639,0.5663265306122449,0.8695988592988098,1.0,3/11,7.87%,PARP12;PARP14;PARP8
prerank,defense response to Gram-positive bacterium (GO:0050830),0.3476391211551702,0.9094749558146021,0.5559895833333334,0.9521239984772064,1.0,7/40,10.20%,PGLYRP3;ANG;ROMO1;STAB2;LBP;RNASE3;PPP1R11
prerank,negative regulation of transport (GO:0051051),0.33231409327681183,0.9094182840334996,0.5861635220125786,0.9516673020075788,1.0,11/51,12.16%,SCAMP5;WWP2;CRYAB;ERBB3;RUBCN;LGALS3;RAB7A;ARL6IP5;SNX33;EPHA3;SNX12
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.33450335174613893,0.9091206897511621,0.5910828025477707,0.9517257672271112,1.0,14/52,15.53%,ZBTB17;ADD1;SHC1;MYDGF;FKBP14;SSR1;HYOU1;DNAJB11;GSK3A;PREB;GFPT1;DNAJC3;LMNA;ATP6V0D1
prerank,regulation of cellular catabolic process (GO:0031329),0.3260168735809902,0.9089542541320818,0.5707317073170731,0.9514920673938129,1.0,17/62,17.51%,NUPR1;ABCD1;EP300;DAPK3;DAPK1;HSPB1;USP10;MAPK15;SMCR8;MTMR3;OSBPL7;WDR91;PIP4K2C;ABL1;KEAP1;HDAC6;FBXL2
prerank,carbohydrate homeostasis (GO:0033500),0.3183177712659884,0.9084134794637886,0.6083832335329341,0.9521033630054412,1.0,11/67,12.51%,PRKAA2;MCU;ALOX5;HECTD4;KLF7;BAD;TCF7L2;CRY2;KCNB1;PDK2;PTPN2
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.3802481689124426,0.9083185639503426,0.5662824207492796,0.9517301099170431,1.0,3/20,10.66%,CCL5;YWHAB;GRK2
prerank,cellular response to nutrient levels (GO:0031669),0.3221874543404384,0.9080306840944872,0.577245508982036,0.9517752792694114,1.0,17/62,20.85%,PRKAA2;SREBF2;GAS2L1;KCNB1;FADS1;PDK2;TFEB;SFRP1;ULK1;EIF4G1;FLCN;MAP1LC3B;RIPOR1;ZFYVE1;STK24;SREBF1;KLF10
prerank,bile acid biosynthetic process (GO:0006699),0.36791339653506694,0.9079987037252164,0.5682819383259912,0.9512727663494063,1.0,4/24,11.13%,OSBPL9;ACOT8;CYP39A1;OSBPL7
prerank,apoptotic DNA fragmentation (GO:0006309),-0.32607342067675604,-0.9077859742504237,0.5918367346938775,0.8727497311699712,1.0,9/16,37.03%,CECR2;DNASE2;HMGB1;EXOG;DICER1;FOXL2;KPNB1;ENDOG;DFFB
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.3614327894101325,-0.9075664238315767,0.5567282321899736,0.8720776452525222,1.0,5/11,23.18%,WNT4;FGFR4;NR1H4;DGKQ;STAR
prerank,sphingolipid metabolic process (GO:0006665),0.30215689634281806,0.9075461516967346,0.5883002207505519,0.9516457018237451,1.0,16/108,11.50%,SPTSSB;HEXA;SGMS2;PPM1L;PPP2CA;ELOVL1;ORMDL3;AGK;GLB1;SUMF1;ELOVL6;HACD4;ABCA2;HEXB;SUMF2;CERS2
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.39588192622518853,0.9073092528727974,0.5838414634146342,0.9515932309000684,1.0,5/17,8.78%,DOCK5;CCL5;S100A11;DOCK7;ADAMTS1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.35356604381834283,-0.9072085767890664,0.6,0.8717611820114122,1.0,4/12,21.12%,NIN;BBS4;CCDC68;CEP19
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.33448067098758555,0.9067705589735244,0.5870098039215687,0.9522088100188376,1.0,18/48,22.26%,EP300;POLR2H;TAF1C;ASF1A;ACTB;POLR1C;MYO1C;POLR1E;POLR1F;SERTAD1;CDCA4;ZMIZ2;POLR2E;ARID1B;TBP;ELOF1;PHF2;POLR1G
prerank,arachidonic acid metabolic process (GO:0019369),-0.27030859076865077,-0.9066441694644828,0.6266094420600858,0.8719968794406437,1.0,7/35,9.27%,PLA2G4A;PTGIS;CYP1B1;MGLL;PTGS2;PNPLA8;PTGES
prerank,motile cilium assembly (GO:0044458),-0.35738964674444285,-0.9066154113585968,0.5895522388059702,0.8709015231407012,1.0,8/12,46.03%,BBOF1;DNAAF3;CCDC39;RSPH9;CCDC40;E2F4;RSPH6A;DNAAF1
prerank,odontogenesis (GO:0042476),0.3529122262045325,0.9062878100267079,0.5962815405046481,0.9526881129070711,1.0,6/35,11.04%,EDA;WNT10A;WNT6;BMP4;TGFB2;AQP1
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.30045993315490105,-0.9062798544603784,0.5895061728395061,0.8705412981358382,1.0,4/23,6.77%,PLA2G4A;MBOAT1;PLAAT3;PNPLA8
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.4249388289453382,0.906251674192176,0.584,0.9521847755754886,1.0,5/12,22.38%,LARP7;HEXIM1;NELFB;NELFA;RNF168
prerank,embryonic heart tube morphogenesis (GO:0003143),0.33417763747604884,0.9061285963898075,0.5753604193971167,0.9518732300802178,1.0,3/44,2.24%,TBR1;SMO;MICAL2
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.427454099882456,0.905837495077293,0.5634266886326195,0.9519186911138762,1.0,1/11,1.77%,EFNB2
prerank,DNA double-strand break processing (GO:0000729),0.39664815401950193,0.9056803650194837,0.5680119581464873,0.9516936687864345,1.0,5/18,18.05%,RNF138;MRE11;UBE2N;NBN;RAD50
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.33132814493462126,0.9053631841711091,0.576530612244898,0.9518103057884812,1.0,6/48,7.98%,ANK2;DIAPH1;PTK2B;SELENON;GSTO1;JPH2
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3414172397167167,0.9050268815471391,0.5815789473684211,0.9519475353513959,1.0,6/38,8.03%,ZC3H12A;TRIM59;PPM1B;USP10;OTUD7B;PPM1A
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.32203211641448237,0.9048885071460758,0.5907429963459196,0.9516761318192645,1.0,21/62,24.81%,MLLT3;GTF2F1;POLR2H;ELOB;POLR2A;SSRP1;ELP4;ELL;ELP2;ERCC2;NELFB;POLR2C;POLR2E;NELFA;ELOF1;AFF4;CTR9;CDK9;LEO1;MNAT1;POLR2K
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.2723352898074374,-0.9048530821095709,0.6222222222222222,0.872832996957845,1.0,9/33,9.23%,ACVRL1;NOTCH1;FGF2;THBS1;CARD10;RGCC;TGFB1;MECP2;PPARG
prerank,regulation of interleukin-2 production (GO:0032663),-0.25767366325845564,-0.9047706525765773,0.6782608695652174,0.8718503216022485,1.0,8/43,11.72%,PDE4D;CD34;GLMN;RUNX1;SPTBN1;PDE4B;TRAF6;PNP
prerank,organelle fission (GO:0048285),0.3674281999825062,0.9046475734215372,0.5659574468085107,0.9515849079538587,1.0,9/24,21.29%,ACOT8;MUL1;PEX11G;MTFR1L;OPA1;DNM1L;MTFR2;TMCC1;MIEF1
prerank,regulation of cell growth (GO:0001558),0.29039309057887935,0.9042536653160551,0.6753381893860562,0.9518757590274015,1.0,39/204,16.35%,AGTR1;CDKN1A;ADAM10;HPN;WNT11;FHL1;SGK3;SESN2;PPP2CA;LTBP4;SH3BP4;ROS1;MUL1;OSGIN2;EGLN2;TGFB2;PSRC1;CDC42;NDUFS3;PML;DCUN1D5;APBB1;ADAM15;SMARCA4;SOCS2;EIF4G2;CHPT1;OGFR;BCAR1;CDKN2AIP;CAPRIN2;PRDM11;SFRP1;EIF4G1;FLCN;RAB33B;IP6K2;CCDC85B;FRZB
prerank,mitochondrion distribution (GO:0048311),-0.3574952768479123,-0.904221937522881,0.5662983425414365,0.8719504903604174,1.0,5/12,16.83%,LRRK2;MTM1;TRAK2;ATCAY;MSTO1
prerank,protein localization to synapse (GO:0035418),0.4280137793324689,0.9040232911461429,0.5799676898222941,0.9518335718545052,1.0,6/12,21.84%,ZDHHC12;BSN;PCLO;NLGN2;SHANK1;DLG4
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.38943423727684223,0.9039110051386471,0.5671191553544495,0.9515138646267931,1.0,2/17,2.90%,PBX1;EP300
prerank,inorganic anion transmembrane transport (GO:0098661),0.31322021110758763,0.9038637537032115,0.607487922705314,0.9510398991578972,1.0,10/63,14.51%,CFTR;SLC12A8;SLC25A3;SLC20A1;ANO7;SLC12A4;ANO6;SLC25A14;ANO3;SLC37A1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.3830981834608057,0.9037693587952468,0.5748865355521936,0.9506821123372193,1.0,4/19,10.39%,ZC3H12A;NLRP2B;PYDC1;CARD16
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.27621220680408826,-0.9034521840759911,0.626984126984127,0.8726204613718329,1.0,3/32,2.43%,PDGFRB;ITGA1;PPP1R16B
prerank,nitric oxide metabolic process (GO:0046209),0.41215870485587736,0.9033857674372759,0.5884146341463414,0.9508818493056129,1.0,3/14,7.65%,CYB5R3;DDAH2;CYB5B
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.3219474525950877,-0.9028333456034965,0.6132930513595166,0.8728923062985725,1.0,5/18,12.76%,NRXN1;SHANK3;NLGN1;CACNG8;NLGN3
prerank,regulation of p38MAPK cascade (GO:1900744),0.3457533579375798,0.9027757257812925,0.5757575757575758,0.9515591677658056,1.0,8/35,11.95%,ZC3H12A;DUSP10;DUSP1;MAP3K4;RELL1;EZR;EMC10;GADD45B
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.3513442957668445,-0.9026224170338296,0.579088471849866,0.8722480337675745,1.0,7/13,26.31%,ZMIZ1;ARID1A;PADI2;SERTAD2;SMARCD1;SPI1;CHEK1
prerank,positive regulation of chemotaxis (GO:0050921),0.3404113582390812,0.9024684050442088,0.5935897435897436,0.9516792449201904,1.0,3/43,4.59%,CDH13;NTRK3;HSPB1
prerank,nitric oxide biosynthetic process (GO:0006809),0.4166870954776277,0.9022396806215273,0.5835913312693498,0.95158144448806,1.0,3/13,7.65%,CYB5R3;DDAH2;CYB5B
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.33478769375312945,-0.9018538591421815,0.5695876288659794,0.8729692665101597,1.0,4/14,16.46%,SRSF4;SAP18;SRSF10;SRSF12
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.35423119399205777,0.9016647959025033,0.5892116182572614,0.9522583200209468,1.0,9/32,14.84%,PHLDB2;DMTN;CASK;ADAM15;BCAS3;DLC1;MMP12;RASA1;ITGB1BP1
prerank,presynapse assembly (GO:0099054),-0.3279165239350456,-0.9015817525383178,0.598314606741573,0.8725029565970304,1.0,6/16,16.06%,IL1RAPL1;WNT5A;NLGN1;FZD1;NLGN3;LRRTM3
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.36942945268524807,0.9013165222303487,0.5889212827988338,0.9524541804745768,1.0,6/25,17.34%,ZYG11B;RNF5;KLHL15;TOR1A;STUB1;HDAC6
prerank,positive regulation of secretion (GO:0051047),0.42059772527881245,0.90125277086612,0.6015748031496063,0.95203712147175,1.0,3/11,19.42%,ACSL3;AQP1;GPLD1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.4384537258839841,0.9008133241132894,0.5634266886326195,0.9523925669292352,1.0,3/10,13.01%,CACNB3;NIPSNAP2;CACNB2
prerank,embryonic skeletal system development (GO:0048706),0.35064731073458355,0.9007655804344367,0.5803452855245684,0.9519378999637407,1.0,3/35,2.61%,KIAA1217;HOXA4;WNT11
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.3245868107932831,0.9006379399281033,0.609511889862328,0.9516162937974542,1.0,7/52,11.34%,SORBS1;STAC3;PTPN9;LGALS3;AKAP5;CNPY4;EPHA3
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.3148743018236459,-0.9006286438560862,0.6163141993957704,0.8736270048912687,1.0,7/20,18.30%,PLA2R1;THBS1;RGCC;ITGA4;SFRP4;PDCD4;CD40
prerank,chromatin organization (GO:0006325),0.2984221182030924,0.9005021720894363,0.6544276457883369,0.9513390205725393,1.0,25/132,13.50%,DAXX;HDAC5;HDAC4;KDM4D;SMARCB1;PIH1D1;KDM4B;PHF1;HCFC1;KDM5C;ATRX;FOXP3;HDAC3;KDM4C;SMARCA4;DR1;KDM6A;ACTL6B;MPND;MYSM1;BAZ2B;SMARCD2;HMGN1;MYC;PWWP3A
prerank,protein N-linked glycosylation (GO:0006487),0.3156421310828451,0.9003669063931853,0.6106408706166868,0.951076717063634,1.0,15/66,13.95%,B4GALNT2;ASGR1;MGAT3;TMEM165;MGAT1;FUT8;DDOST;SRD5A3;ALG1;MCFD2;MGAT4C;DPM2;ALG12;ALG5;GFPT1
prerank,negative regulation of cell junction assembly (GO:1901889),0.3707170764535238,0.9002826146025609,0.5897435897435898,0.9506970679624919,1.0,4/25,10.78%,PHLDB2;DMTN;BCAS3;DLC1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.37199828507443966,-0.900133458967384,0.6089108910891089,0.8735980628694979,1.0,3/10,13.14%,SP100;TP53;RPS6KA6
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.27739218800502746,0.900018621288338,0.901,0.9507279540815509,1.0,294/1667,16.87%,PRKCB;NFATC2;CDH13;ZBTB7C;NR3C2;KLF5;THRB;PRDM6;TMPRSS6;TBR1;KLF4;TFAP2C;PBX3;PPARGC1A;NCOA3;PBX1;KLF3;GAL;ZIC4;TFAP2D;DMRT2;ELF3;OGT;SREBF2;CDKN1A;RORC;SMAD6;FOXP2;GLI3;DDX5;GTF2F1;HOXA4;TRIM33;HIVEP1;ZC3H12A;GABPB1;GABPB2;KLF12;CAV1;FOXP4;MAVS;ZNF436;EP300;ZFHX4;TOX4;HDAC5;ZMYM5;ZNF692;MXD4;CD81;CC2D1B;KANK2;FOXO3;CSRP3;FOS;GDNF;PCGF6;RELB;MGA;FOXC2;SP5;ZNF219;GLIS2;NOP2;KLF16;CGGBP1;PPP1R13L;HDAC4;BMP5;NFE2L2;NR6A1;ZBTB16;ZBTB8A;ANXA4;EPO;WWP2;SSBP3;MTDH;CIAO1;DOT1L;SMARCB1;RHOQ;FOXD2;POU2F3;NFE2L1;NACC1;NFKBIA;BEND3;CDK4;ESRRB;RARG;RFX7;PHF21A;IRF3;PRRX2;SLTM;JUND;OVOL2;NKX2-8;PATZ1;LCOR;CREB1;ZBTB46;ZIK1;FOXM1;HOXA5;ZBTB17;RXRB;RNASEL;MOV10;PCGF3;OTUD7B;FOXD1;HCFC1;AKNA;ZIC2;HAX1;NRF1;ZBTB7B;KAT6B;MYDGF;DDRGK1;PHF10;BMP4;MEF2D;MAPK7;CC2D1A;KLF7;MED30;STAT4;NKAP;PLK3;DVL3;FIZ1;ZNF471;ZFHX3;ZNF418;LARP7;CIC;PPM1A;ATRX;SIX1;PKD1;MAZ;JUN;FZD5;POU3F1;TCF7L2;CRY2;ELP4;ZFP57;GRHL2;FOXP3;TNFRSF1A;KMT2A;POU5F2;BRD7;TXK;DPF2;NR2C1;DNMT3A;ZIC1;RIF1;EZR;HDGFL3;APBB1;CCND1;MED29;PRDM15;ENY2;NFIB;SAP130;ZNF467;NFYC;TWIST1;BCAS3;KDM3A;HDAC3;ARID4A;ZNF205;NFE2L3;NFIC;SOD2;SP2;KDM4C;MYT1;SMARCA4;ABCA2;MAMLD1;ARID3B;TLR4;CREB3L4;CREB3;NCOR1;AEBP2;DR1;CALCOCO1;MEF2B;SRCAP;MMP12;MED8;HOXB5;MAFG;SP1;ZBTB42;COPS5;ZNF148;ACTL6B;MIER2;DCAF6;MAFK;CPEB3;FOXK1;CCNL2;MPND;MED12;TFEB;MYSM1;BAZ2B;PIAS1;PIAS3;PPM1D;ZFP30;CHD3;GATA3;SMARCD2;ZSCAN20;RREB1;ARF4;SBNO2;NFIA;CAPRIN2;MED21;CBX4;MYC;ZNF177;MED24;ZFP1;MEF2C;TLE5;PAX3;PCGF2;ZFP92;MYBL1;ATP2B4;FOXP1;CHUK;SARS1;ZXDC;IRF2;HRAS;NCOR2;SS18L2;GATAD2B;ATMIN;FLCN;ITGB1BP1;TNIP1;RFXAP;ZFP3;MDM2;TLR3;DHX9;MED6;ZMIZ2;TET1;IKBKG;ELP2;IGBP1;KLF6;HMBOX1;RCOR2;TCF25;CDC5L;ZGPAT;IRF2BP2;CREB3L2;IFRD1;SMARCC1;CRK;RNF10;RPS27A;UBC;HEXIM1;E2F1;POU4F1;HINFP;MED27;ABL1;KDM1A;MLLT6;SLC9A1;CAMTA2;UBE2D3
prerank,synaptic vesicle exocytosis (GO:0016079),0.344696539292386,0.8996990151769173,0.5902061855670103,0.9508003145793825,1.0,5/40,8.85%,UNC13C;OTOF;BLOC1S6;DNAJC5;PCLO
prerank,chromatin remodeling at centromere (GO:0031055),-0.2760020498005168,-0.8995244228074427,0.6630434782608695,0.8739569802885061,1.0,17/31,33.60%,RUVBL1;ITGB3BP;CENPP;HJURP;NASP;HELLS;MIS18BP1;KNL1;CENPU;CENPX;NPM1;CENPI;MIS18A;CENPN;CENPA;SMARCA5;CENPV
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.35395109875799413,0.8994778223121179,0.5861601085481682,0.9507276798395826,1.0,7/29,16.23%,KANK2;DDRGK1;LATS1;VPS11;GPAM;VPS18;UFM1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.40045305231991274,0.899316132408711,0.541871921182266,0.9505126417692189,1.0,1/15,1.13%,PPARGC1A
prerank,sulfur amino acid catabolic process (GO:0000098),0.43385873335805414,0.8992393042626455,0.5885328836424958,0.950115765024335,1.0,3/10,22.35%,ADO;TXN2;BLMH
prerank,negative regulation of growth (GO:0045926),0.2978223057853843,0.8985597270488,0.6484983314794216,0.9509844979336466,1.0,25/121,16.35%,NOTCH2;CDKN1A;WNT11;FHL1;SESN2;PPP2CA;SH3BP4;MUL1;OSGIN2;TGFB2;PSRC1;NDUFS3;PML;APBB1;ADAM15;SMARCA4;CDKN2AIP;CAPRIN2;PRDM11;ING4;SFRP1;FLCN;IP6K2;CCDC85B;FRZB
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.3721537461640291,-0.8985415281373751,0.595360824742268,0.8739523574310756,1.0,5/11,21.64%,NOTCH4;TNRC6A;AGO1;ZFP36;AGO4
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.3721537461640291,-0.8985415281373751,0.595360824742268,0.8739523574310756,1.0,5/11,21.64%,NOTCH4;TNRC6A;AGO1;ZFP36;AGO4
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.2815173943531814,-0.8982018044799317,0.5933333333333334,0.8735799568803371,1.0,8/26,17.91%,LYN;AIM2;GRIN2B;STAT3;MBP;PSME1;TTBK1;APH1B
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.3306242438770585,0.8979679283659863,0.6015424164524421,0.9516493464315595,1.0,9/46,11.60%,RAP1B;GSTO1;ANXA2;MSN;MTAP;STAT4;CDC42;SOD2;JAK1
prerank,negative regulation of cell differentiation (GO:0045596),0.28951607203185065,0.8977573909890405,0.6775210084033614,0.9515239924862133,1.0,20/181,6.80%,WNT1;RANBP3L;TRIB2;ADAMTS7;HPN;SMAD6;COL5A2;CRIM1;CAV1;CDK6;PTK2B;PPP2CA;BMP5;ZBTB16;NFKBIA;ESRRB;OVOL2;SPRED3;EFEMP1;BMP4
prerank,cortical cytoskeleton organization (GO:0030865),-0.26339119208548856,-0.897689004821518,0.6810344827586207,0.8736493823333005,1.0,8/41,7.58%,RHOBTB1;RND3;FHOD3;FMNL3;EPB41L3;NLGN1;RHOBTB3;ROCK1
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.2988551250419851,-0.8971857762007728,0.5970149253731343,0.873621981627454,1.0,12/24,29.38%,TTLL4;TTLL11;CFAP20;AGBL4;TTLL5;CEP41;VKORC1;GGCX;TTLL7;TTLL8;AGBL5;TTLL6
prerank,regulation of viral entry into host cell (GO:0046596),0.3528541540352954,0.8969812771915612,0.6038251366120219,0.9525848433830892,1.0,6/30,13.37%,GSN;TRIM25;TRIM21;TRIM26;TRIM11;LGALS1
prerank,plasma membrane tubulation (GO:0097320),0.403082558704124,0.8965194757437578,0.5848765432098766,0.9530055065507709,1.0,4/13,17.28%,CAVIN2;CHMP4A;SNX33;PACSIN1
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.37360826379280826,-0.8965062596559276,0.5823095823095823,0.8740343390518566,1.0,7/10,43.52%,DRD2;FMR1;CALM3;CRHR1;GPR35;DRD3;GNB5
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.3528164492596299,-0.8958907008958717,0.5925925925925926,0.8743063844580463,1.0,3/11,13.14%,SP100;TP53;RPS6KA6
prerank,innate immune response (GO:0045087),0.2866824828550907,0.8958492214613749,0.6896907216494845,0.9538223103708827,1.0,33/217,15.46%,TRIM60;PPP1R14B;SERINC5;MAVS;SLPI;PGLYRP3;PTK2B;RELB;TRIM59;TRIM25;NUB1;CFP;TRIM21;ANG;STYK1;PML;LBP;PYDC1;TRIM26;TRIM11;RNASE3;SRPK2;CR2;ADAM15;TLR4;ANKRD17;FCER1G;SRPK1;IRAK1;CHUK;VNN1;TLR3;IKBKG
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.2844545141514174,0.8958109238760927,0.6922290388548057,0.9533565366540914,1.0,71/241,23.23%,DDX5;GTF2F1;SRSF2;RBM19;POLR2H;SNRNP70;SNRPB;POLR2A;SRRM2;EIF4A3;RALY;LSM4;DDX39B;RBM8A;HNRNPH2;WDR33;PHF5A;DBR1;SF3B3;USP39;MTREX;SRSF7;SF3A2;ZCCHC8;FRG1;HNRNPUL1;GPATCH1;SYNCRIP;RBM10;RNPS1;PNN;CSTF1;SRSF9;SRRT;UPF3B;GEMIN6;PLRG1;ISY1;DHX9;PABPN1;CWC15;CDC5L;MAGOHB;MAGOH;PRPF19;CLP1;PRPF40B;PRPF6;POLR2C;HNRNPA3;SRSF1;PPIL1;POLR2E;PTBP1;SRSF5;ZMAT5;PCBP2;CSTF3;WBP4;SF3A3;PUF60;PRPF8;SFPQ;YBX1;DDX23;GEMIN5;U2AF1;PABPC1;RBM15;SPEN;SRRM1
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.3646157936631176,0.8957627605865898,0.6008583690987125,0.952886661191775,1.0,5/26,10.39%,PPM1B;MUL1;TRIM21;NMI;CARD16
prerank,positive regulation of macrophage migration (GO:1905523),-0.3083375320132167,-0.8957070642175389,0.5792682926829268,0.8735616023344096,1.0,7/19,20.44%,IL34;PTK2;THBS1;CSF1;RARRES2;P2RY12;CX3CL1
prerank,histone modification (GO:0016570),0.30023137260373084,0.8955078295997914,0.6321585903083701,0.9528626202225563,1.0,30/109,21.55%,CPA4;EYA2;EP300;HDAC5;HDAC4;NTMT1;KAT6B;EYA1;MORF4L2;AURKC;UBE2B;ENY2;USP3;MIER2;CDK2;RCOR2;UBE2N;PRMT1;HDAC6;TRRAP;SGF29;PARP2;USP16;USP21;PARK7;MRGBP;PRMT2;RCOR3;USP22;TAF6
prerank,positive regulation of sodium ion transport (GO:0010765),0.4213855188839868,0.8953919330534942,0.5930599369085173,0.9525374762572333,1.0,2/12,6.81%,AHCYL1;ANK3
prerank,axon extension (GO:0048675),0.36955795188094864,0.8953739940712994,0.5985714285714285,0.9520172944851509,1.0,1/23,0.20%,ALCAM
prerank,cellular macromolecule catabolic process (GO:0044265),0.33078107988055916,0.8952222955464063,0.6074534161490683,0.9517892271472044,1.0,9/49,10.45%,RNF5;DENND3;SIDT2;UBE2G2;MANBA;XRN2;RNASE3;DNASE1L2;MTREX
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.2919742511370885,0.8951870608703133,0.6688034188034188,0.9512915198399847,1.0,41/148,23.00%,PRKAA2;DAXX;EP300;NOP2;PPP1R13L;PPP1R13B;MRE11;SSRP1;PLK3;PML;BANP;BRD7;RMI1;TOPBP1;TAF5;MAPKAP1;CHD3;CDK2;RPA3;MDM2;PAK1IP1;MEAF6;ATR;HEXIM1;POU4F1;CCNG1;PRKAG1;NBN;CHEK2;RAD50;CDK5RAP3;TAF9B;TBP;PRKAB1;PRKAB2;USP2;CDK5R1;TAF6;PIP4P1;MDM4;KMT5A
prerank,positive regulation of neutrophil migration (GO:1902624),0.3878928418033689,0.8951694166863435,0.6,0.9507770274870536,1.0,3/18,5.38%,MCU;RIPOR2;MOSPD2
prerank,protein heterotetramerization (GO:0051290),-0.3467930893549538,-0.8950166465005588,0.6027777777777777,0.8740698923009892,1.0,5/13,18.47%,PKD2;GRIN2B;NUDT21;CPSF6;CBR4
prerank,transition metal ion homeostasis (GO:0055076),0.3560879241817271,0.8947122119712406,0.6031518624641834,0.9511667872804965,1.0,4/28,12.83%,TMPRSS6;NEO1;HEPH;CP
prerank,metallo-sulfur cluster assembly (GO:0031163),0.3682108864882291,0.8943383073248408,0.588495575221239,0.9513953572749572,1.0,7/22,20.21%,CIAO1;NFS1;ISCA1;IBA57;CIAO3;CIAPIN1;ISCA2
prerank,mitotic cell cycle phase transition (GO:0044772),-0.19320823182849406,-0.893839533200887,0.7741935483870968,0.8756503187095697,1.0,42/204,16.69%,PLCB1;CDK14;CLASP2;CEP250;EPS8;USP37;CUL4B;BRSK1;CCP110;ACVR1B;CCDC57;CCNH;CEP78;ALMS1;GSPT1;TPD52L1;CCNY;TAF2;NES;RPS6KB1;NDE1;PRKAR2B;UBE2S;RCC1;CTDP1;ANAPC7;NASP;SPDYA;NEDD1;PPME1;CAMK2A;BTRC;CSNK1D;CUL5;CCNJ;CRLF3;SDCCAG8;BORA;DBF4;CUL1;MASTL;CHMP7
prerank,somite development (GO:0061053),0.43173786852990725,0.8937894016192756,0.6016260162601627,0.9519749929934025,1.0,1/11,1.40%,SMO
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.3660735396086498,0.8936500754813019,0.6023391812865497,0.9516975032194397,1.0,4/24,7.61%,ANGPT1;NFE2L2;MAPK7;KRIT1
prerank,cellular response to leucine starvation (GO:1990253),0.42828969973715414,0.893507048757573,0.5737179487179487,0.9514393831143589,1.0,4/10,19.71%,SESN2;SESN1;EIF2AK4;GCN1
prerank,microtubule anchoring (GO:0034453),0.4162308367868679,0.8933358274753371,0.5890850722311396,0.951250784039549,1.0,2/12,7.66%,DAG1;GCC2
prerank,negative regulation of transferase activity (GO:0051348),0.3616559793575654,0.8932976086669079,0.593006993006993,0.950780492911187,1.0,11/28,22.08%,FBXO5;IRS2;GSK3A;PINX1;GSK3B;ABL1;EIF4A2;PARK7;ERCC4;MAPT;MEN1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.2976716522964829,0.8932518400208009,0.6574585635359116,0.9503257284383566,1.0,29/119,19.29%,PITPNM2;TTC7A;PIGU;PITPNM3;MTMR12;PIK3C2B;INPP5E;IP6K1;INPP4A;PI4KA;PIGZ;PGAP2;MTMR3;SOCS2;MBOAT7;PIGA;OCRL;PIP4K2C;EFR3A;DPM2;SOCS6;PIGN;IP6K2;PI4K2A;PTPN13;CDS1;CDIPT;PIGP;PIGQ
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.33168043027115196,-0.893009893827814,0.5897435897435898,0.87519046382668,1.0,6/14,35.88%,SLCO2B1;ABCG2;SLCO1B1;ABCC1;HMOX1;BLVRB
prerank,heme catabolic process (GO:0042167),-0.33168043027115196,-0.893009893827814,0.5897435897435898,0.87519046382668,1.0,6/14,35.88%,SLCO2B1;ABCG2;SLCO1B1;ABCC1;HMOX1;BLVRB
prerank,histone acetylation (GO:0016573),0.31222278322746044,0.8929008918653797,0.6014150943396226,0.950510094396469,1.0,19/69,18.94%,CPA4;EP300;NAA40;BEND3;KAT6B;MORF4L2;APBB1;DR1;ACTL6B;TAF5;JADE2;BRD1;ING4;MEAF6;TRRAP;SGF29;TRIM16;ATF2;MRGBP
prerank,DNA duplex unwinding (GO:0032508),0.3251151050993149,0.8928625378672316,0.5886699507389163,0.9500514103172987,1.0,14/50,21.59%,RECQL4;MRE11;RBX1;DHX9;DDB1;MCM6;RPS27A;UBC;ERCC2;NBN;MCM7;RAD50;TWNK;MCM4
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.27841558851172016,0.8924988428546275,0.7407035175879397,0.9502880618992928,1.0,71/390,15.53%,SORBS1;FGFR1;ANGPT1;CYFIP2;NTRK3;ATP6V1B1;MMP9;NGEF;EPHA4;PDGFC;EFNB2;HPN;FLRT1;GTF2F1;SIPA1L1;GDF15;GAB1;SHB;NGF;RBFOX2;PTK2B;FOXC2;AP2A2;POLR2H;RHOQ;TSC2;CAV2;ROS1;POLR2A;EFNA5;SHC1;AP3S1;PXN;ZFYVE27;ERBB3;FGF22;STYK1;CDC42;VEGFB;LMTK2;ACTB;NRP2;ABI1;MUSK;ACTG1;PDK2;EPHA3;SOCS2;IRS2;MVP;AP2A1;RHOA;BCAR1;EIF2AK3;PTPN2;RASA1;DDR1;DOCK1;GSK3A;FLRT3;SHC2;GSK3B;HRAS;NUS1;ATP6V1E1;EFNA4;AAMP;ATP6V1D;RAPGEF1;HSP90AA1;ATP6V0D1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.2895119554309474,-0.8922895819215714,0.6363636363636364,0.8756554651756071,1.0,10/25,22.07%,TMEM50A;LYST;CHMP3;LAPTM4B;SORT1;CHMP2B;MVB12A;CHMP7;UBXN6;CHMP4C
prerank,regulation of cardiac conduction (GO:1903779),0.32050354355841626,0.8920469096542392,0.6027060270602707,0.9507302303759605,1.0,4/54,4.79%,ITPR2;ANK2;ATP1A2;AHCYL1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.3258966235458238,0.8920167989781862,0.5866141732283464,0.9502492355106325,1.0,2/44,1.06%,ANK2;ACTN2
prerank,protein secretion (GO:0009306),-0.2424113842107437,-0.8917367435316149,0.6524064171122995,0.8757969028337179,1.0,10/56,11.91%,ABCA1;PCSK5;STEAP3;MTTP;RCN3;SEL1L;TVP23B;PPY;TMEM167A;TANGO2
prerank,cellular response to cytokine stimulus (GO:0071345),0.27579579460079795,0.8915974966387836,0.7402206619859579,0.9506053633279914,1.0,79/416,17.13%,FN1;PTPN14;CRLF1;MMP9;CCL5;VIM;ADAMTS7;CDKN1A;RORC;ZC3H12A;IL16;CXCR4;LAMA5;EPRS1;FOXO3;FOS;DAPK3;CLCF1;YBX3;NFE2L2;DAPK1;TIMP1;IL3RA;ALOX5;RIPOR2;DUSP1;USP10;BCL2L1;STK39;HAX1;SHC1;CSK;PTPN9;STAT4;UBE2G2;OXSR1;NDN;LBP;TNFRSF1A;SHMT1;PTPN6;CCND1;TWIST1;GSDME;TLR4;IL1R2;SOCS2;JAK1;RHOA;YWHAZ;NPNT;ST3GAL6;PTPN2;SYNCRIP;GATA3;SBNO2;RHOU;MYC;GSK3A;IRAK1;ZFAND6;SFRP1;SOCS6;CHUK;GSK3B;WNK1;GAPDH;RAPGEF1;DHX9;HSP90AA1;ITGB2;FSCN1;CRK;RPS27A;UBC;POU4F1;PDE1B;PRTN3;PTPN13
prerank,extracellular transport (GO:0006858),0.41219090415525406,0.8911866420248186,0.6006240249609984,0.9509071384160718,1.0,4/13,17.99%,WWP2;SPAG17;ADCY10;TSG101
prerank,organelle assembly (GO:0070925),0.2789855577781461,0.8906117839327554,0.7641129032258065,0.9514953178389636,1.0,83/385,20.09%,RAB17;PGM5;MAPRE2;CYS1;ABLIM1;PARVA;TMOD3;GSN;YTHDF1;NEK7;TMOD2;EHD1;CNGA2;ARL3;INPP5E;VPS37B;LMOD3;CCDC28B;RAB11FIP3;AVIL;NSFL1C;IFT46;PRRC2C;EXOC7;CFAP54;EXOC4;LSM4;PKD1;CHMP4A;CHMP4B;CC2D2A;IFT80;RAB7A;CENPT;EXOC2;HDAC3;EMC6;NCOR1;VPS4B;CPLANE2;CNGB1;EXOC8;ARF4;CHMP1A;OCRL;MKKS;VPS4A;ULK1;RAB1B;ATP6V1D;SQLE;MAP1LC3B;CHMP2A;RB1CC1;ATP6V0D1;FLNA;TMEM41B;ATXN2L;TMEM138;PTPDC1;ATG16L2;DYNC1H1;RAB8B;HDAC6;RILPL1;CDS1;PDCD6IP;PATL1;ZFYVE1;STAM;TSG101;FHDC1;WDR35;UBAP2L;GALNT11;YTHDF3;TUBGCP5;ABCB6;VPS37A;TXNDC15;CENPF;MAPT;IST1
prerank,protein polyubiquitination (GO:0000209),0.2790621724717669,0.890367198334036,0.710204081632653,0.9514884350993476,1.0,74/297,23.50%,FZR1;RNF152;FBXL7;FBXW8;FBXL20;LONRF1;WWP2;RNF5;PSMD11;MUL1;PSMD4;PSMF1;TRIM21;MAGEL2;UBE2G2;FBXL18;RBX1;RNF146;FBXO31;UBE2B;PSMD7;FBXW9;UBE2Q1;RNF126;MIB2;PSMB5;ANAPC4;NPEPPS;PELI1;DDA1;UBE4A;UBR5;NEDD4;UBE2H;MDM2;BFAR;RNF31;UBE2N;PRPF19;TNKS2;FBXL15;TPP2;RPS27A;UBC;UBE2D3;SIAH1;STUB1;UBE2J1;PSMD1;PSMC4;RNF41;PSMD8;UBE3C;FBXO9;THOP1;RMND5A;ZFP91;CHFR;FBXW7;TRIM5;UBE2E1;FBXW2;ARIH2;TRAF3IP2;UBE2V1;SMURF2;BLMH;RNF168;RNF213;TRIM3;RNF14;CDC23;PSMA7;FBXO4
prerank,negative regulation of MAPK cascade (GO:0043409),0.30030456062217487,0.8903367824245612,0.6624569460390356,0.9510032354272727,1.0,25/87,20.65%,DAG1;CAV1;QARS1;DUSP10;DUSP1;FBLN1;FOXM1;SPRED3;BMP4;EZR;PRDM15;SYNJ2BP;TLR4;PTPN2;MYC;FLCN;ITGB1BP1;TNIP1;IGBP1;DUSP3;CAMK2N1;CDK5RAP3;GPER1;RGS2;ABCA7
prerank,regulation of response to stress (GO:0080134),-0.37534381168403336,-0.8900682330802436,0.5965770171149144,0.8783942231434716,1.0,4/10,22.44%,CORO2B;OPRM1;STOX1;ADCY8
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.2755448889633826,0.8900301378627612,0.7720883534136547,0.9511077122208695,1.0,77/476,14.30%,CDH1;NFATC2;WNT1;KLF4;PPARGC1A;MAP3K5;LBH;RORC;NIBAN2;GLI3;MLLT3;CAND2;WNT11;EP300;FOXO3;FOS;FOXC2;GLIS2;CREBL2;HDAC4;ZBTB16;EPO;TRIM44;ESRRB;BICRA;CREB1;FOXM1;RXRB;HCFC1;ZIC2;SHC1;KAT6B;BMP4;MED30;ILK;TGFB1I1;DVL3;ZFHX3;DYRK1B;PPM1A;SIX1;PSRC1;MAZ;JUN;POU3F1;PML;FOXP3;KMT2A;BRD7;MAP2K2;ZIC1;PHF5A;APBB1;ILF2;ENY2;NFIB;KDM3A;SMARCA4;CALCOCO1;NAA15;SP1;FOXK1;MED12;TFEB;SPIN1;GATA3;RREB1;MYC;PRDM11;MED24;MEF2C;PAX3;MYBL1;SFRP1;CHUK;TASP1;ZXDC
prerank,ether lipid metabolic process (GO:0046485),0.40285029501865655,0.8899993618026335,0.5841269841269842,0.9506232917426947,1.0,4/14,14.69%,DHRS7B;PAFAH1B1;TMEM86B;PLA2G6
prerank,negative regulation of protein depolymerization (GO:1901880),0.3666140227490491,0.8897908774824334,0.6081081081081081,0.950509418991828,1.0,1/24,0.23%,FGF13
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.3733452606859826,0.8895143989156631,0.5714285714285714,0.9505019809413522,1.0,11/24,21.23%,NFE2L1;UROS;ATP5IF1;SLC25A38;HMBS;PPOX;ABCB6;TSPO;FLVCR1;SUCLA2;COX10
prerank,negative regulation of mRNA processing (GO:0050686),-0.32615009465829664,-0.8889849399407597,0.6106666666666667,0.8797093183696083,1.0,4/15,16.46%,SRSF4;SAP18;SRSF10;SRSF12
prerank,lymphocyte differentiation (GO:0030098),0.3100627043297172,0.8888748001406124,0.6323877068557919,0.9512719481508465,1.0,20/68,20.22%,PBX1;HDAC5;RELB;HDAC4;CLCF1;NFAM1;CR2;RABL3;PTPN2;GATA3;LMBR1L;GPR89B;GPR89A;KLF6;TPD52;ADAM17;ZBTB7A;IKZF1;DCAF1;SOX4
prerank,regulation of telomere maintenance (GO:0032204),0.3639679627792209,0.8885984098816968,0.5940460081190798,0.9512954775815997,1.0,11/26,25.07%,MRE11;ATRX;PML;MYC;NBN;RAD50;PPP1R10;ERCC4;TERF2;TINF2;HDAC8
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.3940575436312419,0.8885380353287682,0.5778748180494906,0.9508682546967039,1.0,7/18,15.37%,CD81;MSN;EZR;ATP5IF1;ABCA2;VPS11;HSP90AA1
prerank,defense response to Gram-negative bacterium (GO:0050829),0.3386896128252416,0.8883075819047634,0.6052631578947368,0.9507728151159304,1.0,6/42,11.15%,GALP;ROMO1;LBP;RNASE3;AQP1;TLR4
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.4035971421578591,0.8882051914025223,0.6173228346456693,0.9504649188575631,1.0,1/14,1.38%,ETNK2
prerank,erythrocyte development (GO:0048821),-0.37900010498781955,-0.887888367549236,0.6028368794326241,0.8810738628523479,1.0,3/10,10.80%,ALAS1;SH2B3;NCKAP1L
prerank,long-term synaptic potentiation (GO:0060291),-0.3033972939054364,-0.8873545900014009,0.6261682242990654,0.8812075590508092,1.0,5/21,8.77%,SLC8A3;GRIN2A;GRIN2B;SLC24A2;NFATC4
prerank,regulation of small molecule metabolic process (GO:0062012),0.3503195914578522,0.8871885525570273,0.617687074829932,0.9520181146986769,1.0,6/28,14.54%,RORC;TTC39B;ACADL;PDK2;FOXK1;NCOR2
prerank,androgen metabolic process (GO:0008209),0.3801980818956799,0.8865675472667172,0.5943396226415094,0.952745854007005,1.0,3/18,20.00%,SRD5A3;HSD17B11;HSD17B10
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.2885412635817795,0.8864092143078995,0.6888185654008439,0.9525312249826892,1.0,48/168,24.08%,CNOT6;SAMD4A;DDX5;ZC3H12A;SAMD4B;PPP2CA;RPS4X;EIF4A3;UPF3A;SMG7;RBM8A;XRN2;RPL31;RPSA;GSPT2;RPL22;RPL28;RPS26;TUT7;RNPS1;RPL10A;DCP1A;UPF3B;EIF4G1;PYM1;RPL14;MAGOHB;MAGOH;RPS27A;CTIF;PATL1;PELO;RPL6;NBDY;DXO;RPS28;SMG9;ETF1;RPL41;TUT1;RPLP2;RPLP1;RPL7;PABPC1;DCPS;RPL21;PAN3;RPL26
prerank,cellular response to interleukin-2 (GO:0071352),0.4240656473740551,0.8863967800973499,0.6032786885245902,0.9514651269634347,1.0,3/11,11.60%,PTK2B;SHC1;JAK1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.4240656473740551,0.8863967800973499,0.6032786885245902,0.9514651269634347,1.0,3/11,11.60%,PTK2B;SHC1;JAK1
prerank,regulation of hormone secretion (GO:0046883),-0.3294883753606182,-0.8860975115309968,0.5941176470588235,0.8830094870081889,1.0,12/15,52.56%,EDN1;SOX11;EDN3;NMB;IL11;LIF;VAMP3;SNX6;FGF23;OSM;FFAR2;SCG5
prerank,protein phosphorylation (GO:0006468),0.27535023417900995,0.8859828333623314,0.7933801404212638,0.9517536458758422,1.0,112/479,20.13%,PRKCB;FGFR1;STK19;PRKAA2;LIMK2;FAM20C;PRAG1;NRBP2;MAP3K5;TRIB2;EPHA4;GRK5;ADAM10;TSSK6;TSSK4;WNT11;IKBKE;NEK7;CDK10;CDK6;MKNK2;PTK2B;SGK3;DAPK3;DAPK1;CDKL2;CDK4;ROS1;CREB1;RNASEL;STK39;SIK3;CSK;MAPK15;EFEMP1;BMP4;TGFB2;CDK16;ILK;LATS1;DYRK1B;STK16;PKD1;OXSR1;MAPK9;AURKC;BCR;LMTK2;TXK;PTPN6;ABI1;MUSK;SRPK2;CDKL4;GRK2;TLR4;PDK2;CSNK1E;EPHA3;JAK1;YWHAZ;MARK4;TGFBR2;EIF2AK3;CDK18;SRPK1;DDR1;MAP3K13;CDK2;GSK3A;IRAK1;TGFBR3;CHUK;ULK1;GSK3B;WNK1;CDC42BPA;TLR3;PLK2;AAK1;PAK6;TTK;ATR;PRKCZ;RELN;ABL1;PRKAG1;MAP3K6;MAPK6;CDC25B;EIF2AK4;MAPKAPK2;CHEK2;BMPR1A;PEAK1;PRKCQ;MAP3K3;RSKR;RARA;STK38L;STK24;ROCK2;CAB39;TAOK3;PRKD2;APP;MAP3K1;CDK11B;PRKAB1;TBCK;CDC42BPG;PRKX
prerank,protein insertion into membrane (GO:0051205),-0.26437872346647184,-0.8857473676226463,0.6550387596899225,0.8826809550957477,1.0,6/32,8.65%,ALDH3A2;OXA1L;TRAM1;STX5;REEP1;SERP1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.384561341205183,0.8856157602513759,0.5901639344262295,0.9519691817799711,1.0,2/17,2.79%,ANK2;ATP1A2
prerank,cardiac myofibril assembly (GO:0055003),0.3956775377370253,0.8854769008616684,0.6147540983606558,0.9517249774829357,1.0,2/15,3.66%,NEBL;CSRP3
prerank,chemical homeostasis (GO:0048878),-0.23688864883991784,-0.8851725004090372,0.6735751295336787,0.8828449282974367,1.0,11/61,9.65%,ZBTB20;SLC4A10;KLHL3;NR1D2;WNK2;NR1H3;PNPLA8;AQP11;AQP4;PPARG;ACOX1
prerank,embryonic organ development (GO:0048568),0.31472155197551777,0.8846427874501982,0.6213592233009708,0.9529114723149669,1.0,6/61,3.81%,PBX3;COBL;PBX1;GLI3;STRA6;GDNF
prerank,regulation of stem cell differentiation (GO:2000736),-0.21407866477035553,-0.8845760066524451,0.7744360902255639,0.8831016955248303,1.0,24/89,22.82%,JAG1;TCF12;PDGFRA;LMO2;NOTCH1;RUNX1;PSMC6;PSMA6;PUS7;NUDT21;OCIAD1;GATA2;PSME1;PSMB10;PSMD5;PSMD3;TAL1;PSMA4;YAP1;PSMB9;PSMA8;PSMB7;SP7;YTHDF2
prerank,chromosome organization (GO:0051276),0.3014075185554491,0.8842976676449037,0.6460674157303371,0.9530500495147036,1.0,26/99,21.27%,HDAC5;DOT1L;PHF1;LATS1;RBX1;TCF7L2;CENPT;HDAC3;SMARCA4;COPS5;ACTL6B;HMGN1;CENPH;MYC;PWWP3A;DDB1;RPS27A;UBC;ABL1;GATAD1;H3-3A;RAE1;ZBTB7A;NUCKS1;SETD7;TOP2B
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.3720176711773772,-0.8842180267912192,0.6159600997506235,0.8828542960512824,1.0,2/10,5.93%,LGALS9;IL18
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.31192708620081044,0.8841412143193832,0.6348645465253239,0.9528271660264073,1.0,16/66,14.16%,HPN;NUPR1;CAV1;CDK6;DUSP10;ALOX5;CAV2;TGFB2;KRIT1;ATP5IF1;NFIB;CASK;SYNJ2BP;GATA3;SFRP1;TGFBR3
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.30401860767686223,0.8841398917760102,0.6201183431952663,0.9522858890716833,1.0,22/72,19.87%,EP300;POLR2H;POLR2A;RBX1;POLK;COPS5;ERCC5;HMGN1;RPA3;POLD2;ISY1;PCNA;PRPF19;LIG3;DDB1;RPS27A;UBC;ERCC2;POLR2C;RFC1;POLR2E;ERCC4
prerank,myeloid cell development (GO:0061515),-0.3168029781918327,-0.8840170488650192,0.6197604790419161,0.8821662194718495,1.0,5/18,11.25%,ALAS1;SH2B3;KIT;NCKAP1L;NRROS
prerank,protein autoubiquitination (GO:0051865),0.31595009124060436,0.8837581767096219,0.6251497005988024,0.9525094347813768,1.0,16/61,19.08%,RNF220;SH3RF2;WWP2;TRIM21;RNF146;UBE2B;KLHL24;RNF141;MDM2;BFAR;RNF10;UBE2D3;STUB1;TRIM37;RNF112;RNF41
prerank,regulation of endothelial cell migration (GO:0010594),0.2981675870612971,0.8829956034897213,0.6546511627906977,0.9535134558705707,1.0,20/85,14.84%,ANGPT1;ANXA3;EMP2;GLUL;ZC3H12A;GFUS;PTK2B;FOXC2;BMP4;KRIT1;EMC10;NRP2;SYNJ2BP;BCAS3;BCAR1;PTN;GATA3;FOXP1;AAMP;ITGB1BP1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.2724156476177721,0.8829767029231974,0.892,0.9530077437445172,1.0,201/1082,17.48%,CDH1;NFATC2;CDH13;KLF5;THRB;TMPRSS6;WNT1;KLF4;TFAP2C;PPARGC1A;NCOA3;PBX1;GAL;MAP3K5;ELF3;OGT;LBH;SREBF2;RORC;NIBAN2;GLI3;MLLT3;GTF2F1;HIVEP1;ZC3H12A;CAND2;WNT11;GABPB1;GABPB2;MAVS;EP300;HDAC5;CD81;FOXO3;CSRP3;FOS;GDNF;FOXC2;GLIS2;CREBL2;HDAC4;BMP5;NFE2L2;ZBTB16;EPO;SSBP3;DOT1L;TRIM44;SMARCB1;RHOQ;FOXD2;POU2F3;NFKBIA;ESRRB;RARG;IRF3;BICRA;JUND;NKX2-8;ASF1A;CREB1;FOXM1;HOXA5;ZBTB17;RXRB;RNASEL;HCFC1;AKNA;ZIC2;HAX1;NRF1;SHC1;KAT6B;MYDGF;DDRGK1;PHF10;BMP4;MEF2D;MAPK7;KLF7;MED30;ILK;TGFB1I1;DVL3;FIZ1;ZFHX3;DYRK1B;PPM1A;ATRX;SIX1;PSRC1;PKD1;MAZ;JUN;FZD5;POU3F1;TCF7L2;UBTF;DDX39B;PML;GRHL2;FOXP3;TNFRSF1A;KMT2A;BRD7;TXK;DPF2;MAP2K2;ZIC1;PHF5A;APBB1;ILF2;PRDM15;ENY2;NFIB;TWIST1;BCAS3;KDM3A;HDAC3;WDR43;NFIC;SMARCA4;TLR4;CREB3L4;CREB3;DR1;CALCOCO1;MEF2B;MMP12;NAA15;SP1;EIF2AK3;COPS5;ELL;DCAF6;FOXK1;MPND;MED12;TFEB;MYSM1;SPIN1;GATA3;SMARCD2;RREB1;ARF4;HMGN1;SBNO2;NFIA;CAPRIN2;MED21;MYC;PRDM11;MED24;SERTAD1;MEF2C;PAX3;MYBL1;SFRP1;CHUK;TASP1;ZXDC;IRF2;HRAS;ZPR1;SS18L2;ATMIN;FLCN;ITGB1BP1;TNIP1;RFXAP;CDCA4;TLR3;DHX9;MED6;ZMIZ2;TET1;IKBKG;KLF6;CDC5L;CREB3L2;SMARCC1;SFR1;RNF10;RPS27A;UBC;E2F1;POU4F1;HINFP;ABL1;KDM1A;MLLT6;SLC9A1;CAMTA2;RGMB;PRPF6;BCLAF3;F2R;SMAD5;PITHD1;HSF2;CHEK2
prerank,cellular response to interferon-gamma (GO:0071346),0.300627675572672,0.8823817719004542,0.6447058823529411,0.9536517581041271,1.0,16/88,15.49%,CD44;CCL5;EPRS1;DAPK3;DAPK1;TRIM25;IRF3;TRIM21;PML;TRIM26;TLR4;JAK1;SYNCRIP;IRF2;GAPDH;OAS2
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.4083553292970994,0.8821654793768926,0.6079365079365079,0.9535506330365259,1.0,2/13,10.07%,SCAMP5;KCNB1
prerank,protein localization to centrosome (GO:0071539),-0.3125382831862069,-0.882078880031431,0.6202185792349727,0.8851588979462885,1.0,8/17,27.82%,CCDC14;C2CD3;NEDD1;CSNK1D;BBS4;CEP131;SPAG5;PIBF1
prerank,regulation of sodium ion transport (GO:0002028),0.3411102850126688,0.8820135646984583,0.6200814111261872,0.9533193271169138,1.0,15/34,24.97%,SLMAP;AHCYL1;ANK3;ATP2B4;WNK1;NEDD4;YWHAH;SCN4B;ATP1A1;WNK4;SNTA1;NKAIN4;NKAIN1;PER1;P2RX4
prerank,detection of mechanical stimulus (GO:0050982),-0.30638953029474236,-0.8818083270328108,0.6285714285714286,0.8846498852059855,1.0,3/19,4.78%,CDH2;PTK2;PKD2
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.27801754710226373,0.881422594861989,0.7329255861365953,0.9540178760318245,1.0,47/248,14.44%,SCEL;IGFBP6;KANK1;PTK7;GLI3;AMER3;MLLT3;WNT11;CAV1;TMEM198;RNF220;DAPK3;PPM1B;PTPRU;AMER2;PSMD11;RBMS3;PSMD4;WLS;PSMF1;GPC3;ILK;LATS1;DVL3;LGR4;PPM1A;RBX1;TCF7L2;RNF146;UBE2B;ADGRA2;PRDM15;PSMD7;TLE2;CSNK1E;TLE4;GNAQ;TRPM4;PSMB5;CAPRIN2;GSK3A;LMBR1L;TLE5;SFRP1;UBR5;GSK3B;WNK1
prerank,synaptic vesicle membrane organization (GO:0048499),0.38844480600786035,0.8810831796404155,0.603030303030303,0.9541820817364041,1.0,7/17,24.77%,SYP;TOR1A;STX11;STX4;AP3D1;SNAP23;STX3
prerank,visual system development (GO:0150063),0.3379001935017317,0.8805298980057464,0.5810276679841897,0.9547470217491201,1.0,2/37,1.28%,PBX3;PBX1
prerank,neutral amino acid transport (GO:0015804),0.3494754074482512,0.8805173238397328,0.631578947368421,0.9542296741146896,1.0,6/28,13.71%,SLC36A3;CTNS;SLC36A4;LLGL2;SLC1A4;SLC6A7
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.37733221254361193,0.8802516377681908,0.5962373371924746,0.9542219324976531,1.0,5/20,11.06%,BMP5;ERLIN2;ACADL;ERLIN1;ABCA2
prerank,phosphatidylcholine metabolic process (GO:0046470),0.30455544234164433,0.8802090597927876,0.6493506493506493,0.9537639305055998,1.0,8/70,12.85%,PLB1;MBOAT2;PLA2G12A;MBOAT7;LPCAT2;CHPT1;TMEM86B;LPCAT3
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.3865218462605935,0.8800041497548158,0.5901898734177216,0.9536558964169652,1.0,3/16,12.51%,CAV1;PPP2CA;PTPN2
prerank,positive regulation of transferase activity (GO:0051347),0.29028056530028296,0.8798585384308736,0.6713211600429646,0.9533997492655659,1.0,29/142,15.75%,FGFR1;NTRK3;KLF4;EPHA4;SERINC5;CD200;NEK7;LMO4;ROS1;MRE11;MAPK15;ERBB3;MAP3K4;ARRDC3;GRHL2;DCUN1D5;LMTK2;MUSK;EPHA3;DCUN1D1;DDR1;MYC;GSK3A;HSP90AA1;DSTYK;PABPN1;HMBOX1;PCNA;UBE2N
prerank,regulation of cellular senescence (GO:2000772),-0.27151616788129124,-0.8797539770322549,0.6139705882352942,0.8881665820908494,1.0,8/28,12.55%,SLC30A10;AKT3;RBL1;B2M;ING2;RSL1D1;HMGA2;NEK6
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.27339350626338305,0.8797383707888653,0.7887887887887888,0.9531186387769812,1.0,86/497,14.54%,FOXN3;DAXX;TMPRSS6;TBR1;KLF4;ELF3;LBH;CDKN1A;NIBAN2;SAMD4A;FOXP2;GLI3;TRIM33;WNT11;SAMD4B;HDAC5;QARS1;EPRS1;RBFOX2;DAPK3;PCGF6;ZNF219;GLIS2;HDAC4;DAPK1;ZBTB16;WWP2;NACC1;CRYAB;S100A11;PATZ1;FOXM1;FOXD1;ZIC2;SHC1;KDM5C;KAT6B;EIF4A3;PHF10;BMP4;COMMD7;NKAP;MAGEL2;CIC;L3MBTL3;JUN;TCF7L2;CRY2;PML;FOXP3;BRD7;SCML2;SHMT1;DPF2;YWHAQ;TWIST1;HDAC3;ARID4A;TLE2;BCL7A;SMARCA4;NCOR1;SFMBT2;EIF2AK3;ZNF148;CPEB3;FOXK1;SYNCRIP;GATA3;TSC22D4;FXR1;SBNO2;CHMP1A;BEND5;CBX4;GSK3A;BTG2;PRDM11;ING4;TLE5;SFRP1;FOXP1;SET;GSK3B;GAPDH;NCOR2
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.3694300016027784,0.8795996885710405,0.6083707025411061,0.952830554891954,1.0,5/21,9.63%,MMP9;MEF2D;JUN;ADAMTS1;HTR1B
prerank,glutathione biosynthetic process (GO:0006750),0.42525898543765245,0.8791506314129621,0.6084142394822006,0.953216572599315,1.0,1/11,3.31%,HAGH
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.29119557087400005,0.879062112810634,0.658695652173913,0.9528452845839809,1.0,23/122,16.09%,SORBS1;KLF4;VIM;SAMD4A;YTHDF1;RPS4X;EIF4A3;UPF3A;EIF6;TGFB2;TLR4;IRS2;POLDIP3;CPEB3;PLXNB2;FXR1;MYC;UPF3B;PYM1;DHX9;HSPH1;PCNA;EEF2
prerank,eye development (GO:0001654),0.3207600288804435,0.8790370402845201,0.6311166875784191,0.952359633434209,1.0,6/54,7.38%,PBX3;PBX1;COL5A2;STRA6;EFEMP1;TGFB2
prerank,positive regulation of histone methylation (GO:0031062),0.3613364481809677,0.8788043046415323,0.6148359486447932,0.9522964665150039,1.0,4/24,9.55%,OGT;PHF1;KMT2A;RIF1
prerank,protein import into peroxisome matrix (GO:0016558),0.40210011735555284,0.8784562632176454,0.5940902021772939,0.952434712295577,1.0,3/12,18.71%,PEX26;PEX6;PEX2
prerank,metanephros development (GO:0001656),0.3634541380504575,0.8780749932856318,0.6074074074074074,0.9527008057071719,1.0,5/26,8.24%,GDNF;FOXD1;BMP4;SIX1;PKD1
prerank,regulation of superoxide anion generation (GO:0032928),-0.3355433552880931,-0.8780533585771912,0.6475644699140402,0.8907518841012554,1.0,5/14,26.34%,AATF;TGFB1;SOD1;TYROBP;ITGAM
prerank,hexose biosynthetic process (GO:0019319),0.33136309211795745,0.8767758379552495,0.6149870801033591,0.9547380852181314,1.0,10/42,18.34%,PPARGC1A;SLC25A1;ENO2;MDH2;ALDOA;GAPDH;SLC25A12;TPI1;PCK2;CHST15
prerank,protein alkylation (GO:0008213),0.37325569352484245,0.8765502990409806,0.6115214180206795,0.9546726053465882,1.0,9/22,27.17%,EEF2KMT;SNRPB;PRMT1;ETF1;PRMT2;FAM98B;FAM98A;CAMKMT;EEF1AKMT2
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.2829363653678767,-0.876418074216646,0.6373239436619719,0.8932655319347381,1.0,7/27,9.51%,MARK1;IL1RAPL1;MBOAT1;BRSK1;CTNNA2;VPS35;NTNG1
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.31811762784983005,0.8764067150967938,0.6323713927227101,0.9544291895775344,1.0,9/55,10.83%,NUPR1;BBC3;CAV1;PMAIP1;BCL2L1;BAD;PML;BCAP31;GSDME
prerank,zinc ion transmembrane transport (GO:0071577),-0.2939175592742028,-0.8760882382269572,0.6387096774193548,0.8928540473160731,1.0,5/22,12.48%,SLC30A10;SLC39A12;SLC39A8;SLC39A10;SLC30A1
prerank,endoderm development (GO:0007492),0.3986640316515653,0.8760404296032427,0.5848142164781907,0.9546160418768969,1.0,2/13,8.71%,DUSP1;LAMC1
prerank,organophosphate ester transport (GO:0015748),0.3647300590631962,0.8759744691289104,0.6078147612156295,0.9541973514302509,1.0,3/24,6.32%,LDLR;PITPNC1;PRELID3B
prerank,negative regulation of RNA splicing (GO:0033119),-0.3031001433145142,-0.8753874842264756,0.6511627906976745,0.8933586077176714,1.0,6/19,19.70%,SRSF4;SAP18;SRSF10;TMBIM6;SRSF12;PTBP2
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.33213920100018357,0.8752311291443619,0.6124338624338624,0.9551974662999652,1.0,4/36,4.91%,CCL5;PIGU;CAV1;DOT1L
prerank,response to ketone (GO:1901654),-0.28848832409064684,-0.875136496435116,0.6572327044025157,0.8927393590606859,1.0,10/24,22.97%,THBS1;NR1H3;SLIT2;TGFB1;UBE3A;SLIT3;CATSPER3;ABHD2;YAP1;CCL19
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.2711732246086591,0.8750608350472961,0.862,0.9550211149158601,1.0,148/807,16.87%,THRB;PRDM6;FOXN3;DAXX;TMPRSS6;TBR1;KLF4;TFAP2C;ELF3;LBH;SREBF2;RORC;NIBAN2;FOXP2;GLI3;DDX5;TRIM33;HIVEP1;WNT11;KLF12;CAV1;FOXP4;ZNF436;EP300;HDAC5;ZMYM5;ZNF692;MXD4;QARS1;RBFOX2;KANK2;FOXO3;PCGF6;FOXC2;ZNF219;GLIS2;CGGBP1;HDAC4;NR6A1;ZBTB16;EPO;WWP2;MTDH;NACC1;CRYAB;BEND3;RARG;PHF21A;PATZ1;LCOR;CREB1;FOXM1;OTUD7B;FOXD1;HCFC1;ZIC2;SHC1;KDM5C;ZBTB7B;KAT6B;PHF10;BMP4;KLF7;COMMD7;NKAP;PLK3;ZFHX3;MAGEL2;LARP7;CIC;PPM1A;L3MBTL3;MAZ;JUN;TCF7L2;CRY2;ZFP57;PML;FOXP3;BRD7;SCML2;DPF2;NR2C1;DNMT3A;YWHAQ;RIF1;EZR;APBB1;CCND1;SAP130;TWIST1;HDAC3;ARID4A;ZNF205;NFIC;TLE2;BCL7A;SP2;SMARCA4;NCOR1;DR1;SFMBT2;ZNF148;MIER2;MAFK;CPEB3;FOXK1;CHD3;GATA3;TSC22D4;RREB1;SBNO2;CHMP1A;BEND5;CBX4;MYC;ZNF177;PRDM11;ING4;MEF2C;TLE5;PCGF2;SFRP1;FOXP1;SET;SARS1;IRF2;NCOR2;GATAD2B;FLCN;MDM2;IGBP1;HMBOX1;FLNA;RCOR2;TCF25;ZGPAT;IRF2BP2;NAB2;CCDC85B;RPS27A;UBC;HEXIM1;E2F1;POU4F1;HINFP;KDM1A;UBE2D3
prerank,cellular response to unfolded protein (GO:0034620),0.3531315955826208,0.8750236017713688,0.6171428571428571,0.9545656190119406,1.0,4/26,9.27%,DAXX;HSPB8;HSPA14;BAG3
prerank,chloride transmembrane transport (GO:1902476),0.31695214507789643,0.8744938355702311,0.6603535353535354,0.9550744363597182,1.0,2/48,2.32%,CFTR;SLC12A8
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.40351561568545913,0.874280008319306,0.6141732283464567,0.95497182055496,1.0,3/12,10.55%,EPHA4;NFIB;PAFAH1B1
prerank,response to tumor necrosis factor (GO:0034612),0.29450650417275276,0.8741851614207921,0.6746849942726232,0.9546232224712775,1.0,16/91,15.58%,CCL5;ADAMTS7;ADAM10;ZC3H12A;AFF3;YBX3;NFE2L2;NUB1;GSDME;NPNT;GATA3;ZFAND6;SFRP1;CHUK;DHX9;IGBP1
prerank,response to amino acid (GO:0043200),-0.2668883359722543,-0.8740038285800279,0.7012448132780082,0.8941942973132408,1.0,11/31,18.93%,GLRA1;IPO5;CPEB1;SLC38A9;TMBIM6;LAMTOR1;GLRA3;RRAGD;GLRA2;RRAGA;GLRB
prerank,cellular response to BMP stimulus (GO:0071773),0.3064052632516734,0.8739686205466823,0.6446280991735537,0.9545337439165308,1.0,8/66,7.38%,ADAMTS7;SMAD6;DDX5;HIVEP1;GDF15;BMP5;BMP4;TGFB2
prerank,termination of RNA polymerase II transcription (GO:0006369),0.34528897897452965,0.8737529598056422,0.6289893617021277,0.9543977536195078,1.0,7/33,16.63%,LSM10;SNRPB;MAZ;WDR33;CSTF1;PABPN1;CLP1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.3550088918531883,0.8735538719478229,0.5962373371924746,0.9542718980180536,1.0,8/22,19.25%,VPS37B;VPS4B;RNF126;VPS4A;NEDD4;STAM;TSG101;VPS37A
prerank,regulation of cardiac muscle contraction (GO:0055117),0.3372808433692805,0.8734721861695104,0.6410256410256411,0.9539022986332089,1.0,2/34,2.55%,ANK2;ZC3H12A
prerank,chromosome condensation (GO:0030261),0.3415392363901591,0.873324373390489,0.6627296587926509,0.9536588639067658,1.0,12/36,23.00%,ACIN1;TENT4A;NCAPD3;CHMP1A;SET;NCAPH2;GPER1;RB1;PHF13;NCAPH;SMC4;KMT5A
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.42072458419054437,0.8724461662740697,0.6026490066225165,0.9548751594849485,1.0,3/10,19.42%,PMAIP1;IRS2;GPLD1
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.3815732157239155,0.8716318271700192,0.6158631415241057,0.9559661467545493,1.0,4/18,13.52%,HDAC5;HDAC4;HDAC3;GSK3A
prerank,regulation of heart contraction (GO:0008016),0.2943700192604246,0.871352028118277,0.6526674233825198,0.955962544084425,1.0,5/90,4.79%,ITPR2;ANK2;CELF2;ATP1A2;AHCYL1
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),-0.22217126012508584,-0.8712502504564047,0.7365269461077845,0.8992386128133105,1.0,19/70,22.82%,TCF12;LMO2;RUNX1;N4BP2L2;PSMC6;PSMA6;PUS7;GATA2;PSME1;PSMB10;PSMD5;PSMD3;TAL1;PSMA4;YAP1;PSMB9;PSMA8;PSMB7;YTHDF2
prerank,ATP transport (GO:0015867),-0.3636512302423517,-0.8709775532782208,0.6125,0.8986775462906907,1.0,1/10,1.03%,CD47
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.27349245849295567,0.8704032667623288,0.7792472024415056,0.9572949150444622,1.0,59/341,18.09%,FZR1;FBXL7;RNF43;SPSB4;ATE1;NFE2L2;WWP2;RNF5;TRIM25;VPS37B;PSMD11;NUB1;OTUD7B;NSFL1C;PSMD4;PSMF1;FEM1C;FEM1A;TGFB1I1;KLHL15;UBE2G2;RMND5B;RBX1;RNF146;PML;UBE2B;PCNP;PPP1R11;SIAH3;COP1;PSMD7;AGAP3;FEM1B;VPS4B;RNF126;ZSWIM8;WDR91;PSMB5;ANAPC4;PELI1;GSK3A;NPLOC4;VPS4A;UBE4A;NEDD4;UBE2H;MDM2;BFAR;MAEA;UBA6;DDB1;ARMC8;UBE2D3;SIAH1;KEAP1;STUB1;PSMD1;TSG101;PSMC4
prerank,epithelial cell-cell adhesion (GO:0090136),-0.34169118184450925,-0.8700513031304007,0.5939849624060151,0.8995971447271218,1.0,7/11,29.33%,PLEKHA7;KIT;CCN3;KIFC3;DSP;JUP;CAMSAP3
prerank,cholesterol efflux (GO:0033344),0.3720008391448206,0.870036765190007,0.6170520231213873,0.9574806128058732,1.0,3/20,8.94%,SOAT1;NPC1;SOAT2
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.4070112368464494,0.8699692363130058,0.6294573643410852,0.9570913432304041,1.0,6/13,26.04%,RHOA;IRAK1;ITGB2;NFAT5;IL6;RELA
prerank,thyroid hormone generation (GO:0006590),-0.3668103764655659,-0.8694390029461607,0.6348837209302326,0.8998459296703638,1.0,5/10,33.12%,CPQ;SLC5A5;FOXE1;DIO2;TG
prerank,negative regulation of peptidase activity (GO:0010466),0.319717272006925,0.8694074540538357,0.6402966625463535,0.9577101236190949,1.0,6/47,8.76%,CRB2;TIMP4;SERPINC1;TIMP1;TIMP2;SERPINB8
prerank,dicarboxylic acid metabolic process (GO:0043648),0.3216002079221375,0.8693599370578461,0.6427672955974842,0.9572698688191398,1.0,19/52,26.31%,ACOT8;ME3;SHMT1;ALDH1L2;MDH2;ALDH1L1;OGDH;ASS1;DLST;HAAO;SLC19A1;SDHAF3;DGLUCY;ALDH18A1;ACLY;IDH1;GPT2;IDH2;ALDH5A1
prerank,lysosome localization (GO:0032418),0.3290745826791192,0.8693376969697031,0.6472972972972973,0.9567760852591387,1.0,13/37,24.98%,SYTL4;NDEL1;MAP6;PLEKHM1;BLOC1S2;TFEB;FLCN;HDAC6;BORCS6;PIP4P1;ARL8B;KLC2;FAM98A
prerank,relaxation of muscle (GO:0090075),0.3982328196695757,0.8693119516749555,0.6196943972835314,0.9563021314495973,1.0,2/13,2.79%,GSN;ATP1A2
prerank,keratan sulfate biosynthetic process (GO:0018146),0.34764804649324116,0.8693036378161184,0.6270949720670391,0.955790712849158,1.0,3/26,6.63%,ST3GAL4;B4GAT1;PRELP
prerank,response to muramyl dipeptide (GO:0032495),0.4011297603521159,0.8691156371445876,0.601639344262295,0.9556436007537146,1.0,2/12,7.26%,VIM;TRIM41
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.32420697687216876,0.8689704538624063,0.6342105263157894,0.955401505004778,1.0,12/37,19.87%,RBX1;POLK;ERCC5;RPA3;POLD2;PCNA;DDB1;RPS27A;UBC;ERCC2;RFC1;ERCC4
prerank,C4-dicarboxylate transport (GO:0015740),-0.33063248858424144,-0.8689080105694466,0.6470588235294118,0.8998946931646562,1.0,2/14,5.61%,SLC1A2;SLC1A1
prerank,glutamine family amino acid catabolic process (GO:0009065),0.40231244696259705,0.8683712382885873,0.627172195892575,0.956023768978175,1.0,2/13,7.08%,GLUL;GLUD1
prerank,T cell migration (GO:0072678),-0.3361385458000269,-0.8681504671498422,0.6409574468085106,0.9005124970006364,1.0,7/13,31.42%,SLC12A2;CXCL16;PIK3CD;GPR183;S1PR1;PIK3CG;CXCL10
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.36177960743802046,-0.8676552363944361,0.6532066508313539,0.9005166713648836,1.0,4/10,23.46%,APPL2;NCKAP1L;CD300A;C3
prerank,positive regulation of lymphocyte migration (GO:2000403),0.4002251525770637,0.8675638152715421,0.6299840510366826,0.957061218560013,1.0,4/12,19.37%,CCL5;RHOA;JAM2;APP
prerank,"phagocytosis, engulfment (GO:0006911)",0.3331680616189674,0.8674650566238754,0.6379542395693136,0.9567237514410422,1.0,7/36,15.65%,GSN;GULP1;XKR4;CDC42;DOCK1;VAMP7;ITGB2
prerank,DNA replication (GO:0006260),0.2922538542834513,0.867199315390772,0.6848552338530067,0.9567400619226606,1.0,25/105,19.54%,FEN1;GRWD1;RECQL4;MRE11;PTMS;REV1;PCLAF;POLG;RMI1;TOPBP1;CDK2;ING4;RPA3;SET;DONSON;POLD2;MCM8;MCM6;ATR;NBN;MCM7;RAD50;NT5M;RFC1;PNKP
prerank,microvillus assembly (GO:0030033),0.3955793072429867,0.8670101314819038,0.6045016077170418,0.9565912675857594,1.0,4/14,9.58%,RAP1B;RAP1A;ESPN;EZR
prerank,regulation of response to interferon-gamma (GO:0060330),-0.3305832577413846,-0.8669331151841975,0.6277173913043478,0.900950159378472,1.0,6/14,22.21%,IFNGR1;IFNGR2;JAK2;CDC37;HSP90AB1;SOCS3
prerank,protein glycosylation (GO:0006486),0.28355944671010586,0.8668264276966801,0.6846153846153846,0.9564097481785521,1.0,13/125,6.58%,B3GALT1;ST3GAL4;OGT;B4GAT1;GALNT1;MGAT3;GCNT2;LARGE1;TMEM165;MGAT1;FUT8;NPC1;DDOST
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.3583589879996827,-0.8665063158411462,0.6240208877284595,0.9007592207264138,1.0,4/11,15.38%,DAB2;RDX;MTMR2;SORL1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.3770408222720569,0.8664784499921933,0.6309148264984227,0.9565533074767022,1.0,2/17,6.80%,NOTCH2;BMP4
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.3133186548037645,-0.8662933933097696,0.6754385964912281,0.9000983268425838,1.0,6/17,22.02%,NUDT21;CPEB1;HSF1;CPSF6;NELFE;NCBP1
prerank,regulation of phosphatase activity (GO:0010921),0.35140349734365134,0.866243014309248,0.6207386363636364,0.9564952088041271,1.0,3/24,8.65%,PPP6R3;SH3RF2;CHP1
prerank,negative chemotaxis (GO:0050919),0.33575515038746273,0.8660035504222021,0.6524137931034483,0.9564218511941985,1.0,2/33,2.81%,SEMA3D;SEMA3B
prerank,regulation of mononuclear cell migration (GO:0071675),0.3538738062537595,0.8650497848775132,0.5977496483825597,0.9577525934138399,1.0,4/23,8.27%,CCL5;BMP5;MSN;LGALS3
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.4252001949206178,0.8648949689177539,0.6060606060606061,0.9575386819798439,1.0,2/10,7.93%,DLGAP4;NPTX2
prerank,regulation of osteoclast differentiation (GO:0045670),-0.2674724544682299,-0.8645329150746558,0.6968503937007874,0.9028824893149932,1.0,3/33,3.70%,FBN1;UBASH3B;CAMK4
prerank,positive regulation of cell killing (GO:0031343),-0.3489537586602531,-0.8642995392053787,0.6497326203208557,0.9022473718722481,1.0,1/13,2.77%,WNT5A
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.2874251173525355,-0.8642462593740899,0.6666666666666666,0.9012317707974958,1.0,4/21,11.84%,CYP26B1;PPARD;ACOX1;LPIN2
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.28390709879927106,-0.8638120836842716,0.6474576271186441,0.9010365834923032,1.0,6/21,20.54%,SMARCD3;NES;DRD2;TOX;CX3CL1;CX3CR1
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.3258925393995984,0.8634720316930286,0.6279373368146214,0.959789577315977,1.0,8/40,10.22%,ABCD1;PMAIP1;BCL2L1;BAD;PIP5KL1;MTLN;ATP5IF1;ARL6IP5
prerank,leukotriene metabolic process (GO:0006691),0.3769510224042086,0.8634613466623,0.6511976047904192,0.9592810073667425,1.0,5/19,17.33%,ABCC10;ALOX5;MGST3;LTA4H;MAPKAPK2
prerank,heart trabecula morphogenesis (GO:0061384),-0.30279877855295445,-0.863406210936184,0.667574931880109,0.9007618475862943,1.0,3/18,4.22%,ENG;TEK;NOTCH1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.291815093350371,0.8632011387325352,0.6849775784753364,0.9592428841452116,1.0,19/88,21.71%,FBXL7;FBXL20;PSMD11;PSMD4;PSMF1;FBXL18;RBX1;FBXO31;PSMD7;PSMB5;FBXL15;FBXL2;PSMD1;PSMC4;PSMD8;FBXO9;DMAC2;FBXW7;CUL2
prerank,negative regulation of telomere maintenance (GO:0032205),0.3935187803112645,0.8630514956991715,0.6319018404907976,0.9590095332068433,1.0,9/15,29.46%,PINX1;TNKS2;NBN;RAD50;ERCC4;TERF2;PARP1;TERF1;TERF2IP
prerank,relaxation of cardiac muscle (GO:0055119),0.39678357358723537,0.8629968179768513,0.6243654822335025,0.9586025370576835,1.0,2/13,2.79%,GSN;ATP1A2
prerank,negative regulation of insulin secretion (GO:0046676),0.3761397879466009,0.8629632323258907,0.6225266362252664,0.9581338753714755,1.0,10/17,32.95%,KLF7;KCNB1;SFRP1;SIRT4;BMP8A;CHGA;PRKN;PSMD9;REST;MIDN
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.3365657315273498,-0.8626324346296742,0.6538461538461539,0.9012376634108011,1.0,6/14,24.80%,AUTS2;WDR5;PAXIP1;PRDM9;SMAD4;BRCA1
prerank,neuron maturation (GO:0042551),-0.29906298930017217,-0.8625891002353441,0.6811594202898551,0.9002245613876257,1.0,7/18,23.46%,ADGRB3;ANKS1A;B4GALT5;C1QA;EPHA8;CX3CL1;C3
prerank,cellular response to purine-containing compound (GO:0071415),-0.3613787747604433,-0.8622269930174126,0.6220095693779905,0.899813898136362,1.0,4/10,22.16%,SLC8A1;RYR2;P2RY1;CASQ2
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.27555041622221527,-0.8621587666956152,0.6810631229235881,0.8988505786215081,1.0,7/26,17.82%,PDE8A;STAT5B;DAB2IP;PTPN12;GAREM1;DUSP22;ZFP36
prerank,negative regulation of kinase activity (GO:0033673),0.30666324481116014,0.8607939676869725,0.6767189384800965,0.9619349829157636,1.0,10/62,11.67%,TRIB2;QARS1;HSPB1;TARBP2;TSC2;CHP1;PYDC1;SMCR8;GNAQ;IRS2
prerank,positive regulation of heart contraction (GO:0045823),0.36375336798917535,0.8606783165977799,0.6325925925925926,0.9616261051257481,1.0,4/19,13.52%,ATP1A2;TGFB2;TRPM4;GSK3A
prerank,axonogenesis (GO:0007409),0.2715304731543,0.860516850922483,0.7566735112936345,0.9614258122092202,1.0,38/237,11.67%,SEMA3D;NOTCH2;GPC1;EPHA4;EFNB2;DAG1;NIBAN2;S100A6;GAB1;SEMA3B;CXCR4;LAMA5;DOK6;GDNF;SPTBN2;ENAH;GFRA3;DOCK7;EFNA5;SHC1;ANK3;MAPK7;KLF7;PTPRA;UNC5B;AFG3L2;PARD6B;LMTK2;OPHN1;ACTB;EZR;APBB1;SLC9A6;NRP2;SEMA4F;EPHA3;SPTAN1;IRS2
prerank,regulation of intracellular signal transduction (GO:1902531),0.2665492949083335,0.8598574403564855,0.8294884653961886,0.9621499483084691,1.0,109/420,21.85%,PRKAA2;NTRK3;SRGAP3;SRGAP2;MOB3B;DAXX;ARAP1;NGEF;LBH;ARHGEF17;ARHGAP18;AKAP13;EP300;ARHGEF12;ARAP2;TIAM2;NOP2;PPP1R13L;HSPB1;PPP1R13B;RHOQ;NFKBIA;ROS1;ARHGEF18;MRE11;GRM2;ARHGAP29;SSRP1;ARHGAP21;ARHGAP10;PLK3;CDC42;PML;BCR;ARHGEF5;BANP;BRD7;OPHN1;TRIO;EZR;AKAP5;DLC1;RMI1;GNA13;RHOA;TOPBP1;TAF5;MAPKAP1;SOS2;CHD3;INPP5B;CDK2;OCRL;ARHGAP31;RHOU;PIP4K2C;PRDM11;RPA3;ZFAND6;PRKAR2A;FLCN;MDM2;ARHGDIB;PAK1IP1;IKBKG;MEAF6;ARHGEF1;CRK;PAK6;TAGAP;ATR;POU4F1;ARHGAP33;CCNG1;PRKAG1;NBN;PTPN13;XIAP;PLEKHG2;CHEK2;FBXL2;PIDD1;ARHGAP44;RAD50;TMEM127;ARHGEF6;TAOK3;RNF41;TAF9B;PRKD2;RHOT2;FBXO9;TBP;PRKAB1;TBCK;MAPT;ATP6AP2;AGER;PRKAB2;TRAF4;CASTOR2;CMKLR1;USP2;WDR54;CDK5R1;TAF6;ARHGEF11;RHOC;TPTE
prerank,regulation of membrane depolarization (GO:0003254),0.37071198544140305,0.8598233630211031,0.6426426426426426,0.9617050781729873,1.0,2/18,3.11%,ABCD1;FHL1
prerank,regulation of ERAD pathway (GO:1904292),0.4166661840626486,0.8592954522735943,0.6247877758913413,0.9621985553789935,1.0,4/11,23.78%,TMEM259;USP19;USP25;USP13
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.35236696335861406,-0.8587122753146191,0.6307692307692307,0.90516561232254,1.0,5/11,20.24%,ZMIZ1;ARID1A;PADI2;SERTAD2;SMARCD1
prerank,response to estradiol (GO:0032355),0.33156312840280777,0.8585424081771035,0.6461538461538462,0.9631398128055668,1.0,7/31,19.14%,NCOA3;FAM210B;LCOR;SOCS2;SFRP1;POU4F1;GPER1
prerank,male gonad development (GO:0008584),-0.25369339021204723,-0.8583768928548181,0.7018181818181818,0.9047163181103959,1.0,8/34,15.71%,KITLG;WNT4;AR;WNT5A;ING2;KIT;GATA6;FGF9
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.3469672907734765,0.8583483662501676,0.6405405405405405,0.963017897057562,1.0,4/27,10.60%,ZC3H12A;KHNYN;POP1;LACTB2
prerank,neuron development (GO:0048666),0.2819908084063454,0.8581656915073773,0.7486515641855448,0.9628126207916778,1.0,28/141,14.55%,RP1;PBX3;PBX1;EHD1;GDNF;BLOC1S6;ARL3;UNK;DOCK7;MAP4;ZFYVE27;TGFB2;CDK16;OPHN1;HDGFL3;TOR1A;RAB35;SRRM4;ACTL6B;BLOC1S2;SH3GL2;BTG2;FLRT3;MEF2C;ULK1;GSK3B;WNK1;NEDD4
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.3708859696741295,0.8577581723530646,0.6508422664624809,0.9630665336236721,1.0,3/16,6.86%,ANK2;ATP1A2;GSTO1
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.37426175825277147,0.857535267501934,0.6573116691285081,0.9629654373834078,1.0,7/18,24.19%,CDK4;FBXO5;CCND1;VPS4B;CDC25B;RCC2;CDC25A
prerank,negative regulation of defense response (GO:0031348),0.2984933115665499,0.8575178351150118,0.6714456391875747,0.9624687758263172,1.0,19/77,19.72%,KLF4;PPM1B;ALOX5;MUL1;MAPK7;TRIM21;FEM1A;TNFRSF1A;NMI;PTPN2;LPCAT3;GATA3;CDH5;FNDC4;OTULIN;ILRUN;GPER1;PCBP2;RB1
prerank,respiratory chain complex IV assembly (GO:0008535),0.35678857271500614,0.8574242887013789,0.6362275449101796,0.9621068201119837,1.0,4/21,12.05%,COX19;COX16;COX20;COA8
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.31478750184619997,0.8574141962751844,0.6569620253164556,0.9616030574371294,1.0,6/45,8.44%,REPS2;GAB1;PTK2B;SHC1;EFEMP1;IQGAP1
prerank,regulation of ion transmembrane transport (GO:0034765),0.32805091294577526,0.8573723970169259,0.6382113821138211,0.9611619890034034,1.0,6/33,14.55%,WWP2;KCNJ13;AHCYL1;ANO6;WNK1;NEDD4
prerank,response to prostaglandin E (GO:0034695),0.4155921123285419,0.8572555464893086,0.6455906821963394,0.9608618271143458,1.0,3/10,14.16%,ADCY6;SFRP1;TGFBR3
prerank,actin filament network formation (GO:0051639),0.3968407571719596,0.8570600880688797,0.6072607260726073,0.9607077398555678,1.0,1/11,1.26%,COBL
prerank,cellular response to gamma radiation (GO:0071480),0.3694792924528592,0.8569767314379121,0.6425406203840472,0.9603482653705117,1.0,5/17,16.82%,CRYAB;HRAS;MDM2;ATR;KDM1A
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.36226225015743146,0.8567415534821028,0.6273653566229985,0.9602970766416431,1.0,3/22,4.75%,AHNAK;CACNB3;STAC3
prerank,negative regulation of histone acetylation (GO:0035067),-0.35561852411714984,-0.8565197553387401,0.628428927680798,0.9075211998638381,1.0,5/11,25.12%,THAP7;NOC2L;SIN3A;BRCA1;SPI1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.30861681444379957,0.8565176996919502,0.6747572815533981,0.9601969010917355,1.0,14/59,16.71%,CDKN1A;CDK4;MOV10;MED30;JUN;TCF7L2;CCND1;TWIST1;MED8;MED12;PPM1D;MED24;MED6;MED27
prerank,regulation of mitochondrial translation (GO:0070129),-0.2931307172048024,-0.8565051110787669,0.6833855799373041,0.9064424363784817,1.0,10/21,32.51%,RPUSD4;FASTKD2;TSFM;TRMT10C;FASTKD3;ALKBH1;RMND1;SHMT2;MPV17L2;COA3
prerank,substantia nigra development (GO:0021762),0.32556703450810015,0.8564745349795582,0.6337837837837837,0.9597612645600403,1.0,11/37,12.54%,GLUD1;SYNGR3;CDC42;NDUFS3;ACTB;YWHAQ;S100A1;RHOA;ZNF148;ATP5PF;MAPKAP1
prerank,positive regulation of neurogenesis (GO:0050769),0.2981103073530908,0.8564449949898653,0.6922169811320755,0.9592921851682468,1.0,7/68,4.84%,FBXW8;PLXNB1;PLXNA2;NGF;TIAM2;MAP6;PTPRD
prerank,positive regulation of T cell differentiation (GO:0045582),-0.24779716644437663,-0.8562565279999436,0.7125506072874493,0.9058487537870271,1.0,6/36,11.72%,LEF1;GLI2;ZMIZ1;CD46;NCKAP1L;PNP
prerank,neuron projection morphogenesis (GO:0048812),0.281306458707193,0.8561189103020099,0.7064516129032258,0.9593821115081985,1.0,20/137,10.06%,ALCAM;SRGAP2;PLXNB1;FLRT1;NBL1;S100A6;NGF;MAP6;DOCK7;ANK3;KLF7;AFG3L2;PARD6B;IQGAP1;CDC42;LMTK2;ACTB;TRIO;APBB1;SLC9A6
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.3711497479691912,0.8558752236199542,0.631578947368421,0.9593514822607189,1.0,3/20,4.24%,EP300;SESN2;NFE2L2
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.3216599053446299,-0.8558651769360996,0.6747311827956989,0.905548892335284,1.0,8/14,37.36%,IL18;SOCS5;CCL19;CD86;MALT1;CD80;NFKBID;NLRP3
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.35079269501546123,0.8553756186620263,0.6451169188445667,0.9598422302474379,1.0,7/26,19.21%,ABCD1;ALOX5;TLR6;TLR4;COA8;PARK7;RAB27A
prerank,positive regulation of protein secretion (GO:0050714),0.29708411341074004,0.8553535096473156,0.6714116251482799,0.959357470402378,1.0,22/69,20.52%,SYTL4;MCU;GLUD1;WLS;GOLPH3;TGFB2;BAD;ANG;TCF7L2;EZR;APBB1;IER3IP1;TLR4;IRS2;AACS;DNM1L;NLGN2;APBB3;GPER1;MYO18A;SOX4;FRMD4A
prerank,retinoic acid metabolic process (GO:0042573),-0.3228270579716477,-0.8553169272092804,0.6509186351706037,0.9055517949469507,1.0,2/14,5.05%,ALDH1A2;CYP26B1
prerank,response to light stimulus (GO:0009416),0.3101712379440566,0.8551316847961037,0.6613885505481121,0.959276973774844,1.0,12/55,19.93%,OPN1SW;AANAT;REV1;CPT1B;CRY2;UBE2B;PCLAF;ERCC5;ERCC2;CDKN2D;ERCC4;USF1
prerank,negative regulation of signaling (GO:0023057),-0.27482604907140545,-0.8549744903302665,0.7103448275862069,0.9051604088340132,1.0,6/25,21.40%,UBASH3B;GLRA1;SOCS5;KIF26A;OPRM1;OPTN
prerank,negative regulation of cell cycle (GO:0045786),0.295588304730515,0.8545371070723469,0.6888111888111889,0.9598834071633829,1.0,13/73,13.56%,NUPR1;CDK6;PPP1R13B;IPO7;DUSP1;ZBTB17;BMP4;LATS1;NLRP2B;CDK5RAP1;GATA3;CHMP1A;BTG2
prerank,ncRNA processing (GO:0034470),0.2749936107718114,0.8544936379784276,0.7533818938605619,0.9594562595935081,1.0,57/200,22.54%,DGCR8;PES1;UTP11;FARS2;PIH1D1;TARBP2;TRPT1;KRR1;POP4;WDR55;XRN2;RPL31;EXOSC3;POP1;RPL22;INTS2;THG1L;AARS1;RRP12;MPHOSPH6;BMS1;MTREX;WDR43;WDR36;RPL28;PWP2;DDX47;RPP21;ZCCHC8;TUT7;NOC4L;SENP3;RPL10A;NOL6;RRP9;SRRT;SARS1;RPF1;UTP14A;UTP4;IMP4;RPL14;INTS3;PDCD11;IMP3;INTS6;RPL6;RPS28;RPL41;TUT1;RPLP2;DDX52;BYSL;RPLP1;RPL7;INTS1;WDR74
prerank,response to UV-B (GO:0010224),0.39418722675306084,0.8543786588761728,0.6381578947368421,0.9591689377831294,1.0,1/12,1.93%,CDKN1A
prerank,acylglycerol biosynthetic process (GO:0046463),0.35034523144125596,0.8541999545795975,0.6530898876404494,0.958995500344547,1.0,5/23,11.59%,DGAT1;MOGAT3;MOGAT1;ANG;GPAM
prerank,sphingolipid catabolic process (GO:0030149),-0.3220078653686985,-0.85392585556971,0.6473988439306358,0.9063464258080324,1.0,2/15,4.73%,ACER2;ENPP2
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.3325009725951235,0.8539140722489069,0.6589673913043478,0.9589919838601991,1.0,9/33,19.23%,CD81;UBASH3A;LGALS3;EZR;PTPN2;IKBKG;SH2D1A;DUSP3;PRKD2
prerank,regulation of neutrophil migration (GO:1902622),-0.3473068626478423,-0.8538999645161816,0.6267942583732058,0.9052957519630359,1.0,8/10,44.47%,NCKAP1L;RHOH;JAM3;BST1;RAC2;RHOG;OLFM4;RAC1
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.2352760790775673,-0.8536652194592793,0.7685185185185185,0.9046966019525601,1.0,5/46,5.36%,PLA2G4A;DGKH;GPD1L;DGKB;PLD1
prerank,regulation of protein acetylation (GO:1901983),0.4048169139473009,0.8533852210689685,0.6320907617504052,0.9595081007711606,1.0,7/12,30.61%,RAPGEF3;GSK3B;PARK7;KAT5;DDX3X;TERF2IP;TAOK1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.33606006931270016,0.85305195449609,0.6528925619834711,0.959641770874378,1.0,14/27,25.96%,TAB3;TLR6;TLR4;IRAK1;TNIP1;RPS27A;UBC;TAB2;IRAK4;MAP3K1;TLR1;TLR5;LY96;TAB1
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.3003708431054206,-0.8529172362126616,0.6835443037974683,0.9051103214609865,1.0,3/18,8.78%,ADAMTS9;BPGM;SAMHD1
prerank,visual perception (GO:0007601),0.2926183797790998,0.8525832509991372,0.6722783389450057,0.9600281496114995,1.0,9/84,6.71%,ABLIM1;GUCY2F;CRYBB3;CACNA2D4;CRYBG3;UNC119;EML2;ZIC2;EFEMP1
prerank,regulation of fatty acid metabolic process (GO:0019217),0.3752867918686509,0.8523961807661335,0.6256077795786061,0.9598771564117505,1.0,4/17,11.26%,PRKAA2;CAV1;EIF6;NCOR1
prerank,positive regulation of transporter activity (GO:0032411),0.38615141957514065,0.8522165765133743,0.6110183639398998,0.9597001599006768,1.0,3/13,9.03%,STK39;SYNGR3;KMT2A
prerank,cAMP biosynthetic process (GO:0006171),-0.34914607702448736,-0.8517132440903318,0.6370370370370371,0.9065058356497065,1.0,4/10,7.75%,ADCY5;ADCY7;ADCY1;ADCY4
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.29416609131002225,-0.8516033475869235,0.6734104046242775,0.9056315571672376,1.0,3/19,5.34%,IL34;PTK2;THBS1
prerank,regulation of dephosphorylation (GO:0035303),0.3867345483394928,0.8511937149426678,0.6466973886328725,0.9610961959265508,1.0,5/15,18.96%,SMG7;PPP1R16A;MTMR3;IGBP1;CDK5RAP3
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.2758757299154791,-0.8511098650650649,0.6854304635761589,0.9055735205684436,1.0,6/25,10.80%,STAT5B;HIF1A;ACVR1B;ACVR2A;STAT3;NCKAP1L
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),-0.20280909254853732,-0.85077937647762,0.851063829787234,0.9050966670599926,1.0,50/117,33.67%,ADCY5;CALCRL;LYN;GGT5;ADCY7;ADCY1;ADCY4;HTR7;ADORA2A;RAMP2;PRKAR2B;GPR45;CYSLTR1;PTHLH;GNB1;ADM;CYSLTR2;MC5R;ADCY2;PTGDR;PRKAR1B;PTGER4;GLP2R;RXFP1;MAPK14;VIPR2;ADCY3;ADCY8;IAPP;ADCYAP1R1;GPR27;HCK;NPSR1;CALCA;GNG2;HRH2;FGR;TSHR;CD247;ADRB1;PLCG2;LHCGR;PLCG1;TREM2;PTH2R;GPR20;CD163;HTR6;GIPR;CRHR1
prerank,negative regulation of immune response (GO:0050777),-0.19579064083098727,-0.8503205617215506,0.8225806451612904,0.9049688535373168,1.0,69/154,34.41%,ADCY5;CALCRL;LYN;GGT5;ADCY7;IRAK3;ADCY1;ADCY4;HTR7;ENPP3;ADORA2A;RAMP2;PRKAR2B;GPR45;CYSLTR1;MAPKBP1;PTHLH;CD300A;GNB1;SIRT2;ADM;CYSLTR2;MC5R;RC3H1;ADCY2;PTGDR;PRKAR1B;PTGER4;GLP2R;RXFP1;TNFAIP3;MAPK14;VIPR2;ADCY3;ADCY8;IAPP;LYAR;ADCYAP1R1;GPR27;SPI1;HCK;NPSR1;CALCA;GNG2;HRH2;FER;FGR;TSHR;FCGR2B;CD247;ADRB1;TRIM27;PLCG2;CCR2;LHCGR;DHX58;PLCG1;TREM2;PTH2R;SAMSN1;TYRO3;GPR20;RNF26;CD163;HTR6;GIPR;CRHR1;LILRB1;GLP1R
prerank,regulation of dendrite development (GO:0050773),0.32631315352128915,0.850258486444199,0.6775884665792923,0.9623349714293595,1.0,3/37,4.13%,RAB17;COBL;BMP5
prerank,positive regulation of protein phosphorylation (GO:0001934),0.26671619408750424,0.8499858984771507,0.8193743693239153,0.9623520673238077,1.0,38/348,8.78%,ANGPT1;CD44;NTRK3;LIMK2;DAXX;ADTRP;MMP9;PDGFC;CDKN1A;IL15;GDF15;CAV1;TWSG1;MAVS;RAP1A;CD81;NGF;PTK2B;CREBL2;BMP5;DOCK7;EFNA5;CAMKK1;KRAS;MRE11;HAX1;WDFY2;MYDGF;DDRGK1;BMP4;CCND2;TGFB2;ILK;LATS1;DVL3;FGF22;IQGAP1;VEGFB
prerank,negative regulation of inflammatory response (GO:0050728),-0.1892658435207456,-0.8497399880762785,0.9230769230769231,0.9050416654013947,1.0,54/182,25.69%,IGF1;TEK;ADCY5;CALCRL;LYN;PTGIS;MFHAS1;GGT5;ADCY7;NR1H3;RORA;VPS35;PPARD;ADCY1;ADCY4;HTR7;ENPP3;ADORA2A;PPARG;RAMP2;PRKAR2B;GPR45;CYSLTR1;TNFRSF1B;CCN3;PTHLH;MVK;GNB1;ADM;CYSLTR2;MC5R;PPARA;ADCY2;PTGDR;PRKAR1B;PTGER4;GLP2R;RXFP1;TNFAIP3;NR1H4;LRFN5;MAPK14;VIPR2;ADCY3;ADCY8;GPS2;IAPP;ADCYAP1R1;GPR27;HCK;NPSR1;CALCA;GNG2;SMPDL3B
prerank,positive regulation of dendritic spine development (GO:0060999),-0.30203080542105815,-0.8496199013829048,0.6990291262135923,0.9041621015781549,1.0,4/20,10.79%,SHANK3;NLGN1;LRP8;DLG5
prerank,C21-steroid hormone metabolic process (GO:0008207),0.3646940059055899,0.8493612953434877,0.6738197424892703,0.9630304113046264,1.0,4/20,20.43%,STARD3;FDX1;HSD17B10;TSPO
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.2789910660912485,0.8492196327707758,0.7142857142857143,0.9627717801433884,1.0,21/113,14.36%,CDH13;NOTCH2;HPN;BMP5;NRAS;AGGF1;MYDGF;BMP4;BAD;ANG;TCF7L2;LAMC1;VEGFB;EMC10;NRP2;MMP12;PTN;RREB1;MYC;SFRP1;HRAS
prerank,negative regulation of protein phosphorylation (GO:0001933),0.276682820775928,0.8491343737342532,0.7552966101694916,0.962428794289346,1.0,30/150,14.85%,NTRK3;TRIB2;OCLN;SMAD6;ZC3H12A;CAV1;QARS1;HSPB1;TARBP2;TSC2;FBLN1;SPRED3;DMTN;NLRP2B;PIP5KL1;CHP1;PYDC1;FKBP8;PTPN6;SMCR8;TWIST1;GNAQ;LDLRAD4;MVP;SH3GL2;SFRP1;EIF4G1;DNAJC10;ITGB1BP1;DNAJC3
prerank,rRNA processing (GO:0006364),0.273689146930399,0.8483989478063462,0.7331932773109243,0.9633257188813693,1.0,33/172,15.88%,NSA2;NOP2;PES1;UTP11;PIH1D1;EIF6;KRR1;MAK16;POP4;WDR55;XRN2;RPL31;EXOSC3;RPL22;RRP12;MPHOSPH6;BMS1;MTREX;WDR43;WDR36;RPL28;PWP2;DDX47;NOC4L;SENP3;RPL10A;NOL6;RRP9;RPF1;UTP14A;UTP4;IMP4;RPL14
prerank,cellular protein catabolic process (GO:0044257),0.30104521171682597,0.8482596058585367,0.6953883495145631,0.9630684086837457,1.0,17/59,19.31%,ADAMTS7;AP2A2;RNF5;DENND3;CTSZ;CAPN2;UBE2G2;RAB7A;AFG1L;AP2A1;RNF123;BNIP3L;MDM2;CTSH;CHEK2;PISD;IDE
prerank,membrane fusion (GO:0061025),0.3337762653660973,0.8482431165880079,0.6657645466847091,0.9625871137655551,1.0,13/33,24.70%,OTOF;NSFL1C;CHP1;VTI1B;NAPA;OPA1;STX11;DNM1L;NSF;VAMP2;SNAP23;VAPA;UBXN2A
prerank,mRNA export from nucleus (GO:0006406),0.28331414380340203,0.8474330837357846,0.7191392978482446,0.963642385735783,1.0,33/102,25.53%,SRSF2;NUP93;EIF4A3;SMG7;DDX39B;RBM8A;NDC1;WDR33;AGFG1;ENY2;SRSF7;POLDIP3;THOC7;RNPS1;SRSF9;UPF3B;PABPN1;MAGOHB;MAGOH;AAAS;SRSF1;RAE1;SRSF5;THOC1;POM121;U2AF1;TPR;SRRM1;RANBP2;NUP42;NUP62;SEH1L;RBM15B
prerank,response to unfolded protein (GO:0006986),0.3120776038474858,0.847304340881038,0.675776397515528,0.9633582455717065,1.0,10/48,15.87%,DAXX;HSPB1;HSPB2;HSPB8;HSPA4;HSPA14;BAG3;HSP90AA1;HSPH1;DNAJC4
prerank,regulation of mitotic cell cycle (GO:0007346),0.2744229994535559,0.8466804141926,0.7376185458377239,0.9640098043982783,1.0,32/171,19.77%,FZR1;NEK7;CDK10;DAPK3;PSMD11;CAV2;PSMD4;PSMF1;IQGAP1;FBXO5;EIF4EBP1;PSMD7;PKMYT1;PSMB5;ANAPC4;BTG2;MDM2;MAEA;DDB1;ERCC2;CUL9;CDC25B;PSMD1;DUSP3;INTS13;PSMC4;KIF20B;CDK5RAP3;APP;PSMD8;RB1;CDK11B
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.28289605474387025,0.8465467304864335,0.7112359550561798,0.9637438013314893,1.0,34/110,24.08%,PPP2CA;RPS4X;EIF4A3;UPF3A;SMG7;RBM8A;RPL31;RPSA;GSPT2;RPL22;RPL28;RPS26;RNPS1;RPL10A;DCP1A;UPF3B;EIF4G1;PYM1;RPL14;MAGOHB;MAGOH;RPS27A;CTIF;RPL6;RPS28;SMG9;ETF1;RPL41;RPLP2;RPLP1;RPL7;PABPC1;RPL21;RPL26
prerank,prostanoid metabolic process (GO:0006692),-0.3273952507535758,-0.8463668374166032,0.6768447837150128,0.9095608415430352,1.0,5/13,25.59%,PTGES;ACOX1;HPGD;CYP2S1;PTGR1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.2679549494325545,0.8461618113571749,0.8181818181818182,0.9639699254793478,1.0,67/327,18.46%,BNC2;NFATC2;FOXN3;DAXX;PPARGC1A;EP300;DAPK3;ZNF219;PPP2CA;CREBL2;IGSF1;MLF2;ESRRB;PRRX2;PATZ1;PHF1;POLR2A;HCFC1;KAT6B;EFEMP1;RALY;ZFHX3;ATRX;SIX1;PML;FOXP3;MYCBP;APBB1;FADS1;NFYC;ZNF205;GON4L;MYT1;AJUBA;SP1;TAF5;TFEB;SPIN1;CHD3;RREB1;SBNO2;GPBP1;NFIA;REXO4;MEF2C;MYBL1;SRRT;PTP4A3;IRF2;UTP4;ACTN4;NAB2;PAK6;E2F1;HINFP;SPTY2D1;ABL1;MLLT6;LIN54;TRRAP;CHEK2;PRKCQ;BRDT;APBB3;SUFU;WTIP;ATF2
prerank,regulation of protein localization to cell surface (GO:2000008),0.3319912071561113,0.8460716764626403,0.6675712347354138,0.9636385424279358,1.0,5/33,11.06%,ACTN2;TOR1A;SNX33;RAB11FIP5;ABCA2
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.30844911403241554,0.8459139957818985,0.6718346253229974,0.9634303425681057,1.0,8/53,11.13%,NUPR1;DDRGK1;PSMF1;DESI1;PKD1;USP19;OPHN1;OSBPL7
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.3558408001743339,-0.8455838507015022,0.6816037735849056,0.9099604933082157,1.0,2/10,5.46%,CAMK2D;HECW1
prerank,signal peptide processing (GO:0006465),-0.3448500257554308,-0.8454490992795122,0.6641604010025063,0.9091643174735462,1.0,2/11,9.97%,PCSK5;SPCS2
prerank,regulation of Wnt signaling pathway (GO:0030111),0.2848502779785931,0.8447665063753894,0.7308970099667774,0.9650294299760738,1.0,19/108,14.15%,KANK1;NXN;RSPO3;PTK7;AMER3;RNF43;PPP2CA;AMER2;TSC2;WLS;GPC3;CXXC4;FOXP3;SMARCA4;HMGXB4;GNAQ;SPIN1;SFRP1;TRABD2B
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.3877546008317307,0.8447232720194593,0.6519685039370079,0.9645996416742785,1.0,1/13,0.66%,ANK2
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.27022209484727283,0.8447198662051101,0.7502634351949421,0.9640894368373137,1.0,27/163,18.09%,PRKCB;NFATC2;ZC3H12A;FYB2;PSMD11;EIF2B2;CSK;PSMD4;PSMF1;NFAM1;TXK;PSMD7;BCAR1;PSMB5;GATA3;MEF2C;CHUK;WNK1;IKBKG;RNF31;UBE2N;EIF2B4;PSMD1;TAB2;SPPL3;PRKCQ;PSMC4
prerank,MAPK cascade (GO:0000165),0.2666027802661565,0.844655171194066,0.8008171603677222,0.9637033998793657,1.0,45/295,14.36%,FGF13;FGFR1;ANGPT1;MAP3K8;ACTN2;CCL5;MAP3K5;MRAS;GDNF;IL3RA;SPTBN2;PSMD11;GFRA3;RASAL3;BCL2L1;NRAS;KRAS;SHC1;PSMD4;PTPRA;PSMF1;ERBB3;FGF22;RBX1;RALGDS;YWHAB;RASA2;GOLGA7;MAP2K2;RAF1;PSMD7;SPTAN1;JAK1;IRS2;PPP1CB;SYNGAP1;RASA1;PSMB5;RASA3;MYC;MEF2C;SHC2;BRAP;CHUK;HRAS
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.2805914407699592,0.8445060296127189,0.723404255319149,0.9634730142822281,1.0,20/124,14.09%,PLCB3;CELSR1;WNT1;WNT11;AP2A2;PSMD11;MOV10;PSMD4;PSMF1;DVL3;FZD5;TCF7L2;CDC42;PSMD7;GNAO1;AP2A1;RHOA;PSMB5;PDE6B;SFRP1
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.32242911060500357,0.8442638647528018,0.6460526315789473,0.9634175583392912,1.0,6/39,10.55%,DYNC1I1;MYO1H;NDEL1;MYO5A;MYO1C;PAFAH1B1
prerank,glucose transmembrane transport (GO:1904659),-0.29624773893003825,-0.8442446186772927,0.6876790830945558,0.9104127690958789,1.0,3/18,8.80%,SLC2A1;PPARD;SORT1
prerank,negative regulation of protein polymerization (GO:0032272),0.3456463137006421,0.8441452890233291,0.6661971830985915,0.9631211087784565,1.0,8/27,17.47%,KANK1;SSH3;TWF1;EML2;ARFGEF1;KANK4;PFN2;CDH5
prerank,positive regulation of signaling (GO:0023056),-0.25302934291773377,-0.8440549075692474,0.7074235807860262,0.9096658411156229,1.0,12/37,23.00%,GRIK2;ECE1;LGI1;SYT1;CLSTN2;RAB29;EDN1;SOX11;EDN3;KCTD13;RIMS1;RIMS3
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.30817630708470795,0.8437596572152337,0.6727509778357236,0.9633273835488002,1.0,8/48,10.44%,OGT;EP300;NUP93;RUBCNL;EIF6;NDC1;JMJD8;TIGAR
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.38246504807424664,0.8433404371904413,0.6436781609195402,0.9635971949885089,1.0,2/14,9.55%,SHLD2;RIF1
prerank,glycosphingolipid metabolic process (GO:0006687),0.3157248175373574,0.8432677202403369,0.6881578947368421,0.9632210747615466,1.0,10/42,14.43%,HEXA;A4GALT;LARGE1;GLB1;SUMF1;ABCA2;HEXB;SUMF2;ESYT2;SMPD2
prerank,small GTPase mediated signal transduction (GO:0007264),0.28580866861056575,0.843174937906836,0.7244444444444444,0.9628732500484786,1.0,26/103,15.52%,CDKN1A;MRAS;ARHGAP18;TIAM2;ARL3;ARHGEF18;NRAS;KRAS;RHEB;SHC1;KRIT1;JUN;CHP1;BCR;RALGDS;ARFIP2;RREB1;CDK2;ARHGAP31;SHC2;BRAP;HRAS;CCDC88A;SETDB1;PLK2;USP28
prerank,protein ubiquitination (GO:0016567),0.2614133571826849,0.843084412845069,0.8518145161290323,0.9625252681155415,1.0,124/471,23.50%,RNF152;FBXL7;TRIM60;FBXW8;TRIM33;CAND2;RNF43;FBXL20;RNF220;SPSB4;NFE2L2;LONRF1;SH3RF2;WWP2;TRIM25;TRIM44;PSMD11;NUB1;ELOB;RNF138;KLHL21;MUL1;PSMD4;CBLL1;PSMF1;TRIM41;TRIM21;UBE2G2;FBXL18;RBX1;RNF146;FBXO31;SDE2;TRIM47;TRIM26;TRIM11;UBE2B;RNF182;PCNP;KLHL24;PSMD7;FBXW9;UBE2Q1;VPS11;KLHL13;RNF126;MIB2;ZSWIM8;RNF141;PSMB5;DTX3;NPEPPS;PELI1;DDA1;VPS18;UBE4A;BRAP;UBR5;NEDD4;UBE2H;MDM2;BFAR;RNF31;PCNA;UBE2N;CCDC22;MSL2;PRPF19;TNKS2;FBXL15;UBA6;DDB1;TPP2;RNF10;CAND1;RPS27A;UBC;CUL9;DTX2;UBE2D3;SIAH1;KEAP1;STUB1;UBE2J1;FBXL2;PSMD1;PDZRN3;TRIM37;OTULIN;PSMC4;RNF112;PEX2;RNF41;PSMD8;UBE2Z;ASB5;UBE3C;FBXO9;THOP1;RMND5A;CHFR;USP22;VHL;FBXW7;CUL2;TRIM5;UBE2E1;FBXW2;RCHY1;ARIH2;UBE2V1;SMURF2;BLMH;RNF168;DET1;RNF213;TRIM3;CTR9;RNF14;RNF7;CDC23;PSMA7;LEO1;FBXO4
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.29104410948660425,-0.842922145678568,0.6837060702875399,0.9108555138070599,1.0,11/19,34.82%,CORO2B;DKC1;CCT7;CCT2;CCT4;CENPJ;WRAP53;CEP135;TREM2;CCT3;CEP295
prerank,cellular defense response (GO:0006968),-0.2441696941059786,-0.8428803548907656,0.7702127659574468,0.9098465499892222,1.0,7/40,15.78%,DCDC2;LSP1;CCR9;VEZF1;ADORA2A;NCF2;IL1RL2
prerank,positive regulation of protein export from nucleus (GO:0046827),0.37820074834790396,0.8422515521354093,0.6491228070175439,0.9635846695658873,1.0,6/15,22.75%,TCF7L2;BAG3;RAPGEF3;GSK3B;XPO4;TPR
prerank,lipid homeostasis (GO:0055088),0.30380573526958515,0.8421788098817474,0.694829760403531,0.9632040977209918,1.0,8/57,11.67%,PRKAA2;ABCD1;ABHD5;ORMDL3;THADA;TLCD2;ABCA2;IRS2
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.23920263537792882,-0.84174596831028,0.745,0.9111102129046512,1.0,12/42,17.61%,SMARCA2;MBD2;ARID1A;CHD8;ACTR6;SMARCC2;SMARCE1;NASP;ACTR5;CECR2;MBD3;HDAC2
prerank,regulation of cilium assembly (GO:1902017),0.30346325966783955,0.8415945789788183,0.7035670356703567,0.9637735509953766,1.0,21/62,24.31%,LIMK2;RABEP2;CDK10;TBC1D16;MAPK15;TBC1D1;MARK4;ODAD3;CCDC88A;USP6NL;TESK1;TBC1D22A;TBC1D10A;TBC1D17;CROCC;CEP97;RABGAP1;TAPT1;CEP120;ODF2L;ATG3
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.33415877169376845,0.8413960553491435,0.6620689655172414,0.9636284620470542,1.0,8/27,18.38%,DDX5;BMP4;MAP2K2;AJUBA;FXR1;EIF4G1;DHX9;WTIP
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.352780237956829,-0.8411177078785411,0.6633906633906634,0.9112517653951459,1.0,6/10,30.64%,MTHFD2L;DHFR;MTHFR;TYMS;SHMT2;MTHFS
prerank,ion homeostasis (GO:0050801),-0.26616066406719163,-0.8409703642992248,0.7285714285714285,0.9104375268522164,1.0,5/30,7.70%,SLC4A10;CAMK2D;KLHL3;WNK2;UNC80
prerank,regulation of organelle assembly (GO:1902115),0.2995092320472654,0.8409508596295521,0.7106184364060677,0.9639163859011679,1.0,20/73,17.99%,GSN;RABEP2;TBC1D16;MAPK15;MSN;CEP76;EZR;MTMR3;VPS11;TBC1D1;ODAD3;RAB1B;USP6NL;PLK2;ATXN2L;TBC1D22A;TBC1D10A;PDCD6IP;STAM;TSG101
prerank,purine ribonucleotide metabolic process (GO:0009150),0.29246118772819885,0.8408719682306491,0.7,0.9635485045379409,1.0,8/68,9.99%,SULT1A1;ACOT8;SULT2B1;RHOQ;NT5C2;BAD;ACSM3;AK3
prerank,negative regulation of nuclear division (GO:0051784),0.39565807481326376,0.8403724714935938,0.6628664495114006,0.9639593354934908,1.0,4/11,23.62%,BMP4;FBXO5;TOM1L2;AURKAIP1
prerank,acetyl-CoA metabolic process (GO:0006084),0.37490129059314564,0.8401758399157857,0.6521739130434783,0.9637777855865512,1.0,6/15,22.87%,TDO2;PMVK;ACACA;HMGCS1;ACLY;MLYCD
prerank,regulation of epithelial cell proliferation (GO:0050678),0.2883264228015142,0.8391547608086043,0.7031963470319634,0.9651791809125859,1.0,11/85,8.71%,ANGPT1;HPN;NUPR1;CDK6;DUSP10;BMP5;BMP4;TGFB2;BAD;TCF7L2;LAMC1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.336275759253256,0.8390791102212941,0.6598079561042524,0.964807746578763,1.0,7/26,14.38%,LSM10;CDK10;CCND2;ADAMTS1;CCND1;ANKRD17;EIF4G1
prerank,regulation of postsynapse organization (GO:0099175),0.341849922043582,0.8387082874406848,0.6699029126213593,0.964950308015994,1.0,3/28,2.48%,PDLIM5;EPHA4;SIPA1L1
prerank,cellular calcium ion homeostasis (GO:0006874),0.27537604971378793,0.8382513159447275,0.7261774370208105,0.9652699290868493,1.0,15/133,8.83%,ANK2;STIM2;CCL5;CAV1;MCU;CSRP3;ATP13A3;MCUB;TMEM165;CAV2;MICU1;AFG3L2;ATP13A4;PML;HCRTR1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.2958853706374721,-0.8382152837413025,0.6996699669966997,0.9146551712956751,1.0,7/20,18.12%,DCC;FAS;BCL2;CASP9;ITGAV;BAX;BOK
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.3784934460862185,0.8379320214172716,0.6749611197511665,0.9653211876243574,1.0,6/14,21.49%,PPP2CA;DUSP1;PPP2R2D;PPP2CB;PPP2R2C;PPP1R15B
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.372902166108305,0.8378327957918286,0.6752,0.9649974578587006,1.0,4/15,12.14%,EIF4A3;SIX1;TWIST1;TGFBR2
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.29495809536207457,0.8373657255853995,0.7035670356703567,0.9653525620688307,1.0,14/70,15.25%,DAXX;NGF;BCL2L1;ERBB3;TGFB2;BAD;TNFRSF10B;TNFRSF1A;BAG3;DDX47;BLOC1S2;GSK3A;GSK3B;TLR3
prerank,regulation of cellular response to stress (GO:0080135),0.28037904780630263,0.8369238505974181,0.7404063205417607,0.9656843405603661,1.0,38/115,25.76%,NUPR1;ABCD1;EP300;BAG1;ALOX5;CRYAB;HSPB8;NUP93;CHORDC1;USP19;NDC1;BAG3;AJUBA;RPA3;GSK3B;EIF4G1;HSP90AA1;HSPH1;ATR;ABL1;MAPKAPK2;AAAS;RAE1;ROCK2;MAPT;CAMK2B;HIKESHI;PTGES3;POM121;TPR;RANBP2;ARMT1;NUP42;AIFM2;NUP62;SLC38A2;SEH1L;MBTPS2
prerank,negative regulation of cation channel activity (GO:2001258),0.33683690583555187,0.8367360924664261,0.667621776504298,0.9655277685393109,1.0,3/26,6.86%,MMP9;EPO;GSTO1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.33973601530051417,0.8366842240359317,0.6558533145275035,0.9650988279648784,1.0,8/26,23.74%,NINJ1;CAV1;LBP;TLR3;FLOT1;TLR1;WDFY1;TLR5
prerank,negative regulation of intracellular protein transport (GO:0090317),0.3530165512942442,0.8364477213006216,0.6589595375722543,0.9650271008596466,1.0,8/22,18.46%,INSIG1;DMTN;CHP1;SIAH3;ITGB1BP1;UFM1;SUFU;PARK7
prerank,protein dephosphorylation (GO:0006470),0.27618868462062973,0.8359678061889088,0.7335490830636462,0.965429669016858,1.0,33/135,18.00%,PTPN14;EYA2;PPM1L;PPP2CA;DUSP10;PPM1B;PTPRU;PTPRD;PPP1R15A;DUSP12;DUSP1;UBLCP1;PTPRF;EYA1;PTPN9;PTPRA;PP2D1;PPP2R2D;PPM1A;PTPN6;MTMR3;PTPRE;PPP1CB;PTPN2;PPM1D;PGP;PPP2CB;DUSP11;PTPN13;PPP2R2C;PDP1;DUSP3;PTPN11
prerank,positive regulation of transport (GO:0051050),0.2863783664139808,0.8359619989600037,0.7157894736842105,0.9649296566016344,1.0,22/85,20.91%,CHRM1;IL15;ANXA2;CBLL1;GPC3;SYNGR3;ACSL3;CHP1;KMT2A;ACTB;ZNF205;FCER1G;GSK3A;GSK3B;DYNC1H1;CDH3;NUMA1;RAB27A;GPLD1;FLOT1;ABCA7;TULP1
prerank,neuronal action potential (GO:0019228),0.34872822779457163,0.8359361139398355,0.6601123595505618,0.9644686485449757,1.0,6/22,21.41%,SCN3A;ANK3;SCN9A;GPER1;KCNMB3;KCNMB2
prerank,centromere complex assembly (GO:0034508),-0.24183865392395176,-0.8359028557654822,0.7346153846153847,0.9180593096986112,1.0,18/36,33.60%,RUVBL1;ITGB3BP;CENPP;HJURP;NASP;HELLS;MIS18BP1;KNL1;CENPE;CENPU;CENPX;NPM1;CENPI;MIS18A;CENPN;CENPA;SMARCA5;CENPV
prerank,transcription by RNA polymerase I (GO:0006360),0.3250937104038399,0.8358861121071279,0.6680216802168022,0.9640533400518103,1.0,15/34,26.38%,POLR2H;TAF1C;UBTF;POLR1C;POLR1E;POLR1F;ERCC2;POLR2E;TBP;POLR1G;TCOF1;MNAT1;POLR2K;POLR1B;TTF1
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.371057643419514,0.8357039032624337,0.6906906906906907,0.9638904039015269,1.0,5/15,15.99%,HPN;TMC2;PDZD7;MKKS;TMEM120A
prerank,regulation of mitotic spindle organization (GO:0060236),0.3242487670067289,0.8356909574527887,0.6740331491712708,0.9634130110356118,1.0,15/35,26.58%,PARP3;PSRC1;CHMP4B;VPS4B;CHMP1A;CHMP2A;DYNC1H1;NUMA1;PDCD6IP;RAE1;CEP97;TPR;CHMP5;NUP62;CHMP1B
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.2814980638772703,0.8356505544167532,0.7118451025056948,0.9629786685911577,1.0,31/96,25.53%,SRSF2;NUP93;EIF4A3;SMG7;DDX39B;RBM8A;NDC1;WDR33;AGFG1;SRSF7;POLDIP3;THOC7;RNPS1;SRSF9;UPF3B;MAGOHB;MAGOH;AAAS;SRSF1;RAE1;SRSF5;THOC1;POM121;U2AF1;TPR;SRRM1;RANBP2;NUP42;NUP62;SEH1L;RBM15B
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.28733443161674804,0.8355486847673712,0.7215189873417721,0.9626459158352318,1.0,18/88,19.00%,SAMD4A;SAMD4B;EPRS1;DAPK3;DAPK1;EIF4A3;SHMT1;EIF2AK3;CPEB3;SYNCRIP;FXR1;BTG2;GAPDH;HDAC6;CAMK2N1;IGF2BP3;CDK5RAP3;IGF2BP2
prerank,"transcription, DNA-templated (GO:0006351)",0.26739007877931326,0.8352925081502433,0.8033298647242456,0.9626255713849432,1.0,55/207,24.90%,THRB;DDX5;MLLT3;GTF2F1;FOXO3;CREBL2;POLR2H;TAF1C;ELOB;NKX2-8;POLR2A;ZBTB7B;SSRP1;UBTF;POLR1C;NFE2L3;NFIC;PTMA;GTF3C3;GTF2E1;TAF5;ELL;RREB1;RPAP1;TCEA2;RNPS1;POLR3G;GTF3C2;TBPL1;E2F1;ERCC2;NELFB;POLR2C;GTF3C5;POLR3H;POLR2E;NELFA;TAF9B;TBP;MNT;SNAPC3;TWNK;GTF2E2;TAF6;GTF3C4;AFF4;TFAM;CTR9;CDK9;LEO1;GMEB2;MBD1;MNAT1;POLR2K;BAZ2A
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.3213818410968502,0.8352666154479461,0.6967741935483871,0.9621638249360766,1.0,14/38,22.98%,EPHA4;CAV1;UNC119;SHC1;ERBB3;SRCIN1;MVP;RAP2C;RELN;SH3BP5L;APP;DLG4;EFNA1;FCGR1A
prerank,positive regulation of rRNA processing (GO:2000234),0.40609066013207434,0.8351827712436521,0.6677908937605397,0.961811305195793,1.0,4/10,22.26%,BUD23;WDR43;TRMT112;SIRT7
prerank,regulation of actin nucleation (GO:0051125),0.3946630188324741,0.8346895133479926,0.6613418530351438,0.9621821871662578,1.0,2/12,11.72%,GSN;ARFIP2
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.25529768406140363,-0.8345719364306605,0.7614035087719299,0.9196497478438411,1.0,2/33,2.85%,PRKG1;IGFBP5
prerank,muscle tissue morphogenesis (GO:0060415),-0.3017368415711147,-0.8342830041681764,0.7116883116883117,0.9191694308337346,1.0,2/16,4.22%,MYLK;NOTCH1
prerank,positive regulation of metabolic process (GO:0009893),0.28063516872261546,0.8338349564703217,0.7361268403171007,0.9632324041158061,1.0,16/103,12.63%,PPARGC1A;OGT;PDGFC;CAV1;TRPM8;CXCR4;BEND3;ZBTB7B;ACADL;ELOVL6;KDM3A;HDAC3;ACACA;FASN;PIGA;CPT2
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.28891104219233205,0.8338137534410354,0.7164527421236873,0.9627676847593694,1.0,13/78,14.06%,SORBS1;STAC3;RHOQ;BCL2L1;PTPN9;LGALS3;ACTB;AKAP5;CNPY4;EPHA3;VTI1B;VPS4A;ATP2B4
prerank,oxoacid metabolic process (GO:0043436),0.33237794618557076,0.8337019810036687,0.6516220028208745,0.9624538246599448,1.0,2/27,3.24%,SULT1A1;SULT2B1
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.29521143666878324,-0.833672840285619,0.6985074626865672,0.9192688527729458,1.0,5/18,16.87%,DAB2IP;NF1;TP53;CD300A;B4GALT7
prerank,cyclooxygenase pathway (GO:0019371),0.4073052939994805,0.8331452205000978,0.6655629139072847,0.9629909407629785,1.0,3/10,11.22%,PTGDS;HPGDS;PTGES2
prerank,cellular response to ionizing radiation (GO:0071479),0.30828275966009144,0.8330543200924627,0.6900510204081632,0.9626550938383445,1.0,13/47,24.26%,CDKN1A;KDM4D;CRYAB;EEF1D;HRAS;MDM2;ATR;KDM1A;NUCKS1;SWI5;RHOB;RPL26;RAD9A
prerank,T cell homeostasis (GO:0043029),0.40387862683372566,0.8329469635219465,0.6409836065573771,0.962352616817076,1.0,2/10,8.98%,PMAIP1;FOXP3
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.3325690832605416,-0.8329276339177014,0.6747967479674797,0.9196721376990585,1.0,3/12,10.55%,ALDH6A1;CTPS1;DPYSL5
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.34572737949284144,0.8329274940008683,0.6888567293777135,0.9618885310634893,1.0,8/22,20.33%,ZC3H12A;MAP3K4;RELL1;EMC10;GADD45B;PRMT1;RELL2;AGER
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.376004293553315,0.8329157350145915,0.6606260296540363,0.961409980559067,1.0,4/15,14.69%,ORMDL3;TNFRSF1A;SMPD2;PLA2G6
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.3746230034137774,0.8329058089946515,0.6454545454545455,0.9609350178519458,1.0,5/16,21.59%,RECQL4;MCM6;MCM7;TWNK;MCM4
prerank,histone H3 acetylation (GO:0043966),-0.24093932477984012,-0.8317611128854043,0.7608695652173914,0.9208634596357393,1.0,9/40,15.40%,LEF1;MBIP;KAT7;JADE1;TAF12;BRCA2;TAF5L;KAT6A;WDR5
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.27284722930441646,-0.8317054967075704,0.6979166666666666,0.9198715008967479,1.0,6/23,15.80%,TGM2;LRRK2;PDE4B;RYR2;GNB1;SIRT2
prerank,chromatin assembly or disassembly (GO:0006333),-0.3391290243652547,-0.8315802088517432,0.6835443037974683,0.919040039609447,1.0,4/11,24.45%,TP53;NOC2L;SUV39H2;MTA2
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.35222425637122445,0.8315392305383845,0.6681286549707602,0.9629278340087911,1.0,5/21,12.69%,PMAIP1;BCL2L1;CREB3;EIF2AK3;OPA1
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.2659364244391478,0.831527359952075,0.782010582010582,0.9624489744703799,1.0,24/190,10.33%,PRKAA2;PIK3IP1;MMP9;DAG1;UACA;MAGI2;ZC3H12A;CAV1;PHLDA3;TRIM59;PPM1B;DUSP1;SH3BP4;USP10;TSC2;BCL2L1;OTUD7B;MUL1;PPM1A;NDUFS3;UBE2B;NMI;PRDM15;TWIST1
prerank,serine family amino acid biosynthetic process (GO:0009070),0.3856456058467699,0.8314235180913938,0.6533333333333333,0.9621290288135173,1.0,2/12,8.15%,SERINC5;PHGDH
prerank,cardiolipin metabolic process (GO:0032048),-0.3330436970535645,-0.8312506402611164,0.6959798994974874,0.9186205234323678,1.0,2/13,6.77%,PLA2G4A;PNPLA8
prerank,positive regulation of TORC1 signaling (GO:1904263),0.367403390614374,0.8310040054372542,0.663594470046083,0.9623995736088494,1.0,11/16,32.23%,PIH1D1;SIK3;FLCN;PIP4P1;SEH1L;GPR137;LARS1;LAMTOR5;RRAGB;TELO2;CLEC16A
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.3037090439387444,-0.8305916503942025,0.7030812324929971,0.9187644518840634,1.0,1/17,0.03%,PRKG1
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.2794859592665613,0.829490721609317,0.7370203160270881,0.9641250814641403,1.0,19/104,18.09%,EP300;RELB;PSMD11;NRAS;KRAS;PSMD4;PSMF1;MUC6;TAB3;RAF1;PSMD7;FCER1G;PSMB5;CHUK;HRAS;IKBKG;PSMD1;TAB2;PSMC4
prerank,cellular response to lectin (GO:1990858),0.2794859592665613,0.829490721609317,0.7370203160270881,0.9641250814641403,1.0,19/104,18.09%,EP300;RELB;PSMD11;NRAS;KRAS;PSMD4;PSMF1;MUC6;TAB3;RAF1;PSMD7;FCER1G;PSMB5;CHUK;HRAS;IKBKG;PSMD1;TAB2;PSMC4
prerank,regulation of myelination (GO:0031641),-0.2688221935796924,-0.8293364871865346,0.7350993377483444,0.9201122219421913,1.0,7/25,15.80%,TNFRSF21;PTPRZ1;TENM4;TPPP;TNFRSF1B;MYRF;SIRT2
prerank,negative regulation of protein kinase activity (GO:0006469),0.28292654597090156,0.8292185866201286,0.7434733257661748,0.9641154638804323,1.0,23/88,19.72%,TRIB2;CDKN1A;CAV1;QARS1;DUSP10;HSPB1;TARBP2;TSC2;SRCIN1;CHP1;PYDC1;SMCR8;GNAQ;MVP;ITGB1BP1;TESK1;ABL1;DUSP3;CAMK2N1;PARK7;CDK5RAP3;SH3BP5L;RB1
prerank,cellular response to zinc ion (GO:0071294),-0.3029642995741607,-0.8286716083050939,0.6925207756232687,0.9202288215492442,1.0,10/15,36.67%,GLRA1;GLRA2;MT1B;MT1G;MT1E;MT1A;MT1H;MT1M;MT1X;MT1F
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.35482213080277325,-0.8284573482096937,0.695,0.9195662510471986,1.0,6/10,25.64%,NOTCH1;LRP6;SOX11;BMP7;LIN7C;DLL4
prerank,ceramide biosynthetic process (GO:0046513),0.3145643945477237,0.8280529782940074,0.68359375,0.965738774904608,1.0,3/40,5.85%,SPTSSB;SGMS2;AGK
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.34691822437999253,-0.8279139847195802,0.6814814814814815,0.9184157969348486,1.0,3/10,7.52%,CLTA;MYLIP;AP2B1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.34691822437999253,-0.8279139847195802,0.6814814814814815,0.9184157969348486,1.0,3/10,7.52%,CLTA;MYLIP;AP2B1
prerank,regulation of macrophage chemotaxis (GO:0010758),0.3488112297626116,0.8277377598301577,0.6636904761904762,0.9658067836541524,1.0,2/21,3.61%,CCL5;PTK2B
prerank,positive regulation of interleukin-1 production (GO:0032732),0.301239527698936,0.8276451279752628,0.7090680100755667,0.9654637111905062,1.0,7/51,11.15%,NLRP2;IL16;HSPB1;FZD5;PYDC1;TLR6;TLR4
prerank,response to progesterone (GO:0032570),-0.28929330283904253,-0.8274624391703637,0.7079889807162535,0.918234856885563,1.0,7/18,20.30%,THBS1;NR1H3;TGFB1;UBE3A;CATSPER3;ABHD2;YAP1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.27839944803033817,0.8271700776519654,0.7373167981961668,0.9658135115768886,1.0,19/105,18.09%,EP300;RELB;PSMD11;NRAS;KRAS;PSMD4;PSMF1;MUC6;TAB3;RAF1;PSMD7;FCER1G;PSMB5;CHUK;HRAS;IKBKG;PSMD1;TAB2;PSMC4
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.2738016897062663,-0.8269690318848952,0.7278481012658228,0.9181152614219911,1.0,2/22,5.29%,PDE3B;PRKAA1
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.3983690685817903,0.8269278255589222,0.6817391304347826,0.9657380294747377,1.0,4/10,23.95%,ATP1A2;VDAC1;SESTD1;CBARP
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.3184425153599445,0.8269232842416522,0.6875852660300137,0.9652476449786094,1.0,1/35,0.40%,CLU
prerank,PERK-mediated unfolded protein response (GO:0036499),0.4077772423374002,0.826766886177208,0.657051282051282,0.9650226846104041,1.0,2/10,12.28%,NFE2L2;EIF2AK3
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.2968107699045777,0.8267219821340236,0.6853503184713375,0.9646052478390504,1.0,9/48,17.48%,IKBKE;EP300;PHLDA3;BCL2L1;PML;USP28;E2F1;ABL1;CHEK2
prerank,peroxisome organization (GO:0007031),0.3345668626383863,0.8265149540579196,0.6920943134535368,0.9644728117837493,1.0,7/25,18.71%,ACOT8;ABCD1;PEX11G;DNM1L;PEX6;PEX3;PEX2
prerank,phagosome-lysosome fusion (GO:0090385),0.39879288250417133,0.826112935924944,0.6404682274247492,0.964683148926804,1.0,2/10,8.69%,RAB7A;RAB7B
prerank,regulation of cell projection organization (GO:0031344),-0.3285286954236483,-0.8258648703031701,0.673352435530086,0.9191580534951603,1.0,4/13,13.67%,MYO9A;NTNG1;MACF1;MFSD2A
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.2476604642684105,-0.8256972378999555,0.7480916030534351,0.918407230987718,1.0,11/32,24.08%,CDK14;CDK17;BRD4;ID2;DHFR;NPAT;ORC1;TYMS;BACH1;CDC45;TFDP2
prerank,regulation of interleukin-10 production (GO:0032653),-0.23479010039620768,-0.8254273031273233,0.766497461928934,0.9178533772234133,1.0,17/44,29.89%,CD47;CD34;LGALS9;TNFRSF21;CD46;STAT3;HMGB1;HSPD1;TYROBP;NOD2;JAK3;PYCARD;FCGR2B;PIBF1;ISG15;PLCG2;VSIR
prerank,negative regulation of lyase activity (GO:0051350),0.37000802095895996,0.8248037708516069,0.6876971608832808,0.9665627014170236,1.0,4/16,11.56%,PALM;GRM2;AKAP5;GABBR2
prerank,establishment of mitotic spindle localization (GO:0040001),0.3314866923984187,0.8246096171708542,0.696551724137931,0.966422831786043,1.0,7/28,18.67%,NDEL1;NSFL1C;PAFAH1B1;ZW10;INSC;NUMA1;MISP
prerank,negative regulation of GTPase activity (GO:0034260),0.3504263036293882,0.8246014912473127,0.6680790960451978,0.9659435464908597,1.0,7/22,17.03%,CPEB2;SH3BP4;BCAS3;ARFGEF1;HRAS;WNK1;FICD
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.31392861598156047,-0.8243847867461922,0.7030812324929971,0.9187085400061965,1.0,3/14,5.34%,SULF1;FGF2;THBS1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.38062000412375063,0.823976357186684,0.672,0.9665771821840023,1.0,4/13,11.56%,PALM;GRM2;AKAP5;GABBR2
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.37037783854825357,0.823725533509988,0.6707882534775889,0.9665307270931688,1.0,4/14,14.45%,GAB1;VEGFB;MYO1C;NUS1
prerank,negative regulation of hydrolase activity (GO:0051346),0.3093442655689551,0.823647458711937,0.7157232704402515,0.9661788811613409,1.0,12/49,17.03%,CPEB2;SH3RF2;SH3BP4;MAPK7;CHP1;ATP5IF1;BCAS3;ARFGEF1;HRAS;WNK1;NEIL1;FICD
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.2816000656524928,0.8231954698595702,0.7542857142857143,0.9664990162255537,1.0,8/86,6.46%,ANGPT1;CD44;IL15;CD81;PTK2B;EFNA5;DMTN;HAX1
prerank,axonal transport (GO:0098930),0.31634189088882964,0.8230613280736317,0.7101827676240209,0.9662304396309044,1.0,14/36,24.46%,BLOC1S6;AP3B1;KIF1B;AP3S1;PAFAH1B1;BLOC1S2;OPA1;DYNC1H1;AP3S2;AP3M1;MAPT;AP3D1;BLOC1S5;RAB21
prerank,DNA repair (GO:0006281),0.25875574265246587,0.8227508064418253,0.8341810783316378,0.9663113278226614,1.0,66/284,20.43%,FEN1;MLH1;RECQL4;DOT1L;NABP2;KDM4B;ASF1A;NSMCE4A;MRE11;EYA1;PARP3;TEX264;CENPS;INIP;RAD54L;TENT4A;POLK;WDR33;UBE2B;APBB1;MUTYH;USP3;CSNK1E;HUS1B;MDC1;TOPBP1;ABRAXAS1;ERCC5;MBD4;MLH3;PWWP3A;BTG2;RPA3;REXO4;POLH;ENDOV;APTX;POLD2;PCNA;FAN1;UBE2N;DCLRE1C;LIG3;DDB1;ATR;RPS27A;UBC;HINFP;ERCC2;ABL1;NEIL1;NBN;INTS3;TRRAP;CHEK2;RAD50;PARP2;PARK7;CDKN2D;PNKP;NUCKS1;UVRAG;ERCC4;NABP1;POLN;APEX2
prerank,aromatic amino acid family metabolic process (GO:0009072),0.39237254521450304,0.8224882377577799,0.6617161716171617,0.966266143833729,1.0,2/10,19.45%,THAP4;KYAT1
prerank,BMP signaling pathway (GO:0030509),0.29047831269314595,0.8222564246397138,0.7148058252427184,0.9661925714448197,1.0,7/62,7.38%,SMAD6;DDX5;HIVEP1;GDF15;BMP5;BMP4;TGFB2
prerank,regulation of plasminogen activation (GO:0010755),0.38431257888944637,0.8217460506398083,0.6888168557536467,0.966590543531902,1.0,2/12,6.15%,HPN;CTSZ
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.2853686609926221,-0.821696971847661,0.7287066246056783,0.9226422767094524,1.0,5/19,18.91%,MAOB;ACOX1;GPX1;PRDX4;SOD1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),-0.2059757315598128,-0.8216216336469073,0.8940397350993378,0.9217011042027269,1.0,37/83,36.72%,CEP250;CCP110;CEP78;ALMS1;NDE1;PRKAR2B;TP53;NEDD1;CSNK1D;SDCCAG8;KCNH5;CKAP5;CEP41;CENPJ;MAPRE1;HAUS4;HAUS7;CEP72;YWHAE;SSNA1;HAUS6;TPX2;TUBB4B;NPM1;CEP131;CEP135;HMMR;KIF14;PCNT;TUBA4A;ATAD5;HAUS3;NEK10;CETN2;PLK1;AURKA;CDK1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.3209688536041054,-0.821263077739164,0.7020057306590258,0.9212976541489929,1.0,3/12,7.58%,TMED10;RANBP9;ROCK1
prerank,negative regulation of cyclase activity (GO:0031280),0.37653455055611396,0.8209149004401006,0.6953748006379585,0.967586654705083,1.0,4/14,11.56%,PALM;GRM2;AKAP5;GABBR2
prerank,peptidyl-amino acid modification (GO:0018193),0.3967799825235302,0.820863769002579,0.6705298013245033,0.9671829812646027,1.0,1/10,2.90%,PDF
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.3250801612737613,0.8207846521208642,0.6988950276243094,0.966825325339839,1.0,1/32,0.23%,FGF13
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.3801875333355808,0.820702543552716,0.6859375,0.9664877867145661,1.0,6/13,22.61%,RHOQ;AK3;OPA1;GNAI3;RAB23;EFL1
prerank,cell cycle G1/S phase transition (GO:0044843),0.29387319101896797,0.8205355390500543,0.7248484848484849,0.9663039732960215,1.0,13/61,16.70%,CDKN1A;CDK6;USP29;CDK4;PLK3;LATS1;EIF4EBP1;CCND1;CDK2;MYC;PLK2;E2F1;HINFP
prerank,cellular metal ion homeostasis (GO:0006875),0.27554070567704636,0.8205184527127511,0.7365470852017937,0.9658466289072503,1.0,8/102,5.62%,ANK2;STIM2;CCL5;CAV1;ATP1A2;CSRP3;ATP13A3;TMEM165
prerank,protein targeting to membrane (GO:0006612),0.28228392151977355,0.8202653949906585,0.7294797687861272,0.9658018890339225,1.0,24/83,24.31%,PEX26;ABCD1;ZDHHC12;VPS37B;SIL1;CHMP4A;CHMP4B;SSR1;GOLGA7;MYO1C;SLC25A17;PXMP4;RAB8B;PEX3;PEX2;VPS37A;PARD3;ARL6IP1;ZDHHC3;SGTA;SRP14;ARL6;RAB3IP;ATG3
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.2802012100085088,0.8202551224635203,0.7421602787456446,0.9653285870760121,1.0,11/90,10.49%,PPARGC1A;OGT;PDGFC;CAV1;TRPM8;CXCR4;ZBTB7B;ACADL;ELOVL6;KDM3A;HDAC3
prerank,acute inflammatory response (GO:0002526),0.33596443525470593,0.8197098926772044,0.710124826629681,0.965789837928996,1.0,5/23,14.97%,LBP;HP;HPR;ANO6;VNN1
prerank,monocyte chemotaxis (GO:0002548),-0.25175288049980504,-0.8196928522003076,0.796,0.9232217835193054,1.0,1/32,0.06%,FLT1
prerank,regulation of microtubule-based movement (GO:0060632),-0.3391371121657065,-0.8195853541861101,0.6992840095465394,0.9223612278005491,1.0,2/11,5.62%,MAP2;TTC21B
prerank,negative regulation of lymphocyte activation (GO:0051250),-0.2817067272541977,-0.8195635016926834,0.7538940809968847,0.9213291011044978,1.0,13/21,36.10%,PAG1;SOX11;TNFAIP3;JAK3;FCGR2B;PIBF1;BANK1;LST1;FOXJ1;SAMSN1;LAX1;IL4I1;PTPN22
prerank,monocyte differentiation (GO:0030224),-0.34666450185438813,-0.8194528210728645,0.6907730673316709,0.9204797991965333,1.0,3/10,15.42%,IL31RA;PPARG;PIR
prerank,response to peptide (GO:1901652),0.3154456420192385,0.8193897610497815,0.686030428769018,0.9658254774044251,1.0,4/33,7.41%,MMP9;CACNA1A;EIF2B2;STAT4
prerank,phosphatidic acid metabolic process (GO:0046473),-0.2246491334024216,-0.8193027393653468,0.8349056603773585,0.9196842895772762,1.0,5/48,5.36%,PLA2G4A;DGKH;GPD1L;DGKB;PLD1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.30721446127659313,0.819285638386541,0.7174479166666666,0.9655078170079769,1.0,5/46,8.41%,CDH13;CCL5;BMP4;ANG;TCF7L2
prerank,protein-DNA complex assembly (GO:0065004),0.2719926038822638,0.8192450290074543,0.7497206703910615,0.9650850588007223,1.0,24/116,18.28%,DAXX;GRWD1;PSMD11;ASF1A;KAT6B;PSMD4;PSMF1;ATRX;RBX1;PSMD7;ERCC5;PSMB5;RPA3;MCM8;DDB1;MCM6;RPS27A;UBC;ERCC2;SPTY2D1;MCM7;PSMD1;PSMC4;H3-3A
prerank,mRNA methylation (GO:0080009),-0.30127954965192216,-0.8187916336912616,0.7257617728531855,0.9195459897327525,1.0,5/15,21.98%,METTL8;METTL16;TRMT61B;TRMT6;TRMT10C
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.2898560734983237,-0.8187187551288221,0.7395209580838323,0.9186170587779057,1.0,4/18,12.76%,NRXN1;SHANK3;NLGN1;NLGN3
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.3679719771109583,0.8186417816433482,0.6853582554517134,0.9656433008874615,1.0,5/15,14.09%,RSPO3;GPC3;WNT5B;CSNK1E;SFRP1
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.33795149734496854,0.8183155734448362,0.6802325581395349,0.9657378979112398,1.0,2/22,6.80%,CDKN1A;BMP4
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.389272715949318,0.8180689101533256,0.6801292407108239,0.9656893658151668,1.0,1/12,3.31%,HAGH
prerank,T cell receptor signaling pathway (GO:0050852),-0.18831167979979763,-0.8175903816125326,0.9384615384615385,0.9197046906215558,1.0,30/138,20.31%,PTPRJ;PIK3R1;PDE4D;PAK3;PAG1;INPP5D;EIF2B3;PSMC6;RFTN1;PSMA6;PIK3CB;FYB1;TNFRSF21;PDE4B;THEMIS;PIK3CD;TRAF6;RBCK1;BTRC;PSME1;PSMB10;CUL1;PSMD5;SKAP1;RC3H1;PIK3R2;ICOSLG;PSMD3;PSMA4;PSMB9
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.3077909478353099,0.8173443944812091,0.7039030955585465,0.9664397503416143,1.0,16/41,25.46%,OGT;EP300;NUP93;EIF6;NDC1;JMJD8;PRKAG1;AAAS;RAE1;ZBTB7A;POM121;TPR;RANBP2;NUP42;NUP62;SEH1L
prerank,ATP synthesis coupled proton transport (GO:0015986),0.3555653783633257,0.8171235467146893,0.6838905775075987,0.9663073925048521,1.0,9/17,26.14%,ATP5PF;ATP5F1B;STOML2;VPS9D1;ATP5PD;ATP5ME;ATP5F1D;ATP5F1C;ATP5MC3
prerank,cellular response to hexose stimulus (GO:0071331),-0.2707706426792358,-0.8171055085081289,0.7391304347826086,0.9195598088758906,1.0,6/23,12.35%,UNC13B;ZBTB20;GAS6;PRKAA1;IGF1R;RACK1
prerank,regulation of protein polymerization (GO:0032271),0.310859317476022,0.8170285308372605,0.6873385012919897,0.9659845804178256,1.0,13/35,20.64%,ARHGAP18;FCHSD2;FCHSD1;HAX1;LATS1;RASA1;HSP90AA1;CAMSAP1;PFN2;ABL1;PLEKHG2;MAPT;DBN1
prerank,regulation of chemotaxis (GO:0050920),0.3228195523360311,0.8169798526252228,0.6986842105263158,0.9655741374072349,1.0,6/30,12.51%,EFNB2;YTHDF1;CXCR4;ADGRA2;ZSWIM8;PTPN2
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.3779435653726477,0.8169542930369318,0.7035881435257411,0.9651334659176538,1.0,2/14,6.71%,ADAMTS7;EFEMP1
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.2548153801374193,0.8167354457026549,0.8907815631262525,0.9650266403959791,1.0,68/417,14.23%,FOXN3;DAXX;TMPRSS6;TBR1;KLF4;ELF3;LBH;NIBAN2;FOXP2;GLI3;TRIM33;WNT11;HDAC5;QARS1;RBFOX2;PCGF6;ZNF219;GLIS2;HDAC4;ZBTB16;WWP2;NACC1;CRYAB;PATZ1;FOXM1;FOXD1;ZIC2;SHC1;KDM5C;KAT6B;PHF10;BMP4;COMMD7;NKAP;MAGEL2;CIC;L3MBTL3;JUN;TCF7L2;CRY2;PML;FOXP3;BRD7;SCML2;DPF2;YWHAQ;TWIST1;HDAC3;ARID4A;TLE2;BCL7A;SMARCA4;NCOR1;SFMBT2;ZNF148;FOXK1;GATA3;TSC22D4;SBNO2;CHMP1A;BEND5;CBX4;PRDM11;ING4;TLE5;SFRP1;FOXP1;SET
prerank,regulation of cell-substrate adhesion (GO:0010810),0.30123067349514776,0.8166890070214244,0.7217043941411452,0.96462884740528,1.0,7/42,12.79%,WNT1;EMP2;GCNT2;DMTN;RHOA;NPNT;PDPN
prerank,cellular response to amino acid stimulus (GO:0071230),-0.24134653736654835,-0.8164360024392545,0.7679324894514767,0.9197420278810012,1.0,10/33,17.72%,UBR1;GLRA1;IPO5;CPEB1;SLC38A9;LAMTOR1;KLHL22;RRAGD;GLRA2;RRAGA
prerank,positive regulation of protein deacetylation (GO:0090312),-0.3006915394344426,-0.8159773829344671,0.7206703910614525,0.919468750069648,1.0,6/14,21.92%,SAP30BP;ING2;NIPBL;DYRK1A;APLNR;BRMS1
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.33238021138582824,0.8158662521408256,0.6935704514363885,0.9656138680416153,1.0,4/24,10.36%,NUPR1;FOXO3;TGFB2;SRPK2
prerank,homeostasis of number of cells (GO:0048872),0.377565704333623,0.8157062415341175,0.6855753646677472,0.9653846329930753,1.0,1/12,0.90%,NAPEPLD
prerank,vesicle transport along actin filament (GO:0030050),-0.2830767260971187,-0.8156971432204785,0.7264437689969605,0.9189355164603082,1.0,5/19,11.88%,MYO1B;FNBP1L;MYO1D;MYO5B;MYO6
prerank,neuron fate commitment (GO:0048663),-0.31205309700848444,-0.8149189335205378,0.7193460490463215,0.9192508841296833,1.0,8/14,43.72%,ID2;MYT1L;DLL4;SHH;POU3F2;PAX6;ASCL1;ISL1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.36511220676120526,0.8140565940182032,0.6914728682170542,0.9677863729388769,1.0,3/15,6.47%,HOMER2;HOMER3;GRM2
prerank,quinone biosynthetic process (GO:1901663),0.3704081402174778,0.8137669302782129,0.6903225806451613,0.9677966763520349,1.0,2/14,8.22%,UBIAD1;PDSS2
prerank,cellular response to interleukin-12 (GO:0071349),0.29723898498177037,0.8134310527324174,0.7263294422827496,0.9679060858604178,1.0,9/48,11.60%,RAP1B;GSTO1;ANXA2;MSN;MTAP;STAT4;CDC42;SOD2;JAK1
prerank,transferrin transport (GO:0033572),0.30881647565877374,0.8133427669695553,0.7321428571428571,0.9675735884175869,1.0,13/33,27.01%,ATP6V1B1;LMTK2;ATP6V1E1;ATP6V1D;ATP6V0D1;ATP6V1B2;ATP6V0B;ATP6AP1;REP15;ATP6V0E1;HFE;ATP6V0E2;ATP6V0D2
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.26040340189550243,-0.8130816989707903,0.7523809523809524,0.9215882939219233,1.0,3/24,6.46%,CDH2;BOC;CTNNA2
prerank,primary alcohol metabolic process (GO:0034308),0.32492509440742123,0.8128738825437108,0.700139470013947,0.9678835336490226,1.0,2/25,2.95%,NAPEPLD;ADH7
prerank,cilium organization (GO:0044782),0.2597407918476596,0.8127977217603716,0.8132094943240454,0.9675298898106496,1.0,40/210,18.72%,RAB17;CYS1;ABLIM1;PARVA;GSN;EHD1;CNGA2;ARL3;INPP5E;CCDC28B;RAB11FIP3;AVIL;IFT46;EXOC7;CFAP54;EXOC4;PKD1;CC2D2A;IFT80;EXOC2;MARK4;CPLANE2;CNGB1;EXOC8;ARF4;OCRL;MKKS;ATP6V1D;ATP6V0D1;FLNA;TMEM138;PTPDC1;CFAP61;RAB8B;HDAC6;RILPL1;FHDC1;ODF2;WDR35;GALNT11
prerank,DNA packaging (GO:0006323),-0.2908248397175819,-0.8127358005647914,0.7057220708446866,0.9211592742899953,1.0,5/16,24.15%,TP53;KAT6A;NOC2L;AIFM1;BANF1
prerank,positive regulation of immune system process (GO:0002684),0.3608640878622705,0.8125019817035167,0.6806201550387597,0.9675562829928024,1.0,2/16,7.38%,IL15;TGFB2
prerank,receptor internalization (GO:0031623),0.30967376208256614,0.8124823398034359,0.7182175622542595,0.9671027947419855,1.0,9/44,15.65%,CAV1;CD81;ACKR3;RAMP1;CD9;GRK2;FCER1G;NEDD4;ITGB2
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.26801664311796586,-0.8124379835636916,0.7516778523489933,0.9206463195201661,1.0,4/22,7.31%,SLC7A5;RFTN1;IL18;TGFB1
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.2563870491815708,0.8118994447537865,0.8767676767676768,0.9676264574126239,1.0,77/366,19.77%,BNC2;NFATC2;FOXN3;DAXX;PPARGC1A;EP300;FOXO3;DAPK3;ZNF219;PPP2CA;CREBL2;IGSF1;MLF2;ESRRB;PRRX2;PATZ1;PHF1;POLR2A;HCFC1;KAT6B;EFEMP1;ZFHX3;ATRX;SIX1;FBXO5;PML;FOXP3;MYCBP;APBB1;FADS1;NFYC;ZNF205;GON4L;MYT1;ANKRD17;RABL3;AJUBA;SP1;TAF5;TFEB;SPIN1;CHD3;RREB1;SBNO2;GPBP1;NFIA;REXO4;MEF2C;MYBL1;SRRT;PTP4A3;IRF2;CCDC88A;UTP4;NAB2;PAK6;E2F1;HINFP;SPTY2D1;ABL1;EIF2B4;MLLT6;LIN54;TRRAP;CHEK2;PRKCQ;BRDT;APBB3;SUFU;WTIP;ATF2;RPL6;NFKB2;APP;NUCKS1;RB1;CDK11B
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.37371236176012745,0.8118273742243892,0.6834170854271356,0.9672641763171933,1.0,6/12,19.55%,SMARCA4;NCOR1;SFRP1;FOXP1;NCOR2;ZBTB7A
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.321006424736144,-0.8117304682120546,0.7150127226463104,0.9208258482705157,1.0,6/12,23.03%,LRRK2;CLN3;VPS33A;CLN6;CCDC115;TMEM9
prerank,positive regulation of tissue remodeling (GO:0034105),0.39347919217795385,0.8115419523980266,0.6558441558441559,0.9672672169034273,1.0,1/10,2.47%,IL15
prerank,regulation of execution phase of apoptosis (GO:1900117),0.3835930140933991,0.8113526448759938,0.7048092868988391,0.9671182651534952,1.0,3/11,10.78%,ZC3H12A;BCL2L1;DLC1
prerank,B cell proliferation (GO:0042100),-0.29360637504790643,-0.8111444123197775,0.7425149700598802,0.9207496470452975,1.0,4/17,19.45%,BCL2;CTPS1;CD40;HSPD1
prerank,regulation of protein kinase B signaling (GO:0051896),0.2593785300140443,0.8110831860446316,0.8108672936259144,0.9670865106609517,1.0,19/193,8.41%,FGFR1;ANGPT1;NTRK3;DAG1;MAGI2;GDF15;GAB1;PHLDA3;GCNT2;MTDH;TSC2;HAX1;GRM2;MYDGF;MUL1;ERBB3;FGF22;MAZ;TCF7L2
prerank,RNA biosynthetic process (GO:0032774),0.318445490087375,0.8102072472691811,0.7085635359116023,0.968140047490219,1.0,11/31,28.24%,POLR2A;TAF5;TCEA2;PRIM2;TBPL1;TBP;TAF6;TTF1;TAF4;TERT;BRF1
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.3682605102453696,0.8101212264410336,0.6687211093990755,0.9678147402867703,1.0,5/15,18.46%,MRE11;HUS1B;MDC1;CHEK2;ATF2
prerank,stress-activated MAPK cascade (GO:0051403),0.28869303316668965,0.8098896990952368,0.7142857142857143,0.9677190266602407,1.0,13/61,18.37%,MAP3K8;MAP3K5;TAB3;MAPK9;MAP3K13;IRAK1;CHUK;IKBKG;UBE2N;RPS27A;UBC;TAB2;ARHGEF6
prerank,synaptic vesicle recycling (GO:0036465),-0.2516304974579657,-0.8096054931216567,0.7798507462686567,0.9224171060754442,1.0,8/31,14.77%,SYNJ2;SYT1;NLGN1;TBC1D24;STON2;NLGN3;AMPH;FCHO2
prerank,negative regulation of protein modification process (GO:0031400),0.27897152960077876,0.8093900797249085,0.745005875440658,0.9680986147459886,1.0,14/79,14.40%,PRKAA2;NTRK3;OCLN;ZC3H12A;PPP1R15A;FBLN1;PIP5KL1;CHP1;YWHAB;FKBP8;SH3GL2;ATP2B4;GSK3B;DNAJC10
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.32145407577868934,-0.8091491806336812,0.7220708446866485,0.9221899002716477,1.0,3/13,2.88%,WNT5A;GAS6;AXL
prerank,regulation of mRNA processing (GO:0050684),0.31654985825812587,0.809131153694286,0.7016574585635359,0.9680629710497288,1.0,8/32,15.47%,AHCYL1;SON;SLTM;LARP7;SRPK2;SRPK1;DHX9;PABPN1
prerank,positive regulation of histone modification (GO:0031058),0.31496181466748774,0.8090730513583415,0.720112517580872,0.9676648599036535,1.0,7/33,16.82%,PPARGC1A;ZBTB7B;FOXP3;BRD7;TET1;UBE2N;KDM1A
prerank,regulation of hippo signaling (GO:0035330),0.3510777586714511,0.8088955494937565,0.7065868263473054,0.9674895034522027,1.0,1/17,0.88%,MOB3B
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.26885446831638127,-0.807595241625909,0.7574750830564784,0.9238854868139393,1.0,9/22,26.97%,CDK12;KAT7;BRD4;SUPT4H1;ALYREF;EAPP;THOC5;ERCC6;TCERG1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.35902208963493004,0.8074424891416135,0.6882530120481928,0.9694777405356367,1.0,3/15,11.15%,IL17RA;TLR6;TLR4
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.3217280047091254,0.8073364328607918,0.7166900420757363,0.9691786862529858,1.0,7/29,13.47%,EP300;PYGO2;TCF7L2;TLE2;SMARCA4;TLE4;MYC
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.32564409325019716,0.8067077393482558,0.7305555555555555,0.9697784307943557,1.0,5/28,7.59%,ARHGAP18;FCHSD2;FCHSD1;HAX1;LATS1
prerank,telomere capping (GO:0016233),0.3613820585524699,0.8066150522253445,0.7013574660633484,0.9694616927567121,1.0,8/16,29.46%,MRE11;DCLRE1C;NBN;RAD50;TERF2;TINF2;TERF1;TERF2IP
prerank,positive regulation of protein modification process (GO:0031401),0.2595518211513223,0.8065712563950374,0.8174273858921162,0.9690477375307512,1.0,44/203,19.53%,ANGPT1;NTRK3;LIMK2;DAXX;ADTRP;MMP9;MAVS;RAMP1;EFNA5;KRAS;WDFY2;MYDGF;BMP4;CCND2;ILK;DVL3;NNMT;FGF22;CHP1;VEGFB;CCND1;MUSK;HDAC3;DLC1;RAPGEF3;FXR1;TRABD2B;HRAS;FLCN;HSP90AA1;RB1CC1;TESK1;UBE2N;ABL1;CDH5;SPPL3;TMEM119;GPNMB;ROCK2;PTBP1;GPER1;APP;FLOT1;ADAM17
prerank,regulation of biosynthetic process (GO:0009889),0.38482806074050446,0.806251764794785,0.6688851913477537,0.9691196390895156,1.0,1/11,5.07%,ALOX5
prerank,glucose metabolic process (GO:0006006),0.2929843023674701,0.8061407518713546,0.7570552147239263,0.9688328845043382,1.0,11/58,16.08%,PPARGC1A;HECTD4;SLC25A1;ENO2;MDH2;IRS2;ALDOA;GAPDH;SLC25A12;DCXR;TPI1
prerank,inorganic ion transmembrane transport (GO:0098660),0.3835768011485214,0.8061104985148064,0.7299145299145299,0.9684030533573861,1.0,3/12,11.39%,ABCC8;TRPM4;PKD2L1
prerank,tyrosine metabolic process (GO:0006570),-0.3269619921270657,-0.8059117909681346,0.7191780821917808,0.9258579695085022,1.0,1/11,3.53%,GSTZ1
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.3825678556564304,0.8056692360058083,0.6923076923076923,0.9686456353362617,1.0,1/12,2.39%,NUPR1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.34070028912216144,0.8055435076413592,0.6978851963746223,0.9684094248244977,1.0,5/20,15.37%,DAXX;DCUN1D5;DCUN1D1;WASHC1;HSP90AA1
prerank,regulation of secretion by cell (GO:1903530),-0.21824615978250766,-0.8054852974351936,0.845360824742268,0.9255734049485205,1.0,15/54,21.20%,SNCAIP;RIC1;MCTP2;SYT1;STXBP5L;CAMK2A;MCTP1;KCNMB4;RAB3D;CPLX2;DISP1;FMR1;RAB3C;DNAJC1;RIMS1
prerank,organelle disassembly (GO:1903008),0.3113898899409929,0.8054421778151242,0.7241847826086957,0.9681013815617877,1.0,8/33,18.04%,DDRGK1;TEX264;PLK3;KLC1;ULK1;RB1CC1;UFM1;PELO
prerank,negative regulation of neuron differentiation (GO:0045665),-0.26979747679420546,-0.8053452514559112,0.7483221476510067,0.9247431112167935,1.0,5/22,22.26%,DTX1;B2M;NEPRO;BMP7;HEY1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.25540820493706873,-0.8048424546924392,0.8,0.9245617690313279,1.0,8/29,15.09%,TUT4;ADAR;HNRNPA2B1;ZC3H7B;DROSHA;SMAD3;SNIP1;AGO1
prerank,protein catabolic process (GO:0030163),0.28639949574206386,0.8045969525761231,0.7316176470588235,0.9690127607340158,1.0,14/59,19.31%,PMAIP1;ATE1;RNF5;DENND3;UBE2G2;MANBA;SOCS6;HSP90AA1;PRPF19;DDB1;SIAH1;CHEK2;RNF41;IDE
prerank,sphingoid biosynthetic process (GO:0046520),-0.34109680245131824,-0.8045882252411792,0.728021978021978,0.9229090701199285,1.0,6/11,33.30%,ACER2;SPHK1;ASAH2;SPTLC2;ACER3;SPTLC3
prerank,sphingosine biosynthetic process (GO:0046512),-0.34109680245131824,-0.8045882252411792,0.728021978021978,0.9229090701199285,1.0,6/11,33.30%,ACER2;SPHK1;ASAH2;SPTLC2;ACER3;SPTLC3
prerank,ceramide catabolic process (GO:0046514),0.36265350935761576,0.804425785494336,0.69375,0.9688215942685382,1.0,3/14,14.65%,HEXA;HEXB;NAGA
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.36392584024772945,0.8041306628910219,0.6932707355242567,0.9688499490384789,1.0,4/14,9.99%,CMPK1;DCTPP1;AK3;AK5
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.39741194756921566,0.8033931974350172,0.702865761689291,0.969610330676978,1.0,3/10,17.40%,INSIG1;UBE2G2;UBE2J1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.3199498250154902,0.8027598210630393,0.7157001414427157,0.9702015601720199,1.0,4/28,9.55%,KDM4D;SHLD2;PARP3;RIF1
prerank,negative regulation of histone methylation (GO:0031061),-0.3371456252908539,-0.8024705344123994,0.7207446808510638,0.9255452146696339,1.0,6/10,26.80%,JARID2;BCOR;MTF2;WDR5;BRCA1;AASS
prerank,regulation of defense response to virus (GO:0050688),0.3614936312407268,0.8023230504589395,0.7061538461538461,0.970483135515754,1.0,5/14,24.21%,PPM1B;DHX9;ILRUN;PCBP2;C1QBP
prerank,cellular protein-containing complex assembly (GO:0034622),0.25999977313185296,0.8021574252249066,0.8126984126984127,0.9702740054796215,1.0,17/160,9.89%,CLU;ANGPT1;STXBP6;CLTB;PSMD11;NUP93;POMP;PXN;PSMD4;STXBP1;HSPA4;CHMP4A;CHMP4B;CENPT;EIF4B;NDC1;COX7A2L
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.2484361539502187,0.802146547811736,0.959,0.9698128620893699,1.0,146/834,16.86%,CDH13;KLF5;THRB;TMPRSS6;KLF4;TFAP2C;PPARGC1A;NCOA3;PBX1;GAL;ELF3;OGT;SREBF2;MICAL2;GLI3;GTF2F1;HIVEP1;ZC3H12A;GABPB1;GABPB2;MAVS;EP300;HDAC5;CD81;FOXO3;CSRP3;FOS;GDNF;FOXC2;GLIS2;HDAC4;BMP5;NFE2L2;SSBP3;DOT1L;SMARCB1;RHOQ;FOXD2;POU2F3;NFKBIA;ESRRB;RARG;IRF3;JUND;NKX2-8;CREB1;FOXM1;HOXA5;ZBTB17;RXRB;RNASEL;HCFC1;AKNA;HAX1;NRF1;KAT6B;MYDGF;DDRGK1;PHF10;BMP4;MEF2D;MAPK7;KLF7;TGFB2;MED30;DVL3;FIZ1;ZFHX3;LARP7;ATRX;SIX1;PKD1;JUN;FZD5;TCF7L2;GRHL2;FOXP3;TNFRSF1A;KMT2A;TXK;DPF2;APBB1;PRDM15;NFIB;TWIST1;BCAS3;HDAC3;NFIC;SMARCA4;TLR4;CREB3L4;CREB3;DR1;CALCOCO1;MEF2B;MMP12;SP1;COPS5;ELL;DCAF6;MPND;MED12;TFEB;MYSM1;GATA3;SMARCD2;RREB1;ARF4;SBNO2;NFIA;CAPRIN2;MED21;MYC;MED24;MEF2C;PAX3;MYBL1;CHUK;IRF2;HRAS;SS18L2;ATMIN;FLCN;ITGB1BP1;TNIP1;RFXAP;TLR3;DHX9;MED6;ZMIZ2;TET1;IKBKG;KLF6;MEPCE;CDC5L;RNF10;RPS27A;UBC;E2F1;POU4F1;HINFP;ABL1;KDM1A;MLLT6;SLC9A1;CAMTA2
prerank,regulation of trophoblast cell migration (GO:1901163),0.3678731344475531,0.8019630982811685,0.6860643185298622,0.9696406358792946,1.0,5/14,24.21%,TIMP1;ARHGDIB;YTHDF3;SMURF2;C1QBP
prerank,Golgi to lysosome transport (GO:0090160),-0.3302944302091143,-0.8018301240914134,0.7258485639686684,0.9256526307645643,1.0,6/11,24.35%,EHD3;SORT1;CLN3;RBSN;CCDC91;GAK
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.30703142846712705,0.8016735467274642,0.7096774193548387,0.9696684869239877,1.0,2/33,1.44%,ARAP1;MMP9
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.3535497359557001,0.8016686010676525,0.7044410413476263,0.9691950726104599,1.0,3/16,9.55%,SHLD2;KLHL15;RIF1
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.2502824294775501,-0.801366216387076,0.7909407665505227,0.9243022431533361,1.0,14/29,31.03%,RUVBL1;ITGB3BP;CENPP;HJURP;NASP;MIS18BP1;KNL1;CENPU;CENPX;NPM1;CENPI;MIS18A;CENPN;CENPA
prerank,CENP-A containing chromatin organization (GO:0061641),-0.2502824294775501,-0.801366216387076,0.7909407665505227,0.9243022431533361,1.0,14/29,31.03%,RUVBL1;ITGB3BP;CENPP;HJURP;NASP;MIS18BP1;KNL1;CENPU;CENPX;NPM1;CENPI;MIS18A;CENPN;CENPA
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.3455318394117015,0.8011645224764239,0.7307110438729199,0.9695528571267519,1.0,10/17,29.91%,FCHSD2;ARFIP2;WASF1;ARFIP1;BRK1;NCKAP1;WASF3;WASF2;ARF1;CYFIP1
prerank,ncRNA metabolic process (GO:0034660),0.3116256828562428,0.8009687693982689,0.7262059973924381,0.9694075838969722,1.0,7/37,15.76%,DGCR8;TARBP2;MOV10L1;ZCCHC8;TUT7;DTD1;MEPCE
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.2948537858090887,0.8008361404164491,0.7270375161707633,0.9691644140894751,1.0,12/48,16.85%,ADCY9;GUCY2F;IMPDH2;NUDT2;DCAKD;GMPS;ADCY6;AK5;ADCY10;AMPD2;PPCDC;ADSS2
prerank,mitotic metaphase plate congression (GO:0007080),0.2939589969302785,0.8006963694876743,0.7441860465116279,0.9689126651954776,1.0,21/51,26.58%,PSRC1;CHMP4A;CHMP4B;ZW10;VPS4B;CHMP1A;PINX1;VPS4A;MAD1L1;CHMP2A;PDCD6IP;RMDN1;NUDC;CDC23;CHMP5;MIS12;NUP62;SEH1L;DCTN2;RRS1;CHMP1B
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.356140626499657,0.800364488395987,0.7289156626506024,0.9689882955965374,1.0,4/17,9.74%,CCND2;PSRC1;PKD1;CCND1
prerank,B cell differentiation (GO:0030183),0.2970535572677507,0.8003428027947244,0.7563451776649747,0.968548434057371,1.0,13/46,20.21%,HDAC5;HDAC4;CLCF1;NFAM1;CR2;RABL3;PTPN2;KLF6;IRF2BP2;TPD52;ADAM17;ZBTB7A;DCAF1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.29748304555171773,0.8002954246596994,0.71484375,0.9681447203723915,1.0,9/45,15.49%,CD44;TRIM25;IRF3;TRIM21;PML;TRIM26;JAK1;IRF2;OAS2
prerank,regulation of sister chromatid cohesion (GO:0007063),0.37832380588670395,0.8001800745277189,0.6816,0.9678431151033413,1.0,6/12,30.39%,FEN1;WAPL;RB1;HDAC8;CTNNB1;DDX11
prerank,rRNA modification (GO:0000154),-0.2703793275676163,-0.8000268764312789,0.7306397306397306,0.9256330130175134,1.0,10/21,27.09%,NAT10;NSUN4;DKC1;THUMPD1;TFB1M;NOP10;TSR3;DIMT1;MRM2;MTERF4
prerank,RNA export from nucleus (GO:0006405),0.2689420369279483,0.7998838884889732,0.771850170261067,0.9678780682020309,1.0,31/100,25.53%,SRSF2;NUP93;EIF4A3;SMG7;DDX39B;RBM8A;NDC1;WDR33;AGFG1;SRSF7;POLDIP3;THOC7;RNPS1;SRSF9;UPF3B;MAGOHB;MAGOH;AAAS;SRSF1;RAE1;SRSF5;THOC1;POM121;U2AF1;TPR;SRRM1;RANBP2;NUP42;NUP62;SEH1L;RBM15B
prerank,negative regulation of chemotaxis (GO:0050922),0.31321315364372665,0.7992721898105967,0.7057220708446866,0.9684254350532779,1.0,2/31,2.81%,SEMA3D;SEMA3B
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.3330270958997827,0.7991549844904128,0.7161198288159771,0.9681519683515297,1.0,4/22,10.50%,TIMP4;TIMP1;TIMP2;SNX33
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.35968780199418593,0.7990144642278507,0.7060702875399361,0.967895363716069,1.0,1/15,1.18%,LDLR
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.35587100792051823,0.7988034306585083,0.69375,0.9677682759072813,1.0,6/15,23.94%,NGF;ZFYVE27;BCAR1;CASP3;SOS1;FRS2
prerank,positive regulation of protein binding (GO:0032092),0.28863286315802705,0.798543075191484,0.7456359102244389,0.9677246842058707,1.0,16/56,19.46%,MMP9;CAV1;PPP2CA;ADD1;BMP4;TRIM21;PKD1;TCF7L2;CAPRIN2;GSK3B;PPP2CB;ABL1;SPPL3;IDE;APP;FLOT1
prerank,outflow tract septum morphogenesis (GO:0003148),0.32768200610012477,0.798299368215206,0.7093889716840537,0.9676611555562047,1.0,6/24,12.14%,PARVA;SMAD6;BMP4;TGFB2;NRP2;TGFBR2
prerank,intracellular protein transport (GO:0006886),0.2526100735763589,0.7982811550237143,0.8910386965376782,0.9672167988103373,1.0,79/304,22.75%,RAB17;RANBP3L;GRTP1;HOMER3;KIF13A;TBC1D16;EHD1;ARL4A;COPA;AP3B1;SNX8;SIL1;TMED1;IPO7;TSC2;NUP93;WLS;DESI1;STXBP1;PKD1;TNPO2;CHP1;RAB7A;BAG3;MYO1C;GGA1;SGSM2;AP1S3;TECPR2;AP2A1;ARFIP2;RABL3;TBC1D1;MMP12;NAPA;VIPAS39;STX11;ARF4;NAPB;VPS26B;PREB;RAB5C;TNPO1;NXT2;RAB1B;STX16;RANBP6;HEATR3;USP6NL;IPO4;AP4E1;TBC1D22A;NSF;TBC1D10A;HDAC6;ARFRP1;STAM;CSE1L;STX4;SEC23IP;PPP1R10;TMED5;SEC31B;YWHAH;XPO4;TBC1D17;TBCK;HIKESHI;ARFIP1;SEC16A;RANBP3;POM121;VPS26A;RAB3GAP2;SEC31A;RABGAP1;RAB23;AP3D1;TPR
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.32519348666829057,0.7980701271810787,0.7122302158273381,0.9670883460612876,1.0,9/26,18.82%,HOMER2;HOMER3;RCAN1;CHP1;ATP2B4;GSK3B;SLC9A1;SPPL3;PTBP1
prerank,receptor metabolic process (GO:0043112),0.2909463927553479,0.7980258445207729,0.732685297691373,0.9666889861952521,1.0,13/53,15.65%,CAV1;CD81;ACKR3;RAMP1;CD9;LMTK2;GRK2;FCER1G;PHETA2;PLEKHJ1;PHETA1;NEDD4;ITGB2
prerank,regulation of cellular response to heat (GO:1900034),0.27709876833437475,0.7978262125289232,0.757396449704142,0.9665409775187819,1.0,28/77,26.79%,EP300;BAG1;CRYAB;HSPB8;NUP93;CHORDC1;NDC1;BAG3;RPA3;GSK3B;HSP90AA1;HSPH1;ATR;MAPKAPK2;AAAS;RAE1;MAPT;CAMK2B;HIKESHI;PTGES3;POM121;TPR;RANBP2;NUP42;NUP62;SEH1L;RPA2;NUP133
prerank,tRNA methylation (GO:0030488),-0.23608045024924448,-0.7974643981066902,0.8076923076923077,0.9288812432078679,1.0,15/34,25.51%,TARBP1;METTL1;TRMT61B;TRMT10A;THUMPD2;TRMT5;TRMO;TRMT1L;GTPBP3;TRMT44;TRMT10C;ALKBH8;TYW3;BCDIN3D;PRORP
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.3573336364550763,0.7974397990970055,0.7100591715976331,0.966707631989434,1.0,6/16,23.21%,CWC15;SRSF1;WBP4;SFSWAP;DDX23;DCPS
prerank,intermediate filament organization (GO:0045109),0.35113458212819776,0.7972662457297359,0.7142857142857143,0.9665189452616707,1.0,2/17,10.09%,VIM;KLHL24
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.31481662859991166,-0.7964397065660004,0.7338501291989664,0.9295713313464466,1.0,4/12,17.61%,AR;TGFB1;EDN1;HDAC2
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.3013292866868495,-0.7963753777095562,0.7295918367346939,0.9286454395598399,1.0,5/13,24.80%,PTGIS;PTGS2;NAXE;NAXD;NAMPT
prerank,tRNA modification (GO:0006400),0.2826923340951681,0.7962406770952535,0.7346200241254524,0.9677062663319278,1.0,17/62,20.34%,MOCS3;LCMT2;THADA;ELP5;TRIT1;METTL6;THG1L;AARS1;ANKRD16;TYW1;THUMPD3;WDR6;DUS2;CTU1;TRMT112;CTU2;TYW5
prerank,regulation of smooth muscle contraction (GO:0006940),0.33302389632983814,0.7957109808446533,0.7138728323699421,0.9681279140911524,1.0,2/20,3.76%,CAV1;DAPK3
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.2824483860303258,0.7955809659026003,0.7747318235995232,0.9678791341349927,1.0,11/69,15.49%,CLU;MAVS;TNFRSF8;HSPB1;FZD5;LBP;TWIST1;TLR4;TLR3;DHX9;OAS2
prerank,G2/M transition of mitotic cell cycle (GO:0000086),-0.18301964136569063,-0.7954107184140291,0.95,0.9292216628281958,1.0,35/129,23.68%,PLCB1;CDK14;CEP250;BRSK1;CCP110;CCDC57;CCNH;CEP78;ALMS1;TPD52L1;CCNY;TAF2;NES;NDE1;PRKAR2B;NEDD1;PPME1;BTRC;CSNK1D;SDCCAG8;BORA;CUL1;MASTL;CKAP5;CEP41;BRSK2;CENPJ;MAPRE1;OPTN;HAUS4;HAUS7;CEP72;YWHAE;SSNA1;BACH1
prerank,response to amyloid-beta (GO:1904645),0.2957072639490448,0.7951749628077064,0.7363057324840764,0.9680883709711982,1.0,7/44,14.35%,MMP9;EPHA4;CACNA1A;TLR6;TLR4;MMP12;GSK3B
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.33079047055684335,0.794894384870697,0.7430249632892805,0.9680904395622353,1.0,4/22,9.20%,CDKN1A;IPO7;LATS1;CDK5RAP1
prerank,regulation of transport (GO:0051049),-0.23374658636821483,-0.7948924811423356,0.8296943231441049,0.9290457086522071,1.0,6/36,11.88%,LEPR;EPB41;LRRK2;DNAJA1;ICA1;MYO6
prerank,inorganic anion transport (GO:0015698),-0.21570114428951742,-0.7943554996133718,0.8663366336633663,0.9288860321893936,1.0,13/53,19.18%,SLC26A7;ENPP1;SLC4A10;ANO4;GLRA1;ENPP3;XPR1;TTYH1;CLIC5;SLC5A5;SLC26A6;CLCN1;FXYD1
prerank,DNA geometric change (GO:0032392),0.3281401878509261,0.7942883027200933,0.7083333333333334,0.968600700585137,1.0,5/24,18.05%,RECQL4;MRE11;DHX9;NBN;RAD50
prerank,regulation of interleukin-1 beta production (GO:0032651),0.27697684414040297,0.7942015315200139,0.7597087378640777,0.9682655002295849,1.0,9/66,11.15%,NLRP2;ZC3H12A;HSPB1;NLRP2B;FZD5;PYDC1;TLR6;CARD16;TLR4
prerank,glycogen catabolic process (GO:0005980),0.3560634492492663,0.7940006748421236,0.6963434022257552,0.9681140566311824,1.0,4/15,15.49%,PHKA2;PGM2;PHKB;RB1CC1
prerank,regulation of cellular component size (GO:0032535),0.31978278007142197,0.7939314875862297,0.7440890125173852,0.9677595867654473,1.0,6/30,9.58%,PPP1R15A;RARG;MSN;PEX11G;RAB3B;EZR
prerank,cellular response to peptide (GO:1901653),0.2918190574813428,0.7937219143781307,0.7560355781448539,0.9676167570190626,1.0,7/56,11.15%,VIM;EPHA4;CACNA1A;CAV1;TRIM41;TLR6;TLR4
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.38943888468747145,0.7933593720569182,0.7,0.9677268198830846,1.0,4/10,18.34%,RARG;RXRB;ACTN4;RARA
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.3122274997025288,0.7933343475864835,0.7138964577656676,0.9672972188434613,1.0,13/32,26.23%,POLR2H;TAF1C;UBTF;POLR1C;POLR1E;POLR1F;ERCC2;POLR2E;TBP;POLR1G;MNAT1;POLR2K;POLR1B
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.39077019420399367,0.7931480044793692,0.7068676716917923,0.967118612162649,1.0,4/10,23.59%,RIF1;DCLRE1C;TERF2;APEX1
prerank,negative regulation of DNA metabolic process (GO:0051053),0.33440078631934456,0.7930477249276433,0.7238912732474965,0.966830153022126,1.0,2/24,2.09%,CDKN1A;NIBAN2
prerank,regulation of monocyte differentiation (GO:0045655),0.36281876588268275,0.792954553812239,0.7096774193548387,0.9665043521035647,1.0,4/14,14.16%,CDK6;ACIN1;MYC;FOXP1
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.3301720601743905,0.7929025906988848,0.7328358208955223,0.9661133019198915,1.0,5/23,10.61%,DGAT1;ELOVL1;ELOVL6;ACSL3;ACSF3
prerank,cellular response to superoxide (GO:0071451),-0.32704728546422585,-0.7922964965242695,0.7288557213930348,0.9313643014940329,1.0,3/10,18.91%,NOS3;SOD3;SOD1
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.32498725377564613,0.7922644510446396,0.7073863636363636,0.9666820306595201,1.0,5/23,15.84%,ALOX5;ELOVL6;FADS1;LTA4H;GSTM2
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.35012985946250214,0.7920780193668123,0.7171253822629969,0.9660636096155046,1.0,5/17,11.67%,IL7R;SMARCA4;SOCS2;JAK1;IRS2
prerank,cellular response to interleukin-7 (GO:0098761),0.35012985946250214,0.7920780193668123,0.7171253822629969,0.9660636096155046,1.0,5/17,11.67%,IL7R;SMARCA4;SOCS2;JAK1;IRS2
prerank,regulation of aerobic respiration (GO:1903715),0.3477705905205263,0.7919930794520095,0.6964006259780907,0.9657216484488551,1.0,2/15,9.89%,ABCD1;COX7A2L
prerank,superoxide anion generation (GO:0042554),-0.30310790383555497,-0.7912982981894433,0.7085561497326203,0.932062889264881,1.0,3/13,21.29%,NOX4;NCF2;CYBB
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.31246697065125073,0.7912611285348055,0.7171581769436998,0.966453462684462,1.0,2/30,2.09%,CDKN1A;NIBAN2
prerank,import into nucleus (GO:0051170),0.27597945922681466,0.7910256249521744,0.7866817155756207,0.9663842012500238,1.0,28/73,27.60%,IPO7;SNRPB;TSC2;NUP93;TNPO2;MMP12;TNPO1;NXT2;GEMIN6;RANBP6;HEATR3;IPO4;CSE1L;PPP1R10;SNUPN;DDX20;HIKESHI;POM121;GEMIN5;TPR;IPO9;NUP62;GEMIN8;GEMIN2;NUP133;SNRPD2;SNRPD1;IPO8
prerank,calcium ion import (GO:0070509),0.321450737646404,0.790661160280472,0.7455295735900963,0.9665086354381933,1.0,7/28,13.01%,CACNA1A;MCU;MCUB;MICU1;AFG3L2;MCUR1;CACNB2
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.3142879492969376,0.7905675102770564,0.7164179104477612,0.9661877710581327,1.0,10/31,24.39%,SCAMP5;STXBP1;KCNB1;SYT6;SYT11;SYT12;SYT3;SYT2;CBARP;SYT13
prerank,peptide biosynthetic process (GO:0043043),0.2596591879451859,0.7903624856663878,0.827027027027027,0.9660611383339381,1.0,60/153,28.72%,MRPS16;EEF1A1;MRPL24;MRPL37;HARS1;RPS4X;MRPS7;ABCF1;RPL31;RPSA;GSPT2;RPL22;MRPS33;CARNS1;RPL28;SRBD1;RPS26;MRPL9;COPS5;HARS2;RPL10A;MRPS15;SARS1;EIF4G1;TNIP1;MRPS18C;RPL14;RRBP1;RPS27A;HBS1L;IGF2BP3;EIF4EBP2;RPL6;FARSB;RPS28;RHD;RPL41;RPLP2;YARS2;RPLP1;RPL7;IGHMBP2;MRPL32;RPL21;RPL26;MRPS21;RPS27;RPS12;MRPS12;RPL18;MRPL35;RPS17;RPS3;MRPL18;MRPS6;RSL24D1;RPL24;EEF1A2;GGTA1;RPS6
prerank,histone H4 deacetylation (GO:0070933),0.38582358686257234,0.7903610348272947,0.6917922948073701,0.9655963896357564,1.0,2/10,10.49%,HDAC4;HDAC3
prerank,negative regulation of blood coagulation (GO:0030195),0.30239051287964086,0.7900607213012063,0.7621483375959079,0.9656365651682822,1.0,3/38,6.27%,ADTRP;THBD;KLKB1
prerank,phospholipid transport (GO:0015914),0.28832297188105277,0.7896046036215221,0.7394014962593516,0.9659067693850393,1.0,5/52,6.77%,LDLR;ATP10A;PITPNC1;PRELID3B;ATP8B2
prerank,chondroitin sulfate catabolic process (GO:0030207),0.3604488388765662,0.7892112039252104,0.71875,0.9660876045516708,1.0,3/13,11.10%,HEXA;ARSB;HEXB
prerank,long-term memory (GO:0007616),0.3337719374652143,0.7885486300016529,0.7113997113997114,0.9667202945092933,1.0,1/19,1.18%,LDLR
prerank,phagolysosome assembly (GO:0001845),0.37003171220271514,0.7876032816078301,0.696078431372549,0.9678075356391512,1.0,2/12,8.69%,RAB7A;RAB7B
prerank,iron-sulfur cluster assembly (GO:0016226),0.3211106022188621,0.7872787311410538,0.7283406754772394,0.9678307615550297,1.0,7/24,20.21%,CIAO1;NFS1;ISCA1;IBA57;CIAO3;CIAPIN1;ISCA2
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.3581448590132196,0.7872114883907964,0.7295208655332303,0.9674709650627297,1.0,5/14,27.18%,CD81;IKBKG;PRKD2;RELA;RPS3
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.2452765807376541,-0.7872076522993935,0.7906137184115524,0.9375721604724682,1.0,14/28,27.24%,NOTCH3;TSPAN15;ARRB1;GATA2;BEND6;EGFL7;LFNG;EGF;TCIM;HEY1;YTHDF2;DLL4;EGFR;HIF1AN
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.3465888861527595,0.786912092356086,0.7211093990755008,0.9674900294294055,1.0,2/15,5.10%,MAGI2;IGSF1
prerank,receptor recycling (GO:0001881),0.3794350201262952,0.7868664471662284,0.6995073891625616,0.9670858404054844,1.0,4/10,13.88%,LMTK2;PHETA2;PLEKHJ1;PHETA1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.38962164105532104,0.786605837959152,0.7170731707317073,0.9665716495239753,1.0,3/10,20.91%,CACNA2D4;CNGB1;TULP1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.38962164105532104,0.786605837959152,0.7170731707317073,0.9665716495239753,1.0,3/10,20.91%,CACNA2D4;CNGB1;TULP1
prerank,protein insertion into ER membrane (GO:0045048),0.29870200055488966,0.7865872282353359,0.7308707124010554,0.9661327097738845,1.0,13/37,24.95%,OTOF;EMC9;EMC10;GET4;EMC6;EMC2;CCDC47;APP;VAMP2;SGTA;MMGT1;VAPA;CYB5A
prerank,mesenchymal cell differentiation (GO:0048762),0.28925055257896365,0.7863555144909932,0.7442455242966752,0.96607942503933,1.0,5/51,7.38%,FGFR1;RANBP3L;DDX5;AKNA;TGFB2
prerank,nucleus organization (GO:0006997),0.290010168096812,0.7860239807579156,0.7557251908396947,0.9661381794991495,1.0,14/47,17.81%,REEP3;NUP93;CHMP4A;CHMP4B;NDC1;TOR1A;VPS4B;CHMP1A;VPS4A;CHMP2A;REEP4;NUMA1;PDCD6IP;SUN2
prerank,regulation of cytoplasmic transport (GO:1903649),-0.31825523905810227,-0.7859677227433508,0.7643979057591623,0.9386181839806464,1.0,4/11,17.84%,LRRK2;CHMP3;USP7;MAP2K1
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.2937244615358472,0.7854673933549927,0.7610738255033557,0.9665436355485065,1.0,18/40,26.24%,NSMCE4A;FBXO5;FEM1B;FXR1;MYC;POLH;UBE2N;ABL1;PARG;MAPT;UBE2V1;SIRT7;NSMCE1;KMT5A;CDK9;ARMT1;SMYD2;RPA2
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.31987285667739174,0.7839921108085615,0.7475455820476858,0.9684483777298794,1.0,1/27,0.58%,CD44
prerank,sulfur amino acid metabolic process (GO:0000096),-0.258206904701548,-0.7835084253014692,0.7833333333333333,0.9415419031661266,1.0,10/24,33.81%,NOX4;MSRA;MTR;MTHFR;ADI1;CTH;SMS;AHCY;MMUT;GCLC
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.33689552205702095,0.783219481889774,0.7190839694656489,0.9692139897143723,1.0,3/18,7.43%,TSSK4;CD200;LPAR5
prerank,protein export from nucleus (GO:0006611),0.3139807116696768,0.783114049745956,0.7527932960893855,0.9689115518668059,1.0,4/27,8.65%,RANBP3L;DESI1;PKD1;CHP1
prerank,negative regulation of ATP metabolic process (GO:1903579),0.3433784744867734,0.7830365625140542,0.7265625,0.9685666175778419,1.0,6/17,17.29%,NUPR1;HDAC4;TIGAR;NCOR1;FLCN;GIT1
prerank,liver development (GO:0001889),0.30658225058301936,0.7829601660876223,0.7237715803452855,0.9682229640363755,1.0,7/32,18.96%,COBL;NKX2-8;LSR;TGFBR3;PRKCSH;PCK2;CDK5RAP3
prerank,negative regulation of JUN kinase activity (GO:0043508),0.3817254100652929,0.7827001292715231,0.7008403361344537,0.968179331612873,1.0,1/10,4.06%,DUSP10
prerank,necroptotic process (GO:0070266),-0.2861839197839567,-0.7825572066119959,0.7679083094555874,0.9419905703135184,1.0,6/16,22.23%,ITPK1;PGAM5;RIPK1;IPMK;MLKL;CYLD
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.3183006920763111,0.7823341232828898,0.7212205270457698,0.9683147106171667,1.0,6/26,21.91%,OCLN;PSRC1;NUMA1;MAPT;CDK5R1;TRPV4
prerank,mRNA transport (GO:0051028),0.2634776743602789,0.7822432694910728,0.8059023836549376,0.9680110535624462,1.0,31/101,25.53%,SRSF2;NUP93;EIF4A3;SMG7;DDX39B;RBM8A;NDC1;WDR33;AGFG1;SRSF7;POLDIP3;THOC7;RNPS1;SRSF9;UPF3B;MAGOHB;MAGOH;AAAS;SRSF1;RAE1;SRSF5;THOC1;POM121;U2AF1;TPR;SRRM1;RANBP2;NUP42;NUP62;SEH1L;RBM15B
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.30575881714354725,0.7822387498631481,0.7476510067114094,0.9675587670426617,1.0,1/35,0.37%,CDH13
prerank,covalent chromatin modification (GO:0016569),-0.30120922557622926,-0.7821850630497099,0.7561643835616438,0.9415554894932833,1.0,2/14,4.18%,MBD2;SETD5
prerank,regulation of multicellular organismal development (GO:2000026),-0.2537908074596222,-0.7821801725662243,0.8033898305084746,0.9405207650023769,1.0,4/25,13.56%,INSR;SOX17;TRIP12;NIPBL
prerank,DNA conformation change (GO:0071103),-0.2880663011759791,-0.7821065699289602,0.7382352941176471,0.9396040387125691,1.0,6/17,22.80%,TOP3A;KAT6A;ERCC3;HMGB1;HHEX;TOP2A
prerank,transcription preinitiation complex assembly (GO:0070897),-0.31418025081295475,-0.781959195594504,0.7675544794188862,0.9388127769421137,1.0,3/12,11.00%,BDP1;TAF1B;TAF12
prerank,adipose tissue development (GO:0060612),0.37224298085344276,0.7819226909493858,0.7256493506493507,0.9675965962195331,1.0,2/11,7.90%,RORC;DYRK1B
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.29507750604766186,0.7807506743806278,0.785430463576159,0.9689989730115858,1.0,10/39,22.24%,MCU;GLUD1;BAD;TCF7L2;IRS2;AACS;NLGN2;GPER1;SOX4;ADCYAP1
prerank,histone H2B ubiquitination (GO:0033523),-0.32822334578580625,-0.7802228419955579,0.7537688442211056,0.9404435297780473,1.0,3/10,18.20%,WAC;DTX3L;PAF1
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.242373365075973,-0.7797879137476629,0.8241758241758241,0.9400965190463605,1.0,17/30,33.85%,DNAJB4;DNAJC18;DNAJB12;SELENOF;ST13;DNAJB5;CCT2;ENTPD5;HSPA9;DNAJB1;GAK;HSPA1B;UGGT1;HSPA2;SDF2L1;HSPA5;CHCHD4
prerank,regulation of exit from mitosis (GO:0007096),-0.2263936550393736,-0.7796548528358933,0.8604651162790697,0.9392771190289826,1.0,10/38,22.93%,ANAPC11;CDC14A;RGCC;UBE2S;ANAPC15;ANAPC7;SIRT2;ANLN;BUB3;MAD2L1
prerank,regulation of histone modification (GO:0031056),0.3591307642533555,0.7794509937310851,0.7347560975609756,0.9705870781355915,1.0,7/13,23.25%,NNMT;FLCN;UBE2N;PARG;PARK7;AKAP8;CDK9
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.32627740404758615,0.7792060537817163,0.7295690936106983,0.9705197421529871,1.0,5/21,13.64%,MED30;JUN;TWIST1;MED12;MED24
prerank,endothelial tube morphogenesis (GO:0061154),0.3679228231849621,0.77898992876797,0.7101200686106347,0.9703819731342568,1.0,4/10,23.73%,BMP4;RHOA;PRKD2;RHOB
prerank,negative regulation of interleukin-17 production (GO:0032700),0.37239026519433516,0.7786647985431495,0.7086743044189853,0.9704387016391892,1.0,2/10,11.15%,FOXP3;TLR4
prerank,axonal fasciculation (GO:0007413),-0.31109278909908095,-0.7785980230805718,0.7753086419753087,0.9398885834192858,1.0,6/12,17.76%,SEMA5A;NRCAM;EPHB2;MEGF8;EPHB3;ARHGAP35
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.19545024129364347,-0.7783081242117509,0.9491525423728814,0.9393167483107541,1.0,14/91,13.00%,BMP6;SLC30A10;SCARA5;SLC39A12;FBXL5;SLC40A1;SLC39A8;TFRC;ATOX1;SLC39A10;CYB561A3;GLRX3;SLC30A1;FXN
prerank,regulation of integrin activation (GO:0033623),0.3512664472390395,0.7780356220872887,0.7345679012345679,0.9710124936291511,1.0,1/15,2.26%,RAP1B
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.2946153392174094,-0.7780010245277402,0.7700258397932817,0.9387405886592151,1.0,9/15,35.12%,DAB2;PIK3CB;NEU3;HIP1R;TNK2;WASL;BMP2K;SCYL2;DGKD
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.22470283281582054,-0.7778757821856297,0.8289473684210527,0.9378917231861936,1.0,6/41,9.11%,JAG1;ENG;NOTCH1;TGFB1;HEYL;FGFR2
prerank,smoothened signaling pathway (GO:0007224),0.3065731297518336,0.7776925422252655,0.7526881720430108,0.9710976879219512,1.0,4/32,11.39%,SMO;GLI3;CC2D2A;PKD2L1
prerank,ubiquinone metabolic process (GO:0006743),0.3479598620610964,0.7775029084072922,0.731629392971246,0.9709396000017728,1.0,2/15,8.22%,UBIAD1;PDSS2
prerank,regulation of autophagosome assembly (GO:2000785),0.30543802811641646,0.7774194283124612,0.7523680649526387,0.9706103226819635,1.0,12/33,22.64%,NUPR1;TMEM39A;CHMP4A;CHMP4B;SMCR8;MTMR3;PIP4K2C;RAB1B;FEZ1;PHF23;RAB3GAP2;UBQLN2
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.37339938907516274,0.7769450873622967,0.7387820512820513,0.9709498793691154,1.0,3/11,17.88%,MAVS;ITGB2;STX4
prerank,extracellular matrix assembly (GO:0085029),0.3243769286483016,0.776870430599304,0.7438848920863309,0.9706199670412619,1.0,3/23,9.94%,TNXB;PXDN;LAMB2
prerank,B cell activation involved in immune response (GO:0002312),0.3608278716985163,0.7767986142224859,0.733229329173167,0.9702781133861336,1.0,5/13,30.42%,EXOSC3;RNF168;RNF8;MSH2;MSH6
prerank,epithelial cell differentiation (GO:0030855),0.2685111607559531,0.7764835170284148,0.7988505747126436,0.9703375023983317,1.0,14/88,15.68%,UPK1B;ANXA4;PIH1D1;OVOL2;BMP4;LATS1;SIX1;LGALS3;GRHL2;PTER;GATA3;VDAC1;GSTK1;PCNA
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.3181477600271496,0.7763592287904533,0.7507552870090635,0.9700818093516206,1.0,4/21,14.09%,SMO;PDCL;EVC;SFRP1
prerank,amide biosynthetic process (GO:0043604),0.2908445580230333,0.7763444309472012,0.7562814070351759,0.9696395040871056,1.0,4/47,6.97%,SPTSSB;SGMS2;AGK;AANAT
prerank,glycogen metabolic process (GO:0005977),-0.2424566362365504,-0.7761563084454338,0.7740863787375415,0.9395622050874889,1.0,3/27,7.79%,PRKAG2;PHKA1;GAA
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.2991974307891954,0.7761540351814467,0.7526178010471204,0.9694822368028199,1.0,15/35,30.05%,NEK7;MAPK15;MAP3K4;HMBOX1;TNKS2;ATR;PRKCQ;PNKP;FBXO4;CCT5;XRCC5;NAF1;CTNNB1;CCT8;CCT6A
prerank,regulation of endopeptidase activity (GO:0052548),0.2782696836276549,0.7760519936413542,0.7948717948717948,0.9691920460723769,1.0,6/59,8.76%,CRB2;TIMP4;SERPINC1;TIMP1;TIMP2;SERPINB8
prerank,negative regulation of interleukin-1 production (GO:0032692),0.31788795905383144,0.7758262381392952,0.740029542097489,0.9690854295532046,1.0,4/23,10.39%,ZC3H12A;NLRP2B;PYDC1;CARD16
prerank,heterochromatin assembly (GO:0031507),-0.2731185898151204,-0.7755605261305533,0.8031746031746032,0.9394188250467455,1.0,5/20,15.80%,MBD2;SMCHD1;HMGA2;HELLS;SIRT2
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.24087801906256762,-0.7755523615343871,0.8414634146341463,0.9384010466752638,1.0,2/32,2.45%,CEMIP;TRPC3
prerank,ERBB2 signaling pathway (GO:0038128),-0.2418089112965471,-0.7754651316136372,0.7992125984251969,0.9375384996775207,1.0,9/31,17.58%,PIK3R1;ERBIN;PTPN12;ERBB4;MYOC;GRB2;CUL5;CDC37;EGF
prerank,RNA transport (GO:0050658),0.27358965938310037,0.7751871218436763,0.7939759036144578,0.9696600886383404,1.0,24/71,23.23%,SRSF2;EIF4A3;SIDT2;DDX39B;RBM8A;SRSF7;POLDIP3;TGFBR2;THOC7;RNPS1;SRSF9;UPF3B;MAGOHB;MAGOH;SRSF1;RAE1;SRSF5;FLOT1;THOC1;YBX1;POM121;U2AF1;TPR;SRRM1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.25564766976006004,0.7749260595339255,0.8284153005464481,0.96961204568889,1.0,27/128,17.75%,SMAD6;DDX5;HIVEP1;GDF15;TWSG1;FOS;BMP5;GCNT2;ARHGEF18;PXN;BMP4;TGFB2;TGFB1I1;JUN;RHOA;TGFBR2;TGFBR3;ZMIZ2;RPS27A;UBC;PRKCZ;ZYX;RGMB;SMAD5;STUB1;CDH5;BMPR1A
prerank,cilium assembly (GO:0060271),0.2444691811411579,0.7746861877057674,0.9085365853658537,0.9695260323666376,1.0,50/297,18.72%,RAB17;RP1;CYS1;ABLIM1;PARVA;GSN;DYNLRB1;EHD1;CNGA2;ARL3;INPP5E;CCDC28B;RAB11FIP3;AVIL;IFT46;EXOC7;CFAP54;EXOC4;CFAP206;PKD1;CC2D2A;CEP76;IFT80;EXOC2;PAFAH1B1;CSNK1E;MARK4;CPLANE2;CNGB1;EXOC8;ARF4;OCRL;MKKS;TNPO1;ATP6V1D;HSP90AA1;ATP6V0D1;FLNA;KIF17;TMEM138;PTPDC1;DYNC1H1;RAB8B;HDAC6;RILPL1;FHDC1;ODF2;WDR35;SFI1;GALNT11
prerank,copper ion transport (GO:0006825),-0.3120551363968164,-0.7745530111757113,0.7347931873479319,0.9378895708085847,1.0,2/11,6.66%,STEAP3;ATOX1
prerank,histone mRNA metabolic process (GO:0008334),0.3192747909422483,0.7745284039909123,0.7428958051420839,0.9693059351306205,1.0,2/27,5.43%,LSM10;SNRPB
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.31161560875804556,-0.7740895249675386,0.7447368421052631,0.9375483637120433,1.0,3/11,12.22%,FOXO1;NOTCH1;GLRX3
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.34689279515959964,0.7738391122001052,0.7328125,0.9699731812090654,1.0,4/14,12.51%,NLRP2B;PYDC1;CARD16;PTPN2
prerank,cell cycle G2/M phase transition (GO:0044839),-0.17759720588897226,-0.7735613208688209,0.9397590361445783,0.9373416285431901,1.0,34/130,23.56%,PLCB1;CDK14;CEP250;BRSK1;CCP110;CCDC57;CCNH;CEP78;ALMS1;TPD52L1;CCNY;TAF2;NES;NDE1;PRKAR2B;NEDD1;PPME1;BTRC;CSNK1D;SDCCAG8;BORA;CUL1;MASTL;CKAP5;CEP41;BRSK2;CENPJ;MAPRE1;OPTN;HAUS4;HAUS7;CEP72;YWHAE;SSNA1
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.36525169359713605,0.7735179865263295,0.728171334431631,0.9700113157000526,1.0,1/11,2.67%,TWSG1
prerank,myeloid dendritic cell activation (GO:0001773),-0.3009909008558371,-0.7728787020115676,0.7726027397260274,0.9373296504556754,1.0,4/12,25.34%,CAMK4;HMGB1;DOCK2;PYCARD
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.3768788846134893,0.7728004762418822,0.711864406779661,0.9706663559904438,1.0,3/10,16.82%,ATRX;RIF1;KDM1A
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.28973439788543154,0.7726909919009073,0.7786666666666666,0.9703740296303612,1.0,16/41,25.46%,OGT;EP300;NUP93;EIF6;NDC1;JMJD8;PRKAG1;AAAS;RAE1;ZBTB7A;POM121;TPR;RANBP2;NUP42;NUP62;SEH1L
prerank,regulation of ATP biosynthetic process (GO:2001169),0.33872711037609265,0.7725539493563741,0.7550387596899225,0.9701535834900127,1.0,1/16,1.13%,PPARGC1A
prerank,inositol phosphate biosynthetic process (GO:0032958),0.37249611852683584,0.7721143059877768,0.735632183908046,0.9704287265957321,1.0,3/11,15.85%,IP6K1;PPIP5K2;IP6K2
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.29418413093348184,-0.7718015064437306,0.7793296089385475,0.9379661671783837,1.0,5/13,20.66%,SRSF10;CD2BP2;SRSF12;USP4;LSM2
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.28198214854095033,0.771087288988842,0.7888888888888889,0.9715555079416974,1.0,4/51,3.27%,SRGAP2;PLXNB1;NBL1;NGF
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.27378392268267226,0.7710585699794557,0.8103241296518607,0.9711436741073783,1.0,11/73,15.49%,CLU;MAVS;TNFRSF8;HSPB1;FZD5;LBP;TWIST1;TLR4;TLR3;DHX9;OAS2
prerank,negative regulation of signal transduction (GO:0009968),0.24401274434538417,0.7710424540945937,0.8920863309352518,0.9707130760817306,1.0,24/249,8.93%,PRKCB;KANK1;NXN;GPC1;CCL5;NIBAN2;GLI3;GDF15;TMEM25;RNF43;QARS1;KANK2;PALM;GLIS2;BMP5;WWP2;TSC2;GPC3;ERBB3;LGR4;NLRP2B;MAZ;CXXC4;YWHAB
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.3361979543096947,0.7706765583296755,0.7359635811836115,0.9708184195673181,1.0,2/18,3.88%,JCAD;FOXC2
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.2542288698241502,-0.7705684521171952,0.7959183673469388,0.9386971524513623,1.0,6/24,14.75%,JARID2;SUZ12;EZH2;TASOR;CREBZF;MTF2
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.2829002241532704,0.7704599058017461,0.7870485678704857,0.9706903229135023,1.0,14/50,24.76%,CDKN1A;CCND2;ACTB;CCND1;PKMYT1;SERTAD1;CCNG1;CAMK2N1;CDKN2D;CDK5RAP3;CDK5R1;GTPBP4;CDC25A;MNAT1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.2691260253244912,-0.7701908779310729,0.7911392405063291,0.938251270504897,1.0,7/20,20.62%,SULF1;FGF2;THBS1;SPRY4;SPRY1;FGFBP3;SMOC2
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.2628284618602364,0.7698778147330693,0.8121353558926487,0.9711193031356973,1.0,20/87,17.75%,SMAD6;GDF15;TWSG1;FOS;GCNT2;ARHGEF18;PXN;TGFB2;JUN;RHOA;TGFBR2;TGFBR3;ZMIZ2;RPS27A;UBC;PRKCZ;ZYX;SMAD5;CDH5;BMPR1A
prerank,cellular potassium ion homeostasis (GO:0030007),-0.2992024561423714,-0.7696819859371269,0.7718832891246684,0.938028402672084,1.0,3/13,6.35%,ATP1B1;SLC12A2;KCNJ2
prerank,negative regulation of T cell proliferation (GO:0042130),-0.23904769385640287,-0.7695536701574962,0.8315018315018315,0.9372328117711238,1.0,4/28,10.79%,GLMN;LGALS9;TNFRSF21;DLG5
prerank,spliceosomal snRNP assembly (GO:0000387),0.2961651837004105,0.769451841427962,0.764629388816645,0.9713376043771578,1.0,14/38,27.55%,SNRPB;LSM4;GEMIN6;PRPF19;PRPF6;SNUPN;DDX20;PRPF8;GEMIN5;CLNS1A;GEMIN8;GEMIN2;SNRPD2;SNRPD1
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.2839001646656464,0.7692765391111576,0.7815344603381015,0.971146531059093,1.0,9/44,18.79%,YTHDF1;ZC3H12A;CELF1;MOV10;CPEB3;BTG2;MEX3D;YTHDF3;ROCK2
prerank,negative regulation of gluconeogenesis (GO:0045721),0.3715617249361816,0.76891124156534,0.7508361204013378,0.971247231508392,1.0,2/11,14.00%,EP300;PGP
prerank,central nervous system development (GO:0007417),0.2468910388981837,0.7689069949378349,0.8851282051282051,0.9707970479146224,1.0,27/250,10.14%,CELSR1;TBR1;PBX3;PBX1;SMO;ZIC4;PDGFC;GSN;CXCR4;QARS1;ADGRL2;GLIS2;ZBTB16;CTNS;EIF2B2;ZIC2;LSR;ZFHX3;CIC;PHGDH;PKD1;GRHL2;CDK5RAP1;ZIC1;ADGRA2;NFIB;IER3IP1
prerank,regulation of mitotic spindle assembly (GO:1901673),0.33081014657514024,0.7688660778355563,0.7318518518518519,0.9704087153021989,1.0,9/19,26.58%,CHMP4B;VPS4B;CHMP1A;CHMP2A;PDCD6IP;CEP97;TPR;CHMP5;CHMP1B
prerank,sister chromatid segregation (GO:0000819),-0.23988994857764032,-0.7685077971425954,0.8838028169014085,0.9378144557633215,1.0,17/31,32.09%,KIF18A;NCAPG2;RAN;KLHL22;WRAP73;DSN1;NUSAP1;TOP2A;KNSTRN;SPAG5;KIF18B;KIFC1;NSL1;NDC80;TUBG2;CDCA8;SGO1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.3268628260564464,0.7679339008747439,0.749271137026239,0.9713724742736183,1.0,6/21,20.75%,CDK4;FBXO5;CCND1;VPS4B;CDC25B;RCC2
prerank,negative regulation of DNA binding (GO:0043392),0.3046223988471394,0.7676611931483385,0.7528089887640449,0.9713436288370324,1.0,8/28,19.05%,SMO;NFKBIA;JUN;SUMO3;HABP4;E2F1;KDM1A;ILRUN
prerank,ovarian follicle development (GO:0001541),0.3570875918445593,0.7676298943298571,0.7507936507936508,0.9709263088488197,1.0,3/13,16.84%,EIF2B2;ANG;EIF2B4
prerank,positive regulation of double-strand break repair (GO:2000781),0.2918910717644053,0.7676085091850735,0.7671809256661991,0.9705061281289986,1.0,5/39,9.55%,KDM4D;SHLD2;FOXM1;PARP3;RIF1
prerank,cellular response to misfolded protein (GO:0071218),0.32567557293854343,0.7673881483604342,0.7786377708978328,0.9703876582933896,1.0,5/20,17.30%,RNF5;KLHL15;TOR1A;RNF126;STUB1
prerank,ERBB signaling pathway (GO:0038127),0.2735150245460561,0.767249798752125,0.8023668639053254,0.9701491070359292,1.0,16/64,20.15%,REPS2;GAB1;PTK2B;SHC1;EFEMP1;ERBB3;IQGAP1;MVP;BCAR1;AAMP;HSP90AA1;STUB1;PTPN11;PTPN18;ADAM17;HBEGF
prerank,glycine metabolic process (GO:0006544),0.36427032143602245,0.7671435100697848,0.7461139896373057,0.969858828101727,1.0,2/12,12.04%,SHMT1;AMT
prerank,presynaptic endocytosis (GO:0140238),-0.2531537026979336,-0.7669856479479923,0.8256578947368421,0.93914542587843,1.0,7/24,14.77%,SYNJ2;SYT1;NLGN1;STON2;NLGN3;AMPH;FCHO2
prerank,negative regulation of ATPase activity (GO:0032780),-0.28217555475498335,-0.7664748702910087,0.8181818181818182,0.9388437471938661,1.0,3/16,10.36%,TSC1;OXA1L;TP53
prerank,rRNA catabolic process (GO:0016075),-0.2788809910056189,-0.7664114670443585,0.8067885117493473,0.9379183940678458,1.0,3/16,13.21%,DIS3L;EXOSC7;EXOSC2
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.35568207050362033,0.76623112602406,0.7512274959083469,0.9707807467096424,1.0,2/13,6.24%,ZC3H12A;MOV10
prerank,proteasomal protein catabolic process (GO:0010498),0.24343656634993271,0.7656141461911827,0.8797071129707112,0.9712518306052035,1.0,43/201,19.56%,PMAIP1;SPSB4;ATE1;NFE2L2;WWP2;RNF5;PSMD11;NSFL1C;PSMD4;PSMF1;FEM1C;RMND5B;RBX1;PML;UBE2B;PCNP;SIAH3;COP1;PSMD7;AGAP3;FEM1B;RNF126;ZSWIM8;PSMB5;PELI1;GSK3A;SOCS6;NEDD4;MDM2;BFAR;CCDC47;PRPF19;MAEA;DDB1;ARMC8;UBE2D3;SIAH1;STUB1;PSMD1;PSMC4;RNF41;PSMD8;PCBP2
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.33468081649525994,0.7654943994097667,0.7466863033873343,0.9709813608472301,1.0,6/18,24.81%,UBTF;WDR43;EIF2AK3;FLNA;SIRT7;POLR2K
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.28172274803270064,0.7654840108209915,0.7836107554417413,0.9705449336977711,1.0,6/45,11.15%,NLRP2;HSPB1;FZD5;PYDC1;TLR6;TLR4
prerank,regulation of interleukin-6 production (GO:0032675),0.25828829821247423,0.765468815789172,0.8378076062639821,0.9701200200001172,1.0,18/96,18.00%,CD200;IL17RA;ZC3H12A;MAVS;IL16;RAB7B;LBP;TLR6;PTPN6;TWIST1;TLR4;CD200R1;TLR3;SYT11;DHX9;F2R;MAPKAPK2;PTPN11
prerank,tRNA wobble uridine modification (GO:0002098),0.34452273728332095,0.7649403857065787,0.724812030075188,0.9704471434763309,1.0,5/14,23.34%,MOCS3;ELP4;CTU1;CTU2;URM1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.3541490891886914,0.764800213868024,0.7483974358974359,0.9701941968058305,1.0,5/14,17.03%,DDRGK1;TMEM33;COPS5;BFAR;FICD
prerank,cellular response to type I interferon (GO:0071357),-0.22272805985389152,-0.7645556608445729,0.8653846153846154,0.9387095863381172,1.0,16/41,29.10%,SP100;XAF1;ADAR;IFNAR2;IFITM3;SAMHD1;TYK2;IFI35;GBP2;BST2;IFIT3;IRF8;RSAD2;IFITM1;ISG15;IRF7
prerank,type I interferon signaling pathway (GO:0060337),-0.22272805985389152,-0.7645556608445729,0.8653846153846154,0.9387095863381172,1.0,16/41,29.10%,SP100;XAF1;ADAR;IFNAR2;IFITM3;SAMHD1;TYK2;IFI35;GBP2;BST2;IFIT3;IRF8;RSAD2;IFITM1;ISG15;IRF7
prerank,RNA metabolic process (GO:0016070),0.2546906589413848,0.7634959507104492,0.8607456140350878,0.9717650010990962,1.0,30/127,20.31%,CELF2;GTF2F1;ZC3H12A;RBFOX2;POLR2H;POLR2A;RNASEL;SIDT2;DDX39B;XRN2;HNRNPH2;RNASE3;MTREX;TBRG4;HNRNPUL1;SYNCRIP;DHX9;PABPN1;DUSP11;CLP1;RNASE4;WTAP;POLR2C;HNRNPA3;RBMS2;POLR2E;PTBP1;PCBP2;DDX20;THOC1
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.31678216349650556,0.7631720587336667,0.75177304964539,0.9718156081198104,1.0,6/22,18.68%,PDGFC;MRE11;RAP2C;NBN;RAD50;GPNMB
prerank,membrane lipid catabolic process (GO:0046466),-0.31518399787705814,-0.763146048548361,0.7481108312342569,0.9398330426371301,1.0,2/10,4.73%,CYP1B1;ENPP2
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.2552241065343452,-0.7628282852812497,0.8297872340425532,0.9382685059440367,1.0,6/20,17.93%,BCKDHB;ALDH6A1;DLD;BCKDK;HIBADH;BCAT1
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.2552241065343452,-0.7628282852812497,0.8297872340425532,0.9382685059440367,1.0,6/20,17.93%,BCKDHB;ALDH6A1;DLD;BCKDK;HIBADH;BCAT1
prerank,neural crest cell differentiation (GO:0014033),-0.26896387346681866,-0.7628066084509855,0.7916666666666666,0.937310567988529,1.0,8/18,25.44%,CDH2;LRP6;PDCD6;SOX11;NOLC1;KBTBD8;HTR2B;KLHL12
prerank,negative regulation of bone mineralization (GO:0030502),0.34910170528919077,0.7624231517196461,0.7408637873754153,0.9725106835722991,1.0,3/13,11.34%,PTK2B;SRGN;TRPM4
prerank,mitochondrial fission (GO:0000266),0.3400531997258137,0.7623094897574416,0.7340590979782271,0.9722254061044819,1.0,6/16,21.29%,MUL1;MTFR1L;OPA1;DNM1L;MTFR2;MIEF1
prerank,positive regulation of microtubule polymerization (GO:0031116),0.30487105038670775,0.7621244682428022,0.7465373961218836,0.9720589372105036,1.0,6/28,21.47%,OCLN;PSRC1;GIT1;NUMA1;MAPT;CDK5R1
prerank,acute-phase response (GO:0006953),-0.30895024260468307,-0.7619243291188026,0.7583333333333333,0.9376016087312155,1.0,4/12,22.45%,IL6R;PLSCR1;IL22;SIGIRR
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.37076359986367924,0.7618724345878679,0.7613240418118467,0.9719792992479205,1.0,1/10,2.68%,ABCD1
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.3239098075281814,-0.7617990822291378,0.7775,0.9367916830802407,1.0,5/10,20.17%,GALNT13;GALNT16;GALNT2;POGLUT3;MGAT5B
prerank,regulation of T cell proliferation (GO:0042129),0.2727992913915774,0.7616859055948949,0.772782503037667,0.9718167859384451,1.0,5/61,8.98%,CCL5;IL15;SDC4;LGALS3;FOXP3
prerank,endodermal cell fate commitment (GO:0001711),-0.31776636535133734,-0.7613796821133029,0.7620253164556962,0.9363884949622195,1.0,2/10,18.20%,SOX17;PAF1
prerank,positive regulation of viral life cycle (GO:1903902),0.31554951048684665,0.7612902513138883,0.757183908045977,0.9719657996992612,1.0,7/22,17.99%,VPS37B;TRIM11;LGALS1;VPS4A;CHMP2A;DDB1;TSG101
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.28821461897377365,-0.7610782619017804,0.7976878612716763,0.9358379571035335,1.0,5/15,26.19%,NEK6;ANAPC7;HECW2;CENPE;RIOK2
prerank,mesenchyme development (GO:0060485),0.3498652677607522,0.7609343076644653,0.750402576489533,0.9720410108599244,1.0,2/15,6.80%,WNT11;BMP4
prerank,JNK cascade (GO:0007254),0.2869180706959047,0.7605600946463332,0.7762982689747004,0.9721571090152406,1.0,11/40,18.37%,MAP3K5;TAB3;MAPK9;MAP3K13;IRAK1;IKBKG;UBE2N;RPS27A;UBC;TAB2;ARHGEF6
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.3572943910221722,0.7605570509145197,0.7461059190031153,0.9717110100592705,1.0,3/13,17.88%,LAMP1;ITGB2;STX4
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.33081873705450215,0.7596444769066292,0.7646176911544228,0.9726726556011406,1.0,5/17,14.45%,SRD5A3;ALG1;ALG12;DOLK;NUS1
prerank,renal absorption (GO:0070293),0.369831771671147,0.759426398160137,0.7504302925989673,0.9725318715784402,1.0,1/10,2.11%,GSN
prerank,iron ion homeostasis (GO:0055072),-0.20360350534508867,-0.7586882102668822,0.9333333333333333,0.9382300913337543,1.0,16/58,22.77%,BMP6;SCARA5;FBXL5;SLC40A1;TFRC;B2M;CYB561A3;GLRX3;FXN;CUL1;ATP6V1A;ISCU;SOD1;SMAD4;CCDC115;ATP6V1G1
prerank,skeletal system morphogenesis (GO:0048705),0.28631158537561446,0.7585522520505807,0.8010752688172043,0.9733535271599212,1.0,2/42,2.42%,FGFR1;HOXA4
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.2845556829648132,0.7584853142222213,0.7803234501347709,0.9730128395941892,1.0,7/37,10.70%,MMP9;CDKN1A;MEF2D;JUN;ADAMTS1;HTR1B;SOD2
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.2898354058002944,0.7581703904684305,0.7906040268456376,0.9730593293626014,1.0,10/39,16.77%,TTC7A;PIK3C2B;IP6K1;PI4KA;SOCS2;PIP4K2C;EFR3A;SOCS6;IP6K2;PI4K2A
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.30161156296569314,0.7578766742581597,0.7887517146776406,0.9730369712834147,1.0,4/30,9.23%,ABCD1;ELOVL1;ELOVL6;HACD4
prerank,mRNA catabolic process (GO:0006402),-0.2148061494409193,-0.7578762920168726,0.8873873873873874,0.9383631714556603,1.0,19/44,29.97%,TUT4;METTL16;RNH1;AGO1;LSM6;RC3H1;ZFP36;UPF1;LSM2;CNOT10;AGO4;YTHDF2;NUDT16;MRTO4;DCP2;ERN1;EXOSC9;HSPA1B;PNPT1
prerank,histone H2A ubiquitination (GO:0033522),-0.2739802614888937,-0.7574982073839841,0.8037383177570093,0.937906109123484,1.0,8/17,30.25%,CUL4B;BCOR;DTX3L;KDM2B;RYBP;RNF2;DDB2;SKP1
prerank,nucleotide-excision repair (GO:0006289),0.2526131687117249,0.7573224817726087,0.8506271379703535,0.9734346080575823,1.0,25/101,19.87%,EP300;POLR2H;POLR2A;RBX1;POLK;HUS1B;COPS5;ERCC5;HMGN1;RPA3;POLD2;ISY1;PCNA;FAN1;PRPF19;LIG3;DDB1;RPS27A;UBC;ERCC2;POLR2C;RFC1;POLR2E;PNKP;ERCC4
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.2784245298664314,0.7571272175120035,0.8015075376884422,0.9732833219246775,1.0,16/49,24.29%,EP300;MOV10;EIF6;RAB7B;KMT2A;MEF2C;MTURN;PRMT1;PITHD1;PRKCQ;H3-3A;KMT2B;RBM15;KMT2C;KMT2E;ZFPM1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.327760332694919,0.7571266343066909,0.7563150074294205,0.972834892104859,1.0,7/18,21.69%,CHRM1;GRK2;GNAQ;GNA11;GNA15;CDK5R1;CHRM5
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.2827993801879901,-0.7565615798993924,0.7869318181818182,0.9382105279600169,1.0,6/15,26.37%,SRPRB;SPCS2;RYR2;SRPRA;RAB3GAP1;EDEM1
prerank,regulation of fibrinolysis (GO:0051917),0.35501638572686,0.7557895849849208,0.7585669781931464,0.9744302713106904,1.0,2/13,6.27%,THBD;KLKB1
prerank,placenta development (GO:0001890),-0.3004884785301468,-0.7553640232173282,0.8155844155844156,0.9388532702856388,1.0,2/12,9.23%,PTK2;PPARG
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.24571510568087512,0.7553483312172102,0.871244635193133,0.9746553739667423,1.0,29/146,21.01%,FBXL7;FHL1;CDK4;PSMD11;AVEN;PSMD4;PSMF1;RBX1;CEP76;FBXO5;CCND1;PSMD7;PAFAH1B1;CSNK1E;VPS4B;PSMB5;CDK2;PINX1;HSP90AA1;CDC25B;DYNC1H1;PSMD1;PSMC4;ODF2;SFI1;PSMD8;CENPF;RCC2;HAUS1
prerank,Golgi organization (GO:0007030),0.2529895337028536,0.7545980282326809,0.8454746136865342,0.9753253486416139,1.0,26/112,19.43%,FBXW8;TJAP1;TMED1;ATP8B2;NSFL1C;GOLPH3;ARHGAP21;PLK3;GCC2;CDC42;BCAS3;ZW10;YWHAZ;VTI1B;GOLGB1;ARFGEF1;NPLOC4;STX16;ATL2;USP6NL;PI4K2A;SEC23IP;FHDC1;TMED5;VTI1A;MYO18A
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.24496532628889667,0.7533924497341729,0.8802139037433155,0.9766192675292097,1.0,21/151,12.85%,SPTSSB;ST3GAL4;SGMS2;PPM1L;ELOVL1;LARGE1;MOCS3;LCMT2;MGST3;GSTO1;GOLPH3;ELOVL6;HPGDS;HACD4;NFS1;TYW1;CDO1;CERS2;LPCAT2;CHPT1;LPCAT3
prerank,ncRNA catabolic process (GO:0034661),-0.2376940424631994,-0.7533764431677032,0.8645833333333334,0.9406050790683166,1.0,5/28,13.21%,TUT4;DIS3L;EXOSC7;PARN;EXOSC2
prerank,positive regulation of leukocyte activation (GO:0002696),-0.26369892833220193,-0.7531059802818854,0.8103448275862069,0.9399693278130189,1.0,3/18,7.77%,WNT5A;THBS1;IL33
prerank,positive regulation of cell aging (GO:0090343),0.35574791187253163,0.7529485924878533,0.7553719008264462,0.9768293405734925,1.0,3/11,14.96%,YPEL3;EEF1E1;LMNA
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.3026060592838616,0.7528632072979335,0.768377253814147,0.9765157292276678,1.0,5/27,11.88%,CHST12;CHST11;CHPF;CHST13;CHPF2
prerank,cellular iron ion homeostasis (GO:0006879),-0.2042296848800058,-0.7523160650453852,0.9456521739130435,0.9400042703123866,1.0,15/55,22.77%,BMP6;SCARA5;FBXL5;SLC40A1;TFRC;CYB561A3;GLRX3;FXN;CUL1;ATP6V1A;ISCU;SOD1;SMAD4;CCDC115;ATP6V1G1
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.23007945719932643,-0.7520685857709355,0.8367346938775511,0.9393276233582619,1.0,8/32,20.66%,TMED10;TSC1;GRM5;ROCK1;MTPN;ATXN2;NOLC1;NR1H4
prerank,ubiquinone biosynthetic process (GO:0006744),0.3353480312382495,0.751666781399524,0.7523510971786834,0.9778657572378578,1.0,2/15,8.22%,UBIAD1;PDSS2
prerank,regulation of innate immune response (GO:0045088),0.2742250426592109,0.7515054561582108,0.8078381795195955,0.9776587501575099,1.0,12/57,18.00%,CCL5;RNASEL;MUL1;TRIM21;POLR3B;PTPN6;NMI;POLR3C;DHX9;POLR3G;XIAP;PTPN11
prerank,cell differentiation in hindbrain (GO:0021533),0.35913131489097466,0.7514551786474613,0.7508305647840532,0.9772795018030538,1.0,3/11,13.80%,AGTPBP1;OPHN1;CEND1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.3023614551943146,0.7512659642894169,0.7788732394366197,0.9771126228110288,1.0,8/29,20.54%,MAVS;RNASEL;MUL1;PTPN6;PTPN2;PTPN11;YTHDF3;ZBP1
prerank,negative regulation of cellular senescence (GO:2000773),0.34638698697214987,0.7508018515815259,0.7684887459807074,0.9773387529761698,1.0,7/13,21.55%,CDK6;FBXO5;TWIST1;MAP3K3;ZKSCAN3;TERF2;YBX1
prerank,neuromuscular process (GO:0050905),0.32959542826404087,0.7505081780729159,0.7359635811836115,0.9773419164366994,1.0,3/16,10.55%,STRA6;AGTPBP1;PAFAH1B1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.26639915975575884,0.7502508964637001,0.8186101295641932,0.9772649387497714,1.0,12/60,16.71%,CDKN1A;CDK4;MOV10;MED30;TCF7L2;CCND1;MED8;MED12;PPM1D;MED24;MED6;MED27
prerank,lysine metabolic process (GO:0006553),0.3509501694491631,0.7501205887663873,0.7427184466019418,0.9765712129526446,1.0,5/12,22.69%,PIPOX;SLC25A21;OGDH;DLST;GCDH
prerank,lysine catabolic process (GO:0006554),0.3509501694491631,0.7501205887663873,0.7427184466019418,0.9765712129526446,1.0,5/12,22.69%,PIPOX;SLC25A21;OGDH;DLST;GCDH
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.2762297244952305,0.7495075530673352,0.8037037037037037,0.977007601441698,1.0,20/51,30.05%,NEK7;MAPK15;MAP3K4;PINX1;HMBOX1;TNKS2;ATR;PRKCQ;PNKP;TERF2;TINF2;FBXO4;CCT5;EXOSC10;XRCC5;TERF1;NAF1;CTNNB1;CCT8;CCT6A
prerank,7-methylguanosine mRNA capping (GO:0006370),0.29223864938846933,0.7494583498210161,0.7988980716253443,0.9761865005740799,1.0,3/31,6.00%,GTF2F1;POLR2H;POLR2A
prerank,7-methylguanosine RNA capping (GO:0009452),0.29223864938846933,0.7494583498210161,0.7988980716253443,0.9761865005740799,1.0,3/31,6.00%,GTF2F1;POLR2H;POLR2A
prerank,peptidyl-lysine modification (GO:0018205),0.2515818089118329,0.7490918775113157,0.8321995464852607,0.9762837218490403,1.0,31/99,25.46%,EP300;HDAC4;NUP93;EYA1;NDC1;SUMO2;SUMO3;NDUFAB1;SAE1;TRPM4;NSMCE2;PIAS1;PIAS3;VIPAS39;EEF1AKMT3;SENP3;P3H3;HDAC6;AAAS;PARK7;RAE1;SIRT4;ATPSCKMT;POM121;SIRT7;TPR;RANBP2;NUP42;RANGAP1;NUP62;SEH1L
prerank,autophagy of nucleus (GO:0044804),0.32959972153540146,0.74885995862812,0.7764350453172205,0.9761834194755431,1.0,9/16,31.48%,ULK1;RB1CC1;ATG3;WIPI2;ATG2B;ATG12;WDR45;WIPI1;ATG13
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.3300733497611463,0.7487146842818183,0.7663551401869159,0.975938035919207,1.0,3/16,12.61%,RORC;PDK2;FOXK1
prerank,peptidyl-serine modification (GO:0018209),0.24150315400044306,0.7483383541239449,0.8903088391906283,0.9760633518463409,1.0,35/166,19.23%,PRKCB;IKBKE;MKNK2;GALNT1;SGK3;NTMT1;STK39;LATS1;DYRK1B;PKD1;MAPK9;LMTK2;SRPK2;GRK2;CSNK1E;TGFBR2;EIF2AK3;MAP3K13;CDK2;NAA10;CHUK;ULK1;GSK3B;WNK1;PLK2;TTK;ATR;PRKCZ;MAPKAPK2;PRKCQ;PARP2;STK38L;ROCK2;CAB39;PRKD2
prerank,chloride transport (GO:0006821),0.25961154392552355,0.7480890589167907,0.8300117233294255,0.9759555823433067,1.0,8/74,12.23%,CFTR;SLC12A8;ANO8;ANO7;CLIC1;CLCN4;SLC12A4;ANO6
prerank,synaptic vesicle cycle (GO:0099504),-0.22827111770331016,-0.7478904899183493,0.8937728937728938,0.9437937000726789,1.0,9/30,21.20%,BRSK1;NLGN1;SNAPIN;SLC17A6;SNAP25;SYNDIG1;CPLX2;SYT10;RIMS1
prerank,protein localization to nucleus (GO:0034504),0.2518247465941401,0.7477840125015656,0.8437843784378438,0.9759235695879921,1.0,32/102,24.23%,IPO7;TSC2;NUP93;BMP4;SIX1;TNPO2;PML;BANP;TOR1A;MMP12;PINX1;TOR1AIP1;TNPO1;NXT2;RANBP6;HEATR3;LMNA;MDM2;IPO4;CSE1L;INTS13;PPP1R10;ARL2BP;TAF8;ZBTB7A;HIKESHI;ABCA7;POM121;TPR;TOR1AIP2;IPO9;SIX4
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.36003160030005243,0.7474588145093273,0.7619808306709265,0.9759690211998183,1.0,3/11,14.46%,NT5C3A;SLC19A2;CTPS2
prerank,iron ion transport (GO:0006826),0.2694861987941557,0.7473857651565204,0.8023255813953488,0.97563829537947,1.0,13/47,21.11%,ATP6V1B1;LMTK2;HEPH;CP;ATP6V1E1;ATP6V1D;ATP6V0D1;SLC11A2;ATP6V1B2;ATP6V0B;ATP6AP1;REP15;MELTF
prerank,histone H2A acetylation (GO:0043968),0.3243271211245287,0.7473263573523954,0.7538940809968847,0.9752676054318292,1.0,4/16,17.41%,NAA40;MORF4L2;MEAF6;TRRAP
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.3281272488197017,0.7472395015145431,0.7644376899696048,0.9749433796236473,1.0,8/16,26.14%,ATP5PF;ATP5F1B;STOML2;ATP5PD;ATP5ME;ATP5F1D;ATP5F1C;ATP5MC3
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.24742604287701808,-0.7471914831236081,0.8478260869565217,0.9437528798860103,1.0,6/22,20.64%,MAN1C1;SEL1L;SYVN1;UGGT2;EDEM2;TRIM13
prerank,negative regulation of RNA metabolic process (GO:0051253),0.31893564902191274,0.7471879608528932,0.760119940029985,0.9745756040842731,1.0,7/18,23.20%,ZC3H12A;NCOR1;RPS26;NCOR2;PTBP1;NRDE2;SHQ1
prerank,positive regulation of protein transport (GO:0051222),0.2616374615349678,0.7469480520998747,0.8439716312056738,0.9744697592016766,1.0,12/67,10.44%,SYTL4;GOLPH3;TGFB2;PLK3;ANG;ACSL3;CHP1;ARHGEF5;EZR;APBB1;IER3IP1;BCAS3
prerank,miRNA metabolic process (GO:0010586),0.3176078208005465,0.7469121975974103,0.7605633802816901,0.9740758896120845,1.0,3/20,12.98%,DGCR8;TARBP2;TUT7
prerank,cellular response to pH (GO:0071467),0.3256315954609761,0.7466834992771375,0.75,0.9739766879185785,1.0,6/17,19.42%,CHP1;RAB11FIP5;PKD2L1;HVCN1;SLC9A1;GPLD1
prerank,establishment of protein localization to organelle (GO:0072594),0.259197345468661,0.7464205299197009,0.8323699421965318,0.973924951365482,1.0,15/72,18.15%,LAMP5;LAMP1;IPO7;TSC2;NUP93;TNPO2;HK1;MMP12;TNPO1;NXT2;RANBP6;HEATR3;IPO4;CSE1L;PPP1R10
prerank,peptidyl-serine phosphorylation (GO:0018105),0.24225789153318136,0.7464068467213777,0.8782051282051282,0.9735016505431561,1.0,32/153,19.23%,PRKCB;IKBKE;MKNK2;SGK3;STK39;LATS1;DYRK1B;PKD1;MAPK9;LMTK2;MAP2K2;SRPK2;GRK2;CSNK1E;TGFBR2;EIF2AK3;MAP3K13;CDK2;CHUK;ULK1;GSK3B;WNK1;PLK2;TTK;ATR;PRKCZ;MAPKAPK2;PRKCQ;STK38L;ROCK2;CAB39;PRKD2
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.31532003060026526,-0.7458690890807147,0.7710526315789473,0.9425788269110357,1.0,5/10,32.15%,BLM;ERCC1;SLX4;EXO1;DNA2
prerank,t-circle formation (GO:0090656),-0.31532003060026526,-0.7458690890807147,0.7710526315789473,0.9425788269110357,1.0,5/10,32.15%,BLM;ERCC1;SLX4;EXO1;DNA2
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.31532003060026526,-0.7458690890807147,0.7710526315789473,0.9425788269110357,1.0,5/10,32.15%,BLM;ERCC1;SLX4;EXO1;DNA2
prerank,positive regulation of TOR signaling (GO:0032008),0.28049522456050047,0.7454269579278671,0.7915567282321899,0.9744653326929125,1.0,6/40,10.49%,PIH1D1;RHEB;SIK3;GOLPH3;SMCR8;HDAC3
prerank,positive regulation of cell development (GO:0010720),0.2895533037543435,0.7448362734042483,0.7899603698811096,0.9748568104931785,1.0,4/31,7.48%,NIBAN2;LMOD3;BMP4;BAD
prerank,protein methylation (GO:0006479),0.2848507195711427,0.7446866430935367,0.7984293193717278,0.9746214675948375,1.0,15/40,27.17%,EEF2KMT;NTMT1;SNRPB;EEF1AKMT3;PRMT1;TRMT112;ETF1;PRMT2;ATPSCKMT;FAM98B;N6AMT1;FAM98A;CAMKMT;EHMT1;EEF1AKMT2
prerank,zinc ion transport (GO:0006829),0.315334320900501,0.7446659752834676,0.763768115942029,0.9742098731425343,1.0,5/21,14.88%,SLC39A3;SLC39A6;TRPM2;SLC39A13;SLC30A6
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.3443032880610928,0.7444223312504938,0.7624223602484472,0.9741145253071299,1.0,5/13,22.38%,LARP7;HEXIM1;NELFB;NELFA;RNF168
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.3476378202819136,0.744087228385557,0.7798013245033113,0.974172631386214,1.0,3/12,14.54%,ZC3H12A;NCOR1;NCOR2
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.2664707923745486,0.7438870217299877,0.8240291262135923,0.9740117519182778,1.0,14/60,19.54%,KLF4;NEK7;MAPK15;MAP3K4;GRHL2;MYC;HSP90AA1;HMBOX1;PCNA;TNKS2;ATR;PRKCQ;PRKD2;PNKP
prerank,ribosome biogenesis (GO:0042254),0.24126778124223755,0.7437243107279912,0.9,0.9738168675297924,1.0,35/187,15.88%,GLUL;PES1;UTP11;PIH1D1;EIF6;KRR1;POP4;WDR55;XRN2;RPL31;EXOSC3;RPL22;SDAD1;RRP12;MPHOSPH6;BMS1;NIP7;MTREX;WDR43;WDR36;RPL28;PWP2;DDX47;NOC4L;SENP3;RPL10A;NOL6;RRP9;RPF1;UTP14A;HEATR3;UTP4;PAK1IP1;IMP4;RPL14
prerank,gas transport (GO:0015669),-0.3090255918585582,-0.7436483194812035,0.8082901554404145,0.9445136754832287,1.0,3/10,15.21%,IPCEF1;CYGB;CA2
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.3476207126850799,0.7434211681563523,0.7708674304418985,0.9738085556627097,1.0,2/12,8.48%,CHMP4A;CHMP4B
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.3379153184772043,0.7432788985491321,0.7824726134585289,0.9735546789846274,1.0,5/14,18.30%,NFKBIA;PKD1;CCDC22;KEAP1;SUFU
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.32118630159072753,0.7432654978023614,0.7656967840735069,0.9731381390136876,1.0,4/18,10.61%,ELOVL1;ELOVL6;ACSL3;ACSF3
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.2593513300102686,0.7429018093578686,0.8309859154929577,0.9732095364881985,1.0,16/71,18.33%,CYFIP2;NCKIPSD;CDC42;ACTB;MYO1C;ABI1;ACTG1;FCER1G;DOCK1;WIPF2;PLA2G6;HSP90AA1;CRK;ABL1;ARPC2;YES1
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.23767489737757513,0.7427950990247965,0.899895724713243,0.9729239945096622,1.0,30/186,14.35%,IGFBP6;NXN;GLI3;MLLT3;WNT11;CAV1;RNF43;PTPRU;AMER2;PSMD11;TSC2;RBMS3;PSMD4;PSMF1;LATS1;DVL3;RBX1;TCF7L2;CXXC4;PSMD7;TLE2;HMGXB4;TLE4;PSMB5;GSK3A;LMBR1L;TLE5;SFRP1;TRABD2B;GSK3B
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.26913189880842664,0.7427647960459488,0.8339529120198265,0.9725293660613199,1.0,2/54,0.54%,FGFR1;ANGPT1
prerank,negative regulation of lipid storage (GO:0010888),0.31676344997794204,0.7424287277743055,0.7830609212481426,0.9725839203163159,1.0,3/19,5.36%,TTC39B;ABHD5;NFKBIA
prerank,histone lysine methylation (GO:0034968),0.2874895866283036,0.7423637443050943,0.7888888888888889,0.9722283061349353,1.0,13/33,25.43%,DOT1L;SMYD3;KMT2A;KDM6A;SETDB1;TRMT112;DYDC2;SMYD1;MEN1;KMT2B;CXXC1;N6AMT1;SMYD2
prerank,regulation of osteoblast proliferation (GO:0033688),0.32417634682562463,0.7420744427198674,0.772795216741405,0.9721965743702417,1.0,4/17,18.49%,PLXNB1;RHOA;SFRP1;TMEM119
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.31689852999182333,0.7414715749339198,0.7883522727272727,0.9726001181139617,1.0,4/20,15.14%,CHRM1;GRK2;GNAQ;GNA11
prerank,cellular response to mechanical stimulus (GO:0071260),0.27515394100996843,0.740995247512912,0.8146766169154229,0.9728584302652986,1.0,9/46,16.86%,TNFRSF8;BAD;TNFRSF10B;TNFRSF1A;HABP4;AQP1;TLR4;TLR3;SLC9A1
prerank,endochondral bone morphogenesis (GO:0060350),-0.29912526197595457,-0.740310815516131,0.7990654205607477,0.9478518152183403,1.0,5/11,23.59%,COL13A1;BMPR1B;BMPR2;INPPL1;FGFR3
prerank,tRNA 5'-leader removal (GO:0001682),0.34841516566365593,0.7400494257608593,0.7667185069984448,0.973745328487225,1.0,3/13,12.35%,POP4;POP1;RPP21
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.29039279642511073,0.7398404964847223,0.7855153203342619,0.9736048644887614,1.0,5/31,12.14%,HOXA4;EIF4A3;SIX1;TWIST1;TGFBR2
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.3068268765774586,0.7397484322037069,0.7830609212481426,0.9733024403796463,1.0,6/22,17.80%,UBASH3A;LGALS3;EZR;PTPN2;SH2D1A;DUSP3
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.3006382905591924,0.7393456128730103,0.7893258426966292,0.9734546406235661,1.0,6/26,17.28%,ITPR2;ITPR3;LETM1;TRPM2;SLC8B1;F2R
prerank,muscle cell migration (GO:0014812),0.3501905491678869,0.7392070229365627,0.7609756097560976,0.9732141202886049,1.0,4/10,14.84%,SIX1;DDR1;AAMP;ITGB1BP1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.2606946623917225,0.7388099408554377,0.8368794326241135,0.9733283204431787,1.0,14/68,20.33%,IL17RA;MAVS;IL16;RAB7B;LBP;TLR6;TWIST1;TLR4;TLR3;DHX9;F2R;PTPN11;APP;AGER
prerank,histone methylation (GO:0016571),0.30485070059581154,0.7377618748065977,0.7870503597122303,0.9743637150837862,1.0,10/26,26.57%,NTMT1;SMYD3;PRMT1;TRMT112;PRMT2;SMYD1;SIRT7;N6AMT1;SMYD2;EHMT1
prerank,monoacylglycerol metabolic process (GO:0046462),0.3396661032079417,0.7368106874314647,0.7744,0.9752872461645001,1.0,2/13,4.20%,DGAT1;MOGAT3
prerank,natural killer cell activation (GO:0030101),0.30085328292329355,0.7361609346526523,0.7766990291262136,0.9757695297883583,1.0,1/23,1.28%,PBX1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.303130290603606,0.7358219512081938,0.7897058823529411,0.9758445436134051,1.0,9/22,23.92%,PPP1R15A;LGALS3;CRY2;PPP1R11;GSK3B;PPP1R1B;ROCK2;TIPRL;IKBKB
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.3143781025656949,0.7356818438266594,0.7805970149253731,0.9755969249499853,1.0,4/20,14.00%,EP300;NCOR1;GSK3A;PGP
prerank,cellular amide metabolic process (GO:0043603),0.24803886862462976,0.7356767588286716,0.8641425389755011,0.9751689727147208,1.0,25/102,22.87%,NAPEPLD;ACOT8;PPP2CA;ORMDL3;CPE;NNMT;ACSM3;SHMT1;NIT1;ABCA2;ALDH1L2;PCCA;SMPD2;ALDH1L1;VNN1;ABCB9;GNE;SLC19A1;MCCC2;THOP1;ABHD4;AASDHPPT;SGPL1;ST6GAL1;MLYCD
prerank,negative regulation of cell division (GO:0051782),0.3525418175318194,0.7356273175218616,0.7660626029654036,0.9748067482218371,1.0,3/11,13.86%,ZFYVE19;MYC;VPS4A
prerank,protein K63-linked deubiquitination (GO:0070536),-0.22295086861982644,-0.7353483972570857,0.8717948717948718,0.9530659819885392,1.0,12/31,23.81%,USP8;STAMBPL1;OTUD7A;BABAM2;BRCC3;USP7;TNFAIP3;BABAM1;OTUD5;ATXN3;CYLD;YOD1
prerank,negative regulation of bone remodeling (GO:0046851),-0.29054469965078894,-0.7350508234827379,0.8091603053435115,0.9524786789715234,1.0,4/11,25.42%,UBASH3B;TNFAIP3;GREM1;CALCA
prerank,regulation of TOR signaling (GO:0032006),0.2600779724805198,0.7346816857506224,0.8447432762836186,0.9756969413354936,1.0,9/67,10.49%,PRKAA2;PIH1D1;SH3BP4;TSC2;ROS1;RHEB;GOLPH3;SMCR8;HDAC3
prerank,cellular response to inorganic substance (GO:0071241),-0.25244356677599006,-0.7341784185273098,0.8338762214983714,0.9525585416154903,1.0,6/21,19.48%,GUCY1B1;FOXO1;MTR;BLM;SPIDR;FMR1
prerank,positive regulation of cell communication (GO:0010647),-0.22799964322801825,-0.734035703612597,0.8647686832740213,0.9517791296635751,1.0,10/28,23.00%,GRIK2;LGI1;SYT1;CLSTN2;EDN1;SOX11;EDN3;KCTD13;RIMS1;RIMS3
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.21813094777438258,-0.7334988336347196,0.9018867924528302,0.95144684595138,1.0,14/36,27.48%,DAB2IP;PHC3;SUZ12;EZH2;CBX3;YAF2;FOXO4;RYBP;RNF2;RAD51;TFDP2;BRCA1;CHEK1;PHC1
prerank,positive regulation of cellular component movement (GO:0051272),-0.24182484401499316,-0.7332522240005294,0.8461538461538461,0.9507928278518611,1.0,3/24,9.37%,LYN;SPOCK2;CFAP20
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.29386692926802727,0.7330461367089629,0.8156748911465893,0.9776104803030468,1.0,3/26,8.28%,ATP1A2;GSTO1;THADA
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.27504446386766485,0.7322332593245359,0.8342105263157895,0.9783170581805879,1.0,6/39,12.94%,ANGPT1;NFE2L2;MAPK7;KRIT1;ANO6;GATA3
prerank,programmed necrotic cell death (GO:0097300),-0.25702919533315627,-0.73162282919748,0.8727810650887574,0.9518308685759478,1.0,6/18,22.23%,ITPK1;PGAM5;RIPK1;IPMK;MLKL;CYLD
prerank,positive regulation of RNA splicing (GO:0033120),0.28518594715522677,0.7315381261507349,0.8024032042723631,0.978839302462128,1.0,5/29,14.62%,POLR2A;RBM20;HABP4;DAZAP1;ZPR1
prerank,sulfur compound catabolic process (GO:0044273),0.2758857582084074,0.7310034890464323,0.8196286472148541,0.9791499617854241,1.0,7/38,13.96%,HEXA;PRELP;GLB1;ARSB;HEXB;ADO;TXN2
prerank,ceramide transport (GO:0035627),-0.29158058856767516,-0.7309059479798011,0.8125,0.9517590770705832,1.0,3/12,13.63%,PLTP;PLEKHA8;SGPP1
prerank,regulation of macrophage activation (GO:0043030),0.2893909863396195,0.7301667805587431,0.7850340136054422,0.9798584512419087,1.0,5/30,11.15%,CD200;ZC3H12A;LBP;TLR6;TLR4
prerank,cellular response to lipopolysaccharide (GO:0071222),0.24557769793714385,0.7301172659394697,0.888135593220339,0.9794881746879899,1.0,12/101,13.82%,CCL5;VIM;ZC3H12A;MTDH;TRIM41;LBP;CARD16;TLR4;RHOA;SBNO2;IRAK1;MEF2C
prerank,negative regulation of transposition (GO:0010529),0.3268690453694129,0.7301069142006906,0.7757575757575758,0.97906463405155,1.0,5/16,24.43%,MOV10;TUT7;MYBL1;SIRT7;TEX15
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.30687943113148114,-0.7295322019124011,0.8337129840546698,0.9524462048636756,1.0,3/10,13.45%,LRP5;FGFR2;TBX1
prerank,rRNA metabolic process (GO:0016072),0.236628559634092,0.7290715561955413,0.9002123142250531,0.980027670450637,1.0,61/160,29.37%,PES1;UTP11;PIH1D1;KRR1;POP4;WDR55;XRN2;RPL31;EXOSC3;RPL22;RRP12;MPHOSPH6;BMS1;MTREX;WDR43;WDR36;RPL28;PWP2;DDX47;NOC4L;SENP3;RPL10A;NOL6;RRP9;RPF1;UTP14A;UTP4;IMP4;RPL14;PDCD11;IMP3;RPL6;RPS28;MAPT;RPL41;RPLP2;DDX52;BYSL;RPLP1;RPL7;WDR74;RPL21;RPL26;WDR18;RPS27;RPL18;NOP53;MDN1;RPS17;EXOSC4;EXOSC10;ESF1;NOP58;TEX10;RPL24;DDX10;RPS6;POP5;LAS1L;DDX49;RPL37A
prerank,positive regulation of cell growth (GO:0030307),0.24851178903527676,0.7278302167550738,0.8518099547511312,0.9812854619260845,1.0,22/96,21.87%,ISLR2;ADAM10;HPN;NGF;ZFYVE27;TGFB2;CDC42;EIF4G2;CDKN2AIP;MAP3K13;SFRP1;EIF4G1;SHTN1;H3-3A;TAF9B;ADAM17;MAPT;DBN1;MMP14;SYT3;UNC13A;SYT2
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.29621868517189864,0.7276171673616915,0.810126582278481,0.9811496490939201,1.0,1/24,0.49%,ITPR2
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.280210957251071,0.7271613819434439,0.8285714285714286,0.9813636914354701,1.0,4/30,7.59%,TRIM33;TWSG1;LTBP4;LATS1
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.29253673443546596,-0.7270786708563839,0.7975308641975308,0.9544394436044293,1.0,2/12,6.48%,HPRT1;PRPSAP2
prerank,positive regulation of cholesterol efflux (GO:0010875),0.29985043571298364,0.7261887432408156,0.7918486171761281,0.9822453217015653,1.0,2/21,5.36%,CAV1;NFKBIA
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.2530323709022321,0.7259859391372537,0.8586572438162544,0.9820778988007038,1.0,16/73,18.33%,CYFIP2;NCKIPSD;CDC42;ACTB;MYO1C;ABI1;ACTG1;FCER1G;DOCK1;WIPF2;PLA2G6;HSP90AA1;CRK;ABL1;ARPC2;YES1
prerank,regulation of interleukin-8 production (GO:0032677),0.2547440571197332,0.7258981255106031,0.8505338078291815,0.9817737439706807,1.0,7/69,11.15%,KLF4;MAVS;ANXA4;OTUD7B;LBP;TLR6;TLR4
prerank,autophagy of peroxisome (GO:0030242),0.34308948309619697,0.7256732977052276,0.8071895424836601,0.981669352212863,1.0,4/12,27.40%,MAP1LC3B;RB1CC1;PIK3R4;TRAPPC8
prerank,regulation of ion transport (GO:0043269),0.25139695302483145,0.7252356015018943,0.8406658739595719,0.9818438656386633,1.0,24/76,26.10%,CHRM1;GDNF;WWP2;KCNJ13;ANK3;TOR1A;KCNA5;SYT6;WNK1;NEDD4;SYT11;SYT12;YWHAH;ATP1A1;SYT3;VAMP2;SYT2;NKAIN4;NKAIN1;SYT13;PER1;P2RX4;HFE;SNCA
prerank,microvillus organization (GO:0032528),0.338414463359355,0.7247841663209508,0.8065573770491803,0.9820036721719696,1.0,3/13,9.58%,RAP1B;RAP1A;EZR
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.3384555629174471,0.7244302986946909,0.7766497461928934,0.9820637234181165,1.0,1/11,2.65%,CAV1
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.2699999050371169,-0.7233757538148458,0.8209366391184573,0.9579051252353015,1.0,5/15,17.82%,EIF4ENIF1;TNRC6A;POLR2G;CNOT7;ZFP36
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.2495449398003386,0.7231227780204083,0.8670454545454546,0.9833802300866814,1.0,25/80,25.98%,KIF2A;ERGIC1;COPA;KIF1C;GOLPH3;ERGIC2;ZW10;ATP9A;KLC1;ERGIC3;NAPA;ARF4;RAB1B;NSF;COPG1;UVRAG;ARFGAP2;GOLPH3L;KLC2;DNAJC28;TAPBP;RACGAP1;RER1;ARF5;KIF5A
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.2797256062461746,-0.7228096638103381,0.8247978436657682,0.9576025469851592,1.0,5/13,22.55%,PPARD;NFATC4;PPARG;PPARA;SRF
prerank,spindle assembly (GO:0051225),0.2539673835649647,0.7224324472023259,0.848729792147806,0.9838548911733793,1.0,13/67,18.91%,MAPRE2;NEK7;KIF2A;HDAC3;NCOR1;RHOA;ABRAXAS1;FLNA;CHEK2;NUMA1;AAAS;MISP;TUBGCP5
prerank,diacylglycerol metabolic process (GO:0046339),0.2958584148808334,0.7221607627760004,0.7988748241912799,0.9837762647967825,1.0,5/23,11.59%,DGAT1;MOGAT1;ANG;DGKA;GPAM
prerank,integrated stress response signaling (GO:0140467),0.3271446681329532,0.7218668135011457,0.7685185185185185,0.9837544662159722,1.0,3/14,17.03%,NFE2L2;EIF2AK3;EIF2AK4
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.33403646137996734,0.7214316223231088,0.7917329093799682,0.9839015662961109,1.0,3/12,14.54%,ZC3H12A;NCOR1;NCOR2
prerank,positive regulation of vacuole organization (GO:0044090),-0.2968482316720028,-0.7213329458442598,0.8203309692671394,0.9583186177142681,1.0,5/10,22.21%,PIP4K2A;SH3GLB1;PIP4K2B;RALB;RAB3GAP1
prerank,neuron projection fasciculation (GO:0106030),0.3532062790710288,0.7213044309222246,0.7713310580204779,0.9836410313856656,1.0,1/10,1.67%,EPHA4
prerank,positive regulation of macrophage activation (GO:0043032),-0.2593537638948967,-0.7211738394501278,0.8603988603988604,0.957545489981341,1.0,5/17,19.45%,WNT5A;THBS1;IL33;TTBK1;HSPD1
prerank,fatty acid metabolic process (GO:0006631),0.24366951991943742,0.7211390136411308,0.9217877094972067,0.9834492737034018,1.0,16/115,13.28%,PPARGC1A;ACOT8;ALOX5;SLC27A3;CPT1B;ACSL3;MSMO1;ACSM3;NDUFAB1;ACSF3;PON3;ACACA;GPAM;FASN;CPT2;ACADM
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.24148289219717267,0.7208806640514359,0.8701442841287459,0.9833600207650002,1.0,9/107,8.71%,ANK2;STIM2;CCL5;CAV1;CSRP3;ATP13A3;TMEM165;ATP13A4;SLC39A6
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.29699513104884395,0.720711455738885,0.8153409090909091,0.9831501186357611,1.0,8/25,19.72%,NIBAN2;DOT1L;TWIST1;GATA3;POU4F1;PARK7;ZBTB7A;RB1
prerank,DNA-dependent DNA replication (GO:0006261),0.23758203157642996,0.7206477770814786,0.9013303769401331,0.9827986641643485,1.0,30/128,22.26%,RECQL4;PSMD11;PSMD4;PSMF1;POLG;SRPK2;PSMD7;POLE4;TOPBP1;PSMB5;CDK2;RPA3;POLD2;MCM8;PRIM2;MCM6;RPS27A;UBC;MCM7;PSMD1;PSMC4;RFC1;PSMD8;PNKP;GINS3;ORC2;TWNK;MCM4;DDX23;SIRT7
prerank,pyroptosis (GO:0070269),-0.2687478443108892,-0.7198420644229417,0.8355437665782494,0.9580538196519672,1.0,3/15,11.65%,AIM2;GSDMD;CASP4
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.3225618070156261,0.7196452140289066,0.7759643916913946,0.9836910177384888,1.0,5/14,20.83%,TNFRSF10B;TLR6;IRAK1;TLR3;ZFP91
prerank,regulation of cellular amine metabolic process (GO:0033238),0.2593099757361625,0.7195649214972359,0.8341772151898734,0.9833584873289803,1.0,9/50,19.44%,PSMD11;PSMD4;PSMF1;AZIN1;PSMD7;PSMB5;PSMD1;PSMC4;PSMD8
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.29676137678952536,0.719052144120529,0.8165007112375533,0.9836406574191785,1.0,3/25,7.60%,CCL5;ILK;ANG
prerank,T-helper cell differentiation (GO:0042093),0.32572973089359114,0.7184809766800527,0.8095238095238095,0.9839847803773014,1.0,1/14,1.95%,RORC
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.31357747478449216,0.718412144771357,0.8112324492979719,0.9836389872491375,1.0,4/17,19.68%,SPRED3;DMTN;EIF4G1;PARD3
prerank,superoxide metabolic process (GO:0006801),-0.226323107069686,-0.7181071496954818,0.9122137404580153,0.9590779701380276,1.0,8/29,21.29%,SH3PXD2B;NOS3;NOX4;NRROS;NCF2;SOD3;SOD1;CYBB
prerank,protein lipidation (GO:0006497),0.2583427411907147,0.7179479786131641,0.8581907090464548,0.983829627758947,1.0,13/59,21.35%,GLUL;PIGU;ZDHHC12;PIGZ;PGAP2;PIGA;DPM2;PIGN;PIGP;PIGQ;GPLD1;ZDHHC3;ZDHHC13
prerank,positive regulation of endocytosis (GO:0045807),0.2656549143510641,0.7175921122305031,0.8419023136246787,0.9838407403227567,1.0,6/45,12.23%,CLU;CBLL1;GPC3;CDC42;TOR1A;ANO6
prerank,lipid transport (GO:0006869),0.24400191191839335,0.7173897202349125,0.8923766816143498,0.9836708132259095,1.0,7/97,6.47%,SLCO2A1;LDLR;SLC10A5;ABCD1;PITPNC1;PRELID3B;SLC27A3
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.2732073826808851,0.7172101764513997,0.8403693931398417,0.9834704404142066,1.0,9/38,18.28%,ASF1A;CENPS;ATRX;CENPT;UBN1;CENPH;IPO4;CENPO;H3-3A
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.26437633060696586,-0.7160552714782328,0.8723958333333334,0.9603247422050128,1.0,9/15,35.14%,RPL11;DTX3L;BAG5;BAG2;MAD2L1;LIMK1;SMAD7;RPS7;MAD2L2
prerank,defense response to symbiont (GO:0140546),0.24611798288289782,0.7157570630230937,0.8870967741935484,0.9849557468428355,1.0,8/92,6.42%,SERINC5;MAVS;PMAIP1;IRF3;BCL2L1;RNASEL;MOV10;NT5C3A
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.24677420322662158,-0.7156188715550009,0.8343558282208589,0.9598242030022951,1.0,12/19,50.30%,CHRNB1;SLC5A7;CHRNA4;CHRNB2;ACHE;COLQ;CHRNA5;CHRNA3;CHRNE;CHRNB4;CHRNB3;APOE
prerank,protein K48-linked deubiquitination (GO:0071108),0.29736069054104397,0.7152538634981355,0.8031837916063675,0.9851707164334496,1.0,3/23,9.92%,MINDY2;OTUD7B;USP20
prerank,regulation of cellular localization (GO:0060341),0.26161069587287455,0.715230345041013,0.8427835051546392,0.9847695943810421,1.0,12/46,17.59%,GSN;UNC13D;EFNA5;CDK16;DVL3;PARD6B;CSNK1E;HSP90AA1;MAD1L1;KDM1A;DYNC1H1;NUMA1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.25814606181760946,0.7147889685799735,0.8679950186799502,0.9849129021304412,1.0,15/58,19.87%,MRE11;RIF1;MDC1;NSMCE2;ABRAXAS1;PAXX;UBE2N;PRPF19;DCLRE1C;LIG3;NBN;RAD50;ZBTB7A;UVRAG;ERCC4
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.2767591986234601,0.7147437192855576,0.8210947930574098,0.9845397214066632,1.0,2/34,4.18%,SASH3;CLCF1
prerank,regulation of B cell differentiation (GO:0045577),-0.254850210661409,-0.7146814300260892,0.8496932515337423,0.9600005987142106,1.0,8/17,37.91%,ID2;NCKAP1L;CD27;BTK;XBP1;IL4I1;PPP2R3C;IKZF3
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.3058913155190492,0.7140380798771512,0.7954198473282442,0.9850330522820784,1.0,9/18,32.95%,KCNB1;SFRP1;SIRT4;BMP8A;CHGA;PRKN;PSMD9;REST;MIDN
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.3167641557779177,0.713689541942571,0.8006279434850864,0.9850488212163704,1.0,4/15,16.81%,PTK2B;TXK;DDR1;ABL1
prerank,myeloid cell activation involved in immune response (GO:0002275),0.3091462748339674,0.7136035181402848,0.8227474150664698,0.9847387904229316,1.0,4/18,13.15%,LBP;NMI;FCER1G;SBNO2
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.3334989702073562,0.7135514171261363,0.8160919540229885,0.9843802723361716,1.0,2/13,10.39%,CD81;BCAP31
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.23765073892191352,0.7134245837093699,0.9050772626931567,0.9841130172980183,1.0,20/109,19.69%,NFATC2;FOS;PSMD11;SHC1;PSMD4;PSMF1;TAB3;JUN;MAPK9;PSMD7;FCER1G;PSMB5;CHUK;IKBKG;PSMD1;TAB2;PRKCQ;PSMC4;PSMD8;MAP3K1
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.25522992905657865,0.7133933961642892,0.8370646766169154,0.9837202903210323,1.0,20/56,25.96%,TAB3;LBP;TLR6;CNPY3;TLR4;S100A1;IRAK1;TLR3;RPS27A;UBC;MAPKAPK2;TAB2;SFTPA1;SFTPA2;IRAK4;CTSK;TLR1;TLR5;LY96;TAB1
prerank,cellular response to topologically incorrect protein (GO:0035967),0.27722038584931963,0.7132632300730313,0.8103932584269663,0.9834748629037959,1.0,4/31,9.27%,DAXX;HSPB8;HSPA14;BAG3
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.24106312570916727,0.7116445698256697,0.8853575482406356,0.9851640049830961,1.0,21/104,19.79%,TRIB2;CDKN1A;PPP2CA;PIH1D1;CCND2;ACTB;MAP2K2;CCND1;PKMYT1;RHOA;SERTAD1;TESK1;CCNG1;ABL1;MTCP1;TSG101;CDKN2D;CAB39;CDK5RAP3;RB1;UVRAG
prerank,regulation of adaptive immune response (GO:0002819),0.3068933695238211,0.7114689045101569,0.8015625,0.9849650754112375,1.0,1/18,2.07%,SASH3
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.303056728319098,-0.7113273907582749,0.8184143222506394,0.9627243425825919,1.0,4/10,22.04%,DKC1;RPUSD4;NOP10;TSR3
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.30472580685485595,0.7100692090423373,0.8118361153262519,0.9863325095056874,1.0,4/18,14.35%,MUL1;ZNF205;GSK3A;GSK3B
prerank,striated muscle contraction (GO:0006941),0.25853386245948534,0.7097262058215247,0.855,0.986364140615886,1.0,9/53,15.15%,ATP1A2;CSRP3;STAC3;LMOD3;GRK2;MYL4;ALDOA;CCDC78;TNNI3
prerank,cellular response to interferon-beta (GO:0035458),-0.2713703831547111,-0.7092567742018231,0.8571428571428571,0.9639862467146828,1.0,5/14,29.97%,AIM2;IRGM;HTRA2;TRIM6;PNPT1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.2615587893986402,0.7090809928566127,0.8480697384806973,0.9867653660653749,1.0,5/52,8.90%,CNOT6;SAMD4A;SAMD4B;LSM4;EXOSC3
prerank,regulation of intracellular transport (GO:0032386),0.2687276480093591,0.7088681961890418,0.8324468085106383,0.9866224574507055,1.0,7/38,17.61%,NDEL1;LAMP1;CRYAB;ATP9A;DYNC1H1;NUMA1;AAAS
prerank,positive regulation of interleukin-4 production (GO:0032753),0.3135681223614793,0.7088306873008884,0.8299418604651163,0.986231740539276,1.0,5/17,18.34%,FCER1G;GATA3;PRKCZ;PRKCQ;RARA
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.33065019083635855,0.7081970364016983,0.7947882736156352,0.9865826732474402,1.0,6/12,28.66%,HUS1B;TOPBP1;CHEK2;STK33;SETMAR;CDC6
prerank,T cell differentiation (GO:0030217),0.26431552820735926,0.7078738743063082,0.852437417654809,0.9865625906583588,1.0,9/40,15.36%,GLI3;FCER1G;RABL3;PTPN2;GATA3;LMBR1L;GPR89B;GPR89A;MR1
prerank,lipid translocation (GO:0034204),0.2985498350359127,0.707769545557453,0.8264705882352941,0.9862468670220255,1.0,3/21,10.93%,ATP10A;ATP8B2;ATP9A
prerank,amino sugar metabolic process (GO:0006040),0.3451950956604798,0.7075538664658527,0.793918918918919,0.9860854576370854,1.0,1/10,1.52%,B4GALNT2
prerank,Fc receptor signaling pathway (GO:0038093),0.23471553241408927,0.7075148989112624,0.9186813186813186,0.9857001514690555,1.0,20/110,19.69%,NFATC2;FOS;PSMD11;SHC1;PSMD4;PSMF1;TAB3;JUN;MAPK9;PSMD7;FCER1G;PSMB5;CHUK;IKBKG;PSMD1;TAB2;PRKCQ;PSMC4;PSMD8;MAP3K1
prerank,macrophage activation involved in immune response (GO:0002281),0.3184359351120321,0.7074874059293931,0.8181818181818182,0.9853073993849287,1.0,3/13,13.15%,LBP;NMI;SBNO2
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.2627438570706236,-0.7074084717366401,0.8948948948948949,0.9649273738999138,1.0,14/16,51.46%,TNFRSF1B;SOX11;AHR;TNFSF8;IL27;LST1;PTPN22;IKZF3;IL12A;CD22;TNFSF9;FGF10;IL12B;TNFSF18
prerank,regulation of G0 to G1 transition (GO:0070316),-0.20881101695364832,-0.707245492418026,0.921875,0.9641192819402489,1.0,14/38,27.48%,DAB2IP;PHC3;SUZ12;EZH2;CBX3;YAF2;FOXO4;RYBP;RNF2;RAD51;TFDP2;BRCA1;CHEK1;PHC1
prerank,NIK/NF-kappaB signaling (GO:0038061),0.24466033098469925,0.7071238688245645,0.8861788617886179,0.9853250789784714,1.0,16/72,20.83%,RELB;PSMD11;PSMD4;PSMF1;TNFRSF10B;TLR6;PSMD7;PSMB5;IRAK1;CHUK;TLR3;PSMD1;PSMC4;NFKB2;PSMD8;ZFP91
prerank,cardiac muscle contraction (GO:0060048),0.2775380830869749,0.707113417297291,0.8480662983425414,0.9849095073938324,1.0,5/34,11.41%,GSN;ATP1A2;CSRP3;GRK2;MYL4
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.3012290570182373,0.7059870123473171,0.8181818181818182,0.9858931739742419,1.0,2/18,4.97%,PMAIP1;TMEM259
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.2437894000021978,0.705794084510063,0.8940092165898618,0.985702561757001,1.0,17/83,16.70%,CDKN1A;CDK6;USP29;CDK4;CDK16;PLK3;LATS1;FBXO5;EIF4EBP1;CCND1;CDK18;CDK2;MYC;PLK2;PCNA;E2F1;HINFP
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.2466771087054915,0.7057089316996059,0.8769230769230769,0.9853753689185057,1.0,15/70,18.33%,CYFIP2;NCKIPSD;CDC42;ACTB;MYO1C;ABI1;ACTG1;DOCK1;WIPF2;PLA2G6;HSP90AA1;CRK;ABL1;ARPC2;YES1
prerank,response to growth factor (GO:0070848),0.26459733513080014,0.7054960870770632,0.8351063829787234,0.9852131747047035,1.0,9/41,17.75%,KLF4;SHC1;MAPK7;TGFBR2;MYC;SFRP1;LRP2;HDAC6;BMPR1A
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.3075566133872195,0.7047780301277051,0.8352769679300291,0.9857032271007676,1.0,5/18,12.16%,MSN;MAP2K2;EZR;VPS11;SNX12
prerank,early endosome to Golgi transport (GO:0034498),-0.2930163317417557,-0.7043383195370149,0.8578947368421053,0.9662507537956688,1.0,4/11,18.70%,EHD3;STX5;SURF4;RBSN
prerank,rRNA methylation (GO:0031167),0.2947250044869515,0.7042787347390417,0.8245363766048502,0.9859296261789162,1.0,2/22,4.72%,NOP2;BUD23
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.27938732263816435,0.7039688683914248,0.8551136363636364,0.9858927152377407,1.0,10/29,24.30%,COPA;VTI1B;NAPA;COG8;RAB33B;NSF;COPG1;VTI1A;GOSR1;GABARAPL2
prerank,response to hydroxyurea (GO:0072710),-0.28738176001406773,-0.7032340093998987,0.8545918367346939,0.96643820370716,1.0,4/11,19.48%,KAT7;BLM;SPIDR;FMR1
prerank,protein import into nucleus (GO:0006606),0.24701632132542917,0.7023699795291807,0.8692033293697978,0.9874940940986974,1.0,15/66,18.15%,KPNA7;IPO7;TSC2;NUP93;TNPO2;KPNA4;MMP12;TNPO1;NXT2;RANBP6;HEATR3;IPO4;KPNA1;CSE1L;PPP1R10
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.31110594499402505,0.7021713090085066,0.8246951219512195,0.987314552863228,1.0,8/17,25.33%,ADD1;TNFRSF1A;VCL;CDH5;ROCK2;IKBKB;PPP1R12A;F11R
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.34399513859597836,0.7020964613787863,0.8021015761821366,0.986563455487267,1.0,3/10,14.69%,TNFRSF1A;SMPD2;PLA2G6
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.34399513859597836,0.7020964613787863,0.8021015761821366,0.986563455487267,1.0,3/10,14.69%,TNFRSF1A;SMPD2;PLA2G6
prerank,ganglion development (GO:0061548),0.3246663257433623,0.7015147380835103,0.8157894736842105,0.9868469025517658,1.0,2/11,17.93%,NRP2;SEMA3A
prerank,protein processing (GO:0016485),0.23857678171706398,0.7012491222178573,0.9091940976163451,0.9867461230420412,1.0,24/102,21.13%,OGT;ADAM10;PRSS12;KLKB1;CPE;SRGN;AFG3L2;PITRM1;SDE2;KLK1;HP;HPR;SPCS3;CTSH;HM13;BACE1;SEC11A;PIDD1;SPPL3;SPG7;ADAM17;STOML2;APH1A;MMP14
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.2718874338363686,-0.7011004580402177,0.8610354223433242,0.9676826821949047,1.0,7/14,32.51%,RPUSD4;FASTKD2;TRMT10C;FASTKD3;RMND1;MPV17L2;COA3
prerank,response to interferon-gamma (GO:0034341),0.24608396715813896,0.7010648400378917,0.8789731051344744,0.9865612833867756,1.0,6/67,7.36%,CCL5;EPRS1;DAPK3;DAPK1;NUB1;TRIM21
prerank,glial cell differentiation (GO:0010001),0.27805312300871043,0.7010533867129026,0.8502747252747253,0.9861483024316609,1.0,4/28,10.47%,GPC1;ERBB3;NFIB;ADGRG6
prerank,hexose metabolic process (GO:0019318),0.2647925692584249,0.7005826582199426,0.8638184245660881,0.9863220560286299,1.0,8/39,15.06%,SLC35A2;HECTD4;HK1;IRS2;FUOM;ALDOA;DCXR;GALK2
prerank,positive regulation of T cell activation (GO:0050870),0.25169098952928676,0.7001313677506678,0.879951980792317,0.9864390622477962,1.0,4/62,4.97%,CCL5;IL15;CD81;FLOT2
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.3065145130393921,0.700104818093382,0.8095952023988006,0.986049384086306,1.0,2/16,6.80%,VIM;BMP4
prerank,positive regulation of mitochondrial fission (GO:0090141),0.30198012693073234,0.6998718496913118,0.8310911808669657,0.9859136531125589,1.0,5/18,15.11%,MCU;MUL1;MIEF2;DNM1L;DDHD1
prerank,aromatic amino acid family catabolic process (GO:0009074),0.30513282745476256,0.6992572969187307,0.8212634822804314,0.9862589208401061,1.0,4/15,24.53%,TDO2;HAAO;KYAT1;KMO
prerank,peptidyl-arginine modification (GO:0018195),-0.26982058661331404,-0.6986953210840056,0.8895027624309392,0.9691284545462721,1.0,3/15,20.05%,ART3;PADI2;KRTCAP2
prerank,tRNA 5'-end processing (GO:0099116),0.3206959236654161,0.6985525143475589,0.8130699088145896,0.9866886399706335,1.0,5/15,21.56%,POP4;POP1;RPP21;HSD17B10;RPP40
prerank,ncRNA export from nucleus (GO:0097064),-0.20776737975932996,-0.697863471017942,0.9346938775510204,0.9689899478421878,1.0,12/36,23.28%,TSC1;NUP85;NUP54;RAN;NUP210;NUP214;XPOT;NUP88;NUP188;NUP37;PHAX;NUP205
prerank,regulation of Golgi organization (GO:1903358),0.301208921450538,0.6974940438144082,0.80370942812983,0.9875539597119481,1.0,5/17,15.45%,MAP2K2;MYO5A;ARMH3;USP6NL;RAB33B
prerank,negative regulation of receptor internalization (GO:0002091),0.33316601944031043,0.6970830396291762,0.8165584415584416,0.9876637174688385,1.0,7/12,28.29%,RIN3;NECAB2;WDR54;DLG4;UBQLN2;ANKRD13D;ANKRD13B
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.27541322921259026,-0.6964958950461272,0.8392370572207084,0.9693886296285438,1.0,6/12,29.43%,STX2;SNAP25;STX1B;SNAP29;STX19;STX1A
prerank,tRNA wobble base modification (GO:0002097),0.3174268449602803,0.6961899531413631,0.8095975232198143,0.9883226841535376,1.0,5/14,23.34%,MOCS3;ELP4;CTU1;CTU2;URM1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.25219566265154575,0.6955555027326784,0.8736196319018404,0.988681553349594,1.0,11/56,14.38%,LSM10;CDK4;CCND2;FBXO5;ADAMTS1;CCND1;ANKRD17;VPS4B;NSMCE2;ANAPC4;EIF4G1
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.2836758606644973,0.6955259517180064,0.821173104434907,0.9882935331444046,1.0,6/26,18.34%,CDK6;TLR4;PTPN2;MYC;TLR3;RARA
prerank,negative regulation of translational initiation (GO:0045947),0.32766000128615475,0.6949990493711047,0.8241935483870968,0.9885056718932703,1.0,4/13,22.75%,EIF4EBP1;EIF2AK4;EIF4EBP2;TPR
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.32265245036674006,0.6942078137416295,0.8325508607198748,0.9890513373568731,1.0,3/13,15.91%,NIBAN2;NEDD4;CNMD
prerank,positive regulation of ATPase activity (GO:0032781),-0.19500835586187507,-0.6941295998256952,0.9436619718309859,0.9708076620681186,1.0,11/41,24.18%,ATP1B1;MSH3;VMP1;PLSCR1;RYR2;DNAJB2;TNNT3;DYNLL2;DNAL4;DNAJB1;AHSA1
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.2720776025092705,0.6939913482125988,0.8565629228687416,0.9888871732619069,1.0,8/33,17.41%,FAM210B;FOXO3;HOXA5;RAB7B;BRD1;MTURN;PRMT1;PITHD1
prerank,fluid transport (GO:0042044),-0.2728195551988116,-0.693841892269022,0.8723958333333334,0.9701454510487032,1.0,3/12,17.69%,AQP11;AQP4;SLC26A6
prerank,macroautophagy (GO:0016236),0.23072587123271326,0.6933031681940757,0.9236725663716814,0.9892586726599715,1.0,31/118,20.46%,PRKAA2;VPS37B;RUBCNL;TOMM5;CHMP4A;CHMP4B;MTMR3;PLEKHM1;VPS4B;VTI1B;TOMM20;VIPAS39;VDAC1;VPS4A;VAMP7;ULK1;MAP1LC3B;CHMP2A;RB1CC1;ATG4B;PRKAG1;ZFYVE1;STAM;TSG101;ILRUN;VPS37A;UVRAG;PRKAB1;TOMM40;PRKAB2;PIK3R4
prerank,positive regulation of cytokinesis (GO:0032467),0.26959084708180575,0.692851658749562,0.8748317631224765,0.9893605019664393,1.0,7/32,20.16%,PKP4;CDC42;AURKC;RHOA;CDC25B;KIF20B;CSPP1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.25257409296858974,0.6926763716528065,0.8716645489199492,0.9887139569274247,1.0,22/50,28.97%,POLR2H;POLR2A;NUP93;NDC1;EIF4G1;AAAS;POLR2C;H3-3A;RAE1;POLR2E;POM121;TPR;RANBP2;NUP42;POLR2K;NUP62;SEH1L;NUP133;IPO8;TRIM71;NUP35;PUM2
prerank,regulation of gene silencing by RNA (GO:0060966),0.25257409296858974,0.6926763716528065,0.8716645489199492,0.9887139569274247,1.0,22/50,28.97%,POLR2H;POLR2A;NUP93;NDC1;EIF4G1;AAAS;POLR2C;H3-3A;RAE1;POLR2E;POM121;TPR;RANBP2;NUP42;POLR2K;NUP62;SEH1L;NUP133;IPO8;TRIM71;NUP35;PUM2
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.22253052024722045,0.6925849261054887,0.9518324607329843,0.9883996132537065,1.0,26/185,18.57%,FZR1;PSMD11;PSMD4;PSMF1;PKD1;CEP76;FBXO5;PTPN6;PSMD7;PAFAH1B1;ZW10;CSNK1E;PSMB5;ANAPC4;CDK2;HSP90AA1;DDB1;RPS27A;UBC;E2F1;ERCC2;DYNC1H1;PSMD1;PSMC4;ODF2;SFI1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.29758633983742594,0.6925186787508959,0.8374455732946299,0.988060011741832,1.0,4/20,9.74%,CCND2;PSRC1;PKD1;CCND1
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.24137780007511253,-0.6924635435696912,0.9024390243902439,0.9705520538295819,1.0,11/20,30.57%,NR2F2;APC;IPO5;MYOCD;HHEX;INCA1;CDKN1B;PTEN;CEBPA;HEXIM2;CDKN1C
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.28015011606056395,0.6917301836667741,0.839541547277937,0.9885891124917549,1.0,6/29,18.22%,CNOT6;LSM4;EXOSC3;DCP1A;PATL1;HBS1L
prerank,purine-containing compound salvage (GO:0043101),-0.2792203723859536,-0.6914186673510242,0.8648648648648649,0.9706061403835831,1.0,4/12,12.80%,HPRT1;AMPD3;PNP;DCK
prerank,negative regulation of mitotic cell cycle (GO:0045930),-0.19530952997207637,-0.6911874018142802,0.9528301886792453,0.9698444285975837,1.0,14/45,22.93%,BRINP3;RGCC;TGFB1;BTG1;PTPN3;PRCC;TOM1L1;SMAD3;BRINP2;ZWILCH;GAS1;BMP7;CDKN1B;MAD2L1
prerank,protein O-linked glycosylation (GO:0006493),0.23349450963886467,0.6908803540646646,0.9193181818181818,0.9891458159670509,1.0,6/96,4.29%,ST3GAL4;OGT;B4GAT1;TMTC1;GALNT1;LARGE1
prerank,kinetochore organization (GO:0051383),0.32194112072163666,0.6908205846030482,0.8198757763975155,0.9887965582588379,1.0,4/13,24.99%,CENPT;CENPH;CENPF;MIS12
prerank,protein deneddylation (GO:0000338),0.3287266762930734,0.6905849716363036,0.8051529790660226,0.9886514693189643,1.0,2/10,12.29%,TOR1A;COPS5
prerank,negative regulation of receptor binding (GO:1900121),0.33700093345542215,0.6901440090275373,0.819614711033275,0.9887625063249427,1.0,2/10,10.43%,PTPRF;ADAM15
prerank,response to ionizing radiation (GO:0010212),0.24512471981374231,0.6900571440928591,0.9038004750593824,0.9884270160383849,1.0,10/70,13.47%,CDKN1A;KDM4D;NABP2;EYA1;INIP;COP1;TOPBP1;ABRAXAS1;EEF1D;MYC
prerank,C-terminal protein amino acid modification (GO:0018410),0.3272264261439489,0.6900264655260685,0.8006182380216383,0.9880387896330681,1.0,2/11,7.94%,AGTPBP1;AGBL1
prerank,peptidyl-lysine dimethylation (GO:0018027),0.2950109464602848,0.689346148239169,0.8424962852897474,0.9884005316531741,1.0,7/18,28.63%,KMT2A;SETD7;KMT2B;SMYD2;EHMT1;EEF1AKMT2;SETMAR
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.2866217925926824,0.6889603152941631,0.8450502152080345,0.9884216359708554,1.0,3/24,6.84%,SESN2;NFE2L2;MAPK7
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.315825684583416,0.6889461843871578,0.833605220228385,0.9880152689809685,1.0,3/14,9.99%,CMPK1;AK3;AK5
prerank,NAD biosynthetic process (GO:0009435),-0.23416597540359566,-0.6888099037621209,0.9191616766467066,0.9711388682219337,1.0,6/20,24.80%,PTGIS;PTGS2;NAXE;QPRT;NAXD;NAMPT
prerank,glycerophospholipid metabolic process (GO:0006650),0.24214101346699277,0.6881844370927924,0.9090909090909091,0.9884896216041352,1.0,18/75,19.57%,PLCB3;SERINC5;AGK;PIGZ;PAFAH1B1;PIGA;PIGX;DPM2;PGP;PLA2G6;PLCD1;PIGN;ABHD6;SERINC1;PIGP;PIGQ;GPLD1;SMPD4
prerank,retinal metabolic process (GO:0042574),0.31834653305967914,0.6880516101181763,0.8152542372881356,0.9882253708222024,1.0,2/12,9.56%,DHRS13;ALDH8A1
prerank,cellular senescence (GO:0090398),0.27546398105668346,0.6877122832578633,0.8571428571428571,0.9882139352481789,1.0,6/27,16.91%,CDKN1A;PML;NSMCE2;OPA1;HRAS;SMC6
prerank,regulation of stem cell proliferation (GO:0072091),-0.24589918781131895,-0.6874078212280802,0.9063545150501672,0.9715141309627302,1.0,4/17,20.30%,ACE;HMGA2;SOX11;YAP1
prerank,neuron projection organization (GO:0106027),-0.2537097854564767,-0.6871587980836963,0.8912386706948641,0.9707865769659062,1.0,4/15,15.91%,INSR;PLS1;ABCD2;MAP1A
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.2681394690152064,0.6870114029701389,0.8679775280898876,0.9885937087587837,1.0,7/29,16.76%,RBX1;ERCC5;RPA3;DDB1;RPS27A;UBC;ERCC2
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.33090140563253,0.6866106045693023,0.8199672667757774,0.9886311635983401,1.0,4/11,18.38%,AJUBA;FXR1;DHX9;WTIP
prerank,female gamete generation (GO:0007292),0.27255550476445567,0.6865132260679597,0.8186813186813187,0.9883123701708748,1.0,4/29,15.43%,DIAPH2;TOB2;PTN;MCM8
prerank,protein modification process (GO:0036211),-0.1721592458666705,-0.6859263492205435,0.993103448275862,0.9710018218543762,1.0,11/76,12.30%,PLOD2;ST3GAL1;ST8SIA4;MSRA;SERP1;CHRM3;UBE2S;ABL2;ARAF;MAN2B1;LOX
prerank,vasodilation (GO:0042311),-0.2618360821369896,-0.6858825401978395,0.8701657458563536,0.9700830491340094,1.0,3/13,18.91%,NOS3;KCNMA1;SOD1
prerank,stem cell development (GO:0048864),-0.247992102113805,-0.6857661462824151,0.9117647058823529,0.9692263634455263,1.0,10/16,36.45%,CDH2;PDCD6;SOX11;NOLC1;KBTBD8;KLHL12;SNAI2;NRG1;SHH;WNT7A
prerank,histone H2A monoubiquitination (GO:0035518),0.301843048881251,0.6857307335376703,0.8667664670658682,0.9887967888935472,1.0,8/17,26.49%,PCGF6;PCGF3;PCGF2;DDB1;TRIM37;RNF168;RING1;BMI1
prerank,synaptonemal complex assembly (GO:0007130),0.3114331490343006,0.6854561840416377,0.8703703703703703,0.9882632693309091,1.0,1/15,6.12%,SYCP2
prerank,synaptonemal complex organization (GO:0070193),0.3114331490343006,0.6854561840416377,0.8703703703703703,0.9882632693309091,1.0,1/15,6.12%,SYCP2
prerank,potassium ion import across plasma membrane (GO:1990573),0.25618618228566015,0.6851752556100932,0.8741542625169147,0.9881725458844091,1.0,3/41,4.49%,SLC12A8;ATP1A2;KCNJ13
prerank,positive regulation of collagen metabolic process (GO:0010714),0.2970091756454137,0.6848790798470298,0.8313432835820895,0.9881109940943944,1.0,2/17,6.80%,VIM;BMP4
prerank,regulation of lipid catabolic process (GO:0050994),0.2911490617820479,0.6845119088888078,0.8377976190476191,0.9881333693040576,1.0,1/19,2.68%,ABCD1
prerank,lipid catabolic process (GO:0016042),0.3002900395593403,0.6844925289157647,0.8374816983894583,0.9877340022566853,1.0,2/18,7.48%,HSD17B14;ACADL
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.2813703327998476,0.6844895477436252,0.8612303290414879,0.9873172870590351,1.0,11/24,25.80%,BCAP31;FCER1G;SEC23A;ABCB9;CANX;SEC24B;IDE;SEC31A;SEC24D;TAPBP;HFE
prerank,anterior/posterior axis specification (GO:0009948),0.30612297719066184,0.6838197292318949,0.8322475570032574,0.9877213462173273,1.0,2/15,8.35%,WLS;FZD5
prerank,response to hexose (GO:0009746),0.2787968563824863,0.683222514707753,0.8410404624277457,0.988003461304004,1.0,6/25,21.67%,EIF2B2;TCF7L2;IRS2;EIF2B4;GPLD1;VAMP2
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.28350329814864644,0.6831020851169778,0.8517441860465116,0.9877070292876609,1.0,6/21,15.09%,PPP1R15A;CRY2;YWHAB;PPP1R11;GSK3B;PPP1R1B
prerank,stem cell differentiation (GO:0048863),0.2549149744338425,0.6829984750911656,0.8992146596858639,0.9874011790695213,1.0,7/39,16.96%,MLLT3;PSMD11;TGFB2;LMBR1L;MEF2C;SFRP1;NELFB
prerank,ether lipid biosynthetic process (GO:0008611),0.3321223932817068,0.6828690157700771,0.8264604810996563,0.9871308873658822,1.0,3/10,12.13%,DHRS7B;LPCAT2;CHPT1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.22780125537430782,0.6821407887622558,0.9229898074745186,0.987540050854947,1.0,23/94,19.48%,MAP3K8;NFKBIA;PSMD11;PSMD4;PSMF1;TAB3;RBX1;PSMD7;IL1R2;PSMB5;PELI1;IRAK1;CHUK;IKBKG;UBE2N;RPS27A;UBC;PSMD1;TAB2;MAP3K3;PSMC4;PSMD8;IRAK4
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.2734396988440671,0.6817667910536327,0.8398876404494382,0.9875537650736146,1.0,6/26,18.46%,NFE2L2;HSPB1;MAPK7;SOD2;VNN1;PARK7
prerank,response to metal ion (GO:0010038),0.24216025928766877,0.6812898193298912,0.8942992874109263,0.9876585421581884,1.0,13/67,17.52%,NDRG1;CAV1;PEF1;PPP2CA;AHCYL1;ITPR3;NEDD4;SLC25A12;HVCN1;SNCB;PPP2CB;HAAO;SLC11A2
prerank,negative regulation of synaptic transmission (GO:0050805),0.28221702659890396,0.6811401416346771,0.8483063328424153,0.9874217409093192,1.0,5/23,15.36%,TMEM25;STXBP1;SYT11;PLK2;PNKD
prerank,organophosphate biosynthetic process (GO:0090407),0.26591795354779607,0.6810309498386647,0.872,0.9871239157179619,1.0,8/37,16.08%,MOCS3;IP6K1;PPIP5K2;NFS1;FADS1;GPAM;IP6K2;TPI1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.23854413976943345,0.6809456445805568,0.9097303634232122,0.986810833029658,1.0,13/69,17.40%,RNF5;TRIM25;ERLIN2;UBE2G2;ERLIN1;USP19;RNF121;NPLOC4;RHBDD2;UBE4A;DNAJC10;STUB1;UBE2J1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.281441794381941,0.6807101094509832,0.8504936530324401,0.9866731521972134,1.0,3/23,13.95%,GUCY2F;CNGB1;PDE6B
prerank,regulation of DNA repair (GO:0006282),0.2549164836239158,0.6800250519934545,0.8858267716535433,0.9870909325756905,1.0,15/44,23.25%,EYA2;EYA1;PML;TIGAR;ABRAXAS1;UBR5;POLH;DHX9;PCNA;UBE2N;PARG;UBE2V1;SIRT7;RNF168;CDK9
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.2350300773514221,0.6792425722025536,0.9210526315789473,0.9875456189550268,1.0,19/88,18.46%,CLU;PIH1D1;SDC4;LGALS3;RAB7A;MTLN;VPS4B;AJUBA;HRK;VPS4A;TRABD2B;GSK3B;CHMP2A;PFN2;CDH5;PDCD6IP;STAM;TSG101;PARK7
prerank,regulation of receptor recycling (GO:0001919),0.30236040272706405,0.6790425522726828,0.8501529051987767,0.9873412674548735,1.0,2/16,6.89%,TBC1D16;ANXA2
prerank,regulation of centrosome cycle (GO:0046605),0.2880141277391269,0.6784319160679947,0.8547904191616766,0.9876235508096547,1.0,6/21,17.63%,CHMP4B;VPS4B;MARK4;CHMP1A;CHMP2A;PDCD6IP
prerank,skeletal muscle contraction (GO:0003009),0.28792626138111,0.6778180983616108,0.8536585365853658,0.9879156308014614,1.0,3/19,15.15%,STAC3;CCDC78;TNNI3
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.23728857241299417,0.6775750031962169,0.9155920281359906,0.9877744891258965,1.0,22/78,24.76%,CDKN1A;IPO7;CCND2;LATS1;PSRC1;PKD1;CDK5RAP1;ACTB;CCND1;PKMYT1;SERTAD1;HEXIM1;CCNG1;CDKN2D;CDK5RAP3;ADAM17;CDK5R1;MEN1;LATS2;GTPBP4;CDC25A;MNAT1
prerank,peptidyl-threonine modification (GO:0018210),0.24021906456191153,0.6775000929144168,0.9092009685230025,0.9874421349072161,1.0,23/66,25.18%,CDK10;GALNT1;STK39;DYRK1B;OXSR1;LMTK2;TGFBR2;GSK3A;ULK1;GSK3B;WNK1;CDC42BPA;GALNT11;ROCK2;PRKD2;CDC42BPG;CDK5R1;CDC42BPB;MAP3K12;PRKCA;MAP3K10;GALNT3;PDPK1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.32796056396692824,0.6774159200848743,0.8051529790660226,0.9871167417011696,1.0,1/10,2.27%,SYP
prerank,ERAD pathway (GO:0036503),0.23231777803052947,0.6772665595021514,0.9269406392694064,0.9868663373542301,1.0,16/83,17.40%,RNF5;TRIM25;ERLIN2;UBE2G2;ERLIN1;USP19;RNF121;GET4;TOR1A;NPLOC4;RHBDD2;UBE4A;DNAJC10;CCDC47;STUB1;UBE2J1
prerank,phospholipid translocation (GO:0045332),0.27108888965460326,0.6771842785737905,0.8704735376044568,0.986548135587017,1.0,5/28,12.23%,ATP10A;ATP8B2;ATP9A;PLSCR3;ANO6
prerank,tRNA transport (GO:0051031),0.2594519864653759,0.676721662884705,0.8542780748663101,0.9866514235900109,1.0,14/35,26.79%,NUP93;NDC1;TOMM20;NOL6;AAAS;RAE1;YBX1;POM121;TPR;RANBP2;NUP42;NUP62;SEH1L;NUP133
prerank,cellular response to interleukin-1 (GO:0071347),0.2182809943160566,0.6767071589486907,0.9592274678111588,0.9862577079939395,1.0,26/143,18.09%,MAP3K8;CCL5;ADAMTS7;ZC3H12A;NFKBIA;PSMD11;USP10;PSMD4;PSMF1;TAB3;RBX1;PSMD7;IL1R2;PSMB5;PELI1;IRAK1;SFRP1;CHUK;IKBKG;UBE2N;RPS27A;UBC;PSMD1;TAB2;MAP3K3;PSMC4
prerank,regulation of spindle organization (GO:0090224),0.2882041977878049,0.6765786411565091,0.8606431852986217,0.9859801661091906,1.0,5/18,18.53%,PARP3;PSRC1;DYNC1H1;NUMA1;RAE1
prerank,monocarboxylic acid metabolic process (GO:0032787),0.22479174869750648,0.675713455575563,0.9328107502799552,0.9865279962334642,1.0,17/117,11.91%,ADH7;HAGH;ME3;GAMT;LDHB;NPC1;ABAT;CPT1B;ACSL3;MSMO1;LDHAL6B;ALDH8A1;CKMT1A;ACSF3;GPAM;PCCA;FASN
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.3210183542342707,0.6746265665537942,0.8383838383838383,0.987317266912985,1.0,2/10,9.27%,JUN;BAG3
prerank,regulation of oxidoreductase activity (GO:0051341),0.3109269558411324,0.6745743525106623,0.8428571428571429,0.9869601400206288,1.0,5/13,21.94%,HP;ABL1;HDAC6;SIRT4;SZT2
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.2823685709262387,0.6744255774145087,0.8579795021961932,0.9862958520200791,1.0,6/21,19.87%,RBX1;ERCC5;RPA3;DDB1;ERCC2;ERCC4
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.2823685709262387,0.6744255774145087,0.8579795021961932,0.9862958520200791,1.0,6/21,19.87%,RBX1;ERCC5;RPA3;DDB1;ERCC2;ERCC4
prerank,defense response to virus (GO:0051607),0.22829462295795594,0.6738141850754457,0.9228187919463087,0.9865364810194055,1.0,8/100,6.42%,SERINC5;MAVS;PMAIP1;IRF3;BCL2L1;RNASEL;MOV10;NT5C3A
prerank,serine family amino acid catabolic process (GO:0009071),0.3271362505814126,0.6720094024304477,0.8433098591549296,0.9880694665829565,1.0,2/10,12.04%,SHMT1;AMT
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.21142910354729982,-0.6705946083293102,0.924187725631769,0.9818523484710455,1.0,8/26,20.81%,CCDC57;HSF1;RPS6KB1;MEIS2;TAL1;ASNS;SMOC2;SPHK1
prerank,positive regulation of DNA metabolic process (GO:0051054),0.24054857490187684,0.6700019703967188,0.899641577060932,0.9898171279105293,1.0,16/61,19.23%,EYA2;MRE11;EYA1;PARP3;ATRX;PML;TIGAR;ABRAXAS1;MYC;DHX9;PCNA;UBE2N;NBN;RAD50;PPP1R10;PRKD2
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.19097334381587427,-0.6696864254496695,0.9525862068965517,0.9815746603461827,1.0,19/42,32.79%,SMCHD1;UBQLN4;PPP4C;SPIDR;MRNIP;FANCB;WDR48;CGAS;RMI2;ERCC6;RAD51;WRAP53;PARPBP;CHEK1;SIRT6;SHLD3;RTEL1;HELB;RAD51AP1
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.3197621437988744,0.6695818823956129,0.8497495826377296,0.9898824562436689,1.0,2/11,8.90%,LARP7;EXOSC3
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.2400081761311351,0.669405208972346,0.88625,0.9896514494654702,1.0,9/53,19.44%,PSMD11;PSMD4;PSMF1;AZIN1;PSMD7;PSMB5;PSMD1;PSMC4;PSMD8
prerank,pre-replicative complex assembly (GO:0036388),0.2368481443327039,0.6687819169012882,0.9136253041362531,0.989930821581536,1.0,15/64,21.59%,PSMD11;PSMD4;PSMF1;PSMD7;PSMB5;MCM8;MCM6;RPS27A;UBC;MCM7;PSMD1;PSMC4;PSMD8;ORC2;MCM4
prerank,protein acylation (GO:0043543),0.2526575535841757,0.6678265884098865,0.8862115127175368,0.9905035053790553,1.0,3/38,4.61%,GLUL;EP300;ZDHHC12
prerank,regulation of cellular metabolic process (GO:0031323),0.2490433405205299,0.6675618653732208,0.8961038961038961,0.9903798682711944,1.0,13/45,19.46%,TBC1D16;FOXM1;EIF6;ABCA2;PDK2;ACACA;MBOAT7;FASN;ARF4;NCOR2;STUB1;RNF41;FLOT1
prerank,axonemal dynein complex assembly (GO:0070286),0.26838123297231414,0.6672566674754554,0.8685314685314686,0.9902940325784511,1.0,8/28,26.69%,LRRC49;ODAD3;DNAAF5;ODAD2;DNAH5;DRC1;SPAG1;DNAAF4
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.27715821951958114,0.6672149444275942,0.8728571428571429,0.9899291700579923,1.0,10/25,28.29%,UNC119;ABCA2;RIN3;APP;WDR54;DLG4;UBQLN2;PSEN1;ANKRD13D;ANKRD13B
prerank,nuclear body organization (GO:0030575),0.30839283168229525,0.666881291307169,0.8520249221183801,0.9898709127265838,1.0,4/12,14.62%,PML;SRPK2;HABP4;ZPR1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.28758376859503937,0.6664080800416421,0.8722397476340694,0.9899562743071627,1.0,6/18,21.59%,POLD2;PCNA;LIG3;MCM7;GINS3;MCM4
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.27205984264857164,0.666332971246238,0.8781512605042017,0.9896321256080531,1.0,4/26,11.06%,CYB5R3;DDAH2;CYB5B;ABCA2
prerank,negative regulation of neurogenesis (GO:0050768),0.25117749687278174,0.6648932876909835,0.88,0.9907444074608723,1.0,1/34,0.73%,RTN4R
prerank,pancreas development (GO:0031016),-0.26401994761029146,-0.6648802917225402,0.8829516539440203,0.9847488489966106,1.0,5/12,29.28%,NPHP3;ZIC3;NKX6-1;CCDC39;FOXF1
prerank,determination of left/right symmetry (GO:0007368),-0.1993642728200986,-0.6644723425728282,0.966804979253112,0.9840945434474869,1.0,10/37,18.26%,NOTCH1;PKD2;MEGF8;RFX3;NPHP3;ZIC3;TBX1;BBS7;DNAH11;KIF3B
prerank,positive regulation of organelle assembly (GO:1902117),0.24589736379097496,0.6641686690738939,0.9031847133757962,0.9910974850842025,1.0,16/44,25.05%,CNOT6;SDC4;MARK4;PIP4K2C;CCDC88A;FSCN1;DYNC1H1;NUMA1;PDCD6IP;CROCC;RAB3GAP2;TAPT1;PLK4;CEP120;NUP62;LRSAM1
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.24170097841025423,-0.663666407169439,0.9166666666666666,0.9837433114630846,1.0,8/15,35.52%,GLI1;EZH2;PAF1;PHB2;NPM1;PLCG2;ATAD5;FAM83D
prerank,negative regulation of secretion (GO:0051048),-0.27013248584477023,-0.662962064147349,0.8713592233009708,0.9833166496855856,1.0,3/10,17.58%,NR1H3;CD74;EGF
prerank,regulation of protein dephosphorylation (GO:0035304),0.2489745670175184,0.6626860575469911,0.8885941644562334,0.9922499496401012,1.0,8/37,18.82%,PPP6R3;PPP1R15A;YWHAB;PPP1R16A;DLC1;CDH5;SPPL3;PTBP1
prerank,response to leucine (GO:0043201),-0.27859216812598886,-0.6614368980275469,0.8415300546448088,0.9825600804842552,1.0,3/10,15.29%,UBR1;KLHL22;RRAGD
prerank,cellular response to leucine (GO:0071233),-0.27859216812598886,-0.6614368980275469,0.8415300546448088,0.9825600804842552,1.0,3/10,15.29%,UBR1;KLHL22;RRAGD
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.24131235807394205,0.6610850515092811,0.9158415841584159,0.9935410106222514,1.0,1/53,0.76%,CHRM1
prerank,regulation of interleukin-17 production (GO:0032660),0.26198447439173717,0.6606461265387953,0.884,0.9935990441805739,1.0,4/31,11.15%,IL15;ZBTB7B;FOXP3;TLR4
prerank,folic acid metabolic process (GO:0046655),0.2882996304846798,0.6605643123033551,0.8446153846153847,0.9932638759263089,1.0,4/18,18.64%,SHMT1;ALDH1L2;ALDH1L1;SLC19A1
prerank,regulation of collagen biosynthetic process (GO:0032965),0.2849012207020133,0.6605258361507788,0.8793103448275862,0.9928918728373044,1.0,2/19,6.80%,VIM;BMP4
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.2665040427741461,0.6602994899580706,0.8668596237337193,0.9927217447912957,1.0,5/23,16.56%,RBX1;COPS5;DDB1;RPS27A;UBC
prerank,positive regulation of binding (GO:0051099),0.22771406784442688,0.6602716645365366,0.9223416965352449,0.9923358547935929,1.0,9/84,8.41%,MMP9;CAV1;NGF;KDM4D;ADD1;BMP4;TRIM21;PKD1;TCF7L2
prerank,serine family amino acid metabolic process (GO:0009069),0.2866710990743033,0.6600370795250835,0.8605388272583201,0.9921833968390269,1.0,3/16,14.25%,SHMT1;CDO1;SARS1
prerank,phasic smooth muscle contraction (GO:0014821),0.31530957156748024,0.6599658015481198,0.838160136286201,0.9918462178626966,1.0,1/10,3.81%,GDNF
prerank,glycerol metabolic process (GO:0006071),0.3242898661283759,0.6596137979901056,0.8437001594896332,0.9918097255765679,1.0,6/10,30.20%,PGP;TPI1;COQ3;ANGPTL3;GK;COQ2
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.19550504631627236,-0.6595192306263766,0.9617021276595744,0.9831155066202637,1.0,10/37,24.80%,AATF;MTMR2;ITGAV;EDNRB;EDN1;SIRT2;ATXN2;OPTN;PAX2;BRCA1
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.27263280969936793,0.6587826620370348,0.8640776699029126,0.9922310914382572,1.0,8/23,23.93%,MTMR12;MTMR3;INPP5B;OCRL;TPTE;PIP4P1;MTMR10;MTMR9
prerank,polyol biosynthetic process (GO:0046173),0.2988534169680535,0.6585397120877311,0.871875,0.9920805743289332,1.0,3/16,15.85%,IP6K1;PPIP5K2;IP6K2
prerank,mRNA polyadenylation (GO:0006378),0.2673100688579547,0.6582400667553518,0.8689458689458689,0.9915584740959589,1.0,9/26,23.48%,AHCYL1;WDR33;GRSF1;CLP1;APP;CSTF3;TUT1;PABPC1;LEO1
prerank,RNA polyadenylation (GO:0043631),0.2673100688579547,0.6582400667553518,0.8689458689458689,0.9915584740959589,1.0,9/26,23.48%,AHCYL1;WDR33;GRSF1;CLP1;APP;CSTF3;TUT1;PABPC1;LEO1
prerank,membrane repolarization (GO:0086009),0.2900001821434878,0.6581192694699022,0.8662519440124417,0.9912757775655908,1.0,1/15,2.79%,ATP1A2
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.3028723204245607,0.6579802275331533,0.8626817447495961,0.9910019353509595,1.0,2/13,15.36%,PVR;MR1
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.23365765166077096,0.6576601218732877,0.9202988792029888,0.9909273273143046,1.0,12/61,19.44%,CAV1;PSMD11;PSMD4;PSMF1;AZIN1;PSMD7;PDK2;PSMB5;NCOR2;PSMD1;PSMC4;PSMD8
prerank,regulation of erythrocyte differentiation (GO:0045646),0.2566912958681035,0.6575531773509182,0.8984168865435356,0.990631297005108,1.0,4/35,6.12%,CDK6;FAM210B;FOXO3;HOXA5
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.25352655045229433,-0.6574303376199543,0.9201101928374655,0.9837213941475793,1.0,4/13,26.34%,TGFB1;SOD1;TYROBP;ITGAM
prerank,protein deacetylation (GO:0006476),0.24744414113557447,0.657365119227643,0.8813559322033898,0.990410128799465,1.0,11/41,22.26%,HDAC5;HDAC4;MORF4L2;HDAC3;MIER2;FLNA;RCOR2;HDAC6;RCOR3;SIRT4;SIRT7
prerank,mRNA stabilization (GO:0048255),0.2500455596294416,0.657214659397544,0.9031007751937985,0.9901625052200053,1.0,11/40,22.88%,GDNF;YBX3;SYNCRIP;BOLL;PAIP1;DHX9;E2F1;MAPKAPK2;IGF2BP1;YBX1;PABPC1
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.3010218330778461,0.6560474374417676,0.870253164556962,0.990941252955431,1.0,3/13,13.52%,CPE;TGFBR2;GSK3A
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.24386019972162687,0.655714735608578,0.9156010230179028,0.9908672333994519,1.0,9/47,15.58%,QARS1;FOXM1;TGFB2;MAP2K2;ARL6IP5;COPS5;MYC;TGFBR3;IGBP1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.2612876761156475,0.6556571463470939,0.8863955119214586,0.9905206748242118,1.0,6/31,18.22%,CNOT6;LSM4;EXOSC3;DCP1A;PATL1;HBS1L
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.2477733504284872,-0.6555238807387325,0.8867403314917127,0.9842745706143449,1.0,7/14,29.97%,SLC25A33;MTERF2;TFB1M;MRPL12;EARS2;FASTKD5;PNPT1
prerank,erythrocyte differentiation (GO:0030218),0.242022323373003,0.6541837792180077,0.9027777777777778,0.991589210470333,1.0,14/44,24.94%,ACIN1;EPO;DMTN;ATP5IF1;SLC25A38;PTPN2;TGFBR3;CDK5RAP3;IKZF1;FLVCR1;CASP3;KMT2E;ZFPM1;ABCB10
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.24776497144733453,0.6541194790133298,0.9090909090909091,0.9912434579430225,1.0,7/35,15.09%,MAGI2;PPP6R3;PPP1R15A;CRY2;PPP1R11;GSK3B;PPP1R1B
prerank,response to alcohol (GO:0097305),0.26402628238751435,0.6536912086942921,0.9048295454545454,0.9912749071660821,1.0,5/27,14.16%,ADH7;PMVK;ABCA2;TGFBR2;TGFBR3
prerank,regulation of B cell apoptotic process (GO:0002902),0.30209566301869617,0.653404274561932,0.8587848932676518,0.9911457368770847,1.0,3/12,14.16%,ORMDL3;IRS2;FOXP1
prerank,cellular response to estrogen stimulus (GO:0071391),0.2922546124799267,0.6533156416606148,0.8588957055214724,0.9908222427007053,1.0,5/14,23.29%,BCAS3;SFRP1;SFR1;RARA;NCOA4
prerank,negative regulation of T cell activation (GO:0050868),0.25101683242111095,0.6529387096116487,0.9122807017543859,0.9907921733174498,1.0,4/35,8.98%,RIPOR2;SDC4;LGALS3;FOXP3
prerank,negative regulation of cell cycle process (GO:0010948),0.23287696520604326,0.6525814539948966,0.9333333333333333,0.9907417221299273,1.0,14/61,20.96%,PCGF6;MGA;BMP4;ZFYVE19;FBXO5;VPS4A;PCGF2;CHMP2A;E2F1;PPP1R10;WAPL;GPER1;TOM1L2;TERF2
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.3084171647556644,0.6519663291299527,0.8591772151898734,0.9909695432210875,1.0,5/12,26.27%,UPP2;UMPS;UPP1;UCK2;UCKL1
prerank,response to gamma radiation (GO:0010332),0.26619757460136156,0.651758660941734,0.8940027894002789,0.9907840803417312,1.0,6/24,16.82%,CRYAB;MYC;HRAS;MDM2;ATR;KDM1A
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.30162350760473305,0.6515355012536436,0.8609271523178808,0.9906052919008873,1.0,2/13,11.14%,CIAO1;ISCA1
prerank,primary miRNA processing (GO:0031053),0.3145528571054184,0.6515051710022592,0.8612040133779264,0.9902278096286955,1.0,2/10,14.13%,DGCR8;SRRT
prerank,synaptic vesicle localization (GO:0097479),-0.24973413298735458,-0.6512258371249574,0.8915989159891599,0.9865460332849542,1.0,3/13,13.07%,NLGN1;SNAPIN;SYNDIG1
prerank,nucleotide metabolic process (GO:0009117),0.2700812454304082,0.6499602099877005,0.8893805309734514,0.9912948987649145,1.0,4/23,14.46%,FHIT;CMPK1;AK5;CTPS2
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.30671688637790345,0.6490897534500585,0.8652597402597403,0.9917373951060436,1.0,11/11,69.35%,PRKCQ;NLRP10;CLEC6A;IL12B;NFKBIZ;IL23R;IL23A;CARD9;IL12RB1;NFKBID;MALT1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.2958897082412012,0.6488171488467845,0.8531684698608965,0.9916024605526771,1.0,4/14,18.46%,BCL2L1;CREB3;OPA1;PARK7
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.31829951192245176,0.6479325502876373,0.8524590163934426,0.9920652143421739,1.0,4/10,22.87%,NAGK;GNE;GNPDA2;ST6GAL1
prerank,actin filament-based transport (GO:0099515),0.27523640387592824,0.6477552538893523,0.8813314037626628,0.9918359189342782,1.0,7/21,17.81%,MYO1H;MYO5A;MYO1C;MYO15A;ACTN4;MYO1E;SUN2
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.27761817765497904,0.6470241359367143,0.8842857142857142,0.9921697569297638,1.0,5/19,15.65%,LBP;NMI;TLR4;IRAK1;ITGB2
prerank,mitochondrial transcription (GO:0006390),0.3084418160696212,0.6465266144990406,0.8585526315789473,0.9922241986165408,1.0,1/10,3.62%,FOXO3
prerank,regulation of spindle assembly (GO:0090169),0.266013159310893,0.646358444556314,0.8961988304093568,0.991984560426566,1.0,11/25,26.58%,CHMP4B;VPS4B;CHMP1A;CHMP2A;DYNC1H1;NUMA1;PDCD6IP;CEP97;TPR;CHMP5;CHMP1B
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.22031100329069664,-0.6461797553278641,0.9125364431486881,0.9892373871352521,1.0,7/19,21.68%,HPRT1;AMPD3;PNP;DCK;TYMS;GMPR2;CDA
prerank,lipid droplet formation (GO:0140042),0.3116446620437998,0.6451992798900955,0.8647260273972602,0.9926715189280155,1.0,3/10,17.74%,SQLE;CDS1;ZFYVE1
prerank,histone deacetylation (GO:0016575),0.24093766223657848,0.6450535151883734,0.9118421052631579,0.9924160678456954,1.0,14/43,25.07%,HDAC5;HDAC4;MORF4L2;HDAC3;MIER2;RCOR2;HDAC6;RCOR3;SFPQ;SIRT7;PER1;BAZ2A;PER2;HDAC8
prerank,negative regulation of viral transcription (GO:0032897),0.28985940243930436,0.6447740291265011,0.8621236133122029,0.992269128313066,1.0,3/13,9.40%,TRIM21;LARP7;TRIM11
prerank,protein auto-ADP-ribosylation (GO:0070213),0.29586242804694063,0.6440004451796957,0.8660130718954249,0.9926035925558109,1.0,7/12,28.73%,PARP3;PARP6;TNKS2;PARP2;PARP11;PARP1;TIPARP
prerank,regulation of cytokine production (GO:0001817),0.21108516845422806,0.6438775243837243,0.9632107023411371,0.9923083579096988,1.0,24/126,20.54%,SCAMP5;IL15;TWSG1;ALOX5;IRF3;TRIM21;NFAM1;SRGN;LGR4;FOXP3;TXK;PPP1R11;GATA3;FOXP1;GAPDH;SYT11;MAPKAPK2;IGF2BP3;GPNMB;IGF2BP2;FLOT1;HILPDA;IGF2BP1;ZBP1
prerank,regulation of protein localization to centrosome (GO:1904779),0.30992146664560793,0.6437614892640723,0.8672268907563025,0.9920068822720439,1.0,3/10,14.35%,NSFL1C;MARK4;GSK3B
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.23310424689790696,0.6436664521672077,0.9389027431421446,0.9916914789355389,1.0,20/59,25.18%,CDK10;STK39;DYRK1B;OXSR1;LMTK2;TGFBR2;GSK3A;ULK1;GSK3B;WNK1;CDC42BPA;ROCK2;PRKD2;CDC42BPG;CDK5R1;CDC42BPB;MAP3K12;PRKCA;MAP3K10;PDPK1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.2537270507949523,0.6429985888034345,0.9095966620305981,0.9919025736549756,1.0,3/29,8.79%,CAV1;PMAIP1;PML
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.24812475408139806,0.6429192113588935,0.9035326086956522,0.9915729032449523,1.0,11/33,25.26%,CDKN1A;DDRGK1;PKD1;PTPN6;ATP2B4;E2F1;FBXW7;PLK5;SUSD2;CRNN;TRIM39
prerank,regulation of regulated secretory pathway (GO:1903305),0.2520045241741751,0.6426271842999229,0.9099216710182768,0.9914505905126321,1.0,11/34,21.87%,UNC13D;SYN1;RIMS4;VPS18;SYT6;GSK3B;SYT11;SYT12;RAB27A;SYT3;SYT2
prerank,protein localization to Golgi apparatus (GO:0034067),0.2584479031561011,0.6426096585342711,0.9011627906976745,0.9910631529492818,1.0,7/27,17.50%,VPS13A;GOLPH3;GCC2;VPS13D;RAB33B;RIPOR1;ARFRP1
prerank,regulation of peptidase activity (GO:0052547),0.27564541026400735,0.6425611894481862,0.882262996941896,0.9907006836169511,1.0,1/19,2.65%,CAV1
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.25692130954999887,0.6396941687680295,0.9028169014084507,0.9929191108553853,1.0,3/25,8.70%,BAG1;SDF2;HSPA14
prerank,regulation of tumor necrosis factor production (GO:0032680),0.21319004435290306,0.6396113529296065,0.9548954895489549,0.9925965623983656,1.0,20/112,19.37%,CLU;ZC3H12A;MAVS;TNFRSF8;HSPB1;FZD5;LBP;PTPN6;TWIST1;TLR4;FOXP1;TLR3;SYT11;DHX9;OAS2;MAPKAPK2;PTPN11;RARA;ILRUN;APP
prerank,protein palmitoylation (GO:0018345),0.2541191928109353,0.6395961548501439,0.9059474412171508,0.9922068672197893,1.0,3/30,9.25%,GLUL;ZDHHC12;GOLGA7
prerank,regulation of microtubule polymerization (GO:0031113),0.2401383988056632,0.6379615712951369,0.9083969465648855,0.9933099747210905,1.0,10/40,22.90%,OCLN;EML2;PSRC1;CAMSAP1;ABL1;CDH5;NUMA1;MAPT;CDK5R1;TBCD
prerank,I-kappaB phosphorylation (GO:0007252),0.313105357060249,0.6379469325411272,0.8662420382165605,0.9929158698477775,1.0,3/10,15.25%,TLR4;CHUK;TLR3
prerank,regulation of gene silencing by miRNA (GO:0060964),0.22576677541033444,0.6378135080539199,0.9549330085261876,0.9926357751530944,1.0,26/62,28.97%,POLR2H;POLR2A;NUP93;NDC1;AJUBA;FXR1;EIF4G1;DHX9;AAAS;POLR2C;H3-3A;WTIP;RAE1;POLR2E;POM121;TPR;RANBP2;NUP42;POLR2K;NUP62;SEH1L;NUP133;IPO8;TRIM71;NUP35;PUM2
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.29132962927355643,0.6374741581990216,0.8640776699029126,0.9925408812824319,1.0,5/14,27.62%,PES1;DDX18;RPL7;ZNHIT6;URB1
prerank,protein prenylation (GO:0018342),-0.2718724006520439,-0.6374551765836873,0.9183168316831684,0.99430606973305,1.0,5/10,33.86%,FNTB;CHM;PTAR1;RCE1;FNTA
prerank,intracellular sterol transport (GO:0032366),0.28656066109512796,0.6374279891168008,0.8622848200312989,0.9921874486997562,1.0,5/13,18.13%,NPC1;STARD4;VPS4A;RELCH;OSBPL2
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.26395543212059935,0.6372284359331933,0.9113018597997139,0.9919776516675425,1.0,4/21,12.78%,RASAL3;TGFB2;MAPKAP1;SYNGAP1
prerank,membrane lipid metabolic process (GO:0006643),0.26258016010768503,0.6363337575129757,0.8972895863052782,0.9923431994423265,1.0,5/22,18.78%,AGK;ST3GAL6;ST6GALNAC4;SERINC1;TEX2
prerank,protein localization to chromatin (GO:0071168),-0.22226409005406017,-0.6353935706248256,0.9166666666666666,0.9947570878731138,1.0,5/18,18.84%,ESR1;TASOR;NIPBL;CHMP7;MRNIP
prerank,cellular response to acid chemical (GO:0071229),0.25583873937330026,0.6351443998713199,0.9055330634278003,0.9929896851763611,1.0,4/27,12.57%,SESN2;SH3BP4;CAPN2;CPEB3
prerank,histone mRNA catabolic process (GO:0071044),-0.23260254393549845,-0.6344579613055441,0.9088319088319088,0.9944082028208557,1.0,4/15,25.39%,TUT4;TENT2;UPF1;DCP2
prerank,negative regulation of JNK cascade (GO:0046329),0.24832511974626623,0.6343681673962954,0.9298245614035088,0.9932825370205641,1.0,10/31,25.56%,DUSP10;SH3RF2;HDAC3;NCOR1;DUSP3;TAOK3;MEN1;SIRPA;PER1;MAPK8IP1
prerank,protein localization to kinetochore (GO:0034501),0.2845302839773435,0.6343227418665035,0.8659476117103235,0.9929234897765,1.0,5/14,24.99%,CENPT;ZW10;TTK;RCC2;MIS12
prerank,protein targeting (GO:0006605),0.21016156647274378,0.6341021423220251,0.9608062709966405,0.9927258749747635,1.0,30/118,24.31%,TIMM10;HOMER3;TIMM44;ZDHHC12;VPS37B;TOMM5;PITRM1;GOLGA7;MYO1C;BCAP31;SPCS3;AP1S3;TOMM20;ZFAND6;TIMM17B;AP4E1;PEX6;VPS37A;PARD3;TIMM9;TOMM40;TSPO;ZDHHC3;SRP14;TIMM23;AP4M1;AIP;ARL6;RAB3IP;ATG3
prerank,regulation of histone methylation (GO:0031060),0.29494294006942495,0.6340064856911155,0.8708133971291866,0.9924083158677891,1.0,3/13,15.41%,PIH1D1;NNMT;TET1
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.30640105407878093,0.6338685908949528,0.8780487804878049,0.9921355829668774,1.0,4/10,21.17%,TUT7;RPS27A;UBC;CHFR
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.2944286456878756,0.6326899818496726,0.8622950819672132,0.9927404473789828,1.0,3/11,16.44%,STAT4;JAK1;CANX
prerank,alcohol catabolic process (GO:0046164),0.3005143108310968,0.632161336167314,0.8640939597315436,0.9928236646050125,1.0,1/10,8.37%,SRD5A3
prerank,histone deubiquitination (GO:0016578),0.2743172162396581,0.6307132998799891,0.8808049535603715,0.9936723946233448,1.0,6/18,21.26%,ENY2;USP3;TRRAP;USP16;USP21;USP22
prerank,thymus development (GO:0048538),-0.24320711122017075,-0.6294145517517323,0.9210526315789473,0.9966454602001871,1.0,7/13,39.28%,TBX1;EPHB3;SOD1;FOXE1;FADD;SHH;HES1
prerank,regulation of DNA replication (GO:0006275),-0.17390096236964706,-0.629034452250494,0.9818181818181818,0.9958741137162722,1.0,11/49,19.92%,GLI2;ACVRL1;USP37;KAT7;GLI1;ORC5;BCAR3;BLM;EGF;CTC1;STN1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.2088390030893518,0.6289005523101606,0.9644779332615716,0.9948134785641767,1.0,26/125,21.27%,DYNC1I1;NDEL1;KIF2A;MAP4;CENPS;AURKC;CENPT;PAFAH1B1;ZW10;EFHC2;CENPH;PLK2;MAD1L1;DYNC1LI2;CENPO;TTK;DYNC1H1;ZWINT;SUN2;INTS13;TBCE;CENPF;RCC2;WDR62;RMDN1;NUDC
prerank,atrioventricular valve development (GO:0003171),-0.24324686120631528,-0.628207849141313,0.9141274238227147,0.9954530092136449,1.0,4/14,14.37%,NOTCH1;HEYL;SLIT3;BMPR2
prerank,positive regulation of cellular senescence (GO:2000774),0.3041905916482053,0.6281749334810579,0.8781725888324873,0.9950484294738814,1.0,2/10,13.51%,YPEL3;EEF1E1
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.289634412412797,0.6279753999279641,0.9052132701421801,0.994810139340186,1.0,8/13,26.54%,CHP1;UFM1;SUFU;PARK7;RAB23;TPR;RANGAP1;APOD
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.30469760738655016,0.6274707154207401,0.8864,0.9948487109314859,1.0,2/10,13.95%,CNGB1;PDE6B
prerank,cilium movement (GO:0003341),0.23199578309767865,0.6272160157045764,0.931077694235589,0.9946643242088631,1.0,8/48,17.11%,CFAP91;CFAP54;CFAP206;ODAD3;SPAG17;ADCY10;DNAAF5;CFAP61
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.2574928786357418,0.6265513808186277,0.9002808988764045,0.994818542846333,1.0,3/23,7.59%,TRIM33;LTBP4;LATS1
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.22441945039293767,-0.6254926073216469,0.9159663865546218,0.9961950134591646,1.0,1/18,1.34%,FBN1
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.25571926419454366,0.6250582947831932,0.9160530191458026,0.99565007745885,1.0,5/22,16.76%,RBX1;DDB1;RPS27A;UBC;ERCC2
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.2802227612406523,0.6234327707703272,0.875,0.9966508334745764,1.0,3/14,17.33%,YBX3;BOLL;MAPKAPK2
prerank,neurotransmitter secretion (GO:0007269),0.23186940401239653,0.6230926404971567,0.943109987357775,0.9965339472195909,1.0,5/44,8.85%,OTOF;SYN1;STXBP1;DNAJC5;PCLO
prerank,regulation of leukocyte activation (GO:0002694),0.28330950231996666,0.6230351419769737,0.8911042944785276,0.9961882858429861,1.0,1/14,2.15%,CD200
prerank,signal release from synapse (GO:0099643),0.23267190808108995,0.6229753439987883,0.946360153256705,0.9958361152104753,1.0,5/43,8.85%,OTOF;SYN1;STXBP1;DNAJC5;PCLO
prerank,cytoplasmic translational initiation (GO:0002183),0.27308470070012764,0.6229152023730657,0.8944193061840121,0.9954918108278206,1.0,5/17,17.43%,EIF4B;EIF3M;EIF4G1;EIF4A1;EIF4A2
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.30385332804972764,0.6227170757401325,0.8814432989690721,0.9952702581947022,1.0,2/10,12.51%,PPP2CA;PTPN2
prerank,response to glucose (GO:0009749),0.2307668358141652,0.6210681907120252,0.9402390438247012,0.9962137217512385,1.0,11/46,21.67%,PRKAA2;EIF2B2;TCF7L2;KCNB1;IRS2;EIF2B4;PCK2;GPER1;GPLD1;SOX4;VAMP2
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.28084573056553375,0.6207993019523046,0.8923327895595432,0.9960303246584284,1.0,1/13,5.45%,DUSP1
prerank,amyloid-beta metabolic process (GO:0050435),0.2787389977905784,0.6207554454998969,0.8848484848484849,0.9956645800639861,1.0,6/16,23.98%,MGAT3;BACE1;IDE;ABCA7;APH1A;PSEN1
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.28937326633767496,0.6206386881118943,0.8776508972267537,0.995353297965981,1.0,3/11,20.19%,LPCAT3;ATL2;ARL6IP1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.2546870627401116,-0.6196695783454618,0.9267015706806283,0.9987787893998205,1.0,3/12,17.33%,TASOR;APOBEC1;SETDB2
prerank,regulation of DNA recombination (GO:0000018),0.2504549697220426,0.6196289938519569,0.9299610894941635,0.9957792237383913,1.0,7/32,20.31%,SHLD2;MRE11;IL7R;KDM1A;KPNA1;RAD50;THOC1
prerank,positive regulation of type 2 immune response (GO:0002830),0.2885060878899511,0.6191178888557852,0.9035222052067381,0.9957948876041394,1.0,5/14,26.41%,CD81;PRKCZ;RARA;IL6;DENND1B
prerank,cellular response to heat (GO:0034605),0.2335008425173984,0.619037721938502,0.9300411522633745,0.9954612518858947,1.0,9/35,24.28%,DAXX;BAG3;HSP90AA1;STUB1;MAPT;HIKESHI;TRPV4;TPR;PRKACA
prerank,regulation of sequestering of triglyceride (GO:0010889),0.27784073121312214,0.6184751582223772,0.8801313628899836,0.9955088435801096,1.0,1/15,3.17%,ABHD5
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.29627885133046516,0.6170233296073767,0.871499176276771,0.9962770690698919,1.0,3/11,18.46%,ABCD1;COA8;PARK7
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.24791992419772413,-0.6157777821479953,0.9287531806615776,1.0,1.0,2/10,17.23%,LGALS9;RC3H1
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.27354849042357166,0.6155283696165044,0.9003215434083601,0.9970426925246428,1.0,2/15,8.98%,TGFB2;FOXP3
prerank,positive regulation of cholesterol transport (GO:0032376),0.24576868277517286,0.6149538190451435,0.918194640338505,0.9970800615598937,1.0,2/27,5.36%,CAV1;NFKBIA
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.21715492508135595,-0.6147366388184695,0.9629629629629629,0.9997129238113422,1.0,12/18,51.87%,NCKAP1L;PRDM1;CCR2;PRKDC;IL4I1;IKZF3;CRTAM;ZFP36L2;TBX21;SLAMF8;PRELID1;CD2
prerank,positive regulation of hormone secretion (GO:0046887),-0.21681025251102973,-0.6146638818540852,0.9439775910364145,0.9987805608786025,1.0,12/17,50.58%,EDN1;SOX11;EDN3;GRP;RASL10B;VAMP8;NMB;C1QTNF3;PLA2G3;TFR2;CYP19A1;HCAR2
prerank,mesenchymal to epithelial transition (GO:0060231),0.2924418632550241,0.6140537964537066,0.9013377926421404,0.9973834076051986,1.0,2/10,12.94%,BMP4;GATA3
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.22468878233916106,-0.6131622021672091,0.9355742296918768,0.9986519730278247,1.0,8/15,39.40%,SEL1L;SYVN1;FAF2;OS9;DERL1;UFD1;HERPUD1;VCP
prerank,autophagosome assembly (GO:0000045),0.2189517774079925,0.6127374765701438,0.9493827160493827,0.9979905106663397,1.0,23/52,29.49%,NSFL1C;RAB7A;EMC6;ULK1;RAB1B;MAP1LC3B;RB1CC1;TMEM41B;ATG16L2;RAB23;UBQLN2;GABARAPL2;ATG3;UBXN2A;PACS2;WIPI2;ATG2B;STX12;ATG12;TRAPPC8;WDR45;RAB19;WIPI1
prerank,DNA replication initiation (GO:0006270),0.23765043674382294,0.612329176778352,0.9441489361702128,0.9978866246474836,1.0,13/37,26.92%,POLE4;TOPBP1;CDK2;RPA3;MCM8;PRIM2;MCM6;MCM7;ORC2;MCM4;ORC3;RPA2;MCM2
prerank,aspartate family amino acid catabolic process (GO:0009068),0.26606389998604074,0.6121263640575492,0.9191616766467066,0.9976416501557517,1.0,4/19,17.16%,PIPOX;SLC25A21;OGDH;DLST
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.25434667469577443,0.6108495096322278,0.9202279202279202,0.9982459404393346,1.0,11/25,27.89%,LARP7;WDR43;ELL;HEXIM1;NELFB;NELFA;RNF168;LEO1;LDB1;CDK13;RNF8
prerank,regulation of catabolic process (GO:0009894),-0.21513581605407245,-0.6103645845410237,0.9598765432098766,0.999278031264188,1.0,10/18,39.10%,FAP;HPGD;RARRES2;TMEM9;FAF1;ZDHHC2;FAM83D;ZDHHC7;SNF8;HGS
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.20758068451059047,-0.6097752860513503,0.9650145772594753,0.9986560491639942,1.0,7/22,24.74%,PSMA6;PSMB10;PSMA4;PSMB9;PSMA8;PSMB7;PSMA3
prerank,negative regulation of biosynthetic process (GO:0009890),0.2739652681984259,0.6094919317799986,0.8949771689497716,0.9988770881032091,1.0,4/16,19.14%,ABCD1;COA8;PARK7;GPER1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.21287542638695794,-0.6094337656207597,0.9625,0.9978703895034488,1.0,5/19,25.39%,NAT10;GNL3L;CTC1;STN1;DCP2
prerank,interstrand cross-link repair (GO:0036297),-0.16823390821691175,-0.6093693356149154,0.9894736842105263,0.996926491640285,1.0,16/53,26.17%,ERCC6L2;FANCL;FANCI;FANCC;USP1;FAAP100;FANCB;WDR48;FANCD2;DCLRE1A;NEIL3;EXO5;RAD51;ERCC1;RAD51AP2;CENPX
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.21742954064281803,0.6091305585358123,0.9521531100478469,0.9987571710754454,1.0,13/59,18.79%,RELB;NFKBIA;TAB3;TNFRSF1A;TLR4;CHUK;TLR3;IKBKG;RNF31;RPS27A;UBC;TAB2;ROCK2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.2453270168353805,0.6090943822076731,0.9253112033195021,0.9983839633576671,1.0,4/26,12.95%,DUSP1;FBXO5;NSMCE2;ANAPC4
prerank,activation of adenylate cyclase activity (GO:0007190),0.23593391083115012,0.6087366473946891,0.9432432432432433,0.9982504871537339,1.0,4/35,9.97%,ADCY9;ADCY6;LGR4;RAF1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.2899981168491028,0.6081529447460143,0.8933566433566433,0.9982828740071392,1.0,3/11,16.08%,FBXO5;DONSON;LIG3
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.23551193856143715,-0.6078649043548601,0.938375350140056,0.9967596840290881,1.0,5/13,23.34%,GPD1L;MAP1A;HSP90AB1;TYROBP;TMEM35A
prerank,regulation of centrosome duplication (GO:0010824),0.2427599028699552,0.6074043084767454,0.9310810810810811,0.998481716481863,1.0,8/30,17.63%,CHMP4B;CEP76;VPS4B;CHMP1A;PLK2;CHMP2A;CENATAC;PDCD6IP
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.2045482800497786,0.6070995258509713,0.9820828667413214,0.9982946020652013,1.0,11/95,13.82%,VIM;ZC3H12A;TRIM41;FZD5;LBP;CARD16;TLR4;RHOA;SBNO2;IRAK1;MEF2C
prerank,alpha-amino acid catabolic process (GO:1901606),0.23647829470454407,0.6070975667328671,0.9367977528089888,0.9978982189095784,1.0,8/29,24.53%,TDO2;HAAO;PRODH;KYAT1;HSD17B10;SARDH;BLMH;KMO
prerank,negative regulation of interferon-gamma production (GO:0032689),0.2543877669793938,0.6069988036916755,0.9235127478753541,0.9975629768150728,1.0,3/23,11.15%,ZC3H12A;FOXP3;TLR4
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.2874661783858744,0.605269711814689,0.9109697933227345,0.9984787704090621,1.0,2/12,9.54%,PCGF3;LRIF1
prerank,action potential (GO:0001508),0.2268087265185333,0.6052597846829187,0.9457070707070707,0.9980891015090891,1.0,11/44,21.41%,SCN3A;ANK3;KCNB1;GNAQ;GNA11;SCN9A;GPER1;YWHAH;GNA15;KCNMB3;KCNMB2
prerank,mitotic spindle organization (GO:0007052),0.1984807432955713,0.6047690196853579,0.989517819706499,0.9980559754818861,1.0,43/153,25.78%,DYNC1I1;NDEL1;KIF2A;MAP4;CENPS;AURKC;CENPT;PAFAH1B1;ZW10;RHOA;EFHC2;ABRAXAS1;CENPH;PLK2;MAD1L1;FLNA;DYNC1LI2;CENPO;TTK;DYNC1H1;CHEK2;AAAS;ZWINT;SUN2;INTS13;TBCE;MISP;CENPF;RCC2;WDR62;RMDN1;NUDC;CEP192;RANBP2;SMC3;TUBG1;CEP126;RANGAP1;MIS12;KIFC2;SEH1L;RPS27;DCTN2
prerank,positive regulation of phospholipid transport (GO:2001140),0.28911464776687834,0.6046797779414063,0.9089403973509934,0.9977227810329293,1.0,3/10,23.45%,TRIAP1;ABCA7;ABCB4
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.2700099312056189,0.6046747378381498,0.9138461538461539,0.9973267815832138,1.0,6/14,31.82%,ANKRD17;TLR3;TLR5;PUM2;PUM1;USP15
prerank,regulation of rRNA processing (GO:2000232),0.26872434266467116,0.6037480905634139,0.9109062980030722,0.9976048869896726,1.0,5/16,23.20%,BUD23;WDR43;TRMT112;SIRT7;SHQ1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.2451609407203646,0.6028725290906553,0.9402332361516035,0.9978425965434556,1.0,3/26,8.12%,FLOT2;LGR4;NLRP2B
prerank,cellular response to amyloid-beta (GO:1904646),0.2332938043707725,0.6018383613530661,0.9287598944591029,0.998175396881684,1.0,11/35,24.62%,EPHA4;CACNA1A;TLR6;TLR4;GSK3B;APP;AGER;ATP1A3;PSEN1;FYN;CACNA2D1
prerank,actin nucleation (GO:0045010),0.2536448227844566,0.6003216966203074,0.9328571428571428,0.9988345884382095,1.0,4/21,17.04%,LMOD3;MAGEL2;WASHC1;ARPC2
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.2199023824721379,-0.6002999110132122,0.943217665615142,0.9997100300997113,1.0,6/16,24.80%,AUTS2;BCOR;WDR5;PAXIP1;SMAD4;BRCA1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.2676570041654883,0.6000567419670417,0.9129082426127527,0.9986265871720668,1.0,8/16,28.98%,PINX1;TNKS2;ERCC4;TERF2;TINF2;PARP1;TERF1;NAF1
prerank,positive regulation of peptidase activity (GO:0010952),-0.2064400341606068,-0.5998385053278946,0.96,0.998985763438711,1.0,4/20,17.91%,RCN3;MAPK12;PSME1;APH1B
prerank,regulation of viral life cycle (GO:1903900),0.2493590051054704,0.5981458079197656,0.9235294117647059,0.9995882719861315,1.0,5/21,21.75%,TRIM25;TRIM21;VPS4A;TSG101;TRIM5
prerank,regulation of secretion (GO:0051046),0.27981981100274156,0.5974971614545337,0.9044585987261147,0.9996482261868533,1.0,4/13,19.42%,ERBB3;ACSL3;OAS2;GPLD1
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.22172162096693876,-0.5973203518348432,0.9459459459459459,0.9992820373153968,1.0,3/15,21.15%,BCL2L11;ZFP36;NR3C1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.1823940747713212,-0.5969475768420278,0.9852941176470589,0.9985042851780527,1.0,2/32,4.78%,CEMIP;PKD2
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.2590862360144615,0.5969397300908521,0.9137134052388289,0.999641333597398,1.0,8/18,31.82%,ANKRD17;NPLOC4;BIRC3;C1QBP;NOP53;PUM2;PUM1;USP15
prerank,double-strand break repair via break-induced replication (GO:0000727),0.27652902593407847,0.5966286916438479,0.8888888888888888,0.9994624081630908,1.0,4/12,26.92%,MCM6;MCM7;MCM4;MCM2
prerank,positive regulation of dephosphorylation (GO:0035306),-0.1921649243461147,-0.5958255876874784,0.9705882352941176,0.9980605154088963,1.0,7/27,28.34%,PPP1R16B;TGFB1;CNEP1R1;PPP1R7;CDCA2;CALM3;NSMF
prerank,hydrogen peroxide catabolic process (GO:0042744),0.28881848206711563,0.5952416713375572,0.9056316590563166,1.0,1.0,1/11,6.76%,PXDN
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.25003907970553174,0.5938957606246964,0.9364844903988183,1.0,1.0,7/21,22.75%,FBXO5;ZW10;MAD1L1;TTK;ZWINT;CENPF;TPR
prerank,autophagosome organization (GO:1905037),0.21408157991238094,0.593743361227173,0.9576587795765878,1.0,1.0,23/50,30.17%,NSFL1C;RAB7A;EMC6;ULK1;RAB1B;MAP1LC3B;RB1CC1;TMEM41B;ATG16L2;RAB23;UBQLN2;GABARAPL2;ATG3;UBXN2A;PACS2;WIPI2;ATG2B;STX12;ATG12;WDR45;RAB19;WIPI1;ATP13A2
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.27437503777761985,0.5934692328601426,0.9234375,1.0,1.0,3/13,13.66%,SRD5A3;ALG1;ALG12
prerank,RNA methylation (GO:0001510),0.2118195561295047,0.5931842026629873,0.9576059850374065,0.9998066793735161,1.0,8/60,12.32%,NOP2;BUD23;LCMT2;CBLL1;THADA;METTL6;THUMPD3;WDR6
prerank,positive regulation of DNA repair (GO:0045739),0.22096108276763884,0.5931826165732771,0.9563492063492064,0.9994141621212329,1.0,8/46,15.75%,EYA2;FOXM1;EYA1;TIGAR;ABRAXAS1;DHX9;PCNA;UBE2N
prerank,regulation of DNA metabolic process (GO:0051052),0.22476686708264113,0.5925249589371879,0.9560155239327296,0.9994163927157703,1.0,16/44,25.07%,IL7R;GRHL2;MYC;POLH;UBE2N;NBN;KPNA1;PARG;NUCKS1;THOC1;TERF2;UBE2V1;SIRT7;CDK9;WDR18;HDAC8
prerank,innate immune response in mucosa (GO:0002227),0.2915941710484826,0.5915899617335975,0.9001692047377327,0.9996418001907839,1.0,1/10,9.97%,RNASE3
prerank,regulation of myotube differentiation (GO:0010830),0.24298027497872246,0.591464191827642,0.9313868613138686,0.9993316123844925,1.0,3/24,10.49%,HDAC5;HDAC4;HDAC3
prerank,cranial nerve development (GO:0021545),-0.2394803766827212,-0.5908504317154104,0.9305210918114144,0.9994420013695743,1.0,2/11,7.59%,SALL1;CHD7
prerank,cytoplasmic translation (GO:0002181),0.20051714207468052,0.5902932241233385,0.9885974914481186,0.9996988929901234,1.0,29/91,27.53%,TMA7;RPS4X;RPL31;RPSA;GSPT2;RPL22;RPL28;RPS26;RPL10A;EIF3M;EIF4A1;RPL14;RPS27A;EIF4A2;RPL6;RPS28;ETF1;RPL41;RPLP1;RPL7;RPL21;RPL26;RPS27;RPS12;FTSJ1;RPL18;RPS17;RPS3;RPL22L1
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.23683056969475874,0.5892568406926629,0.95,0.9995971805068351,1.0,2/29,9.10%,ACOT8;ACSM3
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.23683056969475874,0.5892568406926629,0.95,0.9995971805068351,1.0,2/29,9.10%,ACOT8;ACSM3
prerank,cellular response to increased oxygen levels (GO:0036295),0.2732383529052589,0.5887501859071128,0.9260450160771704,0.9995254781377544,1.0,1/11,2.65%,CAV1
prerank,fatty acid transport (GO:0015908),0.25667179264618734,0.5880457966084754,0.9229583975346687,0.9995842981630586,1.0,4/17,18.32%,SLC27A3;CPT1B;SLC25A17;SLC27A4
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.2365522360868713,-0.5874090445849084,0.955026455026455,0.9990815151413727,1.0,4/11,19.63%,DKC1;CCT7;CCT2;CCT4
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.2365522360868713,-0.5874090445849084,0.955026455026455,0.9990815151413727,1.0,4/11,19.63%,DKC1;CCT7;CCT2;CCT4
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.2492280930243141,-0.5855273508788775,0.936986301369863,0.9989356988636073,1.0,5/10,27.75%,APC;SIRT2;ECT2;KNSTRN;SPAG5
prerank,cell junction maintenance (GO:0034331),0.26978438587350984,0.585266181675146,0.9193798449612403,1.0,1.0,3/14,17.28%,NLGN2;PRTN3;F2R
prerank,glial cell development (GO:0021782),0.24004571396898153,0.5809003984495293,0.9403409090909091,1.0,1.0,2/25,6.19%,CDK6;EIF2B2
prerank,response to molecule of bacterial origin (GO:0002237),0.20795397072106891,0.5803033109433932,0.9747596153846154,1.0,1.0,11/69,17.62%,SMAD6;SLPI;FZD5;LBP;TLR4;PELI1;IRAK1;FOXP1;F2R;MAPKAPK2;TAB2
prerank,negative regulation of establishment of protein localization (GO:1904950),0.28645824343404047,0.5802429848657654,0.9293924466338259,1.0,1.0,2/10,12.16%,WWP2;SNX12
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.2246186160935636,0.5799795414581663,0.9627249357326478,1.0,1.0,6/37,13.73%,SIDT2;XRN2;RNASE3;DNASE1L2;MTREX;DNASE1L1
prerank,vacuolar acidification (GO:0007035),-0.19990370728547635,-0.5794969069412003,0.9805194805194806,1.0,1.0,9/21,30.41%,ATP6V1H;CLN3;CLN6;CCDC115;TMEM9;ATP6V0A4;DMXL1;SLC11A1;PPT1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.23219370451008745,0.57931019177547,0.9560283687943263,1.0,1.0,13/28,26.04%,TAB3;IRAK1;AAMP;IKBKG;UBE2N;RPS27A;UBC;TAB2;OTULIN;UBE2V1;CASP8;TAB1;RELA
prerank,lipoprotein catabolic process (GO:0042159),0.28004135810521197,0.5789463815675906,0.9186046511627907,1.0,1.0,3/11,19.42%,ABHD10;LYPLAL1;ABHD17C
prerank,DNA recombination (GO:0006310),0.22193507380087238,0.5776641826807031,0.9576379974326059,1.0,1.0,3/37,8.07%,RECQL4;MRE11;RAD54L
prerank,methylguanosine-cap decapping (GO:0110156),-0.24822338764391566,-0.5772916563421856,0.9442970822281167,1.0,1.0,2/10,12.41%,DCP1B;EDC4
prerank,nucleoside salvage (GO:0043174),-0.24003323487272588,-0.577115376742912,0.9604938271604938,0.9996356901358475,1.0,4/10,22.88%,HPRT1;DCK;CDA;UCK1
prerank,cilium-dependent cell motility (GO:0060285),-0.19153042035721854,-0.5769688282178557,0.9637681159420289,0.998750751403898,1.0,10/22,35.75%,CFAP44;RFX3;DNAH3;DNAH2;CCDC39;RSPH9;CCDC65;DNAAF2;TEKT2;DNAH17
prerank,regulation of cholesterol transport (GO:0032374),0.24554577901989827,0.5767969044755867,0.9577874818049491,1.0,1.0,3/20,14.45%,TTC39B;ABCA2;NUS1
prerank,apoptotic nuclear changes (GO:0030262),-0.186554720838935,-0.5767785129679406,0.9855072463768116,0.9978841367462511,1.0,9/24,25.46%,CECR2;DNASE2;HMGB1;EXOG;ACVR1C;DICER1;TOP2A;FOXL2;BLCAP
prerank,negative regulation of double-strand break repair (GO:2000780),0.2290491016676947,0.5767753716461775,0.96045197740113,1.0,1.0,5/30,14.21%,SHLD2;KLHL15;RIF1;TWIST1;UBR5
prerank,RNA modification (GO:0009451),0.20789021476636316,0.5767153301806883,0.9710691823899371,1.0,1.0,7/54,10.26%,NOP2;LCMT2;ELP5;TRIT1;THG1L;AARS1;ANKRD16
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.2437331724258701,-0.5763080864356284,0.9555555555555556,0.9971208039586661,1.0,5/10,37.08%,THAP7;NOC2L;BRCA1;KLF15;TAF7
prerank,carbohydrate transport (GO:0008643),-0.2347029126492633,-0.5755864876144379,0.9491094147582697,0.9964350754273943,1.0,8/11,46.01%,AQP11;SLC26A6;SLC2A2;SLC23A1;SLC23A2;SLC50A1;SLC2A5;AQP9
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.18397020451158447,-0.5753441360804561,0.9769736842105263,0.9955770611728109,1.0,4/25,14.39%,SRSF4;SRSF10;TXNL4A;WDR83
prerank,folic acid-containing compound metabolic process (GO:0006760),0.24756958781675084,0.5751667937793653,0.9283536585365854,1.0,1.0,4/19,18.64%,SHMT1;ALDH1L2;ALDH1L1;SLC19A1
prerank,V(D)J recombination (GO:0033151),-0.22833486707295697,-0.5746768136762228,0.9462915601023018,0.9948941169775929,1.0,2/11,16.47%,LIG1;HMGB1
prerank,negative regulation of histone modification (GO:0031057),0.26658351349969855,0.5743869334003116,0.9319938176197836,1.0,1.0,3/14,14.23%,FOXP3;TWIST1;SET
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.2682528721200327,0.5736212069406628,0.9400630914826499,1.0,1.0,12/12,73.19%,PRKCQ;NLRP10;IL1B;CLEC6A;IL12B;IL23R;ZBTB1;IL23A;CARD9;IL12RB1;CCR2;SLC11A1
prerank,establishment of spindle localization (GO:0051293),0.25755455183748693,0.573232306969435,0.9387755102040817,1.0,1.0,5/14,21.84%,MAP4;LLGL2;DYNC1H1;TLE6;LLGL1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.25482925821400065,0.5718869759196519,0.934984520123839,1.0,1.0,7/16,32.18%,DAZAP1;CELF4;RBM3;RBMXL1;TRA2B;NCL;NUP98
prerank,replication fork processing (GO:0031297),0.21957587217879418,0.5718018083316612,0.9564068692206077,1.0,1.0,11/38,25.24%,MRE11;CENPS;ATRX;MMS22L;PCNA;ATR;NUCKS1;THOC1;CDK9;FANCM;FBH1
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.2375589349847986,0.5714454383893992,0.9455081001472754,1.0,1.0,8/24,17.62%,TAB3;IRAK1;AAMP;IKBKG;UBE2N;RPS27A;UBC;TAB2
prerank,TOR signaling (GO:0031929),0.22827318254712115,0.5696609480268795,0.9449035812672176,1.0,1.0,11/26,28.72%,EIF4EBP1;MAPKAP1;GATA3;CCDC88A;FLCN;EIF4EBP2;TIPRL;SYAP1;AKT1;LARP1;RPS6
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.2163758237417435,-0.5689063489822194,0.9656992084432717,0.9962030834307496,1.0,10/14,49.70%,TRAF6;CSF1;TYROBP;CCR1;TNFSF11;OCSTAMP;IL23A;TNF;IL23R;IL12B
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.22844123626316074,-0.5687760831935318,0.9679012345679012,0.9943521880526527,1.0,5/11,28.78%,SYNJ2;INPP1;PTEN;IMPA2;INPP5J
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.22844123626316074,-0.5687760831935318,0.9679012345679012,0.9943521880526527,1.0,5/11,28.78%,SYNJ2;INPP1;PTEN;IMPA2;INPP5J
prerank,response to lipopolysaccharide (GO:0032496),0.1878617941335879,0.5676384227615767,0.9956521739130435,1.0,1.0,19/138,17.62%,VIM;SMAD6;ZC3H12A;SLPI;TRIM41;LBP;CARD16;TLR4;RHOA;SBNO2;PELI1;IRAK1;MEF2C;FOXP1;PABPN1;F2R;GIT1;MAPKAPK2;TAB2
prerank,tRNA export from nucleus (GO:0006409),0.22162484633620888,0.5667240983470393,0.9547945205479452,1.0,1.0,12/32,26.79%,NUP93;NDC1;NOL6;AAAS;RAE1;POM121;TPR;RANBP2;NUP42;NUP62;SEH1L;NUP133
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.22162484633620888,0.5667240983470393,0.9547945205479452,1.0,1.0,12/32,26.79%,NUP93;NDC1;NOL6;AAAS;RAE1;POM121;TPR;RANBP2;NUP42;NUP62;SEH1L;NUP133
prerank,acyl-CoA metabolic process (GO:0006637),0.21700720871055623,0.5662660473620386,0.9552042160737813,1.0,1.0,8/35,22.87%,ACOT8;ACSM3;ACACA;OGDH;DLST;HMGCS1;SUCLA2;MLYCD
prerank,fibrinolysis (GO:0042730),0.264188849824209,0.5649816157636368,0.943127962085308,1.0,1.0,13/13,73.60%,PLAT;SERPINE1;PLAUR;SERPINF2;FGG;KRT1;F2;GP1BA;CPB2;SERPINB2;PLG;HRG;PLAU
prerank,sulfate transport (GO:0008272),0.2541075890493329,0.5646373477132185,0.9464831804281345,1.0,1.0,3/14,13.61%,SLC13A4;SLC25A14;SLC26A4
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.2189321436579792,0.5643499267023017,0.9690444145356663,1.0,1.0,6/34,15.25%,LGR4;NLRP2B;RAB7B;TLR6;TLR4;TLR3
prerank,regulation of transposition (GO:0010528),0.26148920140632836,0.5628645880519474,0.92018779342723,1.0,1.0,13/13,73.87%,MYBL1;SIRT7;TEX15;SMYD5;AICDA;UBR2;PIWIL1;BTBD18;SPOCD1;PIWIL4;DDX4;TDRD9;PIWIL2
prerank,rRNA 3'-end processing (GO:0031125),0.2779208925115882,0.562780219130714,0.9232081911262798,1.0,1.0,2/10,9.40%,EXOSC3;ERI3
prerank,inner dynein arm assembly (GO:0036159),0.2714375392341495,0.5624134524146422,0.9425675675675675,1.0,1.0,11/11,72.87%,DNAAF5;DNAAF4;CFAP73;CCDC103;ZMYND10;DNAI3;DNAAF1;DNAH1;CCDC40;CFAP100;CCDC39
prerank,myeloid cell differentiation (GO:0030099),0.2094412264033953,0.5621307309467031,0.9808917197452229,1.0,1.0,6/47,12.51%,ACIN1;ZBTB16;EPO;ATP5IF1;SLC25A38;PTPN2
prerank,RNA catabolic process (GO:0006401),0.21060488967840496,0.5617295395530568,0.969173859432799,1.0,1.0,5/46,10.45%,FEN1;SIDT2;XRN2;RNASE3;MTREX
prerank,Golgi inheritance (GO:0048313),0.2703756381959197,0.5612627447674965,0.9368770764119602,1.0,1.0,2/11,11.77%,PLK3;YWHAZ
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.24393436522875664,0.5602891573403017,0.9402985074626866,1.0,1.0,2/20,7.97%,TARBP2;TSNAX
prerank,lipoxygenase pathway (GO:0019372),0.25936393475355657,0.5594455006003738,0.9259259259259259,1.0,1.0,2/14,11.29%,ALOX5;PON3
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.26390566637259033,0.5594343506676366,0.9138211382113821,1.0,1.0,4/12,23.15%,NSMCE2;ANAPC4;RB1;CDC23
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.26390566637259033,0.5594343506676366,0.9138211382113821,1.0,1.0,4/12,23.15%,NSMCE2;ANAPC4;RB1;CDC23
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.26390566637259033,0.5594343506676366,0.9138211382113821,1.0,1.0,4/12,23.15%,NSMCE2;ANAPC4;RB1;CDC23
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.2674576052207098,0.5584831639372668,0.9438943894389439,1.0,1.0,3/10,26.00%,ATRX;STOML2;WIZ
prerank,telomere maintenance via recombination (GO:0000722),0.272467982267192,0.5583998202672904,0.9342948717948718,1.0,1.0,4/11,19.87%,NSMCE2;SMC6;RAD50;ERCC4
prerank,regulation of DNA damage checkpoint (GO:2000001),0.266690516355096,0.5557277797784042,0.932475884244373,1.0,1.0,2/10,10.98%,DDX39B;FEM1B
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.22971459836038238,0.5555913276455202,0.9645293315143247,1.0,1.0,5/25,13.40%,DDX39B;WDR43;ELL;HMGN1;TCEA2
prerank,ribosomal subunit export from nucleus (GO:0000054),0.262333739890113,0.555205784498452,0.9436152570480929,1.0,1.0,2/13,9.69%,EIF6;SDAD1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.22664171325951046,0.5543439730310241,0.9534206695778749,1.0,1.0,8/26,17.62%,TAB3;IRAK1;AAMP;IKBKG;UBE2N;RPS27A;UBC;TAB2
prerank,positive regulation of bone resorption (GO:0045780),0.25958452200794213,0.5517744866419243,0.9392446633825944,1.0,1.0,3/11,24.28%,PLEKHM1;ATP6AP1;PRKCA
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.24523048637067418,0.5498859285677254,0.9587786259541985,1.0,1.0,3/17,21.67%,ANK3;KCNRG;VAMP2
prerank,ncRNA 3'-end processing (GO:0043628),0.2486986709669436,0.5484557819379466,0.9382113821138212,1.0,1.0,3/14,18.76%,INTS2;TRNT1;INTS6
prerank,pinocytosis (GO:0006907),0.2602767179870876,0.5482261173361509,0.9343434343434344,1.0,1.0,2/10,17.33%,SNX33;MAPKAPK2
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.2644529533613709,0.5482143705934602,0.9492635024549918,1.0,1.0,10/10,73.57%,FTO;MGMT;ASCC2;ALKBH5;ASCC1;MPG;ALKBH3;ASCC3;ALKBH1;ALKBH2
prerank,DNA dealkylation (GO:0035510),0.2644529533613709,0.5482143705934602,0.9492635024549918,1.0,1.0,10/10,73.57%,FTO;MGMT;ASCC2;ALKBH5;ASCC1;MPG;ALKBH3;ASCC3;ALKBH1;ALKBH2
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.20951343020180097,0.5469189182276746,0.976158940397351,1.0,1.0,17/40,30.84%,CENPS;ATRX;MMS22L;DONSON;PCNA;ATR;NUCKS1;THOC1;CDK9;FANCM;FBH1;POLD1;SETMAR;PRIMPOL;ZRANB3;DDX11;RFWD3
prerank,pseudouridine synthesis (GO:0001522),-0.20997428668590648,-0.546054534034676,0.9778393351800554,1.0,1.0,3/13,19.85%,PUS7;DKC1;NOP10
prerank,regulation of cilium movement (GO:0003352),0.2671677138453393,0.5454047967044314,0.9366438356164384,1.0,1.0,3/10,24.01%,CFAP206;ODAD2;DRC1
prerank,regulation of T cell activation (GO:0050863),0.20282589144118182,0.5449814813933745,0.9839786381842457,1.0,1.0,6/42,18.68%,CCL5;LGALS3;ABL1;DUSP3;PRKCQ;GPNMB
prerank,positive regulation of cell division (GO:0051781),0.20492798600233497,0.5433191464750438,0.975452196382429,1.0,1.0,7/38,20.16%,PKP4;CDC42;AURKC;RHOA;CDC25B;KIF20B;CSPP1
prerank,global genome nucleotide-excision repair (GO:0070911),0.21673375055946642,0.5430796519954147,0.9706293706293706,1.0,1.0,6/26,19.87%,RBX1;DDB1;RPS27A;UBC;ERCC2;ERCC4
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.266156648183059,0.5416031178588273,0.9569707401032702,1.0,1.0,1/10,5.26%,PIH1D1
prerank,snRNA processing (GO:0016180),0.23758067250164305,0.5400930641205576,0.9535256410256411,1.0,1.0,7/16,29.27%,INTS2;INTS3;INTS6;TUT1;INTS1;INTS9;INTS12
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.22237379706779065,0.5387680616395006,0.975103734439834,1.0,1.0,7/23,25.24%,DNASE1L2;DNASE1L1;REXO4;KPNA1;CASP3;DFFA;FBH1
prerank,organonitrogen compound catabolic process (GO:1901565),0.19420499226555346,0.5386091218945833,0.9865030674846625,1.0,1.0,14/57,22.80%,NAGK;GGACT;NPEPPS;ADO;LTA4H;TXN2;SMPD2;PLA2G6;SIAH1;IDE;PDXDC1;LVRN;GNPDA2;SGPL1
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.2513422926453219,0.5379003236216571,0.9473684210526315,1.0,1.0,1/11,4.79%,AHCYL1
prerank,glucan biosynthetic process (GO:0009250),-0.21470146527074324,-0.5376351915004128,0.9641943734015346,1.0,1.0,6/12,29.96%,UGP2;GBE1;PGM1;GYS1;GYG1;PGM2L1
prerank,glycogen biosynthetic process (GO:0005978),-0.21470146527074324,-0.5376351915004128,0.9641943734015346,1.0,1.0,6/12,29.96%,UGP2;GBE1;PGM1;GYS1;GYG1;PGM2L1
prerank,cellular modified amino acid catabolic process (GO:0042219),0.24082951990301282,0.5374914399635136,0.9422776911076443,1.0,1.0,1/15,3.38%,GGACT
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.22942811199373941,0.5373540128464622,0.9725609756097561,1.0,1.0,3/22,9.40%,PES1;EXOSC3;ERI3
prerank,glutathione metabolic process (GO:0006749),0.2076182683497068,0.5372387557774793,0.9691119691119691,1.0,1.0,6/38,18.46%,HAGH;CTNS;HPGDS;GSTK1;GSTM2;PARK7
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.2409375229015736,0.5370941847897724,0.9455370650529501,1.0,1.0,6/14,28.70%,TRPT1;CLP1;TSEN2;FAM98B;CSTF2;RTCB
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.248990019624151,0.5346899605509067,0.953662182361734,1.0,1.0,3/13,17.40%,UBE2G2;BCAP31;UBE2J1
prerank,hexose transmembrane transport (GO:0008645),0.22241846298576345,0.5342563110221678,0.9694189602446484,1.0,1.0,3/21,12.58%,SLC2A12;SLC2A8;SLC2A9
prerank,regulation of protein localization (GO:0032880),0.1913484932804936,0.5312094650803905,0.9926017262638718,1.0,1.0,15/58,22.75%,TRIM25;TRIM21;DVL3;CSNK1E;SLC26A4;VPS4A;HSP90AA1;TESK1;AAK1;KDM1A;RAB9A;FBXW7;TRIM5;ADCYAP1;TPR
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.19385296049117645,0.5307519087264904,0.9845238095238096,1.0,1.0,14/57,24.08%,GLUL;PES1;SDAD1;NIP7;HEATR3;PAK1IP1;RPL14;METTL17;RPS28;BYSL;RPL7;WDR74;SHQ1;RPL26
prerank,P-body assembly (GO:0033962),-0.21418690977669608,-0.5303325712280292,0.9703504043126685,1.0,1.0,5/12,24.77%,EIF4ENIF1;ATXN2;RC3H1;LIMD1;LSM3
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),-0.1726904800612172,-0.5291547064265478,0.9795918367346939,1.0,1.0,5/24,19.92%,TNKS;NAT10;GNL3L;CTC1;STN1
prerank,protein monoubiquitination (GO:0006513),0.2020456917218458,0.52807428430378,0.975103734439834,1.0,1.0,5/36,12.14%,TRIM25;TRIM21;RBX1;UBE2B;RNF126
prerank,sensory perception of taste (GO:0050909),0.25861527838804854,0.5280219002368417,0.9536082474226805,1.0,1.0,10/10,74.15%,PKD2L1;ASIC2;TAS1R3;GNAT3;TAS1R2;TAS1R1;ASIC3;CD36;ASIC1;PKD1L3
prerank,mitotic sister chromatid segregation (GO:0000070),0.1787612447922648,0.526276080576001,0.9988901220865705,1.0,1.0,30/98,26.58%,PSRC1;CHMP4A;CHMP4B;TENT4A;NCAPD3;ZW10;VPS4B;CHMP1A;PINX1;VPS4A;SET;CHMP2A;NCAPH2;PDCD6IP;ZWINT;RB1;PHF13;NUDC;NCAPH;SMC4;KMT5A;CDC23;TUBG1;CHMP5;MIS12;NUP62;SEH1L;DCTN2;RRS1;CHMP1B
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.2564211991504846,0.5256411605376761,0.9389830508474576,1.0,1.0,5/10,26.14%,VPS9D1;ATP5PD;ATP5F1D;ATP5F1C;ATP5MC3
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.2396547716256474,0.5240532891434121,0.9399075500770416,1.0,1.0,3/13,17.56%,KPNA7;KPNA4;KPNA1
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.25447227753426804,0.5235868224208919,0.9627118644067797,1.0,1.0,2/10,17.34%,HP;HDAC6
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.16132521671615868,-0.5234786547941525,1.0,1.0,1.0,6/29,19.57%,TENT5A;EIF4ENIF1;AXIN2;TENT5D;FMR1;NOCT
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.1868911348584506,0.5220814899378918,0.9924812030075187,1.0,1.0,12/54,19.53%,NLRP2B;TNFRSF1A;PYDC1;CARD16;PTPN2;CHUK;IKBKG;RNF31;SPPL2B;OTULIN;SPPL2A;ADAM17
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.23444135118599113,0.5215022876385274,0.96875,1.0,1.0,3/15,17.04%,MAGEL2;WASHC1;ARPC2
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.22619385042083323,0.5214359592846852,0.97677793904209,1.0,1.0,7/19,26.15%,ELL;POLR3C;POLR3G;NAB2;POLR3F;ICE1;ZC3H8
prerank,regulation of double-strand break repair (GO:2000779),0.19884935622253572,0.520676866409004,0.9858611825192802,1.0,1.0,6/39,16.82%,SHLD2;FOXM1;PML;TWIST1;UBR5;KDM1A
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.23292941303842246,0.5199635630600243,0.9493670886075949,1.0,1.0,2/15,11.67%,PMAIP1;IRS2
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.18557344782293908,-0.5191813421131859,0.9776357827476039,1.0,1.0,3/18,17.40%,LYN;SPG21;SH2B2
prerank,regulation of microtubule nucleation (GO:0010968),0.24098402730924365,0.517191559280104,0.9688013136288999,1.0,1.0,2/10,17.29%,EML2;GIT1
prerank,cotranslational protein targeting to membrane (GO:0006613),0.17698885436706904,0.5167419306540055,0.9977116704805492,1.0,1.0,29/91,28.76%,SIL1;RPS4X;SSR1;RPL31;RPSA;RPL22;RPL28;RPS26;RPL10A;RPL14;RPS27A;RPL6;RPS28;ARL6IP1;RPL41;RPLP2;RPLP1;SRP14;RPL7;RPL21;RPL26;RPS27;RPS12;RPL18;RPS17;RPS3;RPL24;RPS6;SSR2
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.24342097915518235,0.5154533175715826,0.9524617996604414,1.0,1.0,1/11,8.98%,FOXP3
prerank,lipid droplet organization (GO:0034389),-0.17344892812610785,-0.5154451133938258,1.0,1.0,1.0,5/22,22.42%,CDS2;PNPLA3;PLA2G4C;RAB3GAP1;FITM2
prerank,protein localization to condensed chromosome (GO:1903083),-0.20146175405490668,-0.5152507406287764,0.9806629834254144,1.0,1.0,4/12,22.54%,IK;ZWILCH;BUB3;KNL1
prerank,DNA replication checkpoint signaling (GO:0000076),-0.18649803627587447,-0.5146014744520117,0.9741379310344828,1.0,1.0,8/16,37.56%,HUS1;TIPIN;ORC1;CDC45;DNA2;NAE1;RAD9B;TICRR
prerank,snRNA 3'-end processing (GO:0034472),-0.18458858689112898,-0.5141343977074567,0.9852507374631269,1.0,1.0,9/19,32.85%,EXOSC7;EXOSC2;INTS14;TOE1;USB1;INTS5;EXOSC9;EXOSC5;EXOSC8
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",-0.18098152266667225,-0.5136789447981011,0.9849397590361446,0.9992618318356804,1.0,7/17,31.03%,IK;BOD1;ZWILCH;BUB3;KNL1;SPDL1;CENPA
prerank,inositol phosphate catabolic process (GO:0071545),-0.19850637470069366,-0.5120625089082498,0.9775561097256857,0.9986499984016867,1.0,5/12,28.78%,SYNJ2;INPP1;PTEN;IMPA2;INPP5J
prerank,positive regulation of leukocyte migration (GO:0002687),-0.1609568007806028,-0.5094464726056537,0.9928825622775801,0.9982943463839749,1.0,7/27,25.78%,IL6R;NCKAP1L;ICAM1;EDN3;CSF1;JAM3;ADAM8
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.18825938072961368,0.5091799398170463,0.9899749373433584,1.0,1.0,17/45,29.91%,FOXO3;GCNT2;MEX3D;EIF2B4;APP;GEMIN5;ZC3H7A;EIF2A;PER1;TCOF1;ZC3H10;RBM3;LARP1;TRIM71;PUM2;METTL18;CYFIP1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.22569901797084574,0.5082042861068783,0.9603174603174603,1.0,1.0,3/15,18.74%,MUL1;PTPN2;YTHDF3
prerank,regulation of protein localization to cell periphery (GO:1904375),0.22102949678078454,0.505523610740111,0.9782923299565847,1.0,1.0,6/18,21.13%,ACTB;ABCA2;VTI1B;VPS4A;MISP;MMP14
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.21033779839306388,0.5036884287940385,0.9813486370157819,1.0,1.0,2/22,9.25%,ZDHHC12;GOLGA7
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.21033779839306388,0.5036884287940385,0.9813486370157819,1.0,1.0,2/22,9.25%,ZDHHC12;GOLGA7
prerank,modulation by symbiont of host process (GO:0044003),-0.2153141336464175,-0.5035865551823536,0.9707317073170731,0.9985188701215217,1.0,6/10,39.10%,B2M;MRC1;UBB;UBA52;TLR2;HGS
prerank,body fluid secretion (GO:0007589),0.22195171981742506,0.5017577388913546,0.9704968944099379,1.0,1.0,1/15,6.56%,ZBTB7B
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.20483340556897361,-0.5001123189694987,0.9775561097256857,0.996383618534134,1.0,1/11,2.87%,PANK2
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.20483340556897361,-0.5001123189694987,0.9775561097256857,0.996383618534134,1.0,1/11,2.87%,PANK2
prerank,coenzyme A biosynthetic process (GO:0015937),-0.20483340556897361,-0.5001123189694987,0.9775561097256857,0.996383618534134,1.0,1/11,2.87%,PANK2
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.20569356095352434,-0.4982731274467008,0.9822335025380711,0.9957473746236816,1.0,1/11,6.60%,UBQLN1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.17275241026509758,0.49806369084190844,0.9988276670574443,1.0,1.0,16/70,24.73%,PSMD11;PSMD4;PSMF1;PSMD7;FCER1G;PSMB5;CHUK;IKBKG;PSMD1;PSMC4;PSMD8;SNAP23;FCGR1A;PSMA7;IKBKB;TAPBP
prerank,maintenance of protein localization in organelle (GO:0072595),0.2119499694026452,0.4978035554949095,0.9782293178519593,1.0,1.0,5/19,23.61%,PML;HK1;ARL2BP;TAF8;TAPT1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.19750085246448926,0.4973908793353048,0.9861687413554634,1.0,1.0,4/27,14.46%,CMPK1;AK5;AK6;CTPS2
prerank,positive regulation of cilium assembly (GO:0045724),0.21535265401742185,0.4960650387258809,0.9723926380368099,1.0,1.0,6/18,23.96%,MARK4;SEPTIN9;CCDC88A;CROCC;TAPT1;CEP120
prerank,female gonad development (GO:0008585),0.21485675804561502,0.4960049362061009,0.9803921568627451,1.0,1.0,2/19,7.60%,EIF2B2;ANG
prerank,protein localization to chromosome (GO:0034502),0.19474601266454478,0.49494371243203383,0.994475138121547,1.0,1.0,9/34,20.96%,PARP3;ATRX;PINX1;MCM8;TNKS2;ATR;WAPL;RB1;TERF2
prerank,histone ubiquitination (GO:0016574),0.20678799298740902,0.4928138473529297,0.9809384164222874,1.0,1.0,6/21,23.48%,UBE2B;UBE2N;USP22;UBE2E1;CTR9;LEO1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.21333735083654637,0.4927171050843226,0.9770992366412213,1.0,1.0,3/18,16.56%,RNF5;RPS27A;UBC
prerank,mitotic spindle assembly (GO:0090307),0.18728432308332602,0.49222556687477664,0.98625,1.0,1.0,12/42,25.11%,KIF2A;AURKC;RHOA;ABRAXAS1;FLNA;CHEK2;AAAS;MISP;CEP192;SMC3;RACGAP1;KIFC2
prerank,autophagy of mitochondrion (GO:0000422),-0.14336917562724016,-0.49128470566393756,1.0,0.9961114708267101,1.0,38/38,85.70%,ATG5;FIS1;FUNDC2;MAP1LC3A;GABARAP;PHB2;AMBRA1;ATG14;ATG7;ULK2;USP30;BECN1;MARK2;GABARAPL1;FUNDC1;ATG9B;ATG9A;SQSTM1;SPATA18;PINK1;ATG2A;WDR45B;BNIP3;ATG13;PRKN;WIPI1;WDR45;ATG12;FBXO7;CISD2;ATG2B;WIPI2;ATG3;GABARAPL2;CTSK;RB1CC1;MAP1LC3B;ULK1
prerank,mitotic nuclear division (GO:0140014),0.1734069223199079,0.4907993226886639,0.9941656942823804,1.0,1.0,21/71,25.11%,NDEL1;KIF2A;PPP2R2D;CHMP4B;ZW10;RHOA;ABRAXAS1;CHMP2A;FLNA;CHEK2;AAAS;ZWINT;MISP;SMC4;CEP192;SMC3;KLHDC8B;TUBG1;MIS12;NUP62;KIFC2
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.23576674408386178,0.48916357632599056,0.9651162790697675,1.0,1.0,10/10,76.44%,NPLOC4;C1QBP;SEC14L1;RNF125;GPATCH3;TSPAN6;RIOK3;UFD1;DHX58;TKFC
prerank,histone exchange (GO:0043486),0.18738517914534197,0.48852941239957287,0.9906914893617021,1.0,1.0,7/37,17.91%,CENPS;CENPT;SRCAP;CENPH;CENPO;SPTY2D1;ZNHIT1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.2078451501192596,0.4871322825762546,0.984984984984985,1.0,1.0,4/21,18.46%,ABCD1;COA8;HDAC6;PARK7
prerank,male meiosis I (GO:0007141),0.21487773035496718,0.4869299742777777,0.9818181818181818,1.0,1.0,4/16,23.41%,MOV10L1;MYBL1;BRDT;FOXJ2
prerank,negative regulation of innate immune response (GO:0045824),0.18698194085212239,0.4860603507155094,0.9933333333333333,1.0,1.0,4/34,12.51%,MUL1;TRIM21;NMI;PTPN2
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.16679375181675296,0.4803024775414874,0.9976580796252927,1.0,1.0,15/67,24.73%,PSMD11;PSMD4;PSMF1;PSMD7;PSMB5;CHUK;IKBKG;PSMD1;PSMC4;PSMD8;SNAP23;FCGR1A;PSMA7;IKBKB;TAPBP
prerank,osteoclast differentiation (GO:0030316),0.19596589402548248,0.4801002448743067,0.984149855907781,1.0,1.0,3/22,14.16%,ANXA2;SBNO2;FOXP1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.21163313614031112,0.477641713432127,0.9673105497771174,1.0,1.0,6/15,28.70%,TRPT1;CLP1;TSEN2;FAM98B;CSTF2;RTCB
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.21105453972830956,0.4752158355424779,0.9843260188087775,1.0,1.0,2/16,8.48%,CHMP4A;CHMP4B
prerank,protein targeting to ER (GO:0045047),0.16060727372835593,0.4749219654994658,0.9988726042841037,1.0,1.0,26/99,26.52%,RPS4X;CHMP4A;CHMP4B;RPL31;RPSA;RPL22;SPCS3;RPL28;RPS26;RPL10A;RPL14;RPS27A;RPL6;RPS28;RPL41;RPLP2;RPLP1;SGTA;SRP14;RPL7;RPL21;RPL26;RPS27;RPS12;RPL18;RPS17
prerank,ribosomal small subunit biogenesis (GO:0042274),0.18028490157760133,0.4712764679872787,0.9946879150066401,1.0,1.0,7/39,21.33%,MRPS7;RPSA;PWP2;UTP4;METTL17;RPS28;DDX52
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.20140235172032994,0.4676160832572201,0.986822840409956,1.0,1.0,2/17,10.22%,TGFB2;ARL6IP5
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.21522242810740635,0.45801431286046834,0.9793650793650793,1.0,1.0,1/11,11.39%,PKD2L1
prerank,regulation of chromosome organization (GO:0033044),0.19281750667008954,0.4557272082212622,0.98989898989899,1.0,1.0,9/22,29.46%,MYC;WAPL;RB1;MAPT;TERF2;HDAC8;XRCC5;SETMAR;TERF2IP
prerank,piRNA metabolic process (GO:0034587),0.20097125123687787,0.4548863675236077,0.9852724594992637,1.0,1.0,2/19,14.05%,MOV10L1;MYBL1
prerank,oogenesis (GO:0048477),-0.16804177116473748,-0.4541688157736106,0.9856733524355301,0.9999867474294284,1.0,5/15,32.78%,MARF1;PIWIL2;NANOS3;TRIP13;MEI4
prerank,positive regulation of lipid transport (GO:0032370),-0.17986063155251428,-0.45269748571599233,0.9825,0.9991919073525286,1.0,12/12,82.03%,ABCA3;LRP1;ABCA12;CYP19A1;APOE;PRELID1;PRAP1;ADIPOQ;DBI;SPP1;ABCB4;TRIAP1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.2103406597705879,0.452120598537398,0.98,1.0,1.0,2/11,15.84%,GSTO1;GSTM2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.2103406597705879,0.452120598537398,0.98,1.0,1.0,2/11,15.84%,GSTO1;GSTM2
prerank,DNA biosynthetic process (GO:0071897),-0.16703237469508203,-0.4483239566521439,0.9972677595628415,0.9986381309144147,1.0,7/16,35.02%,WRNIP1;TYMS;RFC3;POLA1;POLD4;POLL;POLD3
prerank,coenzyme A metabolic process (GO:0015936),0.20100392262960087,0.44744817643190493,0.9906396255850234,1.0,1.0,4/14,25.06%,DCAKD;PPCDC;ACLY;PANK1
prerank,nucleocytoplasmic transport (GO:0006913),0.17157006817061124,0.4461524245725403,0.9974715549936789,1.0,1.0,13/40,27.55%,SNRPB;NXT2;GEMIN6;RITA1;AAAS;SNUPN;DDX20;GEMIN5;GEMIN8;GEMIN2;RBM15B;SNRPD2;SNRPD1
prerank,mitotic DNA replication (GO:1902969),0.21683545718196362,0.4418833675533805,0.9836956521739131,1.0,1.0,4/10,26.92%,MCM6;GINS3;MCM4;MCM2
prerank,cellular response to hydroxyurea (GO:0072711),0.2132424170509901,0.4396932744801216,0.9833887043189369,1.0,1.0,3/10,23.79%,ATRX;DDI2;RTF2
prerank,calcium-ion regulated exocytosis (GO:0017156),0.17929373672050328,0.4362795797763623,0.9958791208791209,1.0,1.0,9/27,24.39%,SYT6;VAMP7;SYT11;SYT12;SYT3;VAMP2;SYT2;ARL8B;SYT13
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.184855363296561,0.43479711035960567,0.9955223880597015,1.0,1.0,6/20,22.75%,ZW10;MAD1L1;TTK;ZWINT;CENPF;TPR
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.184855363296561,0.43479711035960567,0.9955223880597015,1.0,1.0,6/20,22.75%,ZW10;MAD1L1;TTK;ZWINT;CENPF;TPR
prerank,spindle assembly checkpoint signaling (GO:0071173),0.184855363296561,0.43479711035960567,0.9955223880597015,1.0,1.0,6/20,22.75%,ZW10;MAD1L1;TTK;ZWINT;CENPF;TPR
prerank,mitochondrion disassembly (GO:0061726),0.16310536071149864,0.4347534449176163,0.9986431478968792,1.0,1.0,14/34,30.17%,ULK1;MAP1LC3B;RB1CC1;CTSK;GABARAPL2;ATG3;WIPI2;ATG2B;CISD2;FBXO7;ATG12;WDR45;WIPI1;PRKN
prerank,2-oxoglutarate metabolic process (GO:0006103),0.20299626998224635,0.43323706739553897,0.9862385321100917,1.0,1.0,5/13,26.17%,OGDH;DLST;IDH1;GPT2;IDH2
prerank,positive regulation of mRNA processing (GO:0050685),0.18216080402010057,0.43020629285577683,0.9925149700598802,1.0,1.0,21/21,81.81%,DAZAP1;LEO1;CELF4;RBM3;RBMXL1;TRA2B;NCL;CDC73;NUP98;RBMX;PRDX6;SNW1;TRA2A;CIRBP;THRAP3;CELF3;NCBP2;DHX36;SF3B4;NCBP1;PAF1
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.17991826339379516,0.4298916015508713,0.9957264957264957,1.0,1.0,8/23,28.44%,TECPR2;NPLOC4;PREB;SEC16A;TMEM129;HSP90B1;LMAN1;DERL2
prerank,defense response to fungus (GO:0050832),0.1890856568701334,0.4292844613078038,0.9895366218236173,1.0,1.0,17/17,81.11%,GAPDH;RNASE7;FAM3A;BCL10;DEFB119;NLRP10;CLEC4E;LTF;CLEC6A;S100A8;CLEC4D;CARD9;S100A9;HRG;PLCG2;CX3CR1;RARRES2
prerank,establishment of skin barrier (GO:0061436),0.1926452621958259,0.42880119389877497,0.9922839506172839,1.0,1.0,1/15,7.33%,LSR
prerank,regulation of water loss via skin (GO:0033561),0.1926452621958259,0.42880119389877497,0.9922839506172839,1.0,1.0,1/15,7.33%,LSR
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.20175126474450378,0.42485987091974053,0.9902597402597403,1.0,1.0,4/12,25.46%,MAD1L1;RMDN1;MIS12;SEH1L
prerank,positive regulation of DNA recombination (GO:0045911),0.1696486458428481,0.4226875749654948,0.9985935302390999,1.0,1.0,2/27,9.55%,SHLD2;RIF1
prerank,regulation of dopamine secretion (GO:0014059),0.1746171375568443,0.4172997894968791,0.9986033519553073,1.0,1.0,8/25,26.10%,GDNF;SYT6;SYT11;SYT12;SYT3;SYT2;SYT13;SNCA
prerank,regulation of chromosome segregation (GO:0051983),0.1862480376766089,0.4165856806186681,0.9954682779456193,1.0,1.0,16/16,81.39%,SMC6;NUMA1;IHO1;CDC6;PUM2;PUM1;MKI67;HORMAD1;AURKB;KIF2C;BUB1;CSNK2A2;CSNK2A1;RMI2;RAD18;SMC5
prerank,cellular response to oxygen levels (GO:0071453),0.19688042766219788,0.4153014574531607,0.993431855500821,1.0,1.0,6/10,33.22%,ATP6V0D1;ATP6AP1;TMEM199;ATP6V0A2;CPEB4;NDUFS2
prerank,T cell activation involved in immune response (GO:0002286),0.19778392389843003,0.4151478405093868,0.9968354430379747,1.0,1.0,2/12,17.03%,FCER1G;EIF2AK4
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.18132042906913362,0.4143553952435065,0.9936808846761453,1.0,1.0,5/16,26.65%,GSK3A;NECAB2;GPER1;PRKCA;CHGA
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.16977475643304768,-0.4133233944706816,0.9900990099009901,0.9997409523804273,1.0,2/11,17.33%,TASOR;SETDB2
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.1418962772115296,0.4133063683477168,1.0,0.9999511002587763,1.0,23/87,27.18%,RPS4X;RPL31;RPSA;RPL22;RPL28;RPS26;RPL10A;RPL14;RPS27A;RPL6;RPS28;RPL41;RPLP2;RPLP1;SRP14;RPL7;RPL21;RPL26;RPS27;RPS12;RPL18;RPS17;RPS3
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.17746702063256742,0.41005008812163324,0.9939577039274925,0.9998496435060729,1.0,8/18,33.20%,AQP1;PCK2;ZFP36L1;UBE2L3;FAM107A;REST;HNRNPU;ANXA1
prerank,regulation of catecholamine secretion (GO:0050433),0.16780322525114325,0.40871622738068547,0.9958391123439667,0.9995745686171874,1.0,10/29,26.65%,KCNB1;GRK2;SYT6;SYT11;SYT12;SYT3;SYT2;SYT13;SNCA;CHGA
prerank,regulation of T cell mediated immunity (GO:0002709),0.19889507598360434,0.40321662358342225,0.9916805324459235,0.9996169700329474,1.0,2/10,20.33%,TRPM4;AGER
prerank,meiosis I (GO:0007127),-0.13249112060230706,-0.4018709800683703,1.0,0.9991952871154839,1.0,11/23,40.39%,ING2;BCL2L11;ZSCAN21;HSF2BP;SYCP3;SGO1;TDRD9;DDX4;MEIOB;ZCWPW1;SLC25A31
prerank,regulation of centriole replication (GO:0046599),0.17541146403884644,0.39562949905343503,0.9970059880239521,0.9996915361811817,1.0,5/18,25.05%,CEP76;PLK2;TRIM37;PLK4;NUP62
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.17261082506592992,0.3864321727927366,0.9984399375975039,0.9994407508668817,1.0,15/15,82.76%,CPEB3;PABPC1;ZFP36L1;CNOT1;TOB1;TNRC6C;NANOS1;ZFP36L2;NANOS2;TNRC6B;AGO2;NANOS3;DHX36;ZFP36;CNOT7
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.17261082506592992,0.3864321727927366,0.9984399375975039,0.9994407508668817,1.0,15/15,82.76%,CPEB3;PABPC1;ZFP36L1;CNOT1;TOB1;TNRC6C;NANOS1;ZFP36L2;NANOS2;TNRC6B;AGO2;NANOS3;DHX36;ZFP36;CNOT7
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.16938539184497892,0.381605083250081,0.995475113122172,0.9992975698796943,1.0,6/17,28.44%,NPLOC4;HM13;RHBDD1;TMEM129;HSP90B1;DERL2
prerank,B cell mediated immunity (GO:0019724),0.17942250115803798,0.3740114030704611,0.9983471074380166,0.9992368989118763,1.0,1/10,11.64%,FCER1G
prerank,regulation of RNA export from nucleus (GO:0046831),0.1641512367868016,0.34371317779006233,1.0,0.9996272912905104,1.0,3/11,23.05%,DHX9;TPR;NRDE2
